<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: "…"
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>TW321644B -  - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/TW321644B/en">
    
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="">
    <meta name="DC.date" content="1995-11-18" scheme="dateSubmitted">
    <meta name="DC.description" content="">
    <meta name="citation_patent_application_number" content="TW:084112259A">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/f2/fc/cc/97eea82ed8e1e7/TW321644B.pdf">
    <meta name="citation_patent_number" content="TW:321644:B">
    <meta name="DC.date" content="1997-12-01" scheme="issue">
    <meta name="DC.contributor" content="Fiandor Roman Jose" scheme="inventor">
    <meta name="DC.contributor" content="Gargallo Viola Domingo" scheme="inventor">
    <meta name="DC.contributor" content="Glaxo Wellcome Sa" scheme="assignee">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result" hidden="">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"></section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D"><a id="link" href="#" class="style-scope state-modifier">C07D</a></state-modifier>
                  <span class="description style-scope classification-tree">HETEROCYCLIC COMPOUNDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D493/00"><a id="link" href="#" class="style-scope state-modifier">C07D493/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D493/02"><a id="link" href="#" class="style-scope state-modifier">C07D493/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="C07D493/04"><a id="link" href="#" class="style-scope state-modifier">C07D493/04</a></state-modifier>
                  <span class="description style-scope classification-tree">Ortho-condensed systems</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/00"><a id="link" href="#" class="style-scope state-modifier">A61P31/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/04"><a id="link" href="#" class="style-scope state-modifier">A61P31/04</a></state-modifier>
                  <span class="description style-scope classification-tree">Antibacterial agents</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/00"><a id="link" href="#" class="style-scope state-modifier">A61P31/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/10"><a id="link" href="#" class="style-scope state-modifier">A61P31/10</a></state-modifier>
                  <span class="description style-scope classification-tree">Antimycotics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D"><a id="link" href="#" class="style-scope state-modifier">C07D</a></state-modifier>
                  <span class="description style-scope classification-tree">HETEROCYCLIC COMPOUNDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D311/00"><a id="link" href="#" class="style-scope state-modifier">C07D311/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D311/02"><a id="link" href="#" class="style-scope state-modifier">C07D311/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H"><a id="link" href="#" class="style-scope state-modifier">C07H</a></state-modifier>
                  <span class="description style-scope classification-tree">SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H15/00"><a id="link" href="#" class="style-scope state-modifier">C07H15/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H15/20"><a id="link" href="#" class="style-scope state-modifier">C07H15/20</a></state-modifier>
                  <span class="description style-scope classification-tree">Carbocyclic rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H15/24"><a id="link" href="#" class="style-scope state-modifier">C07H15/24</a></state-modifier>
                  <span class="description style-scope classification-tree">Condensed ring systems having three or more rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P"><a id="link" href="#" class="style-scope state-modifier">C12P</a></state-modifier>
                  <span class="description style-scope classification-tree">FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P17/00"><a id="link" href="#" class="style-scope state-modifier">C12P17/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P17/02"><a id="link" href="#" class="style-scope state-modifier">C12P17/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Oxygen as only ring hetero atoms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P17/06"><a id="link" href="#" class="style-scope state-modifier">C12P17/06</a></state-modifier>
                  <span class="description style-scope classification-tree">Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P"><a id="link" href="#" class="style-scope state-modifier">C12P</a></state-modifier>
                  <span class="description style-scope classification-tree">FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P19/00"><a id="link" href="#" class="style-scope state-modifier">C12P19/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of compounds containing saccharide radicals</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P19/44"><a id="link" href="#" class="style-scope state-modifier">C12P19/44</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of O-glycosides, e.g. glucosides</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 6 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Chemical &amp; Material Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Chemical &amp; Material Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Organic Chemistry"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Organic Chemistry
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">TW321644B</h2>
                  <p class="tagline style-scope patent-result">Taiwan</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Granted Patent or patent of addition</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/f2/fc/cc/97eea82ed8e1e7/TW321644B.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;methyl&quot;,&quot;formula&quot;,&quot;compound&quot;,&quot;group&quot;,&quot;printed&quot;]" data-before="19941108"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/TW321644B"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  
                    <dt class="style-scope patent-result">Other languages</dt>
                    <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/TW321644B/zh"><a id="link" href="#" class="style-scope state-modifier">Chinese</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Fiandor Roman Jose"><a id="link" href="#" class="style-scope state-modifier">Fiandor Roman Jose</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Gargallo Viola Domingo"><a id="link" href="#" class="style-scope state-modifier">Gargallo Viola Domingo</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">1995</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/DK0753001T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">DK</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: DK95938406T</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/DE69512041T2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">DE</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: DE69512041T</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/MX9602563A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">MX</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: MX9602563A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AP614A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">AP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: APAP/P/1996/000824A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/ZA959362B/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">ZA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: ZA959362A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CN1056849C/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">CN</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CN95192028A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/NZ296091A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">NZ</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: NZ296091A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO1996014326A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">WO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PCT/EP1995/004331</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Application Discontinuation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/SK88496A3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">SK</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: SK884-96A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/SI0753001T1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">SI</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: SI9530311T</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EE9600117A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">EE</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EE9600117A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/PE49696A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">PE</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PE1995283875A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Application Discontinuation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/RU2152398C1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">RU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: RU96115273/04A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/KR100391401B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">KR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: KR1019960703661A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US5854280A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US08/669,441</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/ATE184284T1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">AT</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AT95938406T</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/ES2137549T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">ES</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: ES95938406T</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CA2179403A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">CA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CA002179403A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Abandoned</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/HU218611B/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">HU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: HU9701865A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP0753001B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP95938406A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JPH09508144A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">JP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: JP8515051A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Ceased</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/BR9506473A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">BR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: BR9506473A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AU704405B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">AU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AU39809/95A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Ceased</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CZ202796A3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">CZ</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CZ962027A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AR013815A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">AR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: ARP950100073A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-07</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CO4520226A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">CO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CO95052481A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-07</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/IL115905A0/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">IL</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: IL11590595A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-07</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/TW321644B/zh"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline" this="">TW</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: TW084112259A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-18</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">1996</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/IS4352A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">IS</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: IS4352A</div>
                <div class="style-scope application-timeline">Filing date: 1996-06-10</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/OA10303A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">OA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: OA60855A</div>
                <div class="style-scope application-timeline">Filing date: 1996-07-03</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/FI962773A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">FI</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: FI962773A</div>
                <div class="style-scope application-timeline">Filing date: 1996-07-05</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/BG62620B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">BG</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: BG100699A</div>
                <div class="style-scope application-timeline">Filing date: 1996-07-05</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/NO307092B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">NO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: NO962856A</div>
                <div class="style-scope application-timeline">Filing date: 1996-07-05</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">1998</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/HK1004222A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">HK</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: HK98103335A</div>
                <div class="style-scope application-timeline">Filing date: 1998-04-21</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US5952334A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US09/081,090</div>
                <div class="style-scope application-timeline">Filing date: 1998-05-19</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">1999</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/GR3031677T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">GR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: GR990402767T</div>
                <div class="style-scope application-timeline">Filing date: 1999-10-27</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application TW084112259A events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline"><div date="" class="external-priority style-scope application-timeline">1994-11-08</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP0712859A1/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Priority claimed from EP94500173A</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline"><div date="" class="external-priority style-scope application-timeline">1994-11-08</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP0711784A1/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Priority claimed from EP94500175A</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">1995-11-18</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="Glaxo Wellcome Sa"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by Glaxo Wellcome Sa</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="granted style-scope application-timeline">1997-12-01</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Application granted</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">1997-12-01</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/TW321644B/zh"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of TW321644B</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (4)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (25)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=TW&amp;NR=321644B&amp;KC=B&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/publication/TW/321644/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/TW321644B">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result">translated from Chinese</div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><description mxw-id="PDES113585559" lang="EN" load-source="google" class="style-scope patent-text">
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">^^164 4 A7 B7 五、發明説明（1 本發明係關於具有抗眞菌活性的新穎索達林（s〇rdarjn )衍 生物，也關於其製備，含此等化合物的臀藥組合物，以及 其醫學上的用途，更特定地説，是其在預防或治療哺乳動 物’包括人，的由眞菌感染所引起的疾病的用途。 英國專利1，162,027號説明藉培養蛛網糞殼菌眞菌的nrrl 3196菌株製備成抗生素81^226‘6。8!^2266(後稱索達林）據報 告有抑制眞菌活性。同一研究組還於Helvetica Chimica Acta (INI)，g_，説明索達林降解成索達里新 (sordaricin)。已公佈的日本專利申請案J6 2040292A説明 佐菲馬林（zofimarin)抗生素的製備，據報告佐菲馬林也具 有抗眞菌活性。 索達林、索達里新及佐菲馬林可以下式（A)代表 (請先閲讀背面之注意事項再填寫本頁)</span>^^ 164 4 A7 B7 5. Description of the invention (1 The present invention relates to a novel sodarin (s〇rdarjn) derivative with antimycobacterial activity, as well as its preparation, buttock composition containing these compounds, and Its medical use, more specifically, its use in the prevention or treatment of diseases caused by Candida infections in mammals, including humans. British Patent No. 1,162,027 describes the cultivation of Mycobacterium faecalis The nrrl 3196 strain was prepared as an antibiotic 81 ^ 226'6. 8! ^ 2266 (hereinafter called sodarin) was reported to have inhibitory activity against the mycobacterium. The same research group also explained sodarin in Helvetica Chimica Acta (INI), g It is degraded into sordaricin. Published Japanese patent application J6 2040292A shows the preparation of zofimarin antibiotics. It is reported that zofimarin also has antimycobacterial activity. Sodarin, Sodarin Lixin and Zofimarin can be represented by the following formula (A) (please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T 經 中 央 揉 準 貝</span>、 1T kneads the accurate shellfish by the center</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(I) 其中OR爲 OH HCL 人、OCH, 時即是索達林 合 作 社 印 % OR爲OH時即是索達里新；而 4- 本紙張^渡適用中國國家橾準（CNS ) A4规格（210X297公釐） ^1644 A7 B7 五、發明説明（2 ) OR爲 。 9C〇CH=zCH-CH=eCHCH3 -y〇CH3 Ο 丄 ch3 時即是佐菲馬林。 雖則索達林及佐菲馬林展現抗眞菌活性，但此二種化合 物只有中等活性，以各種眞菌作試驗時顯示其作用範圍有 一定限度。發明人等於後面一組新穎殺眞菌索達林衍生物 ，此等衍生物具有極佳抗眞菌活性，且作用範圍更廣。是 以，根據本發明第一方面，發明人等提供式（J)化合物 H0 0 CH.</span>(I) Where OR is OH HCL and OCH, then it is printed by Sodarin Cooperative.% OR is OH, it is Sodarin new; and 4-this paper is suitable for China National Standard (CNS) A4 specification 210X297mm) ^ 1644 A7 B7 V. Description of the invention (2) OR is. 9C〇CH = zCH-CH = eCHCH3 -y〇CH3 〇 丄 ch3 is Zofimaline. Although sodarin and zofimaline exhibited antimycobacterial activity, these two compounds had only moderate activity, and the tests of various mycobacteria showed a limited range of action. The inventors are equal to the latter group of novel candidiasis sodarin derivatives. These derivatives have excellent anti-candidiasis activity and a wider range of action. Yes, according to the first aspect of the present invention, the inventors provided the compound of formula (J) H0 0 CH.</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(I) 經濟部中央梂準局貝工消费合作社印製 其中z是選自下式的四氫喊喃基 本紙張从 tug 緖 (21()&amp;gt;&amp;lt;297公着）~ - (請先閲讀背面之注意事項再填寫本頁)</span>(I) Printed by Beigong Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economic Affairs where z is a basic paper of tetrahydropyridine selected from the following formula from tug thread (21 () &amp;gt; &amp;lt; 297 public) ~-(please read first (Notes on the back then fill this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、發明説明（ R2 R3</span>3. Description of the invention (R2 R3</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標準局員工消费合作社印製 ⑻</span>Printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs ⑻</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">及其醫藥上可接受的鹽及溶劑化物（如水合物）或代謝上不 安定的衍生物， 其中R1代表氫，南素，錄，Ci4虎氧基或酿氧基，尺2及 R可獨立代表氫’ Cu烷基或C14烷氧基烷基，或 R及R3共同與其相聯的碳原子代表c = 〇, c = s或C環 烷基； - 3'8 尺代表氫或CH2R7(此處R7是氫，經基，c MW基图，其中w基或芳基）； R及R可獨互代表氫，Cu烷基或（^._4烷氧基Ci 4烷基 ，或R5及R6共同與其相聯的碳原子代表C = Q，c = 8環烷基； β 3* η代表零或1 ; -6- 表紙張尺度逍用中國國家揉準（CNS ) Α4规格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁}</span>And its pharmaceutically acceptable salts and solvates (such as hydrates) or metabolic instability derivatives, where R1 represents hydrogen, Nansu, Lu, Ci4 tiger or oxo, ruler 2 and R can be independent Represents hydrogen 'Cu alkyl or C14 alkoxyalkyl, or the carbon atom to which R and R3 are linked together represents c = 〇, c = s or C cycloalkyl;-3'8 ruler represents hydrogen or CH2R7 (this Where R7 is hydrogen, radical, c MW group diagram, where w group or aryl group; R and R can independently represent hydrogen, Cu alkyl or (^ ._ 4 alkoxy Ci 4 alkyl, or R5 and R6 The carbon atoms that are commonly associated with it represent C = Q, c = 8 cycloalkyl; β 3 * η represents zero or 1; -6--sheet scales are used in China National Standard (CNS) Α4 specifications (210X297 mm) (Please read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 — B7__ 五、發明説明（4)—'' — ' --- X及Y可獨立代表氧，硫或CR9R10(此處R9及Rl〇可獨立代 表氫，Cl-6烷基，C〗.4烷氧基或。·4烷氧基C】_4烷基，或 R9及Rl〇共同與其相聯的碳原子代表C = 0，C = S，或c3 環烷基或C = CHRll，此處R11代表氫或^“烷基）；或在χ 或Y爲氧且η爲零時，-y_CR2r3或-X_Cr2r3_可分別代表 -N = CR3_ 或 _NR12_CR2R3_(此處 CR2&amp;amp; 尺3是 c = 〇，而 R12是C!_4烷基，C〇R13醯基，此處Rl3!Ci 6烷基）或在 Y是氧且η是零時，χ可代表CH基，此基以雙鍵聯於哌喃環 上； R15代表氫，南素，疊氮基，C16烷基，羥基，C16烷氧 基（視需要由1或2個羥基或其縮酮或1或2個C1-3烷氧基 取代），芳基Ci_4烷氧基，c36烯基氧基，OCORW基图（ 此處R18是芳基(^_4烷氧基或視需要含一或二個雙鍵的Ci 1 - 10燒基）或C1_6烷氧羰基Cu烷氧基，而R16代表氫或R&amp;quot; 及R16共同與其相聯的碳原子代表c = 〇或c = CH2 ; R17代表CH2Ri9，此處Ri9是氫，羥基，Cii4烷氧基或 OCOR20基團，其中r2(^Ci4烷基）；而 w代表氧或硫原子或ch2* ; 經濟部中央揉準局貝工消費合作社印裝 {請先閲讀背面之注意事項再填寫本頁} 又基團（a)之虚線表示有時有另外的键； 式（I)化合物的合適的醫藥上可接受的鹽包括無機絵鹽，如 發金屬鹽（例如鈉及鉀鹽）及銨鹽與有機鹼鹽。合適的有機 驗鹽包括胺鹽’如三烷基胺（如三乙基胺），二烷基胺（如二 環己基胺）’視需要取代的芊基胺（如苯基芊基胺或p_溴苄 基胺），普魯卡因，乙醇胺，二乙醇胺，N-甲基葡糖胺及三 本紙張尺度逍用中國國家橾準（CNS ) A4规格（210X297公釐） A7 ^^1644 ______ Β7 五、發明説明（5 ) (經甲基）甲基胺鹽，以及胺基酸鹽（如賴胺酸鹽及精胺酸鹽） 0 以後所指式（I)化合物包括此化合物及其醫藥上可接受的 鹽。 其他醫藥上不能接受的鹽可用於製備式（I)化合物，而這 又是本發明的另一方面。 代謝上不安定的式（I)化合物是在體内轉化成式（I)化合物 的化合物。此等衍生物的例包括傳統上由分子内的游離態 叛酸所形成的代謝上不安定的酯。 要了解到’本發明包括由式（〗）代表的化合物的任何個別 的異構物’包括光學異構物及其混合物，包括全部或部分 外消旋混合物。 此處所謂&amp;quot;烷基”，無論是烷基本身或C14烷氧基中的烷 基部分可以是直鏈或支鍵的。合適的例包括甲基，乙基， 正丙基，異丙基，正丁基，二級丁基，三級丁基，正己基 ，及正辛基。 此處所謂”芳基”，無論是芳基本身或基團的一部分，意 爲苯基或雜芳基，各視需要由一個或多個（如1，2或3個）選 自鹵素、羥基、Cu烷基、c】_6烷氧基4Ci_4烷氧基羰基 的原子或基困所取代。此雜芳基可以是含一個或多個選自 氮、氧及硫的雜原子的5 -或6 -員的雜芳環。合適的雜芳基 的例包括吡啶基，呋喃基，嘧吩基及咐洛基。 &amp;quot;鹵素” 一詞意爲氟，氣，漠或蛾。 在R 1爲酿乳基時’可代表’例如，〇 C 〇 r 1 3基圏，其中 8 - 本紙張纽速用中關家標率（CNS )以胁（2IGX297公釐)~~~ ---'~~ (請先閲讀背面之注意事項再填寫本頁) 乂</span>A7 — B7__ V. Description of the invention (4) — '' — '--- X and Y can independently represent oxygen, sulfur or CR9R10 (here R9 and Rl〇 can independently represent hydrogen, Cl-6 alkyl, C〗. 4 alkoxy or .4 alkoxy C] _4 alkyl, or R9 and Rl〇 together with the carbon atom to which it represents C = 0, C = S, or c3 cycloalkyl or C = CHRll, here R11 represents hydrogen or ^ "alkyl); or when χ or Y is oxygen and η is zero, -y_CR2r3 or -X_Cr2r3_ may represent -N = CR3_ or _NR12_CR2R3_ (here CR2 &amp; rule 3 is c = 〇 , And R12 is C! _4 alkyl, C〇R13 acetyl, here Rl3! Ci 6 alkyl) or when Y is oxygen and η is zero, χ can represent a CH group, this group is linked to the piper with a double bond On the furan ring; R15 represents hydrogen, Nansu, azido, C16 alkyl, hydroxy, C16 alkoxy (optionally substituted by 1 or 2 hydroxy or its ketal or 1 or 2 C1-3 alkoxy ), Aryl Ci_4 alkoxy, c36 alkenyloxy, OCORW group diagram (where R18 is an aryl group (^ _4 alkoxy or Ci 1-10 burning group containing one or two double bonds as needed) or C1_6 alkoxycarbonyl group Cu alkoxy group, and R16 represents hydrogen or R &amp;quot; and R16 together with the carbon atom associated with it represents c = Or c = CH2; R17 represents CH2Ri9, where Ri9 is hydrogen, hydroxy, Cii4 alkoxy or OCOR20 group, where r2 (^ Ci4 alkyl); and w represents an oxygen or sulfur atom or ch2 *; Printed by the Pui Pui Consumer Cooperative {please read the precautions on the back before filling in this page} and the dotted line of group (a) indicates that sometimes there is another bond; the compound of formula (I) is suitably pharmaceutically acceptable Salts include inorganic salts, such as hair metal salts (such as sodium and potassium salts) and ammonium salts and organic alkali salts. Suitable organic salts include amine salts such as trialkylamines (such as triethylamine), dioxane Amines (such as dicyclohexylamine) 'optionally substituted fluorenylamines (such as phenylfluorenylamine or p-bromobenzylamine), procaine, ethanolamine, diethanolamine, N-methylglucamine And three paper standards for the Chinese National Standard (CNS) A4 specifications (210X297mm) A7 ^^ 1644 ______ Β7 5. Description of the invention (5) (methyl) methylamine salt, and amino acid salt ( (Such as lysine salt and spermine salt) 0 The compound of formula (I) referred to hereinafter includes this compound and its pharmaceutically acceptable salts. Pharmaceutically unacceptable salts can be used to prepare compounds of formula (I), which is another aspect of the present invention. Metabolically unstable compounds of formula (I) are compounds that are converted into compounds of formula (I) in vivo. Examples of such derivatives include metabolically unstable esters traditionally formed from free trait acids in the molecule. It is understood that 'this invention includes any individual isomers of the compound represented by formula (〗)' includes optical isomers and mixtures thereof, including all or part of racemic mixtures. The "alkyl" here refers to either the alkyl group itself or the alkyl portion of the C14 alkoxy group may be linear or branched. Suitable examples include methyl, ethyl, n-propyl, isopropyl , N-butyl, secondary butyl, tertiary butyl, n-hexyl, and n-octyl. The so-called "aryl" here, whether it is an aromatic body or part of a group, means phenyl or heteroaryl , Each optionally substituted by one or more (eg 1, 2 or 3) atoms or radicals selected from halogen, hydroxy, Cu alkyl, c] _6alkoxy 4Ci_4 alkoxycarbonyl. This heteroaryl The group may be a 5- or 6-membered heteroaryl ring containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur. Examples of suitable heteroaryl groups include pyridyl, furyl, pyrenyl, and halo The term "halogen" means fluorine, gas, moth or moth. When R 1 is a brewed milk base 'representable' For example, 〇C 〇r 1 3 base ring, of which 8-the speed of the paper with the Zhongguanjia standard rate (CNS) to threaten (2IGX297 mm) ~~~ --- '~~ (Please read the precautions on the back before filling out this page) 乂</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T 經濟部中央梂準局員工消费合作社印製 / 32j^644 at ___B7 五、發明説明（6 ) R13之定義如前述。 C3_8環烷基的例包括環戊基及環己基。 X基困的例包括氧，CR9R10，其中R9及R10各是氫， &amp;lt;^_4烷氧基或Ci_4烷基，或CR9 R10 /代表c = 0或 C^CHR11基團，例如c = CH2，或X代表NHR11。 Y基图的合適的例包括氧或CR9R10，其中R9是氫，Ch4 烷氧基SCu烷基，而Ri〇是氫或Cu烷基。 在R18爲不飽和的Cii〇烷.基時，可特別代表直鏈或支鏈 的含有二個雙鍵的c5 8烷基，例如_CH=zch- ch=echch3。 在R15爲以羥基或烷氧基取代的（：16烷氧基時，可爲， 例如’ 2,3-二羥基丙氧基及由其衍生的丙酮縮酮，或2,3_ 二甲氧基-丙氧基。 R16較佳是氫原子，有Ri5以構形存在。 R1可代表，例如，氫原子或羥基。 R2可代表，例如，氫或Ci_4烷基（例如甲基），而R3可代 表例如’氣’ c^_4燒基（例如甲基，乙基或正丙基）或 4燒氧基Ci_4烷基（例如曱氧基乙基），或cr2r3可代表 c=〇 ’ c = s或c3_8環燒基（例如環戊基）。 R4可代表’例如，甲基或Ci_4烷氧基甲基（例如甲氧基甲 基）。 R5及R6可獨立代表，例如，氫或4烷基（例如甲基）。 本紙張从遑用中國國^^7^1210)&amp;lt;29二） ---------f -乂------、Tr------( (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局貝工消费合作社印製 321644 A7 B7 五、發明説明（7)</span>1. Printed by the Employee Consumer Cooperative of the Central Bureau of Economics of the 1T Ministry of Economic Affairs / 32j ^ 644 at ___B7 5. Description of Invention (6) The definition of R13 is as described above. Examples of C3_8 cycloalkyl include cyclopentyl and cyclohexyl. Examples of X-based sleepy groups include oxygen, CR9R10, wherein R9 and R10 are each hydrogen, &amp;lt; ^ _ 4 alkoxy or Ci_4 alkyl, or CR9 R10 / represents c = 0 or C ^ CHR11 group, for example, c = CH2, Or X stands for NHR11. Suitable examples of the Y base diagram include oxygen or CR9R10, where R9 is hydrogen, Ch4 alkoxy SCu alkyl, and Ri〇 is hydrogen or Cu alkyl. When R18 is an unsaturated Cioalkane group, it may particularly represent a linear or branched C5 8 alkyl group containing two double bonds, for example, _CH = zch-ch = echch3. When R15 is substituted with hydroxy or alkoxy (16 alkoxy, it can be, for example, '2,3-dihydroxypropoxy and acetone ketal derived from it, or 2,3_ dimethoxy -Propoxy. R16 is preferably a hydrogen atom, and Ri5 exists in a configuration. R1 may represent, for example, a hydrogen atom or a hydroxyl group. R2 may represent, for example, hydrogen or a Ci_4 alkyl group (for example, methyl), and R3 may Represents, for example, "gas" c ^ _4 alkyl (such as methyl, ethyl or n-propyl) or 4 alkyloxy Ci_4 alkyl (such as methoxyethyl), or cr2r3 may represent c = 〇 'c = s Or c3_8 cycloalkyl (eg cyclopentyl). R4 can represent 'for example, methyl or Ci_4 alkoxymethyl (eg methoxymethyl). R5 and R6 can independently represent, for example, hydrogen or 4 alkyl (For example, methyl). This paper is from China ^^ 7 ^ 1210) &amp;lt; 29 II) --------- f-乂 ------, Tr ------ ((Please read the precautions on the back before filling in this page) Printed 321644 A7 B7 by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of the invention (7)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">R 以</span>R to</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">S6 R R (CR5R6)n X γ 代表的環系統包括0\ P R2 R3 5 V R 0 入f Re Ο R2 R3</span>The ring system represented by S6 R R (CR5R6) n X γ includes 0 \ P R2 R3 5 V R 0 into f Re Ο R2 R3</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">R2 R2 R3</span>R2 R2 R3</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、〇 及</span>, 〇 and</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">R2 R3 R11N乂 O 經濟部中央標準局員工消费合作社印策 特定的R1 5基的例包括鹵素（例如氟），疊氮基經基，C丨_ 4 烷氧基，苄氧基，苄氧基羰基氧基，Ci-4烷氧羰基氧基， 及C1-4烷氧基Ci_4烷氧基（例如甲·氧基乙氧基），C1-4烷氧 基羰基-Cid烷氧基，（^_4烷基羰基氧基，2,3-二羥基丙 氧基，及其丙酮縮酮，2,3-二甲氧基丙氧基，C3_6烯氧基 如烯丙氧基或3-甲基烯丙氧基或R15及R16與其相聯的碳原 子代表c = o或c = ch2。 R17可代表，例如，甲基或匸丨-々烷氧基甲基（例如甲氧基 甲基）或羥基甲基。 R15較佳代表Cy烷氧基，c3_4烯氧基，芊氧基或 〇C〇R4(此處R4是Ci_4烷基），特別是位於構形的。 R17較佳代表甲基。 w較佳代表氧。· . 本發明特定組的化合物是式（1)化合物之Ζ爲如下基困者 -10 - 本紙張尺度適用中國國家棣準（CNS ) Α4規格（210χ297公釐） (請先閲讀背面之注意事項再填寫本頁)</span>R2 R3 R11NQO O Examples of specific R1 5 radicals printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs include halogens (such as fluorine), azide bases, C alkoxy, benzyloxy, benzyloxy Carbonyloxy, Ci-4 alkoxycarbonyloxy, and C1-4 alkoxy Ci_4 alkoxy (for example, methyl oxyethoxy), C1-4 alkoxycarbonyl-Cid alkoxy, (^ _4 alkylcarbonyloxy, 2,3-dihydroxypropoxy, and its acetone ketal, 2,3-dimethoxypropoxy, C3_6 alkenyloxy such as allyloxy or 3-methylene Propoxy or R15 and R16 and the carbon atom to which they are associated represent c = o or c = ch2. R17 can represent, for example, methyl or alkoxymethyl (eg methoxymethyl) or hydroxyl R15 preferably represents Cy alkoxy, c3_4 alkenyloxy, fluorenyloxy or 〇C〇R4 (here R4 is Ci_4 alkyl), especially in the configuration. R17 preferably represents methyl. W It is better to represent oxygen. · The compound of the specific group of the present invention is the compound of formula (1). Z is as follows: -10-This paper scale is applicable to China National Standards (CNS) Α4 specification (210 × 297 mm) (please first Note on the back Item and then fill in this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">S21644 五、發明説明（8 ) A7 B7</span>S21644 V. Description of the invention (8) A7 B7</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">CK</span>CK</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">CH R1、A 〇 〇，、R4 或 R2 R3 X^(CR5R6)nR VS '丫人Ar4 經濟部中央樣準局員工消費合作社印製 其中X及y之一爲氧，另一爲氧或cr9r10基圏。在此組中 更特別的是Rl爲羥基或氫；X是氧，或CR9R10其中R9是 氫’ ci-3烷氧基’ Cb*烷基而Rio是氫，或CR9Ri〇代表 c = 0，或OCHR11基團；γ是氧或CHR9，其中尺9是只或 Ci·4烷基，R2及R3各獨立代表氫，ci4烷基，例如甲基， 丙基或C〗_4烷氧基（例如甲氧基甲基），或尺2及尺3共同與其 相聯的碳原子代表環戊基或C = 〇或C = S基團；R5及R6較佳 各是氫。 在R1代表幾基或蜣氧基時，ri基較佳是位於軸構形 上。但R1較佳代表氫原子。 R及R3可分別代表氮或Cl、炫•基。 P4較佳代表甲基。 R5及R6較佳各是氫。 . η較佳代表零。 ______ -11 - 本紙張尺度適用中國國家標準（CNS ) Α4規格（210Χ劝7公釐） (請先閱讀背面之注意事項再填寫本頁〕</span>CH R1, A 〇〇, R4 or R2 R3 X ^ (CR5R6) nR VS 'Arren Ar4 Printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economics where one of X and y is oxygen and the other is oxygen or cr9r10 based Ring. More particular in this group is that R1 is hydroxy or hydrogen; X is oxygen, or CR9R10 where R9 is hydrogen 'ci-3 alkoxy' Cb * alkyl and Rio is hydrogen, or CR9Ri〇 represents c = 0, or OCHR11 group; γ is oxygen or CHR9, wherein ruler 9 is only or Ci · 4 alkyl, R2 and R3 each independently represent hydrogen, ci4 alkyl, such as methyl, propyl or C _4 alkoxy (such as Oxymethyl), or the carbon atoms to which Ruler 2 and Ruler 3 are commonly associated represent a cyclopentyl or C = O or C = S group; R5 and R6 are each preferably hydrogen. When R1 represents a carbonyl group or a mayoxy group, the ri group is preferably located on the axis configuration. However, R1 preferably represents a hydrogen atom. R and R3 may represent nitrogen or Cl, or Hyun · ji, respectively. P4 preferably represents methyl. R5 and R6 are each preferably hydrogen. . η preferably represents zero. ______ -11-This paper scale is applicable to the Chinese National Standard (CNS) Α4 specification (210X persuades 7mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T Λ 五、發明説明（9 &amp;lt; R3 X^jCRVjn Λ A7 B7 R2 R3 代表環系統包括 其中R2及R3之定義如前述，而又及丫各獨立是氧，或 CR R (其中R9及R10之定義如前述），先決條件是至少X 及Y之以是氧或CHC% 環。 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印裝 R2 R3 &amp;gt;5 在 環系統中較佳的環是X及Y之一代表氧， 另一個代表CR9R10(其中R9及Rl〇各獨立代表氩或4烷 基（如甲基）或CR9R10代表c = 0或C = CH2基图）或又及¥都 代表氧；R2及R3代表氫，C14烷基或C0基。 | 了解到，本發明含蓋上述特定及較佳基團的混合。 Λ發明又一特定組化合物是式（1)化合物，其中Z是（a)基困 且其中R1是氫，R4是甲基； η是零，而R2及R3是氫或Ci4烷基，又及丫是氧或γ是氧而 X是CHR9基困，其中R9是氫或Ci 4烷基，c = ()，C = ，或X是CH，Y是氧，n是零而尺2及尺3是氫， 本發明又一特定組化合物是式（Ϊ)化合物，其中Z是（b)基 團 12- 本紙張尺度適用中國國家梯率（CNS ) A4規格（210X297公釐） -訂 Λ</span>、 1T Λ V. Description of the invention (9 &amp;lt; R3 X ^ jCRVjn Λ A7 B7 R2 R3 represents the ring system including where R2 and R3 are as defined above, and each Y is independently oxygen, or CR R (where R9 and R10 The definition is as mentioned above), the prerequisite is that at least X and Y are oxygen or CHC% rings. (Please read the notes on the back before filling this page) Printed R2 R3&gt; 5 The preferred ring in the ring system is that one of X and Y represents oxygen, and the other represents CR9R10 (wherein R9 and R10 each independently represent argon or 4 alkyl (such as methyl) or CR9R10 represents c = 0 or C = CH2 Base map) or both represent oxygen; R2 and R3 represent hydrogen, C14 alkyl or C0 group. | It is understood that the present invention covers a mixture of the above specific and preferred groups. Another specific group of compounds of the invention is Compound of formula (1), wherein Z is (a) group and R1 is hydrogen, R4 is methyl; η is zero, and R2 and R3 are hydrogen or Ci4 alkyl, and Y is oxygen or γ is oxygen and X is a CHR9 group, wherein R9 is hydrogen or Ci 4 alkyl, c = (), C =, or X is CH, Y is oxygen, n is zero and ruler 2 and ruler 3 are hydrogen. Group compounds are compounds of formula (Ϊ), where Z is (b) group 12- This paper scale is applicable to China National Gradient (CNS) A4 specification (210X297 mm) -Subscribe Λ</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央橾準局—工消費合作社印II 3如韌 A7 ^ B7 五、發明説明（10)</span>Ministry of Economic Affairs, Central Bureau of Industry and Commerce-Industrial and Consumer Cooperatives Printed II 3 Ru Ren A7 ^ B7 V. Description of invention (10)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(b) 及其醫藥上可接受的溶劑化物(如水合物），其中w是氧或 硫，而RH之定義如前述。更特定的是，w是氧而Rls是選 自Cl-4烷氧基，苄氧基或OCOR4的基圏（其中R4是c 烷 基，如異丙基或三級丁基），或C3-4烯氧基，C14烷氧1基4羰 基烷氧基。 根據本發明，特定的化合物包括： [1R-(1 a ,3a/3 ,Α β ,Αο,β ,Ί β ,Ίαα ,8a^ )]8a-[[ 1 S,7R,9R]-2,8·二氧-9-甲基-4-亞甲基-順式-雙環[3.4.0]-壬_7_基_ 氧基甲基]-4-甲醯基-4,4a，5,6,7i，7a，8,8a.八氫-7_甲基-3-(l-甲基乙基）-l，4-亞甲基-S-啕噠省-3a(lH)-羧酸； [1R-(1 a，3a0，4々，4a/? ;7y? ,7aar，8ay5 )]8a-[(2,6-二氧基-3,4-0-異亞丙基-卢-〇-別哌喃糖基氧基）甲基]-4-甲醯基- 4,4&amp;amp;，5,6,7,73,8,8&amp;amp;-八氫-7-甲基-3-(1-曱基乙基）-1,4- 1 亞甲基-s-啕噠省-3a(lH)-羧酸； [1R-(1 « ,3ay5 Αβ ,4ay5 ,Ί β ,laa ,8a/? )] 8a-[[ 1 S,4R,7R,9R]-2,8-二氧-4,9-二甲基-順式-雙環[3 ·4.0]-壬-:7-基-氧基-甲 基]-4 -甲醯基-4,4a,5,6,7,7a，8,8a -八氫-7-甲基- 3- (1-甲 基乙基）-1;4-亞甲基-s-β噠省-3a(lH)-羧酸 . -13- ______ &amp;gt;紙張纽逍用中關家梯&amp;quot;?TCNS ) M胁（21GX297公' ---------f - 乂------1T------^ · (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印裝 A7 B7 五、發明説明（11 ) [lR-(la ,3a^ Αβ ,4a/? ,7/9 ,7a^ ,8a/5 ) ] 8 a - [ [ 1 S , 4 S , 6 R, 8 R]-2,7-二氧-4,6-二甲基-順式-雙環[3.4.0]-壬-7-基-氧 基·甲基]-4 -甲醯基-4,4a，5，6,7,7a，8,8a -八氫-7 -曱基- 3-(1-甲基乙基）-l，4 -亞甲基-s -吲噠省- 3a(lH)-叛酸； [1R-(1 a，3a卢，，4a/5，7/?，7aa，8a冷）]8a-[(2,3-脱水-6-去氧- 4- 0-丙基-冷-D -哌喃甘露糖基氧基）甲基]_4_甲醯基 -4,4a，5，6,7,7a，8,8a -八氫-7 -甲基- 3- (1-甲基乙基）-1,4-亞甲基-s-M丨噠省-3a(lH)-羧酸； [1R-(1 a，3a/?，4々，4a卢，7卢，7aa ,8ay5 )]8a-[(2,3-脱水-6-去氧-4-0 -甲基·万-D -哌喃甘露糖基氧基）曱基]-4_甲醯基 -4,43,5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7-曱基-3-(1-甲基乙基）-1，4-亞甲基-s-吲噠省-3a(lH)-羧酸； 及其醫藥上可接受的鹽與溶劑化物（例如水合物）或代謝上 不安定的衍生物。 式（I)化合物爲治療動物，包括人，眞菌感染很有效的殺 眞菌劑。例如，可用於治療由各種念珠菌（如白色念珠菌， 團念珠菌（光滑球擬酵母），熱帶念珠菌，近平滑念珠菌， 及假熱帶念珠菌），新型隱球酵母，卡氏肺囊蟲，各種麴霉 (如黃色麴霉及煙麴霉），球孢菌（如粗球孢菌），副球孢子 菌屬（如巴西副球孢子菌），組織胞漿菌屬（如莢膜組織胞漿 菌）或芽生菌屬（如皮炎芽生菌）所引起的系統性感染。也可 用於治療由各種念珠菌，髮癖菌，小孢子菌或表皮癖菌（如 鬚髮癖菌，深紅色髮癖菌，犬小孢子菌或絮狀表皮癬菌）引 起的局部感染，或由白色念珠菌引起的粘膜感染。 ___ -14- 本紙張尺度逋用中國國家橾準（CNS ) A4^格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁)</span>(b) and its pharmaceutically acceptable solvates (such as hydrates), where w is oxygen or sulfur, and RH is as defined above. More specifically, w is oxygen and Rls is a radical selected from Cl-4 alkoxy, benzyloxy or OCOR4 (where R4 is a C alkyl group, such as isopropyl or tertiary butyl), or C3- 4 alkenoxy, C14 alkoxy 1 yl 4 carbonyl alkoxy. According to the present invention, specific compounds include: [1R- (1 a, 3a / 3, Α β, Αο, β, Ί β, Ίαα, 8a ^)] 8a-[[1 S, 7R, 9R] -2, 8. · Dioxo-9-methyl-4-methylene-cis-bicyclo [3.4.0] -non_7_yl_oxymethyl] -4-carboxamide-4,4a, 5, 6,7i, 7a, 8,8a. Octahydro-7-methyl-3- (l-methylethyl) -l, 4-methylene-S-pyridine-3a (lH) -carboxylic acid ; [1R- (1 a, 3a0, 4々, 4a / ?; 7y ?, 7aar, 8ay5)] 8a-[(2,6-dioxy-3,4-0-isopropylidene-Lu- 〇-epiperanosyloxy) methyl] -4-carboxamide-4,4 &amp;amp;, 5,6,7,73,8,8 &amp;amp; -octahydro-7-methyl-3- (1 -Methyl ethyl) -1,4- 1 methylene-s-pyda-3a (lH) -carboxylic acid; [1R- (1 «, 3ay5 Αβ, 4ay5, Ί β, laa, 8a /? )] 8a-[[1 S, 4R, 7R, 9R] -2,8-dioxo-4,9-dimethyl-cis-bicyclo [3 · 4.0] -non-: 7-yl-oxy -Methyl] -4 -carboxamide-4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3- (1-methylethyl) -1; 4- Methylene-s-β-pyridine-3a (lH) -carboxylic acid. -13- ______ &amp;gt; Zhongguanjia ladder for paper New Zealand &amp;quot;? TCNS) M threat (21GX297 Gong '------- --f-乂 ------ 1T ------ ^ · (Please read the notes on the back before filling this page) A7 B7 printed by the Central Bureau of Standards ’Staff Consumer Cooperative V. Invention description (11) [lR- (la, 3a ^ Αβ, 4a /?, 7/9, 7a ^, 8a / 5)] 8 a-[[1 S , 4 S, 6 R, 8 R] -2,7-dioxo-4,6-dimethyl-cis-bicyclo [3.4.0] -non-7-yl-oxy · methyl] -4 -Methyl-4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3- (1-methylethyl) -l, 4-methylene-s- Indah-3a (lH) -tetioic acid; [1R- (1 a, 3a Lu, 4a / 5, 7 / ?, 7aa, 8a cold)] 8a-[(2,3-anhydro-6-de Oxygen-4-O-propyl-cold-D-piperanmannosyloxy) methyl] _4_carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7 -Methyl- 3- (1-methylethyl) -1,4-methylene-sM-da-3a (lH) -carboxylic acid; [1R- (1 a, 3a / ?, 4々, 4a Lu, 7 Lu, 7aa, 8ay5)] 8a-[(2,3-anhydro-6-deoxy-4-0-methyl · Van-D-piperanmannosyloxy) methyl] -4 _Methyl-4,43,5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene- s-indap-3a (lH) -carboxylic acid; and its pharmaceutically acceptable salts and solvates (such as hydrates) or metabolic instability derivatives. The compound of formula (I) is a very effective fungicide for the treatment of animal infections including humans. For example, it can be used to treat various types of Candida (such as Candida albicans, Candida group (Pseudomonas glabrata), Candida tropicalis, Candida parapsilosis, and Candida pseudotropicalis), Cryptococcus neoformans, and Pneumocystis carinii Insects, various Aspergillus species (such as Aspergillus flavus and Aspergillus fumigatus), Coccidioides (such as Coccidioides), Paracoccidioides (such as Paracoccus brazii), and Histoplasma (such as capsules) Systemic infections caused by histoplasma) or genus Buds (such as dermatitis dermatitis). It can also be used to treat local infections caused by a variety of Candida, Trichoderma, Microsporum or Epidermophilia (such as Trichomonas esculenta, Crimson red bacteria, Microsporum canis or Trichophyton floccus), or caused by Mucosal infection caused by Candida albicans. ___ -14- This paper uses the Chinese National Standard (CNS) A4 ^ (210X297mm) (Please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明（12) 式（I)化合物也可用於治療由各種絲狀眞菌如地絲菌屬（如 Geotrichum clavatum)，絲孢酵母屬（如白吉利氏絲孢酵母） ，Blastoschizomyces(如 Blast〇schizomyCes capitatus)，孢 子絲菌屬（如申克氏孢子絲菌）’ Scedosporium(如 Scedosporium apiosperum)，枝孢屬（如腐肉枝孢）及卵瓶形 酵母所引起的感染。 式（I)化合物也可用於治療由原蟲如弓形體， Cryptoperidum，利什曼原蟲，Tripanos〇rna，賈第亞蟲’ 毛滴蟲所引起的感染。 本發明化合物抗眞菌活性的活體外評估係於液體或固體 培養基上以抗眞菌二倍系列稀釋技術完成，此技術係測定 抗眞菌劑抑制於37°C培氧24至48小時後的眞菌的生長的最 低抑制濃度（MIC)。實行時，以含抗眞菌劑二倍稀釋液的 一系列瓊脂碟或肉湯微稀釋系列培植與臨床有關的病原， 如白色念球菌。然後測定瓊脂碟或肉湯微稀釋系列内眞菌 的生長並記錄恰當的MI C値。 將由無藥物的對照凹内的〇.〇 1及〇. 1微升肉湯作次培養測 定MF C値（即殺死至少原始液體培養基内99 9 %病原菌的最 低抗眞菌濃度），第一凹内有病原菌生長，其他壤脂碟凹無 病原菌生長。 式（I)化合物的活體内評估係以給予（如皮下給予，經口给 予’腹腔内给予或靜脈内給予）接種有白色念球菌株的屬一 系列不同劑量測定。未經治療的鼠於3至9天内死亡，記錄 能使5 0 %受感染的鼠不死亡的劑量。 -15- 尽紙張尺度遑用中國國家標率（CNS )八4规格（21〇x297公釐） (請先閲讀背面之注意事項再填寫本頁} .乂. 、1T. A7</span>A7 B7 Printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of the invention (12) The compound of formula (I) can also be used for the treatment of various filamentous mycetes such as Geotrichum clavatum, Mycelia ( Such as B. gerbilii), Blastoschizomyces (such as BlastozochimyCes capitatus), spore mycelia (such as S. sclerotiorum) Scedosporium (such as Scedosporium apiosperum), Cladosporium (such as Scavenger spores) Infections caused by bottle-shaped yeast. The compound of formula (I) can also be used to treat infections caused by protozoa such as Toxoplasma gondii, Cryptoperidum, Leishmania, Tripanosna, Giardia trichomoniasis. The in vitro evaluation of the anti-smear activity of the compounds of the present invention is performed on liquid or solid media using a two-fold serial dilution technique of anti-smear bacteria. This technique measures the inhibition of anti-smear agents at 37 ° C after 24 to 48 hours The minimum inhibitory concentration (MIC) of the growth of Candida. In practice, clinically relevant pathogens, such as Candida albicans, are cultivated with a series of agar plates or broth microdilution series containing a double dilution of antimycobacterial agent. Then measure the growth of the candida in the agar dish or broth microdilution series and record the appropriate MI C value. The MF C value (that is, the minimum concentration of anti-mycobacteria that kills at least 99.9% of pathogens in the original liquid medium) will be determined by subculture of 0.01 and 0.1 microliter broth in the control cavity without drug. Pathogens grow in the recesses, and other soil fat dish recesses grow without pathogens. The in vivo evaluation of the compound of formula (I) is based on a series of different dosimetry in which administration (eg, subcutaneous administration, oral administration, intraperitoneal administration or intravenous administration) is inoculated with Candida albicans strains. Untreated mice died within 3 to 9 days, and the dose that prevented 50% of infected mice from dying was recorded. -15- Use the Chinese National Standard Rate (CNS) 84 specifications (21〇x297mm) (please read the precautions on the back before filling out this page). 乂. 、 1T. A7</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標準局員工消費合作社印製 由於式（i)化合物具抗眞菌活性，可用於治療人及動物的 各種眞菌感染。此類感染包括表面的，皮的，皮下的及系 統的霉菌感染，如呼吸道感染，胃腸道感染，心血管感染 ，尿道感染，中樞神經系統（CNS)感染，念珠菌病及慢性 枯液念珠菌病（如鵝口瘡及陰道念珠菌病）及由眞菌引起的 皮膚感染，皮及粘膜念珠菌病，包括癖及白癖感染在内的 膚眞菌病，香港腳，甲溝炎，花斑癬，紅癖，擦爛，眞菌 性泡瘆’念珠菌外陰炎及外耳炎。也可用作預防劑以預防 系統性及局部性眞菌感染。用作預防劑時，可作爲選擇性 腸去污染計劃的一部分以預防發生於免疫減弱病人的感染（ 例如愛滋病病人，接受化學治療的癌症病人，及器官移植 病人）。於某些疾病或醫原性情況下可能也需在抗生素治療 期預防眞菌的過度生長。 用於治療時’本發明化合物可以其原料藥給予，但較佳 是使用其醫藥調配物。是以本發明還提供醫藥調配物，含 有式（I)化合物及其醫藥上可接受的鹽，以及一或多種醫藥 上可接受的載劑，並且視需要含有其他治療及/或預防成 分。”可接受的” 一詞意爲與其他成分相容的並對接受者無 害的。 本發明組合物包括特別調配成用於經口給予、經頰給予 、注射給予、植入給予、直腸給予、局部給予、經眼或泌 尿生殖系統給予的形式的組合物，或適於吸入或吹入給予 形式的組合物。 供經口給予的錠或膠囊可含傳統的賦形劑，如結合劑， ________；_ -16- 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） ' (請先閱讀背面之注意事項再填寫本頁) •'户. 、11 經濟部中央標準局員工消費合作社印裝</span>Printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs. The compound of formula (i) has antimycobacterial activity and can be used to treat various infections of human mycetes. Such infections include surface, skin, subcutaneous, and systemic fungal infections, such as respiratory infections, gastrointestinal infections, cardiovascular infections, urinary tract infections, central nervous system (CNS) infections, candidiasis, and candidal candidiasis Diseases (such as thrush and vaginal candidiasis) and skin infections caused by candidiasis, candidiasis of the skin and mucous membranes, skin candidiasis including addiction and white addiction infections, Hong Kong foot, paronychia, variegation Ringworm, red addiction, abrasion, mycobacterial alveolar'candidiasis vulvitis and otitis externa. It can also be used as a preventive agent to prevent systemic and local infections. When used as a preventative, it can be used as part of a selective bowel decontamination program to prevent infections that occur in immunocompromised patients (eg, AIDS patients, cancer patients undergoing chemotherapy, and organ transplant patients). In some diseases or iatrogenic conditions, it may be necessary to prevent the overgrowth of mycetes during antibiotic treatment. When used for treatment, the compound of the present invention can be administered as its raw material, but it is preferred to use its pharmaceutical formulation. Therefore, the present invention also provides pharmaceutical formulations containing the compound of formula (I) and pharmaceutically acceptable salts thereof, and one or more pharmaceutically acceptable carriers, and optionally containing other therapeutic and / or prophylactic ingredients. The term "acceptable" means compatible with other ingredients and not harmful to the recipient. The composition of the present invention includes a composition specially formulated for oral administration, buccal administration, injection administration, implantation administration, rectal administration, topical administration, administration via the eye or urogenital system, or suitable for inhalation or insufflation Into the composition in the form of administration. Tablets or capsules for oral administration may contain traditional excipients, such as binding agents, ________; _ -16- This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) '(Please read the back of the first Matters needing attention and then fill out this page) • 'Household., 11 Printed by the Employees Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ss1644 A7 _______^B7 五、發明説明（14) 例如㈣’阿拉伯膠’明膠，山梨糖醇，黃蓍膠，澱粉漿 或聚乙晞吡咯酮；填充劑，例如乳糖，糖，微結晶纖維素 ’玉米殿粉’鱗酸飼’或山梨糖醇；滑潤劑，例如硬脂酸 鎂，硬脂酸，滑石粉，聚乙烯二醇或二氧化矽；崩溃劑， 例如馬鈴薯澱粉或乙醇酸澱粉鈉，或cr〇sscarmdl〇se sodium ;或增濕劑，例如月桂基硫酸鈉。錠劑，包括可嚼 的、可散的或起泡的錠，可以此技藝已知方法作塗覆。經 口給予的液體製劑可以是，例如，水性或油性懸浮液，溶 液，乳液，糖漿或酏劑，或者也可以是乾產物，在用前以 水或其他載劑調配。此類液體製劑可含傳統的添加物，如 懸浮劑，例如山梨糖醇糖漿，曱基纖維素，葡萄糖/糖漿 ，明膠，羥乙基纖維素，羧甲基纖維素，硬脂酸鋁凝膠或 氫化的可食的脂肪；乳化劑，例如卵磷脂，單油酸脱水山 梨糖醇或阿拉伯膠；非水性載劑（可包括可食的油），例如 ，杏仁油，分餾的椰子油，油性酯，丙二醇或乙醇，及防 腐劑，例如甲基或丙基P-羥基苯甲酸酯或抗壞血酸。 供經頰給予時，此組合物可以是傳統方式製成的錠或舌 片。 本發明组合物可調配成注射或連續輸液給予。注射用調 配物可製成裝於瓿内的單位劑量形式’或加防腐劑裝於多 劑量容器内。此等組合物可以是油性或水性載劑内的懸浮 液、溶液、或乳液，而且可含調配劑，例如懸浮劑，安定 劑及/或分散劑。或者也可將活性成分製成粉，於用前配 以合適的載劑，如滅菌的無熱原的水。 -17- 用中國圃家標準（CNS ) A4規格（210X297公釐） ---------f '乂------，ιτ------^ (請先閱讀背面之注意事項再填寫本頁) A7 ^^^—______B7___ 五、發明説明（15) 本發明組合物供吸入给予時，係以噴霧劑裝入加壓罐内 用合適的推進劑，如二氣二氟甲烷，三氣氟甲烷，二氣四 氟乙烷，二氧化碳或其他合適的氣體投送，或由噴霧投送 。如係加壓噴霧時，劑量單位可藉閥投送定好的劑量。 或者，本發明組合物供吸入給予時，可以是乾散組合物 的形式，例如本發明化合物與合適的散基，如乳糖或澱粉 ’形成的混合物，也可以是物理形式作過改良的單獨的藥 物。散組合物可製成單位劑量形式，如膠囊或明膠藥液筒 的形式，也可是發泡包，藉吸入器或吹入器之助給予。 此组合物可製成塞劑的形式，例如含傳統的塞劑基，或 製成栓劑，内含例如傳統的栓基。 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 此组合物可調配成膏劑、霜劑、凝膠、洗液、洗髮液、 散（包括喷霧散）、栓劑、填塞劑、喷霧劑、點劑、喷劑、 滴劑（例如眼、耳或鼻滴劑、或覆劑（P〇ur_〇ns )供局部給予 。供給予眼晴的膏劑可用滅菌的成分以滅菌方式製備。覆 劑可製成油體供獸醫使用，内含有機溶劑，視需要並使用 調配劑，例如安定劑及助溶劑。供插入陰道使用的栓劑及 塞劑可用傳統技術調配，適宜時並可含有起泡載劑。適宜 時此類組合物也可含其他活性成分如皮質類固醇，抗生素 ’或抗寄生蟲劑。 供鼻内投送的液體製劑可製成溶液或懸浮液的形式，且 可含傳統的賦形劑’如張性調整劑，例如氣化鈉，葡萄糖 或甘露糖；防腐劑，例如氣化苯殺克，乙基汞硫代水楊酸 納’表級乙基醇；及其他調配劑如懸浮劑，緩衝劑，安定 -18- 本紙張尺度逍用中國國家標準（CNS ) A4规格（210X297公釐） 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明（16) 劑，分散劑及/或矯味劑。 經皮給予可藉設計成合適的系統以促進活性成分經皮膚 吸收實現，且一般由調配基構成，調配基封於可貼於皮膚 上的膏藥布内’此膏藥布包括以背膜及釋出襯裡。此系統 可含吸收增強劑，如醇，或藉促進離子電泳增強吸收。 本發明組合物也可調配成長效製劑。此類長效調配物可 藉植入給予（例如皮下植入或肌肉内植入），或藉肌肉内注 射給予。是以，例如’本發明化合物可用合適的聚合物或 疏水材料（如可接受的油内的乳液）或離子交換樹脂調配， 或製成溶解不良的衍生物，例如製成溶解不良的鹽。 在此組合物製成劑量單位時，如本發明化合物係以經口 給予，每一單位較佳含O.OOi毫克至1000毫克，更佳是含 0·01至400毫克活性成分。如係用於治療成人，每天劑量應 爲0.001毫克至5000毫克，最佳是〇.〇1毫克至2〇〇〇毫克，此 劑量可分成1至4次給予，視給予途徑及病人情況及要治的 疾病而異。 此化合物可藉靜脈内輸液給予，劑量爲，例如，5 〇毫克 /公斤/天活性成分。治療期間視反應速度而非任意指定 的天數而定。 本發明化合物也可與其他治療劑合併使用，是以本發明 在另一方面’提供本發明化合物與其他治療活性劑的複合 物0 是以本發明化合物可與一種或多種抗眞菌劑，如 polienics衍生物（二性擻素B(Amphotericin B)，制霉菌素 _ -19- 本紙張尺度適用中國國家標準（CNS ) Α4規格（210Χ297公釐） (請先閱讀背面之注意事項再填寫本育) ί Τ 321644 A7 B7 五、發明説明（17 ) (Nystatin)(二性黴素B的脂調物）），吡咯衍生物（福祿康唑 (Fluconazole))，引他康咬（Intraconazole)，_ 康峻 (Ketoconazole)，咪康也（Miconazole)，克霉 + (Clotrimazole) ZD-08070 (UK-109496))，5-氟胞苷，肺 坎淀（Pneumocandine)或棘坎淀（Echinocandine)衍生物如西 洛霉素（Cilofungin)，LY-303366，L-733560 及/或一或多 種免疫調節劑，如干擾素（IFN- r)，白血球間素（1L-1， 1L-2，1L-3 及 1L-8)和菌落助長因子，[(G)-CSF，（M)-CSF及（GM)-CSF]及防禦素（defensines)合併使用。特別 適於與本發明化合物尺用的化合物括引他康唑 (Intraconazole)，氟胞：y：，福祿康唑（Fluconazole)，或二 性黴素 B(Amphoterican B)。 在本發明化合物與另一抗眞菌劑合併給予時，本發明化 合物與另一抗眞菌劑可以最大推薦劑量或較低劑量給予。 上述複合藥可製成醫藥調配物的形式使用，是以上述含 有複合藥物的及可接受的載劑的醫藥調配物又構成本發明 的另一方面。此等複合藥的各成分可以複合醫藥調配物相 繼給予或同時給予。 在本發明化合物與第二治療劑合併给予以治療同一疾病 時，每一化合物的劑量可不同於化合物單獨使用時的劑量 。精於此技藝者很易知合適的劑量。 根據本發明的m，發明人等提供用於治療的式⑴ ^匕合物或其生理上可接受的鹽或含式（1)化合物或其生理上 〇接又的鹽的醫藥組合物，特別是用以治療動物（特別是人） (請先閲讀背面之注意事項再填寫本頁} I, -訂 經濟部中央棣準局員工消費合作杜印裝</span>Ss1644 A7 _______ ^ B7 5. Description of the invention (14) For example, (iv) gum arabic, gelatin, sorbitol, tragacanth, starch syrup or polyvinylpyrrolidone; fillers such as lactose, sugar, microcrystalline cellulose Cornmeal powder 'saccharin' or sorbitol; lubricants such as magnesium stearate, stearic acid, talc, polyethylene glycol or silicon dioxide; crashing agents such as potato starch or sodium starch glycolate, Or crostscarmdlose sodium; or a moisturizing agent, such as sodium lauryl sulfate. Lozenges, including chewable, dispersible or foamed lozenges, can be coated by methods known in the art. Liquid preparations for oral administration may be, for example, aqueous or oily suspensions, solutions, emulsions, syrups or elixirs, or they may be dry products formulated with water or other carriers before use. Such liquid preparations may contain traditional additives such as suspending agents, such as sorbitol syrup, methyl cellulose, glucose / syrup, gelatin, hydroxyethyl cellulose, carboxymethyl cellulose, aluminum stearate gel Or hydrogenated edible fats; emulsifiers such as lecithin, sorbitan monooleate or gum arabic; non-aqueous carriers (which may include edible oils), such as almond oil, fractionated coconut oil, oily Ester, propylene glycol or ethanol, and preservatives, such as methyl or propyl P-hydroxybenzoate or ascorbic acid. For buccal administration, the composition can be tablets or tongues made in the traditional way. The composition of the present invention can be formulated for administration by injection or continuous infusion. The formulations for injection can be prepared in unit dose form in ampoules or in a multi-dose container with preservatives. These compositions may be suspensions, solutions, or emulsions in oily or aqueous vehicles, and may contain formulating agents such as suspending agents, stabilizers, and / or dispersing agents. Alternatively, the active ingredient can be powdered and mixed with a suitable carrier before use, such as sterilized pyrogen-free water. -17- Use Chinese nursery standard (CNS) A4 specification (210X297mm) --------- f '乂 ------, ιτ ------ ^ (please read the back first (Notes to fill out this page) A7 ^^^ —______ B7___ V. Description of the invention (15) When the composition of the present invention is administered by inhalation, it is filled with a propellant in a pressurized tank with a spray, such as two gas two Fluoromethane, trifluorofluoromethane, difluorotetrafluoroethane, carbon dioxide or other suitable gases are delivered or delivered by spray. In the case of pressurized spraying, the dosage unit can deliver a fixed dose through the valve. Alternatively, when the composition of the present invention is administered by inhalation, it may be in the form of a dry powder composition, for example, a mixture of the compound of the present invention and a suitable powder base, such as lactose or starch, or it may be a separate physical form modified drug. The powder composition can be prepared in a unit dosage form, such as a capsule or a gelatin cartridge, or a blister pack, which is administered with the aid of an inhaler or an insufflator. The composition can be prepared in the form of suppositories, for example, containing traditional suppository bases, or suppositories, containing, for example, traditional suppository bases. Printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling in this page) This composition can be formulated into ointments, creams, gels, lotions, shampoos, powders (including spray powders) , Suppositories, tamponades, sprays, sprays, sprays, drops (such as eye, ear or nasal drops, or coatings (P〇ur_〇ns)) for topical administration. Ointments for the administration of eye clear are available Sterilized ingredients are prepared by sterilization. The coating can be made into an oil body for veterinary use, which contains organic solvents, and if necessary, use formulating agents such as stabilizers and co-solvents. Suppositories and suppositories for vaginal insertion can use traditional techniques Formulated, when appropriate, may contain a foaming carrier. Where appropriate, such compositions may also contain other active ingredients such as corticosteroids, antibiotics' or antiparasitic agents. Liquid preparations for intranasal delivery may be prepared as solutions or suspensions Liquid form, and may contain traditional excipients such as tonicity modifiers, such as vaporized sodium, glucose, or mannose; preservatives, such as vaporized benzalkonium chloride, ethylmercury sodium thiosalicylate. Ethyl alcohol; and others Ingredients such as suspending agent, buffering agent, and stability -18- This paper standard uses the Chinese National Standard (CNS) A4 specification (210X297 mm). The A7 B7 is printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy. V. Invention Instructions (16) Agents, dispersants and / or flavoring agents. Transdermal administration can be achieved by designing a suitable system to promote the absorption of active ingredients through the skin, and is generally composed of a formulation base, which is sealed in a plaster cloth that can be attached to the skin. The plaster cloth includes a backing film and a release liner. This system may contain absorption enhancers, such as alcohol, or enhance ion absorption by promoting ion electrophoresis. The composition of the present invention can also be formulated with long-acting formulations. Such long-acting formulations can be borrowed Implantation (for example, subcutaneous implantation or intramuscular implantation), or by intramuscular injection. Therefore, for example, the compound of the present invention can use suitable polymers or hydrophobic materials (such as acceptable emulsion in oil) or ions Exchange resin formulation, or make poorly soluble derivatives, such as poorly soluble salts. When the composition is made into dosage units, as the compound of the present invention is administered orally, One unit preferably contains from 0.001 mg to 1000 mg, more preferably from 0.01 to 400 mg of active ingredient. If it is used for the treatment of adults, the daily dose should be 0.001 mg to 5000 mg, most preferably 0.001 Mg to 2000 mg, this dose can be divided into 1 to 4 administrations, depending on the route of administration and the condition of the patient and the disease to be treated. This compound can be given by intravenous infusion at a dose of, for example, 50 mg / Kg / day of active ingredient. The treatment period depends on the reaction rate rather than any specified number of days. The compound of the present invention can also be used in combination with other therapeutic agents, so that the present invention provides the compound of the present invention and other therapeutic active agents in another aspect The compound 0 is based on the compound of the present invention and can be combined with one or more anti-mycobacterial agents, such as polienics derivatives (Amphotericin B (Amphotericin B), Nystatin _ -19- This paper scale is applicable to the Chinese National Standard (CNS ) Α4 specification (210Χ297mm) (Please read the precautions on the back before filling out this education) ί Τ 321644 A7 B7 5. Description of the invention (17) (Nystatin) (lipotrope of amphotericin B)), pyrrole derivative( Fluconazole, Intraconazole, Ketoconazole, Miconazole, Clotrimazole ZD-08070 (UK-109496)), 5-Fluoridine Glycosides, Pneumocandine or Echinocandine derivatives such as cilofungin, LY-303366, L-733560 and / or one or more immunomodulators such as interferon (IFN-r ), Interleukin (1L-1, 1L-2, 1L-3 and 1L-8) and colony growth factor, [(G) -CSF, (M) -CSF and (GM) -CSF] and defensin ( defensines) combined use. Compounds particularly suitable for use with the compounds of the present invention include Intraconazole, Fluoride: Y :, Fluconazole, or Amphoterican B. When the compound of the present invention is administered in combination with another antimycobacterial agent, the compound of the present invention and another antimycobacterial agent may be administered at the maximum recommended dose or at a lower dose. The above-mentioned compound medicine can be used in the form of a pharmaceutical preparation, and the pharmaceutical preparation containing the above-mentioned compound drug and an acceptable carrier constitutes another aspect of the present invention. The components of these compound drugs can be administered sequentially or simultaneously with compound drug formulations. When the compound of the present invention and the second therapeutic agent are co-administered to treat the same disease, the dose of each compound may be different from that when the compound is used alone. Those skilled in this art will easily know the appropriate dosage. According to m of the present invention, the inventors provide a compound of formula (1) or a physiologically acceptable salt thereof or a pharmaceutical composition containing the compound of formula (1) or a physiologically acceptable salt thereof for treatment, in particular It is used to treat animals (especially humans) (please read the precautions on the back and then fill out this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">321644 五、發明説明（18) 的眞菌感染。 根據本發明的另一方面，發明人等提供式（1)化合物或其 生理上可接受的鹽的用途，用以製造治療人或人之外的動 物的眞菌感染的藥物。 根據本發明的另一方面，發明人等提供治療人或人之外 的動物的身體的方法以克服眞菌疾病，此法包括给予該身 體治療有效量的式（I)化合物或其生理上可接受的鹽。 精於此技藝者會了解到，此處所指的治療包括預防以及 治療已形成的疾病或感染。 。 本發明化合物可以下述方法製備。 犁備Ζ爲（a)基困的式（I)化合物的通法（Α)包括以式 化合物</span>321644 Fifth, the invention description (18) of Mycobacterium infection. According to another aspect of the present invention, the inventors provided the use of the compound of formula (1) or a physiologically acceptable salt thereof for the manufacture of a medicament for the treatment of candida infections in humans or animals other than humans. According to another aspect of the present invention, the inventors, etc. provide a method of treating the body of a human or an animal other than human to overcome a mycobacterial disease, this method comprises administering to the body a therapeutically effective amount of a compound of formula (I) or a physiologically Accept the salt. Those skilled in the art will understand that the treatment referred to here includes the prevention and treatment of established diseases or infections. . The compound of the present invention can be prepared by the following method. The general method for (a) compound of formula (I) where plow is Z is (a) is based on</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">XH</span>XH</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(II) (其中R1及R4如上述式（1)所界定，Rp是羧基保護基，而χ 及Y如上述式（I)所界定，只是X或γ不能代表CR^R1%反 應生成所需的環系統，然後再除去羧基保護基。 -21 - 本紙張尺度遙用中國國家標率（CNS ) A4規格（210X297公漦） {請先閲讀背面之注意事項再填寫本頁} -訂 經濟部中央標準局員工消費合作社印製 A7 五、發明説明（19) B7 根4據製法(A)的第-具體實施例，式(la)化合物，其中Ri 至R如上述式（〗）所界定，n是零，而χ&amp;amp;γ都是氧，可用 式（III)之二醇</span>(II) (where R1 and R4 are as defined in the above formula (1), Rp is a carboxyl protecting group, and χ and Y are as defined in the above formula (I), but X or γ cannot represent CR ^ R1% Ring system, and then remove the carboxyl protecting group. -21-This paper scale is remotely used in China National Standard (CNS) A4 specification (210X297 Gonglian) {Please read the precautions on the back before filling this page} -Subscribe to the Ministry of Economic Affairs Printed by the Central Bureau of Standards and Staff Consumer Cooperative A7 V. Description of invention (19) B7 Root 4 According to the first-specific embodiment of the manufacturing method (A), the compound of formula (la), where Ri to R are as defined by the above formula (〗) n is zero, and χ &amp;amp; γ are all oxygen, the diol of formula (III) can be used</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">0H</span>0H</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">0H (III) (請先閲讀背面之注意#'項再填寫本頁} 經濟部中央標準局員工消费合作社印製 (其中R1及R4如上述式（1)所界定，RP是羧基保護基）以化 口物（L)2CR2R3(其中l是合適的離去基）處理，再除去幾 基保護基。在R2及R3都·代表氫時，環形成反應可方便地以 式（ΠΙ)化合物在有驗，如氫氧化絵金屬，之存在下用二鹵 素曱虎（如二溴曱烷）處理進行，較佳是在相轉移條件下使 用例如四烷基銨鹽（如溴化四丁基銨）於週邊溫度進行。在 至少R2及R3之一是Ci_.6烷基或氧基Cu烷基，或 CR2R3是c：3_8環燒基時，環形成反應可方便地以式（in)化 合物用縮酮（RO)2CR2R3(其中R!Cl_6烷基，如甲基）處 理進行，較佳是在有合適的酸，如p -甲苯續酸或p_甲笨續 酸吡啶鐳之存在下，於合適的溶劑如酮（如丙酮），腈（如乙 腈）或_化烴屬（如二氣甲燒）内與約室溫進行。式（I a)化合 22- 本紙張尺度逋用中國國家標準（CNS ) A4规格（210X297公釐） -訂· A7 32U44 -- B7 五、發明説明（20) 物’其中X及/或γ代表硫，可以類似方法用對應於式（〗J工) 的中間體，其中一個或二個二醇羥基由硫醇取代，製備。 在CR2R3代表c = 0或c = s時，環形成反應可方便地以式 (III)化合物用羰基二咪唑或硫代羰基二咪唑在合適的溶劑 如煙屬（例如甲苯）或醚（例如四氫呋喃）内在回流下反應進 行。或者CR2R3代表c = S時，環形成反應可以式（III)化合 物用氧化錫（例如氧化二丁基錫）在烴屬溶劑（例如回流中的 甲苯）處理進行，然後再於烴屬溶劑（例如甲苯）内於室溫加 南素硫羰甲酸酯（例如氣硫羰甲酸苯酯）。 根據製法（A)的另一具體實施例’式（I)化合物，其中R1 及R4如上述式（I)所界定，R2及R3之一代表心^烷基，另 一代表氫’ Cu烷基或Cu烷氧基Cu烷基，（CR5R6)n 代表CR5R6，此處尺5及妒如式（1)所界定，而χ&amp;amp;γ都代表n 氧，可用式（111)之二醇與氧化锡（例如氧化二丁基錫）在烴 屬溶劑（例如回流中的曱苯）内反應製備，然後再加烯丙基 南化物HalCR5R6CR2 = CHRl4(其中Rl4是氫或Ci 6烷基， 而Hal是南素，例如溴）及氟化物鹽（例如氟化四丁基銨）於 合適的溶劑如醚（例如四氫呋喃）内，並將混合物加熱至4〇 。至80°C的溫度，製得式（IV)化合物， -23- (請先閱讀背面之注意事項再填寫本頁) .乂. 經濟部中央標準局貝工消费合作社印製 本紙張尺度適用中國Η裳嫌生f CNS) A4抽玫，710X297公螫） \ 經濟部中央標準局員工消费合作社印裝 321644</span>0H (III) (Please read the note # 'on the back before filling in this page) Printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (where R1 and R4 are as defined in the above formula (1), RP is a carboxyl protecting group) to Chemical treatment (L) 2CR2R3 (where l is a suitable leaving group) treatment, and then remove several protecting groups. When both R2 and R3 represent hydrogen, the ring formation reaction can be conveniently In the presence of metal hydroxides, treatment with dihalogenated tigers (such as dibromomethane) in the presence of phase transfer conditions, preferably using, for example, tetraalkylammonium salts (such as tetrabutylammonium bromide) At ambient temperature. When at least one of R2 and R3 is Ci_.6 alkyl or oxyCu alkyl, or CR2R3 is c: 3_8 cycloalkyl, the ring formation reaction can be conveniently condensed with the compound of formula (in) Ketone (RO) 2CR2R3 (where R! Cl_6 alkyl, such as methyl) treatment is carried out, preferably in the presence of a suitable acid, such as p-toluic acid or p-methyl pyridine radium, in the appropriate The solvents such as ketones (such as acetone), nitriles (such as acetonitrile) or _-hydrocarbons (such as two gas methane) are carried out at about room temperature. The compound of formula (I a) 22- This paper scale uses the Chinese National Standard (CNS) A4 specification (210X297mm)-Order · A7 32U44-B7 V. Description of the invention (20) Object 'where X and / or γ represent sulfur, can be used in a similar way Corresponding to the intermediate of formula (JJong), where one or two diol hydroxyl groups are replaced by thiols, prepared. When CR2R3 represents c = 0 or c = s, the ring formation reaction can be conveniently represented by formula (III) The compound is reacted with carbonyldiimidazole or thiocarbonyldiimidazole in a suitable solvent such as Nicotiana (such as toluene) or ether (such as tetrahydrofuran) under reflux. Or CR2R3 represents c = S, the ring formation reaction can be formula (III) The compound is treated with tin oxide (e.g. dibutyltin oxide) in a hydrocarbon solvent (e.g. toluene in reflux), and then added with a nannan thiocarbamate (e.g. gas sulfur) in a hydrocarbon solvent (e.g. toluene) at room temperature Phenyl carboxylate). According to another specific embodiment of the preparation method (A) 'compound of formula (I), wherein R1 and R4 are as defined in the above formula (I), one of R2 and R3 represents an alkyl group, another Represents hydrogen 'Cu alkyl or Cu alkoxy Cu alkyl, (CR5R6 ) n stands for CR5R6, here ruler 5 and jealousy are as defined by formula (1), and χ &amp;amp; γ both represent n oxygen. The diol of formula (111) and tin oxide (such as dibutyltin oxide) can be used in hydrocarbon solvents ( For example, prepared by reaction in refluxing toluene, and then added allyl southern compound HalCR5R6CR2 = CHRl4 (where Rl4 is hydrogen or Ci 6 alkyl, and Hal is Nansu, such as bromine) and fluoride salt (such as fluoride Tetrabutylammonium) in a suitable solvent such as ether (eg tetrahydrofuran), and the mixture is heated to 40. At a temperature of 80 ° C, prepare the compound of formula (IV), -23- (please read the precautions on the back before filling in this page). 乂. Printed by the Beigong Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. The paper size is applicable to China Ηshed is unfamiliar f CNS) A4 draws a rose, 710X297 public sturgeon) \ Printed by the Consumers ’Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 321644</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">此化合物可用汞鹽（例如三氟醋酸汞）引起分子内親電子加 成，形環化轉化成所需的式（la)化合物，然後再行氫化反 應，例如用氩化三烷基錫（例如氫化三丁基錫），然後再除 去羧基保護基。此反應可方便地於約室溫在有合適的溶劑（ 例如四氫呋喃）之存在下進行。 於製法（A)的另一具體實施例中，式（Ia)化合物，其中Rl 至R4如上述式（I)所界定，η是零，X及γ之一代表氧另一 代表是cr9ri〇(此處r9及rio之一代表Ci 6烷基另一代表 氫，Ci_6燒基或Ci_4坑氧基（3卜4坑基或c：R9R_l〇代表 C = CHR&amp;quot;)，可用式（III)化合物。與氧化錫（例如氧化二丁 基錫）在烴屬溶劑（例如回流中的〒苯）内反應製備，並視需 要在有氟化物鹽（例如氟化四丁基銨）之存在下進行，然後 在二醇經基之一經保護後加烯两基南化物 HalCR2R3CR9 = 0HR14或炔基鹵化物 HalCR2R3c=CRl y 此處R11，R14及Hal之定義如前述）或加烯丙基南化物或块 &amp;quot;24 - 冬紙張幻1逋用中國國家揉率（CNS ) A4胁（210X；m公釐) ----- (請先閲讀背面之注意事項再填寫本頁〕 乂 -</span>This compound can be used to induce intramolecular electrophilic addition of mercury salts (such as mercury trifluoroacetate), and form a ring to convert to the desired compound of formula (la), and then perform a hydrogenation reaction, such as trialkyltin argon (such as Tributyltin hydride), and then remove the carboxyl protecting group. This reaction can be conveniently carried out in the presence of a suitable solvent (e.g. tetrahydrofuran) at about room temperature. In another specific embodiment of the manufacturing method (A), the compound of formula (Ia), wherein R1 to R4 are as defined in the above formula (I), η is zero, one of X and γ represents oxygen and the other represents cr9ri. Here, one of r9 and rio represents Ci 6 alkyl and the other represents hydrogen, Ci_6 burned group or Ci_4 pitoxy group (3 Bu 4 pit group or c: R9R_l〇 represents C = CHR &amp;quot;), and the compound of formula (III) can be used. It is prepared by reacting with tin oxide (such as dibutyltin oxide) in a hydrocarbon solvent (such as benzene in reflux), and optionally in the presence of a fluoride salt (such as tetrabutylammonium fluoride), and then in the second After the alcohol is protected by one of the groups, the two-enyl sulfide HalCR2R3CR9 = 0HR14 or the alkynyl halide HalCR2R3c = CRl y where R11, R14 and Hal are as defined above) or the addition of allyl sulfide or block "24- Winter Paper Magic 1 uses China National Crushing Rate (CNS) A4 threat (210X; mmm) ----- (please read the precautions on the back before filling out this page) 乂-</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T A7 B7 五、發明説明（22) 基鹵化物，製成式(-V)化合物 X1</span>1T A7 B7 5. Description of the invention (22) based halide, prepared into compound of formula (-V) X1</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">R4 (V) (請先閲讀背面之注意事項再填寫本頁) (此處 X1 代表 0H，而 Y1 代表 〇cr2r3cr9 = chr144 OCI^I^CsCR11，或 χΐ 代表 0CR2R3CR9 = CHR14 或 Ο CR2 R 3 C sC R 1 1，而Y 1代表經保護的羥基）。環化的完成 .是：在有羥基保護基存在時先除去寒基保護基，然後再藉 ，·例如，形成S-烷基二硫代碳酸酯（例如8_甲基二硫代碳酸 酯）活化游離態的羥基，.然後在根條件下將環封閉，例如在 烴屬溶劑（如甲苯）内於回流下用氫供給體，例如氫化物還 原劑（例如氫化三烷基錫，如氫化三丁基錫）在有活化劑（例 如偶氮雙（異丁腈））内處理活化.的中間體溶液，然後除去羧 基保護基。S-烷基二硫代碳酸酯乏製備可方便地以強鹼金 屬鹸（如氫化鈉），在有咪唑之存嗥下在合適的溶劑如醚（例 如四氫呋喃）内於低溫（例如約〇。匸）處理式（V )化合物，其中 X 及 Y1之一是 〇H，另一是 〇cr2r3cr9 = chr14 或 〇CR2R3CsCRll，進行，然後於約室溫加二硫化碳及烷基 訂 經濟部中央標準局員工消費合作社印裂 -25 經濟部中央橾準局員工消费合作社印裝 32^44 Λ7 --------Έ.-- 五、發明説明（23 ) ~~~~~~--— * . 鹵化物（如甲基碘）。 根據製法（A)的另:一具體實施例，式（1)化合物，其中¥是 氧，η是零，r2及r3是氫，而x*CR9r10基围，可用式 (V)化合物，其中χ是羥基，與三苯基膦，碘及咪唑在合適 的溶劑（如四氫呋喃）内反應，生成所需的4碘衍生物製 備。所需的環封閉然後於根條件下進行，例如用氫化三烷 基錫在烴屬溶劑内加熱反應。</span>R4 (V) (Please read the precautions on the back before filling in this page) (Here X1 stands for 0H and Y1 stands for cr2r3cr9 = chr144 OCI ^ I ^ CsCR11, or χl stands for 0CR2R3CR9 = CHR14 or Ο CR2 R 3 C sC R 1 1 and Y 1 represents a protected hydroxyl group). The completion of cyclization is: in the presence of a hydroxyl protecting group, first remove the cold protecting group, and then borrow, for example, to form S-alkyl dithiocarbonate (such as 8_ methyl dithiocarbonate) Activate the free hydroxyl group, and then close the ring under root conditions, for example, in a hydrocarbon solvent (such as toluene) under reflux with a hydrogen donor, such as a hydride reducing agent (such as trialkyltin hydride, such as tributyltin hydride ) Treat the activated intermediate solution in an activator (such as azobis (isobutyronitrile)), and then remove the carboxyl protecting group. S-alkyl dithiocarbonate can be conveniently prepared as a strong alkali metal emu (eg sodium hydride) in the presence of imidazole in a suitable solvent such as ether (eg tetrahydrofuran) at low temperature (eg about 0).匸) Treatment of the compound of formula (V), where one of X and Y1 is 〇H, and the other is 〇cr2r3cr9 = chr14 or 〇CR2R3CsCRll, and then add carbon disulfide and alkyl at the room temperature to the Ministry of Economic Affairs Central Standards Bureau staff consumption Cooperative printing and cracking -25 Printed by the Central Consumers ’Bureau of the Ministry of Economic Affairs 32 ^ 44 Λ7 -------- Έ .-- V. Description of the invention (23) ~~~~~~ ---- *. Halides (such as methyl iodide). According to another method of preparation (A): a specific embodiment, the compound of formula (1), wherein ¥ is oxygen, η is zero, r2 and r3 are hydrogen, and x * CR9r10 base, you can use the compound of formula (V), where χ It is a hydroxyl group, which reacts with triphenylphosphine, iodine and imidazole in a suitable solvent (such as tetrahydrofuran) to produce the desired 4-iodine derivative. The desired ring closure is then carried out under root conditions, for example by heating the reaction with trialkyltin hydride in a hydrocarbon solvent.</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">於製法（Α)的另一具體實施例中，式（ν)化合物，其中γ 是氧，X是NRU，CR2R3基團是c = 〇，可用式（VI)化合 物與氫化鈉及異氰酸酯Ri2NC0在非質子溶劑如四氫呋喃 内反應再除取羧酸保護基製備。 於製法（A)的另一具體實施例中，式（1)化合物，其中Ri 及R4如上述式（I)所界定，R2及R3各獨立代表氫，6烷 基或Ci·4燒氧基C〗·4烷基或CR2R3代表〇38環烷基，η是 零，X及Υ之一代表-N.R12-(此處R12如上述式（丨）所界定） 另一代表氧，可用式（VI)化合物或其保護的衍生物藉n-醯 •26· 本紙張用中國國家縣（CNS )八4聽_ ( 2丨〇x297公着） ---------7------ΐτ------f V (請先閲讀背面之注意事項再填寫本頁) Α7 Β7 五、發明説明（24 化製備 X11</span>In another specific embodiment of the manufacturing method (Α), the compound of formula (ν), wherein γ is oxygen, X is NRU, and the CR2R3 group is c = 〇, can use the compound of formula (VI) with sodium hydride and isocyanate Ri2NC0 in non- Proton solvent such as tetrahydrofuran reacts and then removes the carboxylic acid protecting group to prepare. In another specific embodiment of the manufacturing method (A), the compound of formula (1), wherein Ri and R4 are as defined in the above formula (I), R2 and R3 each independently represent hydrogen, 6 alkyl or Ci · 4 alkoxy C〗 4 alkyl or CR2R3 represents 〇38 cycloalkyl, η is zero, one of X and Υ represents -N.R12- (where R12 is as defined by the above formula (丨)) The other represents oxygen, available formula (VI) Compounds or their protected derivatives borrow n- 醯 • 26 · This paper is used by China National Counties (CNS) 八四 听 _ (2 丨 〇x297 公 著) --------- 7-- ---- lsτ ------ f V (Please read the precautions on the back before filling in this page) Α7 Β7 5. Description of the invention (24 chemical preparation X11</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(VI) Y11 (請先閲讀背面之注意事項再填寫本頁) Κ. (其中X11及Y11之一是0H，另一是NH2)，例如用醯基鹵 素（如酿基氣）在傳統條件下反應，再用趁或網r2r3C = 〇或 二烷基乙縮醛r2r3c(o烷基）2在有合適的酸（如p_甲苯磺 酸或p -甲苯確酸p比淀錄）之存在下在合適的溶劑如鹵化煙屬 (如二氣曱烷）内於約室溫反應，再除去任何保護基完成。 於製法（A)的另一具體實施例中，式（Ia)化合物’其中Ri 及R4如上述式（I)所界定，η是零，-X-CR2R3或-Y-CR2R3代表-N = CR3-(其中R3是Cl_6烷基或（：卜4烷氧基 Ci-4烷基）’而Y或X是氧’可用亞胺基酯R3c( = NH)OR( 其中R是Cl _6烷基，例如甲基）處理式（VI)化合物製備。</span>(VI) Y11 (please read the precautions on the back before filling in this page) Κ. (Where one of X11 and Y11 is 0H and the other is NH2), for example, with an acyl halide (such as brewing base gas) under traditional conditions Reaction, and then use the net or r2r3C = 〇 or dialkyl acetal r2r3c (o alkyl) 2 in the presence of a suitable acid (such as p-toluenesulfonic acid or p-toluene acid p than recorded) The reaction is carried out in a suitable solvent such as halogenated nicogen (such as dimethane) at about room temperature, and then any protective group is removed. In another specific embodiment of the manufacturing method (A), the compound of formula (Ia) wherein Ri and R4 are as defined in the above formula (I), η is zero, -X-CR2R3 or -Y-CR2R3 represents -N = CR3 -(Where R3 is Cl_6 alkyl or (: Bu 4 alkoxy Ci-4 alkyl) 'and Y or X is oxygen' available imine ester R3c (= NH) OR (where R is Cl_6 alkyl, For example, methyl) is prepared by treating the compound of formula (VI).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">I 另一通法B ’式（I)化合物，其中z是（a)基團，Y是氧，η 是零，R2及R3是氫’而X是CH，可用式（VII)化合物 -27- 本紙張尺度適用中囷國家梂準（CNS ) Α4規格（210X297公釐） '1Τ 經濟部中央棣準局員工消费合作社印装 r 32l^44 A7 --B7 五、發明説明（25) 0</span>I Another general method B 'compound of formula (I), wherein z is (a) group, Y is oxygen, η is zero, R2 and R3 are hydrogen' and X is CH, compound of formula (VII) can be used The paper standard is applicable to China National Standard (CNS) Α4 specification (210X297mm). '1Τ Printed by the Consumer Cooperative of the Central Bureau of Economics of the Ministry of Economic Affairs r 32l ^ 44 A7 --B7 V. Description of invention (25) 0</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(VII) 其中R21是CHO基或其經保護的衍生物’ RP是保護的羧基 與一娱:基二氮曱基膦酸酯在有驗（如三級丁氧化_)在非 質子溶劑（如醚，例如四氫呋喃）内反應，再除去羧基保護 基Rp，如有需要再除去醛保護基製備。 4 _酮四氫哌喃衍生物可以傳統方法（如S w ern氧化）氧化對 應的4 -經基衍生物製備。 製備式（I)化合物（其中Z是（b)基图，W是氧）的通法 包括環化式（VII)化合物· (請先閲讀背面之注意事項再填寫本頁)</span>(VII) where R21 is a CHO group or a protected derivative thereof. RP is a protected carboxyl group and a carboxyl group: a diazomethylphosphonate is tested (such as tertiary butane oxidation) in an aprotic solvent (such Ether, such as tetrahydrofuran), and then remove the carboxyl protecting group Rp, and then remove the aldehyde protecting group if necessary. 4_ Ketotetrahydropyran derivatives can be prepared by oxidizing the corresponding 4-keto derivatives with traditional methods (such as Swern oxidation). General methods for preparing compounds of formula (I) (where Z is (b) base map, W is oxygen) including cyclization of compounds of formula (VII) · (please read the precautions on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T 經濟部中央標準局貝工消費合作社印製</span>, Printed by 1T Beigong Consumer Cooperative, Central Bureau of Standards, Ministry of Economic Affairs</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">R 15a R 17a 1¾ (VIII) -28- 尽紙張尺没通用宁國國家標準（CNS ) A4规格（210X297公釐） 五、發明説明（26) A7 B7 (其中R15a，RbaKRUa如上述式（〇之r15，r16及r17所 界定或其經保護的衍生物，RP是氫或羧基保護基，L是合 適的離去基，如烷基-或芳基績醯氧基，R22是氫，或〇R22 是L所界定的相同的基困），必要時再除去任何存在的保護基。 -* . 環化可方便地以如氫化瞼金屬的強鹼.(例如氫化鈉）在如 二甲基甲醯胺或醚（例如四氫呋喃）的溶劑内於約室溫處理 式（V111)化合物完成。或者，也可使用醇溶劑（例如甲 内的鈉’尤以在OR22是與L所界定的相同基困時爲然。此 實例中’是將驗系統加於如南素化烴屬（例如二氣甲境）人 適溶劑内的式（VIII)化合物溶液内，反應係於室溫 Q 王芏回流 溫度進行。 另一製備W是硫的式（0化合物通法B包括以硫供给 理式（IX)化合物 經濟部中央標準局貝工消費合作社印策</span>R 15a R 17a 1¾ (VIII) -28- Full paper size is not universal Ningguo National Standard (CNS) A4 specification (210X297 mm) 5. Description of invention (26) A7 B7 (where R15a, RbaKRUa are as above (〇 之Defined by r15, r16 and r17 or protected derivatives thereof, RP is a hydrogen or carboxy protecting group, L is a suitable leaving group, such as alkyl- or aryl acyloxy, R22 is hydrogen, or 〇R22 Is the same base as defined by L), if necessary, remove any existing protective groups.-*. Cyclization can be easily used as a strong base such as hydrogenated eyelid metal (such as sodium hydride) in such as dimethylformamide Treatment of the compound of formula (V111) in an amine or ether (such as tetrahydrofuran) solvent at about room temperature is completed. Alternatively, alcohol solvents (such as sodium in formic acid) can also be used, especially when OR22 is the same base defined by L This is true. In this example, the test system is added to a solution of the compound of formula (VIII) in a suitable solvent such as a southern sulfonated hydrocarbon (for example, Erqijiajing). . Another preparation formula W is sulfur (0 compound general method B includes the use of sulfur to formula (IX) compound of the Ministry of Economic Affairs Printed by Peking Consumer Cooperative of Central Bureau of Standards</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15 R R 17 16 (IX) (其中R15，R】6及R】7如上述弍（I)所界定。是以 ，此反應 ---------t^—------訂----- v (請先閲讀背面之注意事項再填寫本頁k -29- 本紙張尺度逍用中國國家揉準（CNS ) A4規格（210X297公釐） 經濟部中央標準局員工消费合作社印製 ^^1644 五、發明説明（27 ) 可方便地用5,5-二甲基_2•硫醇基_2_硫基]3 2 於如二甲基甲酿胺之溶劑内，且較佳是在有如三;Γ基胺^ 如三乙基胺)之存在下於高溫(例如物 :式 (IX)化合物完成。 L)處理式 基可方便地由式(χπι)化合物，其中l是趣 、、 w適的離去基，如烷基-或芳基磺醯氧基， 使用方法（C)所述條件製備，需要時再除去任何保護基。 另一通法（E)包括互變反應，其中式⑴化合物係由不同 的式（I)化合物或其經保護的衍生物製備。 根據通法（E)之第一具體實施例，式（〗）化合物之保護過 的羧基折生物，其中2是（&amp;amp;)基團，而其*Rl是羥基，可轉 化成對應的式（I)化合物，其中Rl是氫，方法是：根據 前述方法生成S-烷基二硫代碳酸酯，（ii)於烴屬溶劑（例如 甲苯）内於高溫（例如約8 〇。至12〇)以氫化物還原劑（例如 氫化三烷基錫，如氫化三丁基錫）處理此中間體化合物溶液 ’然後除去幾基保護基。 於另一通法（E)中，式（I)化合物，其中z是（a)基圏，而 其中R1是C〗_4烷氧基及/或r4是c】_4烷氧基甲基，可藉烷 基化式（I)化合物的經保護的衍生物製備，其中Ri是羥基及 /或R4是羥基甲基及任何經保護的不安定的基團（例如羧基 及羥基），然後再除去存在的經保護的基團。烷基化可方便 地用強鹼金屬鹼（例如氫化鈉）作初步反應，再用烷基鹵化 物（例如甲基碘）反應。此反應可在如醚之合適的溶劑（例如 四氫呋喃）内於0°至30。(：進行。 -30 本紙張尺度適用中國圃家揉準（CNS ) A4规格（210X297公釐）</span>15 RR 17 16 (IX) (where R15, R] 6 and R] 7 are defined as above (I). Therefore, this reaction --------- t ^ ---------- Order ----- v (please read the precautions on the back before filling in this page k -29- This paper size is easy to use China National Standard (CNS) A4 specification (210X297mm) Employee Consumer Cooperative of Central Bureau of Standards of the Ministry of Economic Affairs Printed ^^ 1644 5. Description of the invention (27) 5,5-dimethyl_2 • thiol_2_thio]] 2 can be conveniently used in a solvent such as dimethylmethylamine, and Preferably, it is done in the presence of a trivalent amine such as triethylamine at a high temperature (e.g., a compound of formula (IX). L) The treatment of the formula group can be conveniently made of a compound of formula (χπι), where l It is a suitable leaving group, such as an alkyl- or arylsulfonyloxy group, prepared using the conditions described in method (C), and then removing any protecting groups if necessary. Another general method (E) includes interconversion Reaction, wherein the compound of formula (I) is prepared from a different compound of formula (I) or a protected derivative thereof. According to the first specific embodiment of general method (E), the protected carboxyl group of the compound of formula (〗), Where 2 is (&amp;amp;) base Group, and * Rl is a hydroxyl group, which can be converted into the corresponding compound of formula (I), wherein Rl is hydrogen, the method is: according to the aforementioned method to generate S-alkyl dithiocarbonate, (ii) in a hydrocarbon solvent ( For example, toluene) treats this intermediate compound solution with a hydride reducing agent (such as trialkyltin hydride, such as tributyltin hydride) at a high temperature (for example, about 80 to 120) and then removes several protecting groups. In a general method (E), the compound of formula (I), wherein z is (a) aryl ring, and wherein R1 is C〗 _4 alkoxy and / or r4 is c] _4 alkoxymethyl, can be alkyl Preparation of a protected derivative of the compound of formula (I), where Ri is hydroxy and / or R4 is hydroxymethyl and any protected unstable group (such as carboxy and hydroxy), and then remove the existing protected Alkylation can conveniently use a strong alkali metal base (such as sodium hydride) for the initial reaction, and then use an alkyl halide (such as methyl iodide) reaction. This reaction can be in a suitable solvent such as ether (such as Tetrahydrofuran) within 0 ° to 30. (: proceed. -30 This paper size is suitable for Chinese nursery Associate (CNS) A4 size (210X297 mm)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(請先閲讀背面之注意事項再填寫本頁) A7五、發明説明（28) 經濟部中央揉準局貝工消費合作社印製 、另一通法（E)中，式（1)化合物，其中R1是醯氧基及/ 或R4是CH2〇C〇R8，可藉酸化經保護的式⑴衍生物製備 其中R是經基及/或尺4是CH2〇H及任何不安定的基團 是經保遵的’然後再除去存在的經保護的基困。酿化反應 可用傳統方法進行，例如用羧酸在有活化劑，如二環己基 碳化一亞胺，及合適的鹼，如二甲胺基吡啶，之存在下處 理，並視需要在有合適的鹼，如吡啶或4-二甲胺基吡啶之 存在下處理。 根據另一通法（E)，式（I)化合物，其中R1是平展構形的 羥基，可由經保護的式（1)衍化物製備，其中Rl是軸構形的 羥基而任何不安定的基图（如羧基，羥基及CH〇基團）是經 保遵的，然後再除去存在的經保護的基團。此異構化反應 可方便地以二步驟進行：（i)用合適的氧化系統[例如氧化 鉻，在有吡啶存在下，於含有醋酸酐的_素化烴屬溶劑（例 如二氣甲烷）内]將2，-軸向〇H氧化成氧基，（ii)使用如硼氫 化物（例如硼氫化鈉）的合適的還原劑將氧基還原成〇H基團 。此還原可方便地於如醇之溶劑（例如甲醇水溶液）於〇。至 1 0 C進行。 於另一通法（E)中’式（I)化合物，其中R1是鹵素原予， 可由R1爲羥基的保護過的式（I)衍化物製備，然後再除去任 何存在的保護基。此取代反應係以轉化構形完成。是以， 例如，軸向OH基可藉加碘於起始物質於合適的如烴屬的溶 劑（例如甲苯）内的溶液中在有三苯基膦及碘的存在下並加 熱（例如在回流下）此混合物，轉化成平展的碘原子。 _ -31 - 本紙張尺度適用中國囷家標準（CNS ) A4規格（210X297公f ------— (請先閲讀背面之注§項再填寫本頁) 乂</span>(Please read the precautions on the back before filling in this page) A7 V. Description of Invention (28) Printed by the Ministry of Economic Affairs Central Bureau of Customs and Industry Beigong Consumer Cooperative, another general method (E), the compound of formula (1), where R1 Is an oxy group and / or R4 is CH2〇C〇R8, can be prepared by acidifying a protected derivative of formula (1) where R is a group and / or 4 is CH2〇H and any unstable group is protected Obey 'and then remove the existing protected foundation. The brewing reaction can be carried out by traditional methods, for example, using carboxylic acid in the presence of an activator, such as dicyclohexylcarbodiimide, and a suitable base, such as dimethylaminopyridine, and if necessary, a suitable Treated in the presence of a base such as pyridine or 4-dimethylaminopyridine. According to another general method (E), a compound of formula (I), wherein R1 is a hydroxyl group in a flat configuration, can be prepared from a protected derivative of formula (1), wherein Rl is a hydroxyl group in an axial configuration and any unstable base map (Such as carboxyl, hydroxyl and CH〇 groups) are subject to compliance, and then remove the existing protected groups. This isomerization reaction can be conveniently carried out in two steps: (i) using a suitable oxidation system [such as chromium oxide, in the presence of pyridine, in a solvent containing acetic anhydride, such as dioxo methane, (such as methane) ] Oxidation of 2, -axial OH to oxy groups, (ii) Reduction of oxy groups to OH groups using a suitable reducing agent such as borohydride (eg sodium borohydride). This reduction can be conveniently carried out in a solvent such as alcohol (e.g. aqueous methanol solution). To 1 0 C. In another general method (E), the compound of formula (I), wherein R1 is a halogen atom, can be prepared from a protected derivative of formula (I) in which R1 is a hydroxy group, and then any protective groups present are removed. This substitution reaction is completed in a transformed configuration. Therefore, for example, the axial OH group can be added to the solution of the starting material in a suitable solvent such as hydrocarbons (eg toluene) in the presence of triphenylphosphine and iodine and heated (eg under reflux) ) This mixture is converted into flat iodine atoms. _ -31-This paper scale is applicable to the Chinese Standard (CNS) A4 specification (210X297 public f ------— (please read the note § item on the back and fill in this page) 乂</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T • - - I In 1^1</span>, 1T •--I In 1 ^ 1</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央揉準局員工消費合作社印製 以合適的氟化劑（例如三氟化二乙胺基硫（DAST)在合適 的如南素化烴屬的溶劑（例如二氣甲烷）内或芳香族烴屬（例 如甲苯）内於室溫反應可引入氟。 於另一通法（E)中，式（1)化合物，其中γ是氧，n是零， R及R2是氫，而X是CH，或其經保護的衍化物，可藉用 氫及合適的催化劑（如鈀/碳）在合適的溶劑内還原’再除 去羧基保護基製備。 於另一通法（E)中，式（1)化合物，其中γ是氧，η是零 ，R2及R3是氫，而X是C = CH2，可用四氧化餓及高碘酸鈉 行氧化轉化成對應的又爲(：=〇的化合物。 同樣，式（I)化合物，其中γ是氧，n是零，尺2及尺3是氫 ’而X是C = CH2 ’用三氧化鉻在吡啶内氧化，可轉化成式 (I)化合物，其中R2及R3與其相聯的碳原子代表€ = 〇。 根據方法（E)的另一具體實施例，r 1 5爲羥基的式（j)化合 物之叛基經保護的衍化物可藉標準的取代反應，再除去羧 基保護基，轉化成R1S爲南素的式（1)化合物。是以，以氟 原子取代羥基可藉加三氟化二乙胺基硫（DAST)於起始物質 在合適的如由素化烴屬的溶劑（例如二氣甲烷）内的溶液中 行構形轉化完成。此反應可方便地於室溫進行。 於另一（E)法具體實施例中，式（1)化合物，其中Ri5是 Cu虎氧基或視需要取代的烷氧基及/或尺”是^#烷氧 基甲基，可用經保護的式化合物衍生物，其中Rl5及/ 或R1 7含游離態羥基，而任何不安定的基困（例如羧基及羥 基）已作了合適的保護，行烷基化製備，然後再除去存在的 _ _ 32 - 本紙張尺度逍用中國國家揉準（CNS )八4胁（210X297公釐) ' 一 (請先閲讀背面之注意事項再填寫本頁)</span>Printed by the Consumer Cooperative of the Central Ministry of Economic Affairs of the Ministry of Economic Affairs with a suitable fluorinating agent (such as diethylaminosulfur trifluoride (DAST) in a suitable solvent such as a southern hydrocarbon (such as methane) or aromatic Fluorine can be introduced in a hydrocarbon group (such as toluene) at room temperature. In another general method (E), the compound of formula (1) where γ is oxygen, n is zero, R and R2 are hydrogen, and X is CH , Or its protected derivatives, can be prepared using hydrogen and a suitable catalyst (such as palladium / carbon) reduction in a suitable solvent and then removing the carboxyl protecting group. In another general method (E), formula (1) Compounds, where γ is oxygen, η is zero, R2 and R3 are hydrogen, and X is C = CH2, can be converted to the corresponding compound (: = 〇) by oxidation of sodium tetraoxide and sodium periodate. Similarly, Compound of formula (I), where γ is oxygen, n is zero, ruler 2 and ruler 3 are hydrogen 'and X is C = CH2' oxidized in pyridine with chromium trioxide, can be converted to compound of formula (I), where R2 And the carbon atom to which R3 is associated represents € = 〇. According to another specific embodiment of method (E), the compound of formula (j) where r 1 5 is a hydroxyl group The protected derivative can be converted into a compound of formula (1) with R1S as a southern element by standard substitution reaction, and then the carboxyl protecting group is removed. Therefore, by replacing the hydroxyl group with a fluorine atom, a trifluorodiethylamino group can be added Sulfur (DAST) is converted into a configuration in a solution of the starting material in a suitable solvent such as a chlorinated hydrocarbon (such as methane). This reaction can be conveniently carried out at room temperature. In another (E) In a specific embodiment of the method, the compound of formula (1), wherein Ri5 is Cu tigeroxy or optionally substituted alkoxy and / or ruler "is ## alkoxymethyl, a protected compound derivative of the formula can be used, Wherein Rl5 and / or R1 7 contain free hydroxyl groups, and any unstable radicals (such as carboxyl groups and hydroxyl groups) have been properly protected, prepared by alkylation, and then remove the existing _ _ 32 Use the Chinese National Standard (CNS) 8 4 threats (210X297mm) '1 (please read the precautions on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T A7 A7 經濟部中央揉準局貝工消费合作社印製 B7 五、發明説明（30) 保護基。烷基化可方便地以強鹼金屬瞼（例如氫化鈉）作初 步反應，再以烷基南化物（例如曱基溴）反應進行。此反應 可在如醚（例如四氫呋喃）之溶劑内於約〇 °至5 0 °C溫度完成 。適宜時也可有如由素化四燒基録(例如琪化四丁基銨）之 存在。 或者，直鏈或支鏈的烷基可方便地以二步驟引入：第一 步驟包括使用合適的烯基_素化物在有如碳酸鹽（例如碳酸 铯）之鹼的存在下於約0°至50°C溫度行烷基化；第二步驟 包括在有把催化劑（例如1 0 %把/破）於約室溫行氫化。 於另一（E)法具體實施例中，式（I)化合物，其中R15是 CH2OCOR20或R1是OCOR18，可藉醯化經保護的式（1)化 合物的衍生物，其中R17是CH2OH或R15是羥基，而任何 不安定的基團（例如羧基及羥基）已作了保護，然後再除去 存在的保護基，製備。醯化反應可用傳統方法進行，例如 用羧酸在有如二環己基碳化亞胺之活化劑及合適的鹼（如二 甲胺基吡啶）之存在下進行，或使用醯基南素（醯基氣），視 需要在有合適的鹼（如二甲胺基吡啶）之存在下進行。 根據方法（E)的另一具體實施例，crUr!6代表(：=0的 式（I)化合物可藉氧化經保護的式（1)化合物衍生物，其中 R15是幾基’而任何不安定的基團（例如羧基及羥基）已作了 保濩，然後再除去存在的保護基，製備。氧化反應可方便 地以加如二甲基亞颯之氧化劑在有三氟醋酸酐之存在下進 行。氧化可於在有合適的溶劑如卣素化烴屬（如二氣曱烷） 内於高溫（例如約4 〇。至8 0 °C )進行。 (請先閲讀背面之注意事項再填寫本頁) X. &amp;lt;11 -33 B7 五、發明説明（31) 式（I)化合物，其中CR15R16代表ch = CH2基，可以對應 的CR15R、c = 〇的式⑴化合物或其經保護的衍生物與南 素化烷基-三苯基鳞及烷基鋰於非質子溶劑（如四氫呋喃）内 反應製備。 R15爲疊氮基圏的式（I)化合物可用R15爲羥基的對應的 式（I)化合物或其經保護的衍生物與甲苯磺醯南素反應，然 後以疊氮化鹼金屬（例如疊氮化鋰）在非質子溶劑（如二氣甲 燒）内處理所得甲苯磺酸酯衍生物製備。 上述許多方法都需在最後步驟除取一或多個保護基以製 得所需式（I)化合物。是以另一通法（F )包括使經保護的式 (I)化合物衍生物去保護。此處所用的合適的羧基保護基及 經基保護基包括任何傳統的保護基，例如於,,pr〇tective Groups in Organic Chemistry&amp;quot;, Ed. J. F. W. McOmie (Plenum Press, 1973 )或&amp;quot;Protective Groups in Organic</span>， 1T A7 A7 Printed by Beigong Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs B7 V. Description of invention (30) Protection base. The alkylation can be conveniently carried out with a strong alkali metal eyelid (such as sodium hydride) as the initial reaction, and then with an alkylnanate compound (such as methyl bromide). This reaction can be completed in a solvent such as ether (eg, tetrahydrofuran) at a temperature of about 0 ° to 50 ° C. Where appropriate, there may also be the presence of a basic compound such as tetrabutylammonium (eg, tetrabutylammonium). Alternatively, straight-chain or branched-chain alkyl groups can be conveniently introduced in two steps: the first step involves the use of a suitable alkenyl compound in the presence of a base such as a carbonate (eg cesium carbonate) at about 0 ° to 50 The alkylation is carried out at a temperature of ° C; the second step involves hydrogenation of the catalyst (for example, 10% / cracked) at about room temperature. In another specific embodiment of the method (E), the compound of formula (I), wherein R15 is CH2OCOR20 or R1 is OCOR18, a derivative of the protected compound of formula (1) can be synthesized, wherein R17 is CH2OH or R15 is Hydroxyl group, and any unstable group (such as carboxyl group and hydroxyl group) has been protected, and then remove the existing protecting group to prepare. The acylation reaction can be carried out by conventional methods, for example, using carboxylic acid in the presence of an activator such as dicyclohexylcarbodiimide and a suitable base (such as dimethylaminopyridine), or using acetynannan (acidyl gas) ), If necessary, in the presence of a suitable base (such as dimethylaminopyridine). According to another specific embodiment of method (E), crUr! 6 represents (: = 0 the compound of formula (I) can be oxidized by the protected compound of formula (1) derivative, where R15 is a few groups' and any unstable The groups (such as carboxyl and hydroxy) have been preserved, and then the existing protecting groups are removed to prepare. The oxidation reaction can be conveniently carried out in the presence of trifluoroacetic anhydride by adding an oxidizing agent such as dimethyl sulfa. Oxidation can be carried out in a suitable solvent such as halogenated hydrocarbons (such as dimethane) at high temperature (for example, about 40. to 80 ° C). (Please read the notes on the back before filling this page ) X. &amp;lt; 11 -33 B7 V. Description of the invention (31) The compound of formula (I), wherein CR15R16 represents a ch = CH2 group, which can correspond to the compound of formula ⑴ of CR15R, c = 〇 or its protected derivatives and Nansuated alkyl-triphenylscale and alkyllithium are prepared by reaction in an aprotic solvent (such as tetrahydrofuran). The compound of formula (I) where R15 is an azido ring can be used as the corresponding compound of formula (I) where R15 is a hydroxyl group Or its protected derivative reacts with tolsulfonamide and then uses alkali gold azide (Such as lithium azide) is prepared by treating the tosylate derivative in an aprotic solvent (such as two-gas methane). Many of the above methods require the removal of one or more protective groups in the final step to obtain A compound of formula (I) is required. Another general method (F) includes deprotection of the protected compound derivative of formula (I). Suitable carboxy protecting groups and protected groups used herein include any traditional protecting groups , For example ,, Protective Groups in Organic Chemistry &amp;quot;, Ed. JFW McOmie (Plenum Press, 1973) or &amp;quot; Protective Groups in Organic</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Synthesis&amp;quot; by Theodora W. Greene (John Wiley and Sons, 經濟部中央裸準局貝工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 1991)内所述者。合適的羧基保護基的例包括芳基烷基，如 二苯基甲基’ P-曱氧基苄基及甲矽烷基（例如三甲基曱矽烷 基或二級丁基甲基甲矽烷基）。合適的羥基保護基的例包括 芳基燒基’如P-甲氧基苄基及酯基如苄氧基羰基。醛基可 以環形縮酮的形式保護。 保護基可以傳統技術除去。是以，二苯基甲基可用三氟 醋酸除去’或用加氫分解在有鈀催化劑（例如丨0%鈀/碳) 之存在下除去。芊氧羰基可用加氫分解在有鈀催化劑（例如 10%纪/碳）之存在下除去。p -甲氧基苄基可用2,3 -二氣- __—__ -34- __ 本紙張尺度適用中國國家標率（CNS ) A4规格（210X297公簸） 經濟部中央標準局員工消费合作社印製 321644 Α7 ___Β7 五、發明説明（32) 5,6 -二氰基-1,4 -苯并醌除去。曱矽烷基，然三甲基甲矽烷 基或t -丁基二甲基甲碎燒基可用氟離子除去。環形縮_基 可以加合適的酸，如鹽酸，轉化成醛。 式（II)化合物可用式（VII)化合物</span>Synthesis &amp;quot; by Theodora W. Greene (John Wiley and Sons, Printed by the Ministry of Economic Affairs, Central Bare Bureau, Beigong Consumer Cooperative (please read the precautions on the back before filling out this page) 1991). Examples of suitable carboxy-protecting groups include arylalkyl groups such as diphenylmethyl'P-methoxybenzyl and silyl groups (e.g. trimethylsilyl or secondary butylmethylsilyl groups). Examples of suitable hydroxy protecting groups include arylalkyl 'such as P-methoxybenzyl and ester groups such as benzyloxycarbonyl. The aldehyde group can be protected in the form of a cyclic ketal. The protecting group can be removed by conventional techniques. Therefore, diphenylmethyl can be removed with trifluoroacetic acid 'or hydrodecomposed in the presence of a palladium catalyst (e.g. 0% palladium / carbon). The fluorenyloxycarbonyl group can be removed by hydrodecomposition in the presence of a palladium catalyst (for example, 10% / carbon). p-Methoxybenzyl can be used in 2,3-digas- __—__ -34- __ This paper scale is applicable to China National Standard Rate (CNS) A4 specification (210X297 ounces) Printed by the Employees Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 321644 Α7 ___ Β7 5. Description of the invention (32) 5,6-Dicyano-1,4-benzoquinone is removed. Silyl groups, but trimethylsilyl groups or t-butyl dimethylmethyl pyroalkyl groups can be removed with fluoride ions. The cyclic condensed group can be converted to aldehyde by adding a suitable acid, such as hydrochloric acid. The compound of formula (II) can be used as the compound of formula (VII)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(其中RP是羧基保護基）與式（X)化合物</span>(Where RP is a carboxyl protecting group) and the compound of formula (X)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">XH \ X (XI) 、入R4 (其中R1，R4，X及Y如上述式（11)所界定）或其經保護的 衍生物反應製備，必要時再除去存在的保護基。此反應可 藉加熱於如烴屬的合適溶劑（如甲苯）内之（χ)及（χι)至約 40。至80°C且在有酸氫溴酸_三苯基膦之存在下進行。 在式（X)中的XH及YH代表羥基時，可以醯氧基（如乙醯 氧基）保護，反應後再以式（X)化合物除去保護基。乙醯氧 基保護基之除去係藉添加合適的鹼，如烷氧化物（例如甲氧 化鈉），在合適的如醇（例如曱醇）之溶劑内於約室溫進行。 _____-35- 本紙張尺度逍用中國國家標準（CNS ) Μ规格（21〇χ297公董 (請先閲讀背面之注意事項再填寫本頁) 訂 五、發明説明（33) A7 B7 前述反應特別適於製備R4不是甲基的式（II)化合物。在 R4是甲基時，式（JI)化合物可用V-脱甲基索達林，式（XII) 化合物製備。</span>XH \ X (XI), R4 (where R1, R4, X and Y are as defined in the above formula (11)) or its protected derivatives are prepared by reaction, and the existing protecting groups are removed if necessary. This reaction can be achieved by heating (χ) and (χι) to about 40 in a suitable solvent such as hydrocarbons (such as toluene). To 80 ° C and in the presence of acid hydrobromic acid triphenylphosphine. When XH and YH in the formula (X) represent a hydroxy group, they can be protected by an oxy group (such as acetoxy), and the protective group is removed by the compound of the formula (X) after the reaction. The removal of the acetyloxy protecting group is performed by adding a suitable base, such as an alkoxide (e.g. sodium methoxide), in a suitable solvent such as an alcohol (e.g. methanol) at about room temperature. _____- 35- The size of this paper uses the Chinese National Standard (CNS) Μ specifications (21〇 × 297 public director (please read the notes on the back before filling in this page). Order V. Invention description (33) A7 B7 The above reaction is particularly suitable For the preparation of compounds of formula (II) where R4 is not methyl. When R4 is methyl, the compound of formula (JI) can be prepared with V-demethyl sodarin, compound of formula (XII).</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(請先閱讀背面之注意事項再填寫本頁) 經濟部中央標半局貝工消费合作社印装 是以’例如，R4代表甲基的式（III).化合物可藉傳統方法 保護（XII)的幾基，然後，如果合宜，再將2，_軸向羥基以 前述互變方法轉化成不同的Ri基困製備。在使用2，_軸向羥 基時可能需要保護3·及4’羥基。保護可以方法（a)之第一 具體實施例形成異亞丙基行之。然後以酸，如無機酸（例 如鹽酸）處理形成二醇以除去此基團。 在式（XII)化合物之羧基以二苯基甲基保護時，保護反 應可用式（XII)化合物於醇性溶劑（例如甲醇）内之溶液及 /或南素化的烴屬（例如二氣甲烷）内之溶液以二苯基二氮 甲烷處理行之，較佳是加作爲。由素化的烴屬（例如二氣甲 烷）内之溶液。 X及Y代表氧或硫的式（11)化合物也可藉使對應的經保 護的式（I)化合物衍生物，其中CR2R3代表c = 〇，而η是零 -36- 本紙張尺度遑用中國a家標率（CNS )从胁（21〇χ297公法 ，1Τ A7 B7 經濟部中央揉準局員工消費合作社印製 五、發明説明（34 ) ，行脱羰基化製備。脱羰基化可藉加烷氧基化合物（例如 CHsONa)於如醇的合適的溶劑（例如甲醇）内完成。 式（X)化合物可用索達林以傳統的羧基保護方法製備。是 以’在式（X)化合物的RP代表三曱及甲矽烷基乙基時，此 基困可用0-[2-(三曱基曱矽烷基）乙基]_N,N_二異丙基異 脲處理索達林引入，較佳是於如醚的合適的溶劑（例如四氫 呋喃）内於高溫（例如回流下）進行。在RP代表二苯基甲基時 ，此基團可用前述方法引入。 在索達林之羧基經保護的衍生物或式（χι化合物的羥基 以P -甲氧基苄基保護時，此基團可用氧化錫（例如氧化二丁 基錫）於烴屬溶劑（例如回流中的甲苯）反應，然後再加卜甲 氧基爷基_素化物在有氟化物鹽（例如氟化四丁基銨）之存 在下引入。在以芊氧羰基保護時，此基團可用芊基自甲酸 酯在有合適的胺鹼，如4-二甲胺基吡啶，之存在下，於鹵 素化的烴屬（例如二氣甲烷）内之溶液内反應引入。 式（VII)中L基團之形成，其中L是烷基_或芳基磺醯氧基 及/或R220基團，此處R22〇是烷基_或芳基磺醯氧基，可 用合適保護的索達林或式（ΧΙΙ)化合物與是烷基_或芳基磺 醯鹵素化物在有合適的溶劑如吡啶之存在下且視需要也含 有胺瞼（例如4-二曱胺基吡啶）或於鹵素化的烴屬（例如二氣 甲烷）内在有合適的胺鹼（例如4_二甲胺基吡啶）之存在下進 行。此反應可方便地於室溫進行。其他基團可用傳統方法 以相似方式引入。 會了解到，根據方法（C)可將羥基在環化前轉化成所需的 37- 表紙張尺度it财關家轉(6NS )A4«^( 210x1^^7 (請先閲讀背面之注意事項再填寫本頁) Λ 經 央 標 準 局 Ά 工 消 費 合 作 社 印 製 321644 五、發明説明（35 基困。是以，經合適保護的4，_脱甲基索達林衍生物或 R爲羥基的式（Π)化合物，可用傳統方法反應使4，-羥基 轉化成所需的R1基團。是以，例如，轉化成…^烷氧基烷 基或芳基^—4燒氧基可以傳統烷基化方法完成，例如，根 據前述各法完成。除去羥基製成尺！5爲氫的化合物，可方 便地以二步驟完成：（i)用強鹼（例如氫化鈉）在有咪唑的存 在下，於如醚之合適的溶劑（例如四氫呋喃）内於低溫（例如 、’勺〇 c)處理，生成s -燒基二硫代碳酸醋，然後於約室溫加 二硫化碳及烷基由素化物（例如甲基碘）；（ii)將中間體化合 物於杈屬溶劑（如甲苯）内之溶液於高溫（例如約8 0。至丨20 c )以氫化物還原劑（例如氫化三烷基錫，如氫化三丁基錫） 處理，視需要在有活化劑[例如偶氮雙（異丁基猜）]之存在 下，除去此基團。轉化成C2_6烷基可藉（i)生成前述之8_烷 基二硫代碳酸酯，（ii)與三烷基締基錫化合物在前述條件 下反應以晞基取代此基團，除去S -燒基二硫代碳酸酯基團 ，及（i i i)在有合適的鈀催化劑（例如i 0 %鈀/碳）之存在下 還原此烯基成烷基。 式（I)化合物之鹼鹽可以合適的鹽或鹼處理式（1)化合物生 成。是以，例如，可以式（I)化合物用選自氫氧化鈉或却、 碳酸氫鹽、碳酸鹽或醋酸鹽（例如氫氧化鉀，碳酸氫卸，竣 酸氫鈉，或醋酸鉀）、醋酸銨、醋酸鈣及L·賴胺酸的鹽或驗 處理製備。此鹽可，例如，以加合適的鹽或鹼（如需要時使 用其水溶液）於式（I)化合物於合適的溶劑如醇（例如甲醇） 或二噁烷内的溶液或懸浮液中於0 °C至8 0 °C，較佳是、約室 -38- 本紙張尺度逍用中國國家標準（CNS ) A4規格（210X297公釐）</span>(Please read the precautions on the back and then fill out this page) The Ministry of Economic Affairs Central Standard and Semi-bureau Beigong Consumer Cooperative Printed is based on the formula (III) where R4 represents methyl. The compound can be protected by traditional methods (XII) Several groups, and then, if appropriate, the 2, _ axial hydroxyl groups are converted into different Ri groups by the aforementioned interconversion method. It may be necessary to protect the 3 · and 4 'hydroxyl groups when using 2, _axial hydroxyl groups. Protection can be achieved by forming the isopropylidene in the first specific embodiment of method (a). It is then treated with an acid, such as an inorganic acid (e.g. hydrochloric acid) to form a diol to remove this group. When the carboxyl group of the compound of formula (XII) is protected by diphenylmethyl, the protection reaction can be a solution of the compound of formula (XII) in an alcoholic solvent (such as methanol) and / or a sulfonated hydrocarbon (such as methane gas) ) The solution inside is treated with diphenyl diazomethane, preferably as an addition. A solution in a genus of hydrocarbons (such as methane). Compounds of formula (11) where X and Y represent oxygen or sulfur can also use corresponding protected derivatives of compounds of formula (I), where CR2R3 represents c = 〇, and η is zero-36- A home standard rate (CNS) is printed from the threat (21〇χ297 public law, 1T A7 B7, Ministry of Economic Affairs, Central Bureau of Economic Cooperation, Employee Consumer Cooperatives. Fifth, the invention description (34), prepared by decarbonylation. Decarbonylation can be added by adding alkyl Oxygen compounds (for example, CHsONa) are completed in a suitable solvent such as alcohol (for example, methanol). The compound of formula (X) can be prepared by sodarin using the traditional carboxyl protection method. It is represented by the RP in the compound of formula (X) In the case of trimethyl and silylethyl, this base can be introduced by 0- [2- (trimethylsilyl) ethyl] _N, N_diisopropylisourea treatment sodarin, preferably in Such as ether in a suitable solvent (such as tetrahydrofuran) at a high temperature (such as reflux). When RP represents diphenylmethyl, this group can be introduced by the aforementioned method. The carboxyl-protected derivative of sodarin or When the hydroxyl group of the compound of formula (χι is protected by P-methoxybenzyl, this group can be oxidized (For example, dibutyltin oxide) is reacted with a hydrocarbon solvent (for example, toluene in reflux), and then added with methoxyphenyllinated compound in the presence of a fluoride salt (for example, tetrabutylammonium fluoride). When protected with a fluorenyloxycarbonyl group, this group can be used as a fluorenyl autoformate in the presence of a suitable amine base, such as 4-dimethylaminopyridine, in a halogenated hydrocarbon genus (such as methane) Introduced into the reaction within the solution. Formation of the L group in formula (VII), where L is an alkyl_ or arylsulfonyloxy group and / or R220 group, where R22〇 is an alkyl_ or arylsulfonate Acetyloxy, suitably protected sodarin or a compound of formula (XII) and alkyl- or arylsulfonyl halide in the presence of a suitable solvent such as pyridine and optionally containing amine eyelids (eg 4- Dimethylaminopyridine) or halogenated hydrocarbons (such as methane) in the presence of a suitable amine base (such as 4-dimethylaminopyridine). This reaction can be conveniently carried out at room temperature. Other groups can be introduced in a similar manner using traditional methods. It will be understood that according to method (C), The base is converted into the desired 37-sheet paper size before it is cyclized. It's a financial solution (6NS) A4 «^ (210x1 ^^ 7 (please read the precautions on the back before filling out this page) Λjingyang Standards Bureau Ά Printed by Industrial and Consumer Cooperatives 321644 V. Description of the invention (35 bases. Therefore, properly protected 4, _demethylsodarin derivatives or compounds of formula (Π) where R is hydroxy can be reacted by traditional methods to make 4 , -Hydroxy group is converted to the desired R1 group. Therefore, for example, the conversion into ... ^ alkoxyalkyl or aryl ^ -4 alkoxy group can be accomplished by traditional alkylation methods, for example, according to the aforementioned methods .Remove the hydroxyl group to make the ruler! 5 is a hydrogen compound, which can be conveniently done in two steps: (i) with a strong base (such as sodium hydride) in the presence of imidazole, in a suitable solvent such as ether (such as tetrahydrofuran) Processed at low temperature (eg, scoop 〇c) to produce s-alkyl dithiocarbonate, and then add carbon disulfide and alkyl radicals (such as methyl iodide) at about room temperature; (ii) the intermediate The solution of the compound in a solvent of the genus (such as toluene) is at a high temperature (for example about 80. To 丨 20 c) Treated with a hydride reducing agent (such as trialkyltin hydride, such as tributyltin hydride), if necessary, remove this group in the presence of an activator [such as azobis (isobutyl quinidine)] group. Conversion to C2_6 alkyl can generate (i) the aforementioned 8-alkyl dithiocarbonate, (ii) react with a trialkylalkenyl tin compound under the aforementioned conditions to replace this group with a silyl group to remove S- The alkyl dithiocarbonate group, and (iii) reduce this alkenyl group to an alkyl group in the presence of a suitable palladium catalyst (eg, i 0% palladium / carbon). The base salt of the compound of formula (I) can be produced by treating the compound of formula (1) with a suitable salt or base. Therefore, for example, the compound of formula (I) may be selected from sodium hydroxide or sodium hydroxide, bicarbonate, carbonate or acetate (such as potassium hydroxide, hydrogen carbonate, sodium bicarbonate, or potassium acetate), acetic acid Salt or test preparation of ammonium, calcium acetate and L·lysine. This salt can be added, for example, to a solution or suspension of a compound of formula (I) in a suitable solvent such as alcohol (eg methanol) or dioxane by adding a suitable salt or base (aqueous solution if necessary) ° C to 8 0 ° C, preferably, about room-38- The paper size is free to use the Chinese National Standard (CNS) A4 specification (210X297mm)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">X 訂 A7 經濟部中央揉準局員工消费合作社印裝 五、發明説明（36) 、溫’製備。 醫藥上可接受的鹽也可由其他鹽，包括式（1)化合物的其 他醫藥上可接受的鹽，用傳統方法製備。 式（I)化合物的代謝上不安定的酯可以傳統方法與存在的 幾基反應製備。同樣，代謝上不安定的酯也可與分子上存 在的游離態的叛基生成。 新穎式（XII)化合物可根據後述發酵方法製備，或用生物 轉化方法使索達林去甲基化製備。 發酵方法包括培養能產生式（XII)化合物的微生物，然後 再由培養物中分離式（XII)化合物。 能產生式（XII)化合物的微生物可以是蛛網糞殼菌的變種 菌株’此種菌株可藉分析以標準方法由微生物發酵取得的 試驗樣品篩選謗變種的存活率獲得證實。特別是，方便使 用的微生物是由英國CAB International Mycological Institute, Genetic Resource Reference Collection Bakeham Lane, Egham，Surrey TW20 9TY不變培養集合所存的蛛網糞 殼菌的變種菌株。此菌株係於1994年6月10曰由此機構收 到，給予的取得編號爲IMI 362184，並註明收到曰期及存 活證實日期分別爲1994年6月13日及21曰。此機構依布達 佩斯條約被承a忍爲國際存儲（Internati〇nai Depository)權威 。就IMI 362 184到目前爲止所證實的特性見實例7 4所述。 本發明在又一方面提供原IMI 362184微生物及其變種。 IMI 3 62184變種可自然發生，也可以各種方法，包括HI Adler 於 Radiation and Radioisotops for Industrial -39 匕紙張尺度適用中國國家揲準（CNS ) A4规格（210X297公羞） (請先閱讀背面之注意事項再填寫本頁)</span>X Order A7 Printed by the Employees' Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs V. Description of invention (36), prepared by Wen ’. Pharmaceutically acceptable salts can also be prepared from other salts, including other pharmaceutically acceptable salts of compounds of formula (1), using conventional methods. Metabolically unstable esters of compounds of formula (I) can be prepared by reaction with the existing bases by conventional methods. Similarly, metabolically unstable esters can also be formed with free radicals present on the molecule. The novel compound of formula (XII) can be prepared according to the fermentation method described later, or can be prepared by demethylation of sodarin by a biotransformation method. The fermentation method involves culturing a microorganism capable of producing the compound of formula (XII), and then separating the compound of formula (XII) from the culture. The microorganism capable of producing the compound of formula (XII) may be a variant of D. arachnoides. This strain can be confirmed by analyzing the survival rate of the mutant by screening test samples obtained by fermentation of microorganisms by standard methods. In particular, the microorganisms that are convenient to use are the strains of arachnid coccidioides stored in the constant culture collection of CAB International Mycological Institute, Genetic Resource Reference Collection Bakeham Lane, Egham, Surrey TW20 9TY, United Kingdom. This strain was received by this organization on June 10, 1994, and the acquisition number was given as IMI 362184, and the date of receipt and the date of confirmation of survival were indicated on June 13, 1994 and 21, respectively. This institution is accepted as an international depository (Internati〇nai Depository) authority under the Buda Pace Treaty. For the characteristics proven so far by IMI 362 184, see Example 74. In yet another aspect, the present invention provides the original IMI 362184 microorganism and variants thereof. The IMI 3 62184 variant can occur naturally or in a variety of ways, including HI Adler ’s Radiation and Radioisotops for Industrial -39. The paper size applies to the Chinese National Standard (CNS) A4 (210X297) (please read the notes on the back (Fill in this page again)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T A7 B7 8^1644 五、發明説明（37)</span>、 1T A7 B7 8 ^ 1644 V. Description of the invention (37)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Microorganisms'’ 内 Techniques for the Development of Microorganisms所述的方法，及Proceedings of the</span>Microorganisms ’’ Techniques for the Development of Microorganisms, and Proceedings of the</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Symposium, Vienna 1973, p241, International Atomic Energy authority所述的方法。此等方法包括離子化放射， 化學方法，例如用N -甲基-N'-硝基-N -硝基異脈（n T G)， 熱’基因技術’如基因重組及基因轉化，處理，以及選擇 性的自然變種技術。 以發酵製備式（XII)化合物可以傳統方法完成，即在有可 同化的碳、氮、及礦物鹽源的存在下培養合適的微生物， 然後分離所需產物。 可同化的碳、氮、及礦物鹽源可由簡單的或複合的營養 劑供應。碳源一般包括葡萄糖，麥芽糖，澱粉，甘油，糖 密’糊精，乳糖，蔗糖，水果糖，半乳糖，肌醇，D_甘露 糖’大豆油’羧酸，胺基酸’甘油酯，醇，烷類及植物油 。碳源一般構成的發酵基的〇. 5至1 〇 %重量百分比。水果糖 ’葡萄糖及蔗糖代表較佳的碳源。 氮源一般包括大豆粉，玉米潰液，酒糟，酵母萃取物， 棉子粉，腺，磨碎的硬果粉，麥芽萃取物，糖密，酪蛋白 ’胺基酸混合物，氨（氣體或溶液），銨鹽或硝酸鹽，也可 用脲及其他醯胺。氮源一般構成的發酵基的〇1至1〇%重量 百分比。 可使用於培養基的營養礦物鹽包括一般使用的能產生鈉 、辞、按、鐵、巍、鋅、錄、姑、鞋、訊、路、約、銅、 紐、硼、磷酸鹽、硫酸鹽、氣化物及碳酸鹽離子的鹽。 -40- 本紙張尺度適用中國B家橾準（CNS ) A4規格（210X297公嫠 (請先閲讀背面之注意事項再填寫本頁} Λ. 訂 經濟部中央棣準局員工消費合作社印製 經濟部中央檫準局貝工消費合作社印製 A7 ---------- 五、發明説明（38) 一 *- 微生物的培養一般係於20。至40°C行之，較佳是2〇。(：至 35C ’尤其是約25。(：，有時需要在通風及振盪（如搖動或 攪拌）下進行。培養基内開始時可接種少量的菌絲體及/或 抱子°所得的植物性接種物可轉移至發酵基質，或者轉移 至一或多個種台（seed stages )，於該處進一步生長，然後再 轉移至主發酵基質。發酵一般在pH 3.5至9.5進行，較佳是 4·5至7.5。發酵基質内可能需加鹼或酸以維持pH在所需範 圍内。可加的合適的鹼包括氫氧化鹼金屬，例如氫氧化納 或氫氧化鉀水溶液。合適的酸包括礦物酸，如鹽酸，硫酸 或崎酸·。 發酵可進行4-30天，較佳是約5-15天。爲控制起泡過多 可加抗起泡劑，加入時距視需要而定。碳及/或氮源也可 視需要加於發酵基質内。 式（XII)化合物主要聯於細胞上，可加酸或可與水相溶的 有機溶劑，更佳是加鹼（例如氫氧化鈉），使成溶液。溶液 内的細胞可藉離心、傳統過濾法或膜過濾分離。此液體視 需要可再用酸，如硫酸，處理至p Η低於6 (例如約4.5 )。 式（XII)化合物可以各種分配技術分離並純化，例如用吸 附洗離，沉殿，分級:结晶，溶劑萃取，及液體-液體分配法 ，也可混合數種方法使用。 分離及純化式（IX)化合物以吸附於固體支撑上再做洗離 爲最合適。合適的固體支撑包括二氧化碎；非官能性大網 吸附樹脂，例如交聯的苯乙烯二乙烯基苯聚合物樹脂，如 CG161 及 Amberlite XAD-2，XAD-4，XAD-16 或 XAD-1180 -41 - i紙張尺度逍用中國國家標準（CNS ) A4规格（210X297公釐） ~ ---------f Λ------IT------f (請先閲讀背面之注意事項再填寫本頁)</span>Symposium, Vienna 1973, p241, International Atomic Energy authority. These methods include ionizing radiation, chemical methods such as N-methyl-N'-nitro-N-nitroisomai (n TG), thermal 'gene technology' such as gene recombination and gene conversion, treatment, and Selective natural variant technology. The preparation of the compound of formula (XII) by fermentation can be accomplished by traditional methods, that is, cultivating suitable microorganisms in the presence of assimilable sources of carbon, nitrogen, and mineral salts, and then isolating the desired product. The sources of assimilable carbon, nitrogen, and mineral salts can be supplied by simple or compound nutrients. Carbon sources generally include glucose, maltose, starch, glycerin, molasses dextrin, lactose, sucrose, fruit sugar, galactose, inositol, D_mannose 'soybean oil' carboxylic acid, amino acid 'glyceride, alcohol , Alkanes and vegetable oils. The carbon source generally constitutes 0.5 to 10% by weight of the fermentation base. Fruit sugar 'glucose and sucrose represent preferred carbon sources. Nitrogen sources generally include soybean meal, corn broth, lees, yeast extract, cottonseed meal, glands, ground hard fruit powder, malt extract, molasses, casein 'amino acid mixture, ammonia (gas or solution ), Ammonium or nitrate, urea and other amides can also be used. Nitrogen sources generally constitute 0.01 to 10% by weight of the fermentation base. The nutrient mineral salts that can be used in the culture medium include commonly used sodium, sodium, aluminum, iron, iron, zinc, aluminum, aluminum, phosphate, sulfate, Salts of vapors and carbonate ions. -40- This paper scale is applicable to China ’s B Family Standard (CNS) A4 specification (210X297 public daughter (please read the precautions on the back and then fill out this page) Λ. Order the Ministry of Economic Affairs, Central Bureau of Industry and Commerce Printing Co., Ltd. Printed by the Central Sassafrass Bureau Beigong Consumer Cooperative A7 ---------- V. Description of the invention (38) One *-The cultivation of microorganisms is generally at 20. To 40 ° C, preferably 2 〇. (: To 35C 'especially about 25. (:, sometimes need to be carried out under ventilation and shaking (such as shaking or stirring). At the beginning of the medium can be inoculated with a small amount of mycelium and / or spores obtained The plant-based inoculum can be transferred to the fermentation substrate, or to one or more seed stages, where it is further grown, and then transferred to the main fermentation substrate. The fermentation is generally carried out at pH 3.5 to 9.5, preferably 4.5 to 7.5. It may be necessary to add alkali or acid to the fermentation substrate to maintain the pH in the desired range. Suitable alkalis that can be added include alkali metal hydroxides, such as aqueous sodium hydroxide or potassium hydroxide. Suitable acids include Mineral acids, such as hydrochloric acid, sulfuric acid or succinic acid .. Fermentation can be carried out 4-30 , Preferably about 5-15 days. To control excessive foaming, anti-foaming agent can be added, the time of addition depends on the need. Carbon and / or nitrogen source can also be added to the fermentation matrix as needed. Compound of formula (XII) Mainly attached to cells, it can be added with acid or water-soluble organic solvent, more preferably with alkali (such as sodium hydroxide) to make a solution. The cells in the solution can be separated by centrifugation, traditional filtration method or membrane filtration This liquid can be re-used with acid, such as sulfuric acid, if necessary, and treated to a pH of less than 6 (eg, about 4.5). The compound of formula (XII) can be separated and purified by various distribution techniques, such as washing away by adsorption, Shen Dian, classification: Crystallization, solvent extraction, and liquid-liquid distribution methods can also be used in combination. Separation and purification of the compound of formula (IX) is most suitable for adsorption on a solid support followed by washing away. Suitable solid supports include dioxide ; Non-functional large-mesh adsorption resins, such as cross-linked styrene divinylbenzene polymer resins, such as CG161 and Amberlite XAD-2, XAD-4, XAD-16 or XAD-1180 -41 -i China National Standard (CNS) A4 specification (210X297 PCT) ~ --------- f Λ ------ IT ------ f (Please read the Notes on the back to fill out this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">樹脂（Rohm &amp;amp; Haas Limited)或Kastell SI 12 (Montedison); 經取代的苯乙烯二乙晞基苯聚合物，如Diaion SP207 (Mitsubishi);陰離子交換器[例如 ira-958 或 MacroPrep High Q (BioRad)]，與有機溶劑相容的交聯的葡聚糖，如 Sephadex LH20 (Pharmacia UK Limited)，或反相支撑，如 聯與烴屬的二氧化矽，例如C18•相聯的二氧化矽。 式（XII)化合物也可使用液體陰離子交換器，如LA2，分 離並純化。 合適的洗離式（XII)化合物用的溶劑自然視吸附的性質而 定。在使用聚合物樹脂（如X AD-16)時，可用與水相溶的 溶劑，如甲醇，丙酮，異丙醇或乙腈，可與水作不同比例 使用。 在萃取/分離過程中，式（χπ)化合物的存在可利用次化 物的光旋性質或其他性質藉傳統技術，如高效液體色譜法 (HPLC)或UV光譜法，鑑測。 經濟部中央樣準局—工消費合作社印策 (請先閲讀背面之注意事項再填寫本頁)</span>Resin (Rohm &amp;amp; Haas Limited) or Kastell SI 12 (Montedison); substituted styrene diethylbenzylbenzene polymer, such as Diaion SP207 (Mitsubishi); anion exchanger [eg ira-958 or MacroPrep High Q (BioRad )], Cross-linked dextran compatible with organic solvents, such as Sephadex LH20 (Pharmacia UK Limited), or reversed-phase supports, such as silicon dioxide with hydrocarbons, such as C18 • linked silica. The compound of formula (XII) can also be separated and purified using a liquid anion exchanger such as LA2. A suitable solvent for washing away the compound of formula (XII) will naturally depend on the nature of the adsorption. When using polymer resins (such as X AD-16), solvents that are compatible with water, such as methanol, acetone, isopropanol, or acetonitrile, can be used in different proportions with water. During the extraction / separation process, the presence of the compound of formula (χπ) can be detected by using the optical rotation property or other properties of the secondary compound by traditional techniques, such as high performance liquid chromatography (HPLC) or UV spectroscopy. Printed by the Central Sample Bureau of the Ministry of Economic Affairs-Workers and Consumers Cooperatives (please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T 在取得的式（XII)化合物是有機溶劑内的溶液形式時，例 如以吸附/洗離所取得者，溶劑可藉傳統方法，例如蒸發 ’製得所需化合物。如有必要，此化合物還可進一步用色 層分析技術純化，如使用旋轉萃取器（如多層旋管萃取器） 作反流色層分析，或於有或無鍵合相的吸附劑（如碳，氧化 銘’訊’聚合樹脂或二氧化矽）上作高效液體色譜分析或超 臨界流體色譜分析。適於式（χπ)化合物色譜分析純化/分 離的合適·的溶劑/洗離劑自然視吸附劑的性質而定。在使 用C 8鍵合二氧化矽時，以乙腈及水的混合物爲最合適。或 ____- 42 - 本紙張尺i遗用中國國家標準（( 21〇&amp;gt;&amp;lt;297公釐） - A7 B7 經濟部中央棣準局員工消費合作社印製 五、發明説明（40 ) 者，此化合物可進一步以溶劑萃取純化，例如使用合適的 有機溶劑，如網（例如丙酮或甲基乙基酮），南素化的烴屬 ，醇（例如曱醇），二醇（例如丙烷-1,2-二醇或丁烷_：ι，3_二 醇），或酯（例如醋酸甲酯或醋酸乙酯）。另一種純化方法， 使式（XII)化合物溶液以吸附劑處理，此種吸附劑（如 DEAE-纖維素）所加的量適宜時可選擇性地除去雜質，或以 重結晶法純化（例如用乙腈及水的混合物重結晶），或合併 使用上述諸法純化。 將索達林作生物轉化成4，-脱甲基索達林，及式（χπ)化 合物，可藉將索達林在含有合適的微生物及碳源與氮源， 包括上述的各源’的培養物中培養’然後從培養物中分離 式（XII)化合物。</span>1T When the compound of formula (XII) obtained is in the form of a solution in an organic solvent, such as those obtained by adsorption / washing, the solvent can be prepared by conventional methods, such as evaporation. If necessary, this compound can be further purified by chromatography, such as using a rotary extractor (such as a multi-layer coil extractor) for countercurrent chromatography, or with or without a bonded phase adsorbent (such as carbon , Oxidation Ming 'Xun' polymer resin or silica) for high-performance liquid chromatography or supercritical fluid chromatography. The suitable solvent / eluting agent suitable for the purification / separation of the compound of formula (χπ) by chromatographic analysis naturally depends on the nature of the adsorbent. When using C 8 bonded silica, a mixture of acetonitrile and water is most suitable. Or ____- 42-This paper ruler uses Chinese national standards ((21〇 &amp;gt; &amp;lt; 297mm)-A7 B7 Printed by the Consumer Cooperative of the Central Diplomatic Bureau of the Ministry of Economic Affairs V. Invention Instructions (40), This compound can be further purified by solvent extraction, for example, using a suitable organic solvent, such as a net (such as acetone or methyl ethyl ketone), a sulfonated genus, alcohol (such as methanol), diol (such as propane-1 , 2-diol or butane _: ι, 3_ diol), or ester (such as methyl acetate or ethyl acetate). Another purification method, the compound of formula (XII) solution is treated with an adsorbent, such The amount of adsorbent (such as DEAE-cellulose) can be selectively removed when appropriate, or purified by recrystallization (for example, recrystallized with a mixture of acetonitrile and water), or combined to purify using the above methods. Darling is biologically converted into 4, -demethyl sodarin and a compound of formula (χπ). Sodarin can be used in a culture containing suitable microorganisms, carbon sources and nitrogen sources, including the above sources' Medium culture 'and then the compound of formula (XII) is isolated from the culture.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">能使索達林於4’-位脱甲基的微生物可用小尺度試驗並用 標準方法分析取得的試驗樣品（如用HPLC分析）確定。已證 實能使索達林脱甲基的微生物的例包括纏繞鍵露菌ATC：C： 31963’ Strepomyces avermitillis ATCC 31272，畜群鍵霉菌 NRRL 3176，拉生鏈霉菌ATCC 31771 ^龜裂鏈霉菌ATCC 23955，普拉特鏈霉菌ΑΤΓ,Γ. 29778，馬書鏈霉菌ATCC 23934 泛溫鏈霉菌ATCC 14975 »東方諾卡氏菌ATCC 43491，及長刺孢小克銀漢霖ΑΤΓΓ 36112 ° 微生物之培養可於20。至4(TC，較佳是20。至35Ό，最 佳是約28°C行之，有時需在通風及振盪（如搖動或攪掉）下 進行。培養基内開始時可接種少量的菌絲體及/或孢子。 所得的植物性接種物可轉移至發酵基質，或者轉移至一個 -43- ---------f I------、w------ (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準（CNS ) 格（210X297公癀） 經濟部中央樣準局貝工消費合作社印製 321644 A7 B7 五、發明説明（41 ) 多個種台（seed stages)，於該處進一步生長（例如約1-3天) ，然後再轉移至主發酵基質。主發酵基質也可含索達林， 且發酵一般在pH 3.5至9·5進行，較佳是4 5至7 5。發酵基 質内可能需加瞼或酸以維持pH在所需範圍内。可加的合適 的檢包括氫氧化鹼金屬，例如氫氧化鈉或氫氧化鉀水溶液 。合適的酸包括礦物酸，如鹽酸，硫酸或磷酸。發酵可進 行2 - 5天，較佳是約3天。爲控制起泡過多可加抗起泡劑， 加入時距視需要而定。碳及/或氮源也可視需要加於發酵 基質内。. 從發酵肉湯中分離式（XII)化合物可以前述一般方法進行 。在需要將液體pH降至6以下時（如約2.5)，可以加酸，如 正鱗酸，達成。 應知’生物轉化可根據各種方法完成。例如，細胞可於 加入索達林於例如緩衝劑、用過的發酵基質及水内的溶液 之前接種並收穫。另外，分離並使用合適的酶（同時用合適 的輔酶）或使酶克隆化並過度表達也是可行的。 如上所述，索達林及索達里新都是已知的化合物，可以 有關技藝所述方法製得。是以，例如，英國專利説明 1，162,027號敘述培養蛛網糞殼菌NRRL 3196(t&amp;amp;ATCC 363 86存儲於ATCC)製備索達林。後面將述及以類似方法製 備索達林的特定實例。</span>Microorganisms capable of demethylating sodarin at the 4'-position can be determined by small-scale tests and analysis of test samples obtained by standard methods (such as HPLC analysis). Examples of microorganisms that have been shown to demethylate sodarin include A. tangutorium ATC: C: 31963 'Strepomyces avermitillis ATCC 31272, herd key mold NRRL 3176, Streptomyces praxis ATCC 31771 ^ Streptomyces spp. ATCC 23955 , Streptomyces platatus ΑΓΓ, Γ. 29778, Streptomyces mascus ATCC 23934 Streptomyces pantherus ATCC 14975 »Nocardia orientalis ATCC 43491, and Agaricus lanceolata A. ΓΓ 36112 ° microorganisms can be cultured at 20. To 4 (TC, preferably 20. To 35Ό, most preferably about 28 ° C, sometimes need to be carried out under ventilation and shaking (such as shaking or stirring). The culture medium can be inoculated with a small amount of hypha Body and / or spores. The resulting plant inoculum can be transferred to the fermentation substrate, or to a -43- --------- f I ------, w ------ (Please read the precautions on the back before filling in this page) This paper scale is applicable to the Chinese National Standard (CNS) grid (210X297 Gonghuang) Printed 321644 A7 B7 by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of invention (41 ) Multiple seed stages, where they are further grown (for example, about 1-3 days), and then transferred to the main fermentation substrate. The main fermentation substrate can also contain sodarin, and the fermentation is generally at pH 3.5 to 9 • 5 is carried out, preferably 4 5 to 75. The fermentation medium may need to add eyelid or acid to maintain the pH in the desired range. Suitable tests may include alkali metal hydroxide, such as sodium hydroxide or hydroxide Potassium aqueous solution. Suitable acids include mineral acids such as hydrochloric acid, sulfuric acid or phosphoric acid. Fermentation can be carried out for 2 to 5 days, preferably about 3 days. If there is too much foaming, anti-foaming agent can be added. The time of addition depends on the need. The carbon and / or nitrogen source can also be added to the fermentation matrix as needed. Carry out. When it is necessary to reduce the pH of the liquid to below 6 (such as about 2.5), you can add acid, such as orthosquaric acid, to achieve. It should be understood that biotransformation can be completed according to various methods. For example, buffers, used fermentation substrates and solutions in water are inoculated and harvested before. In addition, it is also feasible to isolate and use appropriate enzymes (while using appropriate coenzymes) or to clone and overexpress the enzymes. As mentioned above, Both Sodarin and Sodarin are known compounds and can be prepared by the method described in the art. Therefore, for example, British Patent No. 1,162,027 describes the cultivation of D. arachnoidis NRRL 3196 (t &amp;amp; ATCC 363 86 Stored at ATCC) to prepare sodarin. Specific examples of preparing sodarin in a similar manner will be described later.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">索達里新可以使用蛛網糞殼菌NRRL 3196或其合適的變 種製備索達林所用的類似發酵方法製備，使用合適的色譜 分析分離所需化合物。一種此種變種已存儲於英國CAB _ - 44 - 本紙張尺度適用中國阐家梯準（CNS ) A4*L格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁) ί&amp;lt; 、π 經濟部中央標準局貝工消費合作社印製 A7 B7 五、發明説明（42 )</span>Sodarin can be prepared using a similar fermentation method used to prepare Sodarin using D. arachnoides NRRL 3196 or a suitable variant thereof, using appropriate chromatographic analysis to isolate the desired compound. One such variant has been stored in the British CAB _-44-This paper scale is suitable for China's Jiejia Step Standard (CNS) A4 * L grid (210X297mm) (Please read the precautions on the back before filling this page) π A7 B7 printed by Beigong Consumer Cooperative of Central Bureau of Standards of the Ministry of Economy V. Description of invention (42)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">International Mycological Institute, Genetic Resource Reference Collection Bakeham Lane, Egham, Surrey TW20 9TY。此菌株係於1994年8月11日由此機構收到，給予的 取得編號爲IMI 362947，存活證實曰期分別爲1994年8月 19日。此機構依布達佩斯條約被承認爲國際存儲 (International Depository)權威。就IMI 362947到目前爲止 所證實的特性見實例26所述。 本發明進一步提供微生物IMI 362947本身及其突變種。 取得IMI 362947變種及其基因物質的方法與前述操作IMI 362184之方法相似。 索達里新也可使用生物轉化法由索達林製備。生物轉化 的完成是：將索達林於含有合適的微生物及碳源與氮源（包 括前述的各種碳源與氮源）的培養物内培育，然後從培養物 内分離索達里新。 能使索達林轉化成索達里新的微生物可用小尺度試驗並 用標準方法分析取得的試驗樣品（如用HPLC分析）確定。發 明人等已證實一種此種微生物，並已存入National Collections of Industrial and Marine Bacteria Limited (NCIMB), 23 St. Machar Drive, Aberdeen AB2 1RY,</span>International Mycological Institute, Genetic Resource Reference Collection Bakeham Lane, Egham, Surrey TW20 9TY. This strain was received by this institution on August 11, 1994, and the obtained accession number was IMI 362947, and the date of survival confirmation was August 19, 1994, respectively. This institution is recognized as an international depository authority under the Budapest Treaty. See Example 26 for the characteristics demonstrated so far by IMI 362947. The present invention further provides the microorganism IMI 362947 itself and its mutants. The method for obtaining the IMI 362947 variant and its genetic material is similar to the method for operating IMI 362184 described above. Sodarin can also be prepared from Sodarin using biotransformation. The biotransformation is accomplished by growing Sodarin in a culture containing suitable microorganisms and carbon and nitrogen sources (including the aforementioned various carbon and nitrogen sources), and then separating Sodarin from the culture. New microorganisms that can convert Sodarin into Sodarin can be determined by small-scale tests and analysis of test samples obtained by standard methods (such as HPLC analysis). The inventors have confirmed one such microorganism and have deposited it in National Collections of Industrial and Marine Bacteria Limited (NCIMB), 23 St. Machar Drive, Aberdeen AB2 1RY,</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Scotland。NCIMB於1994年8月4日收到此菌株，於同一天 接受此菌株作專利並證實此微生物爲活的。此微生物爲棒 狀菌種（Coryneform species)，其特徵如實例2 7所述，已被 指定爲NCIMB 40675號。MCIMB爲布達佩斯條約所承認的 International Depository 權威。 -45- 本紙張尺度逋用中國國家橾準（CNS ) A4规格（210X297公釐） (請先閱讀背面之注意事項再填寫本頁) %Λ·</span>Scotland. NCIMB received this strain on August 4, 1994 and accepted the strain as a patent on the same day and confirmed that the microorganism was alive. This microorganism is a Coryneform species, and its characteristics are as described in Example 27, and it has been designated as NCIMB No. 40675. MCIMB is the international depository authority recognized by the Budapest Treaty. -45- This paper uses the Chinese National Standard (CNS) A4 standard (210X297mm) (Please read the precautions on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">，tT 經濟部中央標準局員工消費合作社印製 38ι^44 Α7 Β7 五、發明説明（43) 是以本發明另一方面還提供NCIMB 40675微生物及其變 種。 根據本發明另一方面，發明人等提供NCIMB 40675及其 變種的基因物質，可使索達林轉化成索達里斯。 取得NCIMB 40675變種及其基因的方法與前述操作IMI 362184的方法相似。 NCIMB 40675之培養可於20。至4〇。(：，較佳是20。至35 C，最佳是約28°C行之，有時需在通風及振盪（如搖動或攪 拌）下進行。培養基内開始時可接種少量的菌絲體及/或孢 子。所得的植物性接種物可轉移至發酵基質，或者轉移至 一或多個種台（seed stages )，於該處進一步生長（例如約工_ 3天），然後再轉移至主發酵基質。主發酵基質也可含索達 林，且發酵一般在pH 3.5至9.5進行，較佳是4·5至75。發 酵基質内可能需加鹼或酸以維持ρΗ在所需範圍内。可加的 合適的鹼包括氫氧化鹼金屬，例如氫氧化鈉或氫氧化鉀水 溶液。合適的酸包括礦物酸，如鹽酸，硫酸或磷酸。發酵 可進仃4 - 8天，較佳是約6天。爲控制起泡過多可加抗起泡 劑，加入時距視需要而定。碳及/或氮源也可視需要加於 發酵基質内。 ' 應知，生物轉化可根據各種方法完成。例如，細胞可於 加入索達林於例如緩衝劑、用過的發酵基質及水内的溶液 又前接種並收穫。另外，分離並使用合適的酶（同時用合適 的輔酶）或使酶克隆化並過度表達也是可行的。 索達里新由發酵肉湯之分離可以前述一般方法行之。在 (請先閱讀背面之注意事項再填寫本頁) 、11</span>Printed by the employee consumer cooperative of the Central Standardization Bureau of the Ministry of Economic Affairs 38ι ^ 44 Α7 Β7 V. Description of the invention (43) The NCIMB 40675 microorganism and its variants are also provided on the other hand of the present invention. According to another aspect of the present invention, the inventors provided the genetic material of NCIMB 40675 and its variants, which can convert sodarin to sodaris. The method for obtaining the NCIMB 40675 variant and its genes is similar to the method for operating IMI 362184 described above. NCIMB 40675 can be cultivated on 20. To 40. (:, Preferably 20. to 35 C, most preferably about 28 ° C. Sometimes it needs to be carried out under ventilation and shaking (such as shaking or stirring). A small amount of mycelium and / Or spores. The resulting plant inoculum can be transferred to the fermentation substrate, or transferred to one or more seed stages (seed stages), where it is further grown (for example, about 3 days), and then transferred to the main fermentation Substrate. The main fermentation substrate may also contain sodarin, and the fermentation is generally carried out at a pH of 3.5 to 9.5, preferably 4.5 to 75. It may be necessary to add alkali or acid to the fermentation substrate to maintain the pH in the desired range. Suitable bases to be added include alkali metal hydroxides, such as aqueous sodium hydroxide or potassium hydroxide. Suitable acids include mineral acids such as hydrochloric acid, sulfuric acid or phosphoric acid. Fermentation can take 4-8 days, preferably about 6 days . To control excessive foaming, anti-foaming agents can be added, the time of addition depends on the need. Carbon and / or nitrogen sources can also be added to the fermentation substrate as needed. ”It should be understood that biotransformation can be accomplished according to various methods. Cells can be added to sodarin in eg buffers, used The solution in the fermentation substrate and water is inoculated and harvested. In addition, it is also feasible to isolate and use the appropriate enzyme (while using the appropriate coenzyme) or to clone and overexpress the enzyme. Sodarin is separated from the fermentation broth It can be done by the general method mentioned above. (Please read the precautions on the back before filling this page), 11</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標準局員工消費合作社印製 A7 ______B7 五、發明説明（44) 需要將液體pH降至6以下時，可以加酸，如正磷酸，達成 〇 應了解到，前述製備索達里新的發酵及生物轉化法代表 本發明的又一方面。 下述各實例説明本發明的各方面，但並不限制本發明。 製備1 索達林之生產 將蛛網糞殼菌NRRL3196(ATCC 36386)培養物與瓊脂培 養基上生長至成熟。將含此成熟菌的6毫米的瓊脂塞移至滅 菌水或腦心輸液肉湯（Brain Heart Infusion broth) (Oxoid) + 1 0 %甘油内，分別存於週邊溫度或_ i 4〇 。用含2個此瓊 脂塞的懸浮液培育含50毫升FS培養基的250毫升的 Erlenmyer 燒瓶。  FS培養基 克/公升  腺（OxoidL34) 10  麥芽萃取物（Oxoid L39) 2 1  甘油（Glycerine CP) 40  Junlon 110 (Honeywell &amp;amp; Stein) 1 蒸餾水 將培養物於迴轉搖動器上於25°C培育5天，此迴轉搖動器 於50毫米直徑的軌道上以250轉/分鐘操作。用整份（2毫 升）已發展的種菌再接種於250毫升含FS培養基（50毫升）的 _-47-__ 表紙張尺度逍用中國國家梯準（CNS ) A4规格（210X297公釐） (請先聞讀背面之注意事項再填寫本頁) X.</span>A7 ______B7 printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of the invention (44) When the pH of the liquid needs to be lowered to below 6, acid can be added, such as orthophosphoric acid, to achieve 〇. Fermentation and biotransformation methods represent yet another aspect of the present invention. The following examples illustrate various aspects of the invention, but do not limit the invention. Preparation 1 Production of sodarin The culture of arachnid arachnoides NRRL3196 (ATCC 36386) and agar medium were grown to maturity. Move the 6 mm agar plug containing the mature bacteria to sterile water or Brain Heart Infusion broth (Oxoid) + 10% glycerol, and store at ambient temperature or _i 4〇, respectively. A 250 ml Erlenmyer flask containing 50 ml FS medium was incubated with a suspension containing 2 of this agar plug. FS medium g / L gland (OxoidL34) 10 Malt extract (Oxoid L39) 2 1 Glycerine CP 40 Junlon 110 (Honeywell &amp; Stein) 1 Distilled water Incubate the culture on a rotary shaker at 25 ° C 5 Today, this rotary shaker is operated at 250 rpm on a 50 mm diameter track. Inoculate 250-ml FS-containing medium (50 ml) with the whole (2 ml) of the developed inoculum and inoculate _-47 -__ sheet paper scale to use the Chinese National Standard (CNS) A4 specification (210X297mm) (please (Read the notes on the back before filling this page) X.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T 經濟部中央樣準局員工消費合作社印製 A7 B7 五、發明説明（45 ) 250毫升Erlenmyer燒瓶内，此FS培養基已作了如上述的培 育。用80毫升於搖動燒瓶内發展的種菌接種於二個各7公 升的含5公升FS培養基的發酵器内。發酵控制於25 °C的溫 度。此培養物以400轉/分鐘搖動，並以2公升/分鐘的速 度通氣。發酵3天後，用10公升培養物接種於含500公升 SM55VAR培養基的780公升的發酵器内。 SM55VAR 克/公升</span>1T Printed by the Employees Consumer Cooperative of the Central Prototype Bureau of the Ministry of Economic Affairs A7 B7 5. Description of the invention (45) In a 250 ml Erlenmyer flask, this FS medium has been cultivated as described above. 80 ml of the inoculum developed in the shaking flask was inoculated into two 7-liter fermentors containing 5 liters of FS medium. The fermentation is controlled at a temperature of 25 ° C. The culture was shaken at 400 rpm and aerated at a rate of 2 liters / min. After 3 days of fermentation, a 780 liter fermentor containing 500 liters of SM55VAR medium was inoculated with 10 liters of culture. SM55VAR g / L</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Glucidex 32D (Roquette Frere) 74 腺(OxoidL37) 10</span>Glucidex 32D (Roquette Frere) 74 glands (OxoidL37) 10</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Proflo (Traders Protein) 30 甜菜糖密 15</span>Proflo (Traders Protein) 30 Beet molasses 15</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">MgS04 .7H2 O(BDH) 5</span>MgS04 .7H2 O (BDH) 5</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">CaC03 (BDH) 5</span>CaC03 (BDH) 5</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">FeS04 .7H2 O(Sigma) 2</span>FeS04 .7H2 O (Sigma) 2</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ZnS04 ,7H2 O(BDH) 〇 〇4 左旋色胺酸(Sigma) 2 PPG2000 (K&amp;amp;K Greef) 0.5</span>ZnS04, 7H2O (BDH) 〇 〇4 L-tryptophan (Sigma) 2 PPG2000 (K &amp;amp; K Greef) 0.5</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Silicone 1520 (Dow Coming) 0.04 蒸餾水 發酵控制於2 5°C的溫度，肉湯以300-350轉/分鐘搖動， 並以200公升/分鐘的速度通氣。培養物内加70 % (重量/ 容積）Meritose (Tunnel Refineries)溶液，以維持正殘留葡 _ -48- 本紙張尺度逋用中國國家橾準（CNS ) A4规格（210X2.97公釐） (請先閱讀背面之注意事項再填寫本頁) *Λ. 訂 經濟部中央標準局員工消费合作社印裝 A7 _ _____B7__ 五、發明説明（46) 萄糖濃度。加蒸餾水以維持培養物容積爲500公升。視需要 加PPG2000抗起泡劑以控制起泡。以反相HPLC鑑定全部肉 湯萃取物（於乙腈水溶液内+1%三氟醋酸）内的索達林。n 天後’在肉湯萃取物樣品顯不索達林滴定度爲0.6克/公升 時收穫培養物。使發酵肉湯含0.1M的氫氧化鈉，於週邊溫 度存放過夜後以Dicalite於迴轉眞空過濾器上過濾（加1 〇/0 Dicalite於肉湯内作過濾助劑）。將濾過物以濃硫酸調整ρ η 至6-7，將此溶液加於XAD16樹脂（濾過物/樹脂容積的1〇 倍）。以水及丙酮/水（1 : 3 )洗吸附劑，得澄清流出物，再 _用丙酮’：水（3 : 1 ;收取二柱容積）洗離索達林。此過程的 流速爲1 - 2柱容積/小時。將洗離物濃縮至小容積（8 5公升) 。濃縮物pH以鱗酸調整至3，於週邊溫度靜置過夜沉澱出 索達林。傾倒出漂浮液，然後離心，將漂浮液去棄。將離 心丸及沉澱物溶於7 5 %的乙腈水溶液内，得3 · 9公升暗標色 溶液。於此溶液内在攪拌下加1.0公升0.2M的ΝΗ4Η2Ρ04 ’再將此溶液pH以鱗酸調整至4.0，以近60%的乙腈_〇im 的NH4H2P〇4使終容積爲5·0公升。將上述粗製索達林溶液 (5_0公升）於7毫米Kromasil C8柱（1 5公分X 25公分）上以1 〇 次注射（每次450-550毫升）作製備性HPLC處理，移動相爲 50%乙腈-0.1\1&amp;gt;1114112?〇4，卩114(以50公升乙骑用水加 至100公升’含575克NH4H2P〇4及40毫升h3P〇4)，流速 600毫升/分鐘，以UV吸光度（210納米）測定。 於15.4及19.2分鐘間分次收取洗離液。集中1 〇次注射的 洗離液（2 3公升），用水稀釋至5 0公升，再將此溶液以2 8公 -49- 本紙張尺度逍用中國國家橾準（CNS ) A4規格（210X297公釐） ---- ---------’ X II 〆 (請先閲讀背面之注意事項再填寫本頁) ,11 A7 38l644 ._____ B7 五、發明説明（47) 升/小時速度經Kromasil柱唧回。此柱用水（25公升）洗， 再以9 0 %乙腈（1 〇公升）洗離。將洗離物蒸發至丨3〇〇毫升殘 餘物，然後凉乾製成標題化合物，爲米色粉（105.6克）。此 產物以質譜（MS)及核磁共振（NMR)分析，顯示與確認的 索達林樣品相同。 製備2 索達林_鹽之生產 將蛛網糞殼菌NRRL 3196 (ATCC 36386)保存於-140°C的 腦心輸液肉湯+ 1 〇 %甘油内，如製備1所述。使用含2個瘦 脂塞的懸浮液接種於含50毫升FS培養基的250毫升的 Erlenmy er燒瓶内。此培養物於迴轉搖動器上於25。(：培育5 天，此迴轉搖動器於50毫米直徑的軌道上以250轉/分鐘 操作。用整份（2毫升）已發展的種菌再接種於250毫升含F S 培養基（5 0毫升）的250毫升Erlenmyer燒瓶内，以上述方法 培育。用80毫升於搖動燒瓶内發展的種菌接種於二個各7 公升的含5公升FS培養基的發酵器内。發酵控制於25 °C的 溫度。此培養物以400轉/分鐘搖動，並以2公升/分鐘的 速度通氣。發酵3天後，用10公升培養物接種於含5〇〇公升 SD1培養基的780公升的發酵器内。 -50- 本紙張尺度適用中國國家標準（CNS ) M规格（210X 297公釐） (請先閲讀背面之注意事項再填寫本頁) νΛ 經濟部中央標準局員工消費合作社印袋 A7 B7</span>Silicone 1520 (Dow Coming) 0.04 Distilled water Fermentation is controlled at a temperature of 25 ° C. The broth is shaken at 300-350 rpm and aerated at a rate of 200 liters / min. Add 70% (weight / volume) Meritose (Tunnel Refineries) solution to the culture to maintain positive residual Portuguese _ -48- This paper scale uses the Chinese National Standard (CNS) A4 specification (210X2.97mm) (please Please read the precautions on the back and then fill out this page) * Λ. Order the A7 _ _____B7__ printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy. V. Invention Instructions (46) Sugar Concentration. Distilled water was added to maintain the culture volume at 500 liters. Add PPG2000 anti-foaming agent as needed to control foaming. Reverse phase HPLC was used to identify Sodarin in all broth extracts (+ 1% trifluoroacetic acid in acetonitrile in water). After n days', the culture was harvested when the broth extract sample showed a sodarin titer of 0.6 g / liter. Make the fermentation broth contain 0.1M sodium hydroxide, store it at ambient temperature overnight and filter with Dicalite on the rotary hollow filter (add 10/0 Dicalite as a filter aid in the broth). The filtrate was adjusted to 6-7 with concentrated sulfuric acid to 6-7, and this solution was added to XAD16 resin (10 times the volume of the filtrate / resin). Wash the adsorbent with water and acetone / water (1: 3) to get a clear effluent, and then _ wash away the sodarin with acetone: water (3: 1; charge two column volume). The flow rate for this process is 1-2 column volumes / hour. Concentrate the eluate to a small volume (85 liters). The pH of the concentrate was adjusted to 3 with squamous acid, and the sodarin precipitated out by standing at ambient temperature overnight. Pour out the floating solution, then centrifuge to discard the floating solution. Dissolve the centrifugal pills and the precipitate in 75% acetonitrile aqueous solution to obtain 3.9 liters of dark standard solution. To this solution was added 1.0 liter of 0.2M NH4Η2Ρ04 'under stirring, and then the pH of the solution was adjusted to 4.0 with squamous acid, and the final volume was 5.0 liter with nearly 60% acetonitrile_〇im NH4H2P〇4. The above crude Sodarin solution (5_0 liter) was subjected to preparative HPLC treatment with 10 injections (450-550 ml each time) on a 7 mm Kromasil C8 column (15 cm X 25 cm) with a mobile phase of 50% Acetonitrile-0.1 \ 1&gt; 1114112? 〇4, ie 114 (add 50 liters of water to 100 liters of acetone 'containing 575 grams of NH4H2P〇4 and 40 milliliters of h3P〇4), with a flow rate of 600 milliliters / minute, with UV absorbance Nano) determination. Collect eluent in portions between 15.4 and 19.2 minutes. Concentrate 10 injections of eluent (2 3 liters), dilute with water to 50 liters, and then use this solution at 28-49-paper size to use the Chinese National Standard (CNS) A4 specifications (210X297 %) ---- --------- 'X II 〆 (please read the precautions on the back before filling in this page), 11 A7 38l644 ._____ B7 V. Description of the invention (47) Liter / hour speed Haw back through the Kromasil column. The column was washed with water (25 liters) and then washed away with 90% acetonitrile (10 liters). The eluate was evaporated to 300 ml of residue, and then dried to prepare the title compound as a beige powder (105.6 g). The product was analyzed by mass spectrometry (MS) and nuclear magnetic resonance (NMR) and showed the same as the confirmed sodarin sample. Preparation 2 Production of Sodarin_Salt The D. arachnoidis NRRL 3196 (ATCC 36386) was stored in brain-heart infusion broth at + 140 ° C + 10% glycerol as described in Preparation 1. A suspension containing 2 fat plugs was used to inoculate a 250 ml Erlenmy er flask containing 50 ml FS medium. This culture is 25 on a rotary shaker. (: Incubate for 5 days. This rotary shaker is operated at 250 rpm on a 50 mm diameter track. The entire (2 ml) of the developed inoculum is then inoculated into 250 ml of 250 containing FS medium (50 ml) Inoculate Erlenmyer flasks, cultivated as described above. Inoculate two fermenters containing 5 liters of FS medium each of 7 liters with 80 mL of inoculum developed in the shaking flask. Fermentation is controlled at a temperature of 25 ° C. Shake at 400 rpm and ventilate at a rate of 2 liters / minute. After 3 days of fermentation, inoculate a 780 liter fermentor containing 500 liters of SD1 medium with 10 liters of culture. -50- This paper size Applicable to China National Standard (CNS) M specifications (210X 297mm) (Please read the precautions on the back before filling in this page) νΛ Printed Bag A7 B7 of the Employees Consumer Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標準局員工消費合作社印I 五、發明説明（48) SD1 克/公升</span>Printed by the Employees ’Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of Invention (48) SD1 g / L</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Meritose (Tunnel refineries) 22 乳糖 20</span>Meritose (Tunnel refineries) 22 Lactose 20</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Glucidex 32D (Roquette Frere) 30</span>Glucidex 32D (Roquette Frere) 30</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Arkasoy (The British Arkady Co) 20 CSL 20</span>Arkasoy (The British Arkady Co) 20 CSL 20</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">FeCl3 · 6H2 O 0.05 NH4H2P04 5</span>FeCl3 · 6H2 O 0.05 NH4H2P04 5</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ZnS04 ,7H2 O(BDH) 〇.i PPG2000 0.5 蒸餾水 發酵控制於2 5°C的溫度，肉湯以350轉/分鐘搖動，並以 200公升/分鐘的速度通氣。加蒸餾水以維持培養物容積於 500公升。以反相HPLC鑑定索達林之存在。培養6天後在 肉湯萃取物樣品顯示索達林滴定度爲1.3克/公升時收穫培 養物。使50毫升收穫肉湯樣品含0.1M的氫氧化鈉，於4°C 存放過夜。加2°/〇的Dicalite至肉湯内作爲過濾助劑以 Dicalite床作眞空過濾除去細胞。濾過物以濃硫酸調整p Η 至近6。將肉湯萃取物經Amberchrom CG161樹脂床以320毫 升/分鐘（每分鐘0.64床容積）唧取。流出物以HPLC鑑測。 45分鐘（相當於14.4公升唧取容積）後，索達林開始透過， 停止唧取。吸附物用水（2公升）洗，再用2 5 %容積/容積水 -51 - 本紙張尺度速用中國國家揉準（CNS )人4^及（21〇Χ297公釐） (請先閱讀背面之注意事項再填寫本頁) *Λ. 訂 ^^1644 A7 經濟部中央標準局員工消費合作社印製 Β7 五、發明説明（49 ) 内的丙酮（2公升）洗。以75 %容積/容積水内的丙酮（15公 升）洗離索達林。將75 %容積/容積丙酮洗離物於4〇。(：以迴 轉蒸發至約200毫升。加200毫升丁燒-1 _醇，繼績蒸發至枯 性油體（含少許丁燒-1 -醇）。此油狀殘餘物再用熱甲醇（2 X 500毫升）萃取。合併萃取物，過濾（Whatman 1號紙），再於 40。至45 °C蒸發’得枯性油體。再以丙嗣（2x 500毫升）萃 取。合併丙酮萃取物，過濾並蒸發至成粘性油體。加丙燒_ 2 ·醇（350毫升），此油體於4 5 °C溶解，成澄清棕色溶液。 將鉀-2 -乙基己酸鹽溶液（39 %重量/重量於丙烷_2醇内之 溶液，54克）稱入500毫升錐形燒瓶内。將含索達林的丙烷_ 2 -醇溶液倒入錐形燒瓶内，使内容物混合，於室溫靜置4小 時。此溶液内種索達林鉀鹽（約5毫克），將燒瓶塞好，於4 °C存放3天。眞空過濾（用4號多孔漏斗）形成的灰白色固體 ，濾過餅以丙烷-2 -醇（約2 0 - 3 0毫升）洗。再將固體移入結 晶碟’於P2〇5上眞空乾燥16小時，製得標題化合物（10.5 克）。 製備3 索達林鉀鹽之咕连 以製備1方法製備5 00公升培養物肉湯。使此肉湯含o.im 的氫乳化納’於〇°C過4天後，用Dicalite床於迴轉眞空過滤 器上過滤。肉湯内加1 % Dicalite作爲過滤助劑。以濃硫酸 將濾過物pH由9.6調整至7·5。再將濾過物（10公升）pH用 Η3?〇4調整至6，使用於包於水内的XAD-16樹脂床（200毫 升）上，流速爲1-1.5床容積/小時。用水（1床容積）洗此樹 _ ' -52- 本紙張尺度適用中國國家標準（（：1^)/^4規/格（210乂297公釐） (請先閲讀背面之注意事項再填寫本頁) 、Tr 44</span>ZnS04, 7H2 O (BDH) 〇.i PPG2000 0.5 Distilled water Fermentation is controlled at a temperature of 25 ° C. The broth is shaken at 350 rpm and aerated at a rate of 200 liters / min. Add distilled water to maintain the culture volume at 500 liters. The presence of Sodarin was identified by reverse-phase HPLC. After 6 days of culture, the culture was harvested when the broth extract sample showed a soda titre of 1.3 g / liter. Make 50 ml of harvest broth sample containing 0.1 M sodium hydroxide and store at 4 ° C overnight. Add 2 ° / 〇 of Dicalite to the broth as a filter aid and use a Dicalite bed as a filter to remove the cells. The filtrate was adjusted to pH 6 with concentrated sulfuric acid to nearly 6. The broth extract was pumped through the Amberchrom CG161 resin bed at 320 mL / min (0.64 bed volume per minute). The effluent was identified by HPLC. After 45 minutes (equivalent to 14.4 liters of pumping volume), Sodarin started to pass through and stopped pumping. The adsorbate is washed with water (2 liters), and then with 25% volume / volume water-51-This paper size is used by the Chinese National Standard (CNS) 4 ^ and (21〇297297mm) (please read the back page first (Notes and then fill out this page) * Λ. Order ^^ 1644 A7 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Β7. The invention description (49) is washed with acetone (2 liters). Wash off Sodarin with acetone (15 litres) in 75% volume / volume water. The 75% volume / volume acetone was washed away at 40. (: Rotary evaporate to about 200 ml. Add 200 ml of butan-1-ol, and then evaporate to a dry oil body (containing a little butan-1-ol). The oily residue is then heated with methanol (2 X 500 ml) extraction. Combine the extracts, filter (Whatman No. 1 paper), and evaporate at 40 to 45 ° C to obtain a dry oil body. Then extract with propylene (2x 500 ml). Combine the acetone extracts, Filter and evaporate to a viscous oil body. Add propane _ 2 · alcohol (350 ml), this oil body dissolves at 4 5 ° C to a clear brown solution. The potassium 2-ethylhexanoate solution (39% Weight / weight solution in propane-2 alcohol, 54 g) was weighed into a 500 ml Erlenmeyer flask. The propane-2-alcohol solution containing Sodarin was poured into the Erlenmeyer flask, the contents were mixed and placed in the chamber Allow to stand for 4 hours. Sodium hydrochloride (approximately 5 mg) is planted in this solution. The flask is stoppered and stored at 4 ° C for 3 days. The off-white solid formed by air filtration (using a No. 4 porous funnel) is filtered The cake was washed with propane-2-ol (approximately 20-30 mL). The solid was transferred to a crystallization dish and dried on P205 for 16 hours to prepare the title compound ( 10.5 g). Preparation 3 Sodalin Potassium Cullin was prepared in Method 1 to prepare 500 liters of culture broth. The broth containing o.im hydrogen emulsifier was used after 4 days at 0 ° C. The Dicalite bed is filtered on a rotary air filter. 1% Dicalite is added as a filter aid in the broth. The pH of the filtrate is adjusted from 9.6 to 7.5 with concentrated sulfuric acid. The pH of the filtrate (10 liters) is then adjusted to Η3? 4 Adjust to 6 and use it on XAD-16 resin bed (200 ml) wrapped in water with a flow rate of 1-1.5 bed volume / hour. Wash this tree with water (1 bed volume) _ '-52- This paper size Applicable to Chinese National Standards ((: 1 ^) / ^ 4 gauge / grid (210 to 297 mm) (please read the precautions on the back before filling out this page), Tr 44</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、發明説明（5〇) 經濟部中央梯準局員工消費合作社印製 脂床’再用25%異丙醇水溶液（2 5床容積）洗，然後以淨異 丙醇洗離。待先流出5〇毫升後，分批各收取1〇〇毫升異丙 醇洗離物。將2-6份富含索達林的部分集中，並蒸發成半容 積。加異丙醇使容積再回至500毫升，重複蒸發至半容積， 以共沛蒸發去殘餘的水。待第三次蒸發至半容積後，將殘 餘物過遽，濾過器用異丙醇洗。於合併的濾過物及洗液 (400毫升）内加2 -乙基己酸鉀（8克）於異丙醉（1〇〇毫升）内的 溶液。此混合物内種索達林鉀鹽，於4。〇靜置數天，即緩慢 形成結晶。於3號多孔過濾器上過濾結晶’用少許冰冷的異 丙醇洗，眞空乾燥，即製得標題化合物，爲棕色粉（4.85克） 〇 t脱甲基索这汰之+產 (0以製備1所述方法將IMI3 62 1 84於-14(TC維持於腦心 輸液肉湯+ 1 0 %甘油内。用含2個瓊脂塞的懸浮液接種 於含50毫升FS培養基的250毫升的Erlenmyer燒瓶内。 此培養物於迴轉搖動器上於25°C培育5天，此迴轉搖動 器於50毫米直徑的軌道上以250轉/分鐘操作。用整份 (2毫升）已發展的種菌再接種於250毫升含FS培養基 (50毫升）的250毫升Erlenmyer燒瓶内，以上述方法培 育。用80毫升於搖動燒瓶内發展的種菌接種於二個各7 公升的含5公升FS培養基的發酵器内。發酵控制於25 °C的溫度。此培養物以400轉/分鐘搖動，並以2公升 /分鐘的速度通氣。發酵3天後，用1〇公升培養物接種 53 1紙張尺度逍用中國國家揉準（&amp;lt;：阳）八4规格（210父297公釐） (请先閲讀背面之注意事項再填寫本頁) 4*λ. 訂 A7 ^^1644 B7 五、發明説明（51 ) 於500公升SM55VAR培養基的780公升的發酵器内（如 製備1所述）。將發酵控制於25 °C的溫度。將肉湯以350 轉/分鐘振動，並以500公升/分鐘的速度通氣。培養 物内加 70 % 重量 / 容積的 Meritose (Tunnel Refineries) 溶液，以維持正殘餘葡萄糖濃度。加蒸餾水以維持培 養物容積爲500公升。以反相HPLC鑑定全部肉湯萃取 物内4'-脱甲基索達林的存在。培養10天後在肉湯萃取 物樣品顯示4'-脱甲基索達林滴定度爲0.8克/公升時， 收穫培養物。使發酵肉湯含0.1M的氫氧化鈉，於週邊 溫度過1小時後，用Dicalite於迴轉眞空過濾器上過濾（ 肉湯内加1 % Dicalite作爲過濾助劑）。以濃硫酸將濾過 物pH調整至4.5，將此溶液加於XAD16樹脂（20克產物 /公升樹脂）。吸附物以0.1 %磷酸（10柱容積）洗，在以 乙腈：水1 : 4 (6柱容積）洗，然後用乙腈：水（丨：1 ; 2 柱容積）洗離產物。此過程的流速爲1 _ 2柱容積/小時 。加丁烷-1 -醇使洗離物濃縮至乾，用甲醇（1 2公升）萃 取固禮，再於60 °C以丙酮（1〇公升）萃取。每一步驟都 以3號玻璃多孔過濾器除去不溶解的物質，再將萃取物 如前法濃縮至乾。以乙腈：水（3 : 7)結晶出固體，再 用相同溶劑重結晶，於P 2 〇 5上乾燥至恆定重量，即製 得標題化合物（244.0克），以質子NMR分析顯示與已確 定之4'-脱甲基索達林相同。 (ii)依（i)發酵方法，在肉湯加0.1M氫氧化鈉後，用ETNA 10A膜（10K Dalton cut-off)作超過濾。以水作滲過濾後 -54- 本紙張尺度逍用中國國家揉準（CNS ) A4規格（210X297公羞) (請先閲讀背面之注意事項再填寫本頁) fc.A_ 、?τ 經濟部中央標準扃—工消費合作社印裝 ^2164 4 A7 B7 經濟部中央標準局員工消費合作社印裝 五、發明説明（52) ’滲出物爲澄清溶液。以濃硫酸將pH調整至5.2後，將 滲出物載於XAD16樹脂柱上，載速爲2柱容積/小時， 最終每公升樹脂載32克4，-脱甲基索達林。此柱以0.1% 容積/容積磷酸洗，再以20%容積/容積乙腈/水洗（ 每種都是10柱容積），洗速爲2柱容積/小時。此柱以 6 5 %乙腈/水洗離，洗離速爲2柱容積/小時。棄掉先 流出的0·75柱容積，由後來1.6柱容積的洗離物收取 85%載入的4··脱甲基索達林。此多量的洗離物以2〇/〇重 量/容積的DE52纖維素攪拌5分鐘處理，然後再取出 過濾。將等分以DE52處理過的洗離物用迴轉蒸發器濃 縮至原容積（4 3 %乙腈）的6 2 %。將濃縮過的洗離物於4 保持1 5小時以結晶，以玻璃多孔過濾器過濾收取的 固體。結晶用4餅容積的3 0 %容積/容積乙腈/水洗， 於3 0 °C眞空乾燥。由濃縮洗離物收取的標題化物（〗94 克）爲淺灰色固體。 製備5 能於4'位使索達林脱甲基的微生物的篩潠 能於卩位使索達林脱甲基的微生物，可藉使其於28。(：（細 菌）或25°C (眞菌）生長於50毫升錐形燒瓶内的1〇毫升容積 的SB1(細菌）或FBI(眞菌）内確證，此燒瓶以250轉/分鐘 搖動。2天後，加索達林至終濃度爲0· 5毫克/毫升（取自於 80 %乙醇内的200毫克/毫升儲存溶液），再將燒瓶培育3天 。由整個培養物取500微升樣品與500微升80%的乙腈/2% 三氟醋酸在Eppendorf管内混合，並任其於室溫萃取3〇分鐘 -55- 本紙張尺度適用中國國家揉準（CNS ) A4规格（210X297公釐) I&amp;quot;-------— —.— I (請先閲讀背面之注意事項再填寫本頁)</span>3. Description of the invention (50) The grease bed printed by the Employee Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs was washed with a 25% aqueous solution of isopropyl alcohol (25 bed volume) and then washed away with net isopropyl alcohol. After 50 ml was flowed out, 100 ml of isopropanol was collected in batches. Collect 2-6 parts rich in sodarin and evaporate to half volume. Isopropanol was added to bring the volume back to 500 ml, and the evaporation was repeated to half volume to co-evaporate the remaining water. After the third evaporation to half volume, the residue was passed through and the filter was washed with isopropyl alcohol. A solution of potassium 2-ethylhexanoate (8g) in isopropyl alcohol (100ml) was added to the combined filtrate and wash (400ml). Sodium hydrochloride is grown in this mixture. 〇 Crystals formed slowly after standing for several days. Filter the crystals on the No. 3 porous filter, wash with a little ice-cold isopropanol, and dry it to obtain the title compound as a brown powder (4.85g). Demethylated product (0 to prepare 1 IMI3 62 1 84 at -14 (TC maintained in brain heart infusion broth + 10% glycerol. 250 ml Erlenmyer flask containing 50 ml FS medium was inoculated with a suspension containing 2 agar plugs This culture was incubated on a rotary shaker for 5 days at 25 ° C. The rotary shaker was operated at 250 rpm on a 50 mm diameter track. The whole (2 ml) of the developed inoculum was re-inoculated in The 250 ml Erlenmyer flask containing FS medium (50 ml) was cultivated as described above. 80 ml of inoculum developed in the shaking flask was inoculated into two 7 liter fermentors containing 5 liter FS medium. Fermentation Controlled at a temperature of 25 ° C. The culture was shaken at 400 rpm and aerated at a rate of 2 liters / minute. After 3 days of fermentation, the 10 liter culture was used to inoculate 53 1 paper scales. (&amp;Lt;: Yang) Eight 4 specifications (210 father 297 mm) (please Read the notes on the back and fill in this page) 4 * λ. Order A7 ^^ 1644 B7 5. Description of the invention (51) In a 780-liter fermenter of 500-liter SM55VAR medium (as described in Preparation 1). Control the fermentation At a temperature of 25 ° C. The broth is shaken at 350 rpm and aerated at a rate of 500 liters / minute. A 70% weight / volume Meritose (Tunnel Refineries) solution is added to the culture to maintain a positive residual glucose concentration Add distilled water to maintain the volume of the culture to 500 liters. Identify the presence of 4'-demethyl sodarin in all broth extracts by reversed-phase HPLC. Samples of the broth extract show 4'-dehydration after 10 days of culture When the titer of methyl sodarin is 0.8 g / L, the culture is harvested. Make the fermentation broth contain 0.1 M sodium hydroxide, and after 1 hour at the ambient temperature, use Dicalite to filter on the rotary empty filter (broth Add 1% Dicalite as a filter aid.) Adjust the pH of the filtrate to 4.5 with concentrated sulfuric acid, add this solution to XAD16 resin (20 g product / liter resin). The adsorbate is washed with 0.1% phosphoric acid (10 column volume) , In acetonitrile: water 1: 4 (6 column volume ) Wash, and then wash away the product with acetonitrile: water (丨: 1; 2 column volume). The flow rate of this process is 1 _ 2 column volume / hour. Add butane-1-ol to concentrate the eluate to dryness, use Methanol (12 liters) was extracted and solidified, and then extracted with acetone (10 liters) at 60 ° C. In each step, the insoluble material was removed with a No. 3 glass porous filter, and then the extract was concentrated to dry. The solid was crystallized from acetonitrile: water (3: 7), then recrystallized from the same solvent, and dried to a constant weight on P 2 〇5 to obtain the title compound (244.0 g), which was confirmed by proton NMR analysis. 4'-demethyl sodarin is the same. (ii) According to (i) fermentation method, after adding 0.1M sodium hydroxide to the broth, use ETNA 10A membrane (10K Dalton cut-off) for ultrafiltration. After water is used for infiltration and filtration -54- This paper scale is used in the Chinese National Standard (CNS) A4 specification (210X297 public shame) (please read the precautions on the back before filling this page) fc.A_ 、? Τ Central Ministry of Economic Affairs Standards—Printed by the Industrial and Consumer Cooperatives ^ 2164 4 A7 B7 Printed and printed by the Employees ’Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs V. Description of the invention (52) 'The exudate is a clear solution. After adjusting the pH to 5.2 with concentrated sulfuric acid, the exudate was loaded on a XAD16 resin column at a loading rate of 2 column volumes / hour, and finally 32 grams of 4, -demethyl sodarin was loaded per liter of resin. This column was washed with 0.1% volume / volume phosphoric acid, and then with 20% volume / volume acetonitrile / water (each with 10 column volumes) at a rate of 2 column volumes / hour. The column was washed off with 65% acetonitrile / water, and the washing off rate was 2 column volumes / hour. Discard the 0.75 column volume that flowed out first, and collect 85% of the loaded 4. · demethylsodarin from the eluate of 1.6 column volume later. This large amount of washed material was treated with 20% weight / volume DE52 cellulose with stirring for 5 minutes, and then taken out and filtered. An aliquot of the eluate treated with DE52 was concentrated using a rotary evaporator to 62% of the original volume (43% acetonitrile). The concentrated eluate was kept at 4 for 15 hours to crystallize, and the collected solid was filtered with a glass porous filter. The crystals were washed with 30% volume / volume acetonitrile / water of 4 cake volume and dried at 30 ° C. The title compound (94 g) collected from the concentrated eluate was a light gray solid. Preparation of 5 sieving microorganisms capable of demethylating sodarin at the 4 'position. Microorganisms capable of demethylating sodarin at the 4 position can be obtained at 28. (: (Bacteria) or 25 ° C (strains) grown in a 50-mL Erlenmeyer flask with a volume of 10 mL of SB1 (bacteria) or FBI (strains). This flask was shaken at 250 rpm. 2 Days later, add sodarin to a final concentration of 0.5 mg / ml (taken from a 200 mg / ml stock solution in 80% ethanol), and incubate the flask for another 3 days. A 500 μl sample is taken from the entire culture Mix with 500 μl of 80% acetonitrile / 2% trifluoroacetic acid in an Eppendorf tube, and allow it to be extracted at room temperature for 30 minutes -55 I &amp;quot; -------— —.— I (Please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">'1T 3^1β44 Α7 Β7五、發明説明（53) 。由微離心器離心過的樣品所得的萃取漂浮物用等度HPLC 鑑定4 '-脱甲基索達林。用3 5 %乙腈於水内的移動相洗離 4'-脱甲基索達林3.3 5分鐘，流速2毫升/分鐘，使用 Spherisorb C6柱（5微米，15公分X4.6毫米）。以此法可證 實下述微生物爲索達林脱曱基者： 經濟部中央標準局員工消費合作社印袋 纏繞鏈霉菌 ATCC 31963  Streptomyces avermitilis ATCC 31272  畜群鏈霉菌 NRRL 3176  抗生錢霉菌 ATCC 31771  龜裂鏈霉菌 ATCC 23955  普拉特鏈霉菌 ATCC 29778  馬書鏈霉菌 ATCC 23934  泛溫鏈霉菌 ATCC 14975  東方諾卡氏菌 ATCC 43491  美麗刺孢小克銀漢霉 ATCC 36112  SB1培養基 克/公升  Arkasoy 25  酵母萃取物 5  kh2po4 5  葡萄糖 20  蒸餾水   pH 7 (請先閲讀背面之注意事項再填寫本頁) -56- 本紙張尺度適用中國國家標準（CNS ) A4规格（210X297公釐） 克/公升 30 10 5 5 20 ^^1644 ΑΊ __2_Β7 五、發明説明（54) FBI培養基 大豆</span>'1T 3 ^ 1β44 Α7 Β7 V. Description of the invention (53). The extracted float obtained from the sample centrifuged by the microcentrifuge was identified by isocratic HPLC using 4'-demethylsodarin. The mobile phase of 35% acetonitrile in water was used to wash away 4'-demethyl sodarin for 3.3 5 minutes at a flow rate of 2 ml / min using a Spherisorb C6 column (5 microns, 15 cm X 4.6 mm). In this way, the following microorganisms can be confirmed as Sodarin demethylators: Ministry of Economic Affairs, Central Bureau of Standards, Employee Consumer Cooperative, Bag-printed Streptomyces ATCC 31963 Streptomyces avermitilis ATCC 31272, Streptomyces herd NRRL 3176, Money-resistant molds ATCC 31771 Mildew ATCC 23955 Streptomyces platensis ATCC 29778 Streptomyces martiniformis ATCC 23934 Streptomyces thermophilus ATCC 14975 Nocardia orientalis ATCC 43491 Streptomyces chrysosporioides Aureobasidium chrysosporium ATCC 36112 SB1 medium g / L Arkasoy 25 Yeast extract 5 kh2po4 5 glucose 20 Distilled water pH 7 (Please read the precautions on the back before filling in this page) -56- This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) g / L 30 10 5 5 20 ^^ 1644 ΑΊ __2_Β7 5. Description of the invention (54) FBI medium soybean</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Arkasoy 酵母萃取物 k2hpo4 葡萄糖 蒸餘水 pH 5.5 製備6 以索達林生物轉化製備41-脱甲基索这林 將0·3毫升纏繞鏈霉菌ATCC 3 1963孢子懸浮液（丨5 %的容 積/容積甘油内的溶液，存於-20 °C的）接種於250毫升 Erlenmeyer燒瓶内的30毫升SB1培養基内，形成種培養物 ，此培養物於28 °C培養’並於迴轉搖動器上以250轉/分 鐘搖動。4天後，用0.5毫升此培養物接種於250毫升燒瓶内 的35毫升SB1，於28°C，250轉/分鐘生長48小時。於此 階段，將培養物整分爲10毫升的量加入Erlenmeyer燒瓶内 ，燒瓶内加5毫克索達林（取自200毫克/毫升乙醇内的存儲 溶液）。再繼續培養3天。於整個肉湯（14毫升）内加80%容 積/容積的乙腈於水内的溶液（1 4毫升），此混合物存放於 室溫下，不時搖動。30分鐘後，離心取出細胞。蒸發除去 乙腈’以正鱗酸將此水溶液pH調整至2.5。將此溶液通過 含有Amberlite XAD-16樹脂的柱（床容積5毫升）。吸附物相 -57- 本紙張尺度逍用中國國家標準（CNS ) A4规格（210X297公釐） ~ (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局貝工消費合作社印製 A7 32l644 B7 五、發明説明（55 ) (請先Μ讀背面之注意事項再填寫本頁) 繼用水（10毫升），10 %容積/容積乙腈於水内的溶液（2〇 毫升），30 %容積/容積乙腈於水内的溶液（20毫升）及9〇 % 容積/容積乙腈於水内的溶液（1〇毫升）洗。各部分用HPLC 鑑測：於50 %容積/容積乙腈於水内的洗離物中有4'-脱甲 基索達林。將含4'-脱甲基索達林的部分於室溫眞空蒸發至 乾，殘餘物再溶於35 %容積/容積乙腈於水内的溶液（15毫 升）。以製備用HPLC純化4’-脱甲基索達林。 柱 Spherisorb 5微米C 6 2 5公分X 2.5公分 流速 25毫升/分鐘 測定 UV，210納米 流動相 用350毫升乙腈用0.05M的磷酸氫銨水溶液加至 1000毫升。pH以正磷酸調整至2.5 注射容積4 · 5毫升 經濟部中央標準局員工消費合作社印製 10分鐘後以此條件洗離4'-脱曱基索達林。集中四次HPLC 的流液’用水作1 : 1稀釋，然後唧回二氧化矽上（在以水洗 並以水在平衡後）。吸附物用水（200毫升）洗，吸附的產物 用95%容積/容積乙腈於水内的溶液（200毫升）洗離。將乙 腈/水洗離物蒸發除去有基溶劑，將水溶液;東乾，製得4，_ 脱甲基索達林（1.5毫克），爲白色粉。 ^ ('H, CDC13); 9.74 (s, 1H); 6.08 (brd, 3, 1H); 4.70 (d, 1.5, 1H); 4.16 (d, 9.5, 1H); 4.08 (dd, 4.5, 3.5, 1H); 3.88 (dd, 4.5, 1-5, 1H); 3.75 (dq, 8.5, 6, 1H); 3.62 (d, 9.5, 1H); 3.68 (dd, 8.5, 3.5, 1H); 2.65 (m, 1H); 2.34 (m, 1H); 1.32 (d, 6, 3H); __ -58- 本紙張尺度逍用中國國家標準（CNS ) A4规格（210X297公釐） 經濟部中央標準局員工消費合作社印製 A7 ----____B7_ 五、發明説明（56)^ ' ' - (d，12.5, 1H); 1.23 (m，1Η); ΐ·〇4 (d，7, 3H); 0.99 (d，7， 3H)； 0.81 (d, 7, 3H) ° 新之生產 依製備1方法進行至包括製備性HpLC階段。收取2i 4及 分^間的洗離部分。集中由10次注射（22公升）所得部 刀，以等量的水稀釋，將此溶液經Kr〇masil柱以2 8公升/ 小時速度唧回。此柱用水（2〇公升）洗，再以9〇%乙腈（4 5 公升）洗離。合併此洗離物與以相同方法發酵所得的洗離物 (4_5公升）。合併的9〇%乙腈洗離物作迴轉蒸發至產物開始 結晶（容積約丨.6公升）。殘餘物於6(TC水浴上加熱，同時加 最少容積的乙腈，製得澄清溶液。將溶液冷卻，並存儲於4 C。於3號多孔過濾器上過濾結晶，並眞空乾燥生成棕色固 體。再將此固體用乙腈水（40 : 6〇)重結晶，並過濾產物， 用2 5 %乙腈洗，眞空乾燥即製得標題化合物（1〇7克）。此 產物經質譜及NMR分析顯示與索達里新樣品相同。 製備8 索達林變成索達里新之生物轉化 用0.2毫升NCIMB 40675之懸浮液接種於50毫升加有 0.2%酵母萃取物的營養肉湯（〇x〇id)的250毫升的 Erlenmyer燒瓶内。將此培養物於迴轉搖動器上於28t培育 29小時，此搖動器於50毫米軌道上以250轉/分鐘搖動。 用整分（1毫升）發展的種菌再接種於含50毫升加有％醇 母萃取物的雙強度營養肉湯（Oxoid)的250毫升的Erlenmyer -59- 本紙張纽逍用中關家標準（CNS ) A4胁（21GX297公嫠) ''~~~---、 (請先閱讀背面之注意事項再填寫本頁)</span>Arkasoy Yeast Extract k2hpo4 Glucose Distilled Water pH 5.5 Preparation 6 Preparation of 41-Demethyl Soxaline by Sodarin Biotransformation 0.3 ml of Streptomyces tangulans ATCC 3 1963 Spore Suspension (丨 5% volume / volume The solution in glycerol, stored at -20 ° C) was inoculated in 30 ml of SB1 medium in a 250 ml Erlenmeyer flask to form a seed culture. / Minute shaking. After 4 days, 0.5 ml of this culture was used to inoculate 35 ml of SB1 in a 250 ml flask and grown at 28 ° C, 250 rpm for 48 hours. At this stage, the culture was divided into 10 ml into Erlenmeyer flask, and 5 mg of sodarin (from the storage solution in 200 mg / ml of ethanol) was added to the flask. Continue to cultivate for another 3 days. Add 80% volume / volume of acetonitrile in water (14 ml) to the entire broth (14 ml). Store this mixture at room temperature with shaking from time to time. After 30 minutes, the cells were removed by centrifugation. The acetonitrile was removed by evaporation, and the pH of the aqueous solution was adjusted to 2.5 with n-scalic acid. This solution was passed through a column containing Amberlite XAD-16 resin (bed volume 5 ml). Adsorbate phase-57- This paper scale is free of Chinese National Standard (CNS) A4 specification (210X297mm) ~ (please read the precautions on the back before filling in this page). Printed by the Beigong Consumer Cooperative of the Central Standards Bureau of the Ministry of Economy A7 32l644 B7 5. Description of the invention (55) (please read the precautions on the back and then fill in this page) Follow up with water (10ml), 10% volume / volume solution of acetonitrile in water (20ml), 30% Wash the volume / volume acetonitrile solution in water (20 ml) and 90% volume / volume acetonitrile solution in water (10 ml). Each part was identified by HPLC: there was 4'-demethylsodarin in the eluate of 50% volume / volume acetonitrile in water. The portion containing 4'-demethyl sodarin was evaporated to dryness at room temperature, and the residue was redissolved in a 35% volume / volume solution of acetonitrile in water (15 mL). 4'-Demethyl sodarin was purified by preparative HPLC. Column Spherisorb 5 μm C 6 2 5 cm X 2.5 cm Flow rate 25 mL / min UV, 210 nm Mobile phase Use 350 mL of acetonitrile to make up to 1000 mL with 0.05 M ammonium hydrogen phosphate aqueous solution. The pH was adjusted to 2.5 with orthophosphoric acid. The injection volume was 4.5 ml. Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs. After 10 minutes, the 4'-demethylsodarin was washed away under this condition. The four concentrated HPLC flows were diluted 1: 1 with water, and then pumped back onto the silica (after washing with water and with water after equilibration). The adsorbate was washed with water (200 ml), and the adsorbed product was washed away with a 95% volume / volume acetonitrile solution in water (200 ml). The acetonitrile / water washes were evaporated to remove the base solvent, and the aqueous solution was dried to prepare 4, _demethylsodarin (1.5 mg) as a white powder. ^ ('H, CDC13); 9.74 (s, 1H); 6.08 (brd, 3, 1H); 4.70 (d, 1.5, 1H); 4.16 (d, 9.5, 1H); 4.08 (dd, 4.5, 3.5, 1H); 3.88 (dd, 4.5, 1-5, 1H); 3.75 (dq, 8.5, 6, 1H); 3.62 (d, 9.5, 1H); 3.68 (dd, 8.5, 3.5, 1H); 2.65 (m , 1H); 2.34 (m, 1H); 1.32 (d, 6, 3H); __ -58- This paper scale uses the Chinese National Standard (CNS) A4 specification (210X297 mm) Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs Printed A7 ----____ B7_ V. Description of the invention (56) ^ ''-(d, 12.5, 1H); 1.23 (m, 1Η); l · 〇4 (d, 7, 3H); 0.99 (d, 7, 3H); 0.81 (d, 7, 3H) ° The new production is carried out according to the preparation 1 method to include the preparative HpLC stage. Charge 2i 4 and the part of the wash off. The knife obtained from 10 injections (22 liters) was concentrated, diluted with an equal amount of water, and the solution was pumped back at a rate of 28 liters / hour through a Kromasil column. The column was washed with water (20 litres) and then washed away with 90% acetonitrile (45 litres). Combine this eluate with the eluate fermented in the same way (4-5 liters). The combined 90% acetonitrile washes were rotary evaporated until the product began to crystallize (volume is about 1.6 liters). The residue was heated on a 6 ° C water bath while adding a minimum volume of acetonitrile to prepare a clear solution. The solution was cooled and stored at 4 C. The crystals were filtered on a No. 3 porous filter and dried to produce a brown solid. This solid was recrystallized from acetonitrile water (40:60), and the product was filtered, washed with 25% acetonitrile, and dried in vacuo to obtain the title compound (107 g). This product was analyzed by mass spectrometry and NMR analysis. The Dalixin sample is the same. Preparation 8 Sodarin to Sodarin Biotransformation Inoculate 0.2 ml of NCIMB 40675 suspension in 50 ml of 250% nutrient broth (〇x〇id) supplemented with 0.2% yeast extract Ml Erlenmyer flask. The culture was incubated on a rotary shaker at 28t for 29 hours. The shaker was shaken on a 50 mm track at 250 rpm. The inoculum developed with aliquots (1 ml) was re-inoculated into 50 ml of Erlenmyer -59 double-strength nutrient broth (Oxoid) supplemented with% alcohol precursor extract- This paper is used in the Zhongguanjia Standard (CNS) A4 threat (21GX297 Gongjia) '' ~~~ ---, (Please read the notes on the back before filling this page )</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 A7 經濟部中央樣準局員工消费合作社印製 五、發明説明（57 燒瓶内。如上培育24小時。將62個此燒瓶内容物集中成 2.65公升已發展的培養物，加於3〇公升索達林發酵濾過物 内，將pH調整至7_5，如製備i所述。此反應於7〇公升發酵 器内於30°C進行，以200轉/分鐘振動，並以〇·5ννΜ通氣 。加1當量的鹽酸將ρΗ控制於7·5。6天後，有近16克索達 林轉化成索達里新。將生物轉化肉湯於眞空過濾器上經 Dicalite過濾，床用水洗’得31 5公升濾過物，pH 8_2。此 ;慮過物以H3P〇4調整pH至6.0，經Amberchrom CG161樹脂 床（25公分X 5公分）以290毫升/分鐘速度唧取。 Amberchrom床以 〇_1〇/〇H3P〇4(2 公升）及 25〇/〇 乙腈（4公升） 洗’然後用60% CH3 C N(2公升）洗離。以迴轉蒸發濃縮洗 離物至開始結晶，然後將殘餘物於6 〇 水浴上加熱，同時 加最少量乙腈，得澄清溶液。將此溶液冷卻，置於4過夜 。過濾結晶，用25%乙腈洗，眞空乾燥，得棕色粉。再將 此粗製產物用1公升乙腈：水（4 0 : 6 0)重結晶，經如上過 濾，洗，及乾燥後得索達里新，爲淺栋色針狀結晶（615克） 〇 製備9 索達林變成索遠里新之生物轉化 使用由NCIMB 40675瓊脂培養物取得的一環表面生長物 接種於含50毫升加有0.2 %酵母萃取物的營養肉湯（〇x〇id) 的250毫升的Erlenmeyer燒瓶内。將此培養物於迴轉搖動器 上於25°C培育26小時，此搖動器於50毫米軌道上以250轉 /分鐘搖動。用1毫升整分發展的種菌再接種如上述的250 -60- 本紙張尺度適用中國困家標準（CNS ) A4規格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁) X · 訂- ^^1644 A7 B7 五、發明説明（58) 毫升的£1&amp;quot;1611!116&amp;gt;^1^燒瓶内。此燒瓶内加於80%乙醇内的純 索達林，使終濃度爲1_25毫克/毫升。將燒瓶如上培育8天 ，然後集中成365毫升含索達里新的培養物肉湯。將此生物 轉化混合物離心除去NCIMB40675細胞，傾析漂浮液（350 毫升）。此漂浮液内加Whatman Partisil P40 ODS-3(5毫升 ，已用乙腈濕過），用H3P04將混合物PH調整至4.0。於 Buchner漏斗上濾除Partisil ’用乙腈（1〇〇毫升）洗離，再用 75%乙腈（100毫升）洗離。將合併之洗離物蒸發至成ι〇_15 毫升水性殘餘物。然後將殘餘物於6 0 °C水浴上加熱，同時 加乙腈至成澄清溶液，然後繼續加熱，並加水至成溶液變 混濁。將此溶液冷卻’置於4 C數天。於3號多孔過滤器上 過遽結晶’用水洗’於P 2 0 5上眞空乾燥，得白色針狀結晶 (92毫克）。 製備10 索達里新之生產 用一安叙冰束IMI 362947接種於250毫升Erlenrmyer燒瓶 内的50毫升種FS培養基。此燒瓶於迴轉搖動器上於25。^诗 育26小時，此搖動器於50毫米直徑軌道搖動。用整分（1毫 經濟部中央樣準局員工消費合作社印策 {請先閲讀背面之注意事項再填寫本頁) 升）發展的種菌再接種於四個含50毫升搖動燒瓶生產培養基 SM55/A 的 250 毫升Erlenmeyer燒瓶内。 -61 -</span>A7 A7 Printed by the Consumers ’Cooperative of the Central Bureau of Samples of the Ministry of Economic Affairs 5. Description of the invention (57 in the flask. Cultivated as above for 24 hours. Concentrate the contents of 62 of this flask into 2.65 liters of developed culture, add 30 liters In the Darling fermentation filtrate, the pH was adjusted to 7-5, as described in Preparation i. This reaction was carried out in a 70-liter fermentor at 30 ° C, vibrated at 200 rpm, and aerated at 0.5 ννΜ. Add 1 The equivalent amount of hydrochloric acid controlled the pH to 7.5. After 6 days, nearly 16 grams of sodarin was converted to sodarin. The biological conversion broth was filtered through Dicalite on the empty filter, and the bed was washed with water. Liter filtrate, pH 8_2. Here, the pH was adjusted to 6.0 with H3P〇4, and it was pumped through Amberchrom CG161 resin bed (25 cm X 5 cm) at a rate of 290 ml / min. 〇H3P〇4 (2 liters) and 25〇 / 〇 acetonitrile (4 liters) was washed 'and then washed away with 60% CH3 CN (2 liters). Concentrate the washings by rotary evaporation to start crystallization, and then the residue in 6 〇Heating on a water bath while adding a minimum amount of acetonitrile to get a clear solution. Cool the solution , Put it on 4 overnight. Filter the crystals, wash with 25% acetonitrile, and dry it to give a brown powder. Then recrystallize this crude product with 1 liter of acetonitrile: water (40:60), filter, wash as above, and After drying, sodarin is obtained as light-colored needle-like crystals (615 g). Preparation 9 Biotransformation of sodarin to soyuanlixin. A ring of surface growth obtained from NCIMB 40675 agar culture was used to inoculate 50 Ml of a 250 ml Erlenmeyer flask supplemented with 0.2% yeast extract in nutrient broth (〇x〇id). The culture was incubated on a rotary shaker at 25 ° C for 26 hours with the shaker on a 50 mm orbit Shake at 250 rpm on the top. Re-inoculate 250 -60 of the above-mentioned inoculum with 1 ml aliquot of the inoculum as described above. This paper scale is applicable to the China Aided Standard (CNS) A4 specification (210X297 mm) Please fill out this page again) X · Order-^^ 1644 A7 B7 V. Description of the invention (58) £ 1 &amp;quot; 1611! 116 &amp;gt; ^ 1 ^ ml in a flask. This flask is added to pure Soda in 80% ethanol Lin, make the final concentration 1_25 mg / ml. Incubate the flask as above for 8 days, then Zhongcheng 365ml broth containing Sodarin's new culture. The biotransformation mixture was centrifuged to remove NCIMB40675 cells, and the floating solution (350ml) was decanted. Whatman Partisil P40 ODS-3 (5ml, already Wet with acetonitrile), the pH of the mixture was adjusted to 4.0 with H3P04. The Partisil was filtered off on a Buchner funnel and washed away with acetonitrile (100 ml) and then with 75% acetonitrile (100 ml). The combined washings were evaporated to 10-15 mL of aqueous residue. Then the residue was heated on a water bath at 60 ° C, while adding acetonitrile until it became a clear solution, then heating was continued, and water was added until the solution became cloudy. Cool this solution to 4 C for several days. After passing through the No. 3 porous filter, the crystal was 'washed with water' and dried on P 2 0 5 to obtain white needle crystals (92 mg). Preparation 10 New production of Sodari 50 ml of seed FS medium in 250 ml Erlenrmyer flasks were inoculated with an Anxu ice beam IMI 362947. This flask is 25 on a rotary shaker. ^ Poetry After 26 hours of incubation, this shaker was shaken on a 50 mm diameter orbit. Use the whole cent (1 cent of the Ministry of Economic Affairs, Central Bureau of Samples and Employee ’s Consumer Cooperative ’s policy {please read the precautions on the back and fill out this page) l) and then inoculate the four inoculated flask production media SM55 / A Inside a 250 ml Erlenmeyer flask. -61-</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明（59) SM55/A 克/公升 麥芽糖糊精MD30E (Roquette Frere) 120 甜菜糖密 15 脉(OxoidL37) 10</span>Printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 5. Description of the invention (59) SM55 / A g / L Maltodextrin MD30E (Roquette Frere) 120 Sugar beet syrup 15 Vein (OxoidL37) 10</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Proflo (Traders Protein) 30 L-色胺酸(Sigma) 2</span>Proflo (Traders Protein) 30 L-Tryptophan (Sigma) 2</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ZnS04 ,7H2 O(BDH) 0 04</span>ZnS04, 7H2 O (BDH) 0 04</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">FeS04 .7H2 O(Sigma) 2</span>FeS04 .7H2 O (Sigma) 2</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">CaC03(BDH) 5</span>CaC03 (BDH) 5</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">MgS04 ,7H2 O(BDH) 5 以蒸餾水完成配方，於121 °C高壓滅菌120分鐘。 將此等培養物如上述培育7天。集中燒瓶内容物，取40毫 升以1當量氫氧化鈉（4毫升）處理45分鐘，並不時搖動。然 後以3000轉/分鐘離心20分鐘去除細胞，取漂浮液，以1 當量鹽酸將pH調整至3。使溶液通過Bond Elut柱（1克大小 ;C18)，育用水（20毫升）洗吸附物，再用90%容積/容積 乙腈於水内的溶液（1 5毫升）洗離。洗離物於室溫蒸發至乾 ，殘餘物溶於50%容積/容積乙腈於水内的溶液（9毫升）。 以製備用HPLC純化索達里新： 柱 Spherisorb 5 微米 ODS-2(25公分 X2.1 公分） 流速 2 5毫升/分鐘 -62- 本紙張尺度逋用中國國家標準（CNS ) A4規格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁)</span>MgS04, 7H2 O (BDH) 5 Complete the formula with distilled water and autoclave at 121 ° C for 120 minutes. These cultures were incubated for 7 days as described above. Concentrate the contents of the flask and take 40 ml with 1 equivalent of sodium hydroxide (4 ml) for 45 minutes, shaking occasionally. Then, the cells were centrifuged at 3000 rpm for 20 minutes to remove the cells, the floating solution was taken, and the pH was adjusted to 3 with 1 equivalent of hydrochloric acid. The solution was passed through a Bond Elut column (1 g size; C18), and the adsorbate was washed with water (20 ml), and then washed away with a 90% volume / volume acetonitrile solution in water (15 ml). The eluate was evaporated to dryness at room temperature, and the residue was dissolved in a 50% volume / volume solution of acetonitrile in water (9 ml). Purify Sodarin by preparative HPLC: Column Spherisorb 5 micron ODS-2 (25 cm X2.1 cm) Flow rate 25 mL / min-62- This paper scale uses the Chinese National Standard (CNS) A4 specification (210X297 Cli) (Please read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7</span>A7</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標準局貝工消费合作社印裝 流動相550毫升乙腈以水加至1000毫升，每毫升流動相 加1毫升三氟醋酸 測定 210納米 注射容積4.5毫升 6分鐘後以此條件洗離索達里新。集中含索達里新部分， 於室溫迴轉蒸發除去乙腈，將水性溶液凍乾，即製得標題 化合物（8.9毫克），爲白色粉。 中間體1 [1R-(1 a，3a/?，4卢，4a/5，7点，7aa，8a/? )]8a-[(6-去氧 D-阿卓哌喃糖基氧基）甲基卜4_甲醯基_4,4a，56,7,7a， 8,8a -八氫-7-甲基- 3- (1-甲基乙基）-1，4 -亞甲基- s-p5丨健省 -3a(lH)-羧酸，二苯基甲基酯 於4·-脱甲基索達林（1〇克）於甲醇（2〇〇毫升）内之溶液中 於室溫滴加0.35 Μ的二苯基二偶氮甲烷（90毫升）於二氣甲 烷内之溶液，將此混合物攪拌6小時。蒸發去溶劑至乾，殘 餘物於二氧化矽膠閃柱上作色層分析，用己烷：醋酸乙酯 (3 : 1)作洗離劑，製得標題化合物（12.6克），爲淺黃色泡 末。 ά (^, CDC13)： 9.73 (s, 1H, CHO), 6.98 (s, 1H, CHPh2), 6.05 (dd，1H, H-2, J=1.5及3.6 Hz), 4.65 (d，1H, H-l’，J=1.5</span>Printed mobile phase of 550 ml of acetonitrile to 1000 ml of water in the Beigong Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. Add 1 ml of trifluoroacetic acid per ml of mobile phase to measure 210 nanometers. Injection volume 4.5 ml. Lixin. The new part containing Sodarin was concentrated, and the acetonitrile was removed by rotary evaporation at room temperature, and the aqueous solution was lyophilized to obtain the title compound (8.9 mg) as a white powder. Intermediate 1 [1R- (1 a, 3a / ?, 4 Lu, 4a / 5, 7 o'clock, 7aa, 8a /?)] 8a-[(6-deoxyD-azorpiperanyloxy) Methyl Bu 4_Methanoyl_4,4a, 56,7,7a, 8,8a -octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene- s-p5 Shunjian-3a (lH) -carboxylic acid, diphenyl methyl ester in a solution of 4 · -demethylsodarin (10 g) in methanol (200 mL) A solution of 0.35 M diphenyl diazomethane (90 ml) in methane gas was added dropwise, and the mixture was stirred for 6 hours. The solvent was evaporated to dryness, and the residue was analyzed on a silica gel flash column using hexane: ethyl acetate (3: 1) as the eluent to obtain the title compound (12.6 g) as a light yellow foam end. ά (^, CDC13): 9.73 (s, 1H, CHO), 6.98 (s, 1H, CHPh2), 6.05 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 4.65 (d, 1H, H -l ', J = 1.5</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.09, 3.76 (2d, 2H, 8a-CH2, J=9 Hz), 4.01 (m, 1H, H-2'), 3.84 (m, 1H, H-3'), 3.75 (m, 1H, H-5'), 3.69 (m, 1H, H-4，)，2.73 (t, 1H, H-l，J=4.2 Hz)。 -63- — 本紙張尺度適用中國國家標率（CNS ) A4規格（210x297公釐） (請先閲讀背面之注意事項再填寫本頁)</span>Hz), 4.09, 3.76 (2d, 2H, 8a-CH2, J = 9 Hz), 4.01 (m, 1H, H-2 '), 3.84 (m, 1H, H-3'), 3.75 (m, 1H , H-5 '), 3.69 (m, 1H, H-4,), 2.73 (t, 1H, Hl, J = 4.2 Hz). -63- — This paper scale is applicable to China National Standard Rate (CNS) A4 (210x297mm)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">32l64 4 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明（61) HR-(1 a，3a冷，4卢，4a；5 ,7/?，7aa ,8ay5 )]8a-[(6-去氧-3,4-0-異亞丙基-々-D-阿卓哌喃糖基氧基）甲基]-4-甲醯基-4,4a，5,6,7,7a，8,8a-八氫-7-甲基-3-(l-甲基乙基）-(1H)-1，4-亞甲基-s-H丨噠省-3a(lH)-羧酸，二苯基甲基酯 於中間體1(650毫克）於15毫升二甲氧基丙烷：丙酮（1 : 2)内之溶液中加p -甲苯磺酸（10毫克）。將此溶液於室溫攪 拌1.5小時，然後加碳酸鉀（1,〇克），繼續攪拌3〇分鐘，蒸 發去溶劑至乾。此粗製混合物於醋酸乙酯（50毫升）及水 (25毫升）間分開，水相以醋酸乙酯（2x50毫升）萃取，有 機相以鹽水洗，於硫酸鎂上乾燥，並蒸發至乾。殘餘物於 二氧化矽膠上作閃色層分析，以醋酸乙酯：己烷（1 : 3 )洗 離，製得標題化合物（600毫克），爲白色泡沫。 e Gh，CDC13): 9.73 (s，1H，CHO)，7.45-7.24 (m，10H， 2Ph),6.98(s,lH,CHPh2)，6.06(dd，lH,H-2，J=1.5&amp;amp;3.3</span>32l64 4 A7 B7 Printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Invention description (61) 6-deoxy-3,4-0-isopropylidene-々-D-azhopyranosyloxy) methyl] -4-carboxamide-4,4a, 5,6,7,7a , 8,8a-octahydro-7-methyl-3- (l-methylethyl)-(1H) -1,4-methylene-sH-da-3s (lH) -carboxylic acid, di P-toluenesulfonic acid (10 mg) was added to a solution of phenylmethyl ester in intermediate 1 (650 mg) in 15 ml of dimethoxypropane: acetone (1: 2). This solution was stirred at room temperature for 1.5 hours, then potassium carbonate (1,0 g) was added, stirring was continued for 30 minutes, and the solvent was evaporated to dryness. The crude mixture was separated between ethyl acetate (50 mL) and water (25 mL). The aqueous phase was extracted with ethyl acetate (2x50 mL). The organic phase was washed with brine, dried over magnesium sulfate, and evaporated to dryness. The residue was analyzed by flash layer on silica gel and washed with ethyl acetate: hexane (1: 3) to obtain the title compound (600 mg) as a white foam. e Gh, CDC13): 9.73 (s, 1H, CHO), 7.45-7.24 (m, 10H, 2Ph), 6.98 (s, lH, CHPh2), 6.06 (dd, lH, H-2, J = 1.5 &amp;amp; 3.3</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.57 (d, 1H, H-l', J=3.0 Hz), 4.30 (dd, 1H, H-3', J=3.6 &amp;amp;5.7Hz)，4.07(d，lH，8aCH2，J=9.0Hz)，3.95-3.93 (m，lH, H-2'),3.85(dd,lH，H-4，，J=5.7&amp;amp;9.3Hz)，3.75(d，lH， 8aCH2, J=9.0 Hz), 3.44 (dq, 1H, H-5', Jd=9.3 Hz,Jq=6.3 Hz), 2.73 (t, 1H, H-l, J=3.6 Hz) ° 中間體3 [111-(1“，3&amp;amp;々，4卢，4&amp;amp;卢，7卢，7&amp;amp;心83々）]83-[(6-去氧-3,4-〇-(2 -亞戊基）-p-D -阿卓哌喃糖基氧基）甲基]-4 -甲醯基-4,4a，5,6,7,7a，8,8a-八氩-7-甲基- 3- (1-甲基乙基）-1,4- -64 - 本紙張尺度逋用中國國家橾率（CMS〉Α4規格（21〇&amp;gt;&amp;lt;2们公釐） (請先閲讀背面之注意事項再填寫本頁) 、11 Λ A7 B7 S21644 五、發明説明（62) 亞甲基-s-啕噠省-3a(lH)-羧酸，二苯基甲基酯 於中間體1(500毫克）及P-曱苯磺酸（5毫克）於二氣甲院（5 毫升）内之懸浮液中加2,2-二甲氧基戊烷（2毫升）。將此混 合物於室溫攪拌2小時。加碳酸鉀（150毫克），繼續授摔3〇 分鐘。蒸發去溶劑至乾，殘餘物於二氧化矽膠上作閃色層 分析，以醋酸乙酯：己烷（15 : 85)洗離，製得標題化合物 (474毫克）。 e Oh, CDC13): 9.73 (s, 1H, CHO), 7.45-7.24 (m，10H， 2Ph)，6.98(s，lH，CiiPh2)，6.06(dd，lH，H-2，J=1.5&amp;amp;3.3</span>Hz), 4.57 (d, 1H, H-l ', J = 3.0 Hz), 4.30 (dd, 1H, H-3', J = 3.6 &amp;amp; 5.7Hz), 4.07 (d, lH, 8aCH2, J = 9.0Hz), 3.95-3.93 (m, lH, H-2 '), 3.85 (dd, lH, H-4 ,, J = 5.7 &amp;amp; 9.3Hz), 3.75 (d, lH, 8aCH2, J = 9.0 Hz ), 3.44 (dq, 1H, H-5 ', Jd = 9.3 Hz, Jq = 6.3 Hz), 2.73 (t, 1H, Hl, J = 3.6 Hz) ° Intermediate 3 [111- (1 “, 3 &amp;amp; 々, 4 Lu, 4 &amp;amp; Lu, 7 Lu, 7 &amp;amp; Heart 83々)] 83-[(6-deoxy-3,4-〇- (2-pentylidene) -pD-azorpiperanosyl Oxy) methyl] -4 -carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1, 4- -64-This paper uses the Chinese National Standard Rate (CMS&gt; Α4 specification (21〇 &amp;gt; &amp;lt; 2mm) (please read the precautions on the back before filling this page), 11 Λ A7 B7 S21644 V. Description of the invention (62) Methylene-s-pyda-3a (lH) -carboxylic acid, diphenyl methyl ester in intermediate 1 (500 mg) and P-toluenesulfonic acid (5 mg) Add 2,2-dimethoxypentane (2 ml) to the suspension in Erqijiayuan (5 ml). Stir the mixture at room temperature for 2 hours. Add potassium carbonate (150 mg) and continue to teach Drop 3 The solvent was evaporated to dryness, and the residue was analyzed by flash chromatography on silica gel and washed away with ethyl acetate: hexane (15:85) to obtain the title compound (474 mg). E Oh, CDC13) : 9.73 (s, 1H, CHO), 7.45-7.24 (m, 10H, 2Ph), 6.98 (s, lH, CiiPh2), 6.06 (dd, lH, H-2, J = 1.5 &amp;amp; 3.3</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.57 (d, 1H, Η-Γ, J=2.1 Hz), 4.30 (dd, 1H, H-3', J=3.9 及6.0 Hz), 4.04 (d, 1H，8aCH2, J=9.0 Hz), 3.94-3.91 (m，1H， H-2')，3.86 (dd, 1H，H.4'，J=6.3及9.6 Hz)，3.73 (d，1H， 8aCH2, J=9.0 Hz), 3.45 (dq, 1H, H-5, Jd=9.0 Hz,Jq-6.0 Hz), 2.72 (t, 1H, H-l, J~3.6 Hz) ° 中間體4 [1R-(1 a，3a0，4A，4a0，7 卢，7aa，8a0 )]8a-[(6-去氧-3,4-0-(4-甲氧基-2-亞丁基）_々-D-阿卓哌喃糖基氧基）甲基]_ 4 -甲醯基-4,4a,5，6,7,7a, 8,8a-八氫-7 -甲基-3-(1-甲基乙 基）-1，4-亞甲基-s-吲噠省_3a(iH)-羧酸，二苯基甲基酯 於中間體1(3 50毫克）及p-曱苯磺酸（5毫克）於二氣甲烷（4 毫升）内之懸浮液中加2,2,4-三甲氧基丁烷（1毫升）。將此 混合物於室溫攪拌1小時。加碳酸卹（丨5〇毫克），繼續攪拌 3 0分鐘。蒸發去溶劑至乾，殘餘物於二氧化矽膠上作閃色 層分析’以醋酸乙酯：己烷: 7)及（4 : 6)洗離，製得標 _ -65- 本紙张尺度適用中國國家標準（CNS ) A4規格（210X297公釐） (請先閲讀背面之注意Ϋ項再填寫本頁) 丁 經濟部中央標準局員工消费合作社印製 經濟部中央樣準局員工消費合作社印製 A7 ___B7 ______ 五、發明説明（63 ) 題化合物（290毫克），差向異構物比3 : 1。 汐（4, CDC13)之成分信號：9_73 (s，1H，CH〇)，7.45_7.20 (m, 10H, 2Ph), 6.98 (s, 1H, CHPh2), 6.06 (dd, 1H, H-2, J=1.5及3.6 Hz), 4.57 (d，1H, Η-Γ，J=2.1 Hz), 4.31 (dd，1H, H-3', J=3.9^.6.0 Hz), 4.05 (d, 1H, 8aCH2, J=9.〇 Hz), 3.95- (d, 1H, 8aCH2, J=9.0 Hz), 3.51(t, 2H, CH2〇, J=7.2 Hz), 3.50-3.45 (m, 1H, H-5'), 3.33 (s, 3H, CH30), 2.72 (t, 1H, H-1，J=3.6 Hz)。 中間體5 [1R-(1 or，3a0，4冷，4ay3 ,7 冷，7aa/，8a/3 )]8a-[(6 -去氧- 3,4-〇·環亞戊基- A-D-阿卓哌喃糖基氧基）]-4 -甲醯基 4,4a,5,6,7,7a,8,8a-八氫-7 -甲基-3-(1-甲基乙基）-1,4-亞甲基- s-»?丨缝省- 3a(lH) -羧酸，二苯基甲基醋 於中間體1(160毫克）於二氣曱烷：ι，ι_二甲氧基環戊烷 (3: 1 ; 4毫升）内之懸浮液中加p -甲苯磺酸（5毫克），此混 合物於室溫挽掉2小時。加碳酸奸（1克），繼續挽拌分鐘 。蒸發去溶劑至乾’殘餘物於二氧化矽膠上作閃色層分析 ，以醋酸乙醋：己娱&amp;gt;(1 : 4)洗離，製得標題化合物（m2毫 克）。 (ln, CDC13)： 9.73 (s, 1H, CHO), 7.45-7.25 (m, 10H, 2Ph)，6.98(s，lH，CHPh2)，6.06(dd，lH，H-2，j=i_5&amp;amp;3.6</span>Hz), 4.57 (d, 1H, Η-Γ, J = 2.1 Hz), 4.30 (dd, 1H, H-3 ', J = 3.9 and 6.0 Hz), 4.04 (d, 1H, 8aCH2, J = 9.0 Hz ), 3.94-3.91 (m, 1H, H-2 '), 3.86 (dd, 1H, H.4', J = 6.3 and 9.6 Hz), 3.73 (d, 1H, 8aCH2, J = 9.0 Hz), 3.45 (dq, 1H, H-5, Jd = 9.0 Hz, Jq-6.0 Hz), 2.72 (t, 1H, Hl, J ~ 3.6 Hz) ° Intermediate 4 [1R- (1 a, 3a0, 4A, 4a0, 7 Lu, 7aa, 8a0)] 8a-[(6-deoxy-3,4-0- (4-methoxy-2-butylene) _々-D-azorpiperanyloxy) methyl Radical] _ 4 -carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene -S-indap_3a (iH) -carboxylic acid, diphenylmethyl ester in intermediate 1 (3 50 mg) and p-toluenesulfonic acid (5 mg) in difluoromethane (4 mL) Add 2,2,4-trimethoxybutane (1 ml) to the suspension inside. The mixture was stirred at room temperature for 1 hour. Add carbonated shirt (丨 50 mg) and continue stirring for 30 minutes. The solvent was evaporated to dryness, and the residue was analyzed on the silica gel for flash layer analysis, and washed away with ethyl acetate: hexane: 7) and (4: 6), and the obtained standard _ -65- This paper size is suitable for China National Standard (CNS) A4 specification (210X297mm) (Please read the note Ϋ on the back before filling in this page) Ding printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy Printed A7 ___B7 by the Employee Consumer Cooperative of the Central Bureau of Standards ______ 5. Description of the invention (63) The title compound (290 mg), epimer ratio 3: 1. The component signals of Xi (4, CDC13): 9_73 (s, 1H, CH〇), 7.45_7.20 (m, 10H, 2Ph), 6.98 (s, 1H, CHPh2), 6.06 (dd, 1H, H-2 , J = 1.5 and 3.6 Hz), 4.57 (d, 1H, Η-Γ, J = 2.1 Hz), 4.31 (dd, 1H, H-3 ', J = 3.9 ^ .6.0 Hz), 4.05 (d, 1H , 8aCH2, J = 9.〇Hz), 3.95- (d, 1H, 8aCH2, J = 9.0 Hz), 3.51 (t, 2H, CH2〇, J = 7.2 Hz), 3.50-3.45 (m, 1H, H -5 '), 3.33 (s, 3H, CH30), 2.72 (t, 1H, H-1, J = 3.6 Hz). Intermediate 5 [1R- (1or, 3a0, 4 cold, 4ay3, 7 cold, 7aa /, 8a / 3)] 8a-[(6 -deoxy-3,4-〇. Cyclopentylene-AD- Azuroporanyloxy)]-4 -carboxamide 4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s- »? Shun Province-3a (lH)-carboxylic acid, diphenyl methyl vinegar in intermediate 1 (160 mg) in dimethane: ι, ι_ di To the suspension of methoxycyclopentane (3: 1; 4 ml) was added p-toluenesulfonic acid (5 mg), and the mixture was removed at room temperature for 2 hours. Add carbonated rape (1 g) and continue to mix for another minute. The solvent was evaporated to dryness, and the residue was analyzed by flash layer on silica gel, and washed away with ethyl acetate: ethyl acetate&gt; (1: 4) to obtain the title compound (m2 mg). (ln, CDC13): 9.73 (s, 1H, CHO), 7.45-7.25 (m, 10H, 2Ph), 6.98 (s, lH, CHPh2), 6.06 (dd, lH, H-2, j = i_5 &amp;amp; 3.6</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.55 (d, 1H, H-l', J=1.8 Hz), 4.17 (dd, 1H, H-3', J=3 〇 及5.1 Hz), 4.08 (d, 1H, 8aCH2, J=9.0 Hz)，3.95 (dt，1H，H-21 -66 - 本紙張尺度遑用中國國家標準（CNS ) A4規格（210&amp;gt;&amp;lt;297公釐） --— (請先閱讀背面之注意事項再填寫本頁)</span>Hz), 4.55 (d, 1H, H-l ', J = 1.8 Hz), 4.17 (dd, 1H, H-3', J = 3 〇 and 5.1 Hz), 4.08 (d, 1H, 8aCH2, J = 9.0 Hz), 3.95 (dt, 1H, H-21 -66-this paper standard uses the Chinese National Standard (CNS) A4 specification (210 &amp;gt; &amp;lt; 297mm) --- (please read the precautions on the back Fill in this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 經濟部中央揉準局員工消費合作社印裝 321644 B7 五、發明説明（</span>A7 Printed and printed by the Employees Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs 321644 B7 V. Description of invention (</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Jd = 1.8 Hz, Jt=3.0 Hz), 3.81 (dd，1H，H-4，，J=5.1 及9.3 Hz)， 3.76 (d, 1H, 8aCH2, J=9.0 Hz), 3.42 (dq, 1H, H-5', Jd=9.3</span>Jd = 1.8 Hz, Jt = 3.0 Hz), 3.81 (dd, 1H, H-4, J = 5.1 and 9.3 Hz), 3.76 (d, 1H, 8aCH2, J = 9.0 Hz), 3.42 (dq, 1H, H-5 ', Jd = 9.3</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz，Jq=6.3 Hz), 2.73 (t, 1H, H-l, J=3.9 Hz)。 中間體6 [1R-(1 a，3a0，4/? ,4 a/? ,7/5，7aa，8ay5 )]8a-[(6 -去氧- 3,4- 0 -異亞丙基- 2- (甲硫基）硫羰基-d_阿卓旅喃糖基氧基) 甲基]-4-甲醯基-4,4&amp;amp;，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7_甲基-3-(1- 甲基乙基）-1,4 -亞甲基- s-M丨違省- 3a(lH) -叛酸，二苯基甲 基酯 於中間體2(100毫克）及咪唑（1毫克）在氮氣下溶於無水四 氫呋喃（4毫升）内。加氫化鈉（5毫克），此懸浮液於室溫挽 拌0_5小時。加二硫化碳（27微升），繼續攪拌20分鐘，加甲 基碘（18微升）。2小時後加1當量氣化銨（2〇毫升）使反應停 止。此混合物以醋酸乙酯（3x25毫升）萃取，有機相用鹽水 洗，於硫酸鎂上乾燥，蒸發去溶劑至乾。殘餘物於二氧化 矽膠上作閃色層分析柱純化，以醋酸乙酯：己烷（丨：9)洗 離，製得標題化合物（110毫克）。 〇U, CDC13): 9.71 (s, 1H, CHO), 7.44-7.25 (m, l〇H, 2Ph), 6.96 (s，1H，CHPh2), 6.01 (dd，1H，H-2, &amp;gt;1.2及3 6 Hz)，6.90 (dd, 1H，H-2，，J=2.4及5.4 Hz)，4·85 (a，ih，H-i·， J=2.4 Hz)，4.53 (dd，1H，H-31, J=5.4及6.3 Hz)，4.00 (dd，1H, H-4’，J=6.3及8.7 Hz)，3.93 (d，1H, 8aCH2, J=9.3 Hz), 3.65 (dq, 1H, H-5', Jd=8.7, Jq=6.3 Hz), 2.68 (t, 1H, H-l, j=3.9 Hz)，2.59 (s, 3H，CH3 S)。 ____-67-___ 本紙張尺度適用中國國家揉準（CNS ) A4规格（21 OX297公釐) ~~ (請先閲讀背面之注意事項再填寫本頁)</span>Hz, Jq = 6.3 Hz), 2.73 (t, 1H, H-l, J = 3.9 Hz). Intermediate 6 [1R- (1 a, 3a0, 4 / ?, 4 a / ?, 7/5, 7aa, 8ay5)] 8a-[(6 -deoxy-3,4- 0 -isopropylidene- 2- (Methylthio) thiocarbonyl-d_azorranosyloxy) methyl] -4-carboxamide-4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp;- Octahydro-7_methyl-3- (1-methylethyl) -1,4-methylene-sM 丨 default- 3a (lH) -tetanoic acid, diphenylmethyl ester in intermediate 2 (100 mg) and imidazole (1 mg) were dissolved in anhydrous tetrahydrofuran (4 ml) under nitrogen. Sodium hydride (5 mg) was added, and the suspension was stirred at room temperature for 0-5 hours. Add carbon disulfide (27 µl), continue stirring for 20 minutes, and add methyl iodide (18 µl). After 2 hours, 1 equivalent of ammonium vapor (20 mL) was added to stop the reaction. The mixture was extracted with ethyl acetate (3x25 ml), the organic phase was washed with brine, dried over magnesium sulfate, and the solvent was evaporated to dryness. The residue was purified on silica gel as a flash chromatography column, and washed with ethyl acetate: hexane (丨: 9) to obtain the title compound (110 mg). 〇U, CDC13): 9.71 (s, 1H, CHO), 7.44-7.25 (m, 10H, 2Ph), 6.96 (s, 1H, CHPh2), 6.01 (dd, 1H, H-2, &amp;gt; 1.2 And 3 6 Hz), 6.90 (dd, 1H, H-2, J = 2.4 and 5.4 Hz), 4.85 (a, ih, Hi ·, J = 2.4 Hz), 4.53 (dd, 1H, H- 31, J = 5.4 and 6.3 Hz), 4.00 (dd, 1H, H-4 ', J = 6.3 and 8.7 Hz), 3.93 (d, 1H, 8aCH2, J = 9.3 Hz), 3.65 (dq, 1H, H -5 ', Jd = 8.7, Jq = 6.3 Hz), 2.68 (t, 1H, Hl, j = 3.9 Hz), 2.59 (s, 3H, CH3 S). ____- 67 -___ The paper size is applicable to China National Standard (CNS) A4 specification (21 OX297mm) ~~ (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央樣準局員工消費合作社印製 A7 B7 五、發明説明（65) 中間體7 [1尺-(1〇^3&amp;amp;;5,4；5,4汪/5,7々，73〇^，8&amp;amp;/5)]83-[(2,6-二去氧-3,4-0 -異亞丙基-卢-D·別哌喃糖基氧基）甲基]_4_甲醯基_ 4,4牡，5,6,7,73,8,8&amp;amp;-八氫-7-甲基-.3-(1-甲基乙基）-1，4-亞甲基-s-啕噠省-3a(lH)-羧酸，二苯基甲基酯 (i)將中間體6(95毫克）在氮氣下溶於無水甲苯（5毫升）内 ’並於110°C加熱。用1.5小時以上滴加氫化三丁基錫 (64微升）於無水曱苯（5毫升）内之溶液，同時攪拌。再 繼續加熱1.5小時’加甲醇（2毫升），蒸發去溶劑至乾。 殘餘物於二氧化矽膠上作閃色層分析，以醋酸乙酯： 己燒^1 · 9)洗離’製得標題化合物（42毫克）。 ^ CDC13): 9.73 (s, 1H, CHO), 7.44-7.25 (m, 10H, 2Ph)，6.98 (1H，s，CHPh2), 6.05 (dd，1H，H-2, J=1.2及 3·3 Hz)，4·54 (dd，1H, Η-Γ, J=2.7 及 9.3 Hz)，4.39 (dt， 1H, H-3', Jd=2.7 Hz, Jt=3.6 Hz), 4.04 (d, 1H, 8aCH2, J=9.0 Hz), 3.67 (d, 1H, 8aCH2, J-9.0 Hz), 3.65 (dd, 1H, H-4’，J=3.6及8.7 Hz), 3.44 (d，1H，H-5', Jd=6.3 Hz，Jq=8.7 Hz)，2.75 (t，1H, J=3.9 Hz)。 (η)將氫化三丁基錫（5.5毫升）於無水甲苯（150毫升）内之溶 液以氬氣流去氣1小時，並於回流加熱。以2小時時間 加中間體6(6克）於無水甲苯（5〇毫升）内之溶液。繼續 加熱至反應完全（1 _ 5小時）。減塵下排除溶劑，得粗製 產物，再於二氧化矽膠上作閃色層分析，以己烷及己 垸：醋酸乙酯（20 : 1至15 : 1)洗離，製得標題化合物 ------------68 - ______ 本紙張纽適财國國家揉準（CN$)八4胁（210 X 297公兼 1&amp;quot; (請先閱讀背面之注意事項再填寫本頁)</span>A7 B7 printed by the Employee Consumer Cooperative of the Central Prototype Bureau of the Ministry of Economy V. Description of the invention (65) Intermediate 7 [1 foot- (1〇 ^ 3 &amp;5;4; ^, 8 &amp;amp; / 5)] 83-[(2,6-dideoxy-3,4-0-isopropylidene-Lu-D · piperanyloxy) methyl] _4_formyl Radical _ 4,4 M, 5,6,7,73,8,8 &amp;amp; -octahydro-7-methyl-.3- (1-methylethyl) -1,4-methylene-s- Chita-3a (lH) -carboxylic acid, diphenylmethyl ester (i) Intermediate 6 (95 mg) was dissolved in anhydrous toluene (5 ml) under nitrogen and heated at 110 ° C. A solution of tributyltin hydride (64 μl) in anhydrous toluene (5 ml) was added dropwise over 1.5 hours while stirring. Continue heating for another 1.5 hours, add methanol (2 ml) and evaporate the solvent to dryness. The residue was analyzed by flash layer on silica gel, and the title compound (42 mg) was prepared by washing away with ethyl acetate: hexane ^ 1.9). ^ CDC13): 9.73 (s, 1H, CHO), 7.44-7.25 (m, 10H, 2Ph), 6.98 (1H, s, CHPh2), 6.05 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.54 (dd, 1H, Η-Γ, J = 2.7 and 9.3 Hz), 4.39 (dt, 1H, H-3 ', Jd = 2.7 Hz, Jt = 3.6 Hz), 4.04 (d, 1H , 8aCH2, J = 9.0 Hz), 3.67 (d, 1H, 8aCH2, J-9.0 Hz), 3.65 (dd, 1H, H-4 ', J = 3.6 and 8.7 Hz), 3.44 (d, 1H, H- 5 ', Jd = 6.3 Hz, Jq = 8.7 Hz), 2.75 (t, 1H, J = 3.9 Hz). (η) A solution of tributyltin hydride (5.5 ml) in anhydrous toluene (150 ml) was degassed with a stream of argon for 1 hour and heated at reflux. A solution of Intermediate 6 (6g) in anhydrous toluene (50ml) was added over 2 hours. Continue heating until the reaction is complete (1_5 hours). Remove the solvent under dust reduction to obtain the crude product, and then analyze the flash layer on the silica gel, and wash it off with hexane and ethyl acetate: ethyl acetate (20: 1 to 15: 1) to obtain the title compound- ---------- 68-______ This paper New Zealand's National Finance Standard (CN $) 8 4 threats (210 X 297 public and 1 &amp;quot; (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央揉準局貝工消費合作社印製 321644 at __B7_ 五、發明説明（66 ) (4 克）。 中間體8 [lR-(la,3ay9,4/?，4ay5,7々，7aa，8a々）]8a-[(2,6-:i*- 3,4-0-(4 -甲氧基-2-亞丁基）-々-D-別旅喃糖基氧基）曱基] -4 -甲酿基-4,4a，5，6,7,7a，8,8a -八氫-7-甲基- 3- (1-甲基 乙基）-1,4-亞甲基-s-吲噠省-3 a(lH)-羧酸，二苯基甲基醋 於中間體4(600毫克）於無水四氫呋喃（1〇毫升）之溶液内 於〇°C在氮氣下加氩化鈉（30毫克）及咪唑（5毫克）。將此溶 液攪拌10分鐘，再加二硫化碳（147微升）。20分鐘後，加 甲基破（127微升），繼續攪拌30分鐘。加1當量氣化銨（2〇 毫升）’此混合物用醋酸乙自旨（3x25毫升）萃取，有機相用 鹽水洗，於硫酸鎂上乾燥，蒸發去溶劑至乾。殘餘物於二 氧化矽膠上作閃色層分析，以醋酸乙酯：己烷（丨5 : 8 5)洗 離，製得白色泡沫。將此泡沫在氮氣下溶於無水曱苯毫 升）内，於115 °C用2小時以上滴加氫化三丁基錫（〇 46毫升) 於甲苯（10毫升）内之溶液。繼續加熱2小時。蒸發去溶劑至 乾，殘餘物於二氧化矽膠上作閃色層分析純化，以醋酸乙 酿·己燒（15 . 85)洗離，製得標題化合物（260毫克），差 向異構物比4 : 1。 ^ CDC13)： 9·63 CHO), 7.44-7.20 (m, 10H, 2Ph)，6.99(s，lH，CHPh2)，6.06(dd，lH,H-2，J=1.2&amp;amp;3.3 Hz), 4.53 (dd，1H, H-l，J-2.7 及 8.7 Hz)，4.42 (dt，1H H-31</span>Printed 321644 at __B7_ by the Pongong Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs. V. Description of Invention (66) (4 grams). Intermediate 8 [lR- (la, 3ay9,4 / ?, 4ay5,7々, 7aa, 8a々)] 8a-[(2,6-: i *-3,4-0- (4-methoxy -2-butylidene) -々-D-pyranoyloxy) methyl] -4 -methylbromo-4,4a, 5, 6,7,7a, 8,8a -octahydro-7- Methyl-3- (1-methylethyl) -1,4-methylene-s-indap-3a (lH) -carboxylic acid, diphenylmethyl acetate in intermediate 4 (600 mg ) Sodium hydride (30 mg) and imidazole (5 mg) were added to a solution of anhydrous tetrahydrofuran (10 ml) at 0 ° C under nitrogen. This solution was stirred for 10 minutes, and then carbon disulfide (147 µl) was added. After 20 minutes, add methyl bromide (127 microliters) and continue stirring for 30 minutes. Add 1 equivalent of vaporized ammonium (20 mL). This mixture was extracted with ethyl acetate (3x25 mL). The organic phase was washed with brine, dried over magnesium sulfate, and evaporated to dryness. The residue was analyzed by flash layer on silica gel and washed with ethyl acetate: hexane (5:85) to obtain a white foam. This foam was dissolved in anhydrous toluene under nitrogen), and a solution of tributyltin hydride (46 mL) in toluene (10 mL) was added dropwise at 115 ° C over 2 hours. Continue heating for 2 hours. The solvent was evaporated to dryness, and the residue was analyzed and purified by flash chromatography on silica gel, washed away with ethyl acetate and hexane (15.85) to obtain the title compound (260 mg), epimer ratio 4: 1. ^ CDC13): 9.63 CHO), 7.44-7.20 (m, 10H, 2Ph), 6.99 (s, lH, CHPh2), 6.06 (dd, lH, H-2, J = 1.2 &amp;amp; 3.3 Hz), 4.53 (dd, 1H, Hl, J-2.7 and 8.7 Hz), 4.42 (dt, 1H H-31</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Jd=3.0 Hz, Jf=4.2 Hz), 4.03 (d, 1H, 8aCH2, J=9.0 Hz), 3.68 (dd，1H, H-4', J=5.1 及9.3 Hz)，3.66 (d，1H, 8aC^，J=9.〇 -69- 本紙張尺度適用中國國家揉準（CNS ) A4规格（210X2.97公釐_)~~~' (請先閱讀背面之注意事項再填寫本頁)</span>Jd = 3.0 Hz, Jf = 4.2 Hz), 4.03 (d, 1H, 8aCH2, J = 9.0 Hz), 3.68 (dd, 1H, H-4 ', J = 5.1 and 9.3 Hz), 3.66 (d, 1H, 8aC ^ ， J = 9.〇-69- This paper scale is suitable for China National Standard (CNS) A4 specification (210X2.97mm_) ~~~ '(please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明（67)</span>Printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Invention Instructions (67)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 3.52 (t, 2H, CH2〇, J=7.2 Hz), 3.40 (dq, 1H, H-5',</span>Hz), 3.52 (t, 2H, CH2〇, J = 7.2 Hz), 3.40 (dq, 1H, H-5 ',</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Jd=9.3 Hz, Jq=6.3 Hz), 3.34 (s, 3H, CH30), 2.74 (t, 1H, H-l, J=4.2 Hz)。 中間體9 [1R-(1 or ,3a卢，4卢，4a；5，7y9，7aa，8ay5 )]8a-[(6-去氧·3,4-〇-硫羰基-/? -D-阿卓哌喃糖基氧基）甲基]_4·甲醯基-4,4a，5,6,7,7a，8,8a-八氫-7-甲基- 3- (1-甲基乙基）-1，4_ 亞甲基-s-啕噠省-3a(lH)-羧酸，二苯基甲基酯 將中間體1 (0.500克）及硫羰基咪唑（0.270克）於四氫呋喃 (10毫升）内之混合物回流6小時。眞空蒸發去溶劑，得黃色 殘餘物，此殘餘物於二氧化矽膠上作閃色層分析，以己烷 :醋酸乙酯（3 : 1)洗離，製得標題化合物（0.263克）。 ^ (^, CDC13): 9.71 (s, 1H, CHO), 7.44-7.26 (m, 10H, 2xPh)，6·97 (s，1H, C02C|iPh2), 6.06 (dd，1H，H-2, J=1.5及 3.3 Hz)，4.93 (dd，1H，Η·3'，J=3.9&amp;amp;7.2Hz),4.63(d,lH，H-1'，J=2.1 Hz)，4.61 (dd，1H，H-4，，J=7.2及9.3 Hz)，4.12 (m, 1H, H-2'), 4.08 (d, 1H, 8aCH2, JAB=9.3 Hz), 3.74 (d, 1H, 8aCH2, Jab=9.3 Hz), 3.64 (m, 1H, H-5'), 2.69 (m, 1H, H-l) o 中間體1 0 [111-(1〇?，3&amp;amp;0，4卢，4&amp;amp;点，7卢，73“，83；5)]8&amp;amp;-[(2,6-二去氧-々-D-別哌喃糖基氧基）甲基]-4_甲醯基_44a，5,6,7,7a, 8,8a-八氫-7 -甲基-3-(1-曱基乙基）-1，4-亞甲基-s-θ丨噠省 -3a(lH)-羧酸，二苯基曱基酯 -70- 本紙張尺度適用中國國家標準（CNS ) A4规格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁) 、tx 經濟部中央標準局員工消費合作社印策 321644 1 A7 B7 五、發明説明（68) 於中間體7(1.5克）於四氫呋喃（3〇毫升）及曱酵（15毫升） 混合物内之溶液中於室溫滴加1當量鹽酸溶液（15毫升），同 時強烈攪拌。反應一旦結束後（以TLC控制），加飽和碳酸 氫鈉（50毫升）及醋酸乙酯（2〇〇毫升），在將此混合物分開。 有機相用水（2x 100毫升）洗，於硫酸鎂上乾燥。除去溶劑 ，得殘餘物，此殘餘物於二氧化矽膠上作閃色層分析，以 己烷··醋酸乙酯（5 : 1 )及（2 : 1 )洗離，製得標題化合物 (1.1克），爲白色泡沫。 〇R, CDC13): 9.73 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s，1H，CHPh2)，6.05 (dd，1H，H-2, J=1.2及3.3 Hz)， 4.64 (dd，1H, Η-Γ，J=2.1 及9.6 Hz)，4.11 (m，1H, H-3')，4.06 (d，1H，8aCH2, JAB=9.3 Hz), 3.70 (m, 2H，H-5,及8aCH2), 3.34 (m, 1H，H-4')，2.75 (t, 1H，H-l, J=3.6 Hz)。 中間體1 1 [1R-(1 a，3ay?，4卢，4a点，7卢，7aa，8a；5 )]8a-[(2,6-二去氧-3,4-〇-硫羰基-召-〇-別哌喃糖基氧基）甲基]_4_甲醯基-4,4&amp;amp;，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7_曱基-3-(1-甲基乙基）-1，4-亞曱基- s-θΐ噠省- 3a(lH) -羧酸，二苯基甲基酯 將中間體10(160毫克）及氧化二丁基錫（124 5毫克）於無 水甲苯（15毫升）内之混合物於裝有Dean_stark冷凝器的燒 瓶内於回流加熱2小時，然後靜置於室溫氮氣下。於此形成 的溶液中加苯基-氣硫羰基甲酸酯（69微升）於無水甲苯（5毫 升）内之溶液。6小時後TLC顯示反應已完全。減壓除去溶 劑，粗製混合物於二氧化矽膠上作閃色層分析，以己烷： _ -71- 本紙張尺度逍用中國國家標準（CNS ) ( 21〇&amp;gt;&amp;lt;297公着 ---------Γ .t------tr------f (请先閱讀背面之注意事項再填寫本頁) A7 B7 經濟部中央棣率局ec H消費合作社印製 321644 五、發明説明（69) 醋酸乙酯（20 : 1)及（15 : 1)洗離，製得標題化合物（15〇毫 克），爲無色油體。 ci 〇n, CDC13): 9.72 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.97 (s，1H，CHPh2), 6.05 (dd, 1H, H-2, J=1.5及3_6 Hz), 5_10 (m, 1H，H-3’），4.61 (dd，1H，Η-Γ，J=2.4及8.4 Hz), 4.44 (dd, 1H, H-4', 1=6.6^9.0 Hz), 4.04^3.67 (2d, 2H, 8aCH2, JAB=9 Hz), 3.62 (m, 1H, H-5'), 2.70 (t, 1H, H-l, J=2.0 Hz) 0 中間體1 2 [lR-(l«X4/?，4a/5,7/?，7aa,8a；5)]8a-[(4-0，il 2,6-二去氧-冷_0_別哌喃糖基氧基）甲基]_4_甲醯基_ 4,4&amp;amp;，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7_甲基_3_(卜甲基乙基）_1，4_ 亞甲基-s-啕噠省-3a(lH)-羧酸，二苯基甲基酯 將中間體10(400毫克）及氧化三丁基錫（24〇毫克）於無水 甲苯（50毫升）内之混合物於裝有DeanStark冷凝器的燒瓶 内加熱至回流，然後靜置於室溫氮氣下（可除去近1〇毫升共 沸混合物）。相繼加烯丙基溴（71微升）及氟化四丁基銨（於 四氫呋喃内的1M溶液，0.95毫升），此混合物於5(rc加熱 24小時。除去溶劑得殘餘物，此殘餘物於二氧化矽膠上作 閃色層分析，以丙酮：己烷（1 : 2〇)及（丨：15)洗離，製得 標題化合物（3 00毫克），爲無色油體。 (1^ CDC13): 9.72 (s, 1H, CHO), 7.52-7.2 (m5 10H, 2Ph), ^•98 (s, H, CHPh2), 6.05 (dd, 1H, H-2, J-l.5^3.6 Hz) 5-89 (m, 1H, CH=CH2)5 5.30-5.20 (m, 2H, CH=CH2), 4.64 -72- (請先閣讀背面之注意事項再填寫本覓)</span>Jd = 9.3 Hz, Jq = 6.3 Hz), 3.34 (s, 3H, CH30), 2.74 (t, 1H, H-l, J = 4.2 Hz). Intermediate 9 [1R- (1 or, 3a Lu, 4 Lu, 4a; 5, 7y9, 7aa, 8ay5)] 8a-[(6-deoxy · 3,4-〇-thiocarbonyl-/?-D- Azuroprenyloxy) methyl] _4 · carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl Group) -1,4-methylene-s-pyda-3a (lH) -carboxylic acid, diphenylmethyl ester, intermediate 1 (0.500 g) and thiocarbonylimidazole (0.270 g) in tetrahydrofuran (10 ML) of the mixture was refluxed for 6 hours. The solvent was evaporated to give a yellow residue. This residue was analyzed by flash layer on silica gel and washed away with hexane: ethyl acetate (3: 1) to obtain the title compound (0.263 g). ^ (^, CDC13): 9.71 (s, 1H, CHO), 7.44-7.26 (m, 10H, 2xPh), 6.97 (s, 1H, C02C | iPh2), 6.06 (dd, 1H, H-2, J = 1.5 and 3.3 Hz), 4.93 (dd, 1H, Η · 3 ', J = 3.9 &amp;amp; 7.2Hz), 4.63 (d, lH, H-1', J = 2.1 Hz), 4.61 (dd, 1H , H-4, J = 7.2 and 9.3 Hz), 4.12 (m, 1H, H-2 '), 4.08 (d, 1H, 8aCH2, JAB = 9.3 Hz), 3.74 (d, 1H, 8aCH2, Jab = 9.3 Hz), 3.64 (m, 1H, H-5 '), 2.69 (m, 1H, Hl) o Intermediate 1 0 [111- (10 °, 3 &amp;amp; 0, 4 Lu, 4 &amp;amp; point, 7 Lu , 73 ", 83; 5)] 8 &amp;amp;-[(2,6-dideoxy-々-D-epiperanosyloxy) methyl] -4_methylaceto_44a, 5,6, 7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-theta province-3a (lH) -carboxylic acid, Diphenyl methyl ester-70- This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297mm) (please read the precautions on the back before filling this page), tx printed by the Employee Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 321644 1 A7 B7 5. Description of the invention (68) To the solution of the intermediate 7 (1.5g) in the mixture of tetrahydrofuran (30ml) and yeast (15ml), add 1 equivalent dropwise at room temperature Hydrochloric acid solution (15 ml) with vigorous stirring. Once the reaction is complete (controlled by TLC), saturated sodium bicarbonate (50 ml) and ethyl acetate (200 ml) are added and the mixture is separated. The organic phase is water (2x 100ml) Wash and dry over magnesium sulfate. Remove the solvent to obtain a residue. This residue was analyzed by flash layer on silica gel, using hexane ·· ethyl acetate (5: 1) and (2 : 1) Wash off to obtain the title compound (1.1 g) as a white foam. 〇R, CDC13): 9.73 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s, 1H , CHPh2), 6.05 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.64 (dd, 1H, Η-Γ, J = 2.1 and 9.6 Hz), 4.11 (m, 1H, H-3 ' ), 4.06 (d, 1H, 8aCH2, JAB = 9.3 Hz), 3.70 (m, 2H, H-5, and 8aCH2), 3.34 (m, 1H, H-4 '), 2.75 (t, 1H, Hl, J = 3.6 Hz). Intermediate 1 1 [1R- (1 a, 3ay ?, 4 Lu, 4a point, 7 Lu, 7aa, 8a; 5)] 8a-[(2,6-dideoxy-3,4-〇-thiocarbonyl -Zhao-〇-piperanosyloxy) methyl] _4_carboxyl-4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp; -octahydro-7_methyl-3 -(1-methylethyl) -1,4-methylidene-s-theta province-3a (lH) -carboxylic acid, diphenylmethyl ester intermediate 10 (160 mg) and dibutyltin oxide A mixture of (124 5 mg) in anhydrous toluene (15 ml) was heated at reflux for 2 hours in a flask equipped with a Dean_stark condenser, and then allowed to stand at room temperature under nitrogen. To the resulting solution was added a solution of phenyl-gasthiocarbonyl formate (69 µl) in anhydrous toluene (5 mL). After 6 hours, TLC showed that the reaction was complete. The solvent was removed under reduced pressure, and the crude mixture was subjected to a flash layer analysis on silica gel, using hexane: _ -71- This paper scale was used in China National Standards (CNS) (21〇 &amp;lt; 297 public --- ------ Γ .t ------ tr ------ f (Please read the precautions on the back before filling this page) A7 B7 Printed by ec H Consumer Cooperative, Central Bureau of Economic Affairs, Ministry of Economic Affairs 321644 V. Description of the invention (69) Ethyl acetate (20: 1) and (15: 1) were washed away to obtain the title compound (15 mg) as a colorless oil. Ci 〇n, CDC13): 9.72 (s , 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.97 (s, 1H, CHPh2), 6.05 (dd, 1H, H-2, J = 1.5 and 3_6 Hz), 5_10 (m, 1H, H-3 '), 4.61 (dd, 1H, Η-Γ, J = 2.4 and 8.4 Hz), 4.44 (dd, 1H, H-4', 1 = 6.6 ^ 9.0 Hz), 4.04 ^ 3.67 (2d, 2H , 8aCH2, JAB = 9 Hz), 3.62 (m, 1H, H-5 '), 2.70 (t, 1H, Hl, J = 2.0 Hz) 0 Intermediate 1 2 [lR- (l «X4 / ?, 4a / 5,7 / ?, 7aa, 8a; 5)] 8a-[(4-0, il 2,6-dideoxy-cold_0_epiperanyloxy) methyl] _4_formyl Base_4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7_methyl_3_ (卜 methylethyl) _1,4_methylene-s- 啕 哒 省 -3a lH) -carboxylic acid Diphenylmethyl ester A mixture of Intermediate 10 (400 mg) and tributyltin oxide (24 mg) in anhydrous toluene (50 mL) was heated to reflux in a flask equipped with a DeanStark condenser, and then allowed to stand Under nitrogen at room temperature (nearly 10 ml of azeotropic mixture can be removed). Allyl bromide (71 μl) and tetrabutylammonium fluoride (1M solution in tetrahydrofuran, 0.95 mL) were added successively. A flash layer was analyzed on the silica gel, and washed away with acetone: hexane (1: 2〇) and (丨: 15) to obtain the title compound (300 mg) as a colorless oil. (1 ^ CDC13) : 9.72 (s, 1H, CHO), 7.52-7.2 (m5 10H, 2Ph), ^ • 98 (s, H, CHPh2), 6.05 (dd, 1H, H-2, Jl.5 ^ 3.6 Hz) 5- 89 (m, 1H, CH = CH2) 5 5.30-5.20 (m, 2H, CH = CH2), 4.64 -72- (please read the notes on the back before filling in this book)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- - r c I * 經濟部中央樣準局貝工消费合作社印策 321644 A7 B7 五、發明説明（7〇) (dd，1H，Η-Γ，J=2.1 及9.6 Hz)，4.19 (m，1H，H-3’），4.15-3.95 (m, 3H, CH2CH=CH2+8aCH2), 3.80-3.60 (m, 2H, H-5'+8aCH2)，3.06(dd，lH，H-4’，J=3.3&amp;amp;9.3Hz)，2.75(t,lH， H-l，J=3.9 Hz)，2.38 (bd，1H，OH)。 中間體1 3 [1R-(1 a，3a0，4々，4a 卢，7万，7aπ，8aθ)]8a-[(2,6_二去氧--4-0-(2-甲基-2-丙缔基）-θ-D-別哝喃糖基氧基）甲基]-4-甲醯基-4,4a,5,6,7,7a,8,8a-八氫-7 -甲基-3-(1-甲基乙基） -1，4-亞甲基-s-〇5丨噠省-3a(lH)-羧酸，二苯基甲基酯 將中間體10(500毫克）及氧化三丁基錫（300毫克）於無水 曱苯（50毫升）内之混合物於裝有Dean-Stark冷凝器的燒瓶 内加熱至回流，然後靜置於室溫氮氣下（可除去近10毫升共 沸混合物）。相繼加3-溴-2-甲基丙烯（202微升）及氟化四丁 基銨（於四氫呋喃内的1M溶液，0.90毫升），此混合物於50 °C加熱24小時。除去溶劑得殘餘物，此殘餘物於二氧化矽 膠上作閃色層分析，以丙酮：己烷（1 : 20)及（1 : 15)洗離 ，製得標題化合物（340毫克），爲無色油體。 δ (^, CDC13): 9.73 (s, 1H, CHO), 7.50-7.20 (m, 10H, 2Ph)，6.98 (s，1H, CHPh2)，6·05 (dd, 1H, H-2, J=1.5及3.6 Hz), 4.96及4.91 (2m，2H，=CH2)，4.65 (dd，1H, Η-Γ, J=1.8 及9.6 Hz)，4.20 (m, 1H, H-3')，4.05及3.68 (2d, 2H, 8aCH2， Jab=9.3 Hz), 4.00A3.87 (2d, 2H, OCH2, Hz), 3.75 (m，1H，H-5’），3.06 (dd，1H, H-4’，J=3及9.6 Hz)，2.75 (t，1H, H-l, J=3.6 Hz), 2.37 (bd, 1H, OH), 1.76 (bs, 3H, CH,C=CH7) -73- 本紙張尺度逍用中國國家標準（CNS ) A4规格（210X297公釐） (請先閱讀背面之注意事項再填寫本頁)</span>--rc I * Printed by 321644 A7 B7, Beigong Consumer Cooperative, Central Bureau of Standards, Ministry of Economic Affairs V. Description of invention (7〇) (dd, 1H, Η-Γ, J = 2.1 and 9.6 Hz), 4.19 (m, 1H , H-3 '), 4.15-3.95 (m, 3H, CH2CH = CH2 + 8aCH2), 3.80-3.60 (m, 2H, H-5' + 8aCH2), 3.06 (dd, lH, H-4 ', J = 3.3 &amp;amp; 9.3Hz), 2.75 (t, lH, Hl, J = 3.9 Hz), 2.38 (bd, 1H, OH). Intermediate 1 3 [1R- (1 a, 3a0, 4々, 4a Lu, 70,000, 7aπ, 8aθ)] 8a-[(2,6_dideoxy--4-0- (2-methyl- 2-propenyl) -θ-D-alsylranosyloxy) methyl] -4-carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7- Methyl-3- (1-methylethyl) -1,4-methylene-s-〇5 Shuda province-3a (lH) -carboxylic acid, diphenylmethyl ester intermediate 10 (500 Mg) and tributyltin oxide (300 mg) in anhydrous toluene (50 ml), heated to reflux in a flask equipped with a Dean-Stark condenser, and then left to stand at room temperature under nitrogen (can remove nearly 10 ml Azeotrope). 3-Bromo-2-methylpropene (202 µl) and tetrabutylammonium fluoride (1M solution in tetrahydrofuran, 0.90 mL) were added successively, and the mixture was heated at 50 ° C for 24 hours. After removing the solvent, a residue was obtained. This residue was subjected to flash chromatography on silica gel and washed away with acetone: hexane (1: 20) and (1: 15) to obtain the title compound (340 mg) as colorless. Oil body. δ (^, CDC13): 9.73 (s, 1H, CHO), 7.50-7.20 (m, 10H, 2Ph), 6.98 (s, 1H, CHPh2), 6.05 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 4.96 and 4.91 (2m, 2H, = CH2), 4.65 (dd, 1H, Η-Γ, J = 1.8 and 9.6 Hz), 4.20 (m, 1H, H-3 '), 4.05 and 3.68 (2d, 2H, 8aCH2, Jab = 9.3 Hz), 4.00A3.87 (2d, 2H, OCH2, Hz), 3.75 (m, 1H, H-5 '), 3.06 (dd, 1H, H-4' , J = 3 and 9.6 Hz), 2.75 (t, 1H, Hl, J = 3.6 Hz), 2.37 (bd, 1H, OH), 1.76 (bs, 3H, CH, C = CH7) -73- paper size Use the Chinese National Standard (CNS) A4 specification (210X297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T 經濟部中央樣準局貝工消費合作社印製 ^^1644 A7 _ B7 五、發明説明（71 ) 中間體1 4 [lR-(la，3a；5,4/5,4a^，7y?，7aa，8a^)]8a-[[lS,7R，9R]- 2.5.8- 三哼-3，7-二曱基）-順式-雙環[4.4.0]-癸-9·基-氧 基-甲基]-4-甲醯基-4,43,5,6,7,7&amp;amp;，8,83-八氫-7-甲基-3-(1-甲基乙基）-1，4-亞甲基-s-峭噠省-3a(lH)-羧酸，二苯 基甲基酯 於中間體12(200毫克）於無水四氫呋喃（1〇毫升）内之溶液 中於室溫及氮氣下分小批加固體三氟醋酸汞（213毫克）。將 此反應混合物於室溫置30分鐘，再於強烈攪拌下加氫化三 丁基錫（135微升）。30分鐘後，加醋酸乙酯（50毫升），形 成之懸浮液經矽藻土過濾，得無色溶液，此溶液以水（3 X 100毫升）洗，於硫酸鎂上乾燥。除去溶劑，得油體，此油 體於二氧化矽膠上作閃色層分析，以丙酮：己烷（1 : 15)洗 離，製得標題化合物（120毫克），爲1 : 1C-3’差向異構物 混合物。 6(111，€〇(：13)包括：4.73((1(1，111,11-9,,】=3.0及6.3 112)， 4.62 (dd, 1H, H-9'，J=2.1 及9.9 Hz)。 中間體1 5 [1R-(1 a,3a/3 β ,4a/? ,7 ,7a or ,8ay5 ) ] 8 a-[ [ 1 S , 7 R, 9 R]- 2.5.8- 三噚-3,3,7-三曱基）-順式-雙環[4.4.0]-癸-9-基-氧基-甲基]-4 -甲醯基-4,4a，5,6,7,7a,8,8a -八氫-7-甲基-3-(1-甲基乙基）-l，4-亞甲基-s-p引健省_3a(iH) -叛酸，二 苯基甲基酯 ___ -74- 本紙張尺ϋ用中國國家標準（CNS ) A4規格（210X297公釐） (請先閱讀背面之注意事項再填寫本頁) Λ 訂 A7 B7 經濟部中央標準局貝工消費合作社印裝 321644 五、發明説明（72) 於中間體13(325毫克）於無水四氫呋喃（1〇毫升）内之溶液 中於室溫及氮氣下分小批加固體三氟醋酸汞（3〇3毫克）。將 此反應混合物於室溫置30分鐘，再於強烈攪拌下加氫化三 丁基錫（192微升）。30分鐘後，加醋酸乙酯（5〇毫升），形成 之懸浮液經矽藻土過濾，得無色溶液，此溶液以水（3 χ丨〇〇 毫升）洗，於硫酸鎂上乾燥。除去溶劑，得油體，此油體於 二氧化矽膠上作閃色層分析，以丙酮：己烷（丨：2〇)及（i ·· 15)洗離，製得標題化合物（210毫克），爲無色油體。 ^ (!Η, CDC13): 9.73 (s, 1H, CHO), 7.50-7.20 (m, 10H, 2Ph), 6.98 (s, 1H, CHPh2), 6.03 (dd, 1H, H-2, J=1.2 Hz, J=3.3 Hz), 4.54 (dd，1H，H-9’，J=2.1 及9.6 Hz)，4.25 (m，2H， H-7,及Η-Γ)，4.05及3_66 (2d，2H，8aCH2, JAB=9 Hz)，3.41 及 3.18 (2d，2H，OCH2, JAB = 11.7 Hz)，3·25 (dd, 1H, H-61， J=3.3及 10_2 Hz), 2.75 (t，1H，H-l，J=3.3 Hz)，1.25及 1.16 (2s， 2CH3)。 中間體1 6 [1R-(1 a，3ayS，4y5 ,4a卢，7y5，7aa ,8a々）]8a-[2,6-二去氧-4-O-p-甲氧基苄基-々-D-別哌喃糖基氧基）甲基]-4 -甲醯 基-4,4a，5,6，7,7a,8,8a-八氫-7-甲基- 3-(1-甲基乙基）-1，4-亞甲基-s-啕噠省-3a(lH)-羧酸，二苯基甲基酯 將中間體10(500毫克）及氧化三丁基錫（374毫克）於無水 甲苯（50毫升）内之混合物於裝有Dean-Stark冷凝器的燒瓶 内加熱至回流，然後靜置於室溫氮氣下（可除去近1〇毫升共 沸混合物）。相繼加P-曱氧基苄基氯（135微升）及氟化四丁 -75- 本紙張尺度遑用中圃固家揉率（CNS ) A4规格（210X297公釐） (請先閱讀背面之注意事項再填寫本頁)</span>, 1T Printed by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy ^^ 1644 A7 _ B7 V. Description of the invention (71) Intermediate 1 4 [lR- (la, 3a; 5,4 / 5,4a ^, 7y? , 7aa, 8a ^)] 8a-[[lS, 7R, 9R]-2.5.8- trihum-3,7-dimethyl) -cis-bicyclo [4.4.0] -dec-9 · yl- Oxy-methyl] -4-carboxamide-4,43,5,6,7,7 &amp;amp;, 8,83-octahydro-7-methyl-3- (1-methylethyl) -1 , 4-Methylene-s-pyridine-3a (lH) -carboxylic acid, diphenylmethyl ester in a solution of intermediate 12 (200 mg) in anhydrous tetrahydrofuran (10 mL) at room temperature Add solid mercury trifluoroacetate (213 mg) in small batches under nitrogen. The reaction mixture was left at room temperature for 30 minutes, and tributyltin hydride (135 µl) was added under vigorous stirring. After 30 minutes, ethyl acetate (50 ml) was added, and the resulting suspension was filtered through celite to obtain a colorless solution. This solution was washed with water (3 X 100 ml) and dried over magnesium sulfate. After removing the solvent, an oil body was obtained. This oil body was subjected to a flash layer analysis on silica gel and washed away with acetone: hexane (1:15) to obtain the title compound (120 mg) as 1: 1 C-3 ' Epimer mixture. 6 (111, € 〇 (: 13) includes: 4.73 ((1 (1,111,11-9 ,,) = 3.0 and 6.3 112), 4.62 (dd, 1H, H-9 ', J = 2.1 and 9.9 Hz). Intermediate 1 5 [1R- (1 a, 3a / 3 β, 4a /?, 7, 7a or, 8ay5)] 8 a- [[1 S, 7 R, 9 R]-2.5.8- Three-threat-3,3,7-trimethyl) -cis-bicyclo [4.4.0] -dec-9-yl-oxy-methyl] -4-carboxamide-4,4a, 5,6 , 7,7a, 8,8a -octahydro-7-methyl-3- (1-methylethyl) -l, 4-methylene-sp Yinjian province_3a (iH) -tetanoic acid, di Phenyl Methyl Ester___ -74- The size of this paper uses the Chinese National Standard (CNS) A4 specification (210X297mm) (please read the precautions on the back before filling this page) Λ Order A7 B7 Central Bureau of Standards, Ministry of Economic Affairs Printed by Beigong Consumer Cooperative 321644 V. Description of the invention (72) In a solution of intermediate 13 (325 mg) in anhydrous tetrahydrofuran (10 mL), add solid mercury trifluoroacetate in small batches at room temperature under nitrogen ( 3〇3 mg). The reaction mixture was left at room temperature for 30 minutes, and then tributyltin hydride (192 μl) was added under vigorous stirring. After 30 minutes, ethyl acetate (50 mL) was added, and the resulting suspension Filtered through diatomaceous earth to be colorless This solution was washed with water (3 × 100 mL) and dried over magnesium sulfate. The solvent was removed to obtain an oil body. This oil body was subjected to a flash layer analysis on silica gel. Acetone: hexane (丨: 2〇) and (i · · 15) wash away to obtain the title compound (210 mg) as a colorless oil. ^ (! Η, CDC13): 9.73 (s, 1H, CHO), 7.50-7.20 (m , 10H, 2Ph), 6.98 (s, 1H, CHPh2), 6.03 (dd, 1H, H-2, J = 1.2 Hz, J = 3.3 Hz), 4.54 (dd, 1H, H-9 ', J = 2.1 And 9.6 Hz), 4.25 (m, 2H, H-7, and Η-Γ), 4.05 and 3_66 (2d, 2H, 8aCH2, JAB = 9 Hz), 3.41 and 3.18 (2d, 2H, OCH2, JAB = 11.7 Hz), 3.25 (dd, 1H, H-61, J = 3.3 and 10_2 Hz), 2.75 (t, 1H, Hl, J = 3.3 Hz), 1.25 and 1.16 (2s, 2CH3). Intermediate 1 6 [1R- (1 a, 3ayS, 4y5, 4a Lu, 7y5, 7aa, 8a々)] 8a- [2,6-dideoxy-4-Op-methoxybenzyl-々-D-piperan Glycosyloxy) methyl] -4 -carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl)- 1,4-methylene-s-pyda-3a (lH) -carboxylic acid, diphenylmethyl ester intermediate 10 (500 mg) and tributyltin oxide (374 G) in a mixture of dry toluene (50 ml) was heated to reflux in a flask equipped with a Dean-Stark condenser and then left to stand (removable near azeotropic mixture 1〇 ml at room temperature under nitrogen). Add P-methoxybenzyl chloride (135 microliters) and tetrabutyl-fluoride-75 successively. This paper uses the Zhongpu Gujia rubbing rate (CNS) A4 specification (210X297mm) (please read the back (Notes and then fill this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 經濟部中央揉準局貝工消費合作社印製 ^21644 _ _ B7 五、發明説明（73 ) 基銨（於四氫呋喃内的1M溶液，1.5毫升），此混合物於6〇 °C加熱24小時。除去溶劑得殘餘物，此殘餘物於二氧化碎 膠上作閃色層分析，以丙酮：己燒（1 : 20)及（1 : 15)洗離 ，製得標題化合物（300毫克），爲無色油體。 β GH，CDC13): 9.72 (s，1H，CHO)，7.5-7.2 (m，12H，2Ph及 2H(鄰位），6.97 (s，H，CHPh2)，6.88 (m，2H，2H間位），6.04 (dd, 1H, H-2, J=1.5 Hz, J=3.6 Hz), 4.64 (dd, 1H, H-l', J=2.4 &amp;amp;9.9Hz)，4.55&amp;amp;4.50(2d,2H,CH2Ph，JAB = li.2Hz)，4.18 (m，1H，H-3’），4.04及3·66 (2d，2H，8aCH2, JAB=9 Hz), 3.80 (s，3H，CH30)，3.74 (m，1H，H-51)，3.12 (dd，1H，H-4，，J=3.0 及9.3 Hz)，2.75 (t，1H，H-l，J=3.9 Hz)。 中間體1 7 [1R-(1 a,3a卢，4点，4a々，7卢，7&amp;amp;&amp;lt;^，88/?)]8杜-[(3-〇-烯丙基_ 2,6 - 一去乳- 4- O- p-甲氧基节基- D-別喊喃糖基氧基）曱 基]-4 -甲酿基-4,4a，5,6,7,7a,8,8a-八氫-7-甲基- 3- (1-甲 基乙基）-1，4-亞甲基-s-吲噠省-3a(lH)-羧酸，二苯基甲基 酯 於強烈攪拌的中間體1 6(400毫克）於無水四氫呋喃（10毫 升）内之溶液中在氬氣下於〇 °C分小批加氫化鈉（48毫克）。 加完後，將混合物靜置於室溫1小時，然後加烯丙基溴（丨9 i 微升）。2 4小時後，加氣化銨（1當量水溶液；10〇毫升）， 此混合物用醋酸乙酯（200毫升）萃取。有機相用水（1 X ι〇〇 毫升）洗’於硫酸鎂上乾燥並濃縮至乾，得油體，此油體於 二氧化碎膠上作閃色層分析，以，丙嗣：己燒（1 : 2〇)及（1 _ — - 76 - 本紙張尺度逋用中國困家揉準（CNS ) A4规格（210X297公兼)&amp;quot; ' (請先閲讀背面之注意事項再填寫本頁)</span>A7 Printed by the Beigong Consumer Cooperative of the Central Kneading Bureau of the Ministry of Economic Affairs ^ 21644 _ B7 5. Description of the invention (73) Ammonium ammonium (1M solution in tetrahydrofuran, 1.5 ml). This mixture was heated at 60 ° C for 24 hours. The solvent was removed to obtain a residue. This residue was subjected to flash layer analysis on the crushed silica and washed away with acetone: hexane (1:20) and (1:15) to obtain the title compound (300 mg) as Colorless oil body. β GH, CDC13): 9.72 (s, 1H, CHO), 7.5-7.2 (m, 12H, 2Ph and 2H (ortho), 6.97 (s, H, CHPh2), 6.88 (m, 2H, 2H meta) , 6.04 (dd, 1H, H-2, J = 1.5 Hz, J = 3.6 Hz), 4.64 (dd, 1H, H-l ', J = 2.4 &amp;amp; 9.9Hz), 4.55 &amp;amp; 4.50 (2d, 2H , CH2Ph, JAB = li.2Hz), 4.18 (m, 1H, H-3 '), 4.04 and 3.66 (2d, 2H, 8aCH2, JAB = 9 Hz), 3.80 (s, 3H, CH30), 3.74 (m, 1H, H-51), 3.12 (dd, 1H, H-4, J = 3.0 and 9.3 Hz), 2.75 (t, 1H, Hl, J = 3.9 Hz). Intermediate 1 7 [1R- (1 a, 3a Lu, 4 o'clock, 4a々, 7 Lu, 7 &amp; &amp;lt; ^, 88 /?)] 8 Du-[(3-〇-allyl_ 2,6-one to milk-4- O-p-methoxybenzyl-D-dopyranosyloxy) methyl] -4-methylbromo-4,4a, 5,6,7,7a, 8,8a-octahydro-7 -Methyl-3- (1-methylethyl) -1,4-methylene-s-indap-3a (lH) -carboxylic acid, diphenylmethyl ester in vigorously stirred intermediate 1 6 (400 mg) in anhydrous tetrahydrofuran (10 ml) was added sodium hydride (48 mg) in small batches under argon at 0 ° C. After the addition was complete, the mixture was allowed to stand at room temperature for 1 hour, then Add allyl bromide (丨 9 i microliter ). After 4 hours, gasified ammonium (1 equivalent aqueous solution; 100 mL) was added, and the mixture was extracted with ethyl acetate (200 mL). The organic phase was washed with water (1 × 100 mL) on magnesium sulfate After drying and concentrating to dryness, an oil body is obtained. This oil body is subjected to a flash layer analysis on the crumb of silica, to Bing Si: hexane (1: 2〇) and (1 _ —-76-the size of the paper. Use the Chinese Sleeping Home (CNS) A4 specification (210X297 public and public) &amp;quot; '(Please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">^21644 A7 B7 五、發明説明（74) :15)洗離，製得標題化合物（400毫克），爲無色油體。 Θ (iH，CDC13): 9.74 (s, 1H，CHO)，7.5-7.2 (m，12H，2Ph及 2H鄰位），6.98 (s，H，CHPh2), 6.86 (m，2H，2H間位），6.04 (dd，lH，H2，J=1.2&amp;amp;3.3Hz)，5_95(m，lH，C|i=CH2)，5.28&amp;amp; 5.15 (2m, 2H, CH=CH2), 4.60 (m, 2H, H-1'^L CH2Ph), 4.42 (d，1H, CH2Ph, JAB二 11·4 Hz)，4.13 (m, 2H, C^-CH=)， 4.02&amp;amp;3.68(2d，2H，8aCH2，JAB=9.6Hz)，3.89(m，2H，H-5i &amp;amp;H-3')，3.80(s，3H，CH30),3.09 (dd,lH，H-4，，J=3.0&amp;amp;9.3</span>^ 21644 A7 B7 V. Description of the invention (74): 15) Wash off to obtain the title compound (400 mg) as a colorless oil. Θ (iH, CDC13): 9.74 (s, 1H, CHO), 7.5-7.2 (m, 12H, 2Ph and 2H ortho), 6.98 (s, H, CHPh2), 6.86 (m, 2H, 2H meta) , 6.04 (dd, lH, H2, J = 1.2 &amp;amp; 3.3Hz), 5_95 (m, lH, C | i = CH2), 5.28 &amp;amp; 5.15 (2m, 2H, CH = CH2), 4.60 (m, 2H , H-1 '^ L CH2Ph), 4.42 (d, 1H, CH2Ph, JAB II 11.4 Hz), 4.13 (m, 2H, C ^ -CH =), 4.02 &amp;amp; 3.68 (2d, 2H, 8aCH2, JAB = 9.6Hz), 3.89 (m, 2H, H-5i &amp;amp; H-3 '), 3.80 (s, 3H, CH30), 3.09 (dd, lH, H-4 ,, J = 3.0 &amp;amp; 9.3</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz)，2.73 (t，1H，H-l，J=3.9 Hz)。 中間體18 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注^^項再填寫本頁} [1R-(1 a，3a/?，4点，4a0，7Θ，7aa ,8ay5 )]8a-[(3-0-烯丙基-2,6·二去氧-/? -D -別哌喃糖基氧基）甲基]_4-甲醯基_ 4，4a，5,6,7，7a，8,8a -八氫-7-甲基-3-(1-甲基乙基）-1,4-亞甲基- s-θ丨噠省- 3a(lH) -羧酸，二苯基甲基酯 將中間體17(2.3克）於二氣甲烷（200毫升）内之溶液用水 (20毫升）攪拌’加2,3-二氣-5,6-二氰基醌（0.79克）。於室 溫攪拌過夜後，將混合物藉更多二氣甲烷之助用矽藻土塾 過濾。然後用碳酸氫鈉水溶液洗二氣甲烷相，再用氯化鈉 溶液洗，於硫酸鈉上乾燥，過濾並濃縮至乾。殘餘物於二 氧化矽膠上作閃色層分析，以二氣曱烷：曱醇（4 9 : 1 )洗離 ，得標題化合物（1.95克），爲白色泡沫。 δ (!Η, CDC13)： 9.75 (s, 1H, CHO), 7.45-7.24 (m, 10H, Ph2)，6.99 (s，1H，C|iPh2), 6.05 (dd, 1H, H-2, J=1.5及3·3 Hz), 5.95 (m, 1H, CH=CH2), 5.26(m, 2H, CH^Ci^), 4.53 -77- 本紙張尺度適用中國國家揉準（CNS ) A4规格（210X297公釐） 經濟部中央橾準局貝工消費合作社印製 A 7 B7 五、發明説明（75) (dd，lH，H-r，J=1.8&amp;amp;9.6Hz)，4.19&amp;amp;3.96(2m，2H， CH2CH=CH2), 4.03^3.69 (2d, 2H, 8a-CH2, J=9.3 Hz), 3.80 (q，1H, H-3', J=3.3 Hz), 3.60 (dq, 1H, H-5', J=9.6及6.3 Hz), 3.23(ddd，lH,H-4’，J=10.8,9.6&amp;amp;3.3Hz)，2.74(t,lH，H-l， J=3.6 Hz), 2.25 (d，1H, OH, J=10.8 Hz)。 中間體1 9 [1R-(1 a，3a/?，4/5，4a/5，7冷，7aa，8a/? )]8a-[(3-0-稀丙基_ 2，6-二去氧- 4- 0- (甲硫基）硫代羰基点-D -別哌喃糖基氧 基）甲基]-4 -甲醯基_4,4&amp;amp;，5,6,7,7&amp;amp;,8,8&amp;amp;-八氫-7-曱基_3_ (1-甲基乙基）-1,4 -亞曱基- s-H丨建省- 3a(lH) -叛酸，二苯 基甲基酯 於中間體18(1.9克）於無水四氫呋喃（50毫升）内之溶液中 在氮氣下分小批加氫化鈉（240毫克）及催化量的咪唑。然後 除去冰浴，將反應混合物置於室溫下攪拌1小時。相繼加二 硫化碳（1.5毫升）及甲基破（1.25毫升）。反應一旦完全後（以 TCL控制），將粗製混合物倒入醋酸乙酯（5〇〇毫升）内，用 〇.1當量的氣化銨水溶液（250毫升）使反應停止。有機相从 鹽水（1 X 500毫升）及水（1 X 500毫升）洗，於無水硫酸鈉上 乾燥，並濃縮至乾。油體殘餘物於二氧化矽膠上作閃色層 分析，以己烷：二氣甲烷（3 : 5)洗離，得標題化合物（185 克），爲白色泡沫。 ^ 〇U, CDC13): 9.74 (s, 1H, CHO), 7.45-7.24 (m, 10H,</span>Hz), 2.73 (t, 1H, H-1, J = 3.9 Hz). Intermediate 18 Printed by the Employees Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the note ^^ on the back and fill in this page) [1R- (1 a, 3a / ?, 4 o'clock, 4a0, 7Θ, 7aa, 8ay5) ] 8a-[(3-0-allyl-2,6 · dideoxy-/?-D-piperanyloxy) methyl] _4-methylaceto_4,4a, 5,6 , 7,7a, 8,8a -Octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-θ 丨 Province-3a (lH) -carboxylic acid , Diphenylmethyl ester, a solution of intermediate 17 (2.3 g) in methane (200 ml) was stirred with water (20 ml), and 2,3-digas-5,6-dicyanoquinone was added ( 0.79g). After stirring at room temperature overnight, the mixture was filtered with diatomite with the aid of more methane. Then the methane phase was washed with aqueous sodium bicarbonate solution, then with sodium chloride solution, and then washed Dry over sodium, filter and concentrate to dryness. The residue was analyzed by flash layer on silica gel and washed away with methane: methanol (4 9: 1) to give the title compound (1.95 g) as white Foam. Δ (! Η, CDC13): 9.75 (s, 1H, CHO), 7.45-7.24 (m, 10H, Ph2), 6.99 (s, 1H, C | iPh2), 6.05 (dd, 1H, H-2 , J = 1.5 3 · 3 Hz), 5.95 (m, 1H, CH = CH2), 5.26 (m, 2H, CH ^ Ci ^), 4.53 -77- This paper size is suitable for China National Standard (CNS) A4 specification (210X297mm ) A 7 B7 printed by the Beigong Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economy V. Description of invention (75) (dd, lH, Hr, J = 1.8 &amp;amp; 9.6Hz), 4.19 &amp;amp; 3.96 (2m, 2H, CH2CH = CH2), 4.03 ^ 3.69 (2d, 2H, 8a-CH2, J = 9.3 Hz), 3.80 (q, 1H, H-3 ', J = 3.3 Hz), 3.60 (dq, 1H, H-5', J = 9.6 and 6.3 Hz), 3.23 (ddd, lH, H-4 ', J = 10.8,9.6 &amp;amp; 3.3Hz), 2.74 (t, lH, Hl, J = 3.6 Hz), 2.25 (d, 1H, OH , J = 10.8 Hz). Intermediate 1 9 [1R- (1 a, 3a / ?, 4/5, 4a / 5, 7 cold, 7aa, 8a /?)] 8a-[(3-0-propylene Group _ 2,6-dideoxy- 4- 0- (methylthio) thiocarbonyl point -D --piperanyloxy) methyl] -4 -methyl acetyl_4,4 &amp;amp;, 5 , 6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl_3_ (1-methylethyl) -1,4-methylidene-sH 丨 建 省-3a (lH) -trait Acid, diphenylmethyl ester in a solution of intermediate 18 (1.9 g) in anhydrous tetrahydrofuran (50 ml) was added sodium hydride (240 mg) and a catalytic amount of imidazole in small portions under nitrogen. The ice bath was then removed and the reaction mixture was stirred at room temperature for 1 hour. Carbon disulfide (1.5 ml) and methyl bromide (1.25 ml) were added successively. Once the reaction was complete (controlled by TCL), the crude mixture was poured into ethyl acetate (500 mL), and the reaction was stopped with 0.1 equivalent of an aqueous vaporized ammonium solution (250 mL). The organic phase was washed from brine (1 X 500 mL) and water (1 X 500 mL), dried over anhydrous sodium sulfate, and concentrated to dryness. The residue of the oil body was analyzed by flash layer on silica gel, and washed away with hexane: methane (3: 5) to obtain the title compound (185 g) as a white foam. ^ 〇U, CDC13): 9.74 (s, 1H, CHO), 7.45-7.24 (m, 10H,</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ph2)，6.99(s，lH，CiiPh2)，6.06(dd，lH，H-2，J=i.2&amp;amp;3.3 Hz)，5_88 (m，1H, C|i=CH2)，5·41 (dd，1H，H-4，，J=2.7及9.ό 78 (請先閱讀背面之注意事項再填寫本頁}</span>Ph2), 6.99 (s, lH, CiiPh2), 6.06 (dd, lH, H-2, J = i.2 &amp;amp; 3.3 Hz), 5_88 (m, 1H, C | i = CH2), 5.41 (dd , 1H, H-4, J = 2.7 and 9.ό 78 (please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T 太紙ft尺廣 用 Φ M ® 定谨?t ( A/Ui 故（Ή η V 7Q7A樓· \ s21644 at B7 五、發明説明（76)</span>， 1T Tai paper ft ruler is widely used Φ M ® fixed? T (A / Ui so (Ή η V 7Q7A building · \ s21644 at B7 V. Invention description (76)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.20-4.02 (m，5Η，H-5', CH2-CH=CH2, Η-3'及8a-CH2 (1H)), 3.71 (d, 1H, 8a-CH2, J=9.3 Hz), 2.75 (t, 1H, H-l, J=3.9 Hz), 2.58 (s, 3H, SCH3)。 中間體20 (a) [lR-(la，3a点，，4a々，7/?，7aa，8a卢）]8a-[[lS，4s ，611，811]-2,7-二氧-4,6-二甲基）-順式-雙環[3.4.0]-壬-8-基-氧基·甲基]-4 -甲醯基-4，4a，5，6,7,7a,8,8a-八氫-7-甲基-3·(1-甲基乙基）-l，4-亞甲基-s-啕噠省_3a(lH)-幾 酸，二苯基甲基酯及 (b) [lR-(la，3a0，4々，4a卢，，7aa ,8a/5 )]8a-[[lS，4R ，6R，8 尽]-2,7-二氧- 4,6-二曱基）-順式-雙環[3.4.0]-壬_ 8-基-氧基-甲基]-4 -甲醯基-4,4a，5，6,7,7a,8,8a-八氫-7-甲基- 3·(1-甲基乙基）-1,4 -亞甲基- s- β噠省- 3a(lH) -羧 酸，二苯基乙基酯 經濟部中央梂準局員工消费合作社印製 (請先閲讀背面之注意事項再填寫本頁) 將中間體19(1.8克）於無水曱苯（250毫升）内之溶液用氬 氣流去氣1小時，然後加熱至回流。於約2小時内用注射筒 加催化量的偶氮雙（異丁腈）及溶於無水甲苯（50毫升）内的 氫化三丁基錫（0.95毫升），同時加熱並維持氬氣流。加完 後，加反應混合物再繼續回流1小時，然後冷卻，再濃縮至 乾，並於二氧化矽膠上作閃色層分析，用己烷，再用己烷 ·*醋酸乙酯（9 : 1)洗離。製得中間體2〇(a)(680毫克； Rf=0.31，於己烷：醋酸乙酯4 : 1内），爲白色泡沫，及中 間體20(b)(180毫克；Rf=〇.25於己燒：醋酸乙酯4: 1内） -79- 本紙張尺度逍用中國囷家橾率（CNS ) M規格（2〖〇&amp;gt;&amp;lt;297公釐） 經濟部中央標準局貝工消費合作社印裝 A7 ___ _B7_ 五、發明説明（77) ，爲白色固體。 (a) e Oh, CDC13): 9.73 (s，1H, CHO)，7.45-7.28 (m, 10H， Ph2)，6.99(s，lH，CHPh2)，6.05(dd，lH，H-2，J=1.2&amp;amp;3.6 Hz)，4.46 (dd，1H, H-8，，J=2.4及9.6 Hz)，4.14-4.05 (m，3H， 8a-CH2 (1H)，Η-Γ及CH2-3’（1H))，3.67 (d，1H，8a-CH2， J=9.3Hz)，3.36-3.25 (m，2H，H-6,及CH2-3,（1H))，2.77 (t，1H, H-l，J=3.9 Hz), 1.05 (d，3H，4'-(：Η3,卜6.9 Hz)。 (b) Θ pH, CDC13): 9.72 (s，1H, CHO)，7.45-7.24 (m，10H， Ph2)，6.99(s,lH,CHPh2)，6.05(dd，lH，H-2，J=1.5(^3.6 Hz)，4_42 (dd，1H, H-8'，J=2.1 及9.6 Hz), 4.20 (m，1H，Η-Γ)， 4.07&amp;amp;3.67(2d,2H,8a-CH2,J=9.3Hz)，3.97(t，lH，CH2-3，， J=8.4 Hz), 3.54 (m, 1H, H-6'), 3.46 (dd, 1H, CH2-3', J=10.5</span>Hz), 4.20-4.02 (m, 5Η, H-5 ', CH2-CH = CH2, Η-3' and 8a-CH2 (1H)), 3.71 (d, 1H, 8a-CH2, J = 9.3 Hz) , 2.75 (t, 1H, Hl, J = 3.9 Hz), 2.58 (s, 3H, SCH3). Intermediate 20 (a) [lR- (la, 3a point, 4a々, 7 / ?, 7aa, 8a Lu)] 8a-[[lS, 4s, 611, 811] -2,7-diox-4 , 6-dimethyl) -cis-bicyclo [3.4.0] -non-8-yl-oxy · methyl] -4-carboxamide-4,4a, 5,6,7,7a, 8 , 8a-octahydro-7-methyl-3 · (1-methylethyl) -1,4-methylene-s-pyridine_3a (lH) -chiric acid, diphenylmethyl ester And (b) [lR- (la, 3a0, 4々, 4a Lu, 7aa, 8a / 5)] 8a-[[lS, 4R, 6R, 8 end] -2,7-diox-4,6 -Dimethyl) -cis-bicyclo [3.4.0] -non_8-yl-oxy-methyl] -4-methylacyl-4,4a, 5,6,7,7a, 8,8a -Octahydro-7-methyl-3 (1-methylethyl) -1,4-methylene-s-β-pyridine-3a (lH) -carboxylic acid, diphenylethyl ester Ministry of Economic Affairs Printed by the Central Consumer Council Cooperative Employees (please read the precautions on the back before filling in this page). Degas the solution of Intermediate 19 (1.8g) in anhydrous toluene (250ml) with argon flow for 1 hour, then Heat to reflux. A catalytic amount of azobis (isobutyronitrile) and tributyltin hydride (0.95 ml) dissolved in anhydrous toluene (50 ml) were added to the syringe in about 2 hours while heating and maintaining the argon flow. After the addition is complete, add the reaction mixture and continue to reflux for another 1 hour, then cool, then concentrate to dryness, and analyze the flash layer on the silica gel, using hexane, and then using hexane * ethyl acetate (9: 1 ) Wash away. Intermediate 2 (a) (680 mg; Rf = 0.31 in hexane: ethyl acetate 4: 1) was prepared as a white foam, and intermediate 20 (b) (180 mg; Rf = 0.25. Yuji burning: ethyl acetate 4: 1) -79- This paper standard is used by the Chinese family rate (CNS) M specification (2 〖〇 &amp;gt; &amp;lt; 297mm) Beigong consumption of the Central Standards Bureau of the Ministry of Economic Affairs Cooperative cooperative printing A7 ___ _B7_ V. Description of invention (77), white solid. (a) e Oh, CDC13): 9.73 (s, 1H, CHO), 7.45-7.28 (m, 10H, Ph2), 6.99 (s, lH, CHPh2), 6.05 (dd, lH, H-2, J = 1.2 &amp;amp; 3.6 Hz), 4.46 (dd, 1H, H-8, J = 2.4 and 9.6 Hz), 4.14-4.05 (m, 3H, 8a-CH2 (1H), Η-Γ and CH2-3 '( 1H)), 3.67 (d, 1H, 8a-CH2, J = 9.3Hz), 3.36-3.25 (m, 2H, H-6, and CH2-3, (1H)), 2.77 (t, 1H, Hl, J = 3.9 Hz), 1.05 (d, 3H, 4 ′-(: Η3, Bu 6.9 Hz). (B) Θ pH, CDC13): 9.72 (s, 1H, CHO), 7.45-7.24 (m, 10H, Ph2), 6.99 (s, lH, CHPh2), 6.05 (dd, lH, H-2, J = 1.5 (^ 3.6 Hz), 4_42 (dd, 1H, H-8 ', J = 2.1 and 9.6 Hz), 4.20 (m, 1H, Η-Γ), 4.07 &amp;amp; 3.67 (2d, 2H, 8a-CH2, J = 9.3Hz), 3.97 (t, lH, CH2-3, J = 8.4 Hz), 3.54 (m , 1H, H-6 '), 3.46 (dd, 1H, CH2-3', J = 10.5</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 2.77 (t，1H, H-l，J=3.9 Hz), 2.53 (m，1H，H-4·)，1.02 (d, 3H, 6-CH3) 〇 中間體2 1 [1R-(1 a,3a々，40，4aA，7/5 ,7aa，8a/9 )]8a-[(4-0-烯丙基-2,6-二去氧- 3- 0- (甲硫基）硫代羰基-点-D -別哌喃糖基氧 基）甲基]-4 -甲醯基-4，4a, 5，6,7,7a，8,8a-八氫-7 -甲基-3-(1-甲基乙基）-1,4-亞甲基-s-啕噠省-3a(lH)-羧酸，二苯 基甲基酯 於中間體12(380毫克）於無水四氫呋喃（1〇毫升）内之溶液 中在氮氣下於0°C分小批加固體氫化鈉（240毫克）及催化量 的咪唑。加完後除去冷浴，將反應物置於室溫下攪拌1小時 。相繼加二硫化碳（300微升）及甲基碘（250微升）。4小時後 -80- 本紙張尺度逍用中國國家標準（CNS ) A4規格（210X297公嫠) (請先聞讀背面之注意事項再填寫本頁) -訂 經濟部中央標準局員工消費合作社印製 A7 _____B7 五、發明説明（78) 將混合物倒入醋酸乙酯（100毫升）内，用丨當量的氣化銨水 溶液（50毫升）使反應停止。有機相以鹽水（1χ1〇〇毫升）及 水（IX 100毫升）洗，於硫酸鎂上乾燥，並濃縮至乾，得黃 色油體，此油體於二氧化矽膠上作閃色層分析，以醋酸乙 酯：己烷（1 : 25)及（1 : 20)洗離’得標題化合物（35〇克） ，爲白色泡沫。 S (^, CDC13): 9.73 (s, 1H, CHO), 7.50-7.20 (m, 10H, 2Ph), 6.98 (s, H, CHPh2), 6.24 (m, 1H, H-3'), 6.05 (dd, 1H, H-2, J=1.5^3.6 Hz), 5.85 (m, 1H, CH=CH2), 5.30-5.20 (m, 2H，CH=C^)，4.56 (dd, 1H, Η-Γ，J=1.8及9.3 Hz), 4.15-3.75 (m, 4H, CH2CH=CH2+8aCH2+H-5'), 3.69 (d, 1H, 8aCH2, J=9.3Hz)，3.21(dd，lH，H-4,,J=3.3&amp;amp;9.3Hz),2.72(t,lH， H-l, J=3.89 Hz), 2.59 (s, 3H, SCH3) 〇 中間體2 2 [1尺-(1(^，33々，4 0，43冷，7冷，73沈，8&amp;amp;/?)]83-[(2,6-二去氧- 3-0-(甲硫基）硫代羰基-4-0-(2 -甲基-2-丙烯基）-e-D-別 哌喃糖基氧基）甲基]-4 -甲醯基-4,4&amp;amp;，5,6,7,7&amp;amp;,8,8&amp;amp;-八氫 -7 -甲基-3-(1_甲基乙基）-1，4-亞甲基-s-啕噠省_3a(lH)-羧酸，二苯基甲基酯 於中間體13(700毫克）於無水四氫呋喃（30毫升）内之已冷 的溶液中在氮氣下分小批加氫化鈉（8 5毫克）及催化量的咪 唑。除去冷浴，反應物置於室溫下以磁性攪拌棒攪拌1小時 。相繼加二硫化碳（0.54毫升）及甲基碘（0.45毫升）。反應完 全後（以TL C控制），將粗製混合物倒入醋酸乙酯（200毫升） -81 - 本紙張尺度逋用中國國家梯準（CNS ) Μ规格（210X297公釐） (請先聞讀背面之注意事項再填寫本育) t^··</span>Hz), 2.77 (t, 1H, Hl, J = 3.9 Hz), 2.53 (m, 1H, H-4 ·), 1.02 (d, 3H, 6-CH3) 〇Intermediate 2 1 [1R- (1 a , 3a々, 40,4aA, 7/5, 7aa, 8a / 9)] 8a-[(4-0-allyl-2,6-dideoxy- 3- 0- (methylthio) thio Carbonyl-dot-D-perpiperanosyloxy) methyl] -4-carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-pyridine-3a (lH) -carboxylic acid, diphenylmethyl ester in intermediate 12 (380 mg) in anhydrous tetrahydrofuran (1 (0 ml) was added solid sodium hydride (240 mg) and a catalytic amount of imidazole in small batches at 0 ° C under nitrogen at 0 ° C. After the addition was complete, the cold bath was removed and the reaction was stirred at room temperature for 1 hour. Add carbon disulfide (300 microliters) and methyl iodide (250 microliters) successively. 4 hours later -80- This paper is used in China National Standards (CNS) A4 (210X297). (Please read the precautions on the back and then fill out this page)-Printed by the Employees Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 _____B7 V. Description of the invention (78) Pour the mixture into ethyl acetate (100 ml) and stop the reaction with an equivalent of aqueous vaporized ammonium solution (50 ml). The organic phase was washed with brine (1 × 100 mL) and water (IX 100 mL), dried over magnesium sulfate, and concentrated to dryness to obtain a yellow oil body. This oil body was subjected to flash layer analysis on silica gel to Ethyl acetate: hexane (1: 25) and (1: 20) were washed away to give the title compound (35〇g) as a white foam. S (^, CDC13): 9.73 (s, 1H, CHO), 7.50-7.20 (m, 10H, 2Ph), 6.98 (s, H, CHPh2), 6.24 (m, 1H, H-3 '), 6.05 ( dd, 1H, H-2, J = 1.5 ^ 3.6 Hz), 5.85 (m, 1H, CH = CH2), 5.30-5.20 (m, 2H, CH = C ^), 4.56 (dd, 1H, Η-Γ , J = 1.8 and 9.3 Hz), 4.15-3.75 (m, 4H, CH2CH = CH2 + 8aCH2 + H-5 '), 3.69 (d, 1H, 8aCH2, J = 9.3Hz), 3.21 (dd, lH, H -4,, J = 3.3 &amp;amp; 9.3Hz), 2.72 (t, lH, Hl, J = 3.89 Hz), 2.59 (s, 3H, SCH3) 〇Intermediate 2 2 [1 ft- (1 (^, 33 々, 4 0, 43 cold, 7 cold, 73 Shen, 8 &amp;amp; /?)] 83-[(2,6-dideoxy-3-0- (methylthio) thiocarbonyl-4-0- ( 2-methyl-2-propenyl) -eD-piperonyloxy) methyl] -4-carboxyl-4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp;- Octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-pyridine_3a (lH) -carboxylic acid, diphenylmethyl ester in the intermediate 13 (700 mg) in a cold solution in anhydrous tetrahydrofuran (30 mL) was added sodium hydride (85 mg) and a catalytic amount of imidazole in small batches under nitrogen. The cooling bath was removed and the reaction was placed at room temperature to Stir for 1 hour with a magnetic stir bar. Add carbon disulfide (0.54 ml) and A Iodine (0.45 ml). After the reaction is complete (controlled by TLC), pour the crude mixture into ethyl acetate (200 ml). -81-This paper scale uses the Chinese National Standards (CNS) M specifications (210X297 mm) (Please read the precautions on the back before filling in this education) t ^ ··</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">，1T A7 B7 五、發明説明（79) 内’用0.1當量的氣化銨水溶液（120毫升）使反應停止。有 機層以鹽水（1 X 200毫升）及水（1 X 200毫升）洗，於無水硫 酸鍰上乾燥，並濃縮至乾。將油體殘餘物於二氧化硬膠上 作閃色層分析，以己烷：醋酸乙酯（1 9 : 1)洗離，得標題化 合物（600毫克）。 (y On, CDC13): 9.73 (s, 1H, CHO), 7.45-7.26 (m, 10H,</span>, 1T A7 B7 V. Description of the invention (79) Use 0.1 equivalent of a vaporized aqueous ammonium solution (120 ml) to stop the reaction. The organic layer was washed with brine (1 X 200 ml) and water (1 X 200 ml), dried over anhydrous sulfuric acid, and concentrated to dryness. The residue of the oil body was analyzed by flash layer on the hard rubber dioxide and washed away with hexane: ethyl acetate (19: 1) to obtain the title compound (600 mg). (y On, CDC13): 9.73 (s, 1H, CHO), 7.45-7.26 (m, 10H,</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ph2), 6.98 (s, 1H, CHPh2), 6.24 (m, 1H, H-3'), 6.05 (dd, 1H, H-2, J=1.5及3.6 Hz), 4_92及4_88 (2m，2H, 0=(：迅），4.55 (dd， 1H，H-l'，J=2.1 及9.6 Hz), 4.03及3.69 (2d，2H，8a-CH2, J=9.3 1H，H-5，），3.19 (dd, 1H，H-4'，J=3及9.3 Hz), 2·72 (t，1H，H-l， J=3.9 Hz), 2.58 (s, 3H, SCH3), 1.70 (s, 3H, CH^C=CH2)。 中間體2 3 (a) [lR-(la ,3a/? ,Α β ,4a/? ,7/3 ,1 a a ,8a/? )]8a-[[lS,4R ，7R，9R]-2,8-二氧- 4,9-二甲基）-順式-雙環[4.4.0]-壬_ 7 -基-氧基-甲基]-4 -甲酷基-4,4a,5,6,7,7a，8,8a -八氫-7-甲基-3-(1-甲基乙基）-1，4·亞甲基-s-啕噠省- 3a(lH)-幾 酸，二苯基曱基酯及 經濟部中央揉準局員工消費合作社印裝 (請先閲讀背面之注意事項再填寫本頁) (b) [lR-(l^ ,3a/? Αβ ,4a/? ,1 β ,l^a ,8a/? )]8a-[[lS,4S ，711，911]-2,8-二氧-4,9-二甲基）-順式-雙環[3.4.0]-壬_ 7-基-氧基-甲基]-4 -甲酿基- 4,4a,5,6,7,7a,8,8a-八氨-7-甲基-3-(l-甲基乙基）-l，4-亞甲基-s-吲噠省3a(lH)-幾 酸，二苯基甲基酯</span>Ph2), 6.98 (s, 1H, CHPh2), 6.24 (m, 1H, H-3 '), 6.05 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 4_92 and 4_88 (2m, 2H, 0 = (: fast), 4.55 (dd, 1H, H-l ', J = 2.1 and 9.6 Hz), 4.03 and 3.69 (2d, 2H, 8a-CH2, J = 9.3 1H, H-5,), 3.19 (dd, 1H, H-4 ', J = 3 and 9.3 Hz), 2.72 (t, 1H, Hl, J = 3.9 Hz), 2.58 (s, 3H, SCH3), 1.70 (s, 3H, CH ^ C = CH2). Intermediate 2 3 (a) [lR- (la, 3a /?, Α β, 4a /?, 7/3, 1 aa, 8a /?)] 8a-[[lS, 4R, 7R, 9R] -2,8-dioxo-4,9-dimethyl) -cis-bicyclo [4.4.0] -non-7-yl-oxy-methyl] -4-methylacyl- 4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3- (1-methylethyl) -1,4 · methylene-s-pyda province-3a (lH) -Chiral acid, diphenylmethyl ester and printed by the Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) (b) [lR- (l ^, 3a / ? Αβ, 4a /?, 1 β, l ^ a, 8a /?)] 8a-[[lS, 4S, 711,911] -2,8-dioxo-4,9-dimethyl) -cis -Bicyclo [3.4.0] -nonan-7-yl-oxy-methyl] -4 -methylbromo-4,4a, 5,6,7,7a, 8,8a-octaamino-7-methyl -3- (l-methylethyl) -l, 4-methylene-s-indap 3a (lH) -chiric acid , Diphenyl methyl ester</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">方法A -82- 本紙張尺度適用中國國家裸準（CNS ) A4规格（210X297公釐） A7 B7 五、發明説明（80) 將中間體21(1.5克）於無水甲苯（150毫升）内之溶液用氣 氣流去氣90分鐘，然後加熱至回流。於此沸騰溶液中加氣 化三丁基錫（847微升）及偶氮雙（異丁腈）（33毫克）。再繼續 加熱3 0分鐘。除去溶劑，得粗製混合物，此混合物於二氧 化矽膠上作閃色層分析二次，用己烷：醋酸乙酯（20 :丨）洗 離。製得標題化合物〇)(150毫克；11卜0.6，於己烷：醋酸 乙酯4 : 1内）及標題化合物（b) (260毫克；Rf=〇.4於己烷： 醋酸乙酯4 : 1内），二者都是無色油體。 (a) δ (!Η, CDC13)： 9.75 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph)，6.99(s，lH，CHPh2),6.06(dd，lH，H-2,J=1.5&amp;amp;3.6 Hz)，4·46 (dd, 1H, H-7，，J=3及7.5 Hz), 4.06-3.95 (m, 2H, H-3,及8aCH2)，3.78-3.60 (m，2H, H-l'及8aCH2), 3.38-3.26 (m, 2H，H-9,及H-3')，2.75 (t, 1H，H-l，J=3.6 Hz), 0.98 (d, 3H， CICH J=6.9 Hz)。 (b) d (lR, CDC13): 9.74 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph)，6.99 (s, 1H，CHPh2)，6.04 (dd，1H，H-l，卜 1.5及3.6 Hz),4.74(t，lH，H-7,，J=3Hz)，3.94&amp;amp;3.61(2d,2H，8aCH2， JAB=9.3Hz),3.88&amp;amp;3.76(2d,2H，H-3,),3.66(m，lH，H-9')， 3.43 (t, 1H，Η-Γ· J=7.8 Hz), 2.72 (t，1H，H-l，J=3_6 Hz)， 2.46 (2m, 2H，C|iCH20及H-5，），0·97 (d, 3H，C^CH，J=6.9</span>Method A -82- This paper scale is applicable to China National Bare Standard (CNS) A4 specification (210X297mm) A7 B7 5. Description of invention (80) A solution of intermediate 21 (1.5g) in anhydrous toluene (150ml) Degas with a stream of gas for 90 minutes, then heat to reflux. To this boiling solution, gasified tributyltin (847 µl) and azobis (isobutyronitrile) (33 mg) were added. Continue heating for another 30 minutes. The solvent was removed to obtain a crude mixture. This mixture was subjected to a flash layer analysis on silica gel twice, and washed with hexane: ethyl acetate (20: 丨). The title compound 〇) (150 mg; 11 Bu 0.6, in hexane: ethyl acetate 4: 1) and the title compound (b) (260 mg; Rf = 0.4 in hexane: ethyl acetate 4: 1) Both are colorless oil bodies. (a) δ (! Η, CDC13): 9.75 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s, lH, CHPh2), 6.06 (dd, lH, H-2, J = 1.5 &amp;amp; 3.6 Hz), 4.46 (dd, 1H, H-7, J = 3 and 7.5 Hz), 4.06-3.95 (m, 2H, H-3, and 8aCH2), 3.78-3.60 ( m, 2H, H-l 'and 8aCH2), 3.38-3.26 (m, 2H, H-9, and H-3'), 2.75 (t, 1H, Hl, J = 3.6 Hz), 0.98 (d, 3H , CICH J = 6.9 Hz). (b) d (lR, CDC13): 9.74 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s, 1H, CHPh2), 6.04 (dd, 1H, Hl, Bu 1.5 and 3.6 Hz), 4.74 (t, lH, H-7 ,, J = 3Hz), 3.94 &amp;amp; 3.61 (2d, 2H, 8aCH2, JAB = 9.3Hz), 3.88 &amp;amp; 3.76 (2d, 2H, H-3, ), 3.66 (m, lH, H-9 '), 3.43 (t, 1H, H-Γ · J = 7.8 Hz), 2.72 (t, 1H, Hl, J = 3_6 Hz), 2.46 (2m, 2H, C | iCH20 and H-5,), 0 · 97 (d, 3H, C ^ CH, J = 6.9</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz)。</span>Hz).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">方法B 將中間體98( 685毫克）於o-二甲苯（I5毫升）内之落液用 氬氣流去氣6 0分鐘，然後加熱至回流。加氮化二丁基錫 本紙張尺度適用中國國家標準（CNS ) Μ规格（210X 297公釐） (請先閲讀背面之注意事項再填寫本萸) -4**^· ,1Τ 經濟部中央標準局員工消費合作社印製 A7 五、發明説明（81) (379微升）再繼續加熱3〇分鐘。冷卻後，將此混合物於乙醚 (150毫升）及水（1〇〇毫升）間分開。有機層用飽和氟化鉀溶 液洗至不再有氣化三丁基錫沉澱，過濾並蒸發至乾，得殘 餘物，此殘餘物於二氧化矽膠上作閃色層分析二次，用己 烷：醋酸乙酯（20 : 1)洗離。製得標題化合物（a)(1〇3毫克） 及標題化合物（b)(235毫克）。</span>Method B The intermediate 98 (685 mg) in o-xylene (15 mL) was degassed with argon flow for 60 minutes and then heated to reflux. The paper standard of dibutyltin nitride is applicable to the Chinese National Standard (CNS) Μ specifications (210X 297 mm) (please read the notes on the back before filling in the cornel) -4 ** ^ ·, 1Τ Employee of Central Standards Bureau A7 printed by the consumer cooperative V. Description of invention (81) (379 microliters) Continue heating for another 30 minutes. After cooling, the mixture was separated between ether (150 ml) and water (100 ml). The organic layer was washed with saturated potassium fluoride solution until there was no more vaporized tributyltin precipitate, filtered and evaporated to dryness to obtain a residue. This residue was analyzed twice on a silica gel as a flash layer, using hexane: acetic acid The ethyl acetate (20: 1) was washed away. The title compound (a) (103 mg) and the title compound (b) (235 mg) were prepared.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">方法C 將氫化二丁基錫（684微升）於無水甲苯（25毫升）内之溶液 於回流用氬氣流去氣1小時，然後用注射筒用2小時以上加 中間體98(610毫克）於無水甲苯（3〇毫升）内之溶液。再繼 續加熱3.5小時。減壓除去溶劑，得粗製產物，此產物於二 氧化矽膠上作閃色層分析二次，用己烷及己烷：醋酸乙酯 (10 : 1)至（8 : 1)洗離，得標題化合物（a)(357毫克）。 中間體2 4 經濟部中央樣準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁} [1R-(1 a ,3 a β ,4/? ,4 a J3 ,Ί β ,7a^,8ay5 )]8a-[[lS,7R,9R]-2,8 -二氧- 4,4,8-三甲基）-順式-雙環[44〇]·壬-7_基-氧 基-甲基]-4 -甲酿基-4,4a，5,6,7,7a，8,8a -八氫-7-甲基-3. (1-甲基乙基）-1,4 -亞甲基-s-啕噠省- 3a(lH) -羧酸，二苯 基甲基酯 將中間體22(5 80毫克）於無水甲苯（150毫升）内之溶液用 氬氣流去氣1小時，然後加熱至回流。在加熱中用注射筒以 2小時以上加催化量的偶氮雙（異丁腈）（027毫升）溶於無水 甲苯（20毫升）内之溶液，同時繼續通入氬氣。加完後再繼 續加熱3小時，然後冷卻，濃縮，於二氧化矽膠上作閃色層 84 本紙張尺度遑用中國圃家揉率（CNS ) A4規格（210X297公釐） A7 B7 經濟部中央標準局員工消费合作社印製 五、發明説明（82) 分析，用己烷再用己烷：醋酸乙酯（4 : 1)洗離，製得橾題 化合物（100毫克），爲白色泡沫。 ^ (lH, CDC13): 9.74 (s, 1H, CHO), 7.45-7.26 (m, i〇H, Ph2)，6.99(S，lH，C|iPh2)，6.04(dd，lH，H-2，j=i.5A3.6</span>Method C: A solution of dibutyltin hydride (684 μl) in anhydrous toluene (25 ml) was degassed under reflux with argon gas flow for 1 hour, and then the intermediate 98 (610 mg) in anhydrous toluene was added to the syringe for more than 2 hours. (30mL). Continue heating for another 3.5 hours. The solvent was removed under reduced pressure to obtain the crude product, which was analyzed twice on a silica gel as a flash layer, washed away with hexane and hexane: ethyl acetate (10: 1) to (8: 1) to obtain the title Compound (a) (357 mg). Intermediate 2 4 Printed by the Employee Consumer Cooperative of the Central Prototype Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) [1R- (1 a, 3 a β, 4 /?, 4 a J3, Ί β, 7a ^, 8ay5)] 8a-[[lS, 7R, 9R] -2,8 -dioxo-4,4,8-trimethyl) -cis-bicyclo [44〇] · non-7_yl- Oxy-methyl] -4 -methylbromo-4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3. (1-methylethyl) -1, 4 -methylene-s-pyridone-3a (lH) -carboxylic acid, diphenylmethyl ester The solution of intermediate 22 (5 80 mg) in anhydrous toluene (150 ml) was degassed with argon flow 1 hour, then heated to reflux. While heating, use a syringe to add a solution of a catalytic amount of azobis (isobutyronitrile) (027 ml) dissolved in anhydrous toluene (20 ml) over 2 hours, while continuing to add argon. After the addition is complete, continue to heat for 3 hours, then cool, concentrate, and make a flash layer on the silica. 84 This paper scale uses the Chinese nursery rubbing rate (CNS) A4 specification (210X297 mm) A7 B7 Central Standard of the Ministry of Economic Affairs Printed by the Bureau Staff Consumer Cooperative V. Description of invention (82) Analysis, wash off with hexane and then with hexane: ethyl acetate (4: 1) to prepare the title compound (100 mg) as a white foam. ^ (lH, CDC13): 9.74 (s, 1H, CHO), 7.45-7.26 (m, i〇H, Ph2), 6.99 (S, lH, C | Ph2), 6.04 (dd, lH, H-2, j = i.5A3.6</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.71 (t，1H，H-7’，J=3.3 Hz), 3.93&amp;amp;3.6l(2d，2H，8a_ CH2, J=9.3 Hz)，3.85 (t，1H, H-l，. J=8.7 Hz)，3.56 (m，lH， H-9’），3.55及3_43 (d, 2H，CH2-3', J=8.4 Hz)，2.73 (m, lH, H-l)，1.08及0.99 (2s, 6H，4--(¾)。 中間體2 5 [1R-(1 a ,3ay3，40，4ay5，7/?，7aa，8ay5 )]8a-[(6-去氧，卢 _ D -阿卓哌喃糖基氧基）甲基]_4_(i,3 -二氧戊環-2-基）_ 4,4&amp;amp;，5,6,7,7&amp;amp;，8,83-八氫-7-甲基-3-(1-甲基乙基）-1，4_ 亞曱基丨噠省-3a(lH)-羧酸，二苯基甲基酯 .於中間體1(2.5克）於無水乙腈（1〇〇毫升）内之撥拌過的溶 液中，於室溫加乙二醇（30毫升），正甲酸三甲酯（2毫升）及 催化量的p -甲苯磺酸。將此混合物攪拌3小時，然後用醋酸 乙酯（300毫升）稀釋，再相繼用5%碳酸氫鈉水溶液及鹽水 洗。有機層於爲水硫酸鈉上乾燥，濃縮，以二氧化碎膠作 色層分析純化，用己烷：醋酸乙酯（3 : 1)洗離，製得襟題 化合物（2·6克）。 β &amp;quot;Η, CDC13): 7.46-7.24 (m, 10Η, Ph2)，6.94 (s, 1Η， C这Ph2)，5.83 (dd，1H，H-2，J=1.2及3.6 Hz)，5.07 (s，ijj beta), 4.65 (d，1H，Η-Γ，J=1.8 Hz), 4.07-4.04 (m，2H，8a CH2 (1H)及H-3.)，3.88-3.69 (m，8H，OC^Ci^O, 8a-CH2 -85- 本紙張尺度逍用中國國家橾準（CNS ) A4B( 210X297公釐） (锖先閱讀背面之注意事項存填寫本貰)</span>Hz), 4.71 (t, 1H, H-7 ', J = 3.3 Hz), 3.93 &amp;amp; 3.6l (2d, 2H, 8a_ CH2, J = 9.3 Hz), 3.85 (t, 1H, Hl,. J = 8.7 Hz), 3.56 (m, lH, H-9 '), 3.55 and 3_43 (d, 2H, CH2-3', J = 8.4 Hz), 2.73 (m, lH, Hl), 1.08 and 0.99 (2s, 6H, 4-(¾). Intermediate 2 5 [1R- (1 a, 3ay3,40,4ay5,7 / ?, 7aa, 8ay5)] 8a-[(6-deoxy, Lu_D -Azhuo Piperanosyloxy) methyl] _4_ (i, 3-dioxolane-2-yl) _ 4,4 &amp;, 5,6,7,7 &amp;amp;, 8,83-octahydro-7-methyl 3- (1-methylethyl) -1,4-methylidene-3a (lH) -carboxylic acid, diphenylmethyl ester. In intermediate 1 (2.5 g) in anhydrous acetonitrile ( 100 ml) of the stirred solution, ethylene glycol (30 ml), trimethyl orthoformate (2 ml) and a catalytic amount of p-toluenesulfonic acid were added at room temperature. The mixture was stirred for 3 Hour, and then diluted with ethyl acetate (300 ml), then washed successively with 5% aqueous sodium bicarbonate solution and brine. The organic layer was dried over sodium sulfate, concentrated, and purified by silica gel chromatography for chromatography. Hexane: ethyl acetate (3: 1) washes away to prepare the title compound ( 2.6 g). Β &amp;quot; Η, CDC13): 7.46-7.24 (m, 10Η, Ph2), 6.94 (s, 1Η, C Ph2), 5.83 (dd, 1H, H-2, J = 1.2 and 3.6 Hz), 5.07 (s, ijj beta), 4.65 (d, 1H, Η-Γ, J = 1.8 Hz), 4.07-4.04 (m, 2H, 8a CH2 (1H) and H-3.), 3.88- 3.69 (m, 8H, OC ^ Ci ^ O, 8a-CH2 -85- This paper size is easy to use China National Standards (CNS) A4B (210X297mm) (Read the precautions on the back first and fill in this book)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">·=ΛI A7 321644 ______B7__ 五、發明説明（83 ) (1H)，H-2’，H-4,及H-5，），2.51 (t，1H，H-l, J=4.5 Hz)，2.37 (d， 1H, OH, J=2.7 Hz), 2.28 (d, 1H, OH, J=3.6 Hz), 2.04 (d, 1H, OH, J=5.7 Hz)。 中間體2 6 [1R-(1 α ,3a冷，,4# ,7y5，7aa ,8a/? )]8a-[(6-去氧-3,4_ 〇·異亞丙基-々-D-阿卓哌喃糖基氧基）曱基]_4_(1,3-二氧 戊環-2-基）-4,4&amp;amp;，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7-甲基-3-(1-甲基 乙基）-1，4-亞曱基_s_吲噠省_3a(iH)-羧酸，二苯基甲基酯 將中間體25(200毫克）於無水乙腈（6毫升）内之溶液在氮 氣下用2,2-二甲氧基丙烷（〇·6毫升）及催化量的p_甲苯磺酸 峨淀鏘處理。於室溫經4小時後，此混合物再以飽和碳酸氫 鈉水溶液（20毫升）處理，用醋酸乙酯（2〇毫升）萃取二次。 合併之有機相用水及鹽水洗，於硫酸鎂上乾燥，過濾並蒸 發。殘餘物於二氧化矽膠上作色層分析純化，用己烷：醋 酸乙醋（4 : 1)洗離’合併合適的各部分並蒸發，製得標題 化合物（205毫克），爲白色泡沫。 S CDC13): 7.47-7.2 (m, 10H, 2Ph), 6.93 (s, 1H, C|iPh2)，5.83 (dd, 1H, H-2, J=1.2及3.6 Hz)，5.08 (s，1H， 1,3-二氧燒)，4.56 (d, 1H，Η-Γ，J=2.1 Hz)，4.3(dd, 1H，H-3', J-3.6及5.7 Hz)，4.04 (d，1H，8aCH2 的 A部分，JAB=9 Hz) 3.95-3.75 (m，7H，H-2’，H-4'，OC^C^O及8aCH2 的B部分） 3.44 (dq，1H，H-5，，J=6及9 Hz)，2.65 (m，1H，C廷Me2)，2.51 (bt，1H，H-l，J=3.6 Hz)，2.35 (d，1H，OH2·)，1.47, 1.36 (2s 6H, 2CH3異亞丙基縮酮）。 -86- 本紙張A度逍用中國國家揉準（CNS ) A4規格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部中央樣準局貝工消费合作社印袋 經濟部中央標準局員工消費合作社印裝 A7 B7 五、發明説明（ 中間體2 7 [1R-(1 ，3a0，4冷，4a 点，7 点，7aa，8a；9 )]8a-[(6 -去氧-3,4_ 〇·異亞丙基- D-別旅喃糖基氧基）甲基]_4_(ι，3_二氧戊 環-2-基）-4,4&amp;amp;，5,6,7,7丑，8,8&amp;amp;-八氫_7-甲基-3-(1-甲基乙 基）-1,4-亞甲基-s-叫丨噠省-3a(lH)-羧酸，二苯基甲基酯 將吡啶（0.67毫升）於0°C加於氧化鉻（CrOjHi2毫克）於 二氣甲烷（25毫升）之混合物内。15分鐘後加醋酸酐（〇.4〇毫 升），再過10分鐘後於相同溫度加中間體26(750毫克）於二 氣甲烷（25毫升）内之溶液。將此混合物攪拌2小時，經有硫 酸鎂頂層的二氧化矽膠柱過濾，將濾過物減壓蒸發至乾， 得漿體。以此漿體溶於甲醇：水（1 0 : 1 ; 1 1毫升）内，然 後於0 °C加硼氫化鈉（4 0毫克）。將此混合物保持於〇 °c 2小 時’用1當量鹽酸溶液酸化pH至6-7，然後減壓蒸發至乾， 得白色固體，於二氧化碎膠上作色層分析純化二次，相繼 用己烷：醋酸乙酯（6: 1)然後（2: 1)洗離。合併含所需產 物部分並眞空蒸發，得標題化合物（585毫克）。 〇H, CDC13)： 7.24-7.46 (m, 10H, 2Ph), 6.92 (s, 1H, C廷Ph2)，5.87 (dd，1H，H-2, J=3.9及 1.5 Hz), 5.09 (s, 1H, 匸廷-二氧烷），4.52 (t，1H, H-3'，J=4.5 Hz), 4.45 (d，1H，H-l'， J=7.8 Hz, 4.07 (d, 1H, 8aCH2, J=9 Hz), 3.74-3.86 (m, 6H, 2C^·二氧烷，H-4'，8aCH2)，3.67 (m, 1H，H-2，），2.65 (m，1H， H-14)，2.58 (t, 1H, H-ll)。 中間體2 8 [lR-(lor，3a々，4々，4a々，7々，7aa ,8a^ )]4-曱酿基 _ -87- 本紙張尺度逋用中國國家標準（CNS ) A4規格（210X297公釐） (諳先閲讀背面之注意事項再填寫本頁) -訂 A7 B7 五、發明説明（85 ) 4,4&amp;amp;，5,6,7,7&amp;amp;,8,8&amp;amp;-八氫-8&amp;amp;-羥甲基-7-甲基-3-(1-甲基 乙基）-1，4-亞甲基-s-β噠省-3a(lH)-羧酸，2-(三甲基甲 矽烷基）乙基酯 將索達里新（6.6克）及〇-[2-(三甲基甲矽烷基）乙基]-Ν,Ν·-二異丙基異脲（9.3克）於無水四氫呋喃（150毫升）内之 溶液於回流加熱3小時。然後將此混合物冷至室溫，過濾並 蒸發至乾。殘餘物溶於醋酸乙酯（750毫升）内，相繼用1當 量鹽酸，5 %碳酸氫鈉水溶液及鹽水洗。有機層於無水硫酸 鈉上乾燥，眞空濃縮，以二氧化矽膠柱作色層分析純化， 用（1 〇 %)醋酸乙酯於己烷内之溶液作洗離劑，製得標題化 合物（6.8克），爲白色泡末。 ά (^, CDC13)： 9.67 (s, 1H, CHO), 6.07 (dd, 1H, H-2, J=1.5&amp;amp;3.6Hz)，4.27(m,2H，CH2C|i20)，3.93&amp;amp;3.49(2m， 2H, 8a-CH2), 2.75 (bs, 1H, OH), 2.54 (t, 1H, H-l), 1.05 (m, 2H, CH2C_H2Si), 0.07 (s, 9U, (CH3)3Si); c?(13C, CDC13): 204.9 (CHO), 173.6 (COOTMSE), 148.2 (C-3), 130.6 (C-2), 66.9 (8a-CH20), 64.0 (CH2CH2〇), 177.7 CH2C^H2Si), 1.6 (CH3)3Si)。 經濟部中央梂準局員工消費合作社印褽 (請先閲讀背面之注意事項再填寫本頁) 1 L.J. Mathias, Synthesis, (1979)，561。 中間體2 9 [1R-(1 a，3a点，4/?，4a0，70，7aa ,8a々）]8a-[(3,4,6-三- O-乙醯基-2-去氧-/? -D-別哌喃糖基氧基）甲基]_4_甲醯基-4,4a，5,6,7,7a，8,8a-八氫-7-甲基-3-(l-甲基乙基）-l，4-亞曱基- s-，5丨噠省- 3a(lH) -羧酸，三甲基曱矽烷基乙基酯 -88- 本紙張尺度適用中國國家橾準（CNS ) A4规格（210X297公釐） A7 A7 經濟部中央樣準局員工消費合作社印製 B7 五、發明説明（86) ~~ 於中間體28(63毫克）及3,4,6_三_〇_乙醯基DaUall(2〇 毫克）於無水曱木（1毫升）内之溶液中加氫漠酸-三苯基膦（9 毫克）。此反應混合物於60°C加熱2小時，倒入ιΜ的碳酸 氫鈉溶液（100毫升）内。加醋酸乙酯（100毫升），有機層用 水洗’於無水硫酸鈉上乾燥並過濾。蒸發去溶劑至乾，殘 餘物以二氧化碎膠閃柱作色層分析純化，用己燒：醋酸乙 酯（10 : 1)洗離，製得標題化合物（16毫克），爲白色泡沫 〇 d (^, CDC13)： 9.73 (s, 1H, CHO), 6.03 (dd, 1H, H-2, J=1.5&amp;amp;3.6Hz)，5.48(m，lH，H-3'),4.89(dd，lH，H-4，， J=3.3&amp;amp;9.6Hz)，4.65(dd，lH,H-r,J=2.4&amp;amp;8.7Hz),4.23(m, 4H, H-6', C00CH? CH9 Si), 4.02 (ddd, 1H, H-5'，J=3, 5.4及 9.6Hz)，3.92&amp;amp;3.69(2d，2H,8aCH2,J=9.6Hz)，2.75(t，lH， H-l), 2.28 (m, 1H, CH(CH3)2)。 1 M. D. Wittman, R. L. Halcomb and S. J. Danishefsky, J.</span>· = ΛI A7 321644 ______B7__ V. Description of the invention (83) (1H), H-2 ', H-4, and H-5, 2.51 (t, 1H, Hl, J = 4.5 Hz), 2.37 (d , 1H, OH, J = 2.7 Hz), 2.28 (d, 1H, OH, J = 3.6 Hz), 2.04 (d, 1H, OH, J = 5.7 Hz). Intermediate 2 6 [1R- (1 α, 3a cold, 4 #, 7y5,7aa, 8a /?)] 8a-[(6-deoxy-3,4_ 〇 · isopropylidene-々-D- Azorpiperanyloxy) methyl] _4_ (1,3-dioxolan-2-yl) -4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro- 7-methyl-3- (1-methylethyl) -1,4-methylidene_s_indap province_3a (iH) -carboxylic acid, diphenylmethyl ester, intermediate 25 (200 Mg) of the solution in anhydrous acetonitrile (6 ml) was treated with 2,2-dimethoxypropane (0.6 ml) and a catalytic amount of p_toluenesulfonate eianqiang under nitrogen. After 4 hours at room temperature, the mixture was treated with saturated aqueous sodium bicarbonate (20 ml) and extracted twice with ethyl acetate (20 ml). The combined organic phase was washed with water and brine, dried over magnesium sulfate, filtered and evaporated. The residue was chromatographed and purified on silica gel, washed away with hexane: ethyl acetate (4: 1), combined the appropriate fractions and evaporated to obtain the title compound (205 mg) as a white foam. S CDC13): 7.47-7.2 (m, 10H, 2Ph), 6.93 (s, 1H, C | iPh2), 5.83 (dd, 1H, H-2, J = 1.2 and 3.6 Hz), 5.08 (s, 1H, 1,3-dioxane), 4.56 (d, 1H, Η-Γ, J = 2.1 Hz), 4.3 (dd, 1H, H-3 ', J-3.6 and 5.7 Hz), 4.04 (d, 1H, Part A of 8aCH2, JAB = 9 Hz) 3.95-3.75 (m, 7H, H-2 ', H-4', OC ^ C ^ O and Part B of 8aCH2) 3.44 (dq, 1H, H-5 ,, J = 6 and 9 Hz), 2.65 (m, 1H, Ctin Me2), 2.51 (bt, 1H, Hl, J = 3.6 Hz), 2.35 (d, 1H, OH2 ·), 1.47, 1.36 (2s 6H, 2CH3 isopropylidene ketal). -86- This paper A degree is made in China National Standard (CNS) A4 (210X297mm) (please read the notes on the back before filling in this page). Order the Ministry of Economic Affairs Central Bureau of Samples and Printing Co., Ltd. A7 B7 printed by the Ministry of Standards and Staff Consumer Cooperative V. Invention description (Intermediate 2 7 [1R- (1, 3a0, 4 cold, 4a point, 7 point, 7aa, 8a; 9)] 8a-[(6- Deoxy-3,4_ 〇.isopropylidene-D-bipyranosyloxy) methyl] _4_ (ι, 3-dioxolane-2-yl) -4,4 &amp;amp;, 5,6 , 7,7 ugly, 8,8 &amp;amp; -octahydro_7-methyl-3- (1-methylethyl) -1,4-methylene-s-called Shuda-3a (lH)- Carboxylic acid, diphenyl methyl ester Pyridine (0.67 ml) was added to a mixture of chromium oxide (CrOjHi 2 mg) and methane (25 ml) at 0 ° C. After 15 minutes, acetic anhydride (0.4. ML), after another 10 minutes, add a solution of intermediate 26 (750 mg) in methane (25 mL) at the same temperature. The mixture was stirred for 2 hours and filtered through a silica gel column with a magnesium sulfate top layer, The filtrate was evaporated to dryness under reduced pressure to obtain a slurry. This slurry was dissolved in methanol: water 1 0: 1; 11 ml), then add sodium borohydride (40 mg) at 0 ° C. Keep this mixture at 0 ° C for 2 hours' acidify the pH to 6-7 with 1 equivalent hydrochloric acid solution, then Evaporate to dryness under reduced pressure to obtain a white solid, which is analyzed and purified twice on a silica gel by chromatography, successively washed away with hexane: ethyl acetate (6: 1) and then (2: 1). The product was partially evaporated in vacuo to give the title compound (585 mg). 〇H, CDC13): 7.24-7.46 (m, 10H, 2Ph), 6.92 (s, 1H, C Ting Ph2), 5.87 (dd, 1H, H- 2, J = 3.9 and 1.5 Hz), 5.09 (s, 1H, etiodioxane), 4.52 (t, 1H, H-3 ', J = 4.5 Hz), 4.45 (d, 1H, H-l ', J = 7.8 Hz, 4.07 (d, 1H, 8aCH2, J = 9 Hz), 3.74-3.86 (m, 6H, 2C ^ · dioxane, H-4', 8aCH2), 3.67 (m, 1H, H-2,), 2.65 (m, 1H, H-14), 2.58 (t, 1H, H-ll). Intermediate 2 8 [lR- (lor, 3a々, 4々, 4a々, 7々, 7aa, 8a ^)] 4- 掱 鹽基 _ -87- This paper scale uses the Chinese National Standard (CNS) A4 specification (210X297mm) (keep reading the precautions on the back and then fill out this page) -Subscribe to A7 B7 5. Description of the invention 85) 4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-8 &amp;amp; -hydroxymethyl-7-methyl-3- (1-methylethyl) -1,4 -Methylene-s-βpyridine-3a (lH) -carboxylic acid, 2- (trimethylsilyl) ethyl ester, sodarin (6.6 g) and 〇- [2- (trimethyl A silyl) ethyl] -Ν, Ν · -diisopropylisourea (9.3 g) in anhydrous tetrahydrofuran (150 ml) was heated at reflux for 3 hours. The mixture was then cooled to room temperature, filtered and evaporated to dryness. The residue was dissolved in ethyl acetate (750 ml) and washed successively with 1 equivalent hydrochloric acid, 5% aqueous sodium bicarbonate solution and brine. The organic layer was dried over anhydrous sodium sulfate, concentrated in vacuo, and purified by silica gel column chromatography, using (10%) ethyl acetate in hexane as the eluent to obtain the title compound (6.8 g ), A white bubble. ά (^, CDC13): 9.67 (s, 1H, CHO), 6.07 (dd, 1H, H-2, J = 1.5 &amp;amp; 3.6Hz), 4.27 (m, 2H, CH2C | i20), 3.93 &amp;amp; 3.49 (2m, 2H, 8a-CH2), 2.75 (bs, 1H, OH), 2.54 (t, 1H, Hl), 1.05 (m, 2H, CH2C_H2Si), 0.07 (s, 9U, (CH3) 3Si); c ? (13C, CDC13): 204.9 (CHO), 173.6 (COOTMSE), 148.2 (C-3), 130.6 (C-2), 66.9 (8a-CH20), 64.0 (CH2CH2〇), 177.7 CH2C ^ H2Si), 1.6 (CH3) 3Si). Printed by the Employee Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economic Affairs (please read the precautions on the back before completing this page) 1 L.J. Mathias, Synthesis, (1979), 561. Intermediate 2 9 [1R- (1 a, 3a point, 4 / ?, 4a0, 70, 7aa, 8a々)] 8a-[(3,4,6-tri-O-acetoxy-2-deoxy -/? -D-perpiperanosyloxy) methyl] _4_carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- ( l-methylethyl) -l, 4-methylidene-s-, 5 ~ da province- 3a (lH) -carboxylic acid, trimethylmethylsilyl ethyl ester-88- This paper size is suitable for China Standard (CNS) A4 specification (210X297mm) A7 A7 Printed B7 by Employee Consumer Cooperative of the Central Prototype Bureau of the Ministry of Economic Affairs V. Description of invention (86) ~~ Intermediate 28 (63 mg) and 3,4,6_ A solution of tri_〇_acetoyl DaUall (20 mg) in anhydrous Mizuki (1 ml) was hydrohydro-acid triphenylphosphine (9 mg). The reaction mixture was heated at 60 ° C for 2 hours and poured into 1M sodium bicarbonate solution (100 ml). Ethyl acetate (100 ml) was added, and the organic layer was washed with water ', dried over anhydrous sodium sulfate and filtered. The solvent was evaporated to dryness, and the residue was purified by chromatography on a silica gel flash column and washed away with hexane: ethyl acetate (10: 1) to obtain the title compound (16 mg) as a white foam. (^, CDC13): 9.73 (s, 1H, CHO), 6.03 (dd, 1H, H-2, J = 1.5 &amp;amp; 3.6Hz), 5.48 (m, lH, H-3 '), 4.89 (dd, lH, H-4 ,, J = 3.3 &amp;amp; 9.6Hz), 4.65 (dd, lH, Hr, J = 2.4 &amp;amp; 8.7Hz), 4.23 (m, 4H, H-6 ', C00CH? CH9 Si), 4.02 (ddd, 1H, H-5 ', J = 3, 5.4 and 9.6Hz), 3.92 &amp;amp; 3.69 (2d, 2H, 8aCH2, J = 9.6Hz), 2.75 (t, lH, Hl), 2.28 (m , 1H, CH (CH3) 2). 1 M. D. Wittman, R. L. Halcomb and S. J. Danishefsky, J.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Org. Chem. (1990), 55^, 1979-1981 ° 中間體3 0 [1R-(1 a，3a/?，4冷，4a々，7卢，7aa ,8ay5 )]8a- [(2-去氧-3,4-〇-異亞丙基-6-0 -甲基-々-D-別哌喃糖基氧基）甲基]-4 -甲 醯基-4,4&amp;amp;，5,6,7,7&amp;amp;,8,8&amp;amp;-八氫-7-甲基-3-(1-甲基乙基）_ 1，4_亞甲基-s-β噠省-3a(lH)-羧酸，2-(三甲基甲矽烷基) 乙基酯 於中間體29(275毫克）於純甲醇（10毫升）内之攪拌過的溶 液中加2或3滴1M的甲氧化鈉於甲醇内之溶液。攪拌1.5小 -89- 本紙張尺度逍用中國國家橾準（CNS ) A4規格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁) 訂</span>Org. Chem. (1990), 55 ^, 1979-1981 ° Intermediate 3 0 [1R- (1 a, 3a / ?, 4 cold, 4a々, 7 Lu, 7aa, 8ay5)] 8a- [(2- Deoxy-3,4-〇-isopropylidene-6-0-methyl-々-D-epiperanyloxy) methyl] -4-carboxamide-4,4 &amp;amp;, 5, 6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) _ 1,4-methylene-s-β-pyridine-3a (lH)- Carboxylic acid, 2- (trimethylsilyl) ethyl ester To a stirred solution of intermediate 29 (275 mg) in pure methanol (10 ml), add 2 or 3 drops of 1M sodium methoxide in methanol The solution inside. Stirring 1.5 small -89- This paper scale is easy to use Chinese National Standard (CNS) A4 specification (210X297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">發明説明 A7 B7 時後，將反應混合物濃縮，用甲苯（10毫升）稀釋，並濃縮 至成黃色漿體。再溶於丙酮（5毫升）内，加2,2_二甲氧基丙 烷（60微升）及p_甲苯磺酸單水合物（75毫克）。此反應混合 物於室溫挽拌1小時，用碳酸納中和，過滤，將慮過物濃縮 至乾。所得油體殘餘物溶於醋酸乙酯（2〇毫升）内，用水及 鹽水洗乾燥並濃縮得油體。將此油體於無水四氫吱喃（5 毫升）内之溶液於(TC以氫化鈉（10毫克）處理，攪拌3〇分鐘 後再加甲基碘（1〇〇微升）。以3小時將此混合物逐漸升至室 溫。加甲醇（1毫升）使反應停止，再將混合物濃縮，殘餘物 以閃柱色層分析純化三次，相繼用己烷：醋酸乙酯（i 〇 : i ) ’（ό ·· 1 )及（4 : 1 )洗離，合併適宜部分，蒸發去溶劑，製 得標題化合物（5 0毫克），爲無色油體。 ^ (lU, CDC13): 9.73 (s, 1H, CHO), 6.04 (dd, 1H, H-2, J=1.2及3·6 Hz)，4.61 (dd，1H，H-l’，J=2.4及8.4 Hz)，4.43 (m， 1氏11-3’），4.34-4_10(111，211,(：112-8£1^保護基)，3.66及3.89 (2d, 2H, 8aCH2, J=9.3 Hz), 3.87 (m, 1H, H-4'), 3.48-3.64 (m, 3H，2H-6'及H-5，），3.24 (s，3H, 6OMe), 2.73 (t, 1H，H-l, J=3.6 Hz)，1.34及 1.35 (2s，6H,異亞丙基之甲基）。 中間體3 1 [1R-(1 df,3ay5 Αβ Μβ ,Ί β ,7a ^ ,8a/9 ) ] 8 a-[(4 - Ο-((E)-2 -丁烯基-2,6-二去氧別哌喃糖基氧基）甲基]-4-甲醯 基- 4,4a,5,6,7,7a，8,8a-八氫-7-甲基- 3-(1-甲基乙基）-1，4-亞甲基-s-吲噠省_3a(lH)_羧酸，二苯基甲基酯 將中間體10(1.5克）及氧化二丁基錫（0.9克）於無水甲苯 -90- 本紙張尺度逍用中國國家梂準（CNS ) A4規格（210X297公釐） f請先閲讀背面之注意事項再填寫本頁〕 、1T_ 經濟部中央標準局員工消費合作社印^ Α7. Β7 321644 五、發明説明（88) (15〇毫升）内之混合物於裝有Dean-Stark冷凝器的燒瓶内於 回流加熱2小時’然後於室溫靜置於氮氣下（除去近20毫升 共沸混合物）。相繼加巴豆基溴（主爲反式，0.37毫升），氟 化四丁基銨（3·6毫升1M的於四氫呋喃内之溶液），及4A分 子篩（活化粉），此混合物於6〇〇c加熱24小時。濾除分子篩 。除去溶劑，殘餘物於二氧化矽膠上作閃色層分析，用己 烷：丙酮（95 : 5)洗離，製得標題化合物（1克），爲白色泡 沫。 ά CDC13): 9.73 (s, 1H, CHO), 7.44-7.23 (m, 10H, 2Ph)，6.98 (s，1H，C||JPh2)，6.05 (dd, 1H, H-2, J=1.5及3.6 Hz)，5.75-5.52 (m，2H，C廷=C廷)，4.64 (dd, 1H，Η-Γ，J=2.1 及 9.6 Hz), 4.16 (m，1H，H-3·)，4·98 (m，3H，8a-CH2,（1H)及 CH2CH=CH(2H)), 3.74 (m, 1H, H-5'), 3.67 (d, 1H, 8a-CH2 (1H), J=9.3 Hz), 3.05 (dd, 1H, H-4', J=3.0A9.6 Hz), 2.75 (t, 1H, H-l, J=3.6 Hz), 2.40 (d, 1H, OH, J=2.1 Hz), 1.72 (m, 3H,</span>Description of the invention After A7 to B7, the reaction mixture was concentrated, diluted with toluene (10 mL), and concentrated to a yellow slurry. Re-dissolve in acetone (5 ml), add 2,2-dimethoxypropane (60 μl) and p-toluenesulfonic acid monohydrate (75 mg). The reaction mixture was stirred at room temperature for 1 hour, neutralized with sodium carbonate, filtered, and the filtrate was concentrated to dryness. The resulting oil body residue was dissolved in ethyl acetate (20 ml), washed with water and brine, dried and concentrated to obtain an oil body. A solution of this oil body in anhydrous tetrahydrofuran (5 ml) was treated with (TC with sodium hydride (10 mg), and after stirring for 30 minutes, methyl iodide (100 μl) was added. For 3 hours The mixture was gradually raised to room temperature. Methanol (1 mL) was added to stop the reaction, and the mixture was concentrated. The residue was purified by flash column chromatography three times, successively with hexane: ethyl acetate (i 〇: i). (Ό ·· 1) and (4: 1) wash away, combine the appropriate fractions, and evaporate the solvent to obtain the title compound (50 mg) as a colorless oil. ^ (LU, CDC13): 9.73 (s, 1H , CHO), 6.04 (dd, 1H, H-2, J = 1.2 and 3.6 Hz), 4.61 (dd, 1H, H-l ', J = 2.4 and 8.4 Hz), 4.43 (m, 1's 11 -3 '), 4.34-4_10 (111, 211, (: 112-8 £ 1 ^ protecting group), 3.66 and 3.89 (2d, 2H, 8aCH2, J = 9.3 Hz), 3.87 (m, 1H, H-4 '), 3.48-3.64 (m, 3H, 2H-6' and H-5,), 3.24 (s, 3H, 6OMe), 2.73 (t, 1H, Hl, J = 3.6 Hz), 1.34 and 1.35 (2s , 6H, isopropylidene methyl). Intermediate 3 1 [1R- (1 df, 3ay5 Αβ Μβ, Ί β, 7a ^, 8a / 9)] 8 a-[(4-Ο-((E ) -2 -butenyl-2,6-dideoxypiperan Yloxy) methyl] -4-carboxamido-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1 , 4-methylene-s-indap _3a (lH) _carboxylic acid, diphenyl methyl ester, intermediate 10 (1.5 g) and dibutyltin oxide (0.9 g) in anhydrous toluene-90-this For paper size, please use the Chinese National Standard (CNS) A4 (210X297mm) f Please read the notes on the back before filling out this page], 1T_ Printed by the Employee Consumer Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs ^ Α7. Β7 321644 V. Inventions The mixture in (88) (15 mL) was heated at reflux in a flask equipped with a Dean-Stark condenser at reflux for 2 hours and then placed under nitrogen at room temperature (removed nearly 20 mL of azeotropic mixture). Crotonyl bromide (mainly trans, 0.37 ml), tetrabutylammonium fluoride (3.6 ml of 1M solution in tetrahydrofuran), and 4A molecular sieve (activated powder), this mixture was heated at 600 ° C for 24 The molecular sieve was filtered off. The solvent was removed, and the residue was analyzed by flash chromatography on silica gel and washed away with hexane: acetone (95: 5) to obtain the title compound (1 g) as white. Foam. ά CDC13): 9.73 (s, 1H, CHO), 7.44-7.23 (m, 10H, 2Ph), 6.98 (s, 1H, C || JPh2), 6.05 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 5.75-5.52 (m, 2H, C = C); 4.64 (dd, 1H, H-Γ, J = 2.1 and 9.6 Hz), 4.16 (m, 1H, H-3 ·), 4 · 98 (m, 3H, 8a-CH2, (1H) and CH2CH = CH (2H)), 3.74 (m, 1H, H-5 '), 3.67 (d, 1H, 8a-CH2 (1H), J = 9.3 Hz), 3.05 (dd, 1H, H-4 ', J = 3.0A9.6 Hz), 2.75 (t, 1H, Hl, J = 3.6 Hz), 2.40 (d, 1H, OH, J = 2.1 Hz ), 1.72 (m, 3H,</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Cl^CIKH)。 - 中間體3 2 [1R-(1 λ，3a/5，40，4a/5，7卢，7aa，8a/? )]8a-[(2,6-二去氧- 4-0-炔丙基-卢-D -別哌喃糖基氧基）曱基]_4_曱醯基_ 4,4&amp;amp;，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7_甲基_3_(1_甲基乙基）_1，4_ 亞甲基- s-M丨達省- 3a(lH) -幾酸，二苯基甲基醋 將中間體10(2克）及氧化二丁基錫（12克）於無水甲苯 (150毫升）内之懸浮液在裝有Dean-Stark冷凝器的燒瓶内於 回流加熱2小時，然後於室溫靜置於氮氣下（除去近2〇毫升 -91 - 本紙張尺度逍用中國B家搮準（CNS〉A4规格（210χ297公釐) (諳先閲讀背面之注意事項再填寫本頁) -Λ.</span>Cl ^ CIKH). -Intermediate 3 2 [1R- (1 λ, 3a / 5, 40, 4a / 5, 7 Lu, 7aa, 8a /?)] 8a-[(2,6-dideoxy-4-4-propargyl -Lu-D-piperanosyloxy) methyl] _4_methyl _4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7_methyl_ 3_ (1_Methylethyl) _1,4_methylene-sM ~ Da province- 3a (lH) -chiric acid, diphenylmethyl acetate intermediate 10 (2g) and dibutyltin oxide (12g) ) The suspension in anhydrous toluene (150 ml) is heated at reflux in a flask equipped with a Dean-Stark condenser at reflux for 2 hours, and then placed under nitrogen at room temperature (remove nearly 20 ml -91-this paper size Happy to use the Chinese B Family Standard (CNS&gt; A4 specification (210 × 297mm) (know the precautions on the back before filling out this page) -Λ.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T 經濟部中央標準局員工消费合作社印製 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明（89 ) 共沸'昆。物）。相繼加炔丙基溴（〇_55毫升80%重量比的於 、苯内、'谷液），氟化四丁基铵（4.8毫升1M於四氫吱喃内之 '谷液）及4人分子筛（活化粉），此混合物於6(TC加熱24小時 戚除分子篩。除去溶劑，殘餘物於二氧化硬膠上作閃色 層分析二次，用己院：丙嗣（96 : 4)洗離，製得標題化合物 (1.25克），爲白色泡沫。 ^ (lHj CDC13)： 9.73 (s, 1H, CHO), 7.44-7.26 (m, 10H, 2Ph)，6.98(S，1H，ciLPh2),6.05(dd，lH，H-2，J=1.2&amp;amp;3.3 Hz)，4.65 (dd，1H，H-l'，J二2.1 及9.6 Hz)，4.29 (m，1H，H-3，）， 4.24^4.22 (2d, 2H, Ci^C.CH, J=2.4 Hz), 4.05^3.68 (2d, 2H, 8a-CH2, J=9.3 Hz), 3.75 (m, 1H, H-5')s 3.25 (dd, 1H, H- 4', 1=3.0^9.3 Hz), 2.75 (t, 1H, H-l, J=3.9 Hz), 2.46 (t, 1H, C^CH^ J=2.4 Hz) 〇 中間體3 3 [1R-(1 a，3a々，4卢，4a々，7々，7aa，8a々）]8a-[(4-0-(3 -甲基 -2-丁烯基）-2，6-二去氧-々-D-別哌喃糖基氧基）甲基]_4_ 甲酿基-4,4a，5，6,7,7a，8,8a-八氫-7 -甲基-3-(1-甲基乙基） -1,4 -亞曱基- s-n引噠省_3a(iH) -羧酸，二苯基甲基酯 將中間體10(1克）及氧化三丁基錫（600毫克）於150毫升無 水甲苯内之懸浮液在裝有Dean-stark冷凝器的燒瓶内於回 流加熱2小時（除去25毫升共沸混合物），然後冷至室溫。加 2 -甲基-4-溴-2-丁晞（276微升）及氟化四丁基銨（1M的於四 氫呋喃内之溶液，2.4毫升），此混合物於50°C加熱24小時 。除去溶劑，粗製產物作閃色層分析（醋酸乙酯··己烷1 : -92- 本紙張尺度逍用中國國家標準（CNS ) A4規格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁) 4.</span>1T printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 Printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of the invention (89) Azeotrope 'Kun. Thing). Successively added propargyl bromide (〇_55 ml of 80% by weight in Yu, benzene, 'valley), tetrabutylammonium fluoride (4.8 ml of 1M in tetrahydrochlorinated' valley) and 4 people Molecular sieve (activated powder), the mixture was heated at 6 ° C for 24 hours to remove the molecular sieve. Remove the solvent, and the residue was analyzed on the hard rubber dioxide for a flash layer for two times, washed with your own hospital: Bingsi (96: 4) The title compound (1.25 g) was prepared as a white foam. ^ (LHj CDC13): 9.73 (s, 1H, CHO), 7.44-7.26 (m, 10H, 2Ph), 6.98 (S, 1H, ciLPh2), 6.05 (dd, lH, H-2, J = 1.2 &amp;amp; 3.3 Hz), 4.65 (dd, 1H, H-l ', J-2 2.1 and 9.6 Hz), 4.29 (m, 1H, H-3,), 4.24 ^ 4.22 (2d, 2H, Ci ^ C.CH, J = 2.4 Hz), 4.05 ^ 3.68 (2d, 2H, 8a-CH2, J = 9.3 Hz), 3.75 (m, 1H, H-5 ') s 3.25 (dd, 1H, H- 4 ', 1 = 3.0 ^ 9.3 Hz), 2.75 (t, 1H, Hl, J = 3.9 Hz), 2.46 (t, 1H, C ^ CH ^ J = 2.4 Hz) 〇 Body 3 3 [1R- (1 a, 3a 々, 4 Lu, 4a 々, 7 々, 7aa, 8a 々)] 8a-[(4-0- (3-methyl-2-butenyl) -2 , 6-dideoxy-々-D-piperanosyloxy) methyl] _4_methylbrenyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl -3- (1-methylethyl) -1,4-methylidene-sn-inducing_3a (iH) -carboxylic acid, diphenylmethyl ester, intermediate 10 (1 g) and trioxide A suspension of butyl tin (600 mg) in 150 ml of anhydrous toluene was heated at reflux for 2 hours in a flask equipped with a Dean-stark condenser (25 ml of azeotropic mixture was removed), and then cooled to room temperature. Add 2-methyl -4-bromo-2-butane (276 μl) and tetrabutylammonium fluoride (1M solution in tetrahydrofuran, 2.4 ml), the mixture was heated at 50 ° C for 24 hours. The solvent was removed and the crude product was used Flash layer analysis (ethyl acetate ·· hexane 1: -92- This paper standard uses the Chinese National Standard (CNS) A4 specification (210X297mm) (please read the precautions on the back and fill in this page) 4.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">，1T 經濟部中央標準局員工消费合作社印聚 A7 B7 五、發明説明（90) 2〇，1 : 15及1 : 10)，製得770毫克標題化合物，爲泡沫（ 產出率69%)。 ^ OH, CDC13)： 9.73 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.98 (s，1H，CHPh2), 6.05 (dd，1H, H2, J=1.5及3.3 Hz)， 5.33(m, 1H, OCH2CH=), 4.64 (dd, 1H, HI', J=2.1^L9.6 Hz), 4.20 (m, 1H, H3'), 4.25-3.95 (m, 3H, OCH^C=+8aCH2), 3.75-3.65 (m, 2H, H5'+8aCH2)，3.03 (dd, 1H，H41，J=3.3及 9.6 Hz), 2.75 (t, 1H, HI, J=3.9 Hz), 2.44 (d, 1H, OH, J=2.1 Hz)。 中間體34 [1 R-( 1 or ,3a/? ,4^ ,4a^ ,7^ ,7a« ,8a/5 )] 8a - [(4-0-((E)-2-丁烯基）-2,6 -二去氧- 3- 0- (甲硫基）硫代羰基_b_D-別哌喃 糖基氧基）甲基]-4 -甲醯基-4,4a，5,6,7,7a，8,8a-八氫-7-甲基-3-(l-甲基乙基）-l,4-亞甲基-S-吲健省_3a(lH)-叛 酸，二苯基甲基酯 於中間體31(1克）於四氫呋喃（20毫升）内的冷溶液中在氮 氣下分小批加氫化鈉（0 _ 15 6克）及催化量的咪吃。然後除去 冰浴，反應混合物置於室溫下攪拌1小時。相繼加二硫化碳 (0.58毫升）及甲基碘（0.8毫升）。反應完全後（tlc控制），將 粗製混合物倒入醋酸乙酯（400毫升）内並用1當量的氣化銨 (500毫升）使反應停止。有機層相繼用1當量的鹽酸（2〇〇毫 升），5%碳酸氫鈉水溶液（200毫升）及鹽水（2〇〇毫升）洗。 有機層於無水硫酸鈉上乾燥，過濾並眞空濃縮。所得殘餘 物於二氧化矽膠上作閃色層分析，用二氣甲烷：己烷（6 : 4) -93- 本紙張尺度適用中國國家揉準（CNS ) A4規格（210X297公釐) &amp;quot; ' ' —-------X-----—訂----—1^ (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印策 A7 B7 五、發明説明（91 ) 洗離，製得標題化合物（1.04克），爲白色泡沫。 ^ (lH, CDCI3)： 9.73 (s, 1H, CHO), 7.45-7.26 (m, 10H, 2Ph), 6.98 (s，1H，Cl|Ph2)，6.23 (dd, 1H，H-31，J=3.0及6.3 Hz)，6.05 (dd，1H, H-2, J=l_5及3.3 Hz)，5.75-5.40 (m，2H, CH=CH), 4.55 (dd, 1H, Η-Γ, J-l.8^9.3 Hz), 4.05-3.80 (m, 4H，8a-CH2(lH), (：^(：Η=(：Η(2Η)&amp;amp;H-5')，3.75(d，lH，8a-CH2(1H)，J=9.3 Hz)，3.20 (dd，1H, H-4'，J=3.0及9.3 Hz)， 2.72 (t, 1H, H-l, J=3.9 Hz), 2.58 (s, 3H, CH3S), 1.68 (m, 3H, C|^CH=CH)。 中間體3 5 [1R-(1 a ,3a々，4/5，4ayS，70，8ay5 )]8a-[(2,6-二去氧-3-0-(甲硫基）硫代羰基-4-0-丙炔基-b-D-別哌喃糖基氧基) 甲基]-4 -甲醯基-4,4a，5，6,7,7a,8,8a-八氫-7 -甲基-3-(1-甲基乙基）-l，4 -亞甲基-s-啕噠省- 3a(lH)-羧酸，二苯基甲 基酉旨 於中間體32(1.25克）於無水四氫呋喃（25毫升）内的冷溶 液中在氮氣下分小批加氫化鈉（0.2克）及催化量的咪唑。然 後除去冰浴，反應混合物置於室溫下攪拌1小時。相繼加二 硫化碳（0.6毫升）及甲基碘（0.75毫升）。反應完全後（tic控 制）’將粗製混合物倒入醋酸乙酯（4〇〇毫升）内並用1當量的 氣化按（500毫升）使反應停止。有機層相繼用！當量的鹽酸 (200毫升）’ 5%碳酸氫鈉水溶液（2〇〇毫升）及鹽水（2〇〇毫升) 洗。有機層於無水硫酸鈉上乾燥，過濾並眞空濃縮。所得 殘餘物於二氧化矽膠上作閃色層分析，用己烷：醋酸乙酯 ________ ―94. 本紙張从適用中固 標準（CNS ) A4^ (21Gx297公羞) (請先閲讀背面之注意事項再填寫本頁)</span>, 1T Ministry of Economic Affairs Central Standards Bureau employee consumer cooperative printed and printed A7 B7 V. Description of the invention (90) 2〇, 1: 15 and 1: 10), 770 mg of the title compound was obtained as a foam (output rate 69%). ^ OH, CDC13): 9.73 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.98 (s, 1H, CHPh2), 6.05 (dd, 1H, H2, J = 1.5 and 3.3 Hz) , 5.33 (m, 1H, OCH2CH =), 4.64 (dd, 1H, HI ', J = 2.1 ^ L9.6 Hz), 4.20 (m, 1H, H3'), 4.25-3.95 (m, 3H, OCH ^ C = + 8aCH2), 3.75-3.65 (m, 2H, H5 '+ 8aCH2), 3.03 (dd, 1H, H41, J = 3.3 and 9.6 Hz), 2.75 (t, 1H, HI, J = 3.9 Hz), 2.44 (d, 1H, OH, J = 2.1 Hz). Intermediate 34 [1 R- (1 or, 3a /?, 4 ^, 4a ^, 7 ^, 7a «, 8a / 5)] 8a-[(4-0-((E) -2-butenyl ) -2,6 -dideoxy- 3- 0- (methylthio) thiocarbonyl_b_D-piperanyloxy) methyl] -4 -methylacetyl-4,4a, 5,6 , 7,7a, 8,8a-octahydro-7-methyl-3- (l-methylethyl) -l, 4-methylene-S-indjian_3a (lH) -tetioic acid, Diphenyl methyl ester in a cold solution of intermediate 31 (1 g) in tetrahydrofuran (20 ml) was added sodium hydride (0 _ 15 6 g) and a catalytic amount of imi in small batches under nitrogen. The ice bath was then removed, and the reaction mixture was stirred at room temperature for 1 hour. Carbon disulfide (0.58 ml) and methyl iodide (0.8 ml) were added successively. After the reaction was complete (tlc control), the crude mixture was poured into ethyl acetate (400 ml) and the reaction was stopped with 1 equivalent of ammonium gasification (500 ml). The organic layer was washed successively with 1 equivalent of hydrochloric acid (200 mL), 5% aqueous sodium bicarbonate solution (200 mL) and brine (200 mL). The organic layer was dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. The resulting residue was analyzed by flash layer on silica gel, using methane: hexane (6: 4) -93- This paper scale is applicable to China National Standard (CNS) A4 (210X297 mm) &amp;quot; ' '—------- X -----— 定 ----— 1 ^ (please read the notes on the back before filling in this page) Employee Consumer Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs A7 B7 Five Description of the invention (91) Wash off to obtain the title compound (1.04g) as a white foam. ^ (lH, CDCI3): 9.73 (s, 1H, CHO), 7.45-7.26 (m, 10H, 2Ph), 6.98 (s, 1H, Cl | Ph2), 6.23 (dd, 1H, H-31, J = 3.0 and 6.3 Hz), 6.05 (dd, 1H, H-2, J = l_5 and 3.3 Hz), 5.75-5.40 (m, 2H, CH = CH), 4.55 (dd, 1H, Η-Γ, Jl.8 ^ 9.3 Hz), 4.05-3.80 (m, 4H, 8a-CH2 (lH), (: ^ (: Η = (: Η (2Η) &amp;amp; H-5 '), 3.75 (d, lH, 8a-CH2 (1H), J = 9.3 Hz), 3.20 (dd, 1H, H-4 ', J = 3.0 and 9.3 Hz), 2.72 (t, 1H, Hl, J = 3.9 Hz), 2.58 (s, 3H, CH3S ), 1.68 (m, 3H, C | ^ CH = CH). Intermediate 3 5 [1R- (1 a, 3a々, 4/5, 4ayS, 70, 8ay5)] 8a-[(2,6-di Deoxy-3-0- (methylthio) thiocarbonyl-4-0-propynyl-bD-epiperanosyloxy) methyl] -4-methylacetyl-4,4a, 5, 6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -l, 4-methylene-s-pyridine- 3a (lH) -carboxylic acid , Diphenylmethyl unitary is intended for a cold solution of intermediate 32 (1.25g) in anhydrous tetrahydrofuran (25ml) under nitrogen under small batches of sodium hydride (0.2g) and a catalytic amount of imidazole. Then remove the ice The reaction mixture was stirred at room temperature for 1 hour. Carbon disulfide (0.6 ml) was added successively Methyl iodide (0.75 mL). After the reaction is complete (tic control), pour the crude mixture into ethyl acetate (400 mL) and stop the reaction with 1 equivalent of vaporization (500 mL). The organic layer is used successively ! Equivalent hydrochloric acid (200 mL) '5% aqueous sodium bicarbonate solution (200 mL) and brine (200 mL). The organic layer was dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. The resulting residue was collected in two For the analysis of the flash layer on the silica gel, use hexane: ethyl acetate ________ ―94. This paper is from the applicable China Solid Standard (CNS) A4 ^ (21Gx297). (Please read the precautions on the back before filling this page )</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T A 7 B7 五、發明説明（92) 97 : 3及95 : 5洗離，製得標題化合物（1.2克），爲白色泡 沐。 〇U, CDC13)： 9.73 (s, 1H, CHO), 7.45-7.26 (m, 10H, 2Ph), 6.99 (s, 1H, CHPh2), 6.28 (q, 1H, H-3', J=3.3 Hz), 6.06 (dd，1H，H-2, J=1.5及3.6 Hz)，4.57 (dd, 1H，H-l'，J=1.8 &amp;amp;9.3Hz)，4.19&amp;amp;4.17(2d，2H，C|i2C^CH，J=2.4Hz)，4.03&amp;amp; 3.70 (2d，2H，8a-CH2，J=9.3 Hz)，3.86 (dq 1H, H-5’，J=6.3及 9.3 Hz)，3.50 (dd，1H, H-4，，J=3.0及9.3 Hz)，2.73 (t，1H，H-l， J=3.9 Hz)，2.58 (s，3H，CH3S)，2.42 (t，1H，CeCII)。 _中間體3 6 [1R-(1 a，3a0，4/?，4a々，7卢，7aa，8a卢）]8a-[(4-0-(3 -甲基 -2 -丁烯基）-2，6·二去氧- 3- 0- (甲硫基）硫代羰基- b- D-別 哌喃糖基氧基）甲基]-4 -甲醯基-4,4a，5,6,7,7a，8,8a-八氫 -7-甲基-3-(1-甲基乙基）-1，4-亞甲基-8-&amp;gt;^丨噠省-3&amp;amp;(111)-羧酸，二苯基甲基酯 於中間體33(770毫克）於無水四氫吱喃（15毫升）内溶液中 在氮氣下於0°C加氫化鈉（105毫克）及咪唑（30毫克）。將混 合物於室溫下攪拌1小時，然後相繼加二硫化碳（300微升) 及甲基破（311微升）。揽掉1小時後，加〇·ι當量的氣化按 (50毫升）使反應停止，用醋酸乙酯（2χΐ 〇〇毫升）萃取二次 ，於硫酸鎂上乾燥並濃縮，得油體，以此油體作閃色層分 析（二氧化矽膠，醋酸乙酯：己烷1 : 25及1 : 20)，製得 780毫克標題化合物（90 % ；)，爲白色泡沫。 ^ (lH, CDCI3): 9.73 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), -95- 本紙張尺度適用中國因家揉準（CNS ) A4規格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁)</span>, 1T A 7 B7 5. Description of the invention (92) 97: 3 and 95: 5 were washed away to obtain the title compound (1.2 g) as white foam. 〇U, CDC13): 9.73 (s, 1H, CHO), 7.45-7.26 (m, 10H, 2Ph), 6.99 (s, 1H, CHPh2), 6.28 (q, 1H, H-3 ', J = 3.3 Hz ), 6.06 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 4.57 (dd, 1H, H-l ', J = 1.8 &amp;amp; 9.3Hz), 4.19 &amp;amp; 4.17 (2d, 2H, C | i2C ^ CH, J = 2.4Hz), 4.03 &amp;amp; 3.70 (2d, 2H, 8a-CH2, J = 9.3 Hz), 3.86 (dq 1H, H-5 ', J = 6.3 and 9.3 Hz), 3.50 ( dd, 1H, H-4, J = 3.0 and 9.3 Hz), 2.73 (t, 1H, Hl, J = 3.9 Hz), 2.58 (s, 3H, CH3S), 2.42 (t, 1H, CeCII). _Intermediate 3 6 [1R- (1 a, 3a0, 4 / ?, 4a々, 7 lu, 7aa, 8a lu)] 8a-[(4-0- (3-methyl-2-butenyl) -2,6 · dideoxy-3-0- (methylthio) thiocarbonyl-b-D-piperanosyloxy) methyl] -4-carboxamide-4,4a, 5, 6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-8-&gt; ^ 丨 达 省 -3 &amp; (111 ) -Carboxylic acid, diphenylmethyl ester in a solution of Intermediate 33 (770 mg) in anhydrous tetrahydrofuran (15 ml) under nitrogen at 0 ° C with sodium hydride (105 mg) and imidazole (30 Mg). The mixture was stirred at room temperature for 1 hour, and then carbon disulfide (300 µl) and methyl bromide (311 µl) were added successively. After taking off for 1 hour, the reaction was stopped by adding equivalence of vaporization (50 mL), extracted twice with ethyl acetate (2 × 100 mL), dried over magnesium sulfate and concentrated to obtain an oil body, This oil body was subjected to flash layer analysis (silica dioxide, ethyl acetate: hexane 1: 25 and 1: 20) to obtain 780 mg of the title compound (90%;) as a white foam. ^ (lH, CDCI3): 9.73 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), -95- This paper size is suitable for China In-House Rubbing Standard (CNS) A4 (210X297mm) (Please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">-MV 丁 經濟部中央揉準局員工消費合作社印裝 經濟部中央標準局貝工消費合作社印製 A7 _B7 __ 五、發明説明（93) 6.98 (s, 1H, CHPh2), 6.26 (m, 1H, H3'), 6.06 (dd, 1H, H2, J=1.2及3.3 Hz)，5.26 (m，1H, OCH2Cm, 4.54 (dd, 1H，Hl，， J=l.8及9.6 Hz)，4.10-3.75 (m，4H，SaCt^+OC^O+HS1), 3.69(d，lH,8aCH2，J=9.6Hz)，3.18(dd，lH，H4',J=3&amp;amp;9.3 Hz), 2·72 (t，1H, HI, J=3.9 Hz), 2.58 (s，3H，SCH3)。 中間體3 7及3 8 a) [lR-(la，3a卢，4点，4a；5，7/?，7aa，8ay5 )]8a-[[lS，4R ，711，911]-2,8-二氧-4-乙基-9-甲基-順式-雙環[3.4.0]-壬 -7-基-氧基-甲基]]-4 -曱醯基-4,4a，5,6,7,7a，8,8a-八氫-7-甲基-3-(l-甲基乙基）-l，4-亞甲基-S-&amp;gt;^5丨噠省-3a(lH)-羧酸，二苯基甲基酯 b) [lR-(l« ,3ay9 ,4/3 ,4a^ ,Ί β ,laa ,8ay9 )]8a-[[lS,4S ，7尺，911]-2,8-二氧-4-乙基-9-甲基-順式-雙環[3.4.0]-壬 -7-基-氧基-甲基]]-4 -甲醯基-4,4a,5，6,7,7a,8,8 a -八氮-7 -甲基-3-(1-甲基乙基）-i,4_亞甲基-s_啕噠省_3a(iH )-叛酸，二苯基乙基酯 將中間體34(1.04克）於無水甲苯（50毫克）内之溶液用氬 氣流在回下去氣1小時。加氫化三丁基錫（〇·55毫升）及催化 量的偶氮雙（異丁腈）。將反應混合物再繼續回流2〇分鐘， 然後冷卻，濃縮，於二氧化矽膠上作閃色層分析二次，用 己燒及己燒：醋酸乙酯（94 : 6)洗離。製得中間體3 7(220 毫克；Rf= 0.27，於己烷：醋酸乙酯4 : 1内），爲白色泡沫 ’及中間體38(444毫克；Rf= 0.27於己娱i :醋酸乙酯4 : 1 内）’爲白色泡沐。 ____-96-___ 本紙張尺度適用中國囤家標準（CNS ) Λ4Μ ( 210X297公釐） (請先閱讀背面之注意事項再填寫本頁) 、1Τ 經濟部中央標準局員工消費合作社印製 A7 B7 _ 五、發明説明（94) 中間體3 7 δ (^, CDC13)： 9.75 (s, 1H, CHO), 7.45-7.26 (m, 10H, 2Ph)，6.99(s，lH,CliPh2)，6.06(dd,lH，H-2，J=1.5&amp;amp;3.6</span>-MV Ding, Ministry of Economic Affairs, Central Bureau of Accreditation, Employee Consumer Cooperative Printed by the Ministry of Economic Affairs, Central Standards Bureau, Beigong Consumer Cooperative Printed A7 _B7 __ V. Description of Invention (93) 6.98 (s, 1H, CHPh2), 6.26 (m, 1H, H3 '), 6.06 (dd, 1H, H2, J = 1.2 and 3.3 Hz), 5.26 (m, 1H, OCH2Cm, 4.54 (dd, 1H, Hl, J = 1.8 and 9.6 Hz), 4.10-3.75 (m, 4H, SaCt ^ + OC ^ O + HS1), 3.69 (d, lH, 8aCH2, J = 9.6Hz), 3.18 (dd, lH, H4 ', J = 3 &amp;amp; 9.3 Hz), 2.72 ( t, 1H, HI, J = 3.9 Hz), 2.58 (s, 3H, SCH3). Intermediate 3 7 and 3 8 a) [lR- (la, 3a Lu, 4 points, 4a; 5, 7 / ?, 7aa, 8ay5)] 8a-[[lS, 4R, 711, 911] -2,8-dioxo-4-ethyl-9-methyl-cis-bicyclo [3.4.0] -non-7-yl -Oxy-methyl]]-4-methyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (l-methylethyl)- l, 4-methylene-S-&gt; ^ 5 丨 pyridine-3a (lH) -carboxylic acid, diphenylmethyl ester b) [lR- (l «, 3ay9, 4/3, 4a ^, Ί β, laa, 8ay9)] 8a-[[lS, 4S, 7 feet, 911] -2,8-dioxo-4-ethyl-9-methyl-cis-bicyclo [3.4.0] -non -7-yl-oxy-methyl]]-4 -formyl-4,4a, 5,6,7,7a, 8,8 a -octazo-7 -methyl-3- (1-methyl Ethyl) -i, 4_ 亚Yl -s_ wail pyridazin Province _3a (iH) - betray acid, diphenyl ethyl ester of Intermediate 34 (1.04 g) in anhydrous toluene solution (50 mg) in a stream of argon within the gas back down for 1 hour. Add tributyltin hydride (0.55 ml) and a catalytic amount of azobis (isobutyronitrile). The reaction mixture was further refluxed for 20 minutes, then cooled, concentrated, and analyzed as a flash layer on silica gel twice, and washed away with hexane and hexane: ethyl acetate (94: 6). Intermediate 37 (220 mg; Rf = 0.27 in hexane: ethyl acetate 4: 1) was obtained as a white foam 'and intermediate 38 (444 mg; Rf = 0.27 in ethyl acetate: ethyl acetate 4: 1)) is white foam. ____- 96 -___ This paper scale is applicable to China Hoarding Standard (CNS) Λ4Μ (210X297mm) (please read the precautions on the back before filling in this page), 1T 7T7 printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (94) Intermediate 3 7 δ (^, CDC13): 9.75 (s, 1H, CHO), 7.45-7.26 (m, 10H, 2Ph), 6.99 (s, lH, CliPh2), 6.06 (dd , lH, H-2, J = 1.5 &amp;amp; 3.6</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz),4.50(dd，lH，H-7’，J=2.7&amp;amp;6.9Hz)，4.06&amp;amp;3.38(2dd， 2H，CH2-3’，J=8.4及7_5 Hz), 4.01 及3.65 (2d，2H，8a-CH2， J=9.0 Hz), 3.71 (dd，1H，Η-Γ, J=7.5及9.0 Hz), 3.34 (m，1H， H-91)，2.75 (t，1H，H-l)，0·93 (t，3H，C^3CH2, J=7.5 Hz)。 中間體3 8 (i (lU, CDC13): 9.74 (s, 1H, CHO), 7.45-7.26 (m, 10H, Ph2),6.99(s，lH，CiiPh2)，6.04(dd，lH，H-2，J=1.2&amp;amp;3.6 Hz), 4.73 (t, 1H, H-7', J-3.0 Hz), 3.92 (m, 2H, 8a-CH2(lH) 及CHj-SXlH))，3.75 (m，2H，H-9'&amp;amp;H-r),3.62(d,lH，8a-CH2, J=9.3 Hz), 3.48 (m, 1H, CH2-3'(1H)), 2.71 (t, 1H, H-l, J=3.6Hz)，2.55&amp;amp;2.23(2m，3H，H-4',H-5，&amp;amp;3-CH)，0.96(m， 3H，Cl3CH2)。 中間體39及40 [lR-(la，3ab，4b，4ab，7b,7aa，8ab)]8a-[[ 1 S，4R ,7R,9R]-2,8-二氧-4-(1-曱基乙基）-9-甲基-順式-雙環[3.4.0]-壬-7-基-氧基甲基）]-4-甲醯基-4,4a,5,6,7，7a，8,8 a -八氫-7-甲基-3-(1-甲基乙基）-1，4·亞曱基-S-吲噠省- 3a(lH)-叛酸’二苯基甲基醋及[lR-(la,3ab，4b,4ab，7b,7aa，8ab)]8a -[[1S，4S ,711，911]-2,8-二氧-4-(1-甲基乙基）-9-甲基-順 式-雙環[3.4.0]-壬-7-基-氧基曱基）]-4-曱醯基-4,4&amp;amp;，5,6,7,7纹，8,8&amp;amp;-八氮-7-甲基-3-(1-甲基乙基）-1，4- _ -97- 本紙張尺度適用中國國家梂準（CNS ) A4規格（210X297公釐） — i - I - - - ^ XI I I I - - - II----^ (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明（95 ) 亞甲基- S- Μ丨噠省- 3a(lH) -羧酸，二苯基甲基酯 將中間體3 6 (780毫克）於無水甲苯（50毫升）内之溶液用氬 氣去氣1小時，然後加熱至回流。加氫化三丁基錫（367微升） 及催化量的a，a ’ -偶氮異丁赌，並將反應混合物回流2小時 ，然後冷卻至室溫。除去溶劑，殘餘物作閃色層分析（二氧 化矽膠，己烷：醋酸乙酯25: 1，20: 1，18: 1，及15: 1)，製得280毫克中間體39(產出率41%)及300毫克中間體 40(產出率44%)，爲油體（分另ij爲Rf : 0,5及0.3，於己燒： 醋酸乙酯容積/容積3 : 1内）。 中間體3 9 ά (^, CDC13)： 9.75 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s, 1H，CHPh2), 6.05 (dd, 1H，H2, J=1.2及3.6 Hz), 4.57 (dd，1H, H7'，J=2.7及5.7 Hz)，4.05-3.90 (m，2H， H3，+8aCH2)，3.73 (dd，1H，ΗΓ, J=8.1 及9.3 Hz)，3.62 (d，1H， 8aCH2, J=9 Hz), 3.50-3.45 (m, 2H, H3'+H9'), 2.74 (t, 1H, H1，J=3.9Hz)。 中間體4 0 ^ 〇R, CDC13): 9.74 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s，1H，CHPh2)，6.03 (dd, 1H，H2, J=1.5及3.3 Hz)， 4.74 (t, 1H, H7', J=3 Hz), 4.0-3.8 (m, 8aCH2+H9'+H3,), 3.73 (dd，lH，Hr，J=3.3&amp;amp;4.5Hz)，3.63(d,lH，8aCH2，J=9.6Hz), 3.52 (dd，1H，H3'，J=8.1 及 10.5 Hz)，2.70 (t，1H，Hl，J=3.9 Hz)。 中間體4 1 -98 - 本紙張尺度適用中國圃家揉準（CNS ) A4规格（21〇Χ297公釐） (請先閲讀背面之注意事項再填寫本頁)</span>Hz), 4.50 (dd, lH, H-7 ', J = 2.7 &amp;amp; 6.9Hz), 4.06 &amp;amp; 3.38 (2dd, 2H, CH2-3', J = 8.4 and 7_5 Hz), 4.01 and 3.65 (2d , 2H, 8a-CH2, J = 9.0 Hz), 3.71 (dd, 1H, Η-Γ, J = 7.5 and 9.0 Hz), 3.34 (m, 1H, H-91), 2.75 (t, 1H, Hl) , 0 · 93 (t, 3H, C ^ 3CH2, J = 7.5 Hz). Intermediate 3 8 (i (lU, CDC13): 9.74 (s, 1H, CHO), 7.45-7.26 (m, 10H, Ph2), 6.99 (s, lH, CiiPh2), 6.04 (dd, lH, H-2 , J = 1.2 &amp;amp; 3.6 Hz), 4.73 (t, 1H, H-7 ', J-3.0 Hz), 3.92 (m, 2H, 8a-CH2 (lH) and CHj-SXlH)), 3.75 (m, 2H, H-9 '&amp;amp; Hr), 3.62 (d, lH, 8a-CH2, J = 9.3 Hz), 3.48 (m, 1H, CH2-3' (1H)), 2.71 (t, 1H, Hl, J = 3.6Hz), 2.55 &amp;amp; 2.23 (2m, 3H, H-4 ', H-5, &amp;amp; 3-CH), 0.96 (m, 3H, Cl3CH2). Intermediates 39 and 40 [lR- (la, 3ab, 4b, 4ab, 7b, 7aa, 8ab)] 8a-[[1 S, 4R, 7R, 9R] -2,8-diox-4- (1- Methyl ethyl) -9-methyl-cis-bicyclo [3.4.0] -non-7-yl-oxymethyl)]-4-carboxamide-4,4a, 5,6,7, 7a, 8,8 a -octahydro-7-methyl-3- (1-methylethyl) -1,4 · methylidene-S-indazole province-3a (lH) -tetioic acid'diphenyl Methyl vinegar and [lR- (la, 3ab, 4b, 4ab, 7b, 7aa, 8ab)] 8a-[[1S, 4S, 711, 911] -2,8-diox-4- (1-methyl Ethyl) -9-methyl-cis-bicyclo [3.4.0] -non-7-yl-oxymethyl)]-4-methyl-4,4 &amp;amp;, 5,6,7, 7 lines, 8,8 &amp;amp; -octazo-7-methyl-3- (1-methylethyl) -1,4- _ -97- This paper scale is applicable to China National Standards (CNS) A4 specification (210X297 Mm) — i-I---^ XI III---II ---- ^ (please read the precautions on the back before filling this page) A7 B7 printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs Description (95) Methylene-S-M | Da Province-3a (lH) -carboxylic acid, diphenylmethyl ester. A solution of intermediate 3 6 (780 mg) in anhydrous toluene (50 ml) was treated with argon Degassed for 1 hour, then heated to reflux. Tributyltin hydride (367 microliters) and a catalytic amount of a, a ’-azoisobutyl are added, and the reaction mixture is refluxed for 2 hours, and then cooled to room temperature. The solvent was removed and the residue was analyzed by flash chromatography (silica dioxide, hexane: ethyl acetate 25: 1, 20: 1, 18: 1, and 15: 1) to obtain 280 mg of intermediate 39 (yield rate) 41%) and 300 mg of intermediate 40 (yield rate 44%), which is an oil body (divided ij is Rf: 0,5 and 0.3, in hexane: volume of ethyl acetate volume / volume 3: 1). Intermediate 3 9 ά (^, CDC13): 9.75 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s, 1H, CHPh2), 6.05 (dd, 1H, H2, J = 1.2 and 3.6 Hz), 4.57 (dd, 1H, H7 ', J = 2.7 and 5.7 Hz), 4.05-3.90 (m, 2H, H3, + 8aCH2), 3.73 (dd, 1H, HΓ, J = 8.1 and 9.3 Hz), 3.62 (d, 1H, 8aCH2, J = 9 Hz), 3.50-3.45 (m, 2H, H3 '+ H9'), 2.74 (t, 1H, H1, J = 3.9Hz). Intermediate 4 0 ^ 〇R, CDC13): 9.74 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s, 1H, CHPh2), 6.03 (dd, 1H, H2, J = 1.5 and 3.3 Hz), 4.74 (t, 1H, H7 ', J = 3 Hz), 4.0-3.8 (m, 8aCH2 + H9' + H3,), 3.73 (dd, lH, Hr, J = 3.3 &amp;amp; 4.5 Hz), 3.63 (d, lH, 8aCH2, J = 9.6Hz), 3.52 (dd, 1H, H3 ', J = 8.1 and 10.5 Hz), 2.70 (t, 1H, Hl, J = 3.9 Hz). Intermediate 4 1 -98-This paper scale is suitable for China Pujia Rubbing Standard (CNS) A4 (21〇297mm) (please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T 經濟部中央標準局員工消費合作社印裝 3^1644 A7 ____B7 五、發明説明（96) [1R-(1 a，3a万，4/S，4a冷，7冷，7aa，8ay5 )]8a-[[lS，7R,9R]-2,8 -二氧-4-亞甲基-9-甲基·順式-雙環[340]·壬-7_基_ 氧基-甲基]]-4 -甲醯基-4,4a，5,6,7, 7a,8,8a -八氫-7-曱 基-3-(1-甲基乙基）-i，4-亞曱基-S_啕噠省_3a(lH)_羧酸 ，二苯基甲基酯 將中間體3 5 ( 1.02克）於無水甲苯（50毫克）内之溶液用氬 氣在回流下去氣1小時。加氫化三丁基錫（〇·55毫升）及催化 量的偶氮雙（異丁腈）。再將反應混合物回流丨小時，然後冷 卻’濃縮，再於二氧化矽膠上作閃色層分析二次，用己烷 及己燒：醋酸乙酯（94 : 6)作洗離劑。即製得純標題化合物 (380毫克），分離出者爲白色泡沫。 ά CDC13): 9.75 (s, 1H, CHO), 7.44-7.28(m, 10H, 2Ph), 6.99 (s, 1H, CHPh2), 6.05 (dd, 1H, H-2, J=1.5A3.6 Hz), 5.075.5.02 (2dd, 2H, Ci^^C, J=2.4^L4.8 Hz), 4.49-4.31 (m, 3H，H-71CH2-3')，3.95&amp;amp;3.66(2d，2H，8a-CH2，J=9.3Hz)， 3.80 (dd，1H，Η-Γ，J=7.5及9.3 Hz), 3.26 (m, 1H, H-9')，3.02 (m, 1H, H-5'), 2.76 (t, 1H, H-l, J=3.9 Hz) ； i (13C, CDC13): 204.4 (QHO)，171.0 (gp〇DPM)，148.8及 148.3 (C-3及C-41)， 139.5及 139.4 (2 CIV Ph), 130.7 (C-2), 128.6, 128.5, 128.2， 128.0，127.7&amp;amp;127.0(2x5£H(Ph))，103.9(gH2=C)，98.3 (C-7')，80.4及69_5 (C-l，及C_9'), 78.5 (CHPh2), 73.9及 70.6(C8a-f及C-31)。 中間體42</span>、 1T Printed and printed by the Employees ’Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 3 ^ 1644 A7 ____B7 V. Description of invention (96) [1R- (1 a, 3a ten thousand, 4 / S, 4a cold, 7 cold, 7aa, 8ay5)] 8a -[[lS, 7R, 9R] -2,8-dioxo-4-methylene-9-methyl · cis-bicyclo [340] · non-7_yl_oxy-methyl]]- 4 -Methyl-4,4a, 5,6,7, 7a, 8,8a -octahydro-7-methyl-3- (1-methylethyl) -i, 4-methylidene-S _ 啕 哒 省 _3a (lH) _carboxylic acid, diphenylmethyl ester A solution of intermediate 3 5 (1.02 g) in anhydrous toluene (50 mg) was degassed with argon for 1 hour at reflux. Add tributyltin hydride (0.55 ml) and a catalytic amount of azobis (isobutyronitrile). The reaction mixture was refluxed for another 1 hour, then cooled and concentrated, and then subjected to a flash layer analysis on silica gel twice, using hexane and hexane: ethyl acetate (94: 6) as the eluent. The pure title compound (380 mg) was prepared, and the white foam was isolated. ά CDC13): 9.75 (s, 1H, CHO), 7.44-7.28 (m, 10H, 2Ph), 6.99 (s, 1H, CHPh2), 6.05 (dd, 1H, H-2, J = 1.5A3.6 Hz ), 5.075.5.02 (2dd, 2H, Ci ^^ C, J = 2.4 ^ L4.8 Hz), 4.49-4.31 (m, 3H, H-71CH2-3 '), 3.95 &amp;amp; 3.66 (2d, 2H, 8a-CH2, J = 9.3Hz), 3.80 (dd, 1H, Η-Γ, J = 7.5 and 9.3 Hz), 3.26 (m, 1H, H-9 '), 3.02 (m, 1H, H-5' ), 2.76 (t, 1H, Hl, J = 3.9 Hz); i (13C, CDC13): 204.4 (QHO), 171.0 (gp〇DPM), 148.8 and 148.3 (C-3 and C-41), 139.5 and 139.4 (2 CIV Ph), 130.7 (C-2), 128.6, 128.5, 128.2, 128.0, 127.7 &amp;amp; 127.0 (2x5 £ H (Ph)), 103.9 (gH2 = C), 98.3 (C-7 '), 80.4 and 69_5 (Cl, and C_9 '), 78.5 (CHPh2), 73.9 and 70.6 (C8a-f and C-31). Intermediate 42</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[1R-(1 a ,3a卢，4点，4a/?，7y?，7aor，8ayS (請先閱讀背面之注意事項再填寫本頁)</span>[1R- (1 a, 3a Lu, 4 o'clock, 4a / ?, 7y ?, 7aor, 8ayS (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明（97) 2,8-二氧-9 -曱基-4-亞甲基-3 -氧基-順式-雙環[3.4.0] -壬 -7-基-氧基-甲基]]-4-甲醯基-4,43,5,6,7，7&amp;amp;，8,8&amp;amp;-八氫 -7 -甲基- 3- (1-曱基乙基）-1,4-亞甲基-S-吲健省- 3a(lH)-羧酸，二苯基甲基酯 於氧化鉻（VI)(0_23克）及無水吡啶（〇·37毫升）於無水二氣 甲烷（3毫升）内之攪拌過的溶液中於〇。〇加無水二氣甲烷（3 毫升）内的中間體4 1 ( 〇. 15克）。繼續於室溫授拌6小時，然 後直接將反應混合物於二氧化矽膠上作閃色層分析，用二 氣甲烷作洗離劑，製得標題化合物（65毫克），爲白色泡沫 〇 ^ (ΧΗ, CDC13)： 9.74 (s, 1H, CHO), 7.44-7.25 (m, 10H, 2Ph)，6.98(s，lH,C^y&amp;gt;h2),6.37&amp;amp;5.64(2d,2H，C||2=C)， 6.04 (dd，1H，H-2, J=1.2及3.3 Hz)，4.47 (dd，1H，H-7', J=3.6 及6.0 Hz)，4.29 (m,lH，H-l，），4.00及3.64 (2d, 2H, 8a-CH2, J=9.3 Hz), 3.40 (m, 1H, H-5'), 3.30 (m, 1H, H-9'), 2.73 (t, 1H, H-l, J=3.9 Hz)。 中間體43</span>A7 B7 printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 5. Description of the invention (97) 2,8-dioxo-9-methyl-4-methylene-3-oxy-cis-bicyclo [3.4.0 ] -Non-7-yl-oxy-methyl]]-4-carboxamide-4,43,5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-Methylethyl) -1,4-methylene-S-indjian-3a (lH) -carboxylic acid, diphenylmethyl ester in chromium oxide (VI) (0_23g) and anhydrous pyridine (〇.37 ml) in a stirred solution in anhydrous digas methane (3 ml) at 0. 〇Intermediate 4 1 (0.15 g) in anhydrous digas methane (3 mL) was added. Continue to stir at room temperature for 6 hours, and then directly analyze the reaction mixture on silica gel for flash layer analysis, and use difluoromethane as the eluent to prepare the title compound (65 mg) as a white foam. , CDC13): 9.74 (s, 1H, CHO), 7.44-7.25 (m, 10H, 2Ph), 6.98 (s, lH, C ^ y &amp;gt; h2), 6.37 &amp;amp; 5.64 (2d, 2H, C || 2 = C), 6.04 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.47 (dd, 1H, H-7 ', J = 3.6 and 6.0 Hz), 4.29 (m, lH, Hl,) , 4.00 and 3.64 (2d, 2H, 8a-CH2, J = 9.3 Hz), 3.40 (m, 1H, H-5 '), 3.30 (m, 1H, H-9'), 2.73 (t, 1H, Hl , J = 3.9 Hz). Intermediate 43</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[1R-(1 a，3a卢，4卢，4a卢，7y9 ,7aa，8a卢）]8a-[[lS,7R，9R]-2，8-二氧-9-甲基-4-氧基-順式-雙環[3.4.0] -壬-7-基-氧 基-曱基]]-4 -甲醯基-4,4a，5,6,7, 7a,8,8a -八氫-7 -甲基-3-(1-甲基乙基）-1,4 -亞甲基-S-Μ丨達省- 3a(lH) -羧酸，二 苯基甲基酯 方法A 於中間體41(105毫克）及N -氧化N_甲基嗎福啉（43毫克) -100- 本紙張尺度速用中國國家標準（CNS ) A4规格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁} 、11 經濟部中央標準局員工消費合作社印裝 A7 B7 五、發明説明（98) ~ 於丙網：水（8 : 1 ’ 9毫升）内之冰冷的混合物中加四氧化餓 (2/5 %重量比的於2-甲基-2-丙醇内的溶液，0.075毫升）。 除去冰浴，混合物於室溫攪拌2 4小時。用硫酸氫鈉使反應 停止’再挽拌1小時，蒸發去溶劑。粗製殘餘物以醋酸乙醋 (100毫升）稀釋’相繼用水(30毫升），1當量的鹽酸（3〇毫升）， 飽和碳酸氫鈉水溶液（30毫升）及水（30毫升）洗，然後乾燥 並蒸發。將粗製產物溶於二氧烷：水（2 : 1，6毫升）内，再 冷至0 °C。分小批加高碘酸鈉（0丨3克），將此混合物於〇 t 至室溫攪拌6小時，然後濃縮，粗製產物於（6〇毫升）及醋酸 乙酯（60毫升）間分開。將有機相乾燥並濃縮’所得殘餘物 於二氧化矽膠上作閃色層分析純化（己燒：醋酸乙酯85 : 15)，即製得標題化合物（0.045克）。</span>[1R- (1 a, 3a Lu, 4 Lu, 4a Lu, 7y9, 7aa, 8a Lu)] 8a-[[lS, 7R, 9R] -2, 8-diox-9-methyl-4-oxo -Cis-bicyclo [3.4.0] -non-7-yl-oxy-methyl]]-4 -carboxyl-4,4a, 5,6,7, 7a, 8,8a -octahydro -7-Methyl-3- (1-methylethyl) -1,4-methylene-S-M ~ Da province-3a (lH) -carboxylic acid, diphenylmethyl ester Method A in the middle Body 41 (105 mg) and N-oxidized N_methylmorpholine (43 mg) -100- This paper scale uses the Chinese National Standard (CNS) A4 specification (210X297 mm) (please read the notes on the back first Refill this page}, 11 Printed A7 B7 by the Employees ’Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs V. Description of the invention (98) ~ Yu Bingwang: add tetroxide to the ice-cold mixture in water (8: 1 ′ 9 ml) (2/5% by weight solution in 2-methyl-2-propanol, 0.075 ml). The ice bath was removed, and the mixture was stirred at room temperature for 24 hours. The reaction was stopped with sodium bisulfate and stirred again. After 1 hour, the solvent was evaporated. The crude residue was diluted with ethyl acetate (100 mL) 'successively with water (30 mL), 1 equivalent of hydrochloric acid (30 mL), saturated bicarbonate Wash with aqueous solution (30 ml) and water (30 ml), then dry and evaporate. Dissolve the crude product in dioxane: water (2: 1, 6 ml), then cool to 0 ° C. Raise in small batches Sodium iodate (0.3g), the mixture was stirred at 0 to room temperature for 6 hours, and then concentrated, the crude product was separated between (60ml) and ethyl acetate (60ml). The organic phase was dried and The residue obtained by concentration was analyzed and purified by flash chromatography on silica gel (hexane: ethyl acetate 85:15) to obtain the title compound (0.045 g).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">方法B 於三氟醋酸酐（0.43毫升）於無水二氣曱烷（2_5毫升）内之 溶液中於-60°C在氮氣下加二曱基亞颯（〇 22毫升），同時強 烈攪拌。10分鐘後，加中間體7 7(47〇毫克）於無水二氣曱 烷（2.5毫升）内之溶液，此混合物於_6〇〇c攪拌2小時。用 10分鐘以上時間滴加三乙基胺（1·4毫升），任溫度升至-2〇 °C。然後加水（20毫升），此混合物於室溫攪拌i小時。將混 合物分開，水層用二氣甲烷（1〇0毫升）萃取。合併之有機層 用1當量的鹽酸（100毫升），飽和碳酸氫鈉水溶液（1〇〇毫升） 及鹽水（100毫升）洗，於硫酸鎂上乾燥並濃縮至乾，得油體 ，此油體再溶於二氣甲烷内，用三乙基胺處理過夜。除去 溶劑，所得油體作閃色層分析（二氧化矽膠，醋酸乙酯：己 __ -101 - 本紙張尺度逋用中國國家揉準（CNS ) A4规格（210x297公釐）~~&amp;quot; ---~ (請先閱讀背面之注意事項再填寫本頁) 訂 ,I— m 經濟部中央橾準局貝工消費合作社印製 A7 _________B7 五、發明説明（99) ~—~' ~ 燒11 · 25 ’ 1 : 20，及1 : 15)，即製得400毫克標題化合物 (產出率8 6 % )。 ^ (lH，CDC13&amp;gt;: 9.71 (s, 1H, CHO), 7.44-7.26 (m, 10H, h), 6.97 (s, 1H, CHPh2), 6.06 (dd, 1H, H-2, J=1.5^L3.6 z)’ 4_18-4.11 (m，3H，H_7,，H1，及H 3，（ih)，糊及3 62 (2d， !H, 8a-CH2, J=9.3 Hz), 3.91 (d, 1H, H-3', J=18 Hz), 3.30 (m, 1H, H-9'), 2.85 (bt, 1H, H-5', J=7.8 Hz), 2.75 (t, 1H, H-l, J==3.9 Hz)。 土_§ 體 44 [1R-(1 a ,3a^ ,4^ ,4a^ ,7/9,7aa,8a/5)]8a-{[4-0-(&amp;gt;l^- 2 丁烯基）-6 -去氧_b_D_阿卓哌喃糖基氧基）甲基卜4-甲醯 基-4,4a，5,6,7,7a，8,8a-八氫·7 -甲基 _3·(1甲基乙基）- Μ-亞甲基-S-，健省-3a(1H)_羧酸，二苯基甲基酯 將中間體1(5克）及氧化二丁基錫（23克）於無水甲苯（3〇〇 毫升）内之懸浮液於裝有Dean_Stark冷凝器的燒瓶内於氮氣 下回流3小時，然後任其冷至6〇χ：。然後相繼加分子篩(4A ’粉）’巴豆基溴（2.4毫升）及氟化四丁基銨於四氫呋喃内 之1M的溶液（2.4毫升），此混合物於㈤^加熱丨小時，再置 於室溫1 2小時。蒸發溶劑至旄，殘餘物於二氧化矽膠上作 閃色層分析’用己烷至己烷：丙酮（9 : 1)洗離，製得標題 化合物（3.2克），爲白色泡沫。 (^, CDC13): 9.73 (s, 1H, CHO), 7.45-7.2 (m, 10H, 2Ph), 6.98 (s，1H，C达Ph2)，6.05 (dd，1H, H-2, J=1.5及3.6 Hz)， 5.8-5.65 (m, 1H, CH=CH), 5.65-5.5 (m, 1H, CH=CH), 4.63 -102- 本紙張尺度逍用中國國家揉準（CNS ) A4規格（21 OX 2.97公釐） (請先閱讀背面之注意事項再填寫本育)</span>Method B To a solution of trifluoroacetic anhydride (0.43 ml) in anhydrous dioxane (2-5 ml) was added dimethyl sulfoxide (0.2 ml) at -60 ° C under nitrogen with vigorous stirring. After 10 minutes, a solution of intermediate 7 7 (47 mg) in anhydrous dioxane (2.5 ml) was added, and the mixture was stirred at -600 ° C for 2 hours. Triethylamine (1.4 ml) was added dropwise over 10 minutes, and the temperature was allowed to rise to -20 ° C. Then water (20 ml) was added and the mixture was stirred at room temperature for 1 hour. The mixture was separated, and the aqueous layer was extracted with methane (100 ml). The combined organic layer was washed with 1 equivalent of hydrochloric acid (100 ml), saturated aqueous sodium bicarbonate solution (100 ml) and brine (100 ml), dried over magnesium sulfate and concentrated to dryness to obtain an oil body. Re-dissolve in methane and treat with triethylamine overnight. After removing the solvent, the resulting oil body was subjected to a flash layer analysis (silica dioxide, ethyl acetate: ___101)-The paper size is in accordance with the Chinese National Standard (CNS) A4 specification (210x297mm) ~~ &amp;quot;- -~ (Please read the precautions on the back before filling in this page). Ordered, I-m A7 _________B7 printed by the Beigong Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economic Affairs 5. Description of the invention (99) ~ — ~ '~ Burn 11 25 '1: 20, and 1: 15), that is, 400 mg of the title compound (yield 86%). ^ (lH, CDC13&gt;: 9.71 (s, 1H, CHO), 7.44-7.26 (m, 10H, h), 6.97 (s, 1H, CHPh2), 6.06 (dd, 1H, H-2, J = 1.5 ^ L3.6 z) '4_18-4.11 (m, 3H, H_7, H1, and H 3, (ih), paste and 3 62 (2d,! H, 8a-CH2, J = 9.3 Hz), 3.91 (d , 1H, H-3 ', J = 18 Hz), 3.30 (m, 1H, H-9'), 2.85 (bt, 1H, H-5 ', J = 7.8 Hz), 2.75 (t, 1H, Hl , J == 3.9 Hz). Soil_§ Body 44 [1R- (1 a, 3a ^, 4 ^, 4a ^, 7 / 9,7aa, 8a / 5)] 8a-{[4-0-(&amp;gt; l ^ -2 butenyl) -6-deoxy_b_D_azorpiperanosyloxy) methyl 4-methyl-4,4a, 5,6,7,7a, 8,8a -Octahydro · 7-methyl_3 · (1methylethyl) -M-methylene-S-, Jianshen-3a (1H) _carboxylic acid, diphenylmethyl ester will be intermediate 1 ( 5 g) and a suspension of dibutyltin oxide (23 g) in anhydrous toluene (300 mL) was refluxed under nitrogen for 3 hours in a flask equipped with a Dean_Stark condenser, and then allowed to cool to 60 × :. Then, molecular sieve (4A 'powder') crotonyl bromide (2.4 ml) and tetrabutylammonium fluoride in tetrahydrofuran in 1M solution (2.4 ml) were added successively. 12 hours. After the solvent was washed, the residue was analyzed by flash chromatography on silica gel, and washed away with hexane to hexane: acetone (9: 1) to obtain the title compound (3.2 g) as a white foam. (^, CDC13): 9.73 (s, 1H, CHO), 7.45-7.2 (m, 10H, 2Ph), 6.98 (s, 1H, C up to Ph2), 6.05 (dd, 1H, H-2, J = 1.5 and 3.6 Hz ), 5.8-5.65 (m, 1H, CH = CH), 5.65-5.5 (m, 1H, CH = CH), 4.63 -102- This paper scale is easy to use China National Standard (CNS) A4 specification (21 OX 2.97 Mm) (Please read the notes on the back before filling in this education)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IT 經濟部中央標準局員工消費合作社印製 A7 B7 _ 五、發明説明（1叫 (d，1Η，Η-Γ，J=〇.9 Hz), 4.2-3.8 (m，5H，H-2'，H-3', 8aCH2 及 0-CH2-C=C), 3.8-3.65 (m, 2H, H-5', 8aCHb), 3.6 (dd, 1H, Η·4'，J=3及9.3 Hz), 2.74 (t，1H, H-l, J=3.9 Hz)，1.71 (dd， 3H，CH3-C=C，J=1.2及6.3 Hz)。 中間禮45，46及47 a) [lR-(l a，3a卢，4卢，4a/3，7；S ,7aa，8a0 )]8a-{[2,3-脱水-4-0-(反式-2-丁晞基）-6-去氧-b-D-哌喃甘露糖基氧基]甲 基}-4-甲醯基-4,4&amp;amp;，5,6,7,7&amp;amp;,8,8&amp;amp;-八氫-7-甲基-3-(1-甲 基乙基）-1,4-亞甲基-S-β噠省-3a(lH)-羧酸，二苯基甲 基酯 b) [lR-(l^ ,3a^ ,Αβ Α^β ,Ί β ,Ί&amp;amp;α ,8a^ ) ] 8 a-[ (1 S, 4 S , 6S，7R，9R]-2,8-二氧·4-乙基-6-羥基-9-甲基-順式-雙環 [3.4.0] -壬-7-基-氧基-曱基]-4 -曱酿基-4,4a,5,6,7,7a， 8,8a -八氫-7-甲基- 3- (1-甲基乙基）-1,4 -亞甲基-s-啕噠省 -3a(lH)-羧酸，二苯基甲基酯 c) [ 1 R - (la，3ab，4b，4ab，7b，7aa，8ab) ]8a-[[lS，4R，6S，7R，9R] -2,8-二氧-4 -乙基-6 -經基-9 -甲基-順式-雙環[3.4.〇]-壬_ 7 -基-氧基-曱基]-4 -曱醯基-4,4a，5,6,7,7a，8,8a-八氫_ 7-甲基- 3- (1-甲基乙基）-l，4-亞甲基- S- 4丨達省- 3a(lH). 羧酸，二苯基甲基酯 將中間體44( 1.225克），三苯基膦（1.38克）及咪唑（〇36克） 於甲苯（35毫升）内回流，同時攪拌，然後用碘（〇· 89克）於 甲苯（15毫升）内之溶液一滴滴處理2小時。加碘化四丁基按 (0.2克），繼續回流1小時。將混合物冷卻，於酷酸乙醋 -103- 本紙張Λ度適用中國國家標準（CNS ) Α4规格（210X2.97公釐） (請先閲讀背面之注意事項再填寫本頁)</span>A7 B7 _ printed by the Staff Consumer Cooperative of the Central Bureau of Standards and Technology of the Ministry of Economy and Economics V. Description of the invention (1 is called (d, 1Η, Η-Γ, J = 0.9 Hz), 4.2-3.8 (m, 5H, H-2 ' , H-3 ', 8aCH2 and 0-CH2-C = C), 3.8-3.65 (m, 2H, H-5', 8aCHb), 3.6 (dd, 1H, Η · 4 ', J = 3 and 9.3 Hz ), 2.74 (t, 1H, Hl, J = 3.9 Hz), 1.71 (dd, 3H, CH3-C = C, J = 1.2 and 6.3 Hz). Middle ceremony 45, 46 and 47 a) [lR- (la , 3a Lu, 4 Lu, 4a / 3, 7; S, 7aa, 8a0)] 8a-{[2,3-anhydro-4-0- (trans-2-butanyl) -6-deoxy-bD- Piperanmannosyloxy] methyl} -4-carboxamide-4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1- Methylethyl) -1,4-methylene-S-βpyridine-3a (lH) -carboxylic acid, diphenylmethyl ester b) [lR- (l ^, 3a ^, Αβ Α ^ β , Ί β, Ί &amp;amp; α, 8a ^)] 8 a- [(1 S, 4 S, 6S, 7R, 9R] -2,8-dioxo · 4-ethyl-6-hydroxy-9-methyl -Cis-bicyclo [3.4.0] -non-7-yl-oxy-methyl] -4 -methyl-4,4a, 5,6,7,7a, 8,8a -octahydro-7 -Methyl-3- (1-methylethyl) -1,4-methylene-s-pyda-3a (lH) -carboxylic acid, diphenylmethyl ester c) [1 R-( la, 3ab, 4b, 4ab, 7b, 7aa, 8ab)] 8a-[[lS , 4R, 6S, 7R, 9R] -2,8-dioxo-4 -ethyl-6 -keto-9 -methyl-cis-bicyclo [3.4.〇] -non-7-yl-oxy -Methyl] -4 -Methylene-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4- Methylene-S-4 4 Da Da-3a (lH). Carboxylic acid, diphenylmethyl ester intermediate 44 (1.225g), triphenylphosphine (1.38g) and imidazole (〇36g) in Toluene (35 ml) was refluxed while stirring, and then treated with a solution of iodine (0.89 g) in toluene (15 ml) dropwise for 2 hours. Add tetrabutyl iodide (0.2 g) and continue to reflux for 1 hour. Cool the mixture to ethyl acetate -103- This paper is suitable for China National Standard (CNS) Α4 specifications (210X2.97mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標準局員工消費合作社印裂 A7 B7 五、發明説明（1(J1) (100毫升）及1當量的鹽酸水溶液（50毫升）間分開。有機層 相繼用1當量的鹽酸水溶液，水，焦亞硫酸鈉水溶液，水及 鹽水洗’然後乾燥（Na2S〇4) ’過遽並眞空濃縮。殘餘物於 二氧化矽膠上作閃色層分析。用己烷：醋酸乙酯（7 : 1}洗 離’製仔1.08克一種化合物的2 : 1混合物，此二化合物於 己虎：醋酸乙醋之比移値很相似（於己燒：醋酸乙醋4 : 1内 之Rf=0_4)。將此混合物溶於無水曱苯（25毫升）内，此溶 液以氬氣流去氣1小時，然後加熱至回流。加氫化三丁基錫 (0.36毫升），再繼續回流20分鐘。冷卻後加四氣化碳（2毫 升）’此溶液於室溫挽拌1小時。然後加琪於謎内之溶液至 形成帶有顏色。然後眞空除去溶劑，將殘餘物溶於乙醚内 ，用飽和氟化鉀水溶液洗幾次至不再見有氟化三丁基錫沉 澱。將有基層乾燥並蒸發，殘餘物於二氧化碎膠上作閃色 層分析二次’用二氣甲烷：醋酸乙酯（95 : 5)及（9 :丨）洗 離’製得標題化合物（a)中間體4 7 (230毫克，Rf=〇.8，二 氣曱烷：醋酸乙酯9 : 1)，標題化合物（b)中間體45(275毫 克’ Rf-0.5，一氣甲燒：醋酸乙醋9 : 1)及標題化合物（c) 中間體46(200毫克，Rf=〇.4，二氣甲烷：醋酸乙酯9 : 〇 中間體4 5 ^ (^, CDC13): 9.72 (s, 1H, CHO), 7.46-7.23 (m, 10H, 2Ph), 6·98 (s，1H, CHPh2)，6.05 (dd，1H, H-2, J=1.2及3·3</span>A7 B7 is printed by the employee consumer cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs. 5. Description of the invention (1 (J1) (100 ml) and 1 equivalent of hydrochloric acid aqueous solution (50 ml). The organic layer is successively used with 1 equivalent of hydrochloric acid aqueous solution, water, Sodium metabisulfite aqueous solution, washed with water and brine, then dried (Na2S〇4), concentrated over the air and emptied. The residue was analyzed by flash layer on silica gel. Wash off with hexane: ethyl acetate (7: 1) 'Made 1.08 g of a 2: 1 mixture of a compound, the two compounds are very similar in the ratio of the ratio of Jihu: ethyl acetate (Rf = 0_4 in Yuji: ethyl acetate 4: 1). This mixture Dissolved in anhydrous toluene (25 ml), the solution was degassed with argon flow for 1 hour, and then heated to reflux. Tributyltin hydride (0.36 ml) was added, and reflux was continued for another 20 minutes. After cooling, carbon tetrachloride (2 Ml) 'This solution was stirred at room temperature for 1 hour. Then add the solution of Qiqi in the mystery until it became colored. Then remove the solvent by emptying, dissolve the residue in diethyl ether, and wash it with saturated potassium fluoride solution several times until No more precipitation of tributyltin fluoride The base layer was dried and evaporated, and the residue was used as a flash layer for analysis on the crushed dioxide. The second compound was washed away with methane: ethyl acetate (95: 5) and (9: 丨) to prepare the title compound. (A) Intermediate 4 7 (230 mg, Rf = 0.8, dimethane: ethyl acetate 9: 1), the title compound (b) Intermediate 45 (275 mg 'Rf-0.5, methane: Ethyl acetate 9: 1) and the title compound (c) Intermediate 46 (200 mg, Rf = 0.4, Difluoromethane: ethyl acetate 9: 〇Intermediate 4 5 ^ (^, CDC13): 9.72 (s , 1H, CHO), 7.46-7.23 (m, 10H, 2Ph), 6.98 (s, 1H, CHPh2), 6.05 (dd, 1H, H-2, J = 1.2 and 3.3</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.61 (d, 1H, H-7', J=3.3 Hz), 4.03 (d, 1H, 8a-CHa, 卜9.3 Hz), 3.90 (dd，1H, Ha-3’，J=6.9及8.7 Hz)，3‘82_3.69 (m， _ -104- 本紙張尺度逍用中國國家榡準（CNS ) A4規格（210X297公釐） (锖先閱讀背面之注意事項再填寫本頁) 丁 經濟部中央樣準局貝工消費合作社印製 A7 B7 五、發明説明（1〇9 3H，H-6'，H-1'及H-9')，3.66 (d，1H，8a-CHb，J=9.6 Hz)，3.61 (dd，1H，Hb-3'，J=6.6及8.4 Hz)，2.69 (t，1H，H-l, J=3.9 Hz) o 中間體46 δ (^, CDC13): 9.74 (s, 1H, CHO), 7.45-7.22 (m, 10H, 2Ph)，6.99(s，lH，CiiPh2)，6.06(dd，lH，H-2，J=1.5&amp;amp;3.6 Hz), 4.50 (d, 1H，H-7'，J=2.1 Hz)，4.1-4.02 (m，2H，8aCHa&amp;amp; Ha-31)，3.84 (dd，1H，H-l’，J=7.5及8.7 Hz)，3.76-3.66 (m，2H， 8aCHb及H-6')，3.5-3.38 (m，2H，H-9,及Hb-3，），2.72 (t，1H， H-l，J=3.9 Hz), 〇_94 (t，3H，CH2-C^3, J=7.5 Hz)。 中間體4 7 ά (!η, CDC13)： 9.75 (s, 1H, CHO), 7.45-7.2 (m, 10H, 2Ph), 6.99(s,lH,CiiPh2)，6.08(dd，lH，H-2,J=1.5&amp;amp;3.6Hz), 5.85-5.7 (m, 1H, CH=CH), 5.65-5.5 (m, 1H, CH=CH), 4.67 (s, 1H，H-l’），4.2-4.05 (m，2H，OCHa-C=C&amp;amp;8aCHa),4.05_ 3.9 (m, 1H, 〇CHb-C=C), 3.78 (d, 1H, 8aCHb, J=9 Hz), 3.3-315 (m，3H, H-3'，H-4'及H-5’），3.12 (d，1H, H-2'，J=3.9 Hz)， 2.86 (t，1H，H-l，J=3.9 Hz)。 中間體4 8 HR-(1 a，3a/5，4々，4a点，7/?,7aα,8ay5)]8a-[(6-去氧-4-0 甲基-々-D-阿卓哌喃糖基氧基）甲基]-4-甲醯基-4,4a，5,6,7,7a，8,8a-八氫-7-甲基-3-(卜甲基乙基）-l，4-亞甲基-s_„5|噠省_3a(lH)_羧酸，二苯基甲基酯 將索達林（10.0克）於二氣甲烷（150毫升）内之溶液以二苯 ______-105-__ 本紙張尺度適用中國國家揉準（cNS) A4规格（ 21〇Χ297 公釐） (請先閲讀背面之注意事項再填寫本頁)</span>Hz), 4.61 (d, 1H, H-7 ', J = 3.3 Hz), 4.03 (d, 1H, 8a-CHa, Bu 9.3 Hz), 3.90 (dd, 1H, Ha-3', J = 6.9 and 8.7 Hz), 3'82_3.69 (m, _ -104- This paper scale is used in China National Standard (CNS) A4 specification (210X297mm) (Read the precautions on the back before filling out this page) Ding Economics A7 B7 printed by the Beigong Consumer Cooperative of the Central Prototype Bureau of the Ministry V. Description of the invention (1〇9 3H, H-6 ', H-1' and H-9 '), 3.66 (d, 1H, 8a-CHb, J = 9.6 Hz), 3.61 (dd, 1H, Hb-3 ', J = 6.6 and 8.4 Hz), 2.69 (t, 1H, Hl, J = 3.9 Hz) o Intermediate 46 δ (^, CDC13): 9.74 ( s, 1H, CHO), 7.45-7.22 (m, 10H, 2Ph), 6.99 (s, lH, CiiPh2), 6.06 (dd, lH, H-2, J = 1.5 &amp;amp; 3.6 Hz), 4.50 (d, 1H, H-7 ', J = 2.1 Hz), 4.1-4.02 (m, 2H, 8aCHa &amp;amp; Ha-31), 3.84 (dd, 1H, H-l', J = 7.5 and 8.7 Hz), 3.76-3.66 (m, 2H, 8aCHb and H-6 '), 3.5-3.38 (m, 2H, H-9, and Hb-3,), 2.72 (t, 1H, Hl, J = 3.9 Hz), 〇_94 ( t, 3H, CH2-C ^ 3, J = 7.5 Hz). Intermediate 4 7 ά (! η, CDC13): 9.75 (s, 1H, CHO), 7.45-7.2 (m, 10H, 2Ph), 6.99 ( s, lH, CiiPh2), 6.08 (dd, lH, H -2, J = 1.5 &amp;amp; 3.6Hz), 5.85-5.7 (m, 1H, CH = CH), 5.65-5.5 (m, 1H, CH = CH), 4.67 (s, 1H, H-l '), 4.2-4.05 (m, 2H, OCHa-C = C &amp; 8aCHa), 4.05_ 3.9 (m, 1H, 〇CHb-C = C), 3.78 (d, 1H, 8aCHb, J = 9 Hz), 3.3-315 (m, 3H, H-3 ', H-4' and H-5 '), 3.12 (d, 1H, H-2', J = 3.9 Hz), 2.86 (t, 1H, Hl, J = 3.9 Hz ). Intermediate 4 8 HR- (1 a, 3a / 5, 4々, 4a point, 7 / ?, 7aα, 8ay5)] 8a-[(6-deoxy-4-0 methyl-々-D-Azhuo Piperanosyloxy) methyl] -4-carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (bmethylethyl) -1 , 4-methylene-s_ „5 | pyridine_3a (lH) _carboxylic acid, diphenyl methyl ester ______- 105 -__ The paper size is applicable to the Chinese National Standard (cNS) A4 (21〇297297 mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 B7 321644 五、發明説明（103) 基二偶氮甲烷於二氣甲烷内之溶液（〇35M，85毫升）一滴 滴處理。將形成之溶液於室溫攪拌24小時。減壓下除去溶 劑，殘餘物於二氧化矽膠上作閃色層分析，用己烷：醋酸 乙酯（4 vl)及（2 : 1)洗離。合併各部分並蒸發，得標題化 合物（11.8克），爲白色泡沫。 ci CDC13): 10.00 (S, 1H, CHO), 7.63 (m, l〇H, 2Ph), 7.26 (s，1H, C||_Ph2)，6_30 (dd, 1H, H-2, J=1.2及3.3 Hz), 4.92 (d, 1H, H-l', J=〇.9 Hz), 4.84 (t, 1H, H-3', J=3.3 Hz), 4.035.4.35 (2d, 2H, 8aCH2, J=9 Hz), 3.88 (m, 1H, H-2'), 3.70 (dq, 1H, H-5', 1=6.3^9.3 Hz), 3.41 (s, 3H, 4'-〇Me), 3.20 (dd，1H, H-4'，J=3.3及9 Hz), 2.75 (t, 1H，H-l)。 中間體4 9 a) [lR-(l a，3a0，40，4ay5，7/?，7aa，8ay5 )]8a-[(6-去氧-4_ O -甲基- 2,3 -二-〇-曱苯績酿基-D -阿卓u展喃糖基氧基） 甲基]-4-甲醯基-4,4汪，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7-甲基-3-(1_ 甲基乙基）-1,4-亞曱基-s-&amp;lt;噠省-3a(lH)-羧酸，二苯基甲 基酯及 b) [lR-(l a，3a；S，4卢，4a々，7/?，7aa，8ayS )]8a-[(6-去氧-4- 〇 -曱基- 2- 0-曱苯績酿基-D -阿卓t»瓜喃糖基氧基）甲基]_ 4 -甲醯基-4,4&amp;amp;，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7-曱基-3-(1-甲基乙 基）-1，4-亞甲基-s-吲噠省-3a(lH)-羧酸，二苯基甲基酯 將中間體48(2克）與4 -二甲胺基吡啶（500毫克）溶於無水 叶匕淀（30毫升）内。滴加曱苯績酿氣（960毫克）於無水ϋ比咬 (20毫升）内之溶液。將此反應混合物於室溫攪拌4天。眞空 -106 本紙張尺度逋用中國圃家橾率&amp;lt; CNS ) Α4规格（210Χ297公釐） (請先閲讀背面之注$項再填寫本頁)</span>A7 B7 321644 V. Description of the invention (103) The solution (〇35M, 85 ml) of the base diazomethane in methane gas is treated drop by drop. The resulting solution was stirred at room temperature for 24 hours. The solvent was removed under reduced pressure, and the residue was subjected to flash chromatography on silica gel and washed away with hexane: ethyl acetate (4 vl) and (2: 1). The parts were combined and evaporated to give the title compound (11.8g) as a white foam. ci CDC13): 10.00 (S, 1H, CHO), 7.63 (m, l〇H, 2Ph), 7.26 (s, 1H, C | _Ph2), 6_30 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.92 (d, 1H, H-l ', J = 〇.9 Hz), 4.84 (t, 1H, H-3', J = 3.3 Hz), 4.035.4.35 (2d, 2H, 8aCH2, J = 9 Hz), 3.88 (m, 1H, H-2 '), 3.70 (dq, 1H, H-5', 1 = 6.3 ^ 9.3 Hz), 3.41 (s, 3H, 4'-〇Me), 3.20 (dd, 1H, H-4 ', J = 3.3 and 9 Hz), 2.75 (t, 1H, Hl). Intermediate 4 9 a) [lR- (la, 3a0, 40, 4ay5, 7 / ?, 7aa, 8ay5)] 8a-[(6-deoxy-4_O-methyl-2,3-di-〇- Toluoyl-D-Azzurol (anranoyloxy)) methyl] -4-carboxyl-4,4,5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro- 7-methyl-3- (1-methylethyl) -1,4-methylidene-s- &amp;lt; pyridine-3a (lH) -carboxylic acid, diphenylmethyl ester and b) [lR- (la, 3a; S, 4 Lu, 4a 々, 7 / ?, 7aa, 8ayS)] 8a-[(6-deoxy-4-〇-methyl- 2- 0-methylbenzene-based -D- Azur t »Guaranosyloxy) methyl] _ 4 -carboxamide-4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-indap-3a (lH) -carboxylic acid, diphenylmethyl ester intermediate 48 (2 g) and 4-dimethyl Aminopyridine (500 mg) was dissolved in anhydrous leaf dagger lake (30 ml). Add dropwise a solution of toluene gas (960 mg) in anhydrous bismuth (20 ml). The reaction mixture was stirred at room temperature for 4 days.眞 空 -106 The size of this paper is based on China's Pujiajiao rate &amp;lt; CNS) Α4 specification (210Χ297mm) (please read the note $ item on the back and fill in this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標準局員工消费合作社印裝 經濟部中央揉準局員工消費合作社印製 A7 _ B7 _ 五、發明説明（1叫 蒸發去溶劑，得黃色殘餘物，此殘餘物於二氧化矽膠拄上 作閃色層分析，用己烷：醋酸乙酯（4 : 1)及（1 : 1)洗離， 得標題化合物（a)，有較高Rf，爲白色泡沫（1.65克）及標題 化合物（b)，有較低Rf，亦爲白色泡沫（1.17克）。 (a) (ί (!Η, CDC13)： 9.71 (s, 1H, CHO), 7.85-7.91 (m, 4H, 正位-Ts)，7.26-7.41 (m，14H,間位 Ts 及 2Ph), 6.95 (s, 1H, C02CHPh2_)，5.87(dd，lH，H-2，J=1.2&amp;amp;3.3Hz)，4.92(dd， 1H，H-3，，J=3.3及4_2 Hz)，4.65 (dd，1H，H-21，J=1.2及4.5 Hz)， 4.61 (d, 1H，Η-Γ，J=1.2 Hz)，3.50及3·94 (2d, 2H，8aCH2， J=9 Hz)，3.68 (dq，1H, H_5'，J=6.6及9Hz)，3.16 (dd，1H，H-4’, J=3及9 Hz), 2.78 (s，3H，4'-OMe)，2.45及2_47 (2s，6H，2Ts) o (b) ci ([H，CDC13): 9.71 (s, 1H，CHO)，7.85 (m，2H，正位-</span>Printed by the Ministry of Economic Affairs, Central Bureau of Standards, Employee Consumer Cooperative Printed by the Ministry of Economic Affairs, Central Bureau of Standardization, Employee Cooperative, printed A7 _ B7 _ V. Description of the invention (1 called evaporation of the solvent to obtain a yellow residue, which is on silica gel. For flash layer analysis, wash away with hexane: ethyl acetate (4: 1) and (1: 1) to obtain the title compound (a), with higher Rf, as a white foam (1.65 g) and the title compound ( b), with lower Rf and white foam (1.17g). (a) (ί (! Η, CDC13): 9.71 (s, 1H, CHO), 7.85-7.91 (m, 4H, ortho-Ts ), 7.26-7.41 (m, 14H, meta Ts and 2Ph), 6.95 (s, 1H, C02CHPh2_), 5.87 (dd, lH, H-2, J = 1.2 &amp;amp; 3.3Hz), 4.92 (dd, 1H , H-3, J = 3.3 and 4_2 Hz), 4.65 (dd, 1H, H-21, J = 1.2 and 4.5 Hz), 4.61 (d, 1H, Η-Γ, J = 1.2 Hz), 3.50 and 3.94 (2d, 2H, 8aCH2, J = 9 Hz), 3.68 (dq, 1H, H_5 ', J = 6.6 and 9Hz), 3.16 (dd, 1H, H-4', J = 3 and 9 Hz) , 2.78 (s, 3H, 4'-OMe), 2.45 and 2_47 (2s, 6H, 2Ts) o (b) ci ([H, CDC13): 9.71 (s, 1H, CHO), 7.85 (m, 2H, Position-</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ts)，7.26-7.41 (m，12H,間位 Ts 及 2Ph)，6_95 (s，1H， C|iPh2)，5.87 (dd，1H，H-2, J=1.5&amp;amp;3.3Hz)，4.61(d，lH，H-Γ，J=1.5 Hz), 4.55 (dd，1H，H-21，J=1.2及4.2 Hz)，4.37 (m, 1H，H-3')，3.50及3.95 (2d，2H, 8aCH2, J=9 Hz)，3.70 (dq, 1H， H-5’，J=8.4及6.3Hz)，3.23 (dd, 1H，H-4'，J=3.3及8.7 Hz)， 2.42 (s, 3H,Ts) ° 中間體5 0 [1R-(1 a，3ay5，4点，4a万，7y5，7aa，8a/? )]8a-[(2,3-脱水-6-去氧-4-0 -甲基阿卓哌喃糖基氧基）甲基]-4 -甲醯基 -4，4a，5,6,7,7a，8,8a -八氫-7-甲基- 3- (1-甲基乙基）-1，4-亞甲基-s-嘀噠省-3a(lH)-羧酸，二苯基甲基酯 __-107-_ 本紙張尺度速用中國國家標準（CNS ) A4規格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁)</span>Ts), 7.26-7.41 (m, 12H, meta Ts and 2Ph), 6_95 (s, 1H, C | iPh2), 5.87 (dd, 1H, H-2, J = 1.5 &amp;amp; 3.3Hz), 4.61 ( d, lH, H-Γ, J = 1.5 Hz), 4.55 (dd, 1H, H-21, J = 1.2 and 4.2 Hz), 4.37 (m, 1H, H-3 '), 3.50 and 3.95 (2d, 2H, 8aCH2, J = 9 Hz), 3.70 (dq, 1H, H-5 ', J = 8.4 and 6.3Hz), 3.23 (dd, 1H, H-4', J = 3.3 and 8.7 Hz), 2.42 ( s, 3H, Ts) ° Intermediate 5 0 [1R- (1 a, 3ay5, 4 points, 4 million, 7y5, 7aa, 8a /?)] 8a-[(2,3-anhydro-6-deoxy- 4-0 -methylazorpiperanyloxy) methyl] -4 -carboxamide-4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3 -(1-methylethyl) -1,4-methylene-s-tida-3a (lH) -carboxylic acid, diphenylmethyl ester __- 107-_ This paper size is used in China National Standard (CNS) A4 specification (210X297mm) (Please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">五、 發明説明（10δ) A7 B7 經濟部中央橾準局員工消费合作社印装 將鈉（0.5克）加於〇°C的無水甲醇（5〇毫升）内，再加於爲 水二氣甲烷（20毫升）内之中間體49( 670毫克）。將此混合 物於室溫攪拌5天，於回流攪拌4天。將混合物過濾，除去 溶劑。以閃色層分析純化殘餘物，用己烷：醋酸乙酯（3 : i) 洗離，製得標題化合物（330毫克）。 (^, CDC13): 9.75 (s, 1H, CHO), 7.26-7.44 (m, 10H, 2Ph)，6.99 (s, 1H，C02CiiPh2)，6.08 (dd，1H，H-2, J=1.5及3 Hz), 4.68 (s, 1H, H-l'), 3.78-4.11 (2d, 2H, 8aCH2, J=9 Hz), 3.49 (s, 3H, 4'-OMe), 3.26 (d, 1H, H-2', J=3.9 Hz), 3.18 (m, 1H, H-5'), 3.12 (d, 1H, H-3', J=3.6 Hz), 3.08 (m, 1H, H-4'), 2.86 (m, 1H, Η-Γ)。 中間體5 1 [1R-(1 a，3a0，4卢，4a/5，7々，7aa，8ay9 )]8已-[(2,3-脱水_6_ 去氧-4-0 -甲基-々-D -別哌喃糖基氧基）甲基]_4_甲醯基· 4,4a，5,6,7,7a，8,8a-八氫-7-甲基-3-(1-甲基乙基4_ 亞曱基-s-吲噠省_3a(lH)_羧酸，二苯基曱基酯 將操水氮化納（25.9毫克）懸浮於無水二甲基甲酿胺（5毫 升）内。滴加於無水二曱基曱醯胺内之中間體49(b)(47〇毫 克），此混合物於室溫攪拌40分鐘。將此反應混合物在攪拌 下倒入冰冷的水（20毫升）内，形成的溶液以醋酸乙酷（3 X 20毫升）處理。合併有機層，於無水硫酸鎂上乾燥。經蒸發 後得膠樣殘餘物作閃柱色層分析純化，用己烷：醋酸乙酉旨 (5 : 1)洗離，製得標題化合物（332毫克），爲白色泡沐。 ^ On, CDC13): 9.73 (s, 1H, CHO), 7.26-7.44 (m, i〇Hj (請先閱讀背面之注意事項再填寫本頁) Λ 訂 — I -II - - -108 經濟部中央橾準局負工消费合作社印装 A7 __B7 五、發明説明（1〇6) 2Ph)，6.98 (s，1H，C02CHPh2)，6.08 (dd，1H，H-2, J=1.5及3 Hz)，4.60 (s，1H，Η-Γ)，3.76及4.03 (2d，2H，8aCH2, J=9.3 Hz)，3.51 (m，4H, H-4'及4'-OMe)，3.33 (m, 3H，H-2·，H-3'及 H-5，），2.80 (m，1H, H-l)。 中間體5 2 [1尺-(1«,3&amp;amp;冷，4点，4巳万，7/?，73〇?，8牡万）]8&amp;amp;-[(2,3_脱水-6-去氧-4-0-甲基-卢-D-阿卓哌喃糖基氧基）曱基]_4_甲醢基 -4,43,5,6,7,7巳，8,8&amp;amp;-八氫-7-曱基-3-(1-甲基乙基）-1，4-亞甲基-s-β噠省-3a(lH)-羧酸 於中間體51(100毫克）於醋酸乙酯（15毫升）内之溶液中在 氮氣下加10%鈀/碳（100毫克）。此混合物於帕爾裝置内在 1 5磅/吋2氫氣下於室溫搖動1小時。濾除催化劑，將溶劑 蒸發至乾。殘餘物於二氧化矽膠上作閃色層分析，用己燒 :醋酸乙酯（3 : 1)及二氣甲燒：曱醇（15 : 1)洗離。合併 適宜的部分，除去溶劑，製得標題化合物（7〇毫克），爲白 色泡沫。</span>V. Description of the invention (10δ) A7 B7 The Ministry of Economic Affairs Central Consortium Bureau Consumer Cooperative Printed Sodium (0.5 g) in anhydrous methanol (50 ml) at 0 ° C, and then added it as water digas methane ( 20 ml) of Intermediate 49 (670 mg). The mixture was stirred at room temperature for 5 days and at reflux for 4 days. The mixture was filtered to remove the solvent. The residue was purified by flash chromatography and washed with hexane: ethyl acetate (3: i) to obtain the title compound (330 mg). (^, CDC13): 9.75 (s, 1H, CHO), 7.26-7.44 (m, 10H, 2Ph), 6.99 (s, 1H, C02CiiPh2), 6.08 (dd, 1H, H-2, J = 1.5 and 3 Hz), 4.68 (s, 1H, H-l '), 3.78-4.11 (2d, 2H, 8aCH2, J = 9 Hz), 3.49 (s, 3H, 4'-OMe), 3.26 (d, 1H, H -2 ', J = 3.9 Hz), 3.18 (m, 1H, H-5'), 3.12 (d, 1H, H-3 ', J = 3.6 Hz), 3.08 (m, 1H, H-4') , 2.86 (m, 1H, Η-Γ). Intermediate 5 1 [1R- (1 a, 3a0, 4 Lu, 4a / 5, 7々, 7aa, 8ay9)] 8 has-[(2,3-anhydro_6_deoxy-4-0 -methyl- 々-D-piperidinosyloxy) methyl] _4_carboxamide · 4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1- Methylethyl 4_methylidene-s-indazole _3a (lH) _carboxylic acid, diphenylmethyl ester Suspended sodium nitrate (25.9 mg) in anhydrous dimethylmethylamine (5 Ml). Intermediate 49 (b) (47 mg) in anhydrous dimethylformamide was added dropwise, and the mixture was stirred at room temperature for 40 minutes. The reaction mixture was poured into ice-cold water with stirring ( 20 ml), the resulting solution was treated with ethyl acetate (3 X 20 ml). The organic layers were combined and dried over anhydrous magnesium sulfate. After evaporation, a gel-like residue was obtained and purified by flash chromatography, using hexane : Ethanol acetate (5: 1) washes away to obtain the title compound (332 mg) as white foam. ^ On, CDC13): 9.73 (s, 1H, CHO), 7.26-7.44 (m, i〇Hj (Please read the precautions on the back before filling in this page) Λ Order — I -II---108 Printed by the Ministry of Economic Affairs Central Cooperative Bureau Consumer Cooperative A7 __B7 5. Description of the invention (1〇6) 2Ph), 6.98 (s, 1H, C02CHPh2), 6.08 (dd, 1H, H-2, J = 1.5 and 3 Hz), 4.60 (s, 1H, Η-Γ), 3.76 and 4.03 (2d, 2H, 8aCH2, J = 9.3 Hz), 3.51 (m, 4H, H-4 'and 4'-OMe), 3.33 (m, 3H, H-2 ·, H-3' and H -5,), 2.80 (m, 1H, Hl). Intermediate 5 2 [1 foot- (1 «, 3 &amp;amp; cold, 4 o’clock, 4 million, 7 / ?, 73〇 ?, 8 million)) 8 &amp;amp;-[(2,3_dehydration-6-go Oxo-4-0-methyl-lu-D-azoroperanyloxy) methyl] _4_methanyl-4,43,5,6,7,7, 8,8 &amp;amp; -octa Hydrogen-7-methyl-3- (1-methylethyl) -1,4-methylene-s-β-pyridin-3a (lH) -carboxylic acid in intermediate 51 (100 mg) in ethyl acetate To a solution in the ester (15 ml) was added 10% palladium / carbon (100 mg) under nitrogen. This mixture was shaken in a Parr device under 15 psi hydrogen at room temperature for 1 hour. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was analyzed by flash layer on silica gel, washed away with hexane: ethyl acetate (3: 1) and two-gas methane: methanol (15: 1). The appropriate fractions were combined and the solvent was removed to prepare the title compound (70 mg) as a white foam.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">On, CDC13): 9.77 (s, 1H, CHO), 6.09 (dd, 1H, H-2, J=1.2&amp;amp;3.6Hz)，4.67(d，lH，H-l，，J=〇.9Hz),3.58&amp;amp;4.17(2d, 2H, 8aCH2, J=9.6 Hz), 3.51 (m, 4H, H-3'^L4'-OMe), 3.38 (m, 1H, H-S*), 3.34 (d, 1H, H-2', J=4.2 Hz), 3.30 (dd, 1H, H-4', J=9及 1.5 Hz), 2.65 (t, 1H，H-l, J=3.9 Hz)。 中間體5 3 [1R-(1 a，3a0，4y5，4a/? ,7/?，7aa ,8ay5 )]8a-[(4-0-烯丙基_ 6-去氧-々-D-阿卓哌喃糖基氧基）甲基]_4_甲醯基- _______ -109- 本紙張尺度逍用中關家揉準（CNS ) A视#· ( 210X297公釐) ' (請先閲讀背面之注意事項再填寫本頁)</span>On, CDC13): 9.77 (s, 1H, CHO), 6.09 (dd, 1H, H-2, J = 1.2 &amp;amp; 3.6Hz), 4.67 (d, lH, Hl, J = 〇.9Hz), 3.58 &amp;amp; 4.17 (2d, 2H, 8aCH2, J = 9.6 Hz), 3.51 (m, 4H, H-3 '^ L4'-OMe), 3.38 (m, 1H, HS *), 3.34 (d, 1H, H -2 ', J = 4.2 Hz), 3.30 (dd, 1H, H-4', J = 9 and 1.5 Hz), 2.65 (t, 1H, Hl, J = 3.9 Hz). Intermediate 5 3 [1R- (1 a, 3a0, 4y5, 4a / ?, 7 / ?, 7aa, 8ay5)) 8a-[(4-0-allyl-6-deoxy-々-D-A Drupranosyloxy) methyl] _4_formyl- _______ -109- This paper scale is easy to use Zhongguanjia rubbing standard (CNS) Ashi # · (210X297mm) '(Please read the back of the first (Notes and then fill this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 __B7 五、發明説明（1〇7) 4,4&amp;amp;，5,6,7,7江，8,8&amp;amp;-八氫-7-曱基_3-(1_甲基乙基）_1，4_ 亞甲基- s-θ丨哮省- 3a(lH) -叛酸，二苯基甲基醋 將中間體1(2克）及氧化二丁基錫（870毫克）於無水甲苯 (25毫升）内之懸浮液於裝有Dean-Stark冷凝器之燒瓶内在 氮氣下回流2小時，然後置於室溫。相繼加烯丙基溴（〇 3毫 升），及1M的氟化四丁基銨溶液（3.5毫升）再將此混合物於 40 °C在氮氣下加熱24小時。蒸發去溶劑至乾，殘餘物於二 氧化碎膠閃柱上作色層分析，用己燒：丙_(!〇 :1)及（9 :1)洗離，製得標題化合物（1.7克），爲白色泡沫。 d CDC13): 9.73 (s, 1H, CHO), 6.98 (s, 1H, CHPh2), 6·05 (dd, 1H, H-2, J=1.5及3.6 Hz)，5.89 (m, 1H， CH=CH2),5.25 (m, 2H, CH=CH2), 4.64 (d, 1H, H-l', J=1.5 Hz), 4.15 (t, 1H, H-3', J=3.3 Hz), 4.09 (m, 3H, Ci^-CH=CH2 及 ea-C^)，3.87 (m，1H，H-21)，3.74 (m，2H, H-5,及 Sa-Cl^)，3.38 (dd，1H，H-4' J=3.3及9 Hz)，2.74 (t，1H，H-l， J=3.9 Hz)。 中間體5 4 經濟部中央梂準局貝工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) [1R-(1 a，3a卢，4卢，4a点，7y5,7aα，8a；3)]8a-[(4-0-苄基-6-去氧-/3-D-阿卓哌喃糖基氧基）甲基]-4-甲醯基-4,4a，5,6,7,7a，8,8a-八氫-7-甲基-3-(l-甲基乙基）-l，4-亞甲基-s-峭噠省-3a(lH)-羧酸，二苯基甲基酯 將中間體1(6.0克）及氧化二丁基錫（3.55克）於無水甲苯 (2 5毫升）内之混合物強烈攪拌下於裝有Dean-Stark冷凝器 之燒瓶内在氮氣下回流3小時。將反應混合物冷至〇 °C，然 -110- 本紙張尺度逍用中國國家標準（CNS ) A4規格（210X297公釐） 經濟部中央梂率局負工消費合作社印製 A7 B7 五、發明説明（1〇8) 後以辛基溴（1.2毫升）及氟化四丁基銨溶液（1m的於四氩呋 喃内之溶液，1〇毫升）處理。於40。(：在氮氣下加熱18小時 後’將混合物作減壓濃縮，殘餘物作閃色層分析純化，用 己炫：醋酸乙酯（6 : 1)及（4 : 1)洗離，合併適宜部分，蒸 發去溶劑，製得標題化合物（3·73克），爲白色泡沫。 CDC13): 9.73 (s，1Η, CHO)，7.24-7.44 (m，15Η， 3Ph)，6.98 (s，1H，C02CHPh2), 6.05 (dd，1H，H-2, J=1.5及 3.6 Hz), 4.65 (d，1H，Η-Γ，J=1.2 Hz), 4·57 (AB 系統， 4OCH2Ph，J=U.i Hz), 4·21 (m，1H，H-3，），3.76及4.07 (2d, 2H, 8aCH2, J=9 Hz), 3.87 (m, 1H, H-2'), 3.76 (m, 1H, H-5'), 3.49 (dd，1H，H-4' J=3.3及9 Hz)，2.74 (t，1H, H-l，J=3.6 Hz) 0 中間體5 5 or ’3a/5 ’4/?，4a卢，70，7aor，8a々）]8a-[(2-0-苄氧羰 基-6-去氧-4-0·甲基_a_d_阿卓哌喃糖基氧基）曱基卜4_ 甲醯基-4,4a，5,6,7,7a，8,8a-八氫-7_甲基_3·(1_甲基乙基） -I，4-亞曱基-S4丨噠省_3a(1H)_羧酸，二苯基甲基酯 於中間體48(3毫莫耳）於無水二氣甲烷（15毫升）内之溶液 中於0C在氮氣下加4-二甲胺基吡啶（6 3毫莫耳）。攪拌b 分鐘後’將混合物冷至_2(rc，滴加苄基氣甲酸酯(3 6毫莫 耳）於無水二氣甲燒（1 5毫升）内之溶液。^小時後蒸發去溶 劑，殘餘物作閃色層分析純化，用己燒：醋酸乙醋（3 洗離’製得標題化合物（1·2克）。 (JH, CDC13): 9.70 (s, 1H, CHO), 7.35 (m, 15H, 3xPh), —______-111 - 本紙張尺度適财s®家料（CNS ) A4胁（21GX297公釐) -—— (請先閎讀背面之注意事項再填寫本頁&amp;gt;</span>A7 __B7 5. Description of the invention (1〇7) 4,4 &amp;amp; 5,6,7,7, 8,8 &amp;amp; -octahydro-7-methyl_3- (1_methylethyl) _1, 4_ methylene-s-θ 丨 shou province-3a (lH) -tetanoic acid, diphenylmethyl vinegar Intermediate 1 (2g) and dibutyltin oxide (870mg) in anhydrous toluene (25ml) The suspension was refluxed in a flask equipped with a Dean-Stark condenser under nitrogen for 2 hours, and then placed at room temperature. Allyl bromide (03 mL) was added successively, followed by 1M tetrabutylammonium fluoride solution (3.5 mL), and the mixture was heated at 40 ° C under nitrogen for 24 hours. The solvent was evaporated to dryness, and the residue was chromatographed on a silica gel flash column, which was washed away with hexane: propyl (! 〇: 1) and (9: 1) to obtain the title compound (1.7 g) , Is a white foam. d CDC13): 9.73 (s, 1H, CHO), 6.98 (s, 1H, CHPh2), 6.05 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 5.89 (m, 1H, CH = CH2), 5.25 (m, 2H, CH = CH2), 4.64 (d, 1H, H-l ', J = 1.5 Hz), 4.15 (t, 1H, H-3', J = 3.3 Hz), 4.09 ( m, 3H, Ci ^ -CH = CH2 and ea-C ^), 3.87 (m, 1H, H-21), 3.74 (m, 2H, H-5, and Sa-Cl ^), 3.38 (dd, 1H , H-4 'J = 3.3 and 9 Hz), 2.74 (t, 1H, Hl, J = 3.9 Hz). Intermediate 5 4 Printed by Beigong Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) [1R- (1 a, 3a Lu, 4 Lu, 4a points, 7y5, 7aα, 8a ; 3)] 8a-[(4-0-benzyl-6-deoxy- / 3-D-azorpiperanyloxy) methyl] -4-carboxamide-4,4a, 5, 6,7,7a, 8,8a-octahydro-7-methyl-3- (l-methylethyl) -l, 4-methylene-s-pyridine-3a (lH) -carboxylic acid , Diphenylmethyl ester The mixture of Intermediate 1 (6.0 g) and dibutyltin oxide (3.55 g) in anhydrous toluene (25 mL) was stirred vigorously in a flask equipped with a Dean-Stark condenser under nitrogen Reflux for 3 hours. The reaction mixture was cooled to 0 ° C, and then -110- the paper size was used in accordance with the Chinese National Standard (CNS) A4 specification (210X297 mm). The A7 B7 was printed by the Consumer Labor Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs. 1〇8) and then treated with octyl bromide (1.2 ml) and tetrabutylammonium fluoride solution (1 m in tetrahydrofuran, 10 ml).于 40. (: After heating under nitrogen for 18 hours, the mixture was concentrated under reduced pressure, and the residue was analyzed and purified by flash chromatography. It was washed away with ethyl acetate: ethyl acetate (6: 1) and (4: 1), and the appropriate parts were combined. , Evaporate the solvent to obtain the title compound (3.73g) as a white foam. CDC13): 9.73 (s, 1Η, CHO), 7.24-7.44 (m, 15Η, 3Ph), 6.98 (s, 1H, C02CHPh2 ), 6.05 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 4.65 (d, 1H, Η-Γ, J = 1.2 Hz), 4.57 (AB system, 4OCH2Ph, J = Ui Hz) , 4.21 (m, 1H, H-3,), 3.76 and 4.07 (2d, 2H, 8aCH2, J = 9 Hz), 3.87 (m, 1H, H-2 '), 3.76 (m, 1H, H -5 '), 3.49 (dd, 1H, H-4' J = 3.3 and 9 Hz), 2.74 (t, 1H, Hl, J = 3.6 Hz) 0 Intermediate 5 5 or '3a / 5' 4 /? , 4a Lu, 70, 7aor, 8a々)] 8a-[(2-0-benzyloxycarbonyl-6-deoxy-4-0 · methyl_a_d_azorpiperanosyloxy) methyl 4_ Methyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7_methyl_3 · (1_methylethyl) -I, 4-methylidene-S4 丨Dasheng_3a (1H) _carboxylic acid, diphenylmethyl ester in a solution of intermediate 48 (3 millimoles) in anhydrous digas methane (15 ml) at 0C Add 4-dimethylaminopyridine (63 mmol) under nitrogen. After stirring for b minutes, the mixture was cooled to _2 (rc, and a solution of benzyl gas formate (36 mmol) in anhydrous two-gas methane (15 ml) was added dropwise. After ^ hours, the solvent was evaporated The residue was analyzed and purified by flash chromatography, using hexane: ethyl acetate (3 washed away) to prepare the title compound (1.2 g). (JH, CDC13): 9.70 (s, 1H, CHO), 7.35 ( m, 15H, 3xPh), —______- 111-This paper size is suitable for s® home materials (CNS) A4 threat (21GX297mm) -—— (please read the precautions on the back before filling this page &amp;gt;</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央梯準局員工消费合作社印裝 A7 B7 -------^ 五、發明説明（1Q9) 6.96 (s，1H，C|i_Ph2)，5.99 (dd，1H，H-2, J=l_5及3.6 Hz)， 5.18 (AB系統，2H，OC^Ph，J=12 Hz), 5.00 (dd，1H，Η·2'， J=1.5&amp;amp;4.2Hz),4.70(d，lH，H-l，，J=1.8Hz)，4.13(m，lH， H-3')，4.01 及3.66 (d，d，1H，1H, 8a-CH2, J=9 Hz)，3.75 (m， 1H，H-5·)，3·40 (s，3H, OMe)，3_17 (dd，1H, H-4, J=3.3及8.4 Hz), 2.62 (t, 1H, H-l, J=3.6 Hz), 2.43 (d, 1H, OH, J=2.4 Hz), 2.21 (m, 1H, CH(CH3)2) ° 中間體5 6 [1R-(1 a，3a/5 ,4^，4ay5，7y9，7aa ,8a/? )]8a-[(4 -稀丙基-2-0-苄氧羰基-6-去氧_々-D-阿卓哌喃糖基氧基）f基]-4 -甲 醯基-4,4&amp;amp;,5,6,7,7&amp;amp;，8,8&amp;amp;-八氫_7-甲基-3-(1-甲基乙基）_ 1,4-亞甲基-s-吲噠省-3a(lH)-羧酸，二苯基甲基酯 於中間體53(1.4克）於無水二氣甲烷（30毫升）内之溶液中 於〇°C加二甲胺基吡啶（513毫克），將此混合物攪拌1 5分鐘 。用15分鐘滴加苄基氣曱酸酯（0.35毫升）於無水二氣甲烷 (1 5毫升）内之溶液，並攪拌4小時。然後將此混合物以甲醇 (1毫升）及二氣甲烷（20毫升）稀釋，並用水、1當量鹽酸及 鹽水洗。有機層於硫酸鎂上乾燥，過濾並蒸發去溶劑至乾 。殘餘物作閃柱色層分析純化，用己烷：醋酸乙酯（7 : 1) 及（5 : 1)洗離，製得標題化合物（1.1克）。 ό (JH, CDC13)： 9.70 (s, 1H, CHO), 6.96 (s, 1H, CH^Ph2), 5.99(dd，lH，H-2，J=1.5&amp;amp;3.6Hz)，5.88(m，lH,C|i=CH2)， 5.20 (m, 4H, Ph-CI^-O, CH2-CH=CH2), 4.99 (dd, 1H, H-2', J=1.5及4.2 Hz)，4.70 (d，1H, Η-Γ, J=1.5 Hz)，4.12 (m, 1H, -112- 本紙張尺度適用中國國家標準（CNS ) A4规格（210X297公釐) f請先閲讀背面之注意本項再填寫本頁j 訂 經濟部中央標準局貝工消費合作社印製 A7 B7 __ 五、發明説明（110) H-3，)，4.03 (m，3H，（：ϋ2-(：Η=(：Η2 及H-Sa-C^)，3.76 (m，1H， H-3'), 3.64 (d, 1Η, ea-CI^, 8.7 Hz), 3.34 (dd, 1H, H-4', J=3.3及8.7 Hz)，2.61 (t, 1H, H-l，J=3.9 Hz)。 中間體5 7 [1R-(1 a，3a/3 ,40，4ay5，70，7aa，8a；3 )]8a-[(4-0 -字基- 2-〇-芊氧羰基-6-去氧-点-D-阿卓哌喃糖基氧基）甲基]-4-甲 酿基-4,4&amp;amp;，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7-甲基-3-(1-甲基乙基）· 1,4-亞甲基-s-，5丨噠省-3a(lH)-羧酸，二苯基曱基酯 於中間體54(3.7克）於無水二氣曱烷（25毫升）内之溶液中 於〇°C在氮氣下加4-二甲胺基吡啶（1.85克）。攪拌15分鐘後 ，將混合物冷至-20°C，滴加苄基氣甲酸酯（0.68毫升）於無 水二氣曱烷（1 〇毫升）内之溶液至以tu測出產物（己烷··醋 酸乙酯4 : 1)。然後蒸發去溶劑至乾，殘餘物作閃色層分析 純化，用己烷：醋酸乙酯（6 : 1)洗離，製得標題化合物 (1 · 2克），爲白色泡沫。 d Cn, CDC13): 9.70 (s, 1H, CHO), 7.26-7.42 (m, 20H, 4Ph)，6.96 (s, 1H, C02C|iPh2), 5.99 (dd，1H, H-2, J=1.2及 3.3 Hz), 5· 1 8 (AB 系統，I'-OCC^C^^Ph，J=12.3 Hz), 5.00 (dd，1H，H-2'，J=1.5及4.2 Hz)，4.71 (d, 1H，H-l'，J=1.5 Hz)， 4.56 (AB 系統，4-OCLPh，J=ll.l Hz), 4.15 (m，1H，H-3，）， 3.66&amp;amp;4.00(2d，2H,8aCH2，J=9Hz),3.81(dq,lH，H-5', J=6.6及9 Hz), 3.43 (dd, 1H, H-4, J=3.3及9 Hz), 2.60 (t, 1H, H-l，J=3.6 Hz)。 中間體5 8 -113- 本紙張尺度適用中國國家揉準（CNS ) A4規格（210X297公釐）~ ~ (請先閲讀背面之注意事項再填寫本頁) 訂 ? 經濟部中央標準局員工消费合作社印裝 A7 ------B7__ 五、發明説明（111) &amp;quot; -- HR-U » ’3ayS，4冷，4a点，7冷，7aor，8ay5 )]8a-[(2-0-苄氧幾 基-6-去氧-4-〇_甲基_3_〇_甲苯磺醯基·冷_D_阿卓哌喃糖 基氧基）曱基]·4_甲醯基-4,43,5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7-甲 基-3-(1-甲基乙基）·14·亞甲基s-m丨噠省_3a(1H)_羧酸 ，二苯基甲基酯 將中間體55 (3毫莫耳）及4-二甲胺基吡啶（5.1毫莫耳）於 操水一氣甲燒（60毫升）内之溶液用甲苯磺醯氣（45毫莫耳） 於無水二氣甲烷（2 〇毫升）内之溶液一滴滴處理。2 4小時後 ’蒸發去溶劑，殘餘物做閃色層分析純化，用己烷：醋酸 乙醋（5 : 1)洗離，製得標題化合物（1 8克）。 ά (lH&amp;gt; CDC13)： 9.70 (Sj 1H, CHO), 7.84A7.32 (d, m, 2H, 17H, Ar), 6.96 (s，1H, C^JPh2)，5.94 (dd，1H, H-2, J=1.5及 3.6 Hz)，5.17 (AB 系統，2H，OCLPh，J=12 Hz), 5.10 (m，1H, H-3’），4.88 (dd，1H，H-2，，J=3及5.4 Hz)，4.68 (d, 1H, H-l，， J=2.1 Hz)，3.97及3.63 (2d，2H，8a-CH2, J=9 Hz), 3·76 (dd, 1H，H-5'，J=6.3及8.1 Hz)，3.18 (dd，1H，H-4' J=3及8.1 Hz), 3.05 (s, 3H, OMe), 2.51 (t5 1H, H-l, J=3.6 Hz), 2.43 (s, 3H, CI^Ar), 2.01 (m, 1H, CH(CH3)2) 〇 中間體5 9 [1R-(1 a，3a0，4冷，4a；5 ,7/?，7aa，8a/5 )]8a-[(4-烯丙基-2-〇-爷氧羰基·6-去氧-3-0-甲苯磺醯基j-D-阿卓唤喃糖基 氧基）甲基]·4 -甲酿基_4,4a,5,6,7,7a，8,8a-八_fti-7·曱基-3-(l-甲基乙基）_l,4-亞甲基-s吲噠省_3a(lH)-羧酸，二 苯基甲基酯 ______-114- _ _ 本紙張尺度逍用中國國家標準（CNS ) Α4规格（210X297公釐） &amp;quot; (請先閲讀背面之注意事項再填寫本頁}</span>A7 B7 printed by the Employees Consumer Cooperative of the Central Escalation Bureau of the Ministry of Economic Affairs ------- ^ V. Description of Invention (1Q9) 6.96 (s, 1H, C | i_Ph2), 5.99 (dd, 1H, H-2, J = l_5 and 3.6 Hz), 5.18 (AB system, 2H, OC ^ Ph, J = 12 Hz), 5.00 (dd, 1H, H · 2 ', J = 1.5 &amp;amp; 4.2Hz), 4.70 (d, lH, Hl ,, J = 1.8Hz), 4.13 (m, lH, H-3 '), 4.01 and 3.66 (d, d, 1H, 1H, 8a-CH2, J = 9 Hz), 3.75 (m, 1H, H -5 ·), 3 · 40 (s, 3H, OMe), 3_17 (dd, 1H, H-4, J = 3.3 and 8.4 Hz), 2.62 (t, 1H, Hl, J = 3.6 Hz), 2.43 ( d, 1H, OH, J = 2.4 Hz), 2.21 (m, 1H, CH (CH3) 2) ° Intermediate 5 6 [1R- (1 a, 3a / 5, 4 ^, 4ay5, 7y9, 7aa, 8a /?)] 8a-[(4-dipropyl-2-0-benzyloxycarbonyl-6-deoxy_々-D-azorpiperanosyloxy) f]]-4-carboxyl- 4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro_7-methyl-3- (1-methylethyl) _ 1,4-methylene-s-indap Provincial-3a (lH) -carboxylic acid, diphenylmethyl ester in a solution of intermediate 53 (1.4 g) in anhydrous digas methane (30 ml) was added dimethylaminopyridine (513 mg ), The mixture was stirred for 15 minutes. A solution of benzyl carbamate (0.35 ml) in anhydrous digas methane (15 ml) was added dropwise over 15 minutes and stirred for 4 hours. This mixture was then diluted with methanol (1 ml) and dichloromethane (20 ml) and washed with water, 1 equivalent hydrochloric acid and brine. The organic layer was dried over magnesium sulfate, filtered and the solvent was evaporated to dryness. The residue was purified by flash column chromatography, and washed away with hexane: ethyl acetate (7: 1) and (5: 1) to obtain the title compound (1.1 g). ό (JH, CDC13): 9.70 (s, 1H, CHO), 6.96 (s, 1H, CH ^ Ph2), 5.99 (dd, lH, H-2, J = 1.5 &amp;amp; 3.6Hz), 5.88 (m, lH, C | i = CH2), 5.20 (m, 4H, Ph-CI ^ -O, CH2-CH = CH2), 4.99 (dd, 1H, H-2 ', J = 1.5 and 4.2 Hz), 4.70 ( d, 1H, Η-Γ, J = 1.5 Hz), 4.12 (m, 1H, -112- This paper scale is applicable to China National Standard (CNS) A4 specification (210X297mm) f Please read the back of this item first Fill in this page j Order A7 B7 printed by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy __ V. Description of Invention (110) H-3,), 4.03 (m, 3H, (: ϋ2- (: Η = (: Η2 and H-Sa-C ^), 3.76 (m, 1H, H-3 '), 3.64 (d, 1Η, ea-CI ^, 8.7 Hz), 3.34 (dd, 1H, H-4', J = 3.3 and 8.7 Hz), 2.61 (t, 1H, Hl, J = 3.9 Hz). Intermediate 5 7 [1R- (1 a, 3a / 3, 40, 4ay5, 70, 7aa, 8a; 3)] 8a-[( 4-0-character-2-〇-fluorenyloxycarbonyl-6-deoxy-dot-D-azorpiperanosyloxy) methyl] -4-methylbranyl-4,4 &amp;amp;, 5, 6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl), 1,4-methylene-s-, 5 da da province-3a (lH ) -Carboxylic acid, diphenyl methyl ester in intermediate 54 (3.7 g) in anhydrous dimethane 25 mL) was added 4-dimethylaminopyridine (1.85 g) under nitrogen at 0 ° C. After stirring for 15 minutes, the mixture was cooled to -20 ° C and benzyl gas formate was added dropwise ( 0.68 mL) in anhydrous dioxane (10 mL) until the product was detected by TU (hexane ·· ethyl acetate 4: 1). Then the solvent was evaporated to dryness and the residue was analyzed by flash chromatography Purify and wash off with hexane: ethyl acetate (6: 1) to obtain the title compound (1.2 g) as a white foam. D Cn, CDC13): 9.70 (s, 1H, CHO), 7.26-7.42 (m, 20H, 4Ph), 6.96 (s, 1H, C02C | iPh2), 5.99 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 5. 1 8 (AB system, I'-OCC ^ C ^^ Ph, J = 12.3 Hz), 5.00 (dd, 1H, H-2 ', J = 1.5 and 4.2 Hz), 4.71 (d, 1H, H-l', J = 1.5 Hz), 4.56 (AB System, 4-OCLPh, J = ll.l Hz), 4.15 (m, 1H, H-3,), 3.66 &amp;amp; 4.00 (2d, 2H, 8aCH2, J = 9Hz), 3.81 (dq, lH, H- 5 ', J = 6.6 and 9 Hz), 3.43 (dd, 1H, H-4, J = 3.3 and 9 Hz), 2.60 (t, 1H, Hl, J = 3.6 Hz). Intermediate 5 8 -113- This paper scale is applicable to China National Standard (CNS) A4 (210X297mm) ~ ~ (Please read the precautions on the back before filling out this page) Order? Employees Consumer Cooperative of Central Bureau of Standards, Ministry of Economic Affairs Printed A7 ------ B7__ 5. Description of the invention (111) &amp;quot;-HR-U »'3ayS, 4 cold, 4a point, 7 cold, 7aor, 8ay5)] 8a-[(2-0- Benzyloxycarbonyl-6-deoxy-4-〇_methyl_3_〇_toluenesulfonyl · cold_D_azorpiperanosyloxy) methyl] · 4_methylacyl-4 , 43,5,6,7,7 &amp;amp;, 8,8 &amp; -octahydro-7-methyl-3- (1-methylethyl) · 14 · methylene sm 丨 da province_3a (1H) _Carboxylic acid, diphenylmethyl ester. A solution of intermediate 55 (3 mmol) and 4-dimethylaminopyridine (5.1 mmol) in water and one gas methane (60 ml) was treated with toluenesulfonate A solution of distillate gas (45 millimoles) in anhydrous digas methane (20 ml) was treated dropwise. After 4 hours, the solvent was evaporated, and the residue was purified by flash chromatography and washed with hexane: ethyl acetate (5: 1) to obtain the title compound (18 g). ά (lH &amp;gt; CDC13): 9.70 (Sj 1H, CHO), 7.84A7.32 (d, m, 2H, 17H, Ar), 6.96 (s, 1H, C ^ JPh2), 5.94 (dd, 1H, H- 2, J = 1.5 and 3.6 Hz), 5.17 (AB system, 2H, OCLPh, J = 12 Hz), 5.10 (m, 1H, H-3 '), 4.88 (dd, 1H, H-2 ,, J = 3 and 5.4 Hz), 4.68 (d, 1H, Hl ,, J = 2.1 Hz), 3.97 and 3.63 (2d, 2H, 8a-CH2, J = 9 Hz), 3.76 (dd, 1H, H-5 ', J = 6.3 and 8.1 Hz), 3.18 (dd, 1H, H-4' J = 3 and 8.1 Hz), 3.05 (s, 3H, OMe), 2.51 (t5 1H, Hl, J = 3.6 Hz), 2.43 (s, 3H, CI ^ Ar), 2.01 (m, 1H, CH (CH3) 2) 〇Intermediate 5 9 [1R- (1 a, 3a0, 4 cold, 4a; 5, 7 / ?, 7aa, 8a / 5)] 8a-[(4-allyl-2-〇-yetoxycarbonyl · 6-deoxy-3-0-tosylsulfonyl jD- atrazolanoyloxy) methyl] · 4 -Methylamino_4,4a, 5,6,7,7a, 8,8a-octa_fti-7 · Methyl-3- (l-methylethyl) _l, 4-methylene- s indida province _3a (lH) -carboxylic acid, diphenylmethyl ester ______- 114- _ _ This paper scale uses Chinese National Standard (CNS) Α4 specifications (210X297 mm) &amp;quot; (please read first Note on the back then fill out this page}</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">321G44 A7 B7 五、發明説明（112) 經濟部中央橾準局貝工消費合作杜印製 於中間體56(1.1克）及二曱胺基吡啶（300毫克）於無水 氣甲烷（40毫升）内之溶液中滴加甲苯磺醯氣（400毫克）於無 水二氣甲烷（20毫升）内之溶液，此混合物於室溫攪拌3天。 蒸發去溶劑至乾，殘餘物於二氧化矽膠閃柱上作色層分析 ，用己烷：醋酸乙酯（9 : 1)及（6 : 1)洗離，製得標題化合 物（820毫克）。 ^ CDC13): 9.70 (s, 1H, CHO), 6.95 (s, 1H, CHPh2), 5.94 (dd, 1H, H-2, J=1.5^3.9 Hz), 5.61 (m, 1H, CH=CH2), 5.12 (m, 4H, Ph-C^-O, CH2-CH=CH2), 4.84 (dd, 1H, H-2', J=3&amp;amp;5_lHz),4.69(d，lH,H-r，J=1.8Hz)，3.96&amp;amp;3.63(2d， 2H, Sa-CH^, J=9.〇 Hz), 3.76 (m, 4H, H-3', CH=CH2), 3.38 (dd, 1H, H-4' J=3及8.1 Hz), 2.50 (t, 1H，H-l， J=3.9 Hz), 2.42 (s, 3H, Ci^Ph) 〇 中間體6 0 [lR-(lor,3ay3 ,4^，4a；9，7y5，7aa，8a/? )]8a-[(4-0 -爷氧碳 基-6-去氧-3-0-甲苯磺醯基_々-；□_阿卓哌喃糖基氧基）甲 基]-4 -甲酿基 _4,4&amp;amp;，5,6,7,7&amp;amp;，8,8压-八氫_7-曱基-3-(1-甲 基乙基）-1,4-亞甲基引噠省_3a(1H)_羧酸，二苯基甲基 酯 於中間體57(3.5克）及二甲胺基吡啶（1 3克）於無水二氣甲 烷（80毫升）内之溶液中滴加甲苯磺醯氣（2克）於無水二氣甲 烷（50毫升）内之溶液，此混合物於室溫攪拌3天。蒸發去溶 劑至乾，殘餘物於二氧化矽膠閃柱上作色層分析，用己烷 .醋酸乙醋（9 : 〇洗離’製得標題化合物（3.14克）。 二</span>321G44 A7 B7 V. Description of the invention (112) Printed by Intermediate Bureau of Economic Affairs of the Ministry of Economic Affairs, Shell Co., Ltd. is printed on intermediate 56 (1.1 g) and dimethylpyridine (300 mg) in anhydrous gas methane (40 ml) To the solution was added dropwise a solution of tosylate gas (400 mg) in anhydrous methane (20 ml), and the mixture was stirred at room temperature for 3 days. The solvent was evaporated to dryness, and the residue was analyzed by chromatography on a silica gel flash column, and washed away with hexane: ethyl acetate (9: 1) and (6: 1) to obtain the title compound (820 mg). ^ CDC13): 9.70 (s, 1H, CHO), 6.95 (s, 1H, CHPh2), 5.94 (dd, 1H, H-2, J = 1.5 ^ 3.9 Hz), 5.61 (m, 1H, CH = CH2) , 5.12 (m, 4H, Ph-C ^ -O, CH2-CH = CH2), 4.84 (dd, 1H, H-2 ', J = 3 &amp;amp; 5_lHz), 4.69 (d, lH, Hr, J = 1.8 Hz), 3.96 &amp;amp; 3.63 (2d, 2H, Sa-CH ^, J = 9.0 Hz), 3.76 (m, 4H, H-3 ', CH = CH2), 3.38 (dd, 1H, H-4 'J = 3 and 8.1 Hz), 2.50 (t, 1H, Hl, J = 3.9 Hz), 2.42 (s, 3H, Ci ^ Ph) 〇Intermediate 6 0 [lR- (lor, 3ay3, 4 ^, 4a ; 9,7y5,7aa, 8a /?)] 8a-[(4-0 -Esteroxycarbonyl-6-deoxy-3-0-tosylsulfonyl _々-; □ _Azetopranosyl Oxy) methyl] -4 -methyl _4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 pressure-octahydro_7-methyl-3- (1-methylethyl) -1,4-methylene lead pyridine_3a (1H) _carboxylic acid, diphenyl methyl ester in intermediate 57 (3.5 g) and dimethylaminopyridine (13 g) in anhydrous digas methane To the solution (80 ml) was added dropwise a solution of tosylate gas (2 g) in anhydrous digas methane (50 ml), and the mixture was stirred at room temperature for 3 days. The solvent was evaporated to dryness, and the residue was analyzed by chromatography on a silica gel flash column, and the title compound (3.14 g) was prepared by washing with hexane. Ethyl acetate (9: 〇).</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(請先閲讀背面之注意事項再填寫本頁)</span>(Please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T Τ ! 經濟部中央標準局員工消费合作社印裝 A7 ____B7_ 五、發明説明（113) ^ (^, CDC13): 9.70 (s, 1H, CHO), 6.95 (s, 1H, CHPh2), 5.95 (dd, 1H，H-2, J=1.2及3.3 Hz), 5.16 (m, 3H-Ph-C^-0， H-2')，4.93 (dd，1H, H-31，J=3及4_8 Hz)，4.71 (d, 1H，Η-Γ, J=1.8 Hz), 4.25 (AB 系統，2H, 0-CH2Ph，J=11.5 Hz), 3.96， 3.63 (2d，2H，8a-C^，J=9.0 Hz), 3.83 (m，1H，H-5’)，3-45 (dd，1H，H-4, J=3及8.4 Hz)，2-51 (t，1H，H-l，J=3.9 Hz), 2_35 (s, 3H，CH3-Ph)。 中間體6 1 [1R-(1 a，3a0，4卢，4a々，7卢，7aa，8a卢）]8a-[(6-去氧-4-0-甲基- 3- 0-甲苯磺醯基-々_d_阿卓哌喃糖基氧基）甲基]_4_ 甲醯基-4,4a，5,6,7,7a,8,8a-八氫-7 -曱基-3-(1-甲基乙基） -1，4-亞甲基-s·弓丨噠省_3a(1H)-羧酸，二苯基甲基酯 於中間體5 8(1.9毫莫耳）於醋酸乙酯（60毫升）内之溶液中 在氮氣下加10 %鈀/碳（1〇〇毫克）。此混合物於帕爾裝置内 在1 5磅/吋2氫氣下於室溫搖動1小時。濾除催化劑，此溶 液以0.35M的二苯基二偶氮曱烷（2〇毫升）處理。二小時後 將溶劑蒸發，殘餘物作閃色層分析純化，用己烷：醋酸乙 酯（3 : 1)洗離，製得標題化合物（1.3毫克）。 (M1!!，CDC13): 9.72 (s，1H，CHO)，7.85及7.32 (d，m，2H, 12H，Ar), 6.98 (s，1H，C|iPh2), 6.06 (dd，1H, H-2, J=1.2及 3.3 Hz)，4.84 (dd, 1H，H-3'，J=3及4.2 Hz)，4.64 (d, 1H，Η-Γ, J=1.5Hz),4.06&amp;amp;3.75(2d，2H，8a-CH2，J=9.3Hz),4.02(m， 1H，H_2')，3.70 (m 1H，H-5，），3.16 (dd, 1H，H-4，，J=3及9Hz)， 2.93 (s, 3H, OMe), 2.69 (t, 1H, H-l, J=3.9 Hz), 2.45 (s, 3H, _ -116- 本紙張从速财關家料（〔叫44胁（2丨〇&amp;gt;&amp;lt;297公釐) — (請先閱讀背面之注意事項再填寫本頁)</span>、 1T Τ! A7 ____B7_ printed by the Employees ’Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of the invention (113) ^ (^, CDC13): 9.70 (s, 1H, CHO), 6.95 (s, 1H, CHPh2), 5.95 ( dd, 1H, H-2, J = 1.2 and 3.3 Hz), 5.16 (m, 3H-Ph-C ^ -0, H-2 '), 4.93 (dd, 1H, H-31, J = 3 and 4_8 Hz), 4.71 (d, 1H, Η-Γ, J = 1.8 Hz), 4.25 (AB system, 2H, 0-CH2Ph, J = 11.5 Hz), 3.96, 3.63 (2d, 2H, 8a-C ^, J = 9.0 Hz), 3.83 (m, 1H, H-5 '), 3-45 (dd, 1H, H-4, J = 3 and 8.4 Hz), 2-51 (t, 1H, Hl, J = 3.9 Hz), 2_35 (s, 3H, CH3-Ph). Intermediate 6 1 [1R- (1a, 3a0, 4lu, 4a々, 7lu, 7aa, 8a lu)] 8a-[(6-deoxy-4-0-methyl-3-0-toluenesulfon Acetyl-々_d_azorpiperanosyloxy) methyl] _4_ methacryl-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s · gongda province_3a (1H) -carboxylic acid, diphenylmethyl ester at intermediate 58 (1.9 mmol) To a solution in ethyl acetate (60 ml) was added 10% palladium / carbon (100 mg) under nitrogen. This mixture was shaken in a Parr apparatus under 15 psi hydrogen at room temperature for 1 hour. The catalyst was filtered off, and the solution was treated with 0.35M diphenyldiazomethane (20 ml). After two hours, the solvent was evaporated, and the residue was purified by flash chromatography and washed with hexane: ethyl acetate (3: 1) to obtain the title compound (1.3 mg). (M1 !!, CDC13): 9.72 (s, 1H, CHO), 7.85 and 7.32 (d, m, 2H, 12H, Ar), 6.98 (s, 1H, C | iPh2), 6.06 (dd, 1H, H -2, J = 1.2 and 3.3 Hz), 4.84 (dd, 1H, H-3 ', J = 3 and 4.2 Hz), 4.64 (d, 1H, Η-Γ, J = 1.5Hz), 4.06 &amp;amp; 3.75 (2d, 2H, 8a-CH2, J = 9.3Hz), 4.02 (m, 1H, H_2 '), 3.70 (m 1H, H-5,), 3.16 (dd, 1H, H-4, J = 3 And 9Hz), 2.93 (s, 3H, OMe), 2.69 (t, 1H, Hl, J = 3.9 Hz), 2.45 (s, 3H, _ -116- 2 丨 〇 &amp;gt; &amp;lt; 297mm) — (Please read the precautions on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ltT 經濟部中央揉率局員工消费合作社印製 A7 B7 五、發明説明（ CILAr), 2.30 (d, 1H, OH, J=3 Hz), 2.23 (m, 1H, CH(CH3)2) o 中間體6 2 [1R-(1 or，3ay9，4y9，4ay5 ,7/9 ,7aa，8ay5 )]8a-[(6 -去氧- 4-0-丙基-3-甲苯磺醯基- -阿卓哝喃糖基氧基）甲基]-4 -曱 酿基-4，4a，5,6,7，7a，8,8 a-八氫-7 -甲基-3-(1-甲基乙基）-1,4-亞曱基_s-吲噠省_3a(lH)-羧酸，二苯基甲基酯 於中間體59(800毫克）於醋酸乙酯（200毫升）内之溶液中 在氮氣下加10%鈀/碳（300毫克）。此混合物於帕爾裝置内 在20磅/吋2氫氣下於室溫搖動1小時。濾除催化劑，將溶 劑蒸發至乾。殘餘物溶於二氣甲烷（5〇毫升）内，滴加 0.35M的二苯基二偶氮甲娱^6毫升）。此混合物於室溫挽拌 3小時。將溶劑蒸發，殘餘物於二氧化矽膠閃柱上作閃色層 分析，用己烷：醋酸乙酯（8 : 1)及（3 : 1)洗離，製得標題 化合物（630毫克）。</span>ltT A7 B7 printed by the Employee Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economy V. Description of invention (CILAr), 2.30 (d, 1H, OH, J = 3 Hz), 2.23 (m, 1H, CH (CH3) 2) o Intermediate Body 6 2 [1R- (1 or, 3ay9,4y9,4ay5, 7/9, 7aa, 8ay5)] 8a-[(6 -deoxy-4- 4-0-propyl-3-tosylsulfonyl- -A Zhuolanosyloxy) methyl] -4 -toluo-4,4a, 5,6,7,7a, 8,8 a-octahydro-7 -methyl-3- (1-methyl Ethyl) -1,4-methylidene_s-indap_3a (lH) -carboxylic acid, diphenylmethyl ester in intermediate 59 (800 mg) in ethyl acetate (200 ml) To the solution was added 10% palladium / carbon (300 mg) under nitrogen. This mixture was shaken in a Parr apparatus under 20 psi hydrogen at room temperature for 1 hour. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was dissolved in dichloromethane (50 mL), and 0.35 M diphenyl diazomethine (6 mL) was added dropwise. This mixture was stirred at room temperature for 3 hours. The solvent was evaporated, and the residue was subjected to flash chromatography on a silica gel flash column and washed away with hexane: ethyl acetate (8: 1) and (3: 1) to obtain the title compound (630 mg).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">On, CDC13): 9 72 (s&amp;gt; 1Η» CHO), 6.98 (s, 1H, CHPh2), 6.06(dd，lH，H-2，J=1.2^.3Hz)，4.84(dd,lH，H-2，，J=3&amp;amp; 4.2 Hz), 4.64 (d, 1H, Η-Γ, J=1.5 Hz)，4.05 (m，2H，H-3,及 H-8a-CH2), 3.73 (m, 2H, H-5’及H-8a-C|^)，3.29 (dd, 1H, H- 4'，J=2.7及9 Hz)，3.01 (t，2H，OC^CH/l·^，J=7 Hz)，2.68 (t，1H，H-l，J=3.9 Hz), 2.44 (s, 3H，p-Ts)。 中間體6 3 [1尺-(1«,3&amp;amp;々，4&amp;gt;9,4&amp;amp;；5,7;5,7&amp;amp;(^，83；5)]8&amp;amp;-[(4-0-芊基-6-去氧- 3- 0-甲苯磺醯基-卢-D-阿卓哌喃糖基氧基）曱基]_4_ -117 - 本紙張尺度逋用中國國家標準（CNS ) A4规格（210X297公釐） (請先閱讀背面之注意事項再填寫本頁) 訂 f ! 經濟部中央揉準局員工消費合作社印装 A7 B7 __ 五、發明説明（13 曱醯基-4,4&amp;amp;，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7-甲基-3-(1-甲基乙基） -1,4 -亞甲基- s-θ丨嚷省- 3a(lH) -叛酸 於中間體60( 1.0克）於醋酸乙酯（70毫升）内之溶液中在氮 氣下加10 %鈀/ (300毫克）。此混合物於帕爾裝置内在15 磅/吋2氫氣下於室溫搖動4小時。濾除催化劑，將溶劑蒸 發至乾。殘餘物於二氧化矽膠上作閃色層分析純化，用己 烷：醋酸乙酯（3 : 1)及（1 : 1)洗離。合併適宜部分，蒸發 去溶劑，製得標題化合物（530毫克）。</span>On, CDC13): 9 72 (s&gt; 1Η »CHO), 6.98 (s, 1H, CHPh2), 6.06 (dd, lH, H-2, J = 1.2 ^ .3Hz), 4.84 (dd, lH, H- 2, J = 3 &amp;amp; 4.2 Hz), 4.64 (d, 1H, Η-Γ, J = 1.5 Hz), 4.05 (m, 2H, H-3, and H-8a-CH2), 3.73 (m, 2H , H-5 'and H-8a-C | ^), 3.29 (dd, 1H, H-4', J = 2.7 and 9 Hz), 3.01 (t, 2H, OC ^ CH / l · ^, J = 7 Hz), 2.68 (t, 1H, Hl, J = 3.9 Hz), 2.44 (s, 3H, p-Ts). Intermediate 6 3 [1 ruler- (1 «, 3 &amp; 々, 4 &amp;gt; 9,4 &amp;amp;;5,7; 5,7 &amp;amp; (^, 83; 5)] 8 &amp;amp;-[(4-0-fluorenyl -6-deoxy- 3- 0-tosylsulfonyl-lu-D-azorpiperanosyloxy) methyl] _4_ -117-This paper scale uses the Chinese National Standard (CNS) A4 specification (210X297 Mm) (Please read the precautions on the back before filling out this page) Order f! Printed by the Ministry of Economic Affairs, Central Bureau of Accreditation and Employee Consumer Cooperatives A7 B7 __ 5. Description of the invention (13 曱 基 -4,4 &amp;amp;, 5, 6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) -1,4 -methylene-s-θ 丨 嚷 省-3a (lH) -Add a 10% palladium / (300 mg) antacid to a solution of Intermediate 60 (1.0 g) in ethyl acetate (70 mL) under nitrogen. This mixture is in a Parr unit under 15 psi hydrogen Shake at room temperature for 4 hours. Filter off the catalyst and evaporate the solvent to dryness. Purify the residue on silica gel by flash layer analysis and wash with hexane: ethyl acetate (3: 1) and (1: 1) Combine the appropriate fractions and evaporate the solvent to obtain the title compound (530 mg).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Oh，CDC13): 9.70 (s, 1H，CHO)，7.81 及7.10-7.30 (2m， 9H，Ts及Ph)，6.08 (dd, 1H，H-2, J=1.5及3.3 Hz)，4.91 (dd, 1H，H-3'，J=3.3及4.5 Hz)，4.68 (d，1H，Η-Γ，J=1.5 Hz)，4.12 (m，3H，Ci|2Pt^H-2')，4.06&amp;amp;3.64(2(i，2H，8aCli2，J=9.3 Hz), 3.46 (m, 1H, H-4'), 2.65 (m, 1H, H-l), 2.36(s, 3H, Ts) o 中間體6 4 [1R-(1 π，3a々，4 0，4a0，7々，7aa，8ay5 )]8a-[(2,3-脱水-6-去氧- 4- 0-曱基-々-D-ι»辰喃糖基氧基）曱基]_4_甲醯基-4,4a，5,6,7,7a，8,8a-八氫-7-甲基_3_(l_曱基乙基）-l，4-亞甲基-s-β噠省-3a(lH)-羧酸，二苯基甲基酯 將氫化鈉（3.2毫莫耳）於無水二甲基甲醯胺（6毫升）内之懸 浮液以中間體61(1.6毫莫耳）於無水二曱基甲醯胺（6毫升） 内之溶液處理。40分鐘後，加水：醋酸乙醋（1 : 1，60毫 升）。將有機相蒸發，殘餘物作閃色層分析純化，用己烷： 醋酸乙酯（4 : 1)洗離，製得標題化合物（96〇毫克），以質子 _ _____-118- _ 本紙張尺度適用家鮮（CNS ) A4*^M 21GX297公釐) (請先閲讀背面之注意事項再填寫本頁) -訂 Α! 經濟部中央樣準局貝工消费合作社印製 A7 B7 五、發明説明（116) NMR譜證實爲中間體50化合物。 中間體6 5 [1R-(1 a，3ay? ,4厶，4a/5，7々，7aa，8a；S )]8a-[(2,3-脱水-6-去乳-4-0-丙基-/5 -D-*1 泉喃糖基氧基）甲基]_4 -甲磁基-4,4a，5,6,7,7a，8,8a-八氫-7-甲基-3-(l-甲基乙基）-l,4-亞甲基-s-吲噠省-3a(lH)-羧酸，二苯基甲基酯 於氫化鈉（35毫克）於無水二甲基甲醯胺（1〇毫升）内之懸 浮液中滴加中間體62(600毫克）於無水二曱基甲酿胺（15毫 升）内之溶液。此混合物於室溫在氮氣下攪拌1小時，然後 以1當量氣化銨（50毫升）及醋酸乙酯（70毫升）處理。有機 層用水及鹽水洗，於無水硫酸鎂上乾燥。殘餘物於二氧化 矽閃柱上作色層分析，用己烷：醋酸乙酯（8 :丨）及（6 : i) 洗離’製得標題化合物（450毫克），爲白色泡沫。 (lU, CDC13): 9.75 (s, 1H, CHO), 6.99 (s, 1H, CHPH2), 6.08(dd,lH,H-2，J=1.5&amp;amp;4.8Hz)，4.68(s,lH，H-l')，4.ll&amp;amp; 3.79 (2d, 2H, 8a-CH2, J=9.0 Hz), 3.68 (m, 1H, H-5(), 3.45 (m，lH，H-4，），3.24&amp;amp;3.12(2d，2H，H-2'，H-3，，J=3.9Hz)， 3.19 (t, 2H, OCH2CH2CH3, J=7 Hz), 2.86 (t, 1H, H-l, J=3.9 Hz)。 中間體66 [111-(1«，3&amp;amp;/5,4々，4&amp;amp;；9,70，7&amp;amp;〇?，8&amp;amp;/3)]8&amp;amp;-[(6-去氧_3_〇- 甲苯磺醯基-々-D-阿卓哌喃糖基氧基）甲基]_4·甲酿基_ 4,4a,5,6,7,7a，8,8a-八氨-7-甲基- 3- (1-甲基乙基）·ι 4_ 亞甲基-s-吲噠省- 3a(lH)-羧酸 -119- 本紙張尺度適用中國國家標準（CNS ) A4规格（210X297公釐）一 -- ----------^------訂------〈_ (請先閲讀背面之注意事項再填寫本頁) A7 B7 五、發明説明（117) 於氫化瓶内的10%鈀/碳（800毫克）於醋酸乙酯（60毫升） 之懸浮液内在氮氣下加中間體60(1.0克）於醋酸乙酯（30毫 升）内之溶液及甲醇：1N鹽酸（3 : 1 ; 4毫升）的混合物。此 瓶於帕爾氫化裝置内於30磅/吋2氣壓下搖動18小時。將 反應混合物過濾’再將濾過物蒸發至乾。殘餘物於二氧化 矽膠上作閃色層分析純化，用二氣甲烷：甲醇（2〇 : 1)洗離 。合併適宜部分，蒸發去溶劑，製得標題化合物（380毫克） 〇 cM1H，CDCl3):9.70(s，lH，CHO)，7.84&amp;amp;7.38(2d，4H，Ts)， 6.06 (dd，1H，H-2, J=1.5及3.6 Hz)，4.75 (dd，1H，H-3'，J=3.3 &amp;amp;4.5Hz),4.61(d，lH,H-l'，J=1.2Hz)，4.05(d，lH,H-8aCH2a，J=9.3Hz)，3.92(dd，lH，H-2'，J=1.2&amp;amp;4.5Hz)，3.65 (m，3H，H-5'，H-4,及H-8aCH2b)，2.63 (m，1H，H-l)，2.46(s， 3H，Ts) 〇 中間體67 [lR-(l&amp;lt;ar，3a0，4/?，4a0，7冷，7aa，8a/? )]8a-[(2,3-脱水-6_ 去氧-冷-D-略喃甘露糖基氧基）甲基]_4_甲醯基_ 4,4已，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7_甲基-3-(1_甲基乙基）_1，4_ 經濟部中央橾準局貝工消費合作社印装 (請先閲讀背面之注意事項再填寫本頁) A I. 亞甲基-S-吲噠省-3a(lH)-羧酸，二苯基甲基酯 將中間體55(585毫克）於無水二氣甲烷（2〇毫升）内之溶液 用一苯基二偶氮甲烷於二氣甲烷内之紫色溶液（〇35 M; 8 毫升）處理。形成之溶液於室溫攪拌14小時。減壓除去溶劑 ，殘餘物於二氧化矽膠上作閃色層分析純化，用己烷：醋 酸乙酯（6 : 1)及（4 · 1)洗離。合併適宜部分，並蒸發，製 -120- 本紙張尺度適用中圉國家橾準（CNS ) A4規格（210X297公釐〉 321644 A7 B7 五、發明説明（118) 得標題化合物（764毫克），爲白色泡末。 e GH，CDC13): 9.75 (s，1H，CHO)，7.26-7.44 (m，10H， 2Ph)，7.00 (s，1H，C02C廷Ph2)，6.09 (dd, 1H，H-2, J=1.2及 3.6 Hz), 4.71 (s，1H，H-l’），3.79及4.12 (2d，2H，8aCH2， J=9.3 Hz), 3.63 (dd, 1H, H-4', J=5.7^8.7 Hz), 3.21 (m, 1H, H-5)，3.15A3.24(2d，2H，H-2^H-3，，J=3.6Hz)，2.86(t， 1H，H_l，J=3.9 Hz)。 中間體6 8 [lR-(la，3ay5，4/5，4a/5，7々，7aa，8a/9 )]8a-[(2,3-脱水- 4,6-二去氧-4_氟_/?-0-旅喃塔羅糖基氧基）甲基]_4_曱醯 基-4,4丑，5,6,7,7&amp;amp;，8,8已-八氫-7-甲基_3_(1_甲基乙基）_ 1，4-亞曱基-s-啕噠省-3a(lH)-羧酸，二苯基甲基酯 將中間體67(300毫克）於無水二氣甲烷（25毫升）内之溶液 用三氟化二乙胺基硫（0.16毫升）處理，所得混合物於室溫 攪拌過夜。將混合物冷至0°C，加甲醇（15毫升）使停止反應 ，然後鉀壓濃縮。殘餘物於二氧化矽膠上作閃色層分析純 化，用己烷：醋酸乙酯（6 : 1)及（4 : 1)洗離，得標題化合 物（160毫克）。 CDC13)： 9.73 (s, 1H, CHO), 7.45-7.26 (m, 10H, 2Ph), 6.98 (s，1H, CliPh2)，6.09 (dd，1H，H-2, J=1.5及3.9 Hz)，5_09 (d，1H，H-l’，J=l_5 Hz)，4.75及4‘58 (2dq，1H，H-5'， J5，F=48.6 Hz, J=6.6 Hz，J=3.9 Hz), 4.18及4.11(2d，1H, H-41, J4，F=23.1Hz，J=3.9Hz)，3.97&amp;amp;3.81(2d，2H，8aCH2,J=9.3 Hz),3.75&amp;amp;3.70(2m，2H，H-2m-3')，2.84(t，lH,H-l)。 __；_ -121 -__ 本紙張尺度適用中國國家揉率（CNS ) A4規格（210X297公釐） (請先閱讀背面之注意事項再填寫本頁}</span>Oh, CDC13): 9.70 (s, 1H, CHO), 7.81 and 7.10-7.30 (2m, 9H, Ts and Ph), 6.08 (dd, 1H, H-2, J = 1.5 and 3.3 Hz), 4.91 (dd , 1H, H-3 ', J = 3.3 and 4.5 Hz), 4.68 (d, 1H, Η-Γ, J = 1.5 Hz), 4.12 (m, 3H, Ci | 2Pt ^ H-2'), 4.06 &amp;amp;; 3.64 (2 (i, 2H, 8aCli2, J = 9.3 Hz), 3.46 (m, 1H, H-4 '), 2.65 (m, 1H, Hl), 2.36 (s, 3H, Ts) o Intermediate 6 4 [1R- (1 π, 3a々, 4 0, 4a0, 7々, 7aa, 8ay5)] 8a-[(2,3-anhydro-6-deoxy- 4- 0-methyl-々-D- ι »Chenranosyloxy) methyl] _4_carboxyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl_3_ (l_methylethyl ) -L, 4-methylene-s-βpyridine-3a (lH) -carboxylic acid, diphenylmethyl ester. Sodium hydride (3.2 mmol) in anhydrous dimethylformamide (6 ml) ) The suspension in was treated with a solution of intermediate 61 (1.6 mmol) in anhydrous dimethylformamide (6 mL). After 40 minutes, water: ethyl acetate (1: 1, 60 mL) was added. The organic phase was evaporated, and the residue was purified by flash chromatography, and washed away with hexane: ethyl acetate (4: 1) to obtain the title compound (96 mg), with protons _____- 118-_ This paper size is suitable for home fresh (CNS) A4 * ^ M 21GX297mm) (please read the notes on the back before filling in this page)-Order A! Printed A7 B7 by Beigong Consumer Cooperative, Central Bureau of Standards, Ministry of Economic Affairs Description of the invention (116) NMR spectrum confirmed intermediate 50 compound. Intermediate 6 5 [1R- (1 a, 3ay ?, 4 Si, 4a / 5, 7々, 7aa, 8a; S)] 8a-[(2,3-anhydro-6-delactated-4-0- Propyl- / 5 -D- * 1 glucopyranosyloxy) methyl] _4 -methoxy-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl- 3- (l-methylethyl) -l, 4-methylene-s-indap-3a (lH) -carboxylic acid, diphenylmethyl ester in sodium hydride (35 mg) in anhydrous dimethyl A solution of intermediate 62 (600 mg) in anhydrous dimethylmethylamine (15 ml) was added dropwise to the suspension in methylformamide (10 ml). The mixture was stirred at room temperature under nitrogen for 1 hour, and then treated with 1 equivalent of vaporized ammonium (50 ml) and ethyl acetate (70 ml). The organic layer was washed with water and brine, and dried over anhydrous magnesium sulfate. The residue was chromatographed on a silica flash column and washed away with hexane: ethyl acetate (8: 丨) and (6: i) to obtain the title compound (450 mg) as a white foam. (lU, CDC13): 9.75 (s, 1H, CHO), 6.99 (s, 1H, CHPH2), 6.08 (dd, lH, H-2, J = 1.5 &amp;amp; 4.8Hz), 4.68 (s, lH, H -l '), 4.ll &amp; 3.79 (2d, 2H, 8a-CH2, J = 9.0 Hz), 3.68 (m, 1H, H-5 (), 3.45 (m, lH, H-4,), 3.24 &amp;amp; 3.12 (2d, 2H, H-2 ', H-3 ,, J = 3.9Hz), 3.19 (t, 2H, OCH2CH2CH3, J = 7 Hz), 2.86 (t, 1H, Hl, J = 3.9 Hz ). Intermediate 66 [111- (1 «, 3 &amp;amp; / 5, 4々, 4 &amp;amp;; 9,70, 7 &amp;amp; 〇 ?, 8 &amp;amp; / 3)] 8 &amp;amp;-[(6-deoxy_3_ 〇-tosyl-々-D- azepinelpyranosyloxy) methyl] _4 · methylbrenyl_4,4a, 5,6,7,7a, 8,8a-octammine-7- Methyl- 3- (1-methylethyl) · ι 4_ methylene-s-indida-3a (lH) -carboxylic acid-119- This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297 Mm) 1 ----------- ^ ------ order ------ &lt;_ (please read the notes on the back before filling this page) A7 B7 5. Invention Instructions (117) In a suspension of 10% palladium / carbon (800 mg) in ethyl acetate (60 ml) in a hydrogenation flask, add intermediate 60 (1.0 g) in ethyl acetate (30 ml) under nitrogen Solution and methanol: 1N hydrochloric acid (3: 1; 4 mmol ). The bottle was shaken in a Parr hydrogenation unit at 30 psig for 18 hours. The reaction mixture was filtered and the filtrate was evaporated to dryness. The residue was purified by flash chromatography on silica gel , Washed off with difluoromethane: methanol (20: 1). Combine the appropriate fractions and evaporate the solvent to obtain the title compound (380 mg) 〇cM1H, CDCl3): 9.70 (s, lH, CHO), 7.84 7.38 (2d, 4H, Ts), 6.06 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 4.75 (dd, 1H, H-3 ', J = 3.3 &amp;amp; 4.5Hz), 4.61 (d , LH, H-l ', J = 1.2Hz), 4.05 (d, lH, H-8aCH2a, J = 9.3Hz), 3.92 (dd, lH, H-2', J = 1.2 &amp;amp; 4.5Hz), 3.65 (m, 3H, H-5 ', H-4, and H-8aCH2b), 2.63 (m, 1H, Hl), 2.46 (s, 3H, Ts) Intermediate 67 [lR- (l &amp;lt; ar, 3a0, 4 / ?, 4a0, 7 cold, 7aa, 8a /?)] 8a-[(2,3-anhydro-6_deoxy-cold-D-slightly mannosyloxy) methyl] _4_A Acetyl_4,4, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7_methyl-3- (1_methylethyl) _1,4_ Central Ministry of Economic Affairs Printed by industrial and consumer cooperatives (please read the notes on the back before filling out this page) A I. Methyl-S-indap-3a (lH) -carboxylic acid, diphenylmethyl ester A solution of intermediate 55 (585 mg) in anhydrous digas methane (20 mL) was used with monophenyl diacyl Treat the purple solution of nitrogen methane in two gas methane (〇35 M; 8 ml). The resulting solution was stirred at room temperature for 14 hours. The solvent was removed under reduced pressure, and the residue was analyzed and purified by flash chromatography on silica gel, and washed away with hexane: ethyl acetate (6: 1) and (4.1). Combine the appropriate parts and evaporate to make -120- This paper scale is applicable to China National Standards (CNS) A4 specifications (210X297mm&gt; 321644 A7 B7. V. Description of the invention (118) The title compound (764 mg) is obtained in white Bubbles. E GH, CDC13): 9.75 (s, 1H, CHO), 7.26-7.44 (m, 10H, 2Ph), 7.00 (s, 1H, C02C Ting Ph2), 6.09 (dd, 1H, H-2, J = 1.2 and 3.6 Hz), 4.71 (s, 1H, H-l '), 3.79 and 4.12 (2d, 2H, 8aCH2, J = 9.3 Hz), 3.63 (dd, 1H, H-4', J = 5.7 ^ 8.7 Hz), 3.21 (m, 1H, H-5), 3.15A3.24 (2d, 2H, H-2 ^ H-3 ,, J = 3.6Hz), 2.86 (t, 1H, H_l, J = 3.9 Hz). Intermediate 6 8 [lR- (la, 3ay5, 4/5, 4a / 5, 7々, 7aa, 8a / 9)] 8a-[(2,3-anhydro-4,6-dideoxy-4_ Fluorine _ /?-0-Loranotarosyloxy) methyl] _4_Methyl-4,4, 5,6,7,7 &amp; 8,8-octahydro-7-methyl Yl_3_ (1_methylethyl) _ 1,4-methylidene-s-pyridine-3a (lH) -carboxylic acid, diphenylmethyl ester intermediate 67 (300 mg) in anhydrous The solution in methane (25 ml) was treated with diethylaminosulfur trifluoride (0.16 ml), and the resulting mixture was stirred at room temperature overnight. The mixture was cooled to 0 ° C, methanol (15 ml) was added to stop the reaction, and then potassium pressure was concentrated. The residue was analyzed and purified on silica gel as a flash layer, and washed away with hexane: ethyl acetate (6: 1) and (4: 1) to obtain the title compound (160 mg). CDC13): 9.73 (s, 1H, CHO), 7.45-7.26 (m, 10H, 2Ph), 6.98 (s, 1H, CliPh2), 6.09 (dd, 1H, H-2, J = 1.5 and 3.9 Hz), 5_09 (d, 1H, H-l ', J = l_5 Hz), 4.75 and 4'58 (2dq, 1H, H-5', J5, F = 48.6 Hz, J = 6.6 Hz, J = 3.9 Hz), 4.18 and 4.11 (2d, 1H, H-41, J4, F = 23.1Hz, J = 3.9Hz), 3.97 &amp;amp; 3.81 (2d, 2H, 8aCH2, J = 9.3 Hz), 3.75 &amp;amp; 3.70 (2m, 2H , H-2m-3 '), 2.84 (t, lH, Hl). __; _ -121 -__ This paper scale is applicable to China National Crushing Rate (CNS) A4 specification (210X297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央樣準局貝工消费合作社印製 經濟部中央標準局員工消費合作社印裝 A7 B7___ 五、發明説明（119) 中間體6 9 [1R-(1 a，3a卢，4；5，4ayS，7y3，7aa，8a/? )]8a-[(2,3-脱水-6-去氧- 4- 0- (2 -甲氧基乙基）-々-D -哌喃甘露糖基氧基）甲基] -4 -甲醯基-4,4a, 5,6，7,7a，8,8a-八氫-7 -甲基-3-(1-甲基 乙基）-1，4-亞甲基-s-,5丨噠省-3a(lH)-羧酸，二苯基甲基酯 於氫化鈉（24毫克）於無水四氫呋喃（20毫升）内之懸浮液 中於0°C在氮氣下加中間體67(300毫克），並將此混合物攪 拌30分鐘。加2-溴乙基甲基醚（300毫克）及1當量碘化四丁 基銨（2毫升），此混合物於40 Ό加熱2天。用1當量的氣化 銨（10毫升）使反應停止，混合物以醋酸乙酯（30毫升）稀釋 。有機層用水及鹽水洗，於硫酸鎂上乾燥，蒸發去溶劑至 乾。殘餘物於二氧化矽閃柱上作色層分析，用己烷：醋酸 乙酯（5 : 1)洗離，製得標題化合物，爲無色油體。 δ CU, CDC13): 9·75 (s, 1H, CHO), 6.98 (s, 1H, CHPh2), 6.08 (dd, 1H, H-2, J=1.2及3.3 Hz)，4.67 (s, 1H, Η-Γ)，4.10及 3.78 (2d, 2H, J=9.0 Hz), 4.09-4.00 (m, 2H, H-4', H- 5'), 3.90-3.53 (m, 4H, OCi^ Ci^ OCH3), 3.40 (s, 3H, CH3〇CH2CH2)5 3.29^.3.11 (2d, 2H, H-3'^H-2'5 J=3.9^ 3.9Hz), 2.86 (t, 1H，H-l, J=3.7 Hz)。 中間趙7 0 [1R-(1 a ,3a/? ,4 卢，4a/? ,7y5，7aa ,8ay5 )]8a-[(2,3-脱水-6-去氧- 4-0-(2 -甲基丙-2-烯基）·点-D-哝喃甘露糖基氧基） 甲基]-4 -甲酿基- 4,4a，5.，6,7,7a,8,8a -八氫-7-甲基- 3- (1-甲基乙基）-l，4 -亞甲基-s -吲噠省- 3a(lH) -羧酸’二笨基甲 _-122-__________ 本紙張尺度適用中圃國家揉準（CNS ) A4规格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁)</span>Printed by the Central Sample Bureau of the Ministry of Economic Affairs Beigong Consumer Cooperative Printed by the Consumer Cooperative of the Central Standard Bureau of the Ministry of Economic Affairs A7 B7___ V. Description of the invention (119) Intermediate 6 9 , 7y3, 7aa, 8a /?)] 8a-[(2,3-anhydro-6-deoxy- 4- 0- (2-methoxyethyl) -々-D-piperanmannosyloxy ) Methyl] -4 -carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4- Methylene-s-, 5-da-3-3 (lH) -carboxylic acid, diphenylmethyl ester in a suspension of sodium hydride (24 mg) in anhydrous tetrahydrofuran (20 ml) at 0 ° C Intermediate 67 (300 mg) was added under nitrogen, and the mixture was stirred for 30 minutes. 2-Bromoethyl methyl ether (300 mg) and 1 equivalent of tetrabutylammonium iodide (2 ml) were added, and the mixture was heated at 40 Ό for 2 days. The reaction was stopped with 1 equivalent of vaporized ammonium (10 ml), and the mixture was diluted with ethyl acetate (30 ml). The organic layer was washed with water and brine, dried over magnesium sulfate, and the solvent was evaporated to dryness. The residue was analyzed by chromatography on a silica flash column and washed away with hexane: ethyl acetate (5: 1) to obtain the title compound as a colorless oil. δ CU, CDC13): 9.75 (s, 1H, CHO), 6.98 (s, 1H, CHPh2), 6.08 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.67 (s, 1H, Η-Γ), 4.10 and 3.78 (2d, 2H, J = 9.0 Hz), 4.09-4.00 (m, 2H, H-4 ', H- 5'), 3.90-3.53 (m, 4H, OCi ^ Ci ^ OCH3), 3.40 (s, 3H, CH3〇CH2CH2) 5 3.29 ^ .3.11 (2d, 2H, H-3 '^ H-2'5 J = 3.9 ^ 3.9Hz), 2.86 (t, 1H, Hl, J = 3.7 Hz). Intermediate Zhao 7 0 [1R- (1 a, 3a /?, 4 Lu, 4a /?, 7y5,7aa, 8ay5)] 8a-[(2,3-anhydro-6-deoxy-4-0- (2 -Methylprop-2-enyl) · dot-D-Nimranylmannosyloxy) methyl] -4 -methylbranyl-4,4a, 5., 6,7,7a, 8,8a- Octahydro-7-methyl-3- (1-methylethyl) -l, 4-methylene-s-indida-3a (lH) -carboxylic acid'dibenzylmethacrylate_-122 -__________ The size of this paper is suitable for Zhongpu National Abrasive (CNS) A4 specification (210X297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標準局貝工消費合作社印製 A7 B7 五、發明説明（12〇) 基酉旨 將中間體67(0.3毫莫耳），碳酸绝（〇3毫莫耳）及3_溴_2_ 甲基-丙晞（0.5毫莫耳）於無水二甲基甲醯胺（15毫升）内之 混合物於室溫攪拌三天。以乙醚（3〇毫升）稀釋後，此混合 物用水洗。蒸發去溶劑，殘餘物作閃色層分析純化，用己 烷：醋酸乙酯（4 : 1)作洗離劑，製得標題化合物（62毫克） 〇 cJ 〇B, CDC13)： 9.75 (s, 1H, CHO), 7.35 (m, 10H, 2xPh), 6.99 (s, 1H, CHPh2), 6.08 (dd, 1H, H-2, J=1.5^L3.6 Hz), 5.00及4.93 (m, m，1H，1H，CH2=C)，4_70(s，1H，H-l，），4.12 &amp;amp;3.79(2d,2H，8a-CH2，J=9.3Hz)，4.12&amp;amp;3.96(d，d，lH，lH, CH2〇, J=12 Hz), 3.26 (m, 3H, H-3', H-4'^LH-5'), 3.13 (d, 1H, H-2', J=3.9 Hz), 2.86 (t, 1H, H-l, J=3.9 Hz), 2.23 (m, 1H, CH(CH3)2) ° t間體7 1 [1 R-( 1 a，3a/? ,4/?，4a/5 ,7点，7aor，8a/? )] 8a-[(2,3 -脱水-6-去氧-4-0-(1-甲基乙基）羰基-卢-D-哌喃甘露糖基氧基）甲 基]-4 -甲醯基-4,4a, 5，6,7,7a, 8,8a -八氫-7-甲基-3-(1-甲 基乙基）-1，4 -亞曱基- s-，3丨噠省- 3a(lH) -羧酸，二苯基甲基 酯 於中間體67(160毫克）於無水二氣甲烷（5毫升）内之溶液 中加4 -二曱胺基吡啶（70毫克）及異丁醯氯（60微升）。此混 合物於室溫攪拌過夜，然後濃縮，得黃色油體，此油體於 二氧化矽閃柱上作色層分析，用己烷：醋酸乙酯（5 : 1)作 _ -123- 本紙張尺度逍用中國國家標準（CNS ) A4規格（210X297公釐） (锖先閲讀背面之注意事項再填寫本頁)</span>A7 B7 printed by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of the invention (12〇) Based on the purpose of the intermediate unit 67 (0.3 millimoles), carbonate (〇3 millimoles) and 3_ bromine_2_ A mixture of methyl-propionate (0.5 mmol) in anhydrous dimethylformamide (15 ml) was stirred at room temperature for three days. After dilution with ether (30 mL), the mixture was washed with water. The solvent was evaporated, and the residue was purified by flash chromatography. Using hexane: ethyl acetate (4: 1) as the eluent, the title compound (62 mg) was obtained (〇cJ 〇B, CDC13): 9.75 (s, 1H, CHO), 7.35 (m, 10H, 2xPh), 6.99 (s, 1H, CHPh2), 6.08 (dd, 1H, H-2, J = 1.5 ^ L3.6 Hz), 5.00 and 4.93 (m, m , 1H, 1H, CH2 = C), 4_70 (s, 1H, Hl,), 4.12 &amp;amp; 3.79 (2d, 2H, 8a-CH2, J = 9.3Hz), 4.12 &amp;amp; 3.96 (d, d, lH, lH, CH2〇, J = 12 Hz), 3.26 (m, 3H, H-3 ', H-4' ^ LH-5 '), 3.13 (d, 1H, H-2', J = 3.9 Hz), 2.86 (t, 1H, Hl, J = 3.9 Hz), 2.23 (m, 1H, CH (CH3) 2) ° t Interbody 7 1 [1 R- (1 a, 3a /?, 4 / ?, 4a / 5, 7 o'clock, 7aor, 8a /?)] 8a-[(2,3-anhydro-6-deoxy-4-0- (1-methylethyl) carbonyl-Lu-D-piperanmannosyl Oxy) methyl] -4 -carboxamide-4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3- (1-methylethyl) -1, 4-Methylidene-s-, 3-dipyridine-3a (lH) -carboxylic acid, diphenylmethyl ester was added to a solution of intermediate 67 (160 mg) in anhydrous digas methane (5 ml) 4-Dimethylpyridine (70 mg) and isobutyl chloride (60 μl). The mixture was stirred at room temperature overnight, and then concentrated to obtain a yellow oil body. This oil body was subjected to chromatography on a silica flash column, using hexane: ethyl acetate (5: 1) as _ -123- this paper For standard use, Chinese National Standard (CNS) A4 specification (210X297mm) (Read the precautions on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T 經濟部中央橾準局貝工消費合作社印製 A7 _____ B7 五、發明説明（121) 洗離劑’製得標題化合物（162毫克），爲白色泡沫。</span>1. Printed by the 1T Ministry of Economic Affairs, Central Bureau of Industry and Commerce, Beigong Consumer Cooperative A7 _____ B7 5. Description of Invention (121) Eluent ’The title compound (162 mg) was obtained as a white foam.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">On, CDCI3): 9.75 (s, 1H, CHO), 7.26-7.44 (m, l〇Hs 2Ph), 6.99 (s, 1H, CHPh2), 6.08 (dd, 1H, H-2), 5.75 (s, 1H, Η-Γ), 4.68 (d，1H，H-4，，J=9 Hz), 4.12 及3.80 (2d, 2H， 8aC^，J=9 Hz), 3.43 (dq，1H, H-5'，J=6.6及9 Hz)，3.15 (s， 2H，H-2’及H-3’），2.86 (m，1H，H-ll)，2.59 (m，1H，4，- OCOC|iMe2)。 中間體7 2 [1R-(1 a，3a/5，4卢，4a万，7y5，7aa，8a点）]8a-[(2,3-脱水-6-去氧- 4- 0- (2,2 -二甲基丙酿基）-卢-D-p底喃甘露糖基氧基） 曱基]-4-甲醯基-4,4&amp;amp;，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7-甲基-3-(1-甲基乙基）-1，4-亞甲基-s-啕噠省-3a(lH)-羧酸，二苯基甲 基酯 將中間體67(0.3毫莫耳）及4-二甲胺基吡啶（0·6毫莫耳） 於無水二氣甲烷（15毫升）内之混合物用新戊醯氣（0.45毫莫 耳）處理。2·5小時後，混合物以水洗。將有機相蒸發，殘 餘物作閃柱色層分析純化，用己烷：醋酸乙酯（5 : 1)作洗 離劑，製得標題化合物（190毫克）。 ^ (^, CDC13): 9.76 (s, 1H, CHO), 7.83 (m, 10H, 2xPh), 7_〇〇 (s，1H, C|£Ph2)，6.08 (dd, 1H，H-2, J=1.5及3.3 Hz), 4.77 (s，1H，Η-Γ)，4_67 (d，1H，H-41，J=9 Hz), 4.13及3-81 (d，d，1H，1H，8a-CH2, J=9 Hz), 3.43 (m, 1H，H-5’)，3.13 (m， 2H，H-2’及H-3'), 2.86 (t, 1H, H-l，J=3.9 Hz)，2.24 (m，1H， CH(CH3)2)〇 _____-124-________ 本紙張尺度適用中國國家標準（CNS ) A4规格（210X 297公嫠） (請先閲讀背面之注意事項再填寫本頁)</span>On, CDCI3): 9.75 (s, 1H, CHO), 7.26-7.44 (m, l〇Hs 2Ph), 6.99 (s, 1H, CHPh2), 6.08 (dd, 1H, H-2), 5.75 (s, 1H, Η-Γ), 4.68 (d, 1H, H-4 ,, J = 9 Hz), 4.12 and 3.80 (2d, 2H, 8aC ^, J = 9 Hz), 3.43 (dq, 1H, H-5 ', J = 6.6 and 9 Hz), 3.15 (s, 2H, H-2' and H-3 '), 2.86 (m, 1H, H-ll), 2.59 (m, 1H, 4,-OCOC | iMe2 ). Intermediate 7 2 [1R- (1 a, 3a / 5, 4 Lu, 4a million, 7y5, 7aa, 8a point)] 8a-[(2,3-anhydro-6-deoxy- 4- 0- (2 , 2-Dimethylpropanoyl) -Lu-Dp mannanosyloxy) methyl] -4-methylacyl-4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -Octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-pyda-3a (lH) -carboxylic acid, diphenylmethyl ester will be in the middle A mixture of body 67 (0.3 millimoles) and 4-dimethylaminopyridine (0.6 millimoles) in anhydrous digas methane (15 ml) was treated with neopentyl gas (0.45 millimoles). After 2.5 hours, the mixture was washed with water. The organic phase was evaporated, and the residue was purified by flash column chromatography, using hexane: ethyl acetate (5: 1) as the eluent to obtain the title compound (190 mg). ^ (^, CDC13): 9.76 (s, 1H, CHO), 7.83 (m, 10H, 2xPh), 7_〇〇 (s, 1H, C | £ Ph2), 6.08 (dd, 1H, H-2, J = 1.5 and 3.3 Hz), 4.77 (s, 1H, Η-Γ), 4_67 (d, 1H, H-41, J = 9 Hz), 4.13 and 3-81 (d, d, 1H, 1H, 8a -CH2, J = 9 Hz), 3.43 (m, 1H, H-5 '), 3.13 (m, 2H, H-2' and H-3 '), 2.86 (t, 1H, Hl, J = 3.9 Hz ), 2.24 (m, 1H, CH (CH3) 2) 〇 _____- 124 -________ This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X 297 public daughter) (please read the notes on the back before filling in page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Α7 Β7 經濟部中央橾準局貝工消費合作社印製 3^ί644 五、發明説明（122) 中間體7 3 [1R_(1 a，3a；5，4冷，4a々，7点，7aa，8ay5 )]8a-[(2,3-脱水-4- 〇-爷氧羧基-5-去氧-々-D_哌喃甘露糖基氧基）甲基]_4_甲 醯基-4,4a，5,6,7,7a，8,8a-八氫-7 -甲基-3-(1-甲基乙基）- 1，4-亞甲基-s-M丨噠省羧酸’二苯基甲基酯 將中間體67(0.3毫莫耳）及4-二甲胺基吡啶（〇.8毫莫耳） 於無水二氣甲统（15毫升）内之混合物用苄氧羰基氣（0.7毫 莫耳）一滴滴處理，並攪拌3小時。用水及鹽水洗後，蒸發 去溶劑’殘餘物作閃色層分析純化，用己烷：醋酸乙酯（5 :1)作洗離劑，製得標題化合物（185毫克）。 d (lH，CDC13): 9.75 (s，1H，CHO)，7_32 (m，15H，3xPh)， 6.99 (s, 1H, CHPh2), 6.08 (dd, 1H, H-2, J=1.2J2L3.3 Hz), 5.20 (m, 2H, OCI^Ph), 4.72 (s, 1H, Η-Γ), 4.57 (d, 1H, H-4', J=8.4 Hz)，4.11 及3.79 (2d, 2H，8a-CH2, J=9 Hz), 3.43 (m， 1H, H-5'), 3.27^3.15 (2d, 2H, H-2'^H-3'5 J=3.6 Hz), 2.85 (t, 1H, H-l，J=3.9 Hz)，2.24 (m，1H，C|i(CH3)2)。 中間體7 4 [1R-(1 a，3a0，4卢，4a/?，7/? ,7aa，8ay3 )]8a-[(2,3-脱水-6-去氧-4-氧基- 万-D -哌喃甘露糖基氧基）甲基卜4_甲醯基-4’4a，5,6,7，7a，8,8a-八氫-7_甲基-3-(l-甲基乙基）-l，4-亞甲基-s-吲噠省- 3a(lH)-羧酸，二苯基甲基酯 於三氟醋酸酐（0.1毫升）於無水二氣甲烷（5毫升）内之溶液 於-60°C用二甲基亞颯（0〇6毫升）及中間體67(〇.39毫莫耳） 於無水二氣曱烷（5毫升）内之溶液一滴滴處理。6〇分鐘後， -125- 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公羞） (請先閲讀背面之注意事項再填寫本頁)</span>Α7 Β7 Printed by Beigong Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economy 3 ^ ί644 V. Description of Invention (122) Intermediate 7 3 [1R_ (1 a, 3a; 5, 4 cold, 4a々, 7 o’clock, 7aa, 8ay5 )] 8a-[(2,3-anhydro-4-o-oxocarboxy-5-deoxy-々-D-piperanmannosyloxy) methyl] _4_carboxyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-sM carboxylic acid 'diphenylmethyl The mixture of intermediate 67 (0.3 millimoles) and 4-dimethylaminopyridine (0.8 millimoles) in anhydrous two gas systems (15 ml) was treated with benzyloxycarbonyl gas (0.7 millimoles) Ear) Drop by drop and stir for 3 hours. After washing with water and brine, the solvent 'residue was evaporated and purified by flash chromatography, using hexane: ethyl acetate (5: 1) as the eluent to obtain the title compound (185 mg). d (lH, CDC13): 9.75 (s, 1H, CHO), 7_32 (m, 15H, 3xPh), 6.99 (s, 1H, CHPh2), 6.08 (dd, 1H, H-2, J = 1.2J2L3.3 Hz), 5.20 (m, 2H, OCI ^ Ph), 4.72 (s, 1H, Η-Γ), 4.57 (d, 1H, H-4 ', J = 8.4 Hz), 4.11 and 3.79 (2d, 2H, 8a-CH2, J = 9 Hz), 3.43 (m, 1H, H-5 '), 3.27 ^ 3.15 (2d, 2H, H-2' ^ H-3'5 J = 3.6 Hz), 2.85 (t, 1H, Hl, J = 3.9 Hz), 2.24 (m, 1H, C | i (CH3) 2). Intermediate 7 4 [1R- (1 a, 3a0, 4 Lu, 4a / ?, 7 / ?, 7aa, 8ay3)] 8a-[(2,3-anhydro-6-deoxy-4-oxy-methane -D-piperanmannosyloxy) methyl bu 4_caramyl-4'4a, 5,6,7,7a, 8,8a-octahydro-7_methyl-3- (l-methyl Ethyl) -l, 4-methylene-s-indap-3a (lH) -carboxylic acid, diphenylmethyl ester in trifluoroacetic anhydride (0.1 ml) in anhydrous difluoromethane (5 ml ) The solution in) was treated dropwise with a solution of dimethyl sulfa (00.6 ml) and intermediate 67 (0.39 mmol) in anhydrous dioxane (5 ml) at -60 ° C. After 60 minutes, -125- This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297 public shame) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、發明説明（123) 經濟部中央標準局貝工消費合作社印製 加二乙基胺（0.24毫升），此混合物於·2〇Ό攪拌2小時。此 混合物用二氣甲烷（20毫升）稀釋，用水洗，除去溶劑，殘 餘物作閃色層分析純化，用己烷：醋酸乙酯（4 : 1)作洗離 劑’製得標題化合物（171毫克）。 ^ C1!!, CDC13): 9-76 (s, 1H, CHO), 7.36 (m, 10H, 2xPh), 6-59 (s, 1H, CHPh2), 6.09 (dd, 1H, H-2, J=1.5^3.6 Hz), 4-84(s，lH，H-l，），4.11&amp;amp;3.84(2d，2H，8a-CH2，J=9Hz)， 3-92(q，lH，H-5',J=6_9Hz)，3.59&amp;amp;3.37(2d，H-2m-3，， J=4.2 Hz), 2.86 (t, 1H, H-l, J^3.9 Hz), 2.26 (m, 1H, CH(CH3)2)〇 中間體7 5 [1R-(1 a，3a/?，4々，4a冷，7万，7aa ,8ay5 )]8a-[(2-0-苯甲醯 基-6-去氧- 4- 0-甲基-万-D -阿卓哌喃糖基氧基）甲基]_4_ 甲酿基-4,4a，5，6,7,7a,8,8a-八氫-7 -甲基-3-(1-曱基乙基） -1,4-亞甲基-s-a噠省_3a(iH)_羧酸，二苯基甲基酯 將中間體48(15.88克）及二甲胺基吡啶（8.83克）於無水二 氣曱烷（200毫升）内之溶液中於_25Ό在氮氣下加苯曱醯氣 (2毫升）於無水二氣甲烷（1()毫升）内之溶液。攪拌45分鐘 後，除去冷浴，小心加1當量鹽酸（1 〇毫升）。分開二相，有 機相用二氣甲烷（600毫升）稀釋，用1當量鹽酸（500毫升）， 1 0 %碳酸氫鈉（500毫升）及鹽水洗。除去溶劑至乾，得油體 ，此油體作閃色層分析（二氧化矽膠，醋酸乙酯：己烷容積 /容積1 : 20及1 : 7)，製得8.75克標題化合物（產出率 4 8 % )，爲泡沫。 -126- 本紙張尺度速用中國國家標準（CNS ) A4規格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁)</span>Description of the invention (123) Printed by Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy. Add diethylamine (0.24 ml), and stir the mixture at 2 ° C for 2 hours. This mixture was diluted with methane (20 mL), washed with water, the solvent was removed, the residue was purified by flash chromatography, and hexane: ethyl acetate (4: 1) was used as the eluent to prepare the title compound (171 Mg). ^ C1 !!, CDC13): 9-76 (s, 1H, CHO), 7.36 (m, 10H, 2xPh), 6-59 (s, 1H, CHPh2), 6.09 (dd, 1H, H-2, J = 1.5 ^ 3.6 Hz), 4-84 (s, lH, Hl,), 4.11 &amp;amp; 3.84 (2d, 2H, 8a-CH2, J = 9Hz), 3-92 (q, lH, H-5 ', J = 6_9Hz), 3.59 &amp;amp; 3.37 (2d, H-2m-3 ,, J = 4.2 Hz), 2.86 (t, 1H, Hl, J ^ 3.9 Hz), 2.26 (m, 1H, CH (CH3) 2 ) 〇 Intermediate 7 5 [1R- (1 a, 3a / ?, 4々, 4a cold, 70,000, 7aa, 8ay5)] 8a-[(2-0-benzoyl-6-deoxy-4 -0-Methyl-Van-D-Azepinelpyranosyloxy) methyl] _4_methylbromo-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl -3- (1-Methylethyl) -1,4-methylene-sapyridine_3a (iH) _carboxylic acid, diphenylmethyl ester intermediate 48 (15.88 g) and dimethylamine A solution of pyridinium (8.83 g) in anhydrous dioxane (200 ml) was added at -25 ° C under nitrogen with benzoxane (2 ml) in anhydrous digas methane (1 () ml). After stirring for 45 minutes, remove the cold bath and carefully add 1 equivalent of hydrochloric acid (10 mL). The two phases were separated, and the organic phase was diluted with methane (600 ml), washed with 1 equivalent hydrochloric acid (500 ml), 10% sodium bicarbonate (500 ml) and brine. After removing the solvent to dryness, an oil body was obtained. This oil body was subjected to flash chromatography analysis (silica, ethyl acetate: hexane volume / volume 1: 20 and 1: 7) to obtain 8.75 g of the title compound (yield 4 8%), which is a foam. -126- This paper uses the Chinese National Standard (CNS) A4 specifications (210X297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央樣準局員工消费合作社印製 A7 B7 五、發明説明（124) e OH, CDC13): 9.66 (s，1H，CHO)，8.15-8.05, 7.60-7 2 (2m 15H, 3Ph), 6.95 (s, 1H, CHPh2), 5.93 (bd5 1H, H2, J=2.1 Hz), 5.35 (dd, 1H, H2’，J=1.5及4.8 Hz)，4.82 (d, 1H, ΗΓ J=l 8</span>A7 B7 printed by the Employee Consumer Cooperative of the Central Prototype Bureau of the Ministry of Economy V. Description of the invention (124) e OH, CDC13): 9.66 (s, 1H, CHO), 8.15-8.05, 7.60-7 2 (2m 15H, 3Ph), 6.95 (s, 1H, CHPh2), 5.93 (bd5 1H, H2, J = 2.1 Hz), 5.35 (dd, 1H, H2 ', J = 1.5 and 4.8 Hz), 4.82 (d, 1H, ΗΓ J = l 8</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.25 (m，1H, H3')，3.99 (d, 1H，8aCH2, J=9 Hz)，3 86 (dq，1H, H5', J=6.3及8.1 Hz)，3.68 (d，1H，8aCH2, J=9 Hz), 3.43 (s，3H，OCH3), 3.22 (dd, 1H，H4'，及=8.1 Hz) 2 02 (t, 1H, HI, J=3.9 Hz), 2.45 (d, 1H, OH, J=2.4 Hz), 2.19 (m 1H，CH(CH3)2)。 ， ， 中間體7 6 a ’3a0，4A ’4a0，70，7aa，8a^ )]8a-[(2-〇_苯甲酿 基-3，6-二去氧-4-0-曱基-3-氧基_D-別哌喃糖基氧基） 曱基]-4 -甲酿基-4,4&amp;amp;，5,6,7,73,8,8&amp;amp;-八氫_7-甲基_3-(1 甲基乙基）-1，4-亞甲基-s-啕噠省-3a(lH)-羧酸，二苯基甲 基酯 將三氟醋酸酐（1.29毫升）於無水二氣甲烷（15毫升）内之 溶液中於-60°C在氮氣下用10分鐘以上時間加二甲基亞石風 (DMSO，0_66毫升）。於此形成的懸浮液中加中間體 7 5(3.45克）於無水二氣甲烷（30毫升）内之溶液，此混合物 於-60 C攪拌1小時。滴加三乙基胺（5.76毫升），將溫度升 至-20C，然後加水（6毫升）於形成的黃色溶液内，此混合 物於室溫攪拌1小時。加二氣甲烷（2〇〇毫升）及水（2〇〇毫升） ’將二相分開。有機層於硫酸鎂上乾燥，並濃縮至乾，得 粗產物’將此粗產物溶於二氣曱烷（1〇毫升）内，用三乙基 胺（2毫升）處理過夜。除去溶劑，得油體，將此油體作閃色 _________-127-__ 本紙張尺度逋用中國國家標準（CNS ) A4規格（210X297公釐） (請先閲讀背面之注意Ϋ項再填寫本頁)</span>Hz), 4.25 (m, 1H, H3 '), 3.99 (d, 1H, 8aCH2, J = 9 Hz), 3 86 (dq, 1H, H5', J = 6.3 and 8.1 Hz), 3.68 (d, 1H , 8aCH2, J = 9 Hz), 3.43 (s, 3H, OCH3), 3.22 (dd, 1H, H4 ', and = 8.1 Hz) 2 02 (t, 1H, HI, J = 3.9 Hz), 2.45 (d , 1H, OH, J = 2.4 Hz), 2.19 (m 1H, CH (CH3) 2). ,, Intermediate 7 6 a '3a0, 4A' 4a0, 70, 7aa, 8a ^)] 8a-[(2-〇_Benzyl 3,6-dideoxy-4-0-methyl- 3-Oxy_D-perpiperanosyloxy) methyl] -4 -methylbromo-4,4 &amp;amp;, 5,6,7,73,8,8 &amp;amp; -octahydro-7-methyl _3- (1 methylethyl) -1,4-methylene-s-pyda-3a (lH) -carboxylic acid, diphenylmethyl ester, trifluoroacetic anhydride (1.29 ml) in anhydrous To the solution in methane (15 ml), add dimethyl sulfite wind (DMSO, 0_66 ml) at -60 ° C under nitrogen for more than 10 minutes. To the suspension formed here was added a solution of Intermediate 75 (3.45 g) in anhydrous digas methane (30 ml), and the mixture was stirred at -60 C for 1 hour. Triethylamine (5.76 ml) was added dropwise, the temperature was raised to -20C, then water (6 ml) was added to the yellow solution formed, and the mixture was stirred at room temperature for 1 hour. Add two gas methane (200 ml) and water (200 ml) to separate the two phases. The organic layer was dried over magnesium sulfate and concentrated to dryness to give a crude product. This crude product was dissolved in dimethane (10 mL) and treated with triethylamine (2 mL) overnight. Remove the solvent to get the oil body, and make this oil body flash color _________- 127 -__ This paper uses the Chinese National Standard (CNS) A4 specification (210X297mm) page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標準局貝工消費合作社印裂 A7 B7 五、發明説明（125) 層分析（二氧化矽膠，醋酸乙酯：己烷容積/容積1 ·· 15及 1 : 10)，製得2.6克標題化合物（產出率76%)，爲泡沫。 A (4, CDC13): 9.68 (s，1H，CHO), 8.2-8.0, 7.6-7.2 (2m， 15H，3Ph)，6.96 (s, 1H，CHPh2)，5_76 (dd，1H，H2, J=i.2 及 3.3Hz)，5.77(dd，lH,H2，J=1.2&amp;amp;3.3Hz)，5.39(dd，lH,H2'， J=1.2及8·1 Hz)，4.53 (d，1H，ΗΓ, J=8.1 Hz)，4.09 ( d, 1H， 8aCH2, J=9 Hz), 3.75 (d, 1H, 8aCH2, J=9 Hz), 3.7-3.4 (m, 5H, Ht+OCHs+HS')，2.63 (t，1H, HI, J=4.2 Hz)。 中間體7 7 [1R_( 1 a，3a/?，4冷，4ay5，7y9，7aa，8a点）]8&amp;amp;-[(2,3,6-三去氧 -4-O-甲基_3-氧基-卢-D —別哌喃糖基氧基）甲基]_4_甲磁 基-4,4&amp;amp;，5,6,7,7&amp;amp;,8,8&amp;amp;-八氫-7-甲基-3-(1-甲基乙基）_ 1，4-亞甲基_s-吲噠省_3a(1H)-羧酸，二苯基甲基酯 於氫化三丁基錫（5.96毫升）於無水曱苯（120毫升）内之充 分去氣的溶液（Ar，15分鐘）中，用注射筒以1小時以上的 時間於90 C加中間體76(5.7克）與a，a'-偶氮異丁腈（420毫 克）於無水甲苯（5〇毫升）内之溶液。繼續加熱至反應完全， 然後冷至室溫。加水（40毫升）及氟化鉀（15克），將混合物 擾掉過夜。所得粗產物於除去溶劑後，用乙醚攪拌1小時， 過濾移除固體。將醚溶液濃縮至乾，所得油體作閃色層分 析（二氧化矽膠，醋酸乙酯：己烷1 : 15及1 : 1〇)，製得 2.克標題化合物（產出率61%)，眞空乾燥後爲泡沫。 ^ Cn, CDC13)： 9.73 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.98 (s，1H，CHPh2)，6.04 (dd，1H，H2, J=1.5及3.6 Hz)，4.45 ) A4^ ( 210Χ297-^Γ) (請先閲讀背面之注^^項再填寫本頁)</span>A7 B7 of the Beigong Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. V. Description of the invention (125) layer analysis (silica dioxide, ethyl acetate: hexane volume / volume 1 ·· 15 and 1:10), obtained 2.6 g The title compound (yield rate 76%) is a foam. A (4, CDC13): 9.68 (s, 1H, CHO), 8.2-8.0, 7.6-7.2 (2m, 15H, 3Ph), 6.96 (s, 1H, CHPh2), 5_76 (dd, 1H, H2, J = i.2 and 3.3Hz), 5.77 (dd, lH, H2, J = 1.2 &amp;amp; 3.3Hz), 5.39 (dd, lH, H2 ', J = 1.2 and 8.1 Hz), 4.53 (d, 1H, ΗΓ, J = 8.1 Hz), 4.09 (d, 1H, 8aCH2, J = 9 Hz), 3.75 (d, 1H, 8aCH2, J = 9 Hz), 3.7-3.4 (m, 5H, Ht + OCHs + HS ' ), 2.63 (t, 1H, HI, J = 4.2 Hz). Intermediate 7 7 [1R_ (1 a, 3a / ?, 4 cold, 4ay5, 7y9, 7aa, 8a point)] 8 &amp;amp;-[(2,3,6-trideoxy-4-O-methyl_3 -Oxyl-Lu-D-Allopyranosyloxy) methyl] _4_methoxy-4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl Yl-3- (1-methylethyl) _ 1,4-methylene_s-indap_3a (1H) -carboxylic acid, diphenylmethyl ester in tributyltin hydride (5.96 ml) In a fully degassed solution (Ar, 15 minutes) in anhydrous toluene (120 ml), add an intermediate 76 (5.7 g) and a, a'-azo at 90 C with a syringe for more than 1 hour. A solution of isobutyronitrile (420 mg) in anhydrous toluene (50 mL). Continue heating until the reaction is complete, then cool to room temperature. Water (40 ml) and potassium fluoride (15 g) were added and the mixture was disturbed overnight. After removing the solvent, the obtained crude product was stirred with ether for 1 hour, and the solid was removed by filtration. The ether solution was concentrated to dryness, and the resulting oil body was subjected to flash chromatography (silica gel, ethyl acetate: hexane 1: 15 and 1: 10) to obtain 2. g of the title compound (yield rate 61%) , After drying, it becomes foam. ^ Cn, CDC13): 9.73 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.98 (s, 1H, CHPh2), 6.04 (dd, 1H, H2, J = 1.5 and 3.6 Hz) , 4.45) A4 ^ (210Χ297- ^ Γ) (Please read the note ^^ on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標準局貝工消費合作社印製 A7 B7 五、發明説明（126) (dd，1H，ΗΓ，J=2.7及8.7 Hz)，4.06 (d, 1H, 8aCH2, J=9 Hz), 3.70 (d, 1H, 8aCH2, J=9 Hz), 3.52 (s, 3H, 〇CH3), 3.5-3.3 (m, 2H, H4'+, H5'), 2.7-2.5 (m, 3H, H1+H2'), 2.24 (m, 1H, CH(CH3)2)。 中間體7 8 [1R-(1 ^ ,3a^ ,4^ ,4a^ ,7y3 ,7aa ,8ay5 )]8a-[(lS,7R,9R)-2,8二氧-9-甲基-順式-雙環[3.4.0]_壬_4_烯-7_基-氧基甲 基]-4 -甲醯基-4，4a ,5,6,7,7a，8,8a -八氫-7 -甲基-3-(1-甲 基乙基）-1,4 -亞甲基-S-啕噠省- 3a(lH) -羧酸，二苯基甲 基酯 於中間體77(260毫克）及膦酸二偶氮甲基二乙酯（11〇毫克） 於無水四氫呋喃内之溶液於0-C在氮氣下緩慢加三級丁氧化 鉀（112毫克）於無水四氫呋喃（丨毫升）之溶液（立即見到有氣 排出）。10分鐘後，此混合物以二氣甲烷（1〇〇毫升）稀釋， 用1當量的鹽酸（2X 100毫升），飽和碳酸氫鈉（2χ 1〇〇毫升） ，鹽水（2 X 100毫升）洗，於硫酸鎂上乾燥。除去溶劑，得 油體，此油體作閃色層分析（二氧化矽膠，醋酸乙酯：己烷 谷積/谷積1 : 15及1 : 12)，製得2〇〇克標題化合物（產出 率77%)，爲泡沫。 ( H, CDCI3): 9-75 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6·99 (s, 1H，CHPh2)，6.05 (dd，1H, H2, J=i.2及3.3 Hz), 5·45 (m, 1H, H4·), 4.65 (m, 2H, H3'), 4.25-4.15 (m, 2H, H7'+H1'), 4.07 (d, 1H, 8aCH2, J=9 Hz), 3.71 (d, lH, 8aCH2, J=9 Hz), 3.19 (dq，1H，H91，J=6及8.4 Hz)，2.77 (t, ih, HI, J = 3_9 Hz) •129- 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） 入請先閲讀背面之注意事項再填寫本育)</span>A7 B7 printed by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of the invention (126) (dd, 1H, HΓ, J = 2.7 and 8.7 Hz), 4.06 (d, 1H, 8aCH2, J = 9 Hz), 3.70 (d, 1H, 8aCH2, J = 9 Hz), 3.52 (s, 3H, 〇CH3), 3.5-3.3 (m, 2H, H4 '+, H5'), 2.7-2.5 (m, 3H, H1 + H2 '), 2.24 (m, 1H, CH (CH3) 2). Intermediate 7 8 [1R- (1 ^, 3a ^, 4 ^, 4a ^, 7y3, 7aa, 8ay5)] 8a-[(lS, 7R, 9R) -2,8diox-9-methyl-cis Formula-Bicyclo [3.4.0] _non_4_en-7-yl-oxymethyl] -4 -carboxamide-4,4a, 5,6,7,7a, 8,8a -octahydro- 7-methyl-3- (1-methylethyl) -1,4-methylene-S-pyridine-3a (lH) -carboxylic acid, diphenylmethyl ester in intermediate 77 (260 Mg) and diazodimethylphosphonate diphosphonate (110 mg) in anhydrous tetrahydrofuran slowly add tertiary potassium butoxide (112 mg) to anhydrous tetrahydrofuran (丨 mL) at 0-C under nitrogen. Solution (see gas discharge immediately). After 10 minutes, the mixture was diluted with methane (100 mL), washed with 1 equivalent of hydrochloric acid (2 × 100 mL), saturated sodium bicarbonate (2 × 100 mL), brine (2 × 100 mL), Dry over magnesium sulfate. After removing the solvent, an oil body was obtained, and this oil body was subjected to flash layer analysis (silica dioxide, ethyl acetate: hexane valley product / valley product 1: 15 and 1: 12) to obtain 200 g of the title compound (product The rate of 77%) is a bubble. (H, CDCI3): 9-75 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s, 1H, CHPh2), 6.05 (dd, 1H, H2, J = i .2 and 3.3 Hz), 5.45 (m, 1H, H4 ·), 4.65 (m, 2H, H3 '), 4.25-4.15 (m, 2H, H7' + H1 '), 4.07 (d, 1H, 8aCH2, J = 9 Hz), 3.71 (d, lH, 8aCH2, J = 9 Hz), 3.19 (dq, 1H, H91, J = 6 and 8.4 Hz), 2.77 (t, ih, HI, J = 3_9 Hz ) • 129- This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297mm). Please read the precautions on the back before filling in this education)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T A7 B7 經濟部中央揉準局負工消費合作社印製 321644 五、發明説明（127) 中間體7 9 [lR-(la ,3a^ ,Αβ ,ΑΆβ ,Ίβ ^ΐΆα Μβ )]8a-[(lS,4R,7R, 9R)-2,8二氧_4-羥基_9_甲基_順式_雙環[3 4 〇]_壬_7_基-’ 氧基甲基]-4-羥基曱基-4,43,5,6,7,73,8,8&amp;amp;-八氫_7-甲基 -3-(1-甲基乙基八丨〆-亞甲基_s^丨噠省_3a(1H)_羧酸， 二苯基甲基酯 於中間體78(620毫克）於無水四氫呋喃（5毫升）内之溶液 中在氮氣下加9_硼雙環[3.3.1]壬烷（〇.5]^的於四氫呋喃内 之溶液；6毫升）。將此混合物加熱至5 〇。〇1小時。再於$ 〇 C用3小時以上的時間加另一同龍積的卜爛雙環[3.3.1]壬 烷落液，以完成反應，並於室溫攪拌丨小時。小心加乙醇（2 毫升）（有氣體產生）’再將溶液攪拌1小時。然後相繼於〇。€ 加3當量的氫氧化鈉（5毫升）及過氧化氫（35%容積/容積， 5毫升），此混合物於室溫、〇°c及70X：攪拌過夜。將所得 溶液冷至室溫並濃縮至半容積，然後以1當量鹽酸（1〇〇毫升） 稀釋’用醋酸乙酯（2X100毫升）萃取二次。有基層用1當量 的鹽酸（2X 100毫升），碳酸氫鈉（2X 1〇〇毫升），鹽水（1〇〇 毫升）洗’於硫酸鎂上乾燥，濃縮至乾，得漿，此漿作閃色 層分析（丙酮/己烷1 : 10及1 : 5)，製得475克標題化合物 (產出率74%)，爲泡沫。 ί CDC13)： 7.5-7.2 (m, 10H, 2Ph), 7.04 (s, 1H, CHPh2), 5.90(dd,lH，H2,J=1.5&amp;amp;3.6Hz),4.75(d，lH，HOCHo， J=10.5 Hz)，4.62 (dd，1H，H7'，J=2.7 及5.1 Hz)，4.27 (m，1H, __-130-___ 本紙張尺度逍用中國國家標準（CNS ) A4規格（210x297公釐） (請先閲讀背面之注意事項再填寫本頁)</span>， 1T A7 B7 Printed by the Ministry of Economic Affairs Central Bureau of Accreditation and Consumer Cooperatives 321644 V. Description of the invention (127) Intermediate 7 9 [lR- (la, 3a ^, Αβ, ΑΆβ, Ίβ ^ ΐΆα Μβ)] 8a- [ (lS, 4R, 7R, 9R) -2,8diox_4-hydroxy_9_methyl_cis_bicyclo [3 4 〇] _non_7_yl-'oxymethyl] -4- Hydroxymethyl-4,43,5,6,7,73,8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyloctadecyl-methylene_s ^ 丨 ida To save _3a (1H) _carboxylic acid, diphenylmethyl ester in a solution of intermediate 78 (620 mg) in anhydrous tetrahydrofuran (5 mL), add 9_boron bicyclo [3.3.1] nonane under nitrogen (〇.5] ^ in tetrahydrofuran solution; 6 ml). This mixture was heated to 5.0 〇1 hour. Then at $ 〇C with more than 3 hours to add another with the same Dragon's bad double ring [ 3.3.1] The nonane drops to complete the reaction, and is stirred at room temperature for 1 hour. Carefully add ethanol (2 ml) (gassing occurs) 'and stir the solution for another 1 hour. Then successively at 0. € Add 3 equivalents Sodium hydroxide (5 ml) and hydrogen peroxide (35% volume / volume, 5 ml), the mixture was stirred at room temperature, 0 ° C and 70X: The resulting solution was cooled to room temperature and concentrated to half volume, then diluted with 1 equivalent of hydrochloric acid (100 mL) 'and extracted twice with ethyl acetate (2X100 mL). The basic layer was extracted with 1 equivalent of hydrochloric acid (2X 100 mL) ), Sodium bicarbonate (2X 100 mL), brine (100 mL), washed over magnesium sulfate, concentrated to dryness, to obtain a slurry, this slurry for flash layer analysis (acetone / hexane 1: 10 And 1: 5), 475 g of the title compound (yield 74%) was obtained as a foam. Ί CDC13): 7.5-7.2 (m, 10H, 2Ph), 7.04 (s, 1H, CHPh2), 5.90 (dd , lH, H2, J = 1.5 &amp;amp; 3.6Hz), 4.75 (d, lH, HOCHo, J = 10.5 Hz), 4.62 (dd, 1H, H7 ', J = 2.7 and 5.1 Hz), 4.27 (m, 1H , __- 130 -___ This paper scale uses the Chinese National Standard (CNS) A4 specification (210x297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央橾準局貝工消费合作社印策 A7 B7 五、發明説明（128)</span>Printed by the Beigong Consumer Cooperative of the Central Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (128)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">H4'), 4.16 (d, 1H, 8aCH2, J=9 Hz), 4.09 (dd, 1H, H3', J=6A 9.6 Hz), 3.91 (t，1H, H3，，J=6.9 Hz)，3.7-3.5 (m，3H， 8aCH2+Hl'+H9'), 3.35 (d, 1H, HOCH2, J=11.5 Hz), 3.22 (dd, 1H, HOCH2, J=ll.l及 12 Hz), 2.57 (t，1H, Hl，J=4.5 Hz), 2.48 (m，1H，H5，），2.30 (m，1H，CH(CH3)2)。 中間體8 0 [1R-(1 a，3a/?，4yS，4a点，7/S，7aa，8a々）]8a-[(lS，7R，9R)· 2,8-二氧-9-順式-雙環[3.4.0]-壬-4-烯-7-基-氧基甲基]_ 4-[三級丁基-二曱基甲矽烷基氧基甲基]4,4a，5,6,7,7a， 8,8a-八氫-7 -甲基-3-(卜曱基乙基）-1，4-亞甲基-S-钊噠省 -3a(lH) -羧酸，二苯基甲基酯 於中間體78(200毫克）於四氫呋喃（5毫升）内之溶液中加 固體棚氫化鈉（18.9毫克）及水（1毫升），此混合物於〇。(：攪 拌30分鐘，再於室溫攪拌！小時。小心於ye加水使反應停 止，並於醋酸乙酯（100毫升）及水（100毫升）間分開。有機 層於硫酸鎂上乾燥，濃縮至乾，得漿，此漿再溶於無水二 曱基甲醯胺（5毫升）内，於室溫在氮氣下用咪唑（204毫克） 及三級丁基-甲基-甲矽烷基氣（316毫克）處理過夜。將溶液 倒於1當量氣化銨及醋酸乙酯（容積/容積1 : 1}之混合物内 ’揽拌1小時。有機層用1當量氣化銨（1〇〇毫升）及鹽水 (100毫升）洗，於硫酸鎂上乾燥，濃縮至乾，得泡沫，此泡 沐作閃色色層分析（二氧化矽膠，醋酸乙酯：己烷容積/容 積1 _ 20)製得215克標题化合物（總產出率92 %)。 ^ (!11, CDC13): 7.5-7.2 (m, 10H, 2Ph), 6.94 (s, 1H, CHPh2), _____ -131 -_ 本紙張认逍用中國國家橾準（CNS )八4胁（21GX297公釐) ' --- C请先閱讀背面之注意事項存填寫本萸)</span>H4 '), 4.16 (d, 1H, 8aCH2, J = 9 Hz), 4.09 (dd, 1H, H3', J = 6A 9.6 Hz), 3.91 (t, 1H, H3, J = 6.9 Hz), 3.7 -3.5 (m, 3H, 8aCH2 + Hl '+ H9'), 3.35 (d, 1H, HOCH2, J = 11.5 Hz), 3.22 (dd, 1H, HOCH2, J = ll.l and 12 Hz), 2.57 ( t, 1H, Hl, J = 4.5 Hz), 2.48 (m, 1H, H5,), 2.30 (m, 1H, CH (CH3) 2). Intermediate 8 0 [1R- (1 a, 3a / ?, 4yS, 4a point, 7 / S, 7aa, 8a々)] 8a-[(lS, 7R, 9R) · 2,8-diox-9- Cis-Bicyclo [3.4.0] -non-4-en-7-yl-oxymethyl] _4- [tertiary butyl-dimethylsilyloxymethyl] 4,4a, 5 , 6,7,7a, 8,8a-octahydro-7-methyl-3- (bumethylethyl) -1,4-methylene-S-zhaoda-3a (lH) -carboxylic acid, di To a solution of phenylmethyl ester in intermediate 78 (200 mg) in tetrahydrofuran (5 mL) was added solid sodium hydride (18.9 mg) and water (1 mL). This mixture was added at 0. (: Stir for 30 minutes, then at room temperature! Hours. Be careful to add water to stop the reaction and separate between ethyl acetate (100 ml) and water (100 ml). The organic layer is dried over magnesium sulfate and concentrated to After drying, a slurry was obtained. This slurry was redissolved in anhydrous dimethylformamide (5 ml), and imidazole (204 mg) and tertiary butyl-methyl-silyl gas (316) were used under nitrogen at room temperature. Milligram) overnight. Pour the solution into a mixture of 1 equivalent of vaporized ammonium and ethyl acetate (volume / volume 1: 1) and stir for 1 hour. The organic layer is treated with 1 equivalent of vaporized ammonium (100 ml) Wash with brine (100 ml), dry over magnesium sulfate, and concentrate to dryness to obtain a foam. This foam is subjected to flash chromatography (silica, ethyl acetate: hexane volume / volume 1 _ 20) to obtain 215 g The title compound (total output rate 92%). ^ (! 11, CDC13): 7.5-7.2 (m, 10H, 2Ph), 6.94 (s, 1H, CHPh2), _____ -131 -_ This paper recognizes the use of China National Standards (CNS) 8 4 threats (21GX297mm) '--- C Please read the notes on the back and fill in this book)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標準局貝工消費合作社印裝 A7 B7 五、發明説明（129) 5.96 (dd，1H，H2, J=1.2及3·6 Hz), 5.54 (m，1H，H41)，4.65 (m, 2H，H3’），4.25-4.15 (m，3H，SiOCH2+H7, ΗΓ)，4·1 (d， 1H, 8aCH2, J=9.3 Hz), 3.69 (d, 1H, SiOCH2, J=9 Hz), 3.30 (d，1H, 8aCH2, J=9.3 Hz), 3_19 (dq，1H，H9，，J=6及9 Hz)， 2.68 (dd, 1H，H6，，J=2及 13.2 Hz)，2.57 (t，1H，Hl，J=4.2), 2.3 (m, 2H，CH(CH3)2+H6·)，-0.017及-0.031 (2s，6H, (CH3)2Si)。 中間體8 1 [1R-(1« ,3ay9 ,4y5 ,4a^ ,Ί β ,7aa ,8a^ ) ] 8 a-[ (1 S , 4R, 7 R, 9R)-2,8-二氧-4-羥基-9 -甲基-順式-雙環[3.4.0]-壬-7-基 -氧基甲基]-4-[三級丁基-二甲基甲矽烷基-氧基甲基 ]4,4a，5, 6,7,7a,8,8a -八复-7-甲基-3-(1-甲基乙基）_ 1，4-亞甲基-S-啕噠省-3a(lH)-羧酸，二苯基甲基酷 於中間體80(700毫克）於四氫呋喃（5毫升）内之溶液中在 氮氣下加9 -硼雙環[3.3.1]壬燒（0.5M的於四氫咬喃内之溶 液；6毫升）。將此混合物加熱至5(TC 1小時。再於5(rc用 3小時以上的時間加另一同容積的9 -硼雙環[3.3.1]壬燒溶 液，以完成反應，然後冷至室溫，小心加乙醇（2毫升）。1 小時後相繼於〇°C加3當量的氫氧化鈉（5毫升）及過氧化氫 (3 5 %谷積/谷積’ 5毫升），此混合物於室溫攪拌！小時， 於70°C攪拌過夜。將所得溶液冷至室溫並濃縮至半容積， 然後以1當量鹽酸（100毫升）稀釋，用醋酸乙酯（2χ 1〇〇毫 升）萃取二次。有基層用i當量的鹽酸（2χ1〇〇毫升），飽和 碳酸氫鈉（100毫升），鹽水（100毫升）洗，於硫酸鎂上乾燥 -132- 本紙張尺度適用中國國家橾準（CNS ) Α4规格（210X297公羞) ------- (請先閲讀背面之注意事項再填寫本頁)</span>A7 B7 printed by Beigong Consumer Cooperative of Central Bureau of Standards of the Ministry of Economy V. Description of Invention (129) 5.96 (dd, 1H, H2, J = 1.2 and 3.6 Hz), 5.54 (m, 1H, H41), 4.65 (m , 2H, H3 '), 4.25-4.15 (m, 3H, SiOCH2 + H7, ΗΓ), 4.1 (d, 1H, 8aCH2, J = 9.3 Hz), 3.69 (d, 1H, SiOCH2, J = 9 Hz ), 3.30 (d, 1H, 8aCH2, J = 9.3 Hz), 3_19 (dq, 1H, H9, J = 6 and 9 Hz), 2.68 (dd, 1H, H6, J = 2 and 13.2 Hz), 2.57 (t, 1H, Hl, J = 4.2), 2.3 (m, 2H, CH (CH3) 2 + H6 ·), -0.017 and -0.031 (2s, 6H, (CH3) 2Si). Intermediate 8 1 [1R- (1 «, 3ay9, 4y5, 4a ^, Ί β, 7aa, 8a ^)] 8 a- [(1 S, 4R, 7 R, 9R) -2,8-diox- 4-hydroxy-9-methyl-cis-bicyclo [3.4.0] -non-7-yl-oxymethyl] -4- [tertiary butyl-dimethylsilyl-oxymethyl ] 4,4a, 5, 6,7,7a, 8,8a -octaplex-7-methyl-3- (1-methylethyl) _ 1,4-methylene-S-pyda province- 3a (lH) -Carboxylic acid, diphenylmethyl ester in intermediate 80 (700 mg) in tetrahydrofuran (5 ml) was added 9-boron bicyclo [3.3.1] nonane (0.5M Solution in tetrahydrofuran; 6 ml). Heat the mixture to 5 ° C for 1 hour. Then add another 9-boron bicyclo [3.3.1] nonane solution of the same volume to the 5 ° C for more than 3 hours to complete the reaction, and then cool to room temperature. Add ethanol (2 mL) carefully. After 1 hour, add 3 equivalents of sodium hydroxide (5 mL) and hydrogen peroxide (35% valley product / valley product 5 mL) successively at 0 ° C. The mixture is at room temperature Stir for 1 hour, stir overnight at 70 ° C. The resulting solution was cooled to room temperature and concentrated to half volume, then diluted with 1 equivalent of hydrochloric acid (100 mL), and extracted twice with ethyl acetate (2 × 100 mL). The basic layer is washed with i equivalent hydrochloric acid (2 × 100 mL), saturated sodium bicarbonate (100 mL), brine (100 mL), and dried on magnesium sulfate-132- This paper size is applicable to China National Standards (CNS) Α4 Specifications (210X297 public shame) ------- (please read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央橾準局員工消费合作社印裝 A7 _____B7 _ 五、發明説明（130) ，濃縮至乾，得漿，此漿作閃色層分析（丙酮/己烷1 · 20 及1 : 15)，製得550克標題化合物（產出率77%)，爲白色泡 沫。 ^ Cn, CDC13): 7.5-7.2 (m, 10H, 2Ph), 6.94 (s, 1H, CHPh2), 5.95 (m, 1H, H2)，4_57 (dd，1H，H7'，J=3及5.1沿），4.30-4.15 (m, 2H, H4'+CH2OSi), 4.10-3.95 (m, 2H, H3'+8aCH2), 3.87 (t, 1H, H3', J=6.9 Hz), 3.7-3.5 (m, 3H, Hl'+8aCH2 + H9'), 3.30 (d, 1H, CH2OSi, J=9.3 Hz), 2.53 (t, 1H, HI, J=3.9</span>A7 _____B7 _ Printed by the Central Consumer ’s Consumer Cooperative of the Ministry of Economic Affairs A. _____B7 _ 5. Description of the invention (130), concentrated to dryness to obtain a slurry, which is used for flash layer analysis (acetone / hexane 1.20 and 1:15), 550 g of the title compound (yield 77%) was obtained as a white foam. ^ Cn, CDC13): 7.5-7.2 (m, 10H, 2Ph), 6.94 (s, 1H, CHPh2), 5.95 (m, 1H, H2), 4_57 (dd, 1H, H7 ', J = 3 and 5.1 edges ), 4.30-4.15 (m, 2H, H4 '+ CH2OSi), 4.10-3.95 (m, 2H, H3' + 8aCH2), 3.87 (t, 1H, H3 ', J = 6.9 Hz), 3.7-3.5 (m , 3H, Hl '+ 8aCH2 + H9'), 3.30 (d, 1H, CH2OSi, J = 9.3 Hz), 2.53 (t, 1H, HI, J = 3.9</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 2.46 (m, 1H, H5，)，2.32 (m, 1H，CH(CH3)2), -0.016及-0.029 (2s, 6H, (CH3)2Si)。 中間體8 2 [lR-(la ,3a/3 ,4β Μβ ,Ί β ,7aa ,8ay5 ) ] 8 a-[ (1 S, 4R, 7 R, 9R)-2,8-二氧-4 -甲氧基-9-甲基-順式-雙環[3.4.0]-壬-7- 基-氧基甲基]-4-[三級丁基-二甲基甲矽烷基-氧基甲基 ]4,4&amp;amp;，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7-甲基-3-(1-甲基乙基）-1，4-亞甲基-S-吲噠省-3a(lH)-羧酸，二苯基甲基酯 於中間體81(537毫克）於無水四氫呋喃（5毫升）内之溶液 中在氮氣下於0°C分小批加氫化鈉（75毫克）。攪拌10分鐘 後，加曱基碘（374微升），此混合物置於室溫至反應完全。 加水（100毫升）使反應停止，然後用醋酸乙酯（丨00毫升）萃 取。有機層用鹽水（100毫升）洗，並濃縮至乾，得泡沫，將 此泡沫溶於THF(5毫升）内，用氟化四丁基銨（1·1Μ的四氫 呋喃内之溶液，2毫升）於40°C處理24小時。將所得溶液濃 縮至乾，殘餘物溶於AcOEI内，用水（2 X 1〇〇毫升）洗，於 _ -133- 本紙張尺度逋用中國國家標準（CNS ) A4^格（210X297公釐） (請先閱讀背面之注意事項再填寫本頁)</span>Hz), 2.46 (m, 1H, H5,), 2.32 (m, 1H, CH (CH3) 2), -0.016 and -0.029 (2s, 6H, (CH3) 2Si). Intermediate 8 2 [lR- (la, 3a / 3, 4β Μβ, Ί β, 7aa, 8ay5)] 8 a- [(1 S, 4R, 7 R, 9R) -2,8-diox-4- Methoxy-9-methyl-cis-bicyclo [3.4.0] -non-7-yl-oxymethyl] -4- [tertiary butyl-dimethylsilyl-oxymethyl ] 4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-S-indene Dasheng-3a (lH) -carboxylic acid, diphenylmethyl ester in a solution of intermediate 81 (537 mg) in anhydrous tetrahydrofuran (5 mL) was added sodium hydride in small batches under nitrogen at 0 ° C 75 mg). After stirring for 10 minutes, methyl iodide (374 µl) was added, and the mixture was left at room temperature until the reaction was complete. Water (100 ml) was added to stop the reaction, and then extracted with ethyl acetate (丨 00 ml). The organic layer was washed with brine (100 mL) and concentrated to dryness to obtain a foam. This foam was dissolved in THF (5 mL), and tetrabutylammonium fluoride (1.1 M in tetrahydrofuran, 2 mL) Treat at 40 ° C for 24 hours. The resulting solution was concentrated to dryness, the residue was dissolved in AcOEI, washed with water (2 X 100 mL), and used on the paper standard _ -133- Chinese National Standard (CNS) A4 ^ (210X297 mm) (Please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T 經濟部中央標準局貝工消费合作社印聚 S21644 A7 ________B7 五、發明説明（131) 硫酸緩上乾燥，濃縮至乾，得衆，此漿再溶於爲水二氣甲 烷（85毫升）内。加氣鉻酸吡啶鏘（215毫克），此混合物於室 溫攪拌至反應完全。將懸浮液倒於二氣曱烷及焦亞硫酸鈉 (10%水溶液）之混合物上。有基層用i當量的鹽酸（2〇〇毫升） 及1當量氫氧化鈉（200毫升）洗，於硫酸鎂上乾燥，濃縮至 乾，得油體，此油體於二氧化矽膠上作閃色層分析（醋酸乙 酯：己烷1 : 15，1 : 1〇及1 : 8)，製得255克標題化合物（ 總產出率5 7 %) 〇 ^ (^, CDC13)： 9.74 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s, 1H，CHPh2)，6.04 (dd，1H, H2, J=1.2及3.6 Hz), 4.60 (m, 1H, H7'), 4.10-3.95 (m, 2H, H4'+8aCH2), 3.90-3.65 (m, 3H, H3'+H1'), 3.65-3.55 (m, 2H, 8aCH2+H9'), 3.35 (s, 3H, 〇CH3), 2.73 (t, 1H, HI, J=3.6 Hz), 2.54 (m, 1H, H5'), 22.4 (m, 1H, CH(CH3)2) 〇 中間體8 3 [1R-(1 a，3a々，4万，4a々，7y5，7aa ,8ay5 )]8a-[(6-去氧-4-0-甲基-y3-D -阿卓哌喃糖基氧基）曱基]_4_(1，3_二氧戊環_2-基）-4,4a，5,6,7,7a，8,8a-八氫-7-甲基-3-(l-甲基乙基）-1，4_亞甲基-s-峭噠省_3a(iH)-羧酸，二苯基甲基酯 將中間體48(9.7毫莫耳）於無水甲醇（40毫升）内之溶液以 乙二醇（110毫升），三甲基正曱酸酯〇 25毫升）及催化量的 P-甲苯磺酸處理。此混合物於40 °C加熱3小時。冷卻後將 混合物倒入醋酸乙酯：碳酸氫鈉水溶液（1 : 1，500毫升）之 混合物内，水層以醋酸乙酯徹底萃取。合併之有機層用水 ____ -134-__ 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐] (請先閲讀背面之注意事項再填寫本頁)</span>、 1T Beigong Consumer Cooperative of Central Bureau of Standards, Ministry of Economic Affairs, Printed and Collected S21644 A7 ________B7 V. Description of the invention (131) Sulfuric acid is slowly dried and concentrated to dryness, and the slurry is redissolved in water digas methane (85 ml) . Aerated pyridium chromate (215 mg) was added, and the mixture was stirred at room temperature until the reaction was complete. Pour the suspension onto a mixture of methane and sodium metabisulfite (10% aqueous solution). The base layer was washed with i equivalent of hydrochloric acid (200 mL) and 1 equivalent of sodium hydroxide (200 mL), dried over magnesium sulfate, and concentrated to dryness to obtain an oil body, which was flashed on silica gel Layer analysis (ethyl acetate: hexane 1:15, 1:10 and 1: 8) to obtain 255 g of the title compound (total yield 57%). ^^^^, CDC13): 9.74 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s, 1H, CHPh2), 6.04 (dd, 1H, H2, J = 1.2 and 3.6 Hz), 4.60 (m, 1H, H7 ') , 4.10-3.95 (m, 2H, H4 '+ 8aCH2), 3.90-3.65 (m, 3H, H3' + H1 '), 3.65-3.55 (m, 2H, 8aCH2 + H9'), 3.35 (s, 3H, 〇CH3), 2.73 (t, 1H, HI, J = 3.6 Hz), 2.54 (m, 1H, H5 '), 22.4 (m, 1H, CH (CH3) 2) 〇Intermediate 8 3 (1R- (1 a, 3a々, 40,000, 4a々, 7y5, 7aa, 8ay5)] 8a-[(6-deoxy-4-0-methyl-y3-D-azorpiperanyloxy) methyl] _4_ (1,3_dioxolane-2-yl) -4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (l-methylethyl) -1,4_methylene-s-pyridine_3a (iH) -carboxylic acid, diphenylmethyl ester, a solution of intermediate 48 (9.7 mmol) in anhydrous methanol (40 mL) was Ethylene glycol (110 ml ), Trimethyl orthoformate (25 ml) and catalytic amount of P-toluenesulfonic acid. This mixture was heated at 40 ° C for 3 hours. After cooling, the mixture was poured into a mixture of ethyl acetate: sodium bicarbonate aqueous solution (1: 1, 500 ml), and the aqueous layer was thoroughly extracted with ethyl acetate. Water for combined organic layer ____ -134 -__ The paper size is in accordance with Chinese National Standard (CNS) A4 (210X297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 A7 經濟部中央揉準局貝工消費合作社印裝 ______B7 五、發明説明（ 及鹽水洗’乾燥。除去溶劑後，殘餘物作閃色層分析，用 己烷：醋酸乙酯(6 Μ )作洗離劑，製得標題化合物(619克) 〇 ^ (ln, CDC13): 7.435.7.30 (m, m, 4H, 6H, 2xPh), 6.94 (s, 1H, CHPh2), 5.83 (dd, 1H, H-2, J=1.2^3.6 Hz), 5.07 (s, 1H, 4-CH), 4.63 (d, 1H, H-l', J-1.5 hz), 4.20 (t, 1H, H-3', J=3.3 Hz), 4.07 (d, 1H, 8a-CHa, J=9.3 Hz), 3.84 (m, 6H, H-2', 8a- CHb及0CH2CH20)，3.71 (m，1H，H-51), 3.42 (s, 3H，OCH3)， 3.21 (dd，1H，H-4’，J=3及9 Hz), 2.63 (m，1H, C廷(CH3)2)， 2.54 (t，1H，H-l，J=3.9 Hz)。 中間體8 4 [lR-(la，3ab，4b，4ab，7b，7aa，8ab)] 8a-[(2-0-苯甲醯基·6·去 氧- 4- 0-甲基_b-D -阿卓哌喃糖基氧基）甲基]二氧 戊環-2-基）-4,4&amp;amp;，5,6,7,73,8,8&amp;amp;-八氫-7-甲基-3-(1-甲基 乙基）-1,4-亞甲基-s_吲噠省_3a(iH)_羧酸，二苯基甲基酯 於中間體83 (12.12克）及二曱胺基吡啶（6.3克）於無水二氣 甲垸（155毫升）内之溶液中於_2(rc在氮氣下滴加苯曱醯氣 (1.40毫升）於50毫升無水二氣甲烷内之溶液。攪拌2小時後 ’任混合物升至室溫，此溶液以當量的鹽酸（5〇〇毫升） ’飽和碳酸氫鈉（500毫升）及鹽水（500毫升）洗。除去溶劑 ’殘餘物作閃色層分析（二氧化矽膠，醋酸乙酯：己烷容積 /容積1 : 4)，製得5.89克標題化合物（42%)，爲白色泡沫 〇 δ (^, CDC13): 8.14-8.05, 7.6-7.2 (2m, 15H, 3Ph), 6.91 (s, _-135- A4规格（210X297公嫠） (請先聞讀背面之注f項再填寫本頁)</span>A7 A7 Printed by Beigong Consumer Cooperative of Central Bureau of Economic Development, Ministry of Economics ______B7 V. Description of invention (and brine washing 'drying. After removing the solvent, the residue is analyzed for flash layer, using hexane: ethyl acetate (6 Μ) As an eluent, the title compound (619 g) was obtained. (^, CDC13): 7.435.7.30 (m, m, 4H, 6H, 2xPh), 6.94 (s, 1H, CHPh2), 5.83 (dd, 1H , H-2, J = 1.2 ^ 3.6 Hz), 5.07 (s, 1H, 4-CH), 4.63 (d, 1H, H-l ', J-1.5 hz), 4.20 (t, 1H, H-3 ', J = 3.3 Hz), 4.07 (d, 1H, 8a-CHa, J = 9.3 Hz), 3.84 (m, 6H, H-2', 8a- CHb and 0CH2CH20), 3.71 (m, 1H, H- 51), 3.42 (s, 3H, OCH3), 3.21 (dd, 1H, H-4 ', J = 3 and 9 Hz), 2.63 (m, 1H, Cting (CH3) 2), 2.54 (t, 1H , Hl, J = 3.9 Hz). Intermediate 8 4 [lR- (la, 3ab, 4b, 4ab, 7b, 7aa, 8ab)] 8a-[(2-0-benzylamide · 6 · deoxy- 4- 0-methyl_bD -azorpiperanyloxy) methyl] dioxolane-2-yl) -4,4 &amp;amp;, 5,6,7,73,8,8 &amp;amp; -octa Hydrogen-7-methyl-3- (1-methylethyl) -1,4-methylene-s_indap_3a (iH) _carboxylic acid, diphenylmethyl ester in intermediate 83 (12.12g) and dimethylaminopyridine (6.3g) A solution of benzoin gas (1.40 ml) in 50 ml of anhydrous digas methane was added dropwise to the solution in anhydrous digas formazan (155 ml) at _2 (rc under nitrogen. After stirring for 2 hours, let the mixture rise At room temperature, the solution was washed with equivalent hydrochloric acid (500 ml) 'saturated sodium bicarbonate (500 ml) and brine (500 ml). Remove the solvent' residue for flash chromatography (silica gel, ethyl acetate) Ester: hexane volume / volume 1: 4) to obtain 5.89 g of the title compound (42%) as a white foam. Δ (^, CDC13): 8.14-8.05, 7.6-7.2 (2m, 15H, 3Ph), 6.91 (s, _-135- A4 specification (210X297 public daughter) (Please read note f on the back and then fill in this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央揉準局員工消費合作社印裝 A7 B7 五、發明説明（133) 1H, CHPh2), 5.70 (bd, 1H, H2, 1=2.1 Hz), 5.34 (dd, 1H H2' J=2.1 及5.1 Hz), 5.01 (s, 1H，OCHO), 4.82 (d，1H，ΗΓ, J=1 8</span>A7 B7 printed by the Employees ’Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs 5. Description of the invention (133) 1H, CHPh2), 5.70 (bd, 1H, H2, 1 = 2.1 Hz), 5.34 (dd, 1H H2 'J = 2.1 and 5.1 Hz), 5.01 (s, 1H, OCHO), 4.82 (d, 1H, ΗΓ, J = 1 8</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.26 (m, 1H, H3'), 3.98 (d, 1H, 8aCH2, J=9.3 Hz), 3.92-3.74 (m, 5H, H5'+OCH2CH2O), 3.72 (d, 1H, 8aCH2, J=9.3 Hz), 3.42 (s，3H, OCH3), 3.23 (dd, 1H，H4·, J=3.3及 8.1 Hz), 2.57 (m, 1H, CH(CH3)2), 2.44-2.38 (m, 2H, OH+H1) o 中間體8 5 [1R-(1 a ,3ay5 ,4yS ,4a;9 ,7y3 ,7aa ,8a々）]8a-[(2-0_苯甲酿 基-3,6 -二去氧- 4- 0-曱基-3-氧基- b- D-別卓哌喃糖基氧基) 曱基]-4-(1，3-二氧戊環-2-基）-4,4a，5,6,7,7a，8,8a-八氫 -7 -甲基- 3- (1-甲.基乙基）-l，4 -亞甲基-s-μ丨建省_3a(iH)_ 羧酸，二苯基甲基酯 於三氟醋酸酐（0.45毫升）於無水二氣甲烷（5毫升）内之溶 液中於-60 °C在氮氣下用1〇分鐘以上的時間加dms〇( 0.23 毫升）。與此形成的懸浮液中加中間體84(12克）於無水二 氣甲烷（5毫升）内之溶液，此混合物於_6〇〇c攪拌1小時。 滴加三乙基胺（1.24毫升），並使溫度升至_ 2 〇 °C，然後加水 至此黃色溶液中，此混合物於室溫攪拌丨小時。加二氣甲燒 (200毫升）及水（250毫升）分成二相。有機層於硫酸鎂上乾 燥’濃縮至乾’得粗產物，將此粗產物再溶於二氣甲垸 毫升）内，以三乙基胺（2毫升）處理過夜。除去溶劑，得油 禮，此油體作閃色層分析（二氧化矽膠，醋酸乙酯：己烷容 積/容積1 : 15及1 : 10)，製得Μ克標題化合物（產出率 136- 本紙張尺度適用中國國家標準（CNS ) A4^格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁)</span>Hz), 4.26 (m, 1H, H3 '), 3.98 (d, 1H, 8aCH2, J = 9.3 Hz), 3.92-3.74 (m, 5H, H5' + OCH2CH2O), 3.72 (d, 1H, 8aCH2, J = 9.3 Hz), 3.42 (s, 3H, OCH3), 3.23 (dd, 1H, H4 ·, J = 3.3 and 8.1 Hz), 2.57 (m, 1H, CH (CH3) 2), 2.44-2.38 (m, 2H, OH + H1) o Intermediate 8 5 [1R- (1 a, 3ay5, 4yS, 4a; 9, 7y3, 7aa, 8a々)] 8a-[(2-0_Benzenyl-3,6 -Dideoxy- 4- 0-methyl-3-oxy-b-D-dezopiperanosyloxy) methyl] -4- (1,3-dioxolan-2-yl) -4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methyl.ethyl) -l, 4-methylene-s-μ 丨 jian _3a (iH) _ carboxylic acid, diphenylmethyl ester in a solution of trifluoroacetic anhydride (0.45 ml) in anhydrous digas methane (5 ml) at -60 ° C under nitrogen for 10 minutes Add dms〇 (0.23ml) for the above time. To the resulting suspension was added a solution of Intermediate 84 (12 g) in anhydrous methane (5 ml), and the mixture was stirred at -600 ° C for 1 hour. Triethylamine (1.24 ml) was added dropwise, and the temperature was raised to -20 ° C, then water was added to the yellow solution, and the mixture was stirred at room temperature for 1 hour. Add two gas methane (200 ml) and water (250 ml) to separate into two phases. The organic layer was dried over magnesium sulfate and concentrated to dryness to obtain the crude product. This crude product was redissolved in dichloromethane (mL) and treated with triethylamine (2 mL) overnight. After removing the solvent, the oil was obtained. The oil body was analyzed by flash layer (silica dioxide, ethyl acetate: hexane volume / volume 1: 15 and 1: 10) to obtain Μg of the title compound (yield 136- The size of this paper is applicable to the Chinese National Standard (CNS) A4 ^ (210X297mm) (Please read the precautions on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T 經濟部中央標準局貝工消费合作社印裝 A7 B7 _______ 五、發明説明（134) 92%)，眞空乾燥後爲泡沫。 ^ 〇H, CDCI3): 8.2-8.0, 7.6-7.2 (2m, 15H, 3Ph), 6.90 (s, 1H，CHPh2)，5.57 (dd，1H, H2, J=1.2及3.6 Hz), 5.37 (dd，1H, H2’，J=1.5及8.1 Hz)，5.05 (s，1H，OCHO)，4.52 (d，1H, Hl'， J=8.1 Hz), 4.08 (d, 1H, 8aCH2, J=8.7 Hz), 3.9-3.7 (m, 5H, OCH2CH20+8aCH2), 3.6-3.4 (Μ, 5H, H4'+OCH3+H5'), 2.62 (m, 1H, CH(CH3)2)，2.43 (t，1H，HI, J=3.9 Hz)。 中間體8 6 [1R-(1 a，3a卢，4/?，4a/J，7々，7&amp;amp;〇?，8&amp;amp;々）]8&amp;amp;-[(2,3,6-三去氧 •4-0 -甲基-3-氧基- b- D-別哌喃糖基氧基）甲基]-4-(1,3-二氧戊環-2-基）-4,4&amp;amp;，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7-甲基-3-(1_ 甲基乙基）-1，4 -亞甲基-s -吲噠省_3a(iH)-羧酸，二苯基甲 基酯 於氫化三丁基錫（263微升）於無水曱苯（1〇毫升）内之充分 去氣的溶液（Ar，15分鐘）中，用注射筒以1小時以上的時 間於90°C加中間體85(250毫克）與a,a’-偶氮異丁腈（16毫克) 於無水甲苯（50毫升）内之溶液。繼續加熱至反應完全，然 後冷至室溫。加水（5毫升）及氟化鉀（1 〇〇毫克），將混合物 攪拌過夜。所得粗產物於除去溶劑後，用乙醚攪拌1小時， 過遽移除固體。將醚溶液濃縮至乾，所得油體作閃色層分 析（二氧化矽膠，醋酸乙酯：己烷1 : 15及1 : 1〇)，製得 168毫克標題化合物（產出率8 〇 %)，眞空乾燥後爲泡沫。 ά (^, CDC13): 7.6-7.1 (m, 10H, 2Ph), 6.92 (s, 1H, CHPh2), 5.80(dd，lH，H2，J=0.9&amp;amp;3.6Hz)，5.08(s，lH，OCHO)，4.44 ____-137_ 本紙張尺度逍用中國國家標準（CNS ) A4规格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁)</span>, 1T Printed by Beigong Consumer Cooperative of Central Bureau of Standards, Ministry of Economic Affairs A7 B7 _______ V. Description of the invention (134) 92%), it is foam after drying. ^ 〇H, CDCI3): 8.2-8.0, 7.6-7.2 (2m, 15H, 3Ph), 6.90 (s, 1H, CHPh2), 5.57 (dd, 1H, H2, J = 1.2 and 3.6 Hz), 5.37 (dd , 1H, H2 ', J = 1.5 and 8.1 Hz), 5.05 (s, 1H, OCHO), 4.52 (d, 1H, Hl', J = 8.1 Hz), 4.08 (d, 1H, 8aCH2, J = 8.7 Hz) ), 3.9-3.7 (m, 5H, OCH2CH20 + 8aCH2), 3.6-3.4 (Μ, 5H, H4 '+ OCH3 + H5'), 2.62 (m, 1H, CH (CH3) 2), 2.43 (t, 1H , HI, J = 3.9 Hz). Intermediate 8 6 [1R- (1 a, 3a Lu, 4 / ?, 4a / J, 7々, 7 &amp;amp; 〇 ?, 8 &amp;amp; 々)] 8 &amp;amp;-[(2,3,6-trideoxy • 4-0-methyl-3-oxy-b-D-piperanyloxy) methyl] -4- (1,3-dioxolan-2-yl) -4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1_ methylethyl) -1,4-methylene-s-indap_3a (iH) -Carboxylic acid, diphenyl methyl ester in a fully degassed solution (Ar, 15 minutes) in tributyltin hydride (263 microliters) in anhydrous toluene (10 ml), using a syringe for more than 1 hour At 90 ° C, add a solution of Intermediate 85 (250 mg) and a, a'-azoisobutyronitrile (16 mg) in anhydrous toluene (50 mL). Continue heating until the reaction is complete, then cool to room temperature. Water (5 ml) and potassium fluoride (100 mg) were added, and the mixture was stirred overnight. After removing the solvent, the resulting crude product was stirred with diethyl ether for 1 hour, and the solid was removed. The ether solution was concentrated to dryness, and the resulting oil body was subjected to flash chromatography (silica gel, ethyl acetate: hexane 1: 15 and 1: 10) to obtain 168 mg of the title compound (yield 80%) , After drying, it becomes foam. ά (^, CDC13): 7.6-7.1 (m, 10H, 2Ph), 6.92 (s, 1H, CHPh2), 5.80 (dd, lH, H2, J = 0.9 &amp;amp; 3.6Hz), 5.08 (s, lH, OCHO), 4.44 ____- 137_ The size of this paper uses the Chinese National Standard (CNS) A4 specification (210X297mm) (Please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 ^21644 B7________ 五、發明説明（135) (dd，1H，HI', J=2.7及8.7 Hz)，4.05 (d, 1H，8aCH2, J=9.3 Hz)， 3.9-3.7 (m, 5H, 0CH2CH20+8aCH2), 3.50-3.30 (m, 2H, H5'+H4'), 2.5-2.l(m, 3H, H2'+CH(CH3)2), 2.50 (t, 1H, HI, J = 4.5 Hz) 〇 中間體8 7 [lR-(la，3ab，4b，4ab，7b，7aa，8ab)]8a-[(l S，7R，9R)-2,8-二 氧-9 -甲基-順式-雙環[3.4.0]-壬-4-烯-7-基-氧基曱基]-4-[1,3-二氧戊環-2-基]4,43,5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7-甲基 -3-(1-甲基乙基）-1,4-亞甲基-S-啕噠省- 3a(lH)-羧酸， 二苯基甲基酯 於中間體86( 160毫克）及膦酸二偶氮曱基二乙酯（63毫克) 於無水四氫呋喃内之溶液於0 °C在氮氣下緩慢加三級丁氧化 鉀（100毫克）於無水四氫呋喃（2.3毫升）之泥樣物（立即見到 有氣排出）。10分鐘後，此混合物以二氣曱烷（1〇〇毫升）稀 釋’用1當量的鹽酸（2x 100毫升），飽和碳酸氫鈉（2x1 〇〇 毫升），鹽水（2X100毫升）洗，於硫酸鎂上乾燥。除去溶劑 ，得油體，此油體作閃色層分析（二氧化矽膠，醋酸乙酯： 己烷容積/容積1 : 15及1 : 12)，製得11〇克標題化合物（ 產出率7 0 % )，爲泡沫。 cy On, CDC13)： 7.5-7.2 (m, 10H, 2Ph), 6.94 (s, 1H, CHPh2), 5.83 (dd，1H，H2, J=1.2及3.3 Hz)，5.53 (m，1H，H4')，5.06 (s, 1H, OCHO), 4.65 (m, 2H, H3'), 4.25-4.10 (m, 2H, H7'+H1')S 4.05 (d, 1H, 8aCH2, J=9.3 Hz), 3.90-3.70 (m, 5H, 〇CH2CH20+8aCH2)，3.18(dq，1H，H9，，J=6及8.7 Hz)，2_75- _ -138- 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局貝工消費合作社印裝 經濟部中央樣準局貝工消費合作社印製 A7 B7 五、發明説明（136) ' 2.50 (m，3H，Η6'+(：Η((：Η3)2+Η1)。 中間體8 8 [1R-(1 a，3a々，4卢，4a 卢，7/5，7aa,8ay5)]8a-[(4-0-埽丙基_ 3,6-二去氧-3-碘-b-D-哌喃甘露糖基氧基）甲基]_ 4,4&amp;amp;，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7_甲基-3-(1-甲基乙基）_1,4_ 亞甲基-s-吲噠省-3a(lH)-羧酸，二苯基甲基酯 將中間體53(gm 2008) (103毫克），三苯基甲基膦（197毫 克）及咪唑（51毫克）於無水四氫呋喃（5毫升）内之溶液用琪 (95毫克）分批處理。於室溫攪拌丨小時後，將溶液回流至所 有起始物質已耗完（tic分析己烷：醋酸乙酯4 : 1)。將反應 混合物冷卻，於醋酸乙酯（5〇毫升）及1當量鹽酸水溶液（3〇 毫升）間分開。有機層相繼用1當量鹽酸水溶液，水，焦亞 硫酸鈉水溶液，水及鹽水洗，然後乾燥（Na2S04)，過濾並 濃縮。殘餘物於二氧化矽膠上作閃色層分析，用己烷：醋 酸乙酯（9 : 1)洗離，製得標題化合物（7〇毫克）。 ^ (lU, CDC13)： 9.73 (s, 1H, CHO), 7.46-7.22 (m, 10H, 2Ph)，6.98(s,lH，C|iPh2)，6.03(dd,lH，H-2，J=1.5&amp;amp;3.6</span>A7 ^ 21644 B7________ 5. Description of the invention (135) (dd, 1H, HI ', J = 2.7 and 8.7 Hz), 4.05 (d, 1H, 8aCH2, J = 9.3 Hz), 3.9-3.7 (m, 5H, 0CH2CH20 + 8aCH2), 3.50-3.30 (m, 2H, H5 '+ H4'), 2.5-2.l (m, 3H, H2 '+ CH (CH3) 2), 2.50 (t, 1H, HI, J = 4.5 Hz) 〇Intermediate 8 7 [lR- (la, 3ab, 4b, 4ab, 7b, 7aa, 8ab)] 8a-[(l S, 7R, 9R) -2,8-dioxo-9-methyl- Cis-bicyclo [3.4.0] -non-4-en-7-yl-oxymethyl] -4- [1,3-dioxolan-2-yl] 4,43,5,6, 7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-S-pyridine- 3a (lH) -carboxylic acid , A solution of diphenyl methyl ester in intermediate 86 (160 mg) and diazoxymethyl diphosphonate (63 mg) in anhydrous tetrahydrofuran was slowly added tertiary potassium butoxide under nitrogen at 0 ° C (100 mg) muddy substance in anhydrous tetrahydrofuran (2.3 ml) (an air discharge is immediately seen). After 10 minutes, the mixture was diluted with methane (100 mL), washed with 1 equivalent of hydrochloric acid (2 × 100 mL), saturated sodium bicarbonate (2 × 100 mL), brine (2 × 100 mL), and washed with sulfuric acid Dry on magnesium. After removing the solvent, an oil body was obtained. This oil body was subjected to flash chromatography analysis (silica dioxide, ethyl acetate: hexane volume / volume 1: 15 and 1: 12) to obtain 110 g of the title compound (yield 7 0%) is a bubble. cy On, CDC13): 7.5-7.2 (m, 10H, 2Ph), 6.94 (s, 1H, CHPh2), 5.83 (dd, 1H, H2, J = 1.2 and 3.3 Hz), 5.53 (m, 1H, H4 ' ), 5.06 (s, 1H, OCHO), 4.65 (m, 2H, H3 '), 4.25-4.10 (m, 2H, H7' + H1 ') S 4.05 (d, 1H, 8aCH2, J = 9.3 Hz), 3.90-3.70 (m, 5H, 〇CH2CH20 + 8aCH2), 3.18 (dq, 1H, H9, J = 6 and 8.7 Hz), 2_75- _ -138- This paper scale is applicable to the Chinese National Standard (CNS) A4 specification ( 210X297mm) (Please read the precautions on the back before filling out this page) Ordered by the Ministry of Economic Affairs Central Bureau of Standardization Bei Gong Consumer Cooperative Printed by the Ministry of Economic Affairs Central Bureau of Standards Bei Gong Consumer Cooperative printed A7 B7 V. Description of the invention (136) '2.50 (m, 3H, Η6' + (: Η ((: Η3) + Η1). Intermediate 8 8 [1R- (1 a, 3a 々, 4 Lu, 4a Lu, 7/5, 7aa, 8ay5 )] 8a-[(4-0-Phenylpropyl-3,6-dideoxy-3-iodo-bD-piperanmannosyloxy) methyl] _4,4 &amp;amp;, 5,6,7 , 7 &amp;amp;, 8,8 &amp;amp; -octahydro-7_methyl-3- (1-methylethyl) _1,4_methylene-s-indap-3a (lH) -carboxylic acid, diphenyl Methyl esters intermediates 53 (gm 2008) (103 mg), triphenylmethylphosphine (197 mg) and imidazole (51 mg) The solution in anhydrous tetrahydrofuran (5 mL) was treated in batches with Qi (95 mg). After stirring at room temperature for 1 hour, the solution was refluxed until all the starting material was consumed (tic analysis hexane: ethyl acetate 4: 1 ). The reaction mixture was cooled and separated between ethyl acetate (50 mL) and 1 equivalent aqueous hydrochloric acid (30 mL). The organic layer was washed successively with 1 equivalent aqueous hydrochloric acid, water, aqueous sodium metabisulfite, water and brine, then Dry (Na2S04), filter and concentrate. The residue was subjected to flash chromatography on silica gel and washed away with hexane: ethyl acetate (9: 1) to obtain the title compound (70 mg). , CDC13): 9.73 (s, 1H, CHO), 7.46-7.22 (m, 10H, 2Ph), 6.98 (s, lH, C | iPh2), 6.03 (dd, lH, H-2, J = 1.5 &amp;amp; 3.6</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 6.02-5.9 (m, 1H, 〇-C-CH=C), 5.35-5.15 (m, 2H, 042-c=cH2)s 4.4-4.32 (m, 1H, 0-CHa-C=C), 4.35 (d, 1H, H-l', J=0.6 Hz), 4.18-3.96 (m, 4H, 0-CHb-C=C, H-2', H-3', 8aCHa), 3.75 (d, 1H, 8a-CHb, J=9 Hz), 3.45 (dd, 1H, H-4', 及 10.2 Hz), 3.34 (dq, 1H，H-5', J=5_7及8.7 Hz)，2.72 (t, 1H，H-l，J=3.9 Hz)。 中間體89a及 _____-139- 本紙張XA逍用中國國家揉準（CNS ) Α4· ( 210X297公嫠) (請先閲讀背面之注意事項再填寫本頁) 訂 Λ 經濟部中央揉準局員工消費合作社印製 A7 B7 五、發明説明（13乃 a)[lR-(l a ,3ay3 ,4 β ,4ay5 ,1 β ,7aa ,8ay9 ) ] 8 a - [ (1 S , 4 S , 6 S , 7R，9R)-2,8-二氧-4,9-二甲基-順式-雙環[3.4.0]_ 壬-7_ 基-氧基甲基]-4-曱醯基_4a，5,6,7,7a，8,8a-八氫-7-甲基-3-(l-甲基乙基）-l，4-亞甲基-S-o5丨建省-3a(lH)-叛酸，二 苯基甲基酯 (b)[lR_( la，3ab，4b，4ab，7b，7aa，8ab)] 8a-[( 1 S，4R，6S，7R， 9R)-2,8-二氧-4,9-二甲基-順式-雙環[3 4 〇]_壬_7_基_氧 基甲基]-4-甲醯基_4-4江，5,6,7,7&amp;amp;，8,8已-八氫-7-甲基-3-(1-甲基乙基）-1，4 -亞甲基_s_吲噠省_3a(lH) -羧酸，二苯 基甲基酯 將中間體88(80毫克）於無水甲苯内之溶液以氬氣流去氣 60分鐘，然後加熱至回流。加氫化三丁基錫（41微升），繼 續回流1 5分鐘。眞空除去溶劑，將殘餘物溶於乙醚（5〇毫 升）内’用飽和氟化钟水溶液洗幾次至不再看到氟化三丁基 錫沉澱。將有機層乾燥並蒸發，得殘餘物，以製備用TLC 純化（二氧化矽膠’二氣甲烷：醋酸乙酯95 : 5)，製得標題 化合物（a)中間體89a(35毫克，Rf=〇.4，二氣甲烷：醋酸 乙酯9 : 1)及標題化合物（b)中間體89b(24毫克，Rf=〇.3， 二氣甲烷：醋酸乙酯9 : 1)。 中間體8 9 a S (]H, CDC13): 9.73 (s, 1H, CHO), 7.46-7.22 (m, 10H, 2Ph)，6.99(s，lH，C|^Ph2)，6_05(dd，lH，H-2，J=1.2&amp;amp;3.3</span>Hz), 6.02-5.9 (m, 1H, 〇-C-CH = C), 5.35-5.15 (m, 2H, 042-c = cH2) s 4.4-4.32 (m, 1H, 0-CHa-C = C ), 4.35 (d, 1H, H-l ', J = 0.6 Hz), 4.18-3.96 (m, 4H, 0-CHb-C = C, H-2', H-3 ', 8aCHa), 3.75 ( d, 1H, 8a-CHb, J = 9 Hz), 3.45 (dd, 1H, H-4 ', and 10.2 Hz), 3.34 (dq, 1H, H-5', J = 5_7 and 8.7 Hz), 2.72 (t, 1H, Hl, J = 3.9 Hz). Intermediate 89a and _____- 139- This paper XA Xiao uses the Chinese National Standard (CNS) Α4 · (210X297 public daughter) (please read the precautions on the back before filling in this page) Order Printed by the consumer cooperative A7 B7 V. Description of the invention (13 is a) [lR- (la, 3ay3, 4 β, 4ay5, 1 β, 7aa, 8ay9)] 8 a-[(1 S, 4 S, 6 S, 7R, 9R) -2,8-dioxo-4,9-dimethyl-cis-bicyclo [3.4.0] _non-7_yl-oxymethyl] -4-methyl-4a, 5 , 6,7,7a, 8,8a-octahydro-7-methyl-3- (l-methylethyl) -1,4-methylene-S-o5 Tetioic acid, diphenylmethyl ester (b) [lR_ (la, 3ab, 4b, 4ab, 7b, 7aa, 8ab)] 8a-[(1 S, 4R, 6S, 7R, 9R) -2,8- Dioxo-4,9-dimethyl-cis-bicyclo [3 4 〇] _non_7_yl_oxymethyl] -4-carboxyl_4-4, 5,6,7, 7 &amp;amp;, 8,8-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene_s_indap province_3a (lH) -carboxylic acid, di Phenylmethyl ester A solution of intermediate 88 (80 mg) in anhydrous toluene was degassed with a stream of argon for 60 minutes, and then heated to reflux. Add tributyltin hydride (41 μl) and continue to reflux for 15 minutes. The solvent was removed in vacuo, and the residue was dissolved in ether (50 mL) 'and washed several times with saturated aqueous fluorinated bell solution until no more precipitation of tributyltin fluoride was seen. The organic layer was dried and evaporated to obtain a residue, which was purified by TLC (silica dioxide 'difluoromethane: ethyl acetate 95: 5) to obtain the title compound (a) intermediate 89a (35 mg, Rf = 0). .4, Difluoromethane: ethyl acetate 9: 1) and the title compound (b) intermediate 89b (24 mg, Rf = 0.3, Difluoromethane: ethyl acetate 9: 1). Intermediate 8 9 a S () H, CDC13): 9.73 (s, 1H, CHO), 7.46-7.22 (m, 10H, 2Ph), 6.99 (s, lH, C | ^ Ph2), 6_05 (dd, lH , H-2, J = 1.2 &amp;amp; 3.3</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.63 (d, 1H, H-7', J-3.3 Hz), 4.02 (d, 1H, 8aCHa, J-9</span>Hz), 4.63 (d, 1H, H-7 ', J-3.3 Hz), 4.02 (d, 1H, 8aCHa, J-9</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz)，3.86(dd，lH，Ha-3'，J=6.6&amp;amp;8.7Hz),3.83-3.6(m,4H， -140- 本紙張尺度適用中國國家標準（CNS ) A4^格（210X297公釐） (請先閱讀背面之注意ί項再填寫本頁)</span>Hz), 3.86 (dd, lH, Ha-3 ', J = 6.6 &amp;amp; 8.7Hz), 3.83-3.6 (m, 4H, -140- This paper scale is applicable to the Chinese National Standard (CNS) A4 ^ grid (210X297 Ali) (Please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T A7 B7 經濟部中央標準局貝工消費合作社印裝 五、發明説明（ Η-6'，Η-Γ，H-9'及8a-CHb)，3.52 (dd，1H，Hb-3, ， ，卜 5.7及 8.7</span>、 1T A7 B7 Printed by Beigong Consumer Cooperative of Central Bureau of Standards of the Ministry of Economy V. Description of Invention (H-6 ', Η-Γ, H-9' and 8a-CHb), 3.52 (dd, 1H, Hb-3,, , Bu 5.7 and 8.7</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz)，2.69 (t，1H, H-l，J=3.9 Hz)。 中間體89b (Μ1^ CDC13): 9.74 (s，1H，CHO)，7.45-7.22 (m，1〇H 2Ph)，6.99 (s，1H，C|^Ph2)，6·06 (dd，1H，H-2, 2及3 6</span>Hz), 2.69 (t, 1H, H-1, J = 3.9 Hz). Intermediate 89b (Μ1 ^ CDC13): 9.74 (s, 1H, CHO), 7.45-7.22 (m, 10H 2Ph), 6.99 (s, 1H, C ^^ 2), 6.06 (dd, 1H, H-2, 2 and 3 6</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz)，4.48 (d，1H，H-7’，J=2.1 Hz)，4.1-4.0 (m，2H，“{取及</span>Hz), 4.48 (d, 1H, H-7 ’, J = 2.1 Hz), 4.1-4.0 (m, 2H," {take and</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ha-3')，3.85 (dd，1H，Η-Γ, J=7.8及9 Hz), 3·76 i ， (m，2h， 8a-CHb及H-6')，3.46-3.3 (m，2H，H-9'及Hb-3，、0 μ , ’ ;，z.73 (t，1H， H-l，J=3.9 Hz)。 中間體9 0 [1R-(1 « ,3a^ ,4^ ,4a^ ,7^ ,7a^ ,8a^ )]8a-rr^ + ^ d 去氧-^ _ D-阿卓哌喃糖基氧基）甲基]-4 -甲醯基_4 a c ，斗a，5,6,7,7a 8,8a -八氫-7-甲基- 3- (1-曱基乙基）-1，4-re甲I ’ &amp;amp; T暴· S · p引缝省 -3a(lH)-羧酸，二苯基甲基酯 ^ 於4’-脱甲基索達林（1〇克）於甲醇内之溶液 、w、 丁於至溫滴加 二苯基二偶氮甲烷（90毫升）於二氣甲烷内之 J,谷淡，將此混 合物攪拌6小時。蒸發去溶劑至乾，殘餘物於二氧化矽膠柱 上作閃色層分析’用正己烷：醋酸乙酯（3 :丨）作洗離劑， 製得標題化合物（12.6克），爲淺黃色泡沫。 ^ (^, CDC13)： 9.73 (s, 1H, CHO), 6.98 (s, 1H, CHPh2), 6.05 (dd，1H, H-2，J=1.5及3.6 Hz)，4.65 (d, 1H H-l'，卜1.5</span>Ha-3 '), 3.85 (dd, 1H, Η-Γ, J = 7.8 and 9 Hz), 3.76 i, (m, 2h, 8a-CHb and H-6'), 3.46-3.3 (m, 2H, H-9 'and Hb-3, 0 μ,';, z.73 (t, 1H, Hl, J = 3.9 Hz). Intermediate 9 0 [1R- (1 «, 3a ^, 4 ^ , 4a ^, 7 ^, 7a ^, 8a ^)] 8a-rr ^ + ^ d deoxy- ^ _ D- azepinepyranosyloxy) methyl] -4 -methylacetyl_4 ac, Bucket a, 5,6,7,7a 8,8a -octahydro-7-methyl-3- (1-methylethyl) -1,4-re A I '&amp;amp; T storm · S · p cited Semen-3a (lH) -carboxylic acid, diphenylmethyl ester ^ in 4'-demethylsodarin (10g) solution in methanol, w, dingyin to warm dropwise addition of diphenyl The diazomethane (90 ml) was dissolved in dichloromethane, and the mixture was stirred for 6 hours. The solvent was evaporated to dryness, and the residue was subjected to flash chromatography on a silica gel column. Using n-hexane: ethyl acetate (3: 丨) as the eluent, the title compound (12.6 g) was obtained as a pale yellow foam . ^ (^, CDC13): 9.73 (s, 1H, CHO), 6.98 (s, 1H, CHPh2), 6.05 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 4.65 (d, 1H H- l ', Bu 1.5</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.09, 3.76 (2d, 2H, Sa-Cl·^, J=9 Hz), 4.〇i (m, 1H, H- 2'), 3.84 (m, 1H, H-3'), 3.75(m, 1H, H-5'), 3.69 (m, 1H, H-4')，2.73 (t, 1H, H-l，J=4.2 Hz)。 -141 - 本紙張尺度適用中國國家揉準（CNS ) A4規格（21 OX 297公釐） (請先閲讀背面之注意事項再填寫本頁〕</span>Hz), 4.09, 3.76 (2d, 2H, Sa-Cl ^, J = 9 Hz), 4.〇i (m, 1H, H- 2 '), 3.84 (m, 1H, H-3'), 3.75 (m, 1H, H-5 '), 3.69 (m, 1H, H-4'), 2.73 (t, 1H, Hl, J = 4.2 Hz). -141-This paper scale is applicable to China National Standard (CNS) A4 (21 OX 297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標準局員工消费合作社印装 A7 B7 五、發明説明（ 中間體9 ] [1R-(1 a，3a/?，4/?，4a0，7点，7aa，8a点）]8阻-[(6-去氧_3,4-〇-々-D-阿卓哌喃糖基氧基）甲基]-4-甲醯基-4,4a，5,6, 7,7a, 8,8a-八氫-7-曱基_3-(l-甲基乙基）-1,4-亞甲基_s_ 吲噠省-3a(lH)-羧酸，二苯基甲基酯 於中間體90(650毫克）於15毫升2,2-二甲氧基丙烷：丙 _(1 : 2)之溶液中加p -曱苯績酸（1〇毫克）。此溶液於室溫 攪拌1.5小時，然後加碳酸鉀（1.0克），繼續攪拌3〇分鐘， 蒸發去溶劑至乾。此粗製混合物於醋酸乙酯（5〇毫升）及水 (25毫升）間分開，水相用醋酸乙酯（2x50毫升）萃取，有 機相用鹽水洗，於硫酸鑊上乾燥，蒸發至乾。殘餘物於二 氧化珍膠上作閃色層分析，用醋酸乙g旨：己垸（1 : 3)洗離 ，製得標題化合物（600毫克），爲白色泡沫。 ^ (!Η, CDC13)： 9.73 (s, 1H, CHO), 7.45-7.24 (m, i〇H, 2Ph)，6.98(s，lH,C|iPh2),6.06(dd，lH，H-2，J=i.5&amp;amp;3.3 Hz), 4.57 (d, 1H, Η-Γ, J=3.0 Hz), 4.30 (dd, 1H, H-3', J=3.6 及5.7 Hz)，4.07 (d，1H，8aCH2, J=9.0 Hz)，3.95-3.93 (m，1H, H-2’），3.85(dd,lH,H-4’，J=5.7&amp;amp;9.3HZ)，3.75(d，1H, 8aCH2, J=9.0 Hz), 3.44 (dq, 1H, H-5', Jd=9.3 Hz, Jq=6.3 Hz), 2.73 (t，1H，H-l，J=3.6 Hz)。 中間體9 2 [1R-(1 a，3a0，4卢，4a/?，7々，7aor ,8a点）]8a-[(6-去氧-3,4-〇-異丙稀基-2-0-(甲硫基）硫代碳基-D-阿卓旅喃糖基 氧基）甲基]-4 -甲酿基-4,4a，5,6,7,7a，8,8a-八氫-7-甲基- -142- J¢^HZΪiϊFFiΐ¾ίT^T^i^~ΰiό7^i^Π ~~' ' (請先閱讀背面之注意事項再填寫本頁)</span>A7 B7 printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of the invention (Intermediate 9] [1R- (1 a, 3a / ?, 4 / ?, 4a0, 7 points, 7aa, 8a points)] 8 Resistance- [(6-Deoxy_3,4-〇-々-D-azorpiperanosyloxy) methyl] -4-carboxamide-4,4a, 5,6, 7,7a, 8, 8a-octahydro-7-methyl_3- (l-methylethyl) -1,4-methylene_s_indap-3a (lH) -carboxylic acid, diphenylmethyl ester in the middle Body 90 (650 mg) was added p-toluic acid (10 mg) in a solution of 15 ml of 2,2-dimethoxypropane: propane_ (1: 2). The solution was stirred at room temperature for 1.5 hours Then, potassium carbonate (1.0 g) was added, stirring was continued for 30 minutes, and the solvent was evaporated to dryness. The crude mixture was separated between ethyl acetate (50 mL) and water (25 mL), and the aqueous phase was treated with ethyl acetate ( 2x50 ml) extraction, the organic phase was washed with brine, dried over wok sulfate, and evaporated to dryness. The residue was analyzed by flash chromatography on rare earth dioxide, washed with ethyl acetate g Purpose: Hexane (1: 3) , To prepare the title compound (600 mg) as a white foam. ^ (! Η, CDC13): 9.73 (s, 1H, CHO), 7.45-7.24 (m, i〇H, 2Ph), 6.9 8 (s, lH, C | iPh2), 6.06 (dd, lH, H-2, J = i.5 &amp;amp; 3.3 Hz), 4.57 (d, 1H, Η-Γ, J = 3.0 Hz), 4.30 (dd , 1H, H-3 ', J = 3.6 and 5.7 Hz), 4.07 (d, 1H, 8aCH2, J = 9.0 Hz), 3.95-3.93 (m, 1H, H-2'), 3.85 (dd, lH, H-4 ', J = 5.7 &amp;amp; 9.3HZ), 3.75 (d, 1H, 8aCH2, J = 9.0 Hz), 3.44 (dq, 1H, H-5', Jd = 9.3 Hz, Jq = 6.3 Hz), 2.73 (t, 1H, Hl, J = 3.6 Hz). Intermediate 9 2 [1R- (1 a, 3a0, 4 Lu, 4a / ?, 7々, 7aor, 8a point)] 8a-[(6-Go Oxygen-3,4-〇-isopropenyl-2-0- (methylthio) thiocarbo-D-Azzuranoglucosyloxy) methyl] -4 -methylsulfonyl-4, 4a, 5,6,7,7a, 8,8a-octahydro-7-methyl- -142- J ¢ ^ HZΪiϊFFil¾ίT ^ T ^ i ^ ~ ΰiό7 ^ i ^ Π ~~ '(Please read the back of the first (Notes and then fill this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">32n44 五、發明説明（14〇) 3-(l -甲基乙基）-1,4 -亞甲基_s_B引噠省_3a(iH) -羧酸，二 苯基甲基酯 將中間體9 1(100毫克）及咪唑（1毫克）在氮氣下溶於無水 四氫呋喃（4毫升）内。加氫化鈉毫克），此懸浮液於室溫 攪拌0.5小時。加二硫化碳（2.7毫升），繼續攪拌2〇分鐘， 再加曱基碘（18毫升）。二小時後加i當量氣化銨（2〇毫升） 使反應停止。此混合物以醋酸乙酯（3x25毫升）萃取，有機 相用鹽水洗，於硫酸鎂上乾燥，蒸發去溶劑至乾。殘餘物 於二氧化矽膠上作閃色層分析純化，用醋酸乙酯：己烷（i :9)洗離，製得標題化合物（11〇毫克）。 ^ (]Η, CDC13): 9.71 (s, 1H, CHO), 7.44-7.25 (m, l〇H, 2Ph)，6.96 (s, 1H，CHPh2)，6.01 (dd，1H，H-2, J=1.2及3.6 Hz), 6.90 (dd, 1H, H-21, J=2.4及5·4 Hz), 4.85 (d, 1H, Η-Γ J=2.4Hz)，4.53(dd，lH，H-3’，J=5.4&amp;amp;6.3Hz)，4.00(dd，lH， H-4’，J=6.3&amp;amp;8.7Hz),3.93(d，lH，8aCH2,J=9.3Hz)，3.65 (dq，1H，H-5'，Jd = 8.7, Jq=6.3 Hz), 2.68 (t，1H，H-l，J=3.9 Hz)，2.59 (s，3H，CH3S)。 中間體9 3 [1R-(1 a，3a/? ,4/?，4a/3，7/?，7aa，8ay3 )]8a-[(6-去氧 _3,4_ 〇-異丙烯基-冷-D-別哌喃糖基氧基）甲基]_4_甲酿基-4,4a，5,6,7,7a，8,8a-八氫-7_甲基-3-(l-甲基乙基）_1，4_ 亞甲基-s-吲噠省-3a(lH)-羧酸，二苯基甲基酯 將中間體92(95毫克）在氮氣下溶於無水甲苯（5毫升）内， 於110°C加熱。用1.5小時以上滴加無水甲苯（5毫升）内之氫 ___-143-_ 本紙張尺度逍用中關家揉準（CNS )八4胁（210X297公釐) ' -- (請先閲讀背面之注意事項再填寫本頁)</span>32n44 V. Description of the invention (14〇) 3- (l-methylethyl) -1,4-methylene_s_B Yinda province_3a (iH) -carboxylic acid, diphenylmethyl ester intermediate 9 1 (100 mg) and imidazole (1 mg) were dissolved in anhydrous tetrahydrofuran (4 ml) under nitrogen. Sodium hydride (mg) was added, and the suspension was stirred at room temperature for 0.5 hour. Add carbon disulfide (2.7 ml) and continue stirring for 20 minutes, then add methyl iodide (18 ml). Two hours later, an equivalent of ammonium vapor (20 mL) was added to stop the reaction. The mixture was extracted with ethyl acetate (3x25 ml), the organic phase was washed with brine, dried over magnesium sulfate, and the solvent was evaporated to dryness. The residue was analyzed and purified by flash chromatography on silica gel, and washed away with ethyl acetate: hexane (i: 9) to obtain the title compound (110 mg). ^ () Η, CDC13): 9.71 (s, 1H, CHO), 7.44-7.25 (m, 10H, 2Ph), 6.96 (s, 1H, CHPh2), 6.01 (dd, 1H, H-2, J = 1.2 and 3.6 Hz), 6.90 (dd, 1H, H-21, J = 2.4 and 5.4 Hz), 4.85 (d, 1H, Η-Γ J = 2.4Hz), 4.53 (dd, lH, H- 3 ', J = 5.4 &amp;amp; 6.3Hz), 4.00 (dd, lH, H-4', J = 6.3 &amp;amp; 8.7Hz), 3.93 (d, lH, 8aCH2, J = 9.3Hz), 3.65 (dq, 1H, H-5 ', Jd = 8.7, Jq = 6.3 Hz), 2.68 (t, 1H, Hl, J = 3.9 Hz), 2.59 (s, 3H, CH3S). Intermediate 9 3 [1R- (1 a, 3a / ?, 4 / ?, 4a / 3, 7 / ?, 7aa, 8ay3)] 8a-[(6-deoxy_3,4_ 〇-isopropenyl- Cold-D-piperanosyloxy) methyl] _4_methylbromo-4,4a, 5,6,7,7a, 8,8a-octahydro-7_methyl-3- (l- Methylethyl) _1,4-methylene-s-indap-3a (lH) -carboxylic acid, diphenylmethyl ester Intermediate 92 (95 mg) was dissolved in anhydrous toluene (5 ml) under nitrogen ), Heat at 110 ° C. Hydrogen in anhydrous toluene (5 ml) is added dropwise for more than 1.5 hours ___- 143-_ This paper scale is easy to use Zhongguanjia rubbing standard (CNS) 8 4 threat (210X297mm) '-(Please read the back first (Notes to fill out this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T 經濟部中央標準局—工消費合作社印製</span>, 1T Printed by the Central Standards Bureau of the Ministry of Economy-Industrial and Consumer Cooperative</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標隼局貝工消費合作社印製 化三丁基錫（64毫升），同時攪拌。繼續加熱i5小時，加 醇（2毫升）’蒸發去溶劑至乾。殘餘物於二氧切膠上作閃 色層分析純化，用醋酸乙酯：己烷（1 : 9)洗離，製得 化合物（42毫克）。 ' δ (lH, CDC13): 9.73 (s, 1H, CHO), 7.44-7.25 (m, i〇Hj 2Ph)，6.98 (1H，s，CHPh2)，6.05 (dd, 1H，H-2, J=1.2及3’3 Hz)，4.54 (dd，1H，H-l’，J=2.7及9.3 Hz)，4.39 (dt，1H，H-3，</span>The Ministry of Economic Affairs, Central Standard Falcon Bureau Beigong Consumer Cooperative Printed Tributyltin (64ml) with stirring. Continue heating for 5 hours, add alcohol (2 ml) 'and evaporate the solvent to dryness. The residue was analyzed and purified by flash chromatography on dioxin gum, and washed away with ethyl acetate: hexane (1: 9) to obtain the compound (42 mg). 'δ (lH, CDC13): 9.73 (s, 1H, CHO), 7.44-7.25 (m, i〇Hj 2Ph), 6.98 (1H, s, CHPh2), 6.05 (dd, 1H, H-2, J = 1.2 and 3'3 Hz), 4.54 (dd, 1H, H-l ', J = 2.7 and 9.3 Hz), 4.39 (dt, 1H, H-3,</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Jd=2.7 Hz，Jt=3.6 Hz)，4.04 (d，1H，8aCH2, J=9.0 Hz;，3 (d，1H，8aCH2, J=9.0 Hz)，3.65 (dd，1H，H-4，，】=3.6及8 7</span>Jd = 2.7 Hz, Jt = 3.6 Hz), 4.04 (d, 1H, 8aCH2, J = 9.0 Hz ;, 3 (d, 1H, 8aCH2, J = 9.0 Hz), 3.65 (dd, 1H, H-4 ,, 】 = 3.6 and 8 7</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz)，3.44 (dq，1H，H-51，Jd=6.3 Hz，Jq=8.7 Hz)，2.75 (t，1H, J=3.9 Hz)。 中間體9 4 [1R-(1 a ,3a々，4々，4a/S ,7y3 ,7a&amp;lt;^，8ay5 )]8a-[(2,6 -二去氧 _ 々-D-別哌喃糖基氧基）曱基]-4 -甲醯基-4,4a,5,6,7,7a 8,8a -八氫-7-甲基- 3- (1-甲基乙基）-1,4 -亞甲基_8_叫丨健省 -3a(lH)-羧酸，二苯基甲基酯 於中間體93(1 _5克）於四氫呋喃（30毫升）及甲醇（15毫升 混合物内之溶液中於室溫在強烈挽拌下滴加1當量鹽酸溶液 (15毫升）。反應完了後（TLC控制），加飽和碳酸氫鈉（5〇 毫升）及醋酸乙酯（200毫升）將混合物分開。有機層用水（2 X 100毫升）洗，於硫酸鎂上乾燥。蒸發去溶劑至乾。殘餘 物於二氧化矽膠上作閃色層分析，用醋酸乙酯：己烷（5 : 1 及（2 : 1)洗離，製得標題化合物（1.1克），爲白色泡沫。 GH，CDC13): 9.73 (s，1H，CHO), 7.5-7.2 (m，10H, 2Ph)， -144- 本紙張尺度逍用中國國家標準（CNS ) A4^格（210 X 297公釐） (請先閲讀背面之注意事項再填寫本頁) *?τ 經濟部中央標準局貝工消費合作社印製 Α7 Β7 五、發明説明（ 6.99 (s，1H，CHPh2)，6.05 (dd，1H，H-2, J=1.2及3.3 Hz)， 4.64 (dd，1H，Η-Γ，J=2.1 及9.6 Hz)，4.11 (m，1H，H-3')，4.06 (d，1H，8aCH2, JAB=9.3 Hz), 3.70 (m，2H，H-5’及8aCH2)， 3.34 (m，1H，H-4'), 2.75 (t，1H，H-l，J=3.6 Hz)。 中間體9 5 [1R-(1 a，3a卢，4万，4ay5，7卢，7aa，8a点）]8a-[(2,3,6-三去氧 -3-碘-D-哌喃葡糖基氧基）甲基]-4 -甲醯基-4,4 a, 5, 6,7,7a，8,8a-八氫-7 -甲基-3-(1-甲基乙基）-1,4-亞甲基-s-θ丨噠省-3a(lH)-羧酸，二苯基甲基酯 將中間體94 (2_0克），三苯基膦（3.4克）及咪唑（186毫克） 在攪拌下回流，然後分小批加碘（610毫升）處理。繼續回流 4小時。將反應混合物冷卻，倒入過量的碳酸氫鈉水溶液中 ，於另一漏斗中加硫代硫酸鈉。將混合物搖盪至碘耗盡。 曱苯相用水洗，於硫酸鎂上乾燥並濃縮。殘餘物作閃柱色 層分析純化，用己烷：醋酸乙酯（15 : 1)及（5 : 1)洗離， 製得標題化合物（1.65克）。 ^ CDC13)： 9.73 (s, 1H, CHO), 7.26-7.44 (m, 10H, 2Ph)，6.98 (s，1H，C||Ph2)，6.04 (dd，1H, H-2, J=1.2及3.3 Hz)，4·25 (dd, 1H, H-l，，J=1.8及9.3 Hz)，4.08 (m，1H，H-41)， 3.67及4.01 (2d，2H，8aCH2, J=9 Hz)，3.40 (m，1H, H-3，）， 3.32(m,lH，H-5')，2.74(t，lH,H-l，J=4.2Hz),2.32&amp;amp;2.53 (2m, 2H, 2Η·2’）。 中間體9 6 [1尺-(13,331)，41)，4已1)，71)，7&amp;amp;3,8压1))]8&amp;amp;-[(2,3,6-三去氧-3-乙 -145- 本紙張尺度適用中國國家揉準（CNS ) Α4規格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁)</span>Hz), 3.44 (dq, 1H, H-51, Jd = 6.3 Hz, Jq = 8.7 Hz), 2.75 (t, 1H, J = 3.9 Hz). Intermediate 9 4 [1R- (1 a, 3a々, 4々, 4a / S, 7y3, 7a &amp;lt; ^, 8ay5)] 8a-[(2,6 -dideoxy_ 々-D-piperanose Yloxy) methyl] -4 -methanyl-4,4a, 5,6,7,7a 8,8a -octahydro-7-methyl-3- (1-methylethyl) -1, 4-Methylene _8_ called Shun Jian-3a (lH) -carboxylic acid, diphenyl methyl ester in the intermediate 93 (1 _ 5 grams) in tetrahydrofuran (30 ml) and methanol (15 ml of the mixture To the solution was added dropwise 1 N hydrochloric acid solution (15 ml) at room temperature under vigorous stirring. After the reaction was completed (TLC control), saturated sodium bicarbonate (50 ml) and ethyl acetate (200 ml) were added to separate the mixture The organic layer was washed with water (2 X 100 ml) and dried over magnesium sulfate. The solvent was evaporated to dryness. The residue was analyzed by flash layer on silica gel using ethyl acetate: hexane (5: 1 and ( 2: 1) Wash off to obtain the title compound (1.1 g) as a white foam. GH, CDC13): 9.73 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), -144- this paper For standard use, Chinese National Standard (CNS) A4 ^ (210 X 297mm) (Please read the notes on the back before filling this page) *? Τ A7 Β7 printed by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of invention (6.99 (s, 1H, CHPh2), 6.05 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.64 (dd, 1H , Η-Γ, J = 2.1 and 9.6 Hz), 4.11 (m, 1H, H-3 '), 4.06 (d, 1H, 8aCH2, JAB = 9.3 Hz), 3.70 (m, 2H, H-5' and 8aCH2), 3.34 (m, 1H, H-4 '), 2.75 (t, 1H, Hl, J = 3.6 Hz). Intermediate 9 5 [1R- (1 a, 3a Lu, 40,000, 4ay5, 7 Lu , 7aa, 8a point)] 8a-[(2,3,6-trideoxy-3-iodo-D-piperanosyloxy) methyl] -4-carboxamide-4,4 a, 5, 6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-theta province-3a (lH) -Carboxylic acid, diphenylmethyl ester Intermediate 94 (2-0 g), triphenylphosphine (3.4 g) and imidazole (186 mg) were refluxed under stirring, and then treated with iodine (610 ml) in small batches. Continue to reflux for 4 hours. The reaction mixture was cooled, poured into excess aqueous sodium bicarbonate solution, and sodium thiosulfate was added to another funnel. The mixture was shaken until the iodine was exhausted. The toluene phase was washed with water and dried over magnesium sulfate And concentrated. The residue was purified by flash column chromatography and washed with hexane: ethyl acetate (15: 1) and (5: 1) to obtain the title compound (1.65 g). ^ CDC13): 9.73 (s, 1H, CHO), 7.26-7.44 (m, 10H, 2Ph), 6.98 (s, 1H, C || Ph2), 6.04 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.25 (dd, 1H, Hl ,, J = 1.8 and 9.3 Hz), 4.08 (m, 1H, H-41), 3.67 and 4.01 (2d, 2H, 8aCH2, J = 9 Hz), 3.40 (m, 1H, H-3,), 3.32 (m, lH, H-5 '), 2.74 (t, lH, Hl, J = 4.2Hz), 2.32 &amp;amp; 2.53 (2m, 2H, 2Η · 2 '). Intermediate 9 6 [1 foot- (13,331), 41), 4 has 1), 71), 7 &amp;amp; 3,8 pressure 1))] 8 &amp;amp;-[(2,3,6-trideoxy-3- B-145- This paper scale is applicable to China National Standard (CNS) Α4 specification (210X297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標準局員工消费合作社印裝 A7 ____B7 五、發明説明（143) 胺基- 3- N- 4- 0-羰基b-D -別哌喃糖基氧基）甲基]_4_曱醯 基-4,4&amp;amp;，5，6,7,7&amp;amp;，8,8&amp;amp;-八氣-7-甲基_3-(1-甲基乙基）_ 1，4 -亞甲基-S -吲噠省- 3a(lH) -幾酸，二苯基甲基酯 將中間體95(200毫克）於無水四氫呋喃（15毫升）内之溶液 用氫化鈉（24毫克；1_0毫莫耳）處理。15分鐘後，加異氰酸 乙酯（0.04毫升）’此反應混合物於回流攪拌6小時。用水（3 毫升）使反應停止後，混合物用酷酸乙酯（3x5毫升）萃取， 合併之有機溶液用鹽水（lx 5毫升）處理，於硫酸鎂上乾燥 ，過濾並眞空濃縮成漿。於二氧化矽膠上作閃色層分析純 化，用己烷：醋酸乙酯3 : 1洗離，製得標題化合物（7 5毫 克）。 ^ CDC13): 9.74 (s, 1H, CHO), 7.44-7.26(m, 10H, 2Ph), 6.98 (s，1H，CHPh2)，6.03 (dd, 1H，H-2, J=3.3及 1.2 Hz)， 4.60 (dd，1H，Η-Γ，J=5.1 及3.9 Hz)，4.12 (m，2H, H-3', H-4')， 4.01 (d, 1H, H-8a, J=9.3 Hz), 3.64 (d, 1H, H-8a, J=9.3 Hz), 3.61(dq，lH，H_5l，J=8.7&amp;amp;6.3Hz),3.49(m，lH，C^2-CH3)， 3.13 (m, 1H, CH2-CH3), 2.70 (t, 1H, H-l, J=3.9 Hz), 2.24 (m, 1H，C廷(CH3)2), 1.14 (t，3H，C^，J=7.2 Hz)。 中間體9 7 [lR-(l&amp;lt;ar ,3a/? ,Α β ,1 β ,la.a ,8a/? ) ] 8 a-[ (1 S , 4 R, 6 S , 711，911)-2,8-二氧-4,9-二甲基-6-(甲硫基）硫代羰基氧基-順式-雙環[3.4.0]-壬-7-基-氧基甲基]-4-甲醯基-4,4a,5,6,7,7a,8,8a-八氫-7-甲基-3_(l-甲基乙基）-l,4-亞甲基-S-啕噠省-3a(lH)-羧酸，二苯基甲基酯 -146- 本紙張&amp;gt;^度逋用中國國家揉準（匚~5)八4規格（210乂297公釐） (請先閲讀背面之注意事項再填寫本頁)</span>A7 ____B7 Printed by the Employees ’Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs V. Description of the invention (143) Amino- 3- N- 4- 0-carbonyl bD -piperanyloxy) methyl] _4_ 曱 膯 基- 4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octaqi-7-methyl_3- (1-methylethyl) _ 1,4 -methylene-S-indap Provincial-3a (lH) -chiric acid, diphenylmethyl ester A solution of intermediate 95 (200 mg) in anhydrous tetrahydrofuran (15 ml) was treated with sodium hydride (24 mg; 1_0 mmol). After 15 minutes, ethyl isocyanate (0.04 ml) was added and the reaction mixture was stirred at reflux for 6 hours. After stopping the reaction with water (3 ml), the mixture was extracted with ethyl acetate (3x5 ml), the combined organic solution was treated with brine (lx 5 ml), dried over magnesium sulfate, filtered and concentrated to a slurry. Analyze and purify by flash layer on silica gel and wash off with hexane: ethyl acetate 3: 1 to prepare the title compound (75 mg). ^ CDC13): 9.74 (s, 1H, CHO), 7.44-7.26 (m, 10H, 2Ph), 6.98 (s, 1H, CHPh2), 6.03 (dd, 1H, H-2, J = 3.3 and 1.2 Hz) , 4.60 (dd, 1H, Η-Γ, J = 5.1 and 3.9 Hz), 4.12 (m, 2H, H-3 ', H-4'), 4.01 (d, 1H, H-8a, J = 9.3 Hz ), 3.64 (d, 1H, H-8a, J = 9.3 Hz), 3.61 (dq, lH, H_5l, J = 8.7 &amp;amp; 6.3Hz), 3.49 (m, lH, C ^ 2-CH3), 3.13 ( m, 1H, CH2-CH3), 2.70 (t, 1H, Hl, J = 3.9 Hz), 2.24 (m, 1H, Cting (CH3) 2), 1.14 (t, 3H, C ^, J = 7.2 Hz ). Intermediate 9 7 [lR- (l &amp;lt; ar, 3a /?, Α β, 1 β, la.a, 8a /?)] 8 a- [(1 S, 4 R, 6 S, 711,911)- 2,8-dioxo-4,9-dimethyl-6- (methylthio) thiocarbonyloxy-cis-bicyclo [3.4.0] -non-7-yl-oxymethyl]- 4-Methanoyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3_ (l-methylethyl) -l, 4-methylene-S- Chita province-3a (lH) -carboxylic acid, diphenylmethyl ester-146-this paper &amp;gt; ^ degree of using the Chinese national standard (匚 ~ 5) 8 4 specifications (210 to 297 mm) (please (Read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標準局貝工消費合作社印製 A7 B7 五、發明説明（144) 將中間體89b(250毫克）及咪唑（催化量）在氬氣下溶於無 水四氫呋喃内。加氫化鈉（45毫克），此懸浮液於室溫攪拌 20分鐘。加二硫化碳（14〇微升），繼續攪拌20分鐘，加甲 基碘（150微升）。2小時後加醋酸乙酯（1 0毫升）使反應停止 ’再滴加水（5毫升）。此混合物於醋酸乙酯（50毫升）及水 (50毫升）間分開，有機層用水及鹽水洗，然後乾燥並蒸發 。殘餘物於二氧化矽膠上作閃色層分析純化，用己烷：醋 酸乙酯（10 : 1)至（8 : 1)洗離，製得標題化合物（211毫克） 〇 ^ (]Η, CDC13): 9.72 (s, 1H, CHO), 7.46-7.22 (m, 10H, 2Ph)，6.97 (s，1H，CHPh2)，6.02 (dd，1H, H-2, J=1.2及3.3 Hz)，5.80 (dd, 1H，H-6·, J=2.1 及6.3 Hz)，4.72 (d，1H，H-7，， J=2.1Hz)，4.05(dd，lH，Ha-3’，J=7.2&amp;amp;8.4Hz)，3.98-3.86 (m， 2H，8aCHa及ΗΓ)，3.66-3.55 (m，2H，8aCHb及H-9.)，3.34 (t, 1H, Hb-3', J=8.4 Hz), 2.73 (t, 1H, HI, J=3.9 Hz), 2.59 (s, 3H，SCH3)。 中間體9 8 [111-(1»，3&amp;amp;点，4点，4&amp;amp;々，7/?,7&amp;amp;心8&amp;amp;々）]83_[(4-0-烯丙基-3 -碘-2,3,6 -三去氧- b- D-哌喃葡糖基氧基）甲基]-4 -甲醯基 -4,4a，5，6,7,7a，8,8a-八氫-7-甲基-3-(1-甲基乙基）-1,4-亞曱基-S-峋噠省-3a(lH)-羧酸，二苯基甲基酯 於中間體12(67毫克），三苯基膦（1〇5毫克）及咪唑（2 8毫 克）於無水四氫呋喃（5毫升）内之溶液以碘（5 1毫克）一滴滴 處理。此混合物於室溫攪拌1.5小時，於醋酸乙酯（30毫升） -147- 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公嫠） (請先閲讀背面之注意事項再填寫本頁)</span>Printed by Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Description of the invention (144) The intermediate 89b (250 mg) and imidazole (catalytic amount) were dissolved in anhydrous tetrahydrofuran under argon. Sodium hydride (45 mg) was added, and the suspension was stirred at room temperature for 20 minutes. Add carbon disulfide (14μl), continue stirring for 20 minutes, and add methyl iodide (150μl). After 2 hours, ethyl acetate (10 mL) was added to stop the reaction. Then water (5 mL) was added dropwise. This mixture was separated between ethyl acetate (50 mL) and water (50 mL), and the organic layer was washed with water and brine, then dried and evaporated. The residue was analyzed and purified by flash chromatography on silica gel, and washed away with hexane: ethyl acetate (10: 1) to (8: 1) to obtain the title compound (211 mg). (^ Η, CDC13 ): 9.72 (s, 1H, CHO), 7.46-7.22 (m, 10H, 2Ph), 6.97 (s, 1H, CHPh2), 6.02 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 5.80 (dd, 1H, H-6 ·, J = 2.1 and 6.3 Hz), 4.72 (d, 1H, H-7 ,, J = 2.1Hz), 4.05 (dd, lH, Ha-3 ', J = 7.2 &amp;amp;; 8.4Hz), 3.98-3.86 (m, 2H, 8aCHa and HΓ), 3.66-3.55 (m, 2H, 8aCHb and H-9.), 3.34 (t, 1H, Hb-3 ', J = 8.4 Hz) , 2.73 (t, 1H, HI, J = 3.9 Hz), 2.59 (s, 3H, SCH3). Intermediate 9 8 [111- (1 », 3 &amp;amp; point, 4 points, 4 &amp;amp; 々, 7 / ?, 7 &amp;amp; heart 8 &amp;amp; 々)] 83 _ [(4-0-allyl-3 -iodine-2 , 3,6-Trideoxy-b-D-glucopyranosyloxy) methyl] -4-carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro- 7-methyl-3- (1-methylethyl) -1,4-methylidene-S-pyrida-3a (lH) -carboxylic acid, diphenylmethyl ester in intermediate 12 (67 Mg), a solution of triphenylphosphine (105 mg) and imidazole (28 mg) in anhydrous tetrahydrofuran (5 ml) was treated dropwise with iodine (51 mg). This mixture is stirred at room temperature for 1.5 hours, and is in ethyl acetate (30 ml) -147- This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 public daughter) (please read the precautions on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T &amp;lt; A7 B7 五、 經濟部中央標準局貝工消費合作杜印製 32l644 發明説明（145) 及1當量鹽酸水溶液（30毫升）間分開。有機層相繼用1當量 鹽酸水溶液，水，焦亞硫酸鈉水溶液，水及鹽水洗，然後 乾燥，過濾並濃縮。殘餘物於二氧化矽膠上作色層分析純 化，用己烷：醋酸乙酯（9 : 1)洗離，製得標題化合物（68 毫克）。 ^ CH, CDC13)： 9.73 (s, 1H, CHO), 7.45-7.22 (m, 10H, 2Ph), 6.97 (s，1H, C|£Ph2)，6.07-5.9 (m, 2H, 11-2及0(：- CH=C), 5.37-5.14 (m, 2H, O-C-C^CI^), 4.45-4.35 (m, 1H, 〇-C廷a-C=C), 4.25-4.1 (m，2H, Η-Γ及〇-C|£b-C=C), 4.1-3.95 (m, 2H，H-3'及8a-CHa), 3.66 (d, 1H，8a-CHb，J=9 Hz), 3.29 (dq, 1H, H-5', J=6^.8.7 Hz), 3.15 (dd, 1H, H-4', J-8.7iL9.9 Hz)，2.73 (t，1H, H-l，J=3.9 Hz)。 中間體9 9 [1R-(1 π ,3aA，4々，4a々，7 0 ,7aa，8aA )]8a_[(2,3·脱水-6-去氧-b-D-哌喃甘露糖基氧基）甲基-4_(i，3·二氧戊環_2_基） -4，4a，5，6,7,7a，8,8a -八氫-7-甲基-3-(1-甲基乙基）-1，4-亞甲基-s-啕噠省-3a(lH)-羧酸，二苯基甲基酯 將中間體67(3.2毫莫耳）於乙腈（40毫升）内之溶液以乙二 醇（39毫升）’三曱基正甲酸酯（1.1毫升）及p_甲苯磺酸（30 毫升）處理。5小時後，此混合物用醋酸乙酯徹底萃取。除 去溶劑後，殘餘物作色層分析純化，用己烷：醋酸乙酯3 : 1洗離，製得標題化合物（2.08克）。 &amp;lt;y(1H,CDCl3):7.43&amp;amp;7.29(m，m,4H，6H，2xPh)，6.95(s， 1H, CHPh2), 5.86 (d, 1H, H-2, J-3.3 Hz), 5.08 (s, 1H, 4-CH), 148- 本紙張尺度逍用中國國家揉準（CNS ) A4規格（210X297公釐） (請先H讀背面之注意事項再填寫本頁)</span>, 1T &amp;lt; A7 B7 V. Du Printed by the Beigong Consumer Cooperation of the Central Standards Bureau of the Ministry of Economic Affairs 32l644 Description of the invention (145) and 1 equivalent of hydrochloric acid aqueous solution (30 ml). The organic layer was washed successively with 1N aqueous hydrochloric acid solution, water, aqueous sodium metabisulfite solution, water and brine, then dried, filtered and concentrated. The residue was chromatographically purified on silica gel and washed away with hexane: ethyl acetate (9: 1) to obtain the title compound (68 mg). ^ CH, CDC13): 9.73 (s, 1H, CHO), 7.45-7.22 (m, 10H, 2Ph), 6.97 (s, 1H, C | £ Ph2), 6.07-5.9 (m, 2H, 11-2 and 0 (：-CH = C), 5.37-5.14 (m, 2H, OCC ^ CI ^), 4.45-4.35 (m, 1H, 〇-C ting aC = C), 4.25-4.1 (m, 2H, Η- Γ and 〇-C | bC = C), 4.1-3.95 (m, 2H, H-3 'and 8a-CHa), 3.66 (d, 1H, 8a-CHb, J = 9 Hz), 3.29 (dq, 1H, H-5 ', J = 6 ^ .8.7 Hz), 3.15 (dd, 1H, H-4', J-8.7iL9.9 Hz), 2.73 (t, 1H, Hl, J = 3.9 Hz). Intermediate 9 9 [1R- (1 π, 3aA, 4々, 4a々, 7 0, 7aa, 8aA)] 8a _ [(2,3 · anhydro-6-deoxy-bD-piperanmannosyloxy ) Methyl-4_ (i, 3 · dioxolane_2_yl) -4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3- (1-methyl Ethyl) -1,4-methylene-s-pyda-3a (lH) -carboxylic acid, diphenylmethyl ester intermediate 67 (3.2 mmol) in acetonitrile (40 mL) The solution was treated with ethylene glycol (39 mL) 'trimethyl orthoformate (1.1 mL) and p-toluenesulfonic acid (30 mL). After 5 hours, the mixture was thoroughly extracted with ethyl acetate. After removing the solvent , The residue was purified by chromatography, washed away with hexane: ethyl acetate 3: 1 To prepare the title compound (2.08 g). &amp;Lt; y (1H, CDCl3): 7.43 &amp;amp; 7.29 (m, m, 4H, 6H, 2xPh), 6.95 (s, 1H, CHPh2), 5.86 (d, 1H, H-2, J-3.3 Hz), 5.08 (s, 1H, 4-CH), 148- The size of this paper is easy to use China National Standard (CNS) A4 specification (210X297mm) (please read the note on the back first (Fill in this page again)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央棣準局貝工消費合作社印製 A7 ^^_B7___ 五、發明説明（146) 4-69 (s, 1H, H-1'), 4.11 (d, 1H, 8a-CHa, J=9.3 Hz), 3.81 (m, 511，8&amp;amp;-。册，0-(：出&amp;lt;：|^-〇)，3.63(111，111,^1-5’），3_23及3.15 (d，d，1H，1H，H-21 及H-3, J=3.6 Hz)，3.20 (m, 1H，H-41)， 2.63 (m, 2H，H-l及C出CH3)2)。 之間體100 [1R-(1 a ,3a々，4々，4a卢，7点，7aa，8a々）]8&amp;amp;-[(2,3-脱水.4_ 氣基-6-去氧-b-D-哌喃甘露糖基氧基）甲基-4-(1, 3-二氧戊 環-2-基）-4,4a,5，6,7,7a，8,8a -八氫-7-甲基- 3- (1甲基 乙基）-1，4-亞甲基-s-啕噠省-3a(lH)-羧酸，二苯基甲基醋 將三氟醋酸酐（230微升）於爲水二氣甲烷（1〇毫升）内之溶 液於0°C以二甲基亞颯（138微升）及中間體99(0.9毫莫耳）於 無水二氣甲燒（10.毫升）内之溶液一滴滴處理。60分鐘後加 三乙基胺（554微升），此混合物於-20X：攪拌2小時。再以 二氣曱烷稀釋，用水洗。除去溶劑後，殘餘物作色層分析 純化，用己烷：醋酸乙酯4 : 1洗離，製得標題化合物（214 毫克）。 d(1H，CDCl3):7.44&amp;amp;7.30(m，m,4H，6H，2xPh),6.94(s， 1H，Cl|Ph2)，5.87 (dd，1H，H-2, J=1.5及3.6 Hz)，5.10 (s，1H， 4-CH), 4.81 (s, 1H, H-l'), 4.09 (d, 1H, 8a-CHa, J-8.7 Hz), 3.88(m,5H，8a-CHb&amp;amp;0-C|i2C|i2-0)，3.58&amp;amp;3.36(d，d，lH, 1H，H-2'及H-3'，J=3.9 Hz), 2.65 (m，2H, H-l及C廷(CH3)2)。 t間體101 [1汉-(1£^，3汪13,415,4313,71?，7&amp;amp;汪，8&amp;amp;1))]8&amp;amp;-[(2,3-脱水-4,6-二 去氧-4-亞曱基- b- D-哌喃甘露糖基氧基）甲基- 4- (1,3 -二氧 ___-149-___ 本紙張尺度適用中國國家標準（CNS ) Μ規格（210X297公釐） (請先閲讀背面之注意Ϋ項再填寫本頁) -訂 五、 經濟部中央裸準局員工消費合作社印裝 A7 B7 發明説明（ 戊環-2 -基）-4,4&amp;amp;,5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7-甲基_3-(1-甲基 乙基）-1,4-亞曱基-s-吲噠省-3 a(lH)-羧酸，二苯基曱基酯 將溴化甲基三苯基燐（0.3毫莫耳）於無水四氫呋喃（10毫 升）内之溶液在氮氣下於-78°C以正丁基鋰2.44M (0·15毫升） 處理。15分鐘後，緩慢加中間體1〇〇 (0.21毫莫耳）於四氫呋 喃（5毫升）内之溶液，此混合物於室溫慢慢加溫。此混合物 以酷酸乙酯稀釋，用氣化銨（1當量）及鹽水洗。除去溶劑後 ’殘餘物作色層分析純化，用己烷：醋酸乙酯4 : 1洗離， 製得標題化合物（9 1毫克）。 6(4, CDC13): 7.45 及 7.29 (m,m, 4Η，6Η，2xPh)，6.95 (S， 出，（：迎112)，5.87(〇1，111,11-2)，5.35及5.22((1,(1，111，111， CH2=C，J=2.4 Hz)，5.08 (s，1H, 4-CH)，4.68 (s，1H，H-l，）， 4·1〇 (m，2H，8a-CHa及H-5')，3.82 (m，5H，8a-CHb及O-C^2Cll2-〇)，3.57&amp;amp;3.35(d，d,lH，lH，H-2m-3,,J=3.9 Hz)，2.63 (m, 2H，H-l及C|i(CH3)2)。 中間體102 [1尺-(^，3&amp;amp;/?，4々，4以，70，7“，8&amp;amp;々）]83-[(2,3-脱水_6_ 去乳-b-D -略喃塔羅糖基氧基）甲基_4_(i,3二氧戊環_2_基） -4’4a，5,6,7,7a，8,8a-八氫-7-甲基-3_(1_甲基乙基）_14_ 亞甲基-s-啕噠省_3a(1H)_羧酸，二苯基甲基酯 ， 於中間體10〇(1·13毫莫耳）於無水四氫呋喃（45毫升）内之 溶液中在氮氣下於_78。匚緩慢加左旋-上當量（2毫 升）。一小時後，此混合物以醋酸乙酯稀釋，於室溫加溫， 用氣化按（1當量）水及鹽水洗。除去溶劑後，殘餘物作閃色 (請先閲讀背面之注意事項再填寫本X )</span>A7 ^^ _ B7___ printed by the Beigong Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economic Affairs 5. Description of the invention (146) 4-69 (s, 1H, H-1 '), 4.11 (d, 1H, 8a-CHa, J = 9.3 Hz), 3.81 (m, 511, 8 &amp;amp;-. Book, 0- (: out &amp;lt;: | ^ -〇), 3.63 (111, 111, ^ 1-5 '), 3_23 and 3.15 (d, d, 1H, 1H, H-21 and H-3, J = 3.6 Hz), 3.20 (m, 1H, H-41), 2.63 (m, 2H, H1 and C out CH3) 2). Interbody 100 [1R- (1 a, 3a々, 4々, 4a Lu, 7 o'clock, 7aa, 8a々)] 8 &amp;amp;-[(2,3-dehydration.4_ gas-based-6-deoxy-bD -Piperanmannosyloxy) methyl-4- (1,3-dioxolan-2-yl) -4,4a, 5,6,7,7a, 8,8a -octahydro-7- Methyl-3- (1methylethyl) -1,4-methylene-s-pyda-3a (lH) -carboxylic acid, diphenylmethyl acetate will trifluoroacetic anhydride (230 μl ) In a solution of dichloromethane (10 ml) in water at 0 ° C with dimethyl salazo (138 μl) and intermediate 99 (0.9 mmol) in anhydrous digas methane (10. ml) ) The solution inside is treated drop by drop. After 60 minutes, triethylamine (554 µl) was added, and the mixture was stirred at -20X: 2 hours. Then dilute with methane and wash with water. After removing the solvent, the residue was purified by chromatography and washed with hexane: ethyl acetate 4: 1 to obtain the title compound (214 mg). d (1H, CDCl3): 7.44 &amp; 7.30 (m, m, 4H, 6H, 2xPh), 6.94 (s, 1H, Cl | Ph2), 5.87 (dd, 1H, H-2, J = 1.5 and 3.6 Hz ), 5.10 (s, 1H, 4-CH), 4.81 (s, 1H, H-l '), 4.09 (d, 1H, 8a-CHa, J-8.7 Hz), 3.88 (m, 5H, 8a-CHb &amp;amp;; 0-C | i2C | i2-0), 3.58 &amp; 3.36 (d, d, lH, 1H, H-2 'and H-3', J = 3.9 Hz), 2.65 (m, 2H, Hl and C Ting (CH3) 2). t Interbody 101 [1 Han- (1 £ ^, 3 Wang 13,415,4313,71 ?, 7 &amp;amp; Wang, 8 &amp;amp; 1))] 8 &amp;amp;-[(2,3-anhydro-4,6-dideoxy -4-Methylene-b-D-piperanmannosyloxy) methyl-4- (1,3-dioxo ___- 149 -___ This paper scale is applicable to China National Standards (CNS) M specifications ( 210X297mm) (please read the note Ϋ on the back and fill in this page)-Order V. Printed A7 B7 Invention Instructions (Pentacyclic-2-yl) -4,4 &amp;amp; , 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl_3- (1-methylethyl) -1,4-methylidene-s-indap-3a (lH) -carboxylic acid, diphenylmethyl ester. A solution of methyltriphenylphosphonium bromide (0.3 millimoles) in anhydrous tetrahydrofuran (10 ml) was taken as n-butyl at -78 ° C under nitrogen. Lithium 2.44M (0.15ml) treatment. After 15 minutes, a solution of intermediate 100 (0.21 millimoles) in tetrahydrofuran (5ml) was slowly added, and the mixture was slowly warmed at room temperature. Diluted with ethyl acetate and washed with vaporized ammonium (1 equivalent) and brine. After removing the solvent, the residue was purified by chromatography, using hexane: ethyl acetate 4: 1 Wash away to obtain the title compound (91 mg). 6 (4, CDC13): 7.45 and 7.29 (m, m, 4Η, 6Η, 2xPh), 6.95 (S, out, (: Ying 112), 5.87 ( 〇1, 111, 11-2), 5.35 and 5.22 ((1, (1, 111, 111, CH2 = C, J = 2.4 Hz), 5.08 (s, 1H, 4-CH), 4.68 (s, 1H , H1,), 4.10 (m, 2H, 8a-CHa and H-5 '), 3.82 (m, 5H, 8a-CHb and OC ^ 2Cll2-〇), 3.57 &amp; 3.35 (d, d, lH, lH, H-2m-3 ,, J = 3.9 Hz), 2.63 (m, 2H, Hl and C | i (CH3) 2). Intermediate 102 [1 ft-(^, 3 &amp;amp; / ?, 4 々, 4 to, 70, 7 ", 8 &amp;amp; 々)] 83-[(2,3-dehydrated_6_ de-lactated-bD-leantalosyloxy) methyl_4_ (i, 3diox Pentane_2_yl) -4'4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3_ (1_methylethyl) _14_methylene-s-chida To save _3a (1H) _carboxylic acid, diphenylmethyl ester, in a solution of intermediate 10〇 (1.13 millimoles) in anhydrous tetrahydrofuran (45 ml) under nitrogen at _78. Slowly add left-handed equivalent (2 milliliters). After one hour, the mixture was diluted with ethyl acetate, heated at room temperature, and washed with water (1 equivalent) and brine with gasification. After removing the solvent, the residue flashes (please read the precautions on the back before filling in this X)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">-150- A7 —___ B7 五、發明説明（14δ) 層分析純化，用己烷：醋酸乙酯3 : 1洗離，製得標題化合 物（431毫克）。 d(1H,CDCl3):7.44&amp;amp;7.31(m,m，4H，6H，2xPh),6.95(s， lH，CiiPh2)，5.85(dd，lH,H-2,J=1.2&amp;amp;3.6Hz)，5.08(s，lH， 4-CH), 4.92 (s, 1H, Η-Γ), 4.11 (d, 1H, 8a-CHa, J=9.3 Hz), 3.83 (m，5H, 8a-CHb及OC^Cii^O)，3.62 (m，1H，H-4')， 3.54 (dd, 1H，H-31，J=3.6及5.1 Hz)，3.40 (m，1H, H-5')，3.24 (d，1H，H-2'，J=3.9 Hz)。 中間體103 [1尺-(1«，3&amp;amp;1)，41)，431)，715,733,8&amp;amp;1))]8&amp;amp;-[(2,3-脱水-4-0-三 級丁基羰基-6-去氧-b-D-哌喃塔羅糖基氧基）甲基-4-(l，3-二氧戊環-2-基）-4,4&amp;amp;,5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7-甲基-3-(1-甲基乙基）-1，4-亞甲基-s-β噠省-3a(lH)-羧酸，二苯基甲 基酯 將中間體102 (0.2毫莫耳）及4-二甲胺基吡啶（0.4毫莫耳） 於無水二氣甲烷（15毫升）内之溶液以新戊醯氣（0.3毫莫耳） 處理。30分鐘後，用.水洗，作閃色層分析純化，用己燒： 醋酸乙酯5 : 1洗離，製得標題化合物（95毫克）。 經濟部中央揉準局貝工消費合作社印裝 (請先閲讀背面之注意事項再填寫本頁) d(1H，CDCl3):7.44&amp;amp;7.30(m，m，4H，6H，2xPh)，6.95(s， 1H，C|iPh2)，5.85(dd，1H，H-2, J=1.2及3.6 Hz)，5.08 (s，in, 4-CH), 4.82 (t, 1H, H-4'，J=3.9 Hz), 4.60 (s, 1H, H-l')，4·12 (d，1H，8a-CHa, J=9.6 Hz), 3·83 (m，5H，8a-CHb及〇-CO^CH^-O), 3.65 (m, 1H, H-5'), 3.53 (t, 1H, H-3', J=4.2 Hz), 3.17 (d, 1H，H-21, J=4.2 Hz), 2.63 (m，2H，H_1 及 -151 - 本紙張尺度適用中國國家搮準（CNS ) A4規格（210X297公釐） &amp;quot; 經濟部中央樣準局貝工消费合作社印製 321644 at B7 五、發明説明（149) CH(CH3)2) 0 中間體104 [1R-(1 a，3ay5 ,4卢，4a万，7万，7aa ,8ayS )]8a-[(4-0-稀丙基- 2，3 -脱水-6-去氧- b- D-哌喃塔羅糖基氧基）甲基4(13- 一氧戊環-2-基）-4,4&amp;amp;，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7-曱基-3-(1_ 甲基乙基）-1，4 -亞甲基- s-θ丨達省- 3a(lH) -叛酸，二苯基甲 基酯 於中間體102 (0.3毫莫耳）於無水四氫呋喃（1〇毫升）内之 溶液中在氮氣下加氫化鈉（0.6毫莫耳）及催化量的破化四丁 基銨。3 0分鐘後加缔丙基溴（0.9毫莫耳），此混合物於室溫 攪拌過夜。然後用醋酸乙酯（10毫升）稀釋，用氣化銨（1當 量）及鹽水洗。除去溶劑後，殘餘物作閃色層分析純化，用 己烷：醋酸乙酯4 : 1洗離，製得標題化合物（163毫克）。 β OH, CDC13): 7·44及7_29 (m，m，4H，6H，2xPh)，6.95 (S, 1H，C廷Ph2)，5.96 (m，1H，H-2M), 5.85 (dd, 1H, H-2, J=1.2及 3.6 Hz)，5.30&amp;amp;5.12(m，m，lH,lH，CH2_3”)，5.06(s，lH，4- CH), 4.58 (s, 1H, Η-Γ), 4.31 (m, 1H, H-4'), 4.10 (m, 2H, H-5’及8a-CHa), 3.83 (m，5H, 8a-CHb^O-CH7 CH〇 -O), 3.53 (m， 2H，CH20), 4.23 (t，1H，H-3’，J=4.2 Hz)，3.19 (d，1H，H-2，， J=4.2 Hz), 2.65 (t, 1H, H-l, J=4.2 Hz), 2.61 (m, 1H, CH(CH3)2) 〇 中間體105 [1R-(1 a，3a卢，4卢，4a0，7卢，7aor，8a々）]8a-[(2,3-脱水-6- 去氧- 4- 0甲苯磺醯基- b- D-哌喃塔羅糖基氧基）甲基_4_ -152- 本紙張尺度逋用中國國家標準（CNS ) A4规格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁) 訂 -S! 經濟部中央標準局貝工消費合作社印聚 A7 B7 五、發明説明（15°) (1，3-二氧戊環-2-基）-4,4&amp;amp;,5,6,7,73,8,8&amp;amp;-八氫-7_甲基_ 3-(1-甲基乙基）-1,4 -亞甲基_s_p?丨噠省_3a(1H)_羧酸，二 苯基甲基酯 將中間體102 (0.45毫莫耳）於無水二氣甲烷毫升）内之 落液以4-二曱胺基吡啶（1.35毫莫耳）及甲苯磺醯氣（0.9毫莫 耳）處理’並於室溫攪拌過夜。此後用水及鹽水洗。除去溶 劑後’殘餘物作色層分析純化，用己烷：醋酸乙酯3 : 1洗 離。蒸發適宜的部分’製得標題化合物（277毫克）。 ^ (!Η, CDC13): 7.86, 7.42^7.29 (m,m, 10H, Ar), 6.93 (s, 1H, CHPh2), 5.82 (m, 1H, H-2), 5.06 (s, 1H, 4-CH), 4.68 (t, 1H, H-3', J=4.2 Hz), 4.55 (s, 1H, H-l'), 4.07 (d, 1H, 8a-CHa, J=8.7 Hz)，3.81 (m，5H, 8a-CHb及O-C^CI^-O)，3.62 (m, 1H, H-5'), 3.30 (t, 1H, H-2', J=4.2 Hz), 3.15 (d, 1H, H-4', J=3.9 Hz), 2·61 (m, 2H, H-l及C|i(CH3)2)。 中間體106 [1R-(1 « ,3ay9，4y5，4a卢，，7aa，8a卢）]8&amp;amp;-[(2,3-脱水-4-4氮基-4,6-二去氧-1)-1)-哌喃甘露糖基氧基）甲基_4_(1，3_ 二氧戊環-2-基）-4,4&amp;amp;，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7-甲基-3-(1_ 甲基乙基）-1,4-亞曱基u丨噠省-3a(lH)-羧酸，二苯基甲 基酯 將中間體105 (0_ 15毫莫耳）及疊氮化鋰（0.45毫莫耳）於無 水二甲基甲醯胺（3毫升）内之溶液於l〇〇〇c加熱過夜。此混 合物以醋酸乙酯稀釋，用水及鹽水洗，殘餘物作閃色層分 析純化’用己烷：醋酸乙酯4 : 1洗離。蒸發適宜的部分， -153- 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） (请先閱讀背面之注意事項再填寫本萸)</span>-150- A7 —___ B7 V. Description of the invention (14δ) Layer analysis and purification, washing away with hexane: ethyl acetate 3: 1 to prepare the title compound (431 mg). d (1H, CDCl3): 7.44 &amp;amp; 7.31 (m, m, 4H, 6H, 2xPh), 6.95 (s, lH, CiiPh2), 5.85 (dd, lH, H-2, J = 1.2 &amp;amp; 3.6Hz) , 5.08 (s, lH, 4-CH), 4.92 (s, 1H, Η-Γ), 4.11 (d, 1H, 8a-CHa, J = 9.3 Hz), 3.83 (m, 5H, 8a-CHb and OC ^ Cii ^ O), 3.62 (m, 1H, H-4 '), 3.54 (dd, 1H, H-31, J = 3.6 and 5.1 Hz), 3.40 (m, 1H, H-5'), 3.24 ( d, 1H, H-2 ', J = 3.9 Hz). Intermediate 103 [1-foot- (1 «, 3 &amp;amp; 1), 41), 431), 715,733,8 &amp;amp; 1))] 8 &amp;amp;-[(2,3-anhydro-4-0-tertiary butylcarbonyl -6-deoxy-bD-piperantalosyloxy) methyl-4- (l, 3-dioxolan-2-yl) -4,4 &amp;amp;, 5,6,7,7 &amp;amp; , 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-βpyridine-3a (lH) -carboxylic acid, diphenyl Methyl ester solution of intermediate 102 (0.2 millimoles) and 4-dimethylaminopyridine (0.4 millimoles) in anhydrous digas methane (15 ml) was neopentyl gas (0.3 millimoles) deal with. After 30 minutes, it was washed with water and purified by flash chromatography. It was washed away with hexane: ethyl acetate 5: 1 to obtain the title compound (95 mg). Printed by the Beigong Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs (please read the notes on the back before filling out this page) d (1H, CDCl3): 7.44 &amp;amp; 7.30 (m, m, 4H, 6H, 2xPh), 6.95 s, 1H, C | iPh2), 5.85 (dd, 1H, H-2, J = 1.2 and 3.6 Hz), 5.08 (s, in, 4-CH), 4.82 (t, 1H, H-4 ', J = 3.9 Hz), 4.60 (s, 1H, H-l '), 4.12 (d, 1H, 8a-CHa, J = 9.6 Hz), 3.83 (m, 5H, 8a-CHb and 〇-CO ^ CH ^ -O), 3.65 (m, 1H, H-5 '), 3.53 (t, 1H, H-3', J = 4.2 Hz), 3.17 (d, 1H, H-21, J = 4.2 Hz ), 2.63 (m, 2H, H_1 and -151-This paper scale is applicable to China National Standard (CNS) A4 specification (210X297mm) &amp;quot; Printed by the Central Sample Bureau of the Ministry of Economic Affairs, 321644 at B7. DESCRIPTION OF THE INVENTION (149) CH (CH3) 2) 0 Intermediate 104 [1R- (1 a, 3ay5, 4 Lu, 4a million, 70,000, 7aa, 8ayS)] 8a-[(4-0-allyl- 2,3-Dehydrated-6-deoxy-b-D-piperantarosyloxy) methyl 4 (13-monooxolane-2-yl) -4,4 &amp;amp;, 5,6,7 , 7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-θda da province-3a (lH) -tetioic acid, Diphenyl methyl ester in intermediate 102 (0 .3 millimoles) in anhydrous tetrahydrofuran (10 ml) was added sodium hydride (0.6 millimoles) and a catalytic amount of decomposed tetrabutylammonium under nitrogen. After 30 minutes, propyl bromide (0.9 mmol) was added, and the mixture was stirred at room temperature overnight. It was then diluted with ethyl acetate (10 mL) and washed with vaporized ammonium (1 equivalent) and brine. After removing the solvent, the residue was purified by flash chromatography and washed with hexane: ethyl acetate 4: 1 to obtain the title compound (163 mg). β OH, CDC13): 7.44 and 7_29 (m, m, 4H, 6H, 2xPh), 6.95 (S, 1H, Cin Ph2), 5.96 (m, 1H, H-2M), 5.85 (dd, 1H , H-2, J = 1.2 and 3.6 Hz), 5.30 &amp;amp; 5.12 (m, m, lH, lH, CH2_3 ”), 5.06 (s, lH, 4-CH), 4.58 (s, 1H, Η-Γ ), 4.31 (m, 1H, H-4 '), 4.10 (m, 2H, H-5' and 8a-CHa), 3.83 (m, 5H, 8a-CHb ^ O-CH7 CH〇-O), 3.53 (m, 2H, CH20), 4.23 (t, 1H, H-3 ', J = 4.2 Hz), 3.19 (d, 1H, H-2 ,, J = 4.2 Hz), 2.65 (t, 1H, Hl, J = 4.2 Hz), 2.61 (m, 1H, CH (CH3) 2) 〇Intermediate 105 [1R- (1a, 3a Lu, 4 Lu, 4a0, 7 Lu, 7aor, 8a々)] 8a-[( 2,3-anhydro-6-deoxy- 4-0 tosylate-b-D-piperantarosyloxy) methyl_4_-152- This paper scale uses the Chinese National Standard (CNS) A4 specification (210X297mm) (please read the notes on the back before filling in this page) Order-S! Printed and printed A7 B7 by the Beigong Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (15 °) (1, 3- Dioxolane-2-yl) -4,4 &amp;amp;, 5,6,7,73,8,8 &amp;amp; -octahydro-7_methyl_3- (1-methylethyl) -1,4 -Methylene_s_p? 丨 da province_3a (1H) _carboxylic acid, diphenyl The ester was treated with 4-dimethylaminopyridine (1.35 mmol) and tosylate (0.9 mmol) in a solution of intermediate 102 (0.45 mmol) in anhydrous methane (mL). The mixture was stirred overnight at room temperature. After that, it was washed with water and brine. After removing the solvent, the residue was purified by chromatography and washed with hexane: ethyl acetate 3: 1. Evaporation of the appropriate fractions gave the title compound (277 mg ). ^ (! Η, CDC13): 7.86, 7.42 ^ 7.29 (m, m, 10H, Ar), 6.93 (s, 1H, CHPh2), 5.82 (m, 1H, H-2), 5.06 (s, 1H , 4-CH), 4.68 (t, 1H, H-3 ', J = 4.2 Hz), 4.55 (s, 1H, H-l'), 4.07 (d, 1H, 8a-CHa, J = 8.7 Hz) , 3.81 (m, 5H, 8a-CHb and OC ^ CI ^ -O), 3.62 (m, 1H, H-5 '), 3.30 (t, 1H, H-2', J = 4.2 Hz), 3.15 ( d, 1H, H-4 ', J = 3.9 Hz), 2 · 61 (m, 2H, Hl and C | i (CH3) 2). Intermediate 106 [1R- (1 «, 3ay9, 4y5, 4a Lu, 7aa, 8a Lu)] 8 &amp;amp;-[(2,3-anhydro-4-4aza-4,6-dideoxy-1 ) -1) -piperanmannosyloxy) methyl_4_ (1,3-dioxol-2-yl) -4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp;- Octahydro-7-methyl-3- (1_methylethyl) -1,4-methylidene u-da-3a (lH) -carboxylic acid, diphenylmethyl ester intermediate 105 (0_ 15 mmol) and lithium azide (0.45 mmol) in anhydrous dimethylformamide (3 mL) were heated at 100 ° C overnight. The mixture was diluted with ethyl acetate, washed with water and brine, and the residue was purified by flash chromatography. It was washed away with hexane: ethyl acetate 4: 1. Appropriate for evaporation, -153- This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297mm) (Please read the precautions on the back before filling in this cornel)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">,1T r A7 B7_______ 五、發明説明（151) 製得標題化合物（53毫克）。 δ (^, CDC13)： 7.46-7.23 (m, 10H, Ph2), 6.94 (s, 1H, C廷Ph2)，5.86(dd，1H, H-2, J=1.2&amp;amp;3.6Hz)，5.08(s，lH，4- CH), 4.67 (s, 1H, H-l'), 4.10 (d, 1H, 8a-CHa, J=8.7 Hz), 3.83 (m, 4H, 8a-CHb及O-Ci^CL-O), 3.40 (d, 1H，H-4’， J=9.3 Hz)，3.31 及3.15 (d，d, H-2'及H-3'，J=3.6 Hz)，3.23 (m， 1H, H-5’），2.65 (m，2H，H-l及C|i(CH3)2)。 中間體107</span>, 1T r A7 B7_______ V. Description of the invention (151) The title compound (53 mg) was prepared. δ (^, CDC13): 7.46-7.23 (m, 10H, Ph2), 6.94 (s, 1H, Ctin Ph2), 5.86 (dd, 1H, H-2, J = 1.2 &amp;amp; 3.6Hz), 5.08 ( s, lH, 4-CH), 4.67 (s, 1H, H-l '), 4.10 (d, 1H, 8a-CHa, J = 8.7 Hz), 3.83 (m, 4H, 8a-CHb and O-Ci ^ CL-O), 3.40 (d, 1H, H-4 ', J = 9.3 Hz), 3.31 and 3.15 (d, d, H-2' and H-3 ', J = 3.6 Hz), 3.23 (m , 1H, H-5 '), 2.65 (m, 2H, Hl and C | i (CH3) 2). Intermediate 107</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[1R-(1 a，3a；9，4y9，4a&amp;gt;5，7冷，7aα^，8ay9)]8a-[(4-0-締丙基_ 2,3-脱水·6-去氧-b-D-哌喃甘露糖基氧基）甲基]-4-甲醯 基-4，4a，5,6,7,7a，8,8a-八氫-7-甲基-3-(1-甲基乙基）_ 1，4-亞曱基-s-β噠省-3a(lH)-羧酸，二苯基甲基酯 步驟A 於中間體2 1 (650毫克）於50毫升THF内之溶液中於〇°C加 90毫克氫化鈉。此混合物在氮氣下於〇°C攪拌30分鐘。然 後加875毫克烯丙基溴及催化量的碘化四丁基銨（5〇毫克）。 於室溫攪拌5小時後反應完成。此粗製品以1當量氣化銨及 醋酸乙酯處理。有機層用水及鹽水洗，於]^1§804上乾燥， 經濟部中央樣準局貝工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 並蒸發至乾。殘餘物於二氧化矽膠柱作色層分析，用正 己烷··醋酸乙酯7 : 1洗離，製得500毫克標題化合物，爲 白色泡沫。</span>[1R- (1 a, 3a; 9, 4y9, 4a &amp;gt; 5, 7 cold, 7aα ^, 8ay9)] 8a-[(4-0-associated propyl 2,3-anhydro-6-deoxy-bD -Piperanmannosyloxy) methyl] -4-carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methyl Ethyl) _ 1,4-methylidene-s-β-pyridin-3a (lH) -carboxylic acid, diphenylmethyl ester Step A solution of intermediate 2 1 (650 mg) in 50 ml of THF Add 90 mg of sodium hydride at 0 ° C. This mixture was stirred at 0 ° C for 30 minutes under nitrogen. Then 875 mg of allyl bromide and a catalytic amount of tetrabutylammonium iodide (50 mg) were added. After stirring at room temperature for 5 hours, the reaction was completed. This crude product is treated with 1 equivalent of gasified ammonium and ethyl acetate. The organic layer is washed with water and brine, dried on] ^ 1§804, and printed by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) and evaporate to dryness. The residue was subjected to chromatography on a silica gel column and washed away with n-hexane · ethyl acetate 7: 1 to obtain 500 mg of the title compound as a white foam.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">步驟B 於中間體53(3克）於無水二氣甲烷（2〇〇毫升）内之溶液中 於室溫加2.35克二甲胺基吡啶。再於攪拌下緩慢加3.66克 __ -154-___ 本紙張认適用中關家揉準（（：叫八4胁（21(^297公釐) ~ &amp;quot; 經濟部中央標準局貝工消費合作社印製 A7 B7 五、發明説明（, '''~~~' ~ 甲苯續酿氣於100毫升二氣甲燒内之溶液。此混合物於室溫 攪拌三天至反應完全。粗製產物用丨當量鹽酸，飽和碳酸氫 鈉溶液及鹽水洗。有機層於硫酸鎂上乾燥，過滤，用2〇毫 升甲氧化鈉於甲醇内之溶液（25重量％)處理。此混合物於 室溫攪拌1天。粗製產物用1當量鹽酸處理，用水及鹽水洗 。有機層於無水硫酸鎂上乾燥並蒸發。殘餘物作閃色層分 析純化’用正己燒：醋酸乙酯8 : 1洗離，製得標題化合物 ，爲白色泡沫（總產出率4 5 %)。 ci (}Η, CDC13)： 9.75 (s, 1H, CHO), 6.99 (s, 1H, CHPh2), 6.08 (dd, 1H, H-12, J=1.2^3.3 Hz), 5.90 (m, 1H, CH=CH2), 5.28 (m, 2H, CH=CH2), 4.69 (d, 1H，H-l，J=l.2 Hz), 4.23 (m， 1H, H-5'), 4.11 (d, 1H, H-19a, J=9 Hz), 4.06 (m, 1H, H-4'), 3.79 (d, 1H, H-19b, J=9 Hz), 3.26 (d, 1H, H-2', J=3.9 Hz), 3.21 (m, 2H, Cii2-CH=CH2)，3.13 (d，1H，H-3.，J=3.9 Hz)， 2.86 (t, 1H，H-ll，J=3.6 Hz)。 中間體108 [1R-(1 a，3a点，4卢，4a/?，7々，7aa ,8a々）]8a-[(2,3-脱水-6-去氧-4-0-(2,3-二羥基丙基）b-D-哌喃甘露糖基氧基）甲基] -4 -曱醯基-4,4a，5,6,7,7a，8,8a -八氫-7-曱基- 3- (1-曱基 乙基）-1，4-亞甲基-s-吲噠省-3a(lH)-羧酸，二苯基甲基酯 於中間體107 (2克）於50毫升丙酮及5毫升水之溶液中於〇 °C加1克N-甲基嗎福啉。於此混合物中緩慢加〇.2毫升四氧 化餓溶液（於異丁醇内的2.5 %重量比溶液）。於室溫經3天 後此GM 218045X羥基化反應即完全。粗製產物用硫氫化 -155- ^紙張尺度逍用中國國家梂準（CNS ) A4規格（210X297公 (請先閱讀背面之注意事項再填寫本頁)</span>Step B To a solution of intermediate 53 (3 g) in anhydrous digas methane (200 ml) was added 2.35 g of dimethylaminopyridine at room temperature. Then slowly add 3.66 grams under stirring __ -154 -___ This paper is suitable for Zhongguanjia rubbing ((: called eight 4 threats (21 (^ 297mm) ~ &amp;quot; Beigong Consumer Cooperative of Central Bureau of Standards, Ministry of Economic Affairs Printed A7 B7 V. Description of the invention (, '' '~~~' ~ A solution of toluene continuous brewing gas in 100 ml of two-gas methane. This mixture was stirred at room temperature for three days until the reaction was complete. The crude product was equivalent Hydrochloric acid, saturated sodium bicarbonate solution and brine. The organic layer was dried over magnesium sulfate, filtered, and treated with 20 ml of sodium methoxide in methanol (25% by weight). The mixture was stirred at room temperature for 1 day. Crude The product was treated with 1 equivalent of hydrochloric acid, washed with water and brine. The organic layer was dried over anhydrous magnesium sulfate and evaporated. The residue was purified by flash chromatography analysis and washed away with n-hexane: ethyl acetate 8: 1 to obtain the title compound, It is a white foam (total output rate 45%). Ci (} Η, CDC13): 9.75 (s, 1H, CHO), 6.99 (s, 1H, CHPh2), 6.08 (dd, 1H, H-12, J = 1.2 ^ 3.3 Hz), 5.90 (m, 1H, CH = CH2), 5.28 (m, 2H, CH = CH2), 4.69 (d, 1H, Hl, J = l.2 Hz), 4.23 (m, 1H , H-5 '), 4.11 (d, 1H, H-19a , J = 9 Hz), 4.06 (m, 1H, H-4 '), 3.79 (d, 1H, H-19b, J = 9 Hz), 3.26 (d, 1H, H-2', J = 3.9 Hz ), 3.21 (m, 2H, Cii2-CH = CH2), 3.13 (d, 1H, H-3., J = 3.9 Hz), 2.86 (t, 1H, H-ll, J = 3.6 Hz). Intermediate 108 [1R- (1 a, 3a point, 4 Lu, 4a / ?, 7々, 7aa, 8a々)] 8a-[(2,3-anhydro-6-deoxy-4-0- (2,3 -Dihydroxypropyl) bD-piperanmannosyloxy) methyl] -4 -methyl-4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl- 3- (1-Methylethyl) -1,4-methylene-s-indap-3a (lH) -carboxylic acid, diphenylmethyl ester in intermediate 107 (2g) in 50ml To a solution of acetone and 5 ml of water, add 1 g of N-methylmorpholine at 0 ° C. To this mixture, slowly add 0.2 ml of a solution of tetrahydrochloride (2.5% by weight solution in isobutanol) The GM 218045X hydroxylation reaction is complete after 3 days at room temperature. The crude product is hydrosulfide-155- ^ paper size and used in China National Standards (CNS) A4 specification (210X297 (please read the precautions on the back (Fill in this page again)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央橾準局負工消费合作社印裝 A7 B7 五、發明説明（153) 鈉處理，於矽藻土上過濾，並蒸發至乾。將殘餘物溶於醋 酸乙酯内，用水及鹽水洗。有機層於無水硫酸鎂上乾燥並 蒸發。殘餘物作色層分析，用正己烷：醋酸乙酯1 : 1及二 氯甲烷：甲醇50 : 1洗離。製得標題化合物（50 : 50對映 異構物混合物），爲白色泡沫（1.75克）。 0 (^, CDC13): 9.75 (s, 1H, CHO), 6.99 (s, 1H, CHPh2), 6.08 (dd，1H, H-12, J=1.5及3.6 Hz), 4.69 (s，1H，Η-Γ)，4.10 (d, 1H, H-19a, J=9.3 Hz), 3.90-3.58 (m, 5H, CI^OH, CHOH, OC^-CHOH in 4'), 3.79 (d, 1H, H-19b, J=9.3 Hz), 3.27, 3.13 (d, d，1H，1H，H-21 及H-31，J=3.9 Hz), 3.28-3.22 (m, 2H, H-4,及H-5'), 2.85 (t，1H，H-ll, J=3.6 Hz)。 中間體109 [1 R-( 1 a，3ab，4b，4ab，7b，7aa，8ab) ]8a-[(2,3 -脱水-6-去氧-4-〇-(2,3-0 -異亞丙基）-2,3 -二羥基丙基]-b-D -哌喃甘露 糖基乳基）甲基]-4 -甲酿基-4，4a,5,6,7,7a, 8,8a -八氣- 7-f基-3-(1-甲基乙基）-1,4-亞甲基-3_4噠省-3&amp;amp;(1”-羧 酸，二苯基曱基酯 於中間體108 (350克）於無水丙_(2〇毫升）之溶液中加 250毫升2,2 -二甲氧基丙烷及催化量的p_甲苯確酸（30毫克) 。此混合物於室溫在氮氣下攪拌2小時。將粗製物蒸發至乾 ，殘餘物再溶於醋酸乙酯（7〇毫升）内，用水及鹽水洗。將 有機層濃縮，以二氧化矽膠柱用正己烷：醋酸乙酯6 : 1純 化’製得標題化合物（5 0 : 5 0異構物），爲白色泡沫（290毫 克，產出率8 0 %)。 __ -156- 本紙張从逍用中國國家揉率（CNS )八4胁（210X297公釐) ' (请先閱讀背面之注意事項再填寫本頁)</span>Printed and printed by the Negative Consumers Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economic Affairs A7 B7 V. Description of the invention (153) Sodium treatment, filtered on diatomaceous earth and evaporated to dryness. The residue was dissolved in ethyl acetate and washed with water and brine. The organic layer was dried over anhydrous magnesium sulfate and evaporated. Chromatographic analysis of the residue was carried out with n-hexane: ethyl acetate 1: 1 and dichloromethane: methanol 50: 1. The title compound (50:50 enantiomer mixture) was obtained as a white foam (1.75 g). 0 (^, CDC13): 9.75 (s, 1H, CHO), 6.99 (s, 1H, CHPh2), 6.08 (dd, 1H, H-12, J = 1.5 and 3.6 Hz), 4.69 (s, 1H, Η -Γ), 4.10 (d, 1H, H-19a, J = 9.3 Hz), 3.90-3.58 (m, 5H, CI ^ OH, CHOH, OC ^ -CHOH in 4 '), 3.79 (d, 1H, H -19b, J = 9.3 Hz), 3.27, 3.13 (d, d, 1H, 1H, H-21 and H-31, J = 3.9 Hz), 3.28-3.22 (m, 2H, H-4, and H- 5 '), 2.85 (t, 1H, H-ll, J = 3.6 Hz). Intermediate 109 [1 R- (1 a, 3ab, 4b, 4ab, 7b, 7aa, 8ab)] 8a-[(2,3 -anhydro-6-deoxy-4-〇- (2,3-0- Isopropylidene) -2,3-dihydroxypropyl] -bD-piperannomannosyl lactyl) methyl] -4-methylbromo-4,4a, 5,6,7,7a, 8, 8a -octagas- 7-fyl-3- (1-methylethyl) -1,4-methylene-3_4pyridine-3 &amp; (1 "-carboxylic acid, diphenylmethyl ester in the middle To a solution of body 108 (350 g) in anhydrous propylene (20 mL), add 250 mL of 2,2-dimethoxypropane and a catalytic amount of p-toluic acid (30 mg). This mixture is at room temperature Stir for 2 hours under nitrogen. The crude material was evaporated to dryness, and the residue was redissolved in ethyl acetate (70 mL), washed with water and brine. The organic layer was concentrated and used silica gel column with n-hexane: ethyl acetate 6: 1 Purification 'to prepare the title compound (50:50 isomer) as a white foam (290 mg, 80% yield). __ -156- This paper is used from the Chinese National Kneading Ratio (CNS) ) Eight 4 threats (210X297mm) '(Please read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央橾準局貝工消費合作社印裝 A7 ____B7___ 五、發明説明（154) ά (ΧΗ, CDC13)： 9.74 (s, 1H, CHO), 6.99 (s, 1H, CHPh2), 6.08 (dd, 1H，H-12, J=〇.9及3.3 Hz), 4.67 (d, 1H, Η-Γ, J=2.1</span>A7 ____B7___ Printed by the Beigong Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economic Affairs 5. Description of Invention (154) ά (ΧΗ, CDC13): 9.74 (s, 1H, CHO), 6.99 (s, 1H, CHPh2), 6.08 (dd, 1H, H-12, J = 0.9 and 3.3 Hz), 4.67 (d, 1H, Η-Γ, J = 2.1</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.32-4.22 (m, 1H, CHOH in 4'), 4.12-4.03 (m, 2H, H-19a及OC^ in 4’），3.82-3.51 (m，4H, H-19b，OC^-CHOH-Cii20)，3.29&amp;amp;3.12(d，d，lH，lH,H-2m-3，，J=3.9Hz)， 3.26-3.20 (m，2H，H-4'及H-5')，2.85 (t, 1H，H-ll，J=3_9 Hz)， 1_42及4.36 (d，d，3H，3H，異丙晞基的（CH3)2-C)。 實例1 [1R-(1 a，3a/5，4/5，4a/5 ,7/9，7aa，8a卢）]8a-[(6-去氧-3,4-〇-異亞丙基-/? -D-阿卓哌喃糖基氧基）甲基]_4_甲醯基_ 4,4a，5,6,7,7a，8,8a-八氫-7-甲基-3-(l-甲基乙基）-l,4-亞甲基-s -丨噠省-3 a (1 Η)-羧酸 於10%鈀/碳（80毫克）於醋酸乙酯（1()毫升）内之懸浮液 中在氮氣下加中間體2(180毫克）於醋酸乙酯（1〇毫升）内之 各液，此混合物於室溫在3 0碎/对2氫壓下氫化1小時。滅 除催化劑’蒸發去溶劑至乾。於二氧化碎膠上作閃色層分 析，用二氣甲烷：曱醇（20 :丨）洗離，製得標題化合物 (128毫克）。</span>Hz), 4.32-4.22 (m, 1H, CHOH in 4 '), 4.12-4.03 (m, 2H, H-19a and OC ^ in 4'), 3.82-3.51 (m, 4H, H-19b, OC ^ -CHOH-Cii20), 3.29 &amp; 3.12 (d, d, lH, lH, H-2m-3, J = 3.9Hz), 3.26-3.20 (m, 2H, H-4 'and H-5') , 2.85 (t, 1H, H-ll, J = 3_9 Hz), 1_42 and 4.36 (d, d, 3H, 3H, isopropyl (CH3) 2-C). Example 1 [1R- (1 a, 3a / 5, 4/5, 4a / 5, 7/9, 7aa, 8a Lu)] 8a-[(6-deoxy-3,4-〇-isopropylidene -/? -D-Azepinelpyranosyloxy) methyl] _4_formyl_4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (l-methylethyl) -l, 4-methylene-s-dipyridine-3 a (1 Η) -carboxylic acid in 10% palladium / carbon (80 mg) in ethyl acetate (1 () Ml) of the suspension in Intermediate 2 (180 mg) in ethyl acetate (10 ml) under nitrogen, the mixture was hydrogenated at room temperature under 30 min / p 2 hydrogen pressure for 1 hour . The catalyst is eliminated and the solvent is evaporated to dryness. A flash layer analysis was carried out on the crushed silica, and washed away with methane: methanol (20: 丨) to obtain the title compound (128 mg).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ci CDC13)： 9.73 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J-1.5及3.3 Hz)，4.61 (d, 1H，Η-Γ, J=2.1 Hz), 4.30 (dd, 1H, H-3’，J=3.6&amp;amp;5.4Hz)，4.04(d,lH，8aCH2，J=9.3Hz)3.95 (dd，1H，H-2'，J=2.1 及3_6 Hz)，3.85 (dd，1H，H-4，，J=5.4及 9.0 Hz), 3.66 (d, 1H, J=9.3 Hz), 3.49 (dq, 1H, H-5' Jd=9.〇 Hz, Jq=6.3 Hz), 2.69 (t, 1H，H-l, J=3.6 Hz); j (13(：, 一 -157- l紙張尺度逍用中國國家揉準（CNS ) A4规格（210X297公釐） ~ (請先閲讀背面之注項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印裝 A7 B7___. 五、發明説明（15弓 CDC13)： 204.8 (CHO), 175.4 (C02H), 148.3 (C-3), 13〇·7 (C-2), 109.3 (Cq.isop), (98.9 (C-l')5 76.9 (C-4'), 75.8 (C-2'), 74.2 (8aCH2), 71.7 (C-3'), 68.6 (C-5'), 65.6 (C-8a), 58.9 (C- 4) o 實例2 [1尺-(1&amp;lt;^，3巳;5,4/?,4&amp;amp;冷，7冷，7&amp;amp;«，8&amp;amp;/5)]8&amp;amp;-[(6-去氣_3,4 0-異亞丙基-y5-D-阿卓哌喃糖基氧基）甲基]-4 -甲祿基-4,4a，5,6,7,7a，8,8a-八氫-7-甲基-3-(卜甲基乙基）_1，4_ 亞甲基-s-啕噠省-3a(lH)-羧酸，鈉鹽 將實例1化合物（246克）溶於二氧烷（2毫升）内，加〇.51^的 碳酸氫鈉（0.99毫升）。將此溶液攪拌15分鐘並凍乾’製得 標題化合物（256毫克）。 ά (^, CDC13)： 9.88 (s, 1H, CHO), 5.95 (dd, 1H, H-2, J=1.5及3.3 Hz)，4.51 (d，1H, Η-Γ，J=1.8 Hz)，4.26 (dd，1H, H-3', J=4.8^16.0 Hz), 4.01 (d, 1H, 8aCH2, J=9.6 Hz), 3.87- 3.80 (m, 2H，H-2'及H-4')，3.74 (d, 1H，8aCH2, J=9_6 Hz), 3.50-3.42 (m, 1H, H-5'), 2.66 (t, 1H, H-l, J=3.9 Hz) 0 實例3 [1R-(1 a ,3a/? ,4点，4a/?，7y5，7aa，8ay9 )]8a-[(6-去氧-3,4- 0-(2-亞戊基 ）-々-D-阿卓哌 喃糖基氧基） 甲基]-4-甲醯基· 4，4a，5,6,7,7a，8,8a-八氫-7-甲基-3-(1-甲基乙基）_1，4_ 亞甲基-s -吲噠省-3 a (1 Η)-羧酸 於10%鈀/碳（30毫克）於醋酸乙酯（10毫升）内之懸浮液 中在氮氣下加中間體3(140毫克）於醋酸乙酯内之溶液’此 _-158-____ 本紙張尺度速用中國國家標準（CNS ) Α4規格（210 X 297公釐） (請先閲讀背面之注意事項存填寫本萸) -· ,1Τ 經濟部中央樣準局員工消費合作社印裝 321644 A7 B7 _ 五、發明説明（156) 混合物在3 0磅/吋2氫壓下氫化4 5分鐘。濾除催化劑，蒸 發去溶劑至乾。於二氧化矽膠上作閃色層分析，用二氯甲 烷：甲醇（30 : 1)作洗離劑，製得標題化合物（75毫克）， 差向異構物比26 : 74。 ά 〇E, CDC13): 9.82 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=1.5及3.3 Hz)，4.60 (d，1H, Η-Γ，J=1.8 Hz)，4.30 (dd, 1H, H-3’，J=4.2及6.0 Hz), 3.98 (d，1H, 8aCH2, J=9.3 Hz), 3·94 (dd，lH，H-2’，J=1.8&amp;amp;4.2Hz)，3.87(dd，lH，H-4，，J=6.(m 9.3 Hz), 3.65 (d, 1H, 8aCH2, J=9.3 Hz), 3.47 (dq, 1H, H-5', Jd=9.3 Hz, Jq = 6.3 Hz), 2.70 (t, 1H, H-l, J-3.9 Hz); S(l3C, CDC13 ): 204.5 (CHO), 176.5 (C〇2H), 148.2 (C-3), 130.6 (C-2), 110.8 (Cq acetal), 98.8 (C-l'), 76.6 (C-4'), 75.6 (C-2'), 73.9 (8aCH2), 71.3 (C-3')5 68.9 (C-5'), 65.5 (C8a), 58.8 (C-4) 0 實例4 [111-(1&amp;lt;^，3&amp;amp;/3,4/9,4&amp;amp;/?，7/?，7&amp;amp;&amp;lt;^，8&amp;amp;卢）]8&amp;amp;-[(6-去氧-3,4-〇-(4-甲氧基-2-亞丁基-卢-D-阿卓哌喃糖基氧基）甲基]_ 4 -甲醯基-4，4a，5,6,7,7a，8,8a -八氫-7-甲基- 3- (1-甲基乙 基）-1，4-亞甲基-S-4丨噠省_3a(lH)-羧酸 於10 %鈀/碳（100毫克）於醋酸乙酯（15毫升）内之懸浮液 中加中間體4(260毫克）於醋酸乙酯（10毫升）内之溶液，此 混合物在30磅/吋2氫壓下氫化45分鐘。濾除催化劑，蒸 發去溶劑至乾。殘餘物於二氧化矽膠上作閃色層分析，用 二氣甲烷：甲醇（3 0 : 1)洗離，製得標題化合物（172毫克） ___-159- 本紙張财關家縣（CNS ) Α4· ( 210X297公釐) ~~ (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部中央梯準局貝工消費合作社印裝 A7 B7 五、發明説明（157) ci On, CDC13)： 9.71 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=1.5及3·6 Hz)，4.60 (d，1H，Η-Γ, J=2.4 Hz)，4.31 (dd，1H， H-3’，J=4.2及6.0 Hz)，3.98 (d，1H，8aCH2, J=9.3 Hz)，3.94 (dd，1H，H-2，，J=2.4及4_2 Hz), 3.88 (dd，1H，H-41，J=6_0及 9.3 Hz)，3.65 (d，1H，8aCH2, J=9.3 Hz)，3.50 (t，1H，CH20, J=7.2 Hz), 3.50-3.40 (m, 1H, H-5'), 2.69 (t, 1H, H-l, J=3.9 Hz); d(13C, CDCI3): 204.5 (CHO), 176.2 (C02H), 148.2 (C-3), 130.6 (C-2), 109.8 (C-2&amp;quot;), 98.8 (C-l'), 76.7 (C-4'), 75.7 (C-2'), 73.8 (8aCH2), 71.2 (C-2'), 68.8 (C-5'), 68.4 (CH20), 65.6 (C8a), 58.9 (C-4), 58.5 (CH3〇) ° 實例5 [1R-(1 a，3a/?，4々，4a/9 ,7卢，7aa，8ay5 )]8a-[(6-去氧-3,4- 〇 -環亞戊基- 0-D -阿卓哌喃糖基氧基）甲基]_4_甲醯基_ 4,4a，5,6,7,7a，8,8a-八氫-7_ 甲基·3-(1-甲基乙基）-1,4- 亞甲基-s-θ丨噠省-3a(lH)-羧酸 於10 0/〇鈀/碳（50毫克）於醋酸乙酯（1()毫升）内之懸浮液 中加中間體5(232毫克）於醋酸乙酯内之溶液，此混合物於 室溫在3 5磅/吋2氫壓下氫化丨·5小時。濾除催化劑，蒸發 去溶劑至乾。殘餘物於二氧化矽膠上作閃色層分析，用二 氣甲烷：甲醇（30 : 1)洗離’製得標題化合物（67毫克）。 ^ CDC13): 9.71 (s, 1H, CHO), 6.07 (dd, 1H, H-2, J=1.5&amp;amp;3.3Hz)，4.59(d，lH，H-l'，J=2.1Hz)，4.17(dd，lH， H-3’，J=3.6及5.4 Hz)，4.54 (d，1H，8aCH2, J=9.3 Hz)，3·97 ________-160-_ 本紙張適用中gj®家棣準（CNS ) A4^ ( 21GX297公兼） (請先閱讀背面之注意事項再填寫本頁)</span>Ci CDC13): 9.73 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J-1.5 and 3.3 Hz), 4.61 (d, 1H, Η-Γ, J = 2.1 Hz), 4.30 (dd , 1H, H-3 ', J = 3.6 &amp;amp; 5.4Hz), 4.04 (d, lH, 8aCH2, J = 9.3Hz) 3.95 (dd, 1H, H-2', J = 2.1 and 3_6 Hz), 3.85 (dd, 1H, H-4, J = 5.4 and 9.0 Hz), 3.66 (d, 1H, J = 9.3 Hz), 3.49 (dq, 1H, H-5 'Jd = 9.〇Hz, Jq = 6.3 Hz), 2.69 (t, 1H, Hl, J = 3.6 Hz); j (13 (:, a-157-l paper size, Chinese National Standard (CNS) A4 specification (210X297mm) ~ (please first Read the notes on the back and fill out this page) Order A7 B7___ of the Employees ’Consumer Cooperative of the Central Standards Bureau of the Ministry of Economy. , 13.7 (C-2), 109.3 (Cq. Isop), (98.9 (C-l ') 5 76.9 (C-4'), 75.8 (C-2 '), 74.2 (8aCH2), 71.7 ( C-3 '), 68.6 (C-5'), 65.6 (C-8a), 58.9 (C- 4) o Example 2 [1 ft- (1 &amp;lt; ^, 3 巳; 5,4 / ?, 4 &amp;amp; Cold, 7 cold, 7 &amp;amp; «, 8 &amp;amp; / 5)] 8 &amp;amp;-[(6-degassed_3,4 0-isopropylidene-y5-D-azhopranosyloxy) methyl ] -4 -Meluyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (p-methylethyl ) _1,4_ methylene-s-pyda-3a (lH) -carboxylic acid, sodium salt The compound of Example 1 (246 g) was dissolved in dioxane (2 ml), and carbonic acid 0.51 ^ was added Sodium hydrogen (0.99 ml). Stir the solution for 15 minutes and freeze-dry to prepare the title compound (256 mg). Ά (^, CDC13): 9.88 (s, 1H, CHO), 5.95 (dd, 1H, H- 2, J = 1.5 and 3.3 Hz), 4.51 (d, 1H, Η-Γ, J = 1.8 Hz), 4.26 (dd, 1H, H-3 ', J = 4.8 ^ 16.0 Hz), 4.01 (d, 1H , 8aCH2, J = 9.6 Hz), 3.87- 3.80 (m, 2H, H-2 'and H-4'), 3.74 (d, 1H, 8aCH2, J = 9_6 Hz), 3.50-3.42 (m, 1H, H-5 '), 2.66 (t, 1H, Hl, J = 3.9 Hz) 0 Example 3 [1R- (1 a, 3a /?, 4 points, 4a / ?, 7y5,7aa, 8ay9)] 8a- [ (6-deoxy-3,4- 0- (2-pentylidene) -々-D-azorpiperanyloxy) methyl] -4-carboxamide · 4,4a, 5,6 , 7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) _1,4-methylene-s-indap-3a (1 Η) -carboxylic acid in A solution of 10% palladium / carbon (30 mg) in ethyl acetate (10 ml) and a solution of intermediate 3 (140 mg) in ethyl acetate under nitrogen is added to this paper's _-158 -____ Quickly use the Chinese national standard (CNS) Α4 specification (210 X 297 mm) (please read the precautions on the back and fill in this booklet)-·, 1Τ Printed by the Central Consumer ’s Consumer Cooperative of the Ministry of Economic Affairs 321644 A7 B7 _ V. Invention description (156 ) The mixture was hydrogenated at 30 psi hydrogen for 45 minutes. The catalyst was filtered off and the solvent was evaporated to dryness. A flash layer analysis was carried out on silica gel, using dichloromethane: methanol (30: 1) as the eluent to obtain the title compound (75 mg), with an epimer ratio of 26:74. ά 〇E, CDC13): 9.82 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J = 1.5 and 3.3 Hz), 4.60 (d, 1H, Η-Γ, J = 1.8 Hz), 4.30 (dd, 1H, H-3 ', J = 4.2 and 6.0 Hz), 3.98 (d, 1H, 8aCH2, J = 9.3 Hz), 3.94 (dd, lH, H-2', J = 1.8 &amp;amp;; 4.2Hz), 3.87 (dd, lH, H-4, J = 6. (M 9.3 Hz), 3.65 (d, 1H, 8aCH2, J = 9.3 Hz), 3.47 (dq, 1H, H-5 ' , Jd = 9.3 Hz, Jq = 6.3 Hz), 2.70 (t, 1H, Hl, J-3.9 Hz); S (l3C, CDC13): 204.5 (CHO), 176.5 (C〇2H), 148.2 (C-3 ), 130.6 (C-2), 110.8 (Cq acetal), 98.8 (C-l '), 76.6 (C-4'), 75.6 (C-2 '), 73.9 (8aCH2), 71.3 (C-3' ) 5 68.9 (C-5 '), 65.5 (C8a), 58.8 (C-4) 0 Example 4 [111- (1 &amp;lt; ^, 3 &amp;amp; / 3,4 / 9,4 &amp;amp; / ?, 7 / ?, 7 &amp;amp; &amp;lt; ^, 8 &amp;amp; Lu)] 8 &amp;amp;-[(6-deoxy-3,4-〇- (4-methoxy-2-butylene-Lu-D-azoroperanyloxy Group) methyl] _ 4 -carboxamide-4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3- (1-methylethyl) -1,4 -Methylene-S-4, Dasheng_3a (lH) -carboxylic acid was added Intermediate 4 (260 mg) in a suspension of 10% palladium on carbon (100 mg) in ethyl acetate (15 ml) Dissolved in ethyl acetate (10 ml) The mixture was hydrogenated under 30 psi hydrogen pressure for 45 minutes. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was analyzed by flash chromatography on silica gel using methane: methanol (30: 1) ) Wash off to prepare the title compound (172 mg) ___- 159- This paper Caiguanjia County (CNS) Α4 · (210X297mm) ~~ (Please read the precautions on the back before filling this page) Order the Ministry of Economy Printed and printed by the Central Bureau of Standards and Technology Beigong Consumer Cooperative A7 B7 V. Description of Invention (157) ci On, CDC13): 9.71 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J = 1.5 and 3. 6 Hz), 4.60 (d, 1H, Η-Γ, J = 2.4 Hz), 4.31 (dd, 1H, H-3 ', J = 4.2 and 6.0 Hz), 3.98 (d, 1H, 8aCH2, J = 9.3 Hz), 3.94 (dd, 1H, H-2, J = 2.4 and 4_2 Hz), 3.88 (dd, 1H, H-41, J = 6_0 and 9.3 Hz), 3.65 (d, 1H, 8aCH2, J = 9.3 Hz), 3.50 (t, 1H, CH20, J = 7.2 Hz), 3.50-3.40 (m, 1H, H-5 '), 2.69 (t, 1H, Hl, J = 3.9 Hz); d (13C, CDCI3): 204.5 (CHO), 176.2 (C02H), 148.2 (C-3), 130.6 (C-2), 109.8 (C-2 &amp;quot;), 98.8 (C-l '), 76.7 (C-4') , 75.7 (C-2 '), 73.8 (8aCH2), 71.2 (C-2'), 68.8 (C-5 '), 68.4 (C H20), 65.6 (C8a), 58.9 (C-4), 58.5 (CH3〇) ° Example 5 [1R- (1 a, 3a / ?, 4々, 4a / 9, 7 Lu, 7aa, 8ay5)] 8a -[(6-Deoxy-3,4-〇-cyclopentylidene- 0-D-azorpiperanosyloxy) methyl] _4_carboxamyl_4,4a, 5,6,7 , 7a, 8,8a-octahydro-7_methyl · 3- (1-methylethyl) -1,4-methylene-s-θ-sap-3a (lH) -carboxylic acid at 10 0 / 〇 Palladium / carbon (50 mg) in a suspension of ethyl acetate (1 () mL) was added a solution of Intermediate 5 (232 mg) in ethyl acetate. Inch 2 hydrogenated under hydrogen pressure for 5 hours. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was analyzed by flash chromatography on silica gel, and washed away with methane: methanol (30: 1) to obtain the title compound (67 mg). ^ CDC13): 9.71 (s, 1H, CHO), 6.07 (dd, 1H, H-2, J = 1.5 &amp;amp; 3.3Hz), 4.59 (d, lH, H-l ', J = 2.1Hz), 4.17 (dd, lH, H-3 ', J = 3.6 and 5.4 Hz), 4.54 (d, 1H, 8aCH2, J = 9.3 Hz), 3.97 ________- 160-_ This paper is suitable for gj® housekeeping standards ( CNS) A4 ^ (21GX297 public and public) (Please read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央橾準局員工消費合作杜印製 A7 ____B7 五、發明説明（15S) (dd，1H, H-2'，J=2.1 及3.6 Hz)，3.81 (dd，1H，H-4'，J=5.4及 9.0 Hz), 3.70 (d, 1H, 8aCH2, J=9.3 Hz), 3.44 (dq, 1H, H-5', Jd=9.0 Hz, Jq=6.3 Hz), 2.69 (t, 1H, H-l, J=3.3 Hz) ° 實例6 [1R-(1 a，3a/?，4/?，4a々，7卢，7aa，8ay9 )]8a-[(6-去氧-3,4· 0-4-異亞丙基-/5 -D -別哌喃糖基氧基）甲基]_4_甲醯基_ 4,4&amp;amp;，5,6,7,73,8,8&amp;amp;-八氫-7-甲基-3-(1-甲基乙基）_1，4_ 亞甲基-s-β噠省-3a(lH)-羧酸 於中間體7(1.2克）於醋酸乙酯（6〇毫升）内之溶液中在氮 氣下分批加1 0 %鈀/碳（600毫克）。此混合物在帕爾裝置内 於40磅/吋2氫壓及室溫下搖動1小時。濾除催化劑，再用 更多醋酸乙酯洗。蒸發去溶劑至乾。殘餘物於二氧化矽膠 上作閃色層分析，用二氣曱烷：甲醇（25 : 1)洗離，製得標 題化合物（0.79克）。 δ (^, CDC13)： 9.81 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J—1.2&amp;amp;3.3Hz)，4.63(dd，lH,H-l,,J=2.4&amp;amp;8.4Hz),4.38(dt， 1H, H-3', Jd=3.0 Hz, Jt-5.1 Hz), 4.29 (d, 1H, 8aCH2, J=9.3</span>Du7 A7 ____B7 for consumer cooperation of the Central Department of Economic Affairs of the Ministry of Economic Affairs 5. Invention description (15S) (dd, 1H, H-2 ', J = 2.1 and 3.6 Hz), 3.81 (dd, 1H, H-4', J = 5.4 and 9.0 Hz), 3.70 (d, 1H, 8aCH2, J = 9.3 Hz), 3.44 (dq, 1H, H-5 ', Jd = 9.0 Hz, Jq = 6.3 Hz), 2.69 (t, 1H, Hl, J = 3.3 Hz) ° Example 6 [1R- (1 a, 3a / ?, 4 / ?, 4a々, 7 Lu, 7aa, 8ay9)] 8a-[(6-deoxy-3,4 · 0 -4-Isopropylidene- / 5-D-perpiperanosyloxy) methyl] _4_formyl_4,4 &amp;amp;, 5,6,7,73,8,8 &amp;amp; -octahydro -7-methyl-3- (1-methylethyl) _1,4-methylene-s-βpyridine-3a (lH) -carboxylic acid in intermediate 7 (1.2 g) in ethyl acetate (6 To the solution in 0 ml), 10% palladium on carbon (600 mg) was added in portions under nitrogen. This mixture was shaken in a Parr apparatus at 40 psi hydrogen pressure for 1 hour at room temperature. The catalyst was filtered off and washed with more ethyl acetate. The solvent was evaporated to dryness. The residue was analyzed by flash chromatography on silica gel and washed away with methane: methanol (25: 1) to obtain the title compound (0.79 g). δ (^, CDC13): 9.81 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J—1.2 &amp;amp; 3.3Hz), 4.63 (dd, lH, Hl ,, J = 2.4 &amp;amp; 8.4 Hz), 4.38 (dt, 1H, H-3 ', Jd = 3.0 Hz, Jt-5.1 Hz), 4.29 (d, 1H, 8aCH2, J = 9.3</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz)，3.64 (dd，1H, H_4·，J=5.1 及9.3 Hz), 4.43 (dq，1H, H-5，，</span>Hz), 3.64 (dd, 1H, H_4 ·, J = 5.1 and 9.3 Hz), 4.43 (dq, 1H, H-5 ,,</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Jd=9.3 Hz, Jq=6.0 Hz), 3.40 (d, 1H, 8aCH2, J=9.3 Hz), 2.53 (t, 1H, H-l, J=3.9 Hz); tf(13C, CDC13): 204.7 (CHO), 174.6 (C02H), 148.2 (C-3), 130.6 (C-2), 108.9 (C(CH3)2), 98.3 (C-l'), 76.6 (C-4'), 73.7 (8aCH2), 72.5 (C-3'), 71.7 (C-5'), 67.0 (C8a), 65.2, 59.0 (C-4)。 實例7 ______-161_-__ 本紙張尺度適用中國國家揉準（CNS ) A4規格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁} u</span>Jd = 9.3 Hz, Jq = 6.0 Hz), 3.40 (d, 1H, 8aCH2, J = 9.3 Hz), 2.53 (t, 1H, Hl, J = 3.9 Hz); tf (13C, CDC13): 204.7 (CHO) , 174.6 (C02H), 148.2 (C-3), 130.6 (C-2), 108.9 (C (CH3) 2), 98.3 (C-l '), 76.6 (C-4'), 73.7 (8aCH2), 72.5 (C-3 '), 71.7 (C-5'), 67.0 (C8a), 65.2, 59.0 (C-4). Example 7 ______- 161 _-__ The paper size is applicable to China National Standard (CNS) A4 (210X297mm) (please read the precautions on the back before filling this page) u</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T 經濟部中央橾準局貝工消费合作社印装 A7 五、發明説明（15弓 [1R-(1 a ,3a/5 ,4/? ,4a；5，7 冷，7aor，8a/? )]8a-[(2,6 -二去氧 _ 3.4- 0-(4-甲氧基-2-亞丁基_D·別哌喃糖基氧基）甲基 ]_4 -甲醯基-4,43,5,6,7,7已，8,8&amp;amp;-八氫-7_曱基-3-(1-甲基 乙基）-1,4 -亞甲基-s-吲噠省_3a(1H)·羧酸 於10%鈀/碳（300毫克）於醋酸乙酯（1〇毫升）内之懸浮液 中加中間體8(246毫克）於醋酸乙酯（1〇毫升）内之溶液，此 混合物於室溫在45磅/吋2氫壓下氫化i小時。濾除催化劑 ’蒸發去溶劑至乾。殘餘物於二氧化矽膠上作閃色層分析 ，用二氣甲烷及二氣甲烷：甲醇（3〇 : 1)洗離，製得標題化 合物（182毫克），爲白色泡沫，差向異構物比4 : 1。 β OH, CDC13)主成分信號：9.81 (s, 1H，CHO), 6.06 (dd, lH，H-2，J=1.5A3.6Hz)，4.62(d，lH，H-l'，J=2.7&amp;amp;8.1Hz)， 4.41 (dt, 1H, H-3', Jd=3.3 Hz, Jt=2.5 Hz), 4.24 (d, 1H, 8aCH2, J=9.0 Hz), 3.68 (dd, 1H, H-4’，J=5.7及9.0 Hz), 3.50 (t, 2H, CH2, J=7.5 Hz), 3.46-3.38 (in, 1H, H-5'), 3.33 (s, 3H, CH30), 2.54 (t, 1H, H-l, J=4.2 Hz); (13C, CDC13): 204.5 (CHO), 175.1 (C02H), 148.2 (C-3), 130.7 (C-2), 109.4 (C-2&amp;quot;), 98.3 (C-l')5 76.4 (C-4'), 73.6 (8aCH2), 71.9 (C-3'), 71.4 (C-5'), 68.6 (CH20), 65.2 (C8a), 58.9 (C-4), 58.6 (CH30) &amp;lt;= 實例8 [1R-(1 a，3a/?，4点，4a/3，7y5，7aa，8ayS )]8a-[(2,6-二去氧- 3.4- 0 -異亞丙基-々-D-別卓哌喃糖基氧基）甲基]_4_甲醯 基-4,4&amp;amp;，5,6,7,7&amp;amp;，8,83-八氨-7-甲基-3-(1-甲基乙基）- 1.4- 亞甲基-s-吲噠省-3a(lH)-羧酸，鈉鹽 -162 本紙張尺度逍用中國國家揉準（CNS ) A4规格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁) &amp;lt;</span>、 1T Ministry of Economic Affairs Central Bureau of Precision Industry Beigong Consumer Cooperative Printed A7 V. Description of invention (15 bows [1R- (1 a, 3a / 5, 4 /?, 4a; 5,7 cold, 7aor, 8a /?) ] 8a-[(2,6 -dideoxy_ 3.4- 0- (4-methoxy-2-butylidene_D · piperanyloxy) methyl] _4 -methylacyl-4, 43,5,6,7,7,8,8 &amp;amp; -octahydro-7_methyl-3- (1-methylethyl) -1,4-methylene-s-indap province_3a (1H) · A solution of Intermediate 8 (246 mg) in ethyl acetate (10 mL) was added to a suspension of carboxylic acid in 10% palladium / carbon (300 mg) in ethyl acetate (10 mL). The mixture was hydrogenated at 45 psig hydrogen pressure for 1 hour at room temperature. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was analyzed by flash chromatography on silica gel using methane and methane. : Methanol (30: 1) was washed away to obtain the title compound (182 mg) as a white foam with an epimer ratio of 4: 1. β OH, CDC13) Main component signal: 9.81 (s, 1H, CHO ), 6.06 (dd, lH, H-2, J = 1.5A3.6Hz), 4.62 (d, lH, H-l ', J = 2.7 &amp;amp; 8.1Hz), 4.41 (dt, 1H, H-3' , Jd = 3.3 Hz, Jt = 2.5 Hz), 4.24 (d, 1H, 8aCH2, J = 9.0 Hz) , 3.68 (dd, 1H, H-4 ', J = 5.7 and 9.0 Hz), 3.50 (t, 2H, CH2, J = 7.5 Hz), 3.46-3.38 (in, 1H, H-5'), 3.33 ( s, 3H, CH30), 2.54 (t, 1H, Hl, J = 4.2 Hz); (13C, CDC13): 204.5 (CHO), 175.1 (C02H), 148.2 (C-3), 130.7 (C-2) , 109.4 (C-2 &amp;quot;), 98.3 (C-l ') 5 76.4 (C-4'), 73.6 (8aCH2), 71.9 (C-3 '), 71.4 (C-5'), 68.6 (CH20) , 65.2 (C8a), 58.9 (C-4), 58.6 (CH30) &amp;lt; = Example 8 [1R- (1 a, 3a / ?, 4 points, 4a / 3, 7y5, 7aa, 8ayS)] 8a- [ (2,6-dideoxy-3.4- 0 -isopropylidene-々-D-dezopiperanosyloxy) methyl] _4_carboxyl-4,4 &amp;amp;, 5,6,7 , 7 &amp;, 8,83-octaamino-7-methyl-3- (1-methylethyl)-1.4-methylene-s-indida-3a (lH) -carboxylic acid, sodium salt- 162 The standard size of this paper is Chinese National Standard (CNS) A4 (210X297mm) (Please read the precautions on the back before filling this page) &amp;lt;</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T 經濟部中央梂準局貝工消費合作社印裝 321644 A7 _ B7 五、發明説明（160) 將實例6化合物（376毫克）溶於二氧烷（3毫升）内，加〇5當 量的碳酸氫鈉（1.50毫升）。將形成的溶液於室溫攪拌3〇分 鐘，然後凍乾，製得標題化合物（392毫克）。 ^ (^, CDC13): 9.84 (s, 1H, CHO), 5.94 (dd, 1H, H-2, J=1.55.3.6 Hz), 4.52 (dd, 1H, Η-Γ, J=2.4A9.0 Hz), 4.41-4.37 (m, 1H, H-3'), 4.02 (d, 1H, 8aCH2, J=9.6 Hz), 3.74 (d, 1H，8aCH2, J=9.6 Hz), 3.57 (dd，1H，H-4'，J=5.4及 10.0 Hz), 3.42 (dq, 1H, H-5', Jd=6.3 Hz, Jq=6.3 Hz), 2.56 (t, 1H, H-l, J=3.6 Hz)。 實例9 [1R-(1 λ，3a/9 ,4 0，4ay?，7Θ，7aa，8a/5 )]8a-[(6-去氧-3,4- 〇-硫羰基-D-阿卓哌喃糖基氧基）甲基卜4_曱醯基-4,4a，5,6,7,7a，8,8a-八氫-7甲基-3-(l-甲基乙基）-l，4-亞甲基-s -吲噠省-3 a (1 Η)-叛酸 將2%的三氟醋酸於二氣甲烷内之溶液（2〇毫升）於οχ：加 於中間體9(0.220克）於二氣曱烷（5毫升）内的溶液中。此反 應混合物於0°C攪拌1小時，然後用水（2 X 20毫升）洗，乾 燥（硫酸鎂）。蒸發去溶劑得殘餘物，此殘餘物於二氧化珍 膠柱上作閃色層分析，用二氣甲烷：曱醇（40 : 1至20 : 1) 洗離，製得標題化合物（0.1克）。 d (:Η, CDC13): 9.68 (s, 1H, CHO), 6.09 (dd, 1H, H-2, J=1.5&amp;amp;3.6Hz)，4.94(dd，lH,H-3，，J=3.9&amp;amp;7.2Hz)，4.62(m, 2H，H-li及H-41)，4.14 (dd，1H，H-2, J=2.1 及3_9 Hz)，4.00 (d, 1H, 8aCH2，Jab=9.3 Hz), 3.72 (d, 1H，8aCH2, JAB=9.3 Hz), -163- 本紙張A度逍用中國國家標準（CNS ) A4«L格（210X297公釐） (请先聞讀背面之注意事項再填寫本頁)</span>、 1T Printed by 321644 A7 _ B7, Beigong Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economy V. Description of the invention (160) Dissolve the compound of Example 6 (376 mg) in dioxane (3 ml) and add 0.5 equivalent of carbonic acid Sodium hydrogen (1.50 ml). The resulting solution was stirred at room temperature for 30 minutes and then lyophilized to prepare the title compound (392 mg). ^ (^, CDC13): 9.84 (s, 1H, CHO), 5.94 (dd, 1H, H-2, J = 1.55.3.6 Hz), 4.52 (dd, 1H, Η-Γ, J = 2.4A9.0 Hz), 4.41-4.37 (m, 1H, H-3 '), 4.02 (d, 1H, 8aCH2, J = 9.6 Hz), 3.74 (d, 1H, 8aCH2, J = 9.6 Hz), 3.57 (dd, 1H , H-4 ', J = 5.4 and 10.0 Hz), 3.42 (dq, 1H, H-5', Jd = 6.3 Hz, Jq = 6.3 Hz), 2.56 (t, 1H, Hl, J = 3.6 Hz). Example 9 [1R- (1 λ, 3a / 9, 4 0, 4ay ?, 7Θ, 7aa, 8a / 5)] 8a-[(6-deoxy-3,4-〇-thiocarbonyl-D-Azhuo Piperanosyloxy) methyl bu 4_methyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7methyl-3- (l-methylethyl)- l, 4-Methylene-s-indap-3a (1 Η) -tetanoic acid 2% trifluoroacetic acid in difluoromethane solution (20 mL) was added to intermediate 9: (0.220 g) in a solution of methane (5 ml). The reaction mixture was stirred at 0 ° C for 1 hour, then washed with water (2 X 20 mL) and dried (magnesium sulfate). The solvent was evaporated to obtain a residue, which was analyzed by flash chromatography on a silica gel column, and washed away with methane: methanol (40: 1 to 20: 1) to obtain the title compound (0.1 g) . d (: Η, CDC13): 9.68 (s, 1H, CHO), 6.09 (dd, 1H, H-2, J = 1.5 &amp;amp; 3.6Hz), 4.94 (dd, lH, H-3, J = 3.9 &amp;amp; 7.2Hz), 4.62 (m, 2H, H-li and H-41), 4.14 (dd, 1H, H-2, J = 2.1 and 3_9 Hz), 4.00 (d, 1H, 8aCH2, Jab = 9.3 Hz), 3.72 (d, 1H, 8aCH2, JAB = 9.3 Hz), -163- This paper uses the Chinese National Standard (CNS) A4 «L grid (210X297mm) for A degree (Please read the precautions on the back first (Fill in this page again)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T λ A7 B7 s2l644 五、發明説明（161) 3.68 (m, 1H, H-5'), 2.71 (m, 1H, H-l)； i(13C, CDC13)： 204.4 (CHO), 190.2 (CS), 176.4 (C02H), 148.4 (C-3), 130.6 (C_2),98.2(C-r)，82.3&amp;amp;80.1(C-3iC-4')，74.5(8aCH2), 71.7 (C-3a), 69.2及66.4 (C-2'&amp;amp;C-5’），65.5(C-8a)，58.8(C-4)，46.0 (C-l)。 實例1 0 [1R-(1 a，3a点，4卢，4a点，7点，7aa，8a々）]8a-[(2,6-二去氧_ 3,4-0-羰基-/?-0-別哌喃糖基氧基）甲基]_4_甲醯基-4,4&amp;amp;，5,6,7,7汪，8,8&amp;amp;-八氫-7-甲基-3-(1-甲基乙基）-1，4-亞甲基-s-β噠省- 3a(lH)-羧酸 於中間體10(125毫克）於回流中的無水甲苯（15毫升）内的 溶液中在氮氣下加分小量超量的羰基二咪唑。反應完全後( 以TLC控制），減壓除去溶劑，將粗製混合物溶於二氯甲烷 (200毫升）内，用1當量鹽酸（3xi〇〇毫升），鹽水（lx 1〇〇 毫升）及水（1 X 100毫升）洗，然後於硫酸鎂上乾燥，並濃縮 至乾，得油體，此油體不必純化即可進一步使用。將此油 體溶於醋酸乙酯（15毫升）内，於帕爾裝置内在2〇磅/吋2 氫壓下’且在有10%鈀/碳（5〇毫克）之存在下於室溫搖動 1小時。濾除催化劑，除去溶劑，得漿體，再以製備用T L C 純化（二氧化矽膠，甲醇：二氣甲烷1 : 15)，製得標題化合 物（5 0毫克），由Rf0.5部分取得。 ό (^, CDC13): 9.70 (s, 1H, CHO), 6.07 (dd, 1H, H-2, J=1.2及3.3 Hz), 4.93 (m, 1H, H-3，），4.63 (dd，1H, H-l，， J=2.4及7.8 Hz), 4.24 (dd，1H, H-4, J=6.6及9.3 Hz)，4.05及 -164- 本紙張尺度逍用中國國家揉準（CNS ) A4规格（210X297公釐) ---------(：·&amp;lt;------訂------^ (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局貝工消费合作社印袈 經濟部中央橾準局—工消費合作社印裝 3^t644 A7 B7 五、發明説明（162) 3.57 (2d，2H，8aCH2, JAB=9 Hz), 3.63 (m, 1H，H-5')，2.66 (t， 1H, H-l, J=3.9 Hz); d(l3C, CDC13): 204.6 (COH), 176.0 (COOH), 154.0 (OCO), 148.2 (C-3), 130.7 (C-2), 97.5 (C-l')s 76_6 (Q-4，)，74.7 (y)，69.9 (g-5，)，31.7 (Q-2，）。 實例1 1 [1R-(1 a，3ay5，4卢，4a/?，7卢，7aor，8a/? )]8a-[(2,6-二去氧. 3,4-0-硫羰基-卢-〇-別哌喃糖基氧基）甲基]-4-甲醯基_ 4,4&amp;amp;，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7-甲基-3-(1-曱基乙基）-1，4· 亞曱基-s-，i丨噠省-3a(lH)-羧酸 於中間體11(130毫克）於無水二氣曱烷（5毫升）内的溶液 中於0°C加三氟醋酸（250毫升）。2小時後此溶液以二氣甲烷 (50毫升）稀釋，用水（2 X 100毫升）洗，於硫酸鎂上乾燥， 濃縮至乾，得油體，以製備用TLC純化（二氧化矽膠，甲醇 :二氣甲烷1 : 15)，製得標題化合物（68克），由Rf0.5部 分取得。 s (!H, CDC13): 9.70 (s, 1H, CHO), 6.07 (dd, 1H, H-2, J=1.2及3.3 Hz), 5.08 (m，1H, H-3')，4.63 (dd，1H, Η-Γ， J=2.7&amp;amp;8.4Hz)，4.45(dd，lH，H-4，J=6.6&amp;amp;9.0Hz)，4.03&amp;amp; 3.59 (2d, 2H，8aCH2, JAB=9.3 Hz), 3.64 (m，1H，H-51)，2.67 (t, 1H, H-l, J=3.0 Hz); S〇3C, CDC13): 204.5 (COH), 190.9 (CS), 176.3 (COOH), 148.2 (C-3), 130.7 (C-2), 97.5 (C-l'), 80.3 (殳-4，)，79.6 (£-3’)，69.5 (y)，31.3 (y)。 實例1 2 [1R-(1 a，3a；5，4/?，4a；5，7y5，7aa，8a/? )]8a-[(2,6-二去氧- -165- (請先閲讀背面之注意事項再填寫本頁}</span>、 1T λ A7 B7 s2l644 V. Description of invention (161) 3.68 (m, 1H, H-5 '), 2.71 (m, 1H, Hl); i (13C, CDC13): 204.4 (CHO), 190.2 (CS) , 176.4 (C02H), 148.4 (C-3), 130.6 (C_2), 98.2 (Cr), 82.3 &amp;amp; 80.1 (C-3iC-4 '), 74.5 (8aCH2), 71.7 (C-3a), 69.2 and 66.4 (C-2 '&amp;amp; C-5'), 65.5 (C-8a), 58.8 (C-4), 46.0 (Cl). Example 1 0 [1R- (1 a, 3a point, 4 Lu, 4a point, 7 point, 7aa, 8a々)] 8a-[(2,6-dideoxy_ 3,4-0-carbonyl- /? -0-epiperanosyloxy) methyl] _4_carboxamide-4,4 &amp;amp;, 5,6,7,7,8,8 &amp; -octahydro-7-methyl-3- ( 1-methylethyl) -1,4-methylene-s-βpyridine-3a (lH) -carboxylic acid in intermediate 10 (125 mg) in refluxing anhydrous toluene (15 ml) Add a small amount of excess carbonyldiimidazole under nitrogen. After the reaction was completed (controlled by TLC), the solvent was removed under reduced pressure, and the crude mixture was dissolved in dichloromethane (200 mL), using 1 equivalent of hydrochloric acid (3 x 100 mL), brine (lx 100 mL) and water ( 1 X 100 ml), then dried over magnesium sulfate, and concentrated to dryness to obtain an oil body, which can be used further without purification. Dissolve this oil in ethyl acetate (15 mL), in a Parr device under 20 psi hydrogen pressure, and shake at room temperature in the presence of 10% palladium / carbon (50 mg) 1 hour. The catalyst was filtered off and the solvent was removed to obtain a slurry, which was then purified by preparation using TLC (silica gel, methanol: methane 1:15) to obtain the title compound (50 mg), which was obtained from Rf0.5. ό (^, CDC13): 9.70 (s, 1H, CHO), 6.07 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.93 (m, 1H, H-3,), 4.63 (dd, 1H, Hl ,, J = 2.4 and 7.8 Hz), 4.24 (dd, 1H, H-4, J = 6.6 and 9.3 Hz), 4.05 and -164- The paper size is free to use China National Standard (CNS) A4 specification (210X297mm) --------- (: · &amp;lt; ------ order ------ ^ (please read the notes on the back before filling in this page) Central Standard of the Ministry of Economic Affairs Bureau of Industry and Consumers Cooperative Printing Agency Central Central Bureau of Economics of the Ministry of Economic Affairs-Industry and Consumers Cooperative Printing 3 ^ t644 A7 B7 V. Description of Invention (162) 3.57 (2d, 2H, 8aCH2, JAB = 9 Hz), 3.63 (m, 1H , H-5 '), 2.66 (t, 1H, Hl, J = 3.9 Hz); d (l3C, CDC13): 204.6 (COH), 176.0 (COOH), 154.0 (OCO), 148.2 (C-3), 130.7 (C-2), 97.5 (C-l ') s 76_6 (Q-4,), 74.7 (y), 69.9 (g-5,), 31.7 (Q-2,). Example 1 1 [1R- (1 a, 3ay5, 4 Lu, 4a / ?, 7 Lu, 7aor, 8a /?)] 8a-[(2,6-dideoxy. 3,4-0-thiocarbonyl-luo-〇-pipera Furanosyloxy) methyl] -4-carboxamide_ 4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methyl) Ethyl) -1,4 · methylidene-s-, i province-3a (lH) -A solution of carboxylic acid in intermediate 11 (130 mg) in anhydrous difluoromethane (5 ml) was added trifluoroacetic acid (250 ml) at 0 ° C. After 2 hours the solution was replaced by difluoromethane (50 ml ) Dilute, wash with water (2 X 100 ml), dry over magnesium sulfate, and concentrate to dryness to obtain an oil body for preparation by TLC purification (silica gel, methanol: difluoromethane 1: 15) to prepare the title compound (68g), obtained from Rf0.5. S (! H, CDC13): 9.70 (s, 1H, CHO), 6.07 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 5.08 (m , 1H, H-3 '), 4.63 (dd, 1H, Η-Γ, J = 2.7 &amp;amp; 8.4Hz), 4.45 (dd, lH, H-4, J = 6.6 &amp;amp; 9.0Hz), 4.03 &amp;amp; 3.59 (2d, 2H, 8aCH2, JAB = 9.3 Hz), 3.64 (m, 1H, H-51), 2.67 (t, 1H, Hl, J = 3.0 Hz); S〇3C, CDC13): 204.5 (COH) , 190.9 (CS), 176.3 (COOH), 148.2 (C-3), 130.7 (C-2), 97.5 (C-l '), 80.3 (殳 -4,), 79.6 (£ -3'), 69.5 (y), 31.3 (y). Example 1 2 [1R- (1 a, 3a; 5, 4 / ?, 4a; 5, 7y5, 7aa, 8a /?)] 8a-[(2,6-dideoxy- -165- (please read first Note on the back then fill out this page}</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T 本紙張尺度適用中國國家橾準（CNS ) 格（210X297公釐） A7 B7 五、發明説明（163) 3.4- 0-亞甲基_万-1)_別哌喃糖基氧基）甲基]_4_曱醯基-4’4a，5,6,7,7a，8,8a-八氫-7_ 曱基-3-(1-甲基乙基）-1,4- 亞甲基-s -，引噠省_ 3 a (1 Η)-羧酸 於中間禮10(450毫克）於無水二氣曱烷（10毫升）内的溶液 在強烈攪拌下加溴化四丁基銨（4 〇毫克）及5 〇 %氫氧化鈉水 溶液（100毫升）。1 2小時後，加1當量鹽酸（1〇〇毫升）使反 應停止’用二氣曱烷（100毫升）萃取。有機層用1當量鹽酸 (1X100毫升）洗’於硫酸鎂上乾燥，濃縮至乾，得白色固 體，可進一步使用不必純化。將此固體溶於醋酸乙酯（15毫 升）内，於帕爾裝置内於20磅/吋2氫壓及室溫下搖動1小 時。濾除催化劑，除去溶劑，將油體殘餘物於二氧化矽膠 上作閃色層分析，用丙酮：己烷（1 : 1 〇)及（1 : 5)洗離， 製得標題化合物（130毫克），爲油體。 (lR, CDC13)： 9.80 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J=1.2及3.3 Hz)，5·12及4·86 (2m, 2H, 0CH20)，4.60 (dd, 1H， H-l，，J=2.4及8.7 Hz)，4.20及3.44 (2d, 2H，8aCH2, Jab=9,3</span>、 1T The size of this paper is applicable to China National Standard (CNS) grid (210X297mm) A7 B7 V. Description of the invention (163) 3.4- 0-methylene_10,000-1) _piperanosyloxy) methyl基] _4_ 曱 膯 基 -4'4a, 5,6,7,7a, 8,8a-octahydro-7_methyl-3- (1-methylethyl) -1,4-methylene- s-， 引 达 省 _ 3 a (1 Η) -carboxylic acid in Zhongli Li 10 (450 mg) in anhydrous digas methane (10 ml) was added under strong stirring tetrabutylammonium bromide (4 〇mg) and 50% aqueous sodium hydroxide solution (100 ml). After 12 hours, add 1 equivalent of hydrochloric acid (100 mL) to stop the reaction 'and extract with methane (100 mL). The organic layer was washed with 1 equivalent of hydrochloric acid (1X100 mL), dried over magnesium sulfate, and concentrated to dryness to obtain a white solid, which can be used further without purification. This solid was dissolved in ethyl acetate (15 mL) and shaken in a Parr device at 20 psi hydrogen pressure for 1 hour at room temperature. The catalyst was filtered off, the solvent was removed, and the residue of the oil body was subjected to flash layer analysis on silica gel, and washed away with acetone: hexane (1: 1) and (1: 5) to obtain the title compound (130 mg ) Is an oil body. (lR, CDC13): 9.80 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 5.12 and 4.86 (2m, 2H, 0CH20), 4.60 ( dd, 1H, Hl ,, J = 2.4 and 8.7 Hz), 4.20 and 3.44 (2d, 2H, 8aCH2, Jab = 9,3</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz),4.13(m，lH，H-3'),3.67(dd，lH，H-4'，J=5.1&amp;amp;8.7Hz)， 經濟部中央揉準局貝工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 3.38 (m, 1H, H-5'), 2.58 (t, 1H, H-l, J=3.9 Hz); i(13C, CDCI3): 204·6 (C〇H), 174.8 (COOH), 148.3 (C-3), 130.6 (C-2), 98.1 (C-l'), 94.9 (0CH20), 75.4 (C-4'), 73.9 (C-3')s 70.3 (y)，32_3 (y)。 實例1 3 [1R-(1 a，3a；5，4/? ,4 a/?，7/S，7aa，8ay5 )]8a-[(2,6 -二去氧 _ 3.4- 0 -亞甲基-々-D -別哌喃糖基氧基）甲基]-4 -甲醯基_ -166- 本紙張尺度逍用中國國家標率（CNS ) A4规格（21〇&amp;gt;&amp;lt;297公釐） ^21644 A7 B7 經濟部中央梂準局貝工消費合作社印製 五、發明説明（1, 4,4&amp;amp;，5,6,7,7&amp;amp;，8,8&amp;amp;_八氫_7_甲基.3_(1_甲基乙基）14_ 亞甲基-S-啕噠省-3a(lH)-羧酸，钟鹽 於實例12化合物（200毫克）於甲辱（5毫升）内之溶液中滴 加0.106當量的氫氧化鈉水溶液（3.98毫升）。3〇分鐘後，減 壓除去溶劑，殘餘物溶於二噁烷（5毫升）内並凍晶，製得標 題化合物（209毫克）。 ci 〇H, CD3OD)： 9.87 (s, 1H, CHO), 6.54 (dd, 1H, H-2, J=1.5&amp;amp;3.6Hz)，5,l(^4.82(2m，2H，OCH20)，4.51(dd，lH， H-r，J=2.4&amp;amp;8.7Hz)，4.12(m，lH，H-3l),4.03&amp;amp;3.73(2d，2H, 8aCH2, Jab=9.9 Hz), 3.61 (m, 1H, H-4'), 3.35 (m, 1H, H-5'), 2.56 (t, 1H, H-l)； δ 〇3C, CD3OD): 200.2 (COH), 169.0 (COOH), 142.9 (C-2), 120.6 (C-2), 90.3 (C-l'), 86.4 (0£H20)，67.5 (y), 66.2 (£-3，)，61.8 (殳-5，）。 實例1 4 (a) [lR-(l« ,3a^ ,4/5 ,4a^ ,1 β ,laa ,8a/? ) ] 8 a-[ [ 1 S , 3 R, 7R，9R]-2,5,8-三噚-3,7-二甲基-順式-雙環[4.4.0]-癸-9-基-氧基-甲基]-4 -甲醯基-4,4a，5,6,7,7a，8,8a-八氫-7-曱基-3-(l-甲基乙基）-l，4-亞曱基-s-吲噠省-3a(lH)-羧 酸 (b) [lR-(l« ,3a/? ,Αβ ,4ay9 ,Ί β ,laa ,8a/? ) ] 8 a - [ [ 1 S, 3 S, 7R，9R]-2,5,8·三哼-3,7-二甲基-順式-雙環[4.4.0]-癸-9-基-氧基-甲基]-4 -甲醯基-4,4a，5，6,7,7a,8,8a-八氫-7-甲基- 3- (1-甲基乙基）-1，4-亞甲基-s-吲建省- 3a(lH) -叛 酸 -167- 本紙張尺度逍用中國國家梂準（CNS ) A4規格（210X 297公釐） (請先閲讀背面之注意事項再填寫本頁) 乂 _ 訂 經濟部中央揉準局貝工消费合作社印裝 A7 B7 五、發明説明（165) 將於醋酸乙酯（15毫升）内的中間體14(120毫克）在帕爾裝 置内於20磅/吋2氫壓及室溫下搖動1小時。濾除催化劑， 減壓蒸發去溶劑得漿體，物於二氧化碎膠上作閃色層分析 ’用丙酮/己烷（1 : 10)，（1 : 7)及（1 : 5)作洗離劑，製 得標題化合物（a)(35毫克，Rf=0.5，於己燒：丙_4 : 1内） 及標題化合物（b)(40毫克，Rf=0.4，於己燒：丙明4 : 1内） ，二者都爲無色油體。 (a) δ (^, CDC13)： 9.80 (s, 1H, CHO), 6.04 (dd, 1H, H-2, J=1.2&amp;amp;3.3Hz)，4.62(dd，lH，H-9'，J=2.1&amp;amp;9.9Hz)，4.20(m， 2H, 8aCH2+H-7'), 3.97 (m, 1H, H-l'), 3.73 (m, 1H, OCHCH3), 3.40 (m, 2H, 8aCH2+OCH2), 3.27 (d, 1H, OCH2, JAB = 10.8 Hz)，3.18 (dd，1H，H-6’，J=3.3及 10.2 Hz); d(13C， CDCI3): 204.6 (COH), 174.6 (COOH), 148.3 (C-3), 130.6 (C-2), 97.9 (C-9'), 73.5 (OCH2), 73.2 (C-6'), 72.1 (C-l'), 71.9 (OCHCH3), 65·4 (C-7'), 31.9 (C-10'), 22.7 (OCHCH3) o (b) ί (!η, CDC13): 9.79 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J=1.5及3‘6 Hz)，4.73 (dd，1H，H-91，J=3.0及6.3 Hz)，4.26 (m, 1H, Η-Γ), 4.15 (m, 2H, 8aCH2+H-7')5 3.98 (m, 1H, OCHCH3), 3.79 (dd, 1H, 0CH2,J=3.1J5L11.4 Hz), 3.41 (d, 1H, 8aCH2, J=9.6 Hz), 3.35 (m, 1H, OCH2, J=3.1 及6.3 Hz), 3.27 (dd，lH,H-6，，J=5.7&amp;amp;11.7Hz)，2.55(t，lH，H-l);e(13C， CDCI3): 204.6 (COH), 174.6 (COOH), 148.3 (C-3), 130.6 (C-2), 99.2 (C-9'), 74.7 (OCHCH3), 73.6 (OCH2), 69.3 (C- -168- 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消费合作社印聚 A7 B7 五、發明説明（16e) 6，)，66.3 (竺-Γ)，65·4 (Q-71)，31.9 (g-l〇')，22.6 (OCH[H3)。 實例1 5 [1R-(1 » ,3a/? ,Αβ ,4a/? ,1 β ,7a « ,8a/5 ) ] 8 a-[ [ 1 S, 7R, 9R]-2,5,8 -三嘮-3,3,7 -三曱基-順式-雙環[4.4.0]-癸_9-基-氧 基-甲基]-4-甲醯基_4,4纹，5,6,7,7已，8,8&amp;amp;-八氫-7-甲基-3-(1-甲基乙基）-l，4-亞甲基-s-，?丨噠省-3a(lH)-羧酸 於中間體15(200毫克）於醋酸乙酯（15毫升）内之溶液中在 氮氣下加10 %鈀/碳（50毫克）。此混合物在帕爾裝置内於 20磅/吋2氫壓及室溫下搖動1小時。濾除催化劑，減壓蒸 發去溶劑得殘餘物，此殘餘物於二氧化矽膠上作閃色層分 析，用丙酮：己烷（1:10)，及（1:15)洗離，製得標題化 合物（140毫克），爲白色泡沫。 ^ CDC13): 9.81 (s, 1H, CHO), 6.03 (dd, 1H, H-2, J=l.5 Hz), 4.62 (dd，1H, Η-Γ，J=2.1 及9.6 Hz)，4.35-4.15 (m， 3H，8aCH2, H-7'及Η-Γ)，3.40 (m，2H，8aCH2 &amp;amp;OCH2)，3.25-3.15 (m，2H, H-6’及OCH2)，2.52 (t，1H, H-l)，1.33及 1.13 (2s， 2CH3); c? (13C, CDCI3): 204.7 (COH), 174.1 (COOH), 148.3 (C-3), 130.6 (C-2), 98.0 (C-9'), 73.4 (〇CH2), 73.3 (C-6'), 65.1 (£·1，)，64.7 (g-7), 31.9 (殳-10·)，21.1 (2£H3)。 實例1 6 [lR-(lor ,3a/? Αβ Μβ ,Ί β ,7aa ) ] 8 a-[ [ 1 S , 4 S , 6 R, 8R]-2,7·二氧-4,6-二甲基-順式-雙環[3.4.0]-壬-8-基-氧 基-甲基]_4 -甲醯基- 4,4a，5,6,7,7a,8,8a -八氫-7-甲基-3-(1-甲基乙基）-1,4-亞曱基-s -啕噠省_3a(lH)-羧酸 -169- 本紙張尺度逍用中國國家標準（CNS ) A4规格（210X2S7公釐） (請先閲讀背面之注意事項再填寫本頁) 乂 ·</span>Hz), 4.13 (m, lH, H-3 '), 3.67 (dd, lH, H-4', J = 5.1 &amp;amp; 8.7Hz), Printed by Beigong Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs (please first Read the notes on the back and fill in this page) 3.38 (m, 1H, H-5 '), 2.58 (t, 1H, Hl, J = 3.9 Hz); i (13C, CDCI3): 204 · 6 (C〇H ), 174.8 (COOH), 148.3 (C-3), 130.6 (C-2), 98.1 (C-l '), 94.9 (0CH20), 75.4 (C-4'), 73.9 (C-3 ') s 70.3 (y), 32_3 (y). Example 1 3 [1R- (1 a, 3a; 5, 4 / ?, 4 a / ?, 7 / S, 7aa, 8ay5)] 8a-[(2,6 -dideoxy_ 3.4- 0 -methylene -々-D-piperanosyloxy) methyl] -4-formyl-_166- This paper scale is free to use the Chinese National Standard Rate (CNS) A4 specification (21〇 &amp;lt; 297 g ^) 21644 A7 B7 Printed by the Central Bureau of Economic Affairs of the Ministry of Economic Affairs Beigong Consumer Cooperatives V. Invention Instructions (1, 4, 4 &amp;, 5, 6, 7, 7 &amp;amp;, 8,8 &amp;amp; _ 八 氢 _7_ 甲A solution of 3_ (1_methylethyl) 14_methylene-S-pyda-3a (lH) -carboxylic acid, bell salt in the compound of Example 12 (200 mg) in meme (5 ml) A 0.106 equivalent of aqueous sodium hydroxide solution (3.98 ml) was added dropwise. After 30 minutes, the solvent was removed under reduced pressure, and the residue was dissolved in dioxane (5 ml) and frozen to obtain the title compound (209 mg). ci 〇H, CD3OD): 9.87 (s, 1H, CHO), 6.54 (dd, 1H, H-2, J = 1.5 &amp;amp; 3.6Hz), 5,1 (^ 4.82 (2m, 2H, OCH20), 4.51 (dd, lH, Hr, J = 2.4 &amp;amp; 8.7Hz), 4.12 (m, lH, H-3l), 4.03 &amp;amp; 3.73 (2d, 2H, 8aCH2, Jab = 9.9 Hz), 3.61 (m, 1H, H-4 '), 3.35 (m, 1H, H-5'), 2.56 (t, 1H, Hl); δ 〇3C, C D3OD): 200.2 (COH), 169.0 (COOH), 142.9 (C-2), 120.6 (C-2), 90.3 (C-l '), 86.4 (0 £ H20), 67.5 (y), 66.2 (£ -3,), 61.8 (殳 -5,). Example 1 4 (a) [lR- (l «, 3a ^, 4/5, 4a ^, 1 β, laa, 8a /?)] 8 a- [[1 S, 3 R, 7R, 9R] -2 , 5,8-tris-3,7-dimethyl-cis-bicyclo [4.4.0] -dec-9-yl-oxy-methyl] -4 -carboxamide-4,4a, 5 , 6,7,7a, 8,8a-octahydro-7-methyl-3- (l-methylethyl) -l, 4-methylidene-s-indap-3a (lH) -carboxy Acid (b) [lR- (l «, 3a /?, Αβ, 4ay9, Ί β, laa, 8a /?)] 8 a-[[1 S, 3 S, 7R, 9R] -2,5,8 · Trihum-3,7-dimethyl-cis-bicyclo [4.4.0] -dec-9-yl-oxy-methyl] -4-carboxamide-4,4a, 5,6,7 , 7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-indjian- 3a (lH) -etacid-167- The standard size of this paper is Chinese National Standard (CNS) A4 (210X 297mm) (please read the notes on the back before filling out this page) 乂 _ Order A7 B7 printed by Bei Gong Consumer Cooperatives 5. Description of the invention (165) Intermediate 14 (120 mg) in ethyl acetate (15 ml) is shaken in a Parr device at 20 psi hydrogen pressure and room temperature for 1 hour. The catalyst was filtered off, the solvent was evaporated under reduced pressure to obtain a slurry, and the material was analyzed on the silica gel for flash layer analysis. Wash with acetone / hexane (1:10), (1: 7) and (1: 5) Separating agent to prepare the title compound (a) (35 mg, Rf = 0.5, in hexane: propane 4: 1) and the title compound (b) (40 mg, Rf = 0.4, in hexane: propionate 4 : Within 1), both are colorless oil bodies. (a) δ (^, CDC13): 9.80 (s, 1H, CHO), 6.04 (dd, 1H, H-2, J = 1.2 &amp;amp; 3.3Hz), 4.62 (dd, lH, H-9 ', J = 2.1 &amp;amp; 9.9Hz), 4.20 (m, 2H, 8aCH2 + H-7 '), 3.97 (m, 1H, H-l'), 3.73 (m, 1H, OCHCH3), 3.40 (m, 2H, 8aCH2 + OCH2), 3.27 (d, 1H, OCH2, JAB = 10.8 Hz), 3.18 (dd, 1H, H-6 ', J = 3.3 and 10.2 Hz); d (13C, CDCI3): 204.6 (COH), 174.6 (COOH), 148.3 (C-3), 130.6 (C-2), 97.9 (C-9 '), 73.5 (OCH2), 73.2 (C-6'), 72.1 (C-l '), 71.9 (OCHCH3 ), 65.4 (C-7 '), 31.9 (C-10'), 22.7 (OCHCH3) o (b) ί (! Η, CDC13): 9.79 (s, 1H, CHO), 6.05 (dd, 1H , H-2, J = 1.5 and 3'6 Hz), 4.73 (dd, 1H, H-91, J = 3.0 and 6.3 Hz), 4.26 (m, 1H, Η-Γ), 4.15 (m, 2H, 8aCH2 + H-7 ') 5 3.98 (m, 1H, OCHCH3), 3.79 (dd, 1H, 0CH2, J = 3.1J5L11.4 Hz), 3.41 (d, 1H, 8aCH2, J = 9.6 Hz), 3.35 ( m, 1H, OCH2, J = 3.1 and 6.3 Hz), 3.27 (dd, lH, H-6 ,, J = 5.7 &amp;amp; 11.7Hz), 2.55 (t, lH, Hl); e (13C, CDCI3): 204.6 (COH), 174.6 (COOH), 148.3 (C-3), 130.6 (C-2), 99.2 (C-9 '), 74.7 (OCHCH3), 73.6 (OCH2), 69.3 (C- -168- The paper standard is applicable to the Chinese National Standard (C NS) A4 specification (210X297mm) (please read the notes on the back before filling in this page) Order the A7 B7 printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economy V. Invention Instructions (16e) 6,), 66.3 (Zhu- Γ), 65 · 4 (Q-71), 31.9 (gl〇 '), 22.6 (OCH [H3). Example 1 5 [1R- (1 », 3a /?, Αβ, 4a /?, 1 β, 7a«, 8a / 5)] 8 a- [[1 S, 7R, 9R] -2,5,8- Trimethyl-3,3,7-trimethyl-cis-bicyclo [4.4.0] -dec-9-yl-oxy-methyl] -4-carboxyl_4,4 lines, 5,6 , 7,7,8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-,? da province-3a (lH) -A solution of carboxylic acid in intermediate 15 (200 mg) in ethyl acetate (15 ml) was added 10% palladium / carbon (50 mg) under nitrogen. This mixture was shaken in a Parr device at 20 psi hydrogen pressure at room temperature for 1 hour. The catalyst was filtered off, and the solvent was evaporated under reduced pressure to obtain a residue. This residue was analyzed by flash layer on silica gel, washed away with acetone: hexane (1:10), and (1:15) to prepare the title The compound (140 mg) is a white foam. ^ CDC13): 9.81 (s, 1H, CHO), 6.03 (dd, 1H, H-2, J = 1.5 Hz), 4.62 (dd, 1H, Η-Γ, J = 2.1 and 9.6 Hz), 4.35 -4.15 (m, 3H, 8aCH2, H-7 'and Η-Γ), 3.40 (m, 2H, 8aCH2 &amp; OCH2), 3.25-3.15 (m, 2H, H-6' and OCH2), 2.52 (t , 1H, Hl), 1.33 and 1.13 (2s, 2CH3); c? (13C, CDCI3): 204.7 (COH), 174.1 (COOH), 148.3 (C-3), 130.6 (C-2), 98.0 (C -9 '), 73.4 (〇CH2), 73.3 (C-6'), 65.1 (£ · 1,), 64.7 (g-7), 31.9 (殳 -10 ·), 21.1 (2 £ H3). Example 1 6 [lR- (lor, 3a /? Αβ Μβ, Ί β, 7aa)] 8 a- [[1 S, 4 S, 6 R, 8R] -2,7 · diox-4,6-di Methyl-cis-bicyclo [3.4.0] -non-8-yl-oxy-methyl] _4 -carboxamide- 4,4a, 5,6,7,7a, 8,8a -octahydro- 7-Methyl-3- (1-methylethyl) -1,4-methylidene-s-Tida province_3a (lH) -carboxylic acid-169 ) A4 specification (210X2S7mm) (Please read the precautions on the back before filling this page) 佂 ·</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">-、1T 經濟部中央標準局貝工消费合作社印製 ^21644 A7 B7 五、發明説明（ 於中間體20(a)( 680毫克）於醋酸乙酯（1〇〇毫升）内之溶液 中在氮氣下加10%鈀/碳（2〇〇毫克）。此混合物在帕爾裝置 内於25磅/吋2氫壓及室溫下搖動2小時。濾除催化劑，蒸 發去溶劑至乾。將殘餘物作閃色層分析純化，用二氣曱烷 ••甲醇（49 : 1)洗離，製得標題化合物（450毫克），爲白色 泡沐β ^ On, CDC13): 9.86 (s, 1H, CHO), 6.04 (dd, 1H, H-2, J^l.5^3.6 Hz), 4.57 (dd, 1H, H-8', J=2.4^L9.3 Hz), 4.40 (d, 1H, 8a-CH2, J=9.6 Hz), 4.08 (m, 2H, Η-Γ及CH2-3' (1H))， 3-27 (m, 3H, H-6', CH2-3' (1H), 8a-CH2 (1H)), 2.47 (t, 1H, H-l, J=3.9 Hz), 1.02 (d, 3H, 4'-CH3, J=6.6 Hz); ^(13C, CDCI3): 204.7 (CHO), 173.8 (COOH), 148.4 (C-3), 130.5 (C-2), 98.5 (C-8'), 75.2 (C-l'), 74.3 (8a-CH2), 73.3 (C-3')s 71.9 (C-6'), 51.2 (C-5'), 36.0 (C-4'), 32.9 (C-9'), 19.4 (4'-CH3) o 實例1 7 [lR-(la ,3a^ Αβ Α^β ,Ί β ,Ιάοι ,8ay5 ) ] 8 a-[ [ 1 S , 4 S, 6 R, 8R]-2,7-二氧-4,6-二甲基-順式-雙環[3.4.Ο]-壬-8-基-氧 基-甲基]-4-甲醯基-4,43,5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7-甲基-3-(1-曱基乙基）-1,4 -亞甲基- s-，引噠省_3a(lH)_羧酸，鈉鹽 於實例16化合物（450毫克）於甲醇（1〇〇毫升）内之溶液中 滴加氫氧化鈉水溶液（0.099N，9.5毫升）。減壓除去溶劑， 將殘餘物溶於水（80毫升）内，凍晶，製得標題化合物（470 毫克）。 -170- 本紙張尺度逍用中國國家標準（CNS ) A4規格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部中央揉準局貝工消費合作杜印製 A7 B7_ 五、發明説明（168) δ (iH, CD3OD): 9.86 (s, 1H, CHO), 5.94 (dd, 1H, H-2, J=1.5&amp;amp;3.6Hz)，4.43(dd,lH，H-8’，J=2.1&amp;amp;9.3Hz)，4.13- 4.02 (m, 3H，8a-CH2(lH)，Η-Γ，CH2-3' (1H))，3.74 (d，1H, 8a-CH2, J=9.9 Hz), 3.34-3.23 (m, 2H, CH2-3' (1H), H-6'), 2.56 (t, 1H, H-l, J=3.9 Hz), 2.34 (m, 1H, H-4'), 0.99 (d, 3H, 4'-CH3, J=6.9 Hz); ^(13C, CD3OD): 209.7 (CHO), 178.4 (COO'Na + ), 152.4 (C-3), 130.1 (C-2), 100.1 (C-8'), 77.2 (ΟΙ'), 77.0 (C-3'), 75.3 (8a-CH2), 73.0 (C-6'), 52.8 (C-5')s 37.2 (C-4，)，34_5 (C-9，)，19.6 (4、CH3)。 實例1 8 [1R-(1^ ,3a^ ,4a/? ,7/3 ,7aa ,8a/? ) ] 8 a-[ [ 1 S , 4 R, 6 R, 8R]-2,7-二氧-4,6-二曱基順式-雙環|；3.4.〇]-壬-8-基·氧 基-甲基]-4 -甲醯基-4,4a,5,6,7，7a,8,8a-八氫-7 -甲基-3-(1-甲基乙基）-l，4-亞甲基-s-η丨噠省_3a(lH)_羧酸 於中間體20(b)(180毫克）於醋酸乙酯（60毫升）内之溶液 中在氮氣下加10%鈀/碳（100毫克）。此懸浮液在帕爾裝置 内於25磅/吋2氫壓及室溫下搖動2小時。濾除催化劑，蒸 發去溶劑至乾。殘餘物於二氧化矽膠上作二次閃色層分析 ，相繼用二氣甲烷：甲醇（49 : 1)及己烷：丙酮（4 : 1)作 洗離劑，製得標題化合物（9 0毫克），爲白色泡沫。 cy (^, CDC13)： 11.5 (bs, 1H, COOH), 9.87 (s, 1H, CHO), 6.04 (dd, 1H，H-2, J=1.2及3.3 Hz)，4.53 (dd, 1H, H-8'，J=2.4 &amp;amp;9.9Hz)，4.45&amp;amp;3.26(2d,2H，8a-CH2,J=9.3Hz)，4.19(q， 1H, H-l', J=3.3 Hz), 3.96 (t, 1H, CH2-3', J=8.4 Hz), 3.58 (m, ___ -171 - 本紙張尺度適用中國國家橾準（CNS ) A4規格（210X297公嫠） (請先閲讀背面之注意Ϋ項再填寫本頁) 訂 經濟部中央揉準局I工消费合作社印袋 3^1644 A7 ___B7 五、發明説明（169) 1H, H-6'), 3.43 (dd, 1H, CH2-3', J=10.2 Hz), 2.55 (m, 1H, H-4'); ci (13C, CDC13): 204.6 (CHO), 174.4 (COOH), 148.3 (C-3), 130.6 (C-2), 97.9 (C-8'), 78.7 (C-l'), 73.3 (C-3'), 72.9 (8a-CH2), 68.7 (C-6'), 46.1 (C-5'), 36.6 (C-4'), 34.02 (C-9'), 21.8 (6，-CH3)，13.6 (4’-CH3)。 實例1 9 [lR-(la ,3a/? ,4/5 ,4ay5 ,Ί β ,7a« ,8a^ ) ] 8 a-[ [ 1 S, 4 R, 7 R, 9R]-2,8-二氧-4,9-二甲基-順式-雙環[3_4.〇]·壬_7_基_氧 基-甲基]-4 -甲醯基-4,4a，5,6,7,7a，8,8a-八氫-7 -甲基-3-(1-甲基乙基）-1,4 -亞甲基-s-啕噠省_3a(lH)-羧酸 於中間體23(a)(150毫克）於醋酸乙酯（15毫升）内之溶液 中在氮氣下加10 %鈀/碳（50毫克）。此混合物在帕爾裝置 内於20磅/吋2氫壓及室溫下搖動ί小時。濾除催化劑，蒸 發去溶劑至乾。殘餘物作閃色層分析純化，相繼用丙酮： 己燒（1 : 3 )洗離，製得標題化合物（100毫克），爲結晶固體 〇 δ (!Η, CDC13): 9.86 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J=1.2及3.3 Hz)，4.63 (dd, 1H，H-71，J=3.3及6.6 Hz)，4.37 (d， lH，8aCH2，JAB=9.6Hz)，3.98&amp;amp;3.67(2dd，2H，H-3'，J=6.6 及8.1 Hz), 3.40-3.20 (m，3H, 8aCH2, H-9,及Η-Γ)，2_46 (t， 1H, H-l, J=3.9 Hz), 1.04 (d, 3H, CH3CH) ° 實例2 0 [lR-(lor ,3ayS ,Α β Aa/3 ,Ί/3 ,7aa ,8a^ ) ] 8 a-[ [ 1 S ,4R, 7R, 9R]-2,8 -二氧·4,9_二甲基_順式·雙環[no卜7_基_氧基- _ -172- 本紙張尺度逍用中國國家樣準（CNS ) A4g ( 21〇χ297公董) (請先閲讀背面之注意事項再填寫本頁)</span>-, 1T Printed by Beigong Consumer Cooperative of Central Bureau of Standards, Ministry of Economic Affairs ^ 21644 A7 B7 V. Description of the invention (in the solution of intermediate 20 (a) (680 mg) in ethyl acetate (100 mL) under nitrogen Next, 10% palladium / carbon (200 mg) was added. The mixture was shaken in a Parr device at 25 psi hydrogen pressure and room temperature for 2 hours. The catalyst was filtered off, and the solvent was evaporated to dryness. The residue It was purified by flash chromatography and washed away with methane •• methanol (49: 1) to obtain the title compound (450 mg) as white foam β ^ On, CDC13): 9.86 (s, 1H, CHO ), 6.04 (dd, 1H, H-2, J ^ l.5 ^ 3.6 Hz), 4.57 (dd, 1H, H-8 ', J = 2.4 ^ L9.3 Hz), 4.40 (d, 1H, 8a -CH2, J = 9.6 Hz), 4.08 (m, 2H, Η-Γ and CH2-3 '(1H)), 3-27 (m, 3H, H-6', CH2-3 '(1H), 8a -CH2 (1H)), 2.47 (t, 1H, Hl, J = 3.9 Hz), 1.02 (d, 3H, 4'-CH3, J = 6.6 Hz); ^ (13C, CDCI3): 204.7 (CHO), 173.8 (COOH), 148.4 (C-3), 130.5 (C-2), 98.5 (C-8 '), 75.2 (C-l'), 74.3 (8a-CH2), 73.3 (C-3 ') s 71.9 (C-6 '), 51.2 (C-5'), 36.0 (C-4 '), 32.9 (C-9'), 19.4 (4'-CH3) o Example 1 7 [lR- (la, 3a ^ Αβ Α ^ β, Ί β, Ι άοι, 8ay5)] 8 a- [[1 S, 4 S, 6 R, 8R] -2,7-dioxo-4,6-dimethyl-cis-bicyclo [3.4.Ο] -Non-8 -Yl-oxy-methyl] -4-carboxamide-4,43,5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl Group) -1,4-methylene-s-, Yinda province_3a (lH) _carboxylic acid, sodium salt was added dropwise to a solution of the compound of Example 16 (450 mg) in methanol (100 mL) Sodium hydroxide aqueous solution (0.099N, 9.5 ml). The solvent was removed under reduced pressure, the residue was dissolved in water (80 ml), and the crystals were frozen to prepare the title compound (470 mg). -170- This paper standard uses the Chinese National Standard (CNS) A4 specification (210X297mm) (please read the precautions on the back and then fill out this page). Ordered by the Ministry of Economic Affairs Central Bureau of Industry and Commerce Co., Ltd. Du Printing A7 B7_ 5. Description of the invention (168) δ (iH, CD3OD): 9.86 (s, 1H, CHO), 5.94 (dd, 1H, H-2, J = 1.5 &amp;amp; 3.6Hz), 4.43 (dd, lH, H- 8 ', J = 2.1 &amp;amp; 9.3Hz), 4.13-4.02 (m, 3H, 8a-CH2 (lH), Η-Γ, CH2-3' (1H)), 3.74 (d, 1H, 8a-CH2, J = 9.9 Hz), 3.34-3.23 (m, 2H, CH2-3 '(1H), H-6'), 2.56 (t, 1H, Hl, J = 3.9 Hz), 2.34 (m, 1H, H- 4 '), 0.99 (d, 3H, 4'-CH3, J = 6.9 Hz); ^ (13C, CD3OD): 209.7 (CHO), 178.4 (COO'Na +), 152.4 (C-3), 130.1 ( C-2), 100.1 (C-8 '), 77.2 (ΟΙ'), 77.0 (C-3 '), 75.3 (8a-CH2), 73.0 (C-6'), 52.8 (C-5 ') s 37.2 (C-4,), 34_5 (C-9,), 19.6 (4, CH3). Example 1 8 [1R- (1 ^, 3a ^, 4a /?, 7/3, 7aa, 8a /?)] 8 a- [[1 S, 4 R, 6 R, 8R] -2,7-II Oxygen-4,6-dimethyl cis-bicyclo |; 3.4.〇] -non-8-yl · oxy-methyl] -4-carboxamide-4,4a, 5,6,7,7a , 8,8a-octahydro-7-methyl-3- (1-methylethyl) -l, 4-methylene-s-η-soda_3a (lH) _carboxylic acid in intermediate 20 (b) (180 mg) in ethyl acetate (60 ml) was added 10% palladium / carbon (100 mg) under nitrogen. This suspension was shaken in a Parr device at 25 psi hydrogen pressure at room temperature for 2 hours. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was subjected to secondary flash layer analysis on silica gel, using methane: methanol (49: 1) and hexane: acetone (4: 1) as the eluent, to obtain the title compound (90 mg ) Is a white foam. cy (^, CDC13): 11.5 (bs, 1H, COOH), 9.87 (s, 1H, CHO), 6.04 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.53 (dd, 1H, H -8 ', J = 2.4 &amp;amp; 9.9Hz), 4.45 &amp;amp; 3.26 (2d, 2H, 8a-CH2, J = 9.3Hz), 4.19 (q, 1H, H-l', J = 3.3 Hz), 3.96 (t, 1H, CH2-3 ', J = 8.4 Hz), 3.58 (m, ___ -171-This paper scale is applicable to China National Standards (CNS) A4 specification (210X297 public daughter) (please read the note on the back first Ϋ Item and then fill out this page) Order the printed bag of the Central Industrial Development Bureau of the Ministry of Economic Affairs, I Industrial and Consumer Cooperatives 3 ^ 1644 A7 ___B7 V. Description of the invention (169) 1H, H-6 '), 3.43 (dd, 1H, CH2-3', J = 10.2 Hz), 2.55 (m, 1H, H-4 '); ci (13C, CDC13): 204.6 (CHO), 174.4 (COOH), 148.3 (C-3), 130.6 (C-2), 97.9 (C-8 '), 78.7 (C-l'), 73.3 (C-3 '), 72.9 (8a-CH2), 68.7 (C-6'), 46.1 (C-5 '), 36.6 (C- 4 '), 34.02 (C-9'), 21.8 (6, -CH3), 13.6 (4'-CH3). Example 1 9 [lR- (la, 3a /?, 4/5, 4ay5, Ί β, 7a «, 8a ^)] 8 a- [[1 S, 4 R, 7 R, 9R] -2,8- Dioxo-4,9-dimethyl-cis-bicyclo [3_4.〇] · non_7_yl_oxy-methyl] -4-carboxamide-4,4a, 5,6,7, 7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-pyridine_3a (lH) -carboxylic acid in intermediate 23 (a) (150 mg) in ethyl acetate (15 mL) was added 10% palladium / carbon (50 mg) under nitrogen. This mixture was shaken in a Parr device at 20 psi hydrogen pressure at room temperature for 1 hour. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was analyzed and purified by flash chromatography, successively washed away with acetone: hexane (1: 3) to obtain the title compound (100 mg) as a crystalline solid 〇δ (! Η, CDC13): 9.86 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.63 (dd, 1H, H-71, J = 3.3 and 6.6 Hz), 4.37 (d, lH, 8aCH2, JAB = 9.6 Hz), 3.98 &amp;amp; 3.67 (2dd, 2H, H-3 ', J = 6.6 and 8.1 Hz), 3.40-3.20 (m, 3H, 8aCH2, H-9, and Η-Γ), 2_46 (t, 1H , Hl, J = 3.9 Hz), 1.04 (d, 3H, CH3CH) ° Example 2 0 [lR- (lor, 3ayS, Α β Aa / 3, Ί / 3, 7aa, 8a ^)] 8 a- [[ 1 S, 4R, 7R, 9R] -2,8 -Dioxy · 4,9_dimethyl_cis · Bicyclo [no 卜 7_ 基 _oxy- _ -172- This paper scale is used in the country of China Sample Standard (CNS) A4g (21〇 × 297 Public Director) (Please read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央橾準局貝工消费合作社印製 A7 B7 五、發明説明（17〇) 甲基]-4-曱酿基-4,4&amp;amp;，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫_7-甲基-3-(1- 甲基乙基）-1,4 -亞甲基- s-Ί丨達省- 3a(lH) -叛酸，納鹽 於實例19化合物（100毫克）於甲醇（5毫升）内之溶液中滴 加氫乳化納水/谷液（0.106N水落液，ι_88毫升）。3〇分鐘後 減壓除去溶劑，將殘餘物溶於水（3毫升）内，；東晶，製得標 題化合物（104毫克）。 3 dH，CD3OD): 9.88 (s，1H，CHO)，5.93 (dd, 1H，H-2, J-1.2；^3.3Hz)，4.49(m，lH，H-7')，4.02(m，2H,H-3{ 8aCH2), 3.72 (d, 1H, 8aCH2, JAB=9 3 hz)，2.56 (t，1H, Η·1， J-3.6 Hz); δ (13C, CD3OD): 209.7 (CHO), 178.4 (COOH), 152.4 (C-3), 130.1 (C-2), 99.9 (C-7'), 82.1 (C-l')5 76.5 (8aCH2)，72.2 (C-9')，37.5 (C-5’)，15.2 (^H3-CH)。 實例2 1 [lR-(lar，3a&amp;gt;5，4/5，4a/?，7y?，7a〇r，8a；5 )]8a-[[lS，4S，7R, 9R]-2,8 -二氧-4,9 -二甲基-順式-雙環[34〇]_壬_7_基-氧 基-甲基]-4 -甲醯基-4,4a，5,6,7,7a，8,8a-八氫-7_ 甲基-3_ (1-甲基乙基）-l，4 -亞甲基_s -吲噠省_3a(lH)_羧酸 於中間體23(b)(260毫克）於醋酸乙酯（15毫升)内之溶液 中在氮氣下加10 %免/碳（50毫克）。此混合物在帕爾裝置 内於20磅/吋2氫壓及室溫下搖動1小時。濾除催化劑，蒸 發去溶劑至乾。殘餘物以製備用TLC純化（二氧化矽膠，甲 醇：二氣甲烷1 : 20)，製得標題化合物（185毫克），爲油體 ，於Rf=0.6。 ά CDC13): 9.85 (s5 1H, CHO), 6.04 (dd, 1H, H-2, -173- 本紙張尺度逋用中國國家標準（CNS〉A4規格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁)</span>A7 B7 printed by the Beigong Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economic Affairs V. Description of the invention (17〇) Methyl] -4-methylbenzene-4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -Octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-Ί 丨 达 省 -3a (lH) -tetanoic acid, sodium salt in Example 19 compound ( 100 mg) in a solution of methanol (5 ml) was added dropwise hydrogen emulsified sodium / valley solution (0.106N water drop, ι_88 ml). After 30 minutes, the solvent was removed under reduced pressure, and the residue was dissolved in water (3 ml); Tojing, the title compound (104 mg) was prepared. 3 dH, CD3OD): 9.88 (s, 1H, CHO), 5.93 (dd, 1H, H-2, J-1.2; ^ 3.3Hz), 4.49 (m, lH, H-7 '), 4.02 (m, 2H, H-3 {8aCH2), 3.72 (d, 1H, 8aCH2, JAB = 9 3 hz), 2.56 (t, 1H, Η · 1, J-3.6 Hz); δ (13C, CD3OD): 209.7 (CHO ), 178.4 (COOH), 152.4 (C-3), 130.1 (C-2), 99.9 (C-7 '), 82.1 (C-l') 5 76.5 (8aCH2), 72.2 (C-9 '), 37.5 (C-5 '), 15.2 (^ H3-CH). Example 2 1 [lR- (lar, 3a&gt; 5, 4/5, 4a / ?, 7y ?, 7a〇r, 8a; 5)] 8a-[[lS, 4S, 7R, 9R] -2,8- Dioxo-4,9-dimethyl-cis-bicyclo [34〇] _non_7_yl-oxy-methyl] -4-methylacyl-4,4a, 5,6,7,7a , 8,8a-octahydro-7_ methyl-3_ (1-methylethyl) -l, 4-methylene_s-indida_3a (lH) _carboxylic acid in intermediate 23 (b) (260 mg) in a solution of ethyl acetate (15 ml) was added 10% carbon / carbon (50 mg) under nitrogen. This mixture was shaken in a Parr device at 20 psi hydrogen pressure at room temperature for 1 hour. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was purified by preparative TLC (silica dioxide, methanol: methane 1:20) to obtain the title compound (185 mg) as an oil body at Rf = 0.6. ά CDC13): 9.85 (s5 1H, CHO), 6.04 (dd, 1H, H-2, -173- This paper scale adopts the Chinese National Standard (CNS&gt; A4 specification (210X297 mm) (please read the notes on the back (Fill in this page again)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T Λ A7 ___B7__ 五、發明説明（171) J=1.5&amp;amp;3.6Hz),4.88(t，lH，H-7’，2.7Hz)，4.27&amp;amp;3.28(2d， 2H，8aCH2，JAB=9.9Hz)，3.85&amp;amp;3.73(2m,2H，OCH2)，3.60 (m，1H, H-9')，3.37 (dd, 1H，H-l，，J=7_2及8.4 Hz)，2.47 (m, 3H, H-5'+CHCH3+Hl); d(13C, CDC13): 204.4 (CHO), 173.7 (COOH), 148.2 (C-3), 130.5 (C-2), 98.7 (C-7'), 81.2 (C-Γ), 72.8 (8aCH2 + OCH2), 69.9 (C-9'), 25.4 (C-6'), 12.4(CH3CH) o 實例2 2 [1R-(1 « ,3ay5 ,4^ ,4ay3 ,1 β ,7a or ,8a^ ) ] 8a-[ [ 1 S ,7R,9R]- 2.8 -二氧- 4,4,9 -三甲基-順式-雙環[3.4.0]·壬-7-基-氧基 -甲基]-4-甲醯基-4,4a，5,6,7,7a，8,8a-八氫-7-甲基-3-(l-曱基乙基）-l，4-亞甲基-s·吲噠省_3a(lH)-羧酸 於中間體24(100毫克）於醋酸乙酯（45毫升）内之溶液中在 氮氣下加10 %鈀/碳（50毫克）。此混合物在帕爾裝置内於 25磅/吋2氫壓及室溫下搖動2小時。濾除催化劑，蒸發去 溶劑至乾。殘餘物作二次閃色層分析，相繼用1 ·5 %二氣甲 燒内的甲醇及15 %己烷内的丙酮作洗離劑，製得標題化合 物（40毫克），爲白色泡沫。 經濟部中央樣準局貝工消费合作社印袋 (請先閲讀背面之注意事項再填寫本頁)</span>、 1T Λ A7 ___B7__ V. Description of the invention (171) J = 1.5 &amp;amp; 3.6Hz), 4.88 (t, lH, H-7 ′, 2.7Hz), 4.27 &amp;amp; 3.28 (2d, 2H, 8aCH2, JAB = 9.9 Hz), 3.85 &amp;amp; 3.73 (2m, 2H, OCH2), 3.60 (m, 1H, H-9 '), 3.37 (dd, 1H, Hl ,, J = 7_2 and 8.4 Hz), 2.47 (m, 3H, H-5 '+ CHCH3 + Hl); d (13C, CDC13): 204.4 (CHO), 173.7 (COOH), 148.2 (C-3), 130.5 (C-2), 98.7 (C-7'), 81.2 (C-Γ), 72.8 (8aCH2 + OCH2), 69.9 (C-9 '), 25.4 (C-6'), 12.4 (CH3CH) o Example 2 2 [1R- (1 «, 3ay5, 4 ^, 4ay3 , 1 β, 7a or, 8a ^)] 8a- [[1 S, 7R, 9R]-2.8 -dioxa-4,4,9 -trimethyl-cis-bicyclo [3.4.0] · non- 7-yl-oxy-methyl] -4-carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (l-methylethyl ) -L, 4-methylene-s · indap province_3a (lH) -carboxylic acid in a solution of intermediate 24 (100 mg) in ethyl acetate (45 ml) was added 10% palladium under nitrogen / Carbon (50 mg). This mixture was shaken in a Parr device at 25 psi hydrogen pressure at room temperature for 2 hours. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was subjected to secondary flash chromatography, using methanol in 1.5% two-gas methane and acetone in 15% hexane as the eluent, to obtain the title compound (40 mg) as a white foam. Printed bags of the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">On, CDC13): 9.85 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J=1.2&amp;amp;3.6Hz)，4.84(t,lH，H-7,,J=3Hz)，4.23&amp;amp;3.29(2d， 2H, 8a-CH2, J=9.6 Hz), 3.81 (t, 1H, Η-Γ, J=8.7 Hz), 3.52 (dq，1H, H-9', J=9.3及6.3 Hz), 3.50及3.42 (2d, 2H, CH2-3'， JU Hz)，2·48 (t，1H，H-l，J=4.2 Hz)，1.09及0.98 (2s, 6H, H-CH3); ^(13C, CDCI3)： 204.5 (CHO), 174.0 (COOH), ____-174- 本紙張A度逍用中國國家梯率（CNS ) 格（210X297公釐） 經濟部中央標準局負工消費合作社印製 A7 B7 五、發明説明（172) 148.2 (C-3), 130.5 (C-2), 98.7 (C-7'), 81.01 (C-1'), 78.8 (C-3'), 72.7 (8a-CH2), 70.2 (C-9'), 41.3 (C-4'), 40.4 (C-5'), 27.3 (4-CH3), 26.5 (C-6，），22.8 (4’-(：Η3)。 實例2 3 [1R-(1 a，3a々，4y5，4a々，7卢，7aa，8ay9 )]8a-[(6-去氧-3,4- O-異亞丙基-D -別哌喃糖基氧基）甲基]_4_甲醯基_ 4，4a, 5,6,7,7a，8,8a -八氫-7-甲基-3-(1-甲基乙基）-1,4-亞甲基-s-吲噠省-3a(lH)-羧酸 於中間體27(125毫克）於甲醇（2 5毫升）内之溶液中在氮氣 下加1 0 %鈀/碳（100毫克）。此混合物在帕爾裝置内於i 5 磅/吋2氫壓及室溫下搖動1.5小時。濾除催化劑，濾過物 於0°C加於1當量鹽酸（0.5毫升）内。攪拌1小時後，此混合 物以10%碳酸氫鈉中和。蒸發去溶劑至乾，油體殘餘物作 閃柱色層分析純化，用己烷：醋酸乙酯（4: 1)及二氣曱烷 :甲醇（20 : 1)洗離，製得標題化合物（62毫克）。 cJ (lK, CDC13): 9.73 (s, 1H, CHO), 6.10 (dd, 1H, H-2, J=1.2&amp;amp;3.3Hz),4.51(t,lH，H-2'，J=4.5Hz)，4.48(d，lH，H-l，，J=7.5Hz),3.65&amp;amp;4.07(2d，2H，8aCH2，J=9.3Hz)，3.78 (dd，1H，H-41，J=9及5.1 Hz), 3.69 (dd，1H，H-3'，J=7.5及5.1 Hz), 3·50 (m，1H, H-5’，J=6及9 Hz)，2.59 (t，1H，H-l，J=3.9 Hz), 2.32 (m, 1H, CHMe2); tf(13C, CDC13 ): 204.6 (CHO), 176_1 (C02H)，148.2 (C-3)，130.8 (C-2), 110.4 (四級C異亞丙 基），100.9 (C-Γ)，78.34 (C-4’），75.1 (C-2，），74.7 (8aCH2)， 72.5 (C-4a), 71.7 (C-3'), 69.3 (C-5'), 65.6 (C-8a), 58.9 (C- -175- 本紙張尺度適用中國國家梯準（CNS ) A4规格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁〕 乂· ,ιτ 經濟部中央標準局員工消費合作社印裝 A7 _________B7 五、發明説明（173) 4')，46.3(C-1)。 實例2 4 [1尺-(1«，3&amp;amp;卢，4々，4&amp;amp;;5,7/?，7&amp;amp;“，8&amp;amp;卢）]8&amp;amp;-[(2-去氧-3,4-〇 -異亞丙基-6-0 -甲基-々-D-別略喃糖基氧基）甲基]-4 -甲 酿基-4,4a，5,6,7,7a，8,8a-八氫-7 -甲基-3-(1-甲基乙基）-1，4-亞甲基-8_,5丨噠省_3&amp;amp;(111)-羧酸 將中間體30(50毫克）於四氫呋喃（5毫升）内之溶液於室溫 以氟化四丁基銨（1·〇Μ的於四氫呋喃内之溶液，200微升）處 理。24小時後將反應混合物濃縮至乾，成爲黃色油體，作 閃柱色層分析純化，用二氣子烷：曱醇（丨5 :丨）洗離，製得 標題化合物（1 8毫克）。 ^ (lU, CDC13): 9.80 (s, 1H, CHO), 5.98 (dd, 1H, H-2, J=1.2及3.3 Hz)，4.64 (dd，1H，Η-Γ，J=2.7及8.1 Hz)，4.42 (m, 1H，H-3')，3.68及4.01 (2d，2H, 8aCH2, J=9 Hz), 3.90 (m, 1H， H-4')，3.45-3.65 (m，3H，H-5'&amp;amp;2H-6')，3.22(s，3H，6，-〇CH3)，2.60 (m，1H，Η-Γ), 1.34及 1.35 (2s, 6H，亞丙基之曱 S);e(13C，CDCl3):206.3 (CHO)，175.7(CO2H)，149.7(C- 3)，129.7 (C-2), 108.9 (亞丙基之四級(：），98.2(01，），74.8((：-3a), 74.8 (C-4), 74.4 (8aCH2), 72.6 (C-3'), 71.3 (C-5'), 65.1 (C-8a), 61.1 (C-6')5 58.4 (C-4), 48.4 (6'-OMe), 46.1 (C-l), 32.8 (C-2')。 實例2 5 [1R-(1^ ,3ay5 ,4y5 ,4a^ ,1 β ,laa ,8a/? ) ] 8 a-[ [ 1 S , 4 R, 7 R, 9R]-2,8 -二氧-4 -乙基-9 -甲基-順式-雙環[3_4_0] -壬-7-基 ____-176-__ 本紙張尺度遑用中國國家標準（CNS ) A4规格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁) 乂·</span>On, CDC13): 9.85 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J = 1.2 &amp;amp; 3.6Hz), 4.84 (t, lH, H-7 ,, J = 3Hz), 4.23 &amp;amp; 3.29 (2d, 2H, 8a-CH2, J = 9.6 Hz), 3.81 (t, 1H, Η-Γ, J = 8.7 Hz), 3.52 (dq, 1H, H-9 ', J = 9.3 and 6.3 Hz), 3.50 and 3.42 (2d, 2H, CH2-3 ', JU Hz), 2.48 (t, 1H, Hl, J = 4.2 Hz), 1.09 and 0.98 (2s, 6H, H-CH3); ^ (13C, CDCI3): 204.5 (CHO), 174.0 (COOH), ____- 174- This paper is printed on the Chinese National Gradient (CNS) grid (210X297 mm) for the A-degree use of this paper A7 B7 5. Description of the invention (172) 148.2 (C-3), 130.5 (C-2), 98.7 (C-7 '), 81.01 (C-1'), 78.8 (C-3 '), 72.7 (8a -CH2), 70.2 (C-9 '), 41.3 (C-4'), 40.4 (C-5 '), 27.3 (4-CH3), 26.5 (C-6,), 22.8 (4'-(: Η3). Example 2 3 [1R- (1a, 3a々, 4y5, 4a々, 7 Lu, 7aa, 8ay9)] 8a-[(6-deoxy-3,4-O-isopropylidene-D -Allopyranosyloxy) methyl] _4_carboxamide_ 4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3- (1-methylethyl Group) -1,4-methylene-s-indap-3a (lH) -carboxylic acid dissolved in intermediate 27 (125 mg) in methanol (25 mL) 10% palladium / carbon (100 mg) was added under nitrogen. The mixture was shaken in a Parr device at 1.5 psi hydrogen pressure at room temperature for 1.5 hours. The catalyst was filtered off and the filtrate was filtered at 0 ° C Added to 1 equivalent of hydrochloric acid (0.5 ml). After stirring for 1 hour, the mixture was neutralized with 10% sodium bicarbonate. The solvent was evaporated to dryness, and the oily residue was purified by flash chromatography, using hexane: acetic acid Ethyl ester (4: 1) and dimethane: methanol (20: 1) were washed away to obtain the title compound (62 mg). CJ (lK, CDC13): 9.73 (s, 1H, CHO), 6.10 (dd , 1H, H-2, J = 1.2 &amp;amp; 3.3Hz), 4.51 (t, lH, H-2 ', J = 4.5Hz), 4.48 (d, lH, Hl ,, J = 7.5Hz), 3.65 &amp;amp;; 4.07 (2d, 2H, 8aCH2, J = 9.3Hz), 3.78 (dd, 1H, H-41, J = 9 and 5.1 Hz), 3.69 (dd, 1H, H-3 ', J = 7.5 and 5.1 Hz ), 3 · 50 (m, 1H, H-5 ', J = 6 and 9 Hz), 2.59 (t, 1H, Hl, J = 3.9 Hz), 2.32 (m, 1H, CHMe2); tf (13C, CDC13): 204.6 (CHO), 176_1 (C02H), 148.2 (C-3), 130.8 (C-2), 110.4 (quaternary C isopropylidene), 100.9 (C-Γ), 78.34 (C-4 '), 75.1 (C-2,), 74.7 (8aCH2), 72.5 (C-4a), 71.7 (C-3'), 69.3 (C -5 '), 65.6 (C-8a), 58.9 (C-175- This paper size is applicable to China National Standard (CNS) A4 specification (210X297mm) (please read the precautions on the back before filling this page)佂, ιτ A7 _________B7 printed by the Employees ’Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs V. Description of Invention (173) 4 '), 46.3 (C-1). Example 2 4 [1 ruler- (1 «, 3 &amp;amp; Lu, 4々, 4 &amp;amp;; 5,7 / ?, 7 &amp;amp;", 8 &amp;amp; Lu)] 8 &amp;amp;-[(2-deoxy-3,4- 〇-Isopropylidene-6-0-methyl-々-D-allyloranosyloxy) methyl] -4-methylbromo-4,4a, 5,6,7,7a, 8, 8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-8_, 5 ~ da province_3 &amp; (111) -carboxylic acid intermediate 30 (50 Mg) solution in tetrahydrofuran (5 mL) was treated with tetrabutylammonium fluoride (1.0 M in tetrahydrofuran solution, 200 μl) at room temperature. After 24 hours, the reaction mixture was concentrated to dryness and became The yellow oil was purified by flash column chromatography and washed away with dioxane: methanol (丨 5: 丨) to obtain the title compound (18 mg). ^ (LU, CDC13): 9.80 (s, 1H, CHO), 5.98 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.64 (dd, 1H, Η-Γ, J = 2.7 and 8.1 Hz), 4.42 (m, 1H, H-3 '), 3.68 and 4.01 (2d, 2H, 8aCH2, J = 9 Hz), 3.90 (m, 1H, H-4'), 3.45-3.65 (m, 3H, H-5 '&amp;amp; 2H-6') , 3.22 (s, 3H, 6, -〇CH3), 2.60 (m, 1H, Η-Γ), 1.34 and 1.35 (2s, 6H, propylene propylene); e (13C, CDCl3): 206.3 ( CHO) 175.7 (CO2H), 149.7 (C-3), 129.7 (C-2), 108.9 (Propylene grade four (:), 98.2 (01,), 74.8 ((: -3a), 74.8 (C-4 ), 74.4 (8aCH2), 72.6 (C-3 '), 71.3 (C-5'), 65.1 (C-8a), 61.1 (C-6 ') 5 58.4 (C-4), 48.4 (6'- OMe), 46.1 (Cl), 32.8 (C-2 '). Example 2 5 [1R- (1 ^, 3ay5, 4y5, 4a ^, 1 β, laa, 8a /?)] 8 a- [[1 S , 4 R, 7 R, 9R] -2,8 -dioxo-4 -ethyl-9 -methyl-cis-bicyclo [3_4_0] -non-7-yl ____- 176 -__ Use the Chinese National Standard (CNS) A4 specification (210X297mm) (please read the precautions on the back before filling this page) 佂 ·</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T 經濟部中央揉準局員工消费合作社印裝 A7 B7_____ 五、發明説明（174) -氧基-甲基]-4 -甲醯基-4,4a,5，6,7,7a,8,8a-八氫-7 -甲基 -3-U -甲基乙基）-1,4-亞甲基-s-β噠省-3 a(lH)-羧酸 於中間體3 7(200毫克）於醋酸乙酯（40毫升）内之溶液中在 氮氣下加10%鈀/碳（50毫克）。此混合物在帕爾裝置内於 30磅/吋2氫壓及室溫下搖動2小時。濾除催化劑，蒸發去 溶劑至乾。殘餘物於二氧化矽膠上作閃色層分析，用二氣 甲烷：甲醇（98 : 2)作洗離劑，製得標題化合物（125毫克) 〇 ^ (^, CDC13)： 9.86 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J=1.5&amp;amp;3.3Hz),4.66(dd，lH，H-7’，J=3.0&amp;amp;6.0Hz),4.32&amp;amp; 3.29 (2d, 2H, 8a-CH2, J=9.6 Hz), 4.02 (dd, 1H, CH2-3', (1H), J=7.2&amp;amp;8.4Hz)，3.67(dd，lH，H-r，J=7.8&amp;amp;9.3Hz)，3.41-3.22 (m，2H，H-9’及CH2-3' (1H))，2.48 (t，1H，H_l，J=3.9 Hz), 0.92 (t, 3H, CH3CH2, J=7.5 Hz); ^ (13C, CDC13): 204.5 (CHO), 174.2 (COOH), 148.3 (C-3), 130.5 (C-2), 98.5 (C-7，），80.3 (C-Γ)，73.0及73.0 (8a_g及C-3，），70.9 (C-9，）。 實例2 6 [lR-(la，3a卢，4点，4a卢，7/5，7aa ,8a/? )]8a_[[lS，4R，7R， 9R]-2,8-二氧-4 -乙基-9-曱基-順式-雙環[3.4.0]-壬-7-基 -氧基-甲基]-4 -甲酿基-4,4a,5,6,7,7a，8,8a -八氫-7-甲基 -3-(1-甲基乙基）-1,4-亞曱基- s-θ丨建省_3a(lH)_叛酸， 納鹽 於實例25化合物（88毫克）於甲醇（1〇毫升）内之溶液中， 滴加0.099當量的氫氧化鈉水溶液（1.8毫升）。減壓除去溶劑 -177- 本紙張尺度逋用中國國家標準（CNS &amp;gt; A4规格（210x297公釐） ---------f 乂II (請先閲讀背面之注意事項再填寫本頁)</span>、 1T Printed and printed by the employee consumer cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs A7 B7_____ V. Description of the invention (174) -Oxy-methyl] -4 -Methyl-4,4a, 5,6,7,7a, 8, 8a-octahydro-7-methyl-3-U-methylethyl) -1,4-methylene-s-β-pyridin-3 a (lH) -carboxylic acid in intermediate 37 (200 mg ) To a solution in ethyl acetate (40 ml) was added 10% palladium / carbon (50 mg) under nitrogen. This mixture was shaken in a Parr device at 30 psi hydrogen pressure at room temperature for 2 hours. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was analyzed by flash layer on silica gel, using methane gas: methanol (98: 2) as the eluent to obtain the title compound (125 mg). ^^^^, CDC13): 9.86 (s, 1H , CHO), 6.05 (dd, 1H, H-2, J = 1.5 &amp;amp; 3.3Hz), 4.66 (dd, lH, H-7 ', J = 3.0 &amp;amp; 6.0Hz), 4.32 &amp;amp; 3.29 (2d, 2H, 8a-CH2, J = 9.6 Hz), 4.02 (dd, 1H, CH2-3 ', (1H), J = 7.2 &amp;amp; 8.4Hz), 3.67 (dd, lH, Hr, J = 7.8 &amp;amp; 9.3 Hz), 3.41-3.22 (m, 2H, H-9 'and CH2-3' (1H)), 2.48 (t, 1H, H_l, J = 3.9 Hz), 0.92 (t, 3H, CH3CH2, J = 7.5 Hz); ^ (13C, CDC13): 204.5 (CHO), 174.2 (COOH), 148.3 (C-3), 130.5 (C-2), 98.5 (C-7,), 80.3 (C-Γ), 73.0 And 73.0 (8a_g and C-3,), 70.9 (C-9,). Example 2 6 [lR- (la, 3a Lu, 4 o'clock, 4a Lu, 7/5, 7aa, 8a /?)] 8a _ [[lS, 4R, 7R, 9R] -2,8-diox-4- Ethyl-9-methyl-cis-bicyclo [3.4.0] -non-7-yl-oxy-methyl] -4-methylbromo-4,4a, 5,6,7,7a, 8 , 8a -octahydro-7-methyl-3- (1-methylethyl) -1,4-methylidene-s-θ 丨 建 省 _3a (lH) _trait acid, sodium salt in Example 25 To a solution of the compound (88 mg) in methanol (10 mL), 0.099 equivalent of aqueous sodium hydroxide solution (1.8 mL) was added dropwise. Removal of solvent under reduced pressure-177- This paper scale uses the Chinese National Standard (CNS &amp;gt; A4 specification (210x297mm) --------- f 伂 II (Please read the precautions on the back before filling this page )</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T 4 A7 B7 五、發明説明（17今 ’將殘餘物溶於水（5 〇毫升）内，凍晶，製得標題化合物 (92毫克）。 d DMSO-d6)： 9.77 (s, 1H, CHO), 5.78 (m, 1H, H-2), 4-4〇 (brdd, 1H, H-7'), 3.92 (m, 1H, H-3'), 3.87 (d, 1H, 8a-CH2 (1H), J=9.6 Hz), 3.50 (m, 2H，8a-CH2 (1H)及Η-Γ)， 3-38-3.21 (m，2H，H-3’及H-9，）。 實例2 7 [lR-(lflr ,3a^ ,Αβ ,4ay5 ,1 β ,Ί^α Μβ ) ] 8 a-[ [ 1 S, 4 S , 7 R, 9R]-2,8-二氧-4 -乙基-9 -甲基-順式-雙環[3.4_0]-壬-7-基 -氧基-甲基]-4 -曱醯基-4，4a,5,6,7,7a,8,8a-八氫-7 -甲基 -3_(1-甲基乙基）-l，4-亞曱基-s-M丨噠省- 3a(lH)-羧酸， 納鹽 於中間體38(420毫克）於醋酸乙酯（80毫升）内之溶液中在 氮乳下加10°/。把/碳（100毫克）。此混合物在帕爾裝置内於 3 0磅/吋2氫壓及室溫下搖動h5小時。濾除催化劑，蒸發 去溶劑至乾。殘餘物於二氧化矽膠上作閃色層分析，用二 氣甲烷：甲醇（98 : 2)作洗離劑，製得標題化合物（280毫克） 〇 d (!H, CDC13)： 9.86 (s, 1H, CHO), 6.05 (dd, 1H, H-2, CH2, J=9.9 Hz), 3.90 (dd，1H，H-3’，J=7.5及8.7 Hz), 3·75 (m， 1H，Η-Γ), 3.64 (m，1H, H-9’），3.43 (t，1H, H_3I，J=8 7 Hz)， 2.46 (t，1H，H-l，J=3.6 Hz)，0.93 (t, 3H, J=7.2</span>, 1T 4 A7 B7 V. Description of the invention (17 Jin 'The residue was dissolved in water (50 mL), frozen crystals to obtain the title compound (92 mg). D DMSO-d6): 9.77 (s, 1H, CHO), 5.78 (m, 1H, H-2), 4-4〇 (brdd, 1H, H-7 '), 3.92 (m, 1H, H-3'), 3.87 (d, 1H, 8a-CH2 (1H), J = 9.6 Hz), 3.50 (m, 2H, 8a-CH2 (1H) and Η-Γ), 3-38-3.21 (m, 2H, H-3 'and H-9,). Example 2 7 [lR- (lflr, 3a ^, Αβ, 4ay5, 1β, Ί ^ α Μβ)] 8 a-[[1 S, 4 S, 7 R, 9R] -2,8-diox-4 -Ethyl-9-methyl-cis-bicyclo [3.4_0] -non-7-yl-oxy-methyl] -4-methyl-4,4a, 5,6,7,7a, 8 , 8a-octahydro-7-methyl-3_ (1-methylethyl) -l, 4-methylidene-sM-da-3a (lH) -carboxylic acid, sodium salt in intermediate 38 (420 Mg) in a solution of ethyl acetate (80 ml), add 10 ° / under nitrogen milk. Put / carbon (100 mg). This mixture was shaken in a Parr device at 30 psi hydrogen pressure for 5 hours at room temperature. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was analyzed by flash layer on silica gel, using methane gas: methanol (98: 2) as the eluent to obtain the title compound (280 mg). Od (! H, CDC13): 9.86 (s, 1H, CHO), 6.05 (dd, 1H, H-2, CH2, J = 9.9 Hz), 3.90 (dd, 1H, H-3 ', J = 7.5 and 8.7 Hz), 3.75 (m, 1H, Η-Γ), 3.64 (m, 1H, H-9 '), 3.43 (t, 1H, H_3I, J = 8 7 Hz), 2.46 (t, 1H, Hl, J = 3.6 Hz), 0.93 (t, 3H, J = 7.2</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz); (i(13C, CDC13): 204.4 (CHO), 173.7 (COOH), 148.2 __-178- 本紙張尺度適用中國國家梂率（CNS ) A4規格（21〇x 297公着） (請先閲讀背面之注意事項再填寫本頁) ，-° 丁 經濟部中央搮準局貝工消费合作社印裝 經濟部中央揉準局貝工消费合作社印製 A7 ΒΊ_______ 五、發明説明（17¾ (C-3),130.5(C-2)，98.8(C-7，），81.3(C-l')，72.8&amp;amp;70.9(8a-&amp;amp;及C-3’），69.8 (C-9')。 實例2 8 [lR-(la，3ay9，4卢，4a/?，7点，7aa，8a卢）]8a-[[lS，4S，7R， 9R]-2,8 -二氧-4-乙基-9 -甲基-順式-雙環[3.4.0] -壬-7-基 -氧基-甲基]-4 -甲醯基-4，4a，5,6,7,7a，8,8a -八氫-7-甲基 -3-(1-甲基乙基）-l，4-亞甲基-S-W噠省- 3a(lH)-羧酸， 鈉鹽 於實例27化合物（262毫克）於甲醇（20毫升）内之溶液中， 滴加0.099當量的氫氧化鈉水溶液（5.3毫升）。減壓^除去溶劑 ，將殘餘物溶於水（1〇〇毫升）内，凍晶，製得標題化合物 (272毫克” (y On, DMSO-d6): 9.77 (s, 1H, CHO), 5.79 (dd, 1H, H-2, J=1.2&amp;amp;3.6Hz)，4.57(m，lH，H_7,)，3.83&amp;amp;3.45(2d，2H，8a-CH2，J=9.6Hz)，3.76&amp;amp;3.33(2m，2H，CH2-3l)，3.52(m，2H， Η-Γ及H-9。。 實例2 9 [lR-(la ,3Άβ ,Αβ ,4ay3 ,1 β ,7a« Μβ ) ] 8 a - [ [ 1 S , 4 R, 7 R, 9R]-2,8-二氧-4-(1-甲基乙基）-9 -曱基-順式-雙環[3.4.0 ] -壬-7-基-氧基-甲基]-4 -甲醯基- 4,4a,5,6,7,7a，8,8a_八 氫-7 -甲基-3-(1-甲基乙基）-1,4-亞甲基-S-吲噠省-3a(lH)·羧酸 於中間體39(280毫克）於醋酸乙酯（15毫升）内之溶液中在 氮氣下加鈀/碳（10 % )(50毫克）。此混合物在帕爾裝置内 __-179-_ 本紙張尺度適用中國國家梂準（CNS ) A4规格（210X 297公釐） (請先閲讀背面之注意事項再填寫本頁}</span>Hz); (i (13C, CDC13): 204.4 (CHO), 173.7 (COOH), 148.2 __- 178- This paper scale is applicable to the Chinese National Frame Rate (CNS) A4 specification (21〇x 297 public) (please first Read the precautions on the back and fill out this page),-° D Printed by the Ministry of Economic Affairs, Central Bureau of Economic Affairs, Beigong Consumer Cooperatives Printed by the Ministry of Economic Affairs, Central Bureau of Economics, Beigong Consumer Cooperatives A7 ΒΊ _______ V. Description of invention (17¾ (C-3 ), 130.5 (C-2), 98.8 (C-7,), 81.3 (C-l '), 72.8 &amp;amp; 70.9 (8a- &amp;amp; and C-3'), 69.8 (C-9 '). Examples 2 8 [lR- (la, 3ay9, 4 Lu, 4a / ?, 7 points, 7aa, 8a Lu)] 8a-[[lS, 4S, 7R, 9R] -2,8-diox-4-ethyl -9 -methyl-cis-bicyclo [3.4.0] -non-7-yl-oxy-methyl] -4 -carboxamide-4,4a, 5,6,7,7a, 8,8a -Octahydro-7-methyl-3- (1-methylethyl) -l, 4-methylene-SW pyridine-3a (lH) -carboxylic acid, sodium salt of the compound of Example 27 (262 mg) To a solution in methanol (20 mL), was added dropwise 0.099 equivalent of sodium hydroxide aqueous solution (5.3 mL). The solvent was removed under reduced pressure, the residue was dissolved in water (100 mL), and the crystal was frozen to prepare The title compound (272 mg "(y On, DMSO-d6): 9.77 (s, 1H, CHO), 5.79 (dd, 1H, H-2, J = 1.2 &amp;amp; 3.6Hz), 4.57 (m, lH, H_7,), 3.83 &amp;amp; 3.45 (2d, 2H, 8a-CH2, J = 9.6Hz), 3.76 &amp;amp; 3.33 (2m, 2H, CH2-3l), 3.52 (m, 2H, Η-Γ and H-9 ... Example 2 9 [lR- (la, 3Άβ, Αβ, 4ay3, 1 β, 7a «Μβ)] 8 a-[[1 S, 4 R, 7 R, 9R] -2,8-dioxo-4- (1-methylethyl) -9 -Methyl-cis-bicyclo [3.4.0] -non-7-yl-oxy-methyl] -4-carboxamide- 4,4a, 5,6,7,7a, 8,8a_octa Hydrogen-7-methyl-3- (1-methylethyl) -1,4-methylene-S-indazole-3a (lH) · carboxylic acid in intermediate 39 (280 mg) in ethyl acetate Palladium / carbon (10%) (50 mg) is added to the solution in the ester (15 ml) under nitrogen. This mixture is in the Parr device __- 179-_ This paper size is applicable to China National Standards (CNS) A4 Specifications (210X 297mm) (Please read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 B7 經濟部中央標準局貝工消費合作社印装 五、發明説明（口7) (PH2 20碎/叫*2)在室溫下搖動丨小時。濾除催化劑，蒸發 去溶劑得殘餘物，再作閃色層分析純化（二氧化碎膠，己燒 丙酮奋積/谷積10 : 1及5 : 1)製得標題化合物（180毫克） ，爲油體（產出率8 4 %)。 ^ (lH，CDC13)： 12-11 (b, in, COOH), 9.88 (s, 1H, CHO), 6.053 (dd, 1H, H2, J=1.5^3.6 Hz), 4.77 (m, 1H, H-7'), 4.37 (d, 1H, 8aCH2, J=9.3 Hz), 3.95 (dd, 1H, H3's J-7.2^8.7 Hz), 3.67 (dd, 1H，Hl’，J=8.7及9 Hz), 3.5-3.36 (m, 2H，Η3，+Η9')， 3.23 (d, 1H, 8aCH2, J=9.3 Hz), 2.43 (t, 1H, HI, J=3.9 Hz) 〇 實例3 0 [1R-(1« ,3a^ ,Αβ ,4a/? ,Ί β ίηΆα ^aJ3 ) ] 8 a-[ [ 1 S , 4R, 7 R, 9R]-2,8-二氧-4·(1_甲基乙基）_9_甲基_順式雙環[3 4 〇 ] -壬-7-基-氧基-曱基]_4_ 甲 _基_4,4&amp;amp;，5,677&amp;amp;，8,83_八 氫-7 -甲基-3-(1-甲基乙基）_丨，拉亞甲基_s_吲噠省_ 3a(lH)-羧酸，鈉鹽 於實例29化合物（170毫克）於甲醇（15毫升）内之溶液中， 加0.0956當量的氫氧化鈉水溶液（3 45毫升）。挽掉】小時後 ，除去溶劑至乾，將所得固體溶於3毫升水内並來乾。 〇U, DMSO-d6): 9.78 (s, 1H, CHO), 5.80 (dd, 1H, H2, J=1.2及3.6 Hz)，4.46 (dd，1H, H7’，J=2.7及5.1 Hz), 3.9-3.8 (m，2H，H3’+8aCH2)，3.54 (dd，1H，ΗΓ，J=8.1 及9 Hz), 3.47 (d, 1H, 8aCH2, J=9.3 Hz) ; ά (13C, DMSO-d6): 206.4 (CHO), 174.3 (COO'), 151.3 (C3), 127.6 (C2), 97.1 (C7'), 80.7 (Cl')。 -180- 私紙張尺度逍用中國國家搮半（CNS ) A4规格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁)</span>A7 B7 Printed by Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of the invention (mouth 7) (PH2 20 pieces / call * 2) Shake at room temperature for 1 hour. The catalyst was filtered off, and the solvent was evaporated to obtain a residue, which was then subjected to flash chromatography analysis and purification (dioxide crushed rubber, acetone, acetone, and distillate / valley 10: 1 and 5: 1) to obtain the title compound (180 mg) as Oil body (yield rate 84%). ^ (lH, CDC13): 12-11 (b, in, COOH), 9.88 (s, 1H, CHO), 6.053 (dd, 1H, H2, J = 1.5 ^ 3.6 Hz), 4.77 (m, 1H, H -7 '), 4.37 (d, 1H, 8aCH2, J = 9.3 Hz), 3.95 (dd, 1H, H3's J-7.2 ^ 8.7 Hz), 3.67 (dd, 1H, Hl', J = 8.7 and 9 Hz) , 3.5-3.36 (m, 2H, Η3, + Η9 '), 3.23 (d, 1H, 8aCH2, J = 9.3 Hz), 2.43 (t, 1H, HI, J = 3.9 Hz) 〇Example 3 0 [1R- (1 «, 3a ^, Αβ, 4a /?, Ί β ίηΆα ^ aJ3)] 8 a- [[1 S, 4R, 7 R, 9R] -2,8-dioxo-4 · (1_methyl Ethyl) _9_methyl_cis-bicyclo [3 4 〇] -non-7-yl-oxy-methyl] _4_methyl_yl_4,4 &amp;amp;, 5,677 &amp;amp;, 8,83_octahydro- 7-methyl-3- (1-methylethyl) _ 丨, lamethylene_s_indap province_3a (lH) -carboxylic acid, sodium salt of the compound of Example 29 (170 mg) in methanol ( 15 mL), add 0.0956 equivalent of sodium hydroxide aqueous solution (3 45 mL). After removing it for 1 hour, remove the solvent to dryness, dissolve the obtained solid in 3 ml of water and dry. 〇U, DMSO-d6): 9.78 (s, 1H, CHO), 5.80 (dd, 1H, H2, J = 1.2 and 3.6 Hz), 4.46 (dd, 1H, H7 ', J = 2.7 and 5.1 Hz), 3.9-3.8 (m, 2H, H3 '+ 8aCH2), 3.54 (dd, 1H, HΓ, J = 8.1 and 9 Hz), 3.47 (d, 1H, 8aCH2, J = 9.3 Hz); ά (13C, DMSO- d6): 206.4 (CHO), 174.3 (COO '), 151.3 (C3), 127.6 (C2), 97.1 (C7'), 80.7 (Cl '). -180- The private paper standard is used in China National Standard (CNS) A4 specification (210X297mm) (please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">,1T 人！ 321644 A7 ___B7 五、發明説明（ 實例3 1 [lR_(la，3a/?，4yS，4ay3，7冷，7aor，8a点）]8a-[[lS,4S,7R, 9R]-2,8-二氧-4-(1-甲基乙基）_9甲基_順式_雙環[3 4 〇 ] -壬-7-基-氧基-甲基]_4-甲醯基_4,4&amp;amp;，5,6,7,7&amp;amp;，8,83_八 氫-7-甲基- 3-(1-甲基乙基亞甲基_s_吲噠省_ 3a(lH)-羧酸 於中間體40(280毫克）於醋酸乙酯（15毫升）内之溶液中在 氮氣下加把/碳（10%)(50毫克）。此混合物在帕爾裝置内 (PH2 = 2 0磅/吋2)在室溫下搖動丨小時。濾除催化劑，蒸發 去溶劑得殘餘物，再作閃色層分析純化（二氧化矽膠，己烷 :丙酮容積/容積10 : 1及5 : 1)製得標題化合物（190毫克） ，爲油體（產出率8 9 %)。 δ (!Η, CDC13): 9.88 (s, 1H, CHO), 6.05 (dd, 1H, H2, J=1.5 &amp;amp;3.3Hz),4.92(t,lH，H7,，J=2.7Hz，4.33(d，lH，8aCH2， J=10.2 Hz), 3.94 (t, 1H, H3', J=8.1 Hz), 3.8-3.7 (m, 2H, Hl'+H9’），3.47 (dd，1H, H3'，J=8.4及 10.8 Hz)，3.29 (d，1H, 8aCH2, J=10_5 Hz)。 實例3 2 經濟部中央揉準局貝工消费合作社印製 (請先閲讀背面之注意事項再填寫本頁) [1R-(1^ ,3a^ ,Αβ Α^β ,1 β ,laa ,8a/3 ) ] 8 a-[ [ 1 S , 4 S , 7R, 9R]-2,8-二氧-4-(1-甲基乙基）·9_甲基-順式-雙環[3.4.0 ] -壬-7-基-氧基-甲基]-4 -甲醯基-4,4a，5，6,7,7a,8,8a -八 氫-7-甲基- 3- (1-甲基乙基）-1,4-亞甲基- S-p5l缝省-3a(lH)-羧酸，鈉鹽 於實例31化合物（165毫克）於曱醇（15毫升）内之溶液中， -181 - 本紙張尺度適用中國國家棵準（CNS〉A4規格（21〇X 297公釐） 經濟部中央標率局貝工消费合作社印製 A7 五、發明説明（17^ ~ --- 加0.0956當量的氫氧化納水溶液（3 35毫升）。攪拌丨小時後 ，除1去溶劑至乾，將所得固體溶於3毫升水内並凍乾。 ^ ('H, CDC13)： 9.77 (s, 1H, CHO), 5.79 (dd, 1H, H2, J=0.9 及3·3 Hz), 4.58 (bs, 1H，H7，)，3.85-3.72 (m，2H， H3’+8aCH2)，3.71-3.56 (m，2H，H9，+H1，），3.45 (d，1H， 8aCH2, J=9.9 Hz); d (^c, CDC13): 206.3 (CHO), 174.3 (COO·)，151.4 (£3)，127.5 ㈣，96 7 (C7,)，8〇 8 (cr)。 實例3 3 [1R-(1 « ,3a^ ,4^ ,4ay5 ,7,7a a ,8a/? ) ] 8 a-[ [ 1 S , 7R, 9R]- 2,8-二氧-9- .甲基-4_亞甲基_順式-雙環[3 4 〇]壬_7-基 -氧基-曱基]-4 -甲醯基_4,4&amp;amp;,5,6,7,7&amp;amp;，8,83-八氫-7_甲基 -3-(1-曱基乙基）_1,4_亞甲基_8_,5丨噠省_3&amp;amp;(111)_羧酸 於中間體41(330毫克）於二氣甲烷（4毫升）内之溶液中加 三氟醋酸（0.2毫升）。此混合物於〇。〇攪拌2〇分鐘，然後用 二氣甲燒（150毫升）稀釋，用水（1〇〇毫升）洗三次。有機層 於硫酸鎂上乾燥，濃縮至乾，得油體，再於二氧化矽上作 閃色層分析’用二氣曱烷：甲醇（98 : 2)作洗離劑。收取合 宜部分’在中等壓力（約1〇巴）下作RP_18色層分析，用線 性梯度水内之乙腈（6 〇至7 5 % )，製得標題化合物。 δ (^, CDC13): 9.87 (s, 1H, CHO), 6.04 (d, 1H, H-2, J=3.3 及8.4 Hz)，4.48-4.29 (m，3H，CH2-3’及8a-CH2(lH))，3.76 (dd，1H，H-l’，J=7.2及9.3 Hz), 3.27 (m，1H, H-9·)，3.02 (m， 1H, H-5'), 2.45 (m, 1H, H-l); ά (13C, CDC13): 205.1 (CHO), -182- 本紙張尺度逋用中國國家標率（CNS ) A4規格（2I0X297公釐） (請先閲讀背面之注意事項再填寫本頁)</span>, 1T people! 321644 A7 ___B7 5. Description of the invention (Example 3 1 [lR_ (la, 3a / ?, 4yS, 4ay3, 7 cold, 7aor, 8a point)] 8a-[[lS, 4S, 7R, 9R] -2, 8- Dioxo-4- (1-methylethyl) _9methyl_cis_bicyclo [3 4 〇] -non-7-yl-oxy-methyl] _4-carboxamide_4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,83_octahydro-7-methyl-3- (1-methylethylmethylene_s_indap province_ 3a (lH) -carboxylic acid in intermediate A solution of 40 (280 mg) in ethyl acetate (15 ml) was added with carbon / carbon (10%) (50 mg) under nitrogen. This mixture was in a Parr device (PH2 = 20 lb / in2) Shake at room temperature for 1 hour. Filter off the catalyst, evaporate the solvent to obtain a residue, and then purify by flash chromatography (silica gel, hexane: acetone volume / volume 10: 1 and 5: 1) to obtain the title compound (190 mg) as an oil body (yield rate 8 9%). Δ (! Η, CDC13): 9.88 (s, 1H, CHO), 6.05 (dd, 1H, H2, J = 1.5 &amp;amp; 3.3Hz) , 4.92 (t, lH, H7 ,, J = 2.7Hz, 4.33 (d, lH, 8aCH2, J = 10.2 Hz), 3.94 (t, 1H, H3 ', J = 8.1 Hz), 3.8-3.7 (m, 2H, Hl '+ H9'), 3.47 (dd, 1H, H3 ', J = 8.4 and 10.8 Hz), 3.29 (d, 1H, 8aCH2, J = 10_5 Hz) Example 3 2 Printed by the Beigong Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs (please read the precautions on the back before filling in this page) [1R- (1 ^, 3a ^, Αβ Α ^ β, 1 β, laa, 8a / 3)] 8 a- [[1 S, 4 S, 7R, 9R] -2,8-dioxo-4- (1-methylethyl) · 9_methyl-cis-bicyclo [3.4.0 ] -Non-7-yl-oxy-methyl] -4 -carboxyl-4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3- (1- Methylethyl) -1,4-methylene-S-p5l Gap-3a (lH) -carboxylic acid, sodium salt in a solution of the compound of Example 31 (165 mg) in methanol (15 ml), -181-This paper scale is applicable to the Chinese National Standard (CNS&gt; A4 specification (21〇X 297 mm). The A7 is printed by the Beigong Consumer Cooperative of the Central Standard Rating Bureau of the Ministry of Economic Affairs. 5. Description of the invention (17 ^ ~ --- plus 0.0956 An equivalent of aqueous sodium hydroxide solution (3 35 ml). After stirring for 1 hour, the solvent was removed to dryness, and the resulting solid was dissolved in 3 ml of water and lyophilized. ^ ('H, CDC13): 9.77 (s, 1H, CHO), 5.79 (dd, 1H, H2, J = 0.9 and 3.3 Hz), 4.58 (bs, 1H, H7,), 3.85-3.72 (m , 2H, H3 '+ 8aCH2), 3.71-3.56 (m, 2H, H9, + H1,), 3.45 (d, 1H, 8aCH2, J = 9.9 Hz); d (^ c, CDC13): 206.3 (CHO) , 174.3 (COO ·), 151.4 (£ 3), 127.5 (iv), 96 7 (C7,), 8〇8 (cr). Example 3 3 [1R- (1 «, 3a ^, 4 ^, 4ay5, 7,7a a, 8a /?)] 8 a- [[1 S, 7R, 9R]-2,8-dioxo-9- .Methyl-4_methylene_cis-bicyclo [3 4 〇] non_7-yl-oxy-methyl] -4 -methylacyl_4,4 &amp;amp;, 5,6,7,7 &amp;amp;;, 8,83-octahydro-7_methyl-3- (1-methylethyl) _1,4_methylene_8_, 5 丨 Province_3 &amp; (111) _carboxylic acid in intermediate To a solution of 41 (330 mg) in methane (4 ml) was added trifluoroacetic acid (0.2 ml). This mixture is 0. 〇 Stir for 20 minutes, then dilute with two gas methane (150 ml), wash three times with water (100 ml). The organic layer was dried over magnesium sulfate and concentrated to dryness to obtain an oil body, which was then subjected to a flash layer analysis on silica. Dioxane: methanol (98: 2) was used as the washing away agent. The appropriate portion was collected under moderate pressure (approximately 10 bar) for RP_18 chromatographic analysis, using linear gradient water in acetonitrile (60 to 75%) to prepare the title compound. δ (^, CDC13): 9.87 (s, 1H, CHO), 6.04 (d, 1H, H-2, J = 3.3 and 8.4 Hz), 4.48-4.29 (m, 3H, CH2-3 'and 8a-CH2 (lH)), 3.76 (dd, 1H, H-l ', J = 7.2 and 9.3 Hz), 3.27 (m, 1H, H-9 ·), 3.02 (m, 1H, H-5'), 2.45 ( m, 1H, Hl); ά (13C, CDC13): 205.1 (CHO), -182- This paper uses the Chinese national standard (CNS) A4 specification (2I0X297mm) (Please read the precautions on the back first Fill in this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標準局貝工消費合作社印裝 A7 B7 五、發明説明（180) 176.0 (COOH), 148.6 (C-3), 130.4 (C-2), 104.2 (CH2=), 98.2 (〇7’），80.1((：-1')，73.4及70.6(8&amp;amp;-^12及(：-3，），69.8((：-9，） 〇 實例3 4 [1R-(1 « ,3a^ ,4^ ,4a^ ,7 ^ ,7a a ,8a^ ) ] 8 a - [ [ 1 S , 7 R, 9 R]- 2.8- 二氧-9-甲基-4-亞甲基-順式-雙環[3.4.0]-壬-7-基-氧基-曱基]-4-曱醯基-4,4a，5,6,7,7a，8,8a-八氫-7-曱基-3-(l-甲基乙基）-l，4-亞甲基-S-啕噠省-3a(lH)-羧酸，納 鹽 於實例33化合物（140毫克）於曱醇（15毫升）内之溶液中， 滴加0.945當量的氫氧化鈉水溶液（3.06毫升）。減壓除去溶 劑，將殘餘物溶於水（6 0毫升）内並凍晶，製得標題化合物 (145毫克）。 〇ΐί, DMSO-d6): 9.76 (s, 1H, CHO), 5.76 (d, 1H, H-2, J= 3.3 Hz), 5.04 (m, 2H, H2C=), 4.34-4.20 (m，3H，H-7'及CH2_ 3’），3_84&amp;amp;3.50(2d，2H，8a-CH2，J=9.9Hz)，3.62(dd,lH,H-Γ，J=7.5及9.3 Hz), 3.15 (m, 1H，H-9’），2.89 (m，1H，H-51)。 實例3 5 [1R-(1 a，3a/5 ,4々，4a卢，7万，7aa，8a々）]8a-[[ls,7R，9R]_ 2.8- 二氧-9 -甲基-4-亞甲基-3-氧基順式-雙環[34〇]_壬 -7-基-氧基·甲基]_4 -甲醯基-4,4a，5,6,7,7a，8,8a-八氫- 7-甲基-3-(l-甲基乙基）-l，4-亞甲基-S-吲噠省_3a(1H)_ 羧酸 於中間體42(62毫克）於二氣曱烷（1_1毫升）内之溶液中加 ___ - 183- 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐) ' ---- (請先閲讀背面之注意事項再填寫本頁)</span>A7 B7 printed by Beigong Consumer Cooperative of Central Bureau of Standards of the Ministry of Economy V. Description of Invention (180) 176.0 (COOH), 148.6 (C-3), 130.4 (C-2), 104.2 (CH2 =), 98.2 (〇7 ' ), 80.1 ((: -1 '), 73.4 and 70.6 (8 &amp;amp;-^ 12 and (: -3,), 69.8 ((: -9,)) Example 3 4 [1R- (1 «, 3a ^, 4 ^, 4a ^, 7 ^, 7a a, 8a ^)] 8 a-[[1 S, 7 R, 9 R]-2.8-dioxo-9-methyl-4-methylene-cis- Bicyclo [3.4.0] -non-7-yl-oxy-methyl] -4-methyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl- 3- (l-methylethyl) -l, 4-methylene-S-pyridine-3a (lH) -carboxylic acid, sodium salt of Example 33 compound (140 mg) in methanol (15 ml) To the solution in the solution, 0.945 equivalent of aqueous sodium hydroxide solution (3.06 ml) was added dropwise. The solvent was removed under reduced pressure, and the residue was dissolved in water (60 ml) and frozen to obtain the title compound (145 mg). Ιί, DMSO-d6): 9.76 (s, 1H, CHO), 5.76 (d, 1H, H-2, J = 3.3 Hz), 5.04 (m, 2H, H2C =), 4.34-4.20 (m, 3H, H-7 'and CH2_3'), 3_84 &amp; 3.50 (2d, 2H, 8a-CH2, J = 9.9Hz), 3.62 (dd, lH, H-Γ, J = 7.5 and 9.3 Hz), 3.15 (m, 1H, H-9 ') , 2.89 (m, 1H, H-51). Example 3 5 [1R- (1 a, 3a / 5, 4々, 4a Lu, 70,000, 7aa, 8a々)] 8a-[[ls, 7R, 9R ] _ 2.8-Dioxo-9 -methyl-4-methylene-3-oxycis-bicyclo [34〇] _non-7-yl-oxy · methyl] _4 -carboxamide-4 , 4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (l-methylethyl) -l, 4-methylene-S-indap province_3a ( 1H) _ Carboxylic acid is added to a solution of intermediate 42 (62 mg) in methane (1_1 ml) ___-183- This paper scale is applicable to China National Standard (CNS) A4 specification (210X297mm) ---- (please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T 經濟部中央標準局W工消费合作社印裝 A7 B7 五、發明説明（181) 三氟醋酸（0.05毫升）。此混合物於〇°C攪拌20分鐘，然後用 二氣甲烷（50毫升）稀釋，用水（3X25毫升）洗。有機層於硫 酸鈉上乾燥並濃縮，得油體，再於二氧化矽上作閃色層分 析二次，用二氣曱烷：甲醇（98 : 2)作洗離劑。製得標題化 合物（2 5毫克），爲淺黃色泡沫。 d(1H,CDCl3):9.75(s,lH,CHO),6.35&amp;amp;5,63(2d,2H， l^OC，J=3.3 Hz)，6.04 (dd，1H，H-2, J=1.2及3.3 Hz)，4.52 (t，lH，H-7，，J=4.8Hz)，4.24(t，lH，H-4’，J=8.7Hz)，4.09&amp;amp; 3.46 (2d, 2H, 8a-CH2, J=9.3 Hz), 3.38 (m, 1H, H-5'), 3.30 (m, 1H, H-9'), 2.59 (t, 1H, H-l, J=3.9 Hz); ^ (13C, CDC13)： 204.5 (CHO), 175.3 (COOH), 169.7 (C-3'), 148.2 (C-3), 136.8 (C-4'), 130.6 (C-2), 122.4 (C=CH2), 97.7 (C-7'), 77.8 (C-Γ)及71_2 (C-9，）。 實例3 6 [lR-(la,3a/5,4y5,4a々，7/5,7aa,8a^)]8a-[[lS，7R，9R]-2，8-二氧-9 -甲基-4-亞曱基-3-氧基-順式-雙環[3.4.0]-壬 -7-基-氧基-甲基]-4 -甲醯基- 4,4a，5,6,7,7a，8,8a-八氫-7-曱基-3-(l-甲基乙基）-l,4-亞甲基-S-啕噠省-3a(；lH)-羧酸，鈉鹽 於實例35化合物（25毫克）於曱醇（10毫升）内之溶液中， 加0.945當量的氫氧化鈉水溶液（0.53毫升）。減壓除去溶劑 ，將殘餘物溶於水（25毫升）内並凍晶，製得標題化合物 (26毫克）。 ci(1H，DMSO-d6):9.75(s，lH，CHO)，6.15&amp;amp;5.82(2d,2H， -184- 本紙張尺度適用中國國家標準（CNS ) A4规格（210X297公釐） (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部中央揉準局—工消費合作社印装 A7 B7 五、發明説明（182) 1^0=0, J=3.3 Hz), 5.76 (brd, 1H, H-2), 4.31 (dd, 1H, H-7', J=2.4&amp;amp;7.8Hz)，4.24(t，lH，H-r，J=8.7Hz)，3.84&amp;amp;3.52(2d, 2H, 8a-CH2, J=9.9 Hz), 3.38 (m5 1H, H-5'), 3.21 (m, 1H, H-9')。 實例3 7 [1R-(1 « ,3ay5 ,Αβ ,4a^ ,1 β ,1^α Μβ )]8a-[[lS,7R,9R]-2,8-二氧-9-甲基-4-氧基-順式-雙環[3.4.〇]_壬_7_基_氧 基-甲基]-4 -甲醯基-4,4a，5，6,7,7a，8,8a-八氫-7 -曱基-3-U -甲基乙基）-1，4 -亞甲基_s -吲噠省- 3a(lH) -羧酸 於中間體43(45毫克）於醋酸乙酯（15毫升）内之溶液中在 氮氣下加10%鈀/碳（25毫克）。此混合物在帕爾裝置内於 25磅/吋2氫壓下及室溫下搖動丨小時。濾除催化劑，蒸發 去溶劑至乾。殘餘物於二氧化矽膠上作閃色層分析純化， 用己拔：醋酸乙酯（65 : 35)作洗離劑，製得標題化合物 (25毫克）。 ^ (^, CDC13): 9.77 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J=1.5及3.6 Hz), 4.17 (m, 4H，H-3,（1H), 8a-CH2 (1H)，H-7， CH2 (1H)，J=9 Hz), 3.31 (m, 1H，H-9，），2.85 (m，1H，H-5，）， 2-58 (t, 1H, H-3, J=3.9 Hz); i (13C, CDC13): 214.4 (C-4), 204.8 (£H0), 148.3 (C-3), 130.6 (C-2)，98.9 (C-7，)，78.6及 70.3 (C-厂及C-9，），73.6及69.1 (C8a-g及C-3，）。 實例3 8_ [lR-(la，3a/5 ,4/3，4a/5，7y3，7aa，8a^ )]8a-[[lS，4S，6S, -185- 本紙張尺度適用中國國家橾準（CNS ) A4規格（210X 297公釐〉 (請先閲讀背面之注意Ϋ項再填寫本頁)</span>1. Printed by the 1T Ministry of Economic Affairs, Central Bureau of Standards, W Industrial and Consumer Cooperatives A7 B7 5. Description of the invention (181) Trifluoroacetic acid (0.05 ml). The mixture was stirred at 0 ° C for 20 minutes, then diluted with methane (50 ml) and washed with water (3 × 25 ml). The organic layer was dried over sodium sulfate and concentrated to obtain an oil body, which was then analyzed as a flash layer on silicon dioxide twice, using dichloromethane: methanol (98: 2) as the washing agent. The title compound (25 mg) was obtained as a pale yellow foam. d (1H, CDCl3): 9.75 (s, lH, CHO), 6.35 &amp;amp; 5,63 (2d, 2H, l ^ OC, J = 3.3 Hz), 6.04 (dd, 1H, H-2, J = 1.2 And 3.3 Hz), 4.52 (t, lH, H-7, J = 4.8Hz), 4.24 (t, lH, H-4 ', J = 8.7Hz), 4.09 &amp;amp; 3.46 (2d, 2H, 8a- CH2, J = 9.3 Hz), 3.38 (m, 1H, H-5 '), 3.30 (m, 1H, H-9'), 2.59 (t, 1H, Hl, J = 3.9 Hz); ^ (13C, CDC13): 204.5 (CHO), 175.3 (COOH), 169.7 (C-3 '), 148.2 (C-3), 136.8 (C-4'), 130.6 (C-2), 122.4 (C = CH2), 97.7 (C-7 '), 77.8 (C-Γ) and 71_2 (C-9,). Example 3 6 [lR- (la, 3a / 5,4y5,4a々, 7 / 5,7aa, 8a ^)] 8a-[[lS, 7R, 9R] -2,8-dioxo-9-methyl -4-Methylidene-3-oxy-cis-bicyclo [3.4.0] -non-7-yl-oxy-methyl] -4-methylacyl-4,4a, 5,6,7 , 7a, 8,8a-octahydro-7-methyl-3- (l-methylethyl) -1,4-methylene-S-pyridine-3a (; lH) -carboxylic acid, sodium To a solution of the compound of Example 35 (25 mg) in methanol (10 ml), add 0.945 equivalent of aqueous sodium hydroxide solution (0.53 ml). The solvent was removed under reduced pressure, and the residue was dissolved in water (25 ml) and frozen to obtain the title compound (26 mg). ci (1H, DMSO-d6): 9.75 (s, lH, CHO), 6.15 &amp;amp; 5.82 (2d, 2H, -184- This paper size is applicable to China National Standard (CNS) A4 specification (210X297mm) (please first Read the precautions on the back and fill out this page) Order A7 B7 Printed by the Ministry of Economy Central Bureau of Industry and Commerce-Industrial and Consumer Cooperatives V. Description of Invention (182) 1 ^ 0 = 0, J = 3.3 Hz), 5.76 (brd, 1H, H-2), 4.31 (dd, 1H, H-7 ', J = 2.4 &amp;amp; 7.8Hz), 4.24 (t, lH, Hr, J = 8.7Hz), 3.84 &amp;amp; 3.52 (2d, 2H, 8a- CH2, J = 9.9 Hz), 3.38 (m5 1H, H-5 '), 3.21 (m, 1H, H-9'). Example 3 7 [1R- (1 «, 3ay5, Aβ, 4a ^, 1 β, 1 ^ α Μβ)] 8a-[[lS, 7R, 9R] -2,8-dioxo-9-methyl-4 -Oxy-cis-bicyclo [3.4.〇] _non_7_yl_oxy-methyl] -4-methylacyl-4,4a, 5,6,7,7a, 8,8a-octa Hydrogen-7-methyl-3-U-methylethyl) -1,4-methylene_s-indap-3a (lH) -carboxylic acid in intermediate 43 (45 mg) in ethyl acetate To the solution (15 ml) was added 10% palladium / carbon (25 mg) under nitrogen. This mixture was shaken in a Parr device under 25 psi hydrogen pressure at room temperature for 1 hour. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was analyzed and purified on silica gel as a flash layer, using ethyl acetate: ethyl acetate (65:35) as the eluent to obtain the title compound (25 mg). ^ (^, CDC13): 9.77 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 4.17 (m, 4H, H-3, (1H), 8a- CH2 (1H), H-7, CH2 (1H), J = 9 Hz), 3.31 (m, 1H, H-9,), 2.85 (m, 1H, H-5,), 2-58 (t, 1H, H-3, J = 3.9 Hz); i (13C, CDC13): 214.4 (C-4), 204.8 (£ H0), 148.3 (C-3), 130.6 (C-2), 98.9 (C- 7,), 78.6 and 70.3 (C-factory and C-9,), 73.6 and 69.1 (C8a-g and C-3,). Example 3 8_ [lR- (la, 3a / 5, 4/3, 4a / 5, 7y3, 7aa, 8a ^)] 8a-[[lS, 4S, 6S, -185- This paper size is applicable to the Chinese national standard (CNS) A4 specification (210X 297mm) (Please read the note Ϋ on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">3^1644 A7 B7</span>3 ^ 1644 A7 B7</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">五、發明説明（183) 7R，9R]-2,8-二氧-4 -乙基-6-羥基-9-甲基-順式-雙環 (請先閲讀背面之注意事項再填寫本頁) [3·4·0]-壬-7-基-氧基·甲基]-4-甲酿基-4,4a，5,6,7, 7a，8,8a-八氫-7-甲基-3-(1-甲基乙基）-i，4-亞甲基-S-4 噠省-3a(lH)-羧酸 於中間體45(123毫克）於醋酸乙酯（50毫升）内之溶液中在 氮氣下加10 %鈀/碳（65毫克）。此混合物於15镑/吋2氫 壓下在室溫氫化1小時。濾除催化劑，蒸發去溶劑至乾。殘 餘物於二氧化矽膠上作閃色層分析純化，用二氣甲烷：甲 醇（19 : 1)及（18 ·· 2)洗離。製得標題化合物（90毫克）。 δ (^, CDC13): 9.67 (s, 1H, CHO), 6.07 (d, 1H, H-2, J=3.3 Hz), 4.64 (d, 1H, H-7',J=3.6 Hz), 4.02 (d, 1H, 8aCHa, J=9.9</span>5. Description of the invention (183) 7R, 9R] -2,8-dioxo-4 -ethyl-6-hydroxy-9-methyl-cis-bicyclo (please read the precautions on the back before filling this page) [3 · 4 · 0] -Non-7-yl-oxy · methyl] -4-methyl-2,4a, 5,6,7, 7a, 8,8a-octahydro-7-methyl -3- (1-methylethyl) -i, 4-methylene-S-4 pyridine-3a (lH) -carboxylic acid in intermediate 45 (123 mg) in ethyl acetate (50 ml) To the solution was added 10% palladium / carbon (65 mg) under nitrogen. This mixture was hydrogenated at room temperature for 1 hour under a hydrogen pressure of 15 psi. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was analyzed and purified by flash layer on silica gel, and washed away with methane: methanol (19: 1) and (18 ·· 2). The title compound (90 mg) was prepared. δ (^, CDC13): 9.67 (s, 1H, CHO), 6.07 (d, 1H, H-2, J = 3.3 Hz), 4.64 (d, 1H, H-7 ', J = 3.6 Hz), 4.02 (d, 1H, 8aCHa, J = 9.9</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 3.89 (dd, 1H, Ha-3，，J=6.9及9 Hz), 3.85-3.7 (m, 3H, H-6'，Η-Γ及H-9，），3.68-3.5 (m，2H, Hb-3,及8a-CHb)，2.65 (t， λ 1H, H-l, J=3.6 Hz); c^(13C5 CDC13): 204.9 (CHO), 176.3 (C02H), 148.9 (C-3), 130.1 (C-2), 99.2 (C-7'), 80.5, 70.1^ 65.5(C-6，，C-HC-9.)，73.7l71.0(8a-QH2&amp;amp;C-3，），13.4 (CH2-£H3)。 實例3 9 經濟部中央樣準局貝工消費合作社印製 [lR-(la，3ay5，4y5，4ay5，7y?，7aa，8a/5 )]8a-[[lS，4R，6S， 7R，9R]-2,8 -二氧-4-乙基-6-輕基-9-曱基-順式-雙環 [3_4.0]-壬-7-基-氧基-曱基]_4-甲醯基_4,4&amp;amp;,5,6,7, 7a, 8,8a-八氫-7 -甲基-3-(1-甲基乙基）-1,4-亞甲基-S-p弓1 噠省-3a(lH)-羧酸 於中間體46(102毫克）於醋酸乙酯（25毫升）内之溶液中在 -186- 本紙張尺度適用中國國家橾準（CNS)Α4規格（2ΐ〇χ297公釐） A7 B7 五、發明説明（184) 氮氣下加10 %把/碳（60毫克）。此混合物於15碎/叫*2氮 壓下在室溫氫化1小時。濾除催化劑，蒸發去溶劑至乾。殘 餘物於二氧化碎膠上作閃色層分析純化，用二氣甲垸：甲 醇（26 : 1)洗離。製得標題化合物（75毫克）。 ci CDC13)： 9.73 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=1.2及3.6 Hz), 4.53 (d，1H，H-7'，J=1.8 Hz), 4.05 (dd，1H Ha-3', J=7.2及8.4 Hz)，4.02 (d, 1H, 8aCHa, J=9.3 Hz) 3 83 (dd, 1H, H-l’，J=7.2及8.7 Hz), 3.72 (dd，1H，H-6、J=2.1 及</span>Hz), 3.89 (dd, 1H, Ha-3, J = 6.9 and 9 Hz), 3.85-3.7 (m, 3H, H-6 ', Η-Γ and H-9,), 3.68-3.5 (m , 2H, Hb-3, and 8a-CHb), 2.65 (t, λ 1H, Hl, J = 3.6 Hz); c ^ (13C5 CDC13): 204.9 (CHO), 176.3 (C02H), 148.9 (C-3 ), 130.1 (C-2), 99.2 (C-7 '), 80.5, 70.1 ^ 65.5 (C-6 ,, C-HC-9.), 73.7l71.0 (8a-QH2 &amp;amp; C-3,) , 13.4 (CH2- £ H3). Example 3 9 Printed by the Beigong Consumer Cooperative of the Central Prototype Bureau of the Ministry of Economic Affairs [lR- (la, 3ay5, 4y5, 4ay5, 7y ?, 7aa, 8a / 5)] 8a-[[lS, 4R, 6S, 7R, 9R ] -2,8 -Dioxo-4-ethyl-6-hydroxy-9-methyl-cis-bicyclo [3_4.0] -non-7-yl-oxy-methyl] _4-carboxamide Base_4,4 &amp;amp;, 5,6,7, 7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-Sp bow 1 Province-3a (lH) -carboxylic acid in a solution of intermediate 46 (102 mg) in ethyl acetate (25 ml) at -186- This paper scale is applicable to China National Standards (CNS) A4 specifications (2〇〇297 Mm) A7 B7 5. Description of the invention (184) Add 10% carbon / carbon (60 mg) under nitrogen. This mixture was hydrogenated at room temperature for 1 hour at 15 min / * 2 nitrogen pressure. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was analyzed and purified by flash chromatography on the crushed silica, and washed away with difluoromethane: methanol (26: 1). The title compound (75 mg) was prepared. ci CDC13): 9.73 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J = 1.2 and 3.6 Hz), 4.53 (d, 1H, H-7 ', J = 1.8 Hz), 4.05 ( dd, 1H Ha-3 ', J = 7.2 and 8.4 Hz), 4.02 (d, 1H, 8aCHa, J = 9.3 Hz) 3 83 (dd, 1H, H-l', J = 7.2 and 8.7 Hz), 3.72 (dd, 1H, H-6, J = 2.1 and</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">4.8 Hz), 3.64 (d, 1H, 8a-CHb, J=9.3 Hz), 3.54-3.36 (m, 2H H-91 &amp;amp;Hb-3’)，2.68(t，lH，H-l，J=3.9Hz),〇.96(t，3H，Cl-CH2, J=7.5 Hz); tf(13C，CDC13): 204.7 (CHO)，176.1 (C02H), 148.5 (C-3)，130.5 (C-2)，98.8 (C-7，)，79.2, 7〇.7及 69.1((：-6'，（：-1，及(：-9，），73.7及72.7(8&amp;amp;-四2及(：-3，），12.7 (CH2-£H3)。 實例4 0</span>4.8 Hz), 3.64 (d, 1H, 8a-CHb, J = 9.3 Hz), 3.54-3.36 (m, 2H H-91 &amp;amp; Hb-3 '), 2.68 (t, lH, Hl, J = 3.9Hz ), 〇.96 (t, 3H, Cl-CH2, J = 7.5 Hz); tf (13C, CDC13): 204.7 (CHO), 176.1 (C02H), 148.5 (C-3), 130.5 (C-2) , 98.8 (C-7,), 79.2, 70.7 and 69.1 ((: -6 ', (: -1, and (: -9,), 73.7 and 72.7 (8 &amp;amp;-4 2 and (:- 3,), 12.7 (CH2- £ H3). Example 4 0</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[1R-(1^ ,3&amp;amp;/3 ,Αβ Α^β ,1 β ,7a» ) ] 8 a-[ [ 1 S , 4R, 6 S 經濟部中央梂準局貝工消費合作社印製 {請先閲讀背面之注意事項再填寫本頁) r ! 7R，9R]-2,8 -二氧-4-乙基-6-經基_9_甲基_順式_雙環 [3.4.0]-壬-7-基-氧基-甲基]-4-甲醯基 _4,4a，5,6,7 7a，8,8a -八氫-7-曱基- 3- (1-甲基乙基）亞甲基_s_p引 噠省-3a(lH)-羧酸，鈉鹽 於實例39化合物（490毫克）於甲醇（5〇毫升）内之溶液中， 加0.095當量的氫氧化鈉水溶液（1〇毫升）。3〇分鐘後減壓除 去溶劑’將殘餘物溶於水（1 0毫升）内並凍晶，製得標題化 合物（475毫克）。 -187 - 本紙張尺度逍用中國國家梯率（CNS ) A4規格（210X297公釐） A7 A7 經濟部中央標率局貝工消費合作社印褽 B7 五、發明説明（185) ^ On, (CD3)2SO): 9.77 (s, 1H, CHO), 5.8 (d, 1H, H-2, ^=2.4 Hz), 4.41 (bs, 1H, -OH), 4.31 (d, 1H, H-7', J=2.1 Hz), 3·94-3_82 (m，2H, 8aCHa&amp;amp;Ha-3，），3.66 (t，1H，H-l，，J=8.1</span>[1R- (1 ^, 3 &amp;amp; / 3, Αβ Α ^ β, 1 β, 7a »)] 8 a- [[1 S, 4R, 6 S Printed by Beigong Consumer Cooperative of Central Bureau of Economics of the Ministry of Economic Affairs {please Read the precautions on the back before filling in this page) r! 7R ， 9R] -2,8 -Dioxy-4-ethyl-6-keto_9_methyl_cis_bicyclo [3.4.0]- Non-7-yl-oxy-methyl] -4-carboxamide_4,4a, 5,6,7 7a, 8,8a -octahydro-7-methyl-3- (1-methylethyl Radical) methylene_s_p Yinda province-3a (lH) -carboxylic acid, sodium salt in a solution of the compound of Example 39 (490 mg) in methanol (50 mL), and 0.095 equivalent of aqueous sodium hydroxide 10 ml). After 30 minutes, the solvent was removed under reduced pressure. The residue was dissolved in water (10 ml) and crystallized by freezing to obtain the title compound (475 mg). -187-This paper scale uses the Chinese National Gradient (CNS) A4 specification (210X297 mm) A7 A7 Central Standard Rating Bureau of the Ministry of Economic Affairs, Beigong Consumer Cooperative Printed B7. Invention Description (185) ^ On, (CD3) 2SO): 9.77 (s, 1H, CHO), 5.8 (d, 1H, H-2, ^ = 2.4 Hz), 4.41 (bs, 1H, -OH), 4.31 (d, 1H, H-7 ', J = 2.1 Hz), 3 · 94-3_82 (m, 2H, 8aCHa &amp; Ha-3,), 3.66 (t, 1H, Hl ,, J = 8.1</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 3.54-3.34 (m, 3H, 8aCHb, H-6'^LH-9'), 3.24 (t, 1H, Hb-3’，J=8.1 Hz), 2.55 (t, 1H, H-l，J=3.6 Hz)。 實例4 1 [1R-(la,3a^,4^,4ay5,7y5,7aar,8a^)]8a-[[lS,7R,9R]-2，8·二氧-9-甲基-4·氧基-順式-雙環[3.4.0] -壬-7-基-氧 基-甲基]-4 -甲醯基-4,4a，5，6,7,7a，8，8a-八氫-7 -甲基-3-U -甲基乙基）-1，4 -亞甲基- S-〇5丨噠省- 3a(lH) -羧酸，鈉鹽 於中間體43(350毫克）於醋酸乙酯（15毫升）内之溶液中在 氮氣下加10%鈀/碳（50毫克）《此混合物在帕爾裝置内 (PH2=15磅/吋2)在室溫氫化1小時。濾除催化劑，蒸發去 溶劑得殘餘物，再作閃色層分析（二氧化矽膠，二氣甲烷： 甲醇容積/容積100 : 1，70 : 1及50 : 1)製得200毫克泡 朱’此泡沫再溶於曱醇（1〇毫升）内，用0.0947 μ的氫氧化 鈉（4.54毫升）處理，眞空除去溶劑，再將所得固體溶於水 (1 5毫升）内並凍乾。 ^ (^, DMSO-d6): 9.76 (s, 1H, CHO), 5.80 (dd, 1H, H2, J=〇.9&amp;amp;3.3Hz)，4.20-3.95 (m,4H，H7’+Hr+H3')，3.89(d， 1H, 8aCH2, J=9.6 Hz), 3.47 (d, 1H, 8aCH2, J=9.6 Hz), 2.92 (m, 1H，H5’）。 實例4 2 [HUa，3a^，4/?，4a/?，7々，7aa，8a0 )]8a-[(ls，4R,7R, -188- 本紙張尺度適用中國國家揉準（CNS ) A4規格（21〇&amp;gt;&amp;lt; 297公釐) (請先閱讀背面之注意事項再填寫本頁)</span>Hz), 3.54-3.34 (m, 3H, 8aCHb, H-6 '^ LH-9'), 3.24 (t, 1H, Hb-3 ', J = 8.1 Hz), 2.55 (t, 1H, Hl, J = 3.6 Hz). Example 4 1 [1R- (la, 3a ^, 4 ^, 4ay5,7y5,7aar, 8a ^)] 8a-[[lS, 7R, 9R] -2,8 · diox-9-methyl-4 · Oxy-cis-bicyclo [3.4.0] -non-7-yl-oxy-methyl] -4-carboxyl-4,4a, 5,6,7,7a, 8,8a-octahydrogen -7-Methyl-3-U-Methylethyl) -1,4-Methylene-S-〇5 丨 Province-3a (lH) -carboxylic acid, sodium salt in intermediate 43 (350 mg) To a solution in ethyl acetate (15 ml) was added 10% palladium / carbon (50 mg) under nitrogen. This mixture was hydrogenated at room temperature for 1 hour in a Parr device (PH2 = 15 psi). The catalyst was filtered off, the solvent was evaporated to obtain the residue, and then the flash layer analysis was carried out (silica dioxide, methane gas: methanol volume / volume 100: 1, 70: 1 and 50: 1) to prepare 200 mg of bubble gum. The foam was redissolved in methanol (10 mL), treated with 0.0947 μ of sodium hydroxide (4.54 mL), the solvent was removed in vacuo, and the resulting solid was dissolved in water (15 mL) and lyophilized. ^ (^, DMSO-d6): 9.76 (s, 1H, CHO), 5.80 (dd, 1H, H2, J = 〇.9 &amp;amp; 3.3Hz), 4.20-3.95 (m, 4H, H7 '+ Hr + H3 '), 3.89 (d, 1H, 8aCH2, J = 9.6 Hz), 3.47 (d, 1H, 8aCH2, J = 9.6 Hz), 2.92 (m, 1H, H5'). Example 4 2 [HUa, 3a ^, 4 / ?, 4a / ?, 7々, 7aa, 8a0)] 8a-[(ls, 4R, 7R, -188- This paper scale is applicable to China National Standard (CNS) A4 Specifications (21〇 &amp;lt; 297mm) (Please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T 經濟部中央揉準局貝工消费合作社印製 A7 B7 五、發明説明（186) 9R)-2,8-二氧-4 -甲氧基-9-甲基-順式-雙環[3.4.0]-壬-7_ 基-氧基-甲基]-4-曱醯基-4,4&amp;amp;，5,6,7,7&amp;amp;，8,8心八氫-7-甲 基- 3- (1-曱基乙基）_ι，4-亞甲基- S- H丨建省_3a(lH) -叛酸 ，納鹽 於中間體82(250毫克）於醋酸乙酯（15毫升）内之溶液中在 氮氣下加10 %鈀/碳（50毫克）。此混合物在帕爾裝置内 (PH2=15磅/吋2)在室溫氫化1小時。濾除催化劑，蒸發去 溶劑得殘餘物，再作閃色層分析（二氧化矽膠，二氣甲烷： 甲醇容積/容積100: 1，70 : 1及50 : 1)製得120毫克衆 體’此漿體再溶於甲醇（15毫升）内，用0.0947 Μ的氫氧化 納（2.51毫升）處理，除去溶劑，得半固體，溶於水（15毫升） 内並凍乾。 ci (lR, DMSO-d6): 9.77 (s, 1H, CHO), 5.80 (dd, 1H, H2, 1=1.2^3.3 Hz), 4.47 (t, 1H, H7', J=3.9 Hz), 3.96-3.84 (m, 2H, H3'+8aCH2,), 3.80 (m, 1H, H4'), 3.65-3.40 (m, 4H, H9-+8aCH2+H3'+Hl'), 3.23 (s, 3H, OCH3), 2.46-2.2 (m, 4H, H1+H6'+H5'+CH(CH3)2);&amp;gt; (13C&amp;gt; DMSO-d6): 206.4 (CHO), 174.4 (COO-), 151.3 (C3), 127.6 (C2), 96.9 (C7&amp;quot;), 84.1 (£4')，56.6 (0逆3)。 實例4 3 [1R-(1 a ,3ay5 ,Α β ,4ay3 ,1 β a ,8ay5 )]8a-[(lS,7R,9R)-2,8-二氧-9-甲基-順式-雙環[3.4.〇]_壬_4_晞-7_基_氧基_ 甲基]-4 -甲酿基-4,4a，5,6,7,7a, 8,8a -八氫-7-曱基- 3- (1-甲基乙基）-1,4-亞甲基-S-M丨噠省- 3a(lH)-羧酸 -189- 本紙張尺度逍用中國國家標準（CNS ) Α4規格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁) 訂 ! A7 B7 五、發明説明（187) 於中間體87(120毫克）於無水二氣甲烷（2〇毫升）内之溶液 中於0C在氮乳下加二氟醋酸（1〇〇微升）。5分鐘後此混合物 以二氣甲烷（100毫升）稀釋，用水（100毫升）及鹽水（1〇〇毫 升）洗，然後於硫酸鎂上乾燥並濃縮’得粗製產物，再溶於 四氫呋喃：甲醇（容積/容積2 : 1，15毫升）之混合物内， 用1當量鹽酸（5毫升）處理。反應完全後以水（1〇〇毫升）稀釋 ’用一氣甲燒萃取二次。有機層於硫酸誤上乾燥，得油體 ’再以製備用TLC純化（二氧化矽膠，丙酮：己燒1 : 3)， 製得62毫克標題化合物（產出率73%)，爲白色泡沫。 δ CDC13): 9.79 (s, 1H, CHO), 6.06 (dd, 1H, H2, J-1.2 及3.3 Hz), 5.56 (m, 1H，H4’），4.65-4.65 (m, 2H，H3'), υ-ΐΟ (m, 3H， H7’+8aCH2+Hl，）， 3.50 (d， 1H, 8aCH2, J=9 Hz)， 3.18 (dq，1H，H91，J=6.3及9Hz), 2.72 (m, 1H, H6')，2.62 (t, 1H, HI, J=3 Hz); ά (13C, CDC13)： 204.6 (CHO), 175.2 (COOH), 148.3 (C3), 136.3 (C5'), 130.6 (C2), 119.15 (C-4')5 101.5 (C7，)，86.5 (Cl，）。 實例44 經濟部中央揉準局負工消費合作社印策 (請先閲讀背面之注意Ϋ項再填寫本頁) [lR-(l«,3a^ ,Αβ ,4ay5,7^)7a«,8a/5)]8a-[(lS,7R,9R)-2,8-二氧-9-曱基-順式-雙環[3.4.0]-壬-4-烯-7-基-氧基-曱基]-4 -甲醯基-4,4a，5,6，7，7a，8,8a -八氫-7-甲基- 3-(1-甲基乙基）-1，4·亞甲基-S-吲建省- 3a(lH) -叛酸，鈉鹽 於實例43化合物（50毫克）於甲醇（5毫升）内之溶液中，加 0.0966當量的氫氧化鈉（1.09毫升）。將此混合物攪拌15分鐘 ，除去溶劑至乾。殘餘物溶於水（1毫升）内並凍晶，製得標 -190- 本紙張尺度適用中國國家揉準（CNS ) A4規格（210X297公釐） 經濟部中央樣準局負工消費合作社印装 A7 B7 五、發明説明（18δ) 題化合物（475毫克）。 ^ (ΧΗ, DMS0-d6): 9.78 (s, 1H, CHO), 5.80 (bd, 1H, H2, J=3.6 Hz), 5.64 (bs, 1H, H4'), 4.6-4.4 (m, 2H, H3'), 4.1 (dd, 1H，H7'，J=2.7及9.3 Hz)，4.05-3.90 (m，2H，Hl'+8aCH2)， 3.56 (d，1H, 8aCH2, J=9.6 Hz)，3·06 (dq，1H，H9·，J=6.3及 8.7 Hz); ά (13C, DMSO-d6): 215.9 (CHO), 183.9 (COO'), 160.9 (C3), 146.1 (C5'), 137.2(C2), 128.3 (C4'), 110.9 (Cl'), 95.7 (Cl·)。 實例4 5 [1R-(1 ,3a；5 ,4/? ,4a&amp;gt;5 ,7/? ,7a or ,8ay5 )] 8a-[(1 S ,7R,9R)- 2,8-二氧-9-曱基-順式-雙環[3·4·0]-壬-7·基-氧基-甲基 ]-4 -甲醯基-4,4 a，5,6,7,7a, 8,8a -八氫-7-甲基-3-(1-甲基 乙基）-1,4-亞甲基-S-吲噠省-3a(lH)-羧酸 於中間體87(100毫克）於醋酸乙酯（15毫升）内之溶液中在 氮氣下加1 0 %鈀/碳（5 0毫克）。此混合物在帕爾裝置内 (PH2 = 20磅/吋2)在室溫搖動1小時。濾除催化劑，蒸發去 溶劑得殘餘物，此殘餘物再溶於四氫吱喃：甲醇（容積/容 積2 : 1，15毫升）混合物内，用1當量鹽酸（5毫升）處理。 反應完全後加二氣曱烷（1〇〇毫升）及水（1〇〇毫升），分開二 層。有機層於硫酸鎂上乾燥，濃縮，製得油體，再以製備 用TLC純化（己烷：丙酮容積/容積3 : 1)，製得2〇毫克標 题化合物，爲透明油體（產出率3 〇 〇/0)。 CDC13): 9_86 (s, 1H，CHO), 6.05 (dd，1H, H2, J=l.5 及3_6 Hz), 4.07 (dd，1H，H7，，J=3及5.4 Hz), 4·33 (d，1H， -191 - 本紙張尺度適用中國國家標準（CNS〉A4規格&amp;quot;(210X297公釐） ' — (請先聞讀背面之注項再填寫本頁)</span>、 1T Printed by the Ministry of Economic Affairs Central Bureau of Precision Industry Beigong Consumer Cooperative A7 B7 V. Description of the invention (186) 9R) -2,8-dioxo-4 -methoxy-9-methyl-cis-bicyclo [3.4 .0] -non-7-yl-oxy-methyl] -4-methyl-4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8-octahydro-7-methyl-3- (1-Methylethyl) _ι, 4-methylene-S-H 丨 Jianjian_3a (lH) -tetanoic acid, sodium salt in intermediate 82 (250 mg) in ethyl acetate (15 mL) To the solution was added 10% palladium / carbon (50 mg) under nitrogen. This mixture was hydrogenated in a Parr device (PH2 = 15 psi) at room temperature for 1 hour. The catalyst was filtered off, and the solvent was evaporated to obtain a residue, which was then subjected to flash chromatography (silica dioxide, methane gas: methanol volume / volume 100: 1, 70: 1, and 50: 1) to obtain 120 mg of the body. The slurry was redissolved in methanol (15 ml), treated with 0.0947 M sodium hydroxide (2.51 ml), and the solvent was removed to obtain a semi-solid, dissolved in water (15 ml) and lyophilized. ci (lR, DMSO-d6): 9.77 (s, 1H, CHO), 5.80 (dd, 1H, H2, 1 = 1.2 ^ 3.3 Hz), 4.47 (t, 1H, H7 ', J = 3.9 Hz), 3.96 -3.84 (m, 2H, H3 '+ 8aCH2,), 3.80 (m, 1H, H4'), 3.65-3.40 (m, 4H, H9- + 8aCH2 + H3 '+ Hl'), 3.23 (s, 3H, OCH3), 2.46-2.2 (m, 4H, H1 + H6 '+ H5' + CH (CH3) 2); &amp;gt; (13C &amp;gt; DMSO-d6): 206.4 (CHO), 174.4 (COO-), 151.3 (C3 ), 127.6 (C2), 96.9 (C7 &amp;quot;), 84.1 (£ 4 '), 56.6 (0 inverse 3). Example 4 3 [1R- (1 a, 3ay5, A β, 4ay3, 1 β a, 8ay5)] 8a-[(lS, 7R, 9R) -2,8-dioxo-9-methyl-cis- Bicyclo [3.4.〇] _non_4_ 晞 -7_yl_oxy_methyl] -4 -methylbromo-4,4a, 5,6,7,7a, 8,8a -octahydro-7 -Methyl- 3- (1-methylethyl) -1,4-methylene-SM-Province- 3a (lH) -carboxylic acid-189- Chinese paper standard for standard use of this paper (CNS) Α4 Specifications (210X297mm) (Please read the precautions on the back before filling in this page) Order! A7 B7 5. Description of the invention (187) In the intermediate 87 (120 mg) in anhydrous digas methane (20 ml) To the solution was added difluoroacetic acid (100 μl) under nitrogen at 0C. After 5 minutes, the mixture was diluted with methane (100 mL), washed with water (100 mL) and brine (100 mL), then dried over magnesium sulfate and concentrated to give the crude product, which was then dissolved in tetrahydrofuran: methanol ( The volume / volume 2: 1, 15 ml) mixture was treated with 1 equivalent of hydrochloric acid (5 ml). After the reaction was completed, it was diluted with water (100 ml) and extracted twice with one-shot methane. The organic layer was dried on sulfuric acid by mistake to obtain an oil body, which was then purified by TLC (silica dioxide, acetone: hexane 1: 3) to prepare 62 mg of the title compound (yield 73%) as a white foam. δ CDC13): 9.79 (s, 1H, CHO), 6.06 (dd, 1H, H2, J-1.2 and 3.3 Hz), 5.56 (m, 1H, H4 '), 4.65-4.65 (m, 2H, H3') , υ-ΙΟ (m, 3H, H7 '+ 8aCH2 + Hl,), 3.50 (d, 1H, 8aCH2, J = 9 Hz), 3.18 (dq, 1H, H91, J = 6.3 and 9Hz), 2.72 (m , 1H, H6 '), 2.62 (t, 1H, HI, J = 3 Hz); ά (13C, CDC13): 204.6 (CHO), 175.2 (COOH), 148.3 (C3), 136.3 (C5'), 130.6 (C2), 119.15 (C-4 ') 5 101.5 (C7,), 86.5 (Cl,). Example 44 The policy of the Ministry of Economic Affairs, Central Bureau of Accreditation and Unemployment Consumer Cooperative (please read the note Ϋ on the back and then fill in this page) 5)] 8a-[(lS, 7R, 9R) -2,8-dioxo-9-methyl-cis-bicyclo [3.4.0] -non-4-ene-7-yl-oxy-methyl Radical] -4 -carboxamide-4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3- (1-methylethyl) -1,4 · methylene Base-S-indjian-3a (lH) -tetanoic acid, sodium salt in a solution of the compound of Example 43 (50 mg) in methanol (5 mL) was added 0.0966 equivalent of sodium hydroxide (1.09 mL). The mixture was stirred for 15 minutes and the solvent was removed to dryness. The residue is dissolved in water (1 ml) and frozen crystals, the standard -190- This paper size is suitable for China National Standard (CNS) A4 specifications (210X297 mm) Printed by the Consumer Labor Cooperative of the Central Bureau of Standards A7 B7 V. Description of the invention (18δ) The title compound (475 mg). ^ (ΧΗ, DMS0-d6): 9.78 (s, 1H, CHO), 5.80 (bd, 1H, H2, J = 3.6 Hz), 5.64 (bs, 1H, H4 '), 4.6-4.4 (m, 2H, H3 '), 4.1 (dd, 1H, H7', J = 2.7 and 9.3 Hz), 4.05-3.90 (m, 2H, Hl '+ 8aCH2), 3.56 (d, 1H, 8aCH2, J = 9.6 Hz), 3 06 (dq, 1H, H9 ·, J = 6.3 and 8.7 Hz); ά (13C, DMSO-d6): 215.9 (CHO), 183.9 (COO '), 160.9 (C3), 146.1 (C5'), 137.2 (C2), 128.3 (C4 '), 110.9 (Cl'), 95.7 (Cl ·). Example 4 5 [1R- (1, 3a; 5, 4 /?, 4a &amp;gt; 5, 7 /?, 7a or, 8ay5)] 8a-[(1 S, 7R, 9R)-2,8-dioxo- 9-Methyl-cis-bicyclo [3 · 4 · 0] -non-7-yl-oxy-methyl] -4-methylacyl-4,4 a, 5,6,7,7a, 8 , 8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-S-indap-3a (lH) -carboxylic acid in intermediate 87 (100 mg ) To a solution in ethyl acetate (15 mL) was added 10% palladium / carbon (50 mg) under nitrogen. This mixture was shaken in a Parr device (PH2 = 20 psi) at room temperature for 1 hour. The catalyst was filtered off, and the solvent was evaporated to obtain a residue. The residue was redissolved in a mixture of tetrahydrofuran: methanol (volume / volume 2: 1, 15 ml) and treated with 1 equivalent of hydrochloric acid (5 ml). After the reaction was complete, dimethane (100 ml) and water (100 ml) were added to separate the two layers. The organic layer was dried over magnesium sulfate, concentrated to prepare an oil body, and then purified by TLC for preparation (hexane: acetone volume / volume 3: 1) to obtain 20 mg of the title compound as a transparent oil body (yield rate) 3 〇〇 / 0). CDC13): 9_86 (s, 1H, CHO), 6.05 (dd, 1H, H2, J = 1.5 and 3_6 Hz), 4.07 (dd, 1H, H7, J = 3 and 5.4 Hz), 4.33 (d, 1H, -191-This paper scale is applicable to Chinese national standard (CNS&gt; A4 specification &amp;quot; (210X297mm) '— (please read the notes on the back and fill in this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T A7 B7 經濟部中央標準局貝Η消費合作社印策 五、發明説明（189) 8aCH2, J=9.6 Hz), 3.90 (m, 1H, H3'), 3.69 (m, 1H, H3'), 3.61 (dd, 1H, ΗΓ, J=8.1 及9 Hz), 3.39 (dq, 1H, H9，，J=6及9</span>, 1T, A7, B7, Ministry of Economic Affairs, Central Standards Bureau, BeiH Consumer Cooperative Institution V. Invention Instructions (189) 8aCH2, J = 9.6 Hz), 3.90 (m, 1H, H3 '), 3.69 (m, 1H, H3'), 3.61 (dd, 1H, ΗΓ, J = 8.1 and 9 Hz), 3.39 (dq, 1H, H9 ,, J = 6 and 9</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 3.28 (d, 1H, 8aCH2, J=9.6 Hz), 2.6-2.4 (m, 2H, H5'+H1), 2.32 (m, 1H, CH(CH3)2) 〇 實例4 6 [1R-(1« ,3a^ ,4/3 Μβ ,Ί β ,7a^ Μβ ) ] 8 a-[ (1 S , 4R, 6 S , 7R，9R)-2,8 -二氧-4,9 -二甲基-6-經基-順式-雙環[340 ] -壬-7-基-氧基-甲基]_4_甲醯基_4,4&amp;amp;，5,6,7,7&amp;amp;，8，8&amp;amp;-八 氫-7-甲基-3-(1-甲基乙基）_1，4-亞甲基_s_啕噠省_ 3a(lH)-羧酸 於中間體89b(90毫克）於醋酸乙酯（25毫升）内之溶液中 在氮氣下加10%鈀/碳（60毫克）。此混合物於4〇磅/对2 氫壓下在室溫氫化4 5分鐘。濾除催化劑，蒸發去溶劑至乾 。所得殘餘物於二氧化矽膠上作閃色層分析，用二氣甲烷 :醋酸乙酯（10 : 1)洗離。製得標題化合物（6〇毫克）。 ^ (^, CDC13): 9.74 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J-1.5及3.6 Hz)，4.53 (d，1H, H-7', J=2.1 Hz)，4.09 (d, 1H, 8a-CHa，J=9.6HZ)，4.02(dd，lH，Ha-3，，J=7.5&amp;amp;8.4HZ), 3.84 (dd, 1H, H-l'，J=7.8及9 Hz), 3.74 (dd，1H, H-6·, J=2.1 及5.1 Hz), 3.60 (d, 1H, 8a-CHb, J=9.3 Hz), 3.42 (dq, 1H, H_ 9', J=6^9 Hz), 3.34 (t, 1H, Hb-3's J=8.7 Hz), 2.66 (t, 1H, H-1，卜3_9 Hz)。 實例4 7 [lR-(la ,3a^ AP ,4a/5 ,1 β ,laa ,8ay9 ) ] 8 a-[ (1 S , 4R, 6 S , -192- 本紙張尺度適用中國國家揉準（CNS ) A4规格（210X297公釐） (請先閱讀背面之注意事項再填寫本頁) 、11 A7 B7 經濟部中央揉準局貝工消費合作社印製 五、發明説明（190) 7R，9R)-2,8-二氧-4,9-二甲基·6_羥基-順式-雙環[3.4.0 ] -壬-7-基-乳基-甲基]-4 -甲酿基_4,4&amp;amp;，5,6,7,7江，8,8已-八 氫-7-甲基-3-(1-甲基乙基）4·亞甲基-S-吲噠省_ 3a(lH)-羧酸，鈉鹽 於實例46化合物（258毫克）於甲醇（20毫升）内之溶液中， 滴加0.103當量的氫氧化鈉水溶液（4.98毫升）。1 5分鐘後減 壓除去溶劑’殘餘物溶於水（1 〇毫升）内並凍晶，製得標題 化合物（250毫克）。 ά (^, (CD3)2SO)： 9.77 (s, 1H, CHO), 5.79 (d, 1H, H-2, J=3.6 Hz), 4.29 (d, 1H, H-7', J=1.8 Hz), 3.94-3.8 (m, 2H, 8a-CHa及Ha-3'), 3.67 (t，1H, H-l1，J=8.4 Hz)，3.55-3.25 (m, 3H, 8a-CHb, H-6', H-9'), 3.14 (t, 1H, Hb-3', J=8.4 Hz), 2.54 (t，1H，H-l, J = 3.6 Hz) 〇 實例4 8 [1R-(1 a，3a点，4万，4a点，7卢，7aa ,8aA )]8a-(((2,3,6-三去 氧-3 -乙胺基-3-N，4-0-羰基-b-D-別哌喃糖基氧基）甲基]_ 4 -甲醯基-4,43,5,6,7,73,8,83-八氫-7_甲基-3-(1-甲基乙 基）-1，4 -亞甲基-S·峭噠省- 3a(lH) -羧酸 於中間體96(180毫克）於醋酸乙醋（15毫升）内之溶液中在 氮風下加10%鈀/碳（30毫克）。此混合物在帕爾裝置内 (PH2 = 2 0砖/吋2)在室溫搖動2小時。濾除催化劑，蒸發 去溶劑至乾。所得殘餘物於二氧化矽膠上作閃色層分析， 用己燒：醋酸乙酯（1:1)洗離，製得純GM233〇39X (7〇毫 克）。 193- t紙張A度適用中國國家梂率（CNS ) A4規格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁} 、11 經濟部中央揉準局貝工消費合作社印製 A7 B7_____ 五、發明説明（191) β GH，CDC13): 9.76 (s, 1H, C廷0)，6.05 (dd，1H，H-2, J=3.0及 1.2 Hz), 4.64 (dd，1H, Η-Γ，J=5_7及3·3 Hz), 4.11 (m， 2H, H-3', H-4'), 4.04 (d, 1H, H-8a, J=9.3 Hz), 3.62 (dq, 1H, H-5', J=8.4J5L6.0 Hz), 3.51 (d, 1H, H-8a, J=9.3 Hz), 3.49 (m, 1H，C^-CH〗），3.13 (m, 1H, Cii2-CH3),2.62 (t，1H，H-l, J=3.6 Hz), 2.32 (m, 1H, CH(CH3)2), 1.15 (t, 3H, , J=7.2 Hz); (J (13C, CDC13): 204.4 (CHO), 175.7 (COOH), 157.6 (N-COO), 148.3 (C-3), 130.5 (C-2), 97.2 (C-l'), 74.2 (C-41)，73.4 (8a-QH2)，69.4 (C-5'), 51.2 (£-N)。 實例49 [1R-(1 a，3ay3，4y5，4ay5，7/?，7aa，8ay5 )]83-[(2,3-脱水-6-去氧-4-0 -甲基-々-D-哌喃甘露糖基氧基）曱基]-4-甲醯基 -4，4a，5,6,7,7a，8,8a -八氫-7·曱基- 3- (1-甲基乙基）-1,4-亞甲基-s-啕噠省-3a(lH)-羧酸 於中間體50(140毫克）於醋酸乙酯（20毫升）内之溶液中在 氮氣下加10%鈀/碳（100毫克）。此混合物於帕爾裝置内於 15磅/吋2氫壓下在室溫搖動1小時。濾除催化劑，蒸發去 溶劑至乾。所得殘餘物於二氧化矽膠上作閃色層分村. ’用己垸：醋酸乙醋（5 : 1)及二氣甲虎：甲醇（20 : 1)洗 離，製得標題化合物（85毫克），爲泡沫。 ^ (^, CDC13): 9.76 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=1.2&amp;amp;3.3Hz),4.74(s，lH，H-l')，3.63&amp;amp;4.13(2d，2H， 8aCH2, J=9.3 Hz)，3.48 (m，4H，H-4’及4-OMe)，2.26 (d, 1H， H-2', J=3.9 Hz), 3.19 (m, 1H, H-5'), 3.13 (d, 1H, H-3', J=3.9 ____ -194- 本紙張尺度適财關家解 ( CNS ) A4娜·（ 210X297公嫠) ' ' (請先閱讀背面之注意事項再填寫本頁)</span>Hz), 3.28 (d, 1H, 8aCH2, J = 9.6 Hz), 2.6-2.4 (m, 2H, H5 '+ H1), 2.32 (m, 1H, CH (CH3) 2) 〇Example 4 6 (1R- (1 «, 3a ^, 4/3 Μβ, Ί β, 7a ^ Μβ)] 8 a- [(1 S, 4R, 6 S, 7R, 9R) -2,8 -diox-4,9 -di Methyl-6-benzyl-cis-bicyclo [340] -non-7-yl-oxy-methyl] _4_methanyl_4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8, 8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) _1,4-methylene_s_pyda province_ 3a (lH) -carboxylic acid in intermediate 89b (90 mg) To a solution in ethyl acetate (25 ml) was added 10% palladium / carbon (60 mg) under nitrogen. This mixture was hydrogenated at room temperature under a hydrogen pressure of 40 psi / p 2 for 45 minutes. The catalyst was filtered off and the solvent was evaporated to dryness. The resulting residue was analyzed by flash layer on silica gel and washed away with methane: ethyl acetate (10: 1). The title compound (60 mg) was prepared. ^ (^, CDC13): 9.74 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J-1.5 and 3.6 Hz), 4.53 (d, 1H, H-7 ', J = 2.1 Hz) , 4.09 (d, 1H, 8a-CHa, J = 9.6HZ), 4.02 (dd, lH, Ha-3 ,, J = 7.5 &amp;amp; 8.4HZ), 3.84 (dd, 1H, H-l ', J = 7.8 and 9 Hz), 3.74 (dd, 1H, H-6 ·, J = 2.1 and 5.1 Hz), 3.60 (d, 1H, 8a-CHb, J = 9.3 Hz), 3.42 (dq, 1H, H_ 9 ' , J = 6 ^ 9 Hz), 3.34 (t, 1H, Hb-3's J = 8.7 Hz), 2.66 (t, 1H, H-1, Bu 3_9 Hz). Example 4 7 [lR- (la, 3a ^ AP, 4a / 5, 1 β, laa, 8ay9)] 8 a- [(1 S, 4R, 6 S, -192- This paper size is suitable for Chinese national standards ( CNS) A4 specification (210X297mm) (please read the precautions on the back before filling in this page), 11 A7 B7 Printed by Beigong Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economy V. Invention Instructions (190) 7R, 9R)- 2,8-dioxa-4,9-dimethyl · 6_hydroxy-cis-bicyclo [3.4.0] -non-7-yl-lactyl-methyl] -4-methanyl_4, 4 &amp;amp;, 5,6,7,7 Jiang, 8,8-octahydro-7-methyl-3- (1-methylethyl) 4 · methylene-S-indap province_ 3a (lH ) -Carboxylic acid, sodium salt In a solution of the compound of Example 46 (258 mg) in methanol (20 mL), 0.103 equivalent of aqueous sodium hydroxide solution (4.98 mL) was added dropwise. After 15 minutes, the solvent was removed under reduced pressure. The residue was dissolved in water (10 ml) and frozen to obtain the title compound (250 mg). ά (^, (CD3) 2SO): 9.77 (s, 1H, CHO), 5.79 (d, 1H, H-2, J = 3.6 Hz), 4.29 (d, 1H, H-7 ', J = 1.8 Hz ), 3.94-3.8 (m, 2H, 8a-CHa and Ha-3 '), 3.67 (t, 1H, H-l1, J = 8.4 Hz), 3.55-3.25 (m, 3H, 8a-CHb, H- 6 ', H-9'), 3.14 (t, 1H, Hb-3 ', J = 8.4 Hz), 2.54 (t, 1H, Hl, J = 3.6 Hz) 〇Example 4 8 [1R- (1 a, 3a point, 40,000, 4a point, 7 Lu, 7aa, 8aA)] 8a-(((2,3,6-trideoxy-3-ethylamino-3-N, 4-0-carbonyl-bD- Isopiperosyloxy) methyl] _ 4 -carboxamide-4,43,5,6,7,73,8,83-octahydro-7_methyl-3- (1-methylethyl Radical) -1,4-methylene-S · Qiaoda province-3a (lH) -carboxylic acid in a solution of intermediate 96 (180 mg) in ethyl acetate (15 ml) was added 10% under nitrogen wind Palladium / carbon (30 mg). The mixture was shaken in a Parr device (PH2 = 20 bricks / inch 2) at room temperature for 2 hours. The catalyst was filtered off and the solvent was evaporated to dryness. The resulting residue was on silica gel For flash layer analysis, wash off with hexane: ethyl acetate (1: 1) to prepare pure GM233〇39X (70 mg). 193-t paper A degree is applicable to China National Frame Rate (CNS) A4 specification ( 210X297mm) (Please read first Please pay attention to this page and fill out this page}, 11 Printed by the Ministry of Economic Affairs, Central Bureau of Economic Development, Beigong Consumer Cooperative A7 B7_____ 5. Description of Invention (191) β GH, CDC13): 9.76 (s, 1H, C Ting 0), 6.05 (dd, 1H, H-2, J = 3.0 and 1.2 Hz), 4.64 (dd, 1H, Η-Γ, J = 5_7 and 3.3 Hz), 4.11 (m, 2H, H-3 ', H- 4 '), 4.04 (d, 1H, H-8a, J = 9.3 Hz), 3.62 (dq, 1H, H-5', J = 8.4J5L6.0 Hz), 3.51 (d, 1H, H-8a, J = 9.3 Hz), 3.49 (m, 1H, C ^ -CH〗), 3.13 (m, 1H, Cii2-CH3), 2.62 (t, 1H, Hl, J = 3.6 Hz), 2.32 (m, 1H, CH (CH3) 2), 1.15 (t, 3H,, J = 7.2 Hz); (J (13C, CDC13): 204.4 (CHO), 175.7 (COOH), 157.6 (N-COO), 148.3 (C-3 ), 130.5 (C-2), 97.2 (C-l '), 74.2 (C-41), 73.4 (8a-QH2), 69.4 (C-5'), 51.2 (£ -N). Example 49 [1R- (1 a, 3ay3, 4y5, 4ay5, 7 / ?, 7aa, 8ay5)] 83-[(2,3-anhydro-6-deoxy-4-0-methyl-々-D- Pipermannosyloxy) methyl] -4-methylacetate-4,4a, 5,6,7,7a, 8,8a -octahydro-7 · methyl-3- (1-methylethyl Radical) -1,4-methylene-s-pyda-3a (lH) -carboxylic acid in a solution of intermediate 50 (140 mg) in ethyl acetate (20 ml) was added 10% under nitrogen Palladium / carbon (100 mg). This mixture was shaken at room temperature under a pressure of 15 psi for 1 hour in a Parr device. The catalyst was filtered off and the solvent was evaporated to dryness. The resulting residue was separated on silica gel as a flash layer. 'Use ethyl acetate: ethyl acetate (5: 1) and two gas tiger: methanol (20: 1) was washed away to obtain the title compound (85 mg ) Is a bubble. ^ (^, CDC13): 9.76 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J = 1.2 &amp;amp; 3.3Hz), 4.74 (s, lH, H-l '), 3.63 &amp;amp; 4.13 (2d, 2H, 8aCH2, J = 9.3 Hz), 3.48 (m, 4H, H-4 'and 4-OMe), 2.26 (d, 1H, H-2', J = 3.9 Hz), 3.19 (m , 1H, H-5 '), 3.13 (d, 1H, H-3', J = 3.9 ____ -194- This paper size is suitable for financial solutions (CNS) A4 Na (210X297 Gongmai) '' (please (Read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 A7 經濟部中央樣準局貝Η消費合作社印製 B7____ 五、發明说明（192)</span>A7 A7 Printed by Bei H Consumer Cooperative, Central Bureau of Standards, Ministry of Economic Affairs B7____ V. Description of Invention (192)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 3.06 (d, 1H, H-4', J=8.7 Hz), 2.74 (t, 1H, H-l, J=3.6 Hz); S〇3C, CDC13): 204.8 (CHO), 175.6 (C02H), 148.2 (C-3), 130.8 (C-2), 98.0 (C-Γ), 76.5 (C-4'), 74.3 (8aCH2), 74.4 (C-3a), 72.5 (C-5')s 65.6 (C-8a), 59.0 (C-4), 58.2 (4'-OMe)，53.6 (C-2’），50.3 (C-3，），46.4 (C-l)。 實例5 0 [1R-(1 a，3a/3 ,4y5，4a々，70 ,7aa，8aA )]8a-[(2,3-脱水-6- 去氧-4-0 -甲基哌喃甘露糖基氧基）甲基]-4-甲醯基 -4,4a,5,6,7,7a，8,8a-八氫-7-甲基-3-(卜曱基乙基）-1,4-亞甲基-s-钊噠省-3a(lH)-羧酸，鈉鹽 於實例49化合物（310毫克）於甲醇（10毫升）内之溶液中， 滴加氫氧化鈉水溶液（0.0976N，6·69毫升）。此混合物於室 溫攪拌2小時。除去溶劑，殘餘物溶於水（2毫升）内並凍晶 ，製得標題化合物（324毫克），爲白色固體。 δ (JH, CDCI3)： 9.87 (s, 1H, CHO), 5.98 (dd, 1H, H-2, J=1.5及3_6 Hz)，4.69 (s，1H, H-l，），3.85及4.07 (2d，2H， 8aCH2, J=9.6 Hz), 3.47 (s, 3H, 4'-OMe), 3.26 (d, 1H, H-2', J=3.9 Hz), 3.19 (dq, 1H，H-5’，J=5.7&amp;amp;9Hz),3.12(d，lH，H-3'，J=3.9 Hz)，2.97 (dd，1H，H-4'，J=0.6及8.7 Hz)，2.66 (t， 1H, H-l, J=3.6 Hz); cJ(13C, CDCI3): 209.6 (CHO), 178.6 (C02H), 152.4 (C-3), 130.2 (C-2), 100.1 (C-l'), 78.2 (C-4'), 77.9 (8aCH2), 73.8 (C-3a), 73.9 (C-5'), 65.6 (C-8a), 59.2 (C-4), 58.2 (4'-OMe), 54.6 (C-2'), 51.9 (C-3'), 46.4 (C-l) ° 實例5 1 、 __ -195- _ 本紙張尺度適用中國國家橾準（CNS ) A4規格（210X 297公釐） (請先閱讀背面之注意事項再填寫本頁)</span>Hz), 3.06 (d, 1H, H-4 ', J = 8.7 Hz), 2.74 (t, 1H, Hl, J = 3.6 Hz); S〇3C, CDC13): 204.8 (CHO), 175.6 (C02H) , 148.2 (C-3), 130.8 (C-2), 98.0 (C-Γ), 76.5 (C-4 '), 74.3 (8aCH2), 74.4 (C-3a), 72.5 (C-5') s 65.6 (C-8a), 59.0 (C-4), 58.2 (4'-OMe), 53.6 (C-2 '), 50.3 (C-3,), 46.4 (Cl). Example 5 0 [1R- (1 a, 3a / 3, 4y5, 4a々, 70, 7aa, 8aA)] 8a-[(2,3-anhydro-6-deoxy-4-0-methyl piperan mannose Glycosyloxy) methyl] -4-carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (bumethylethyl) -1,4 -Methylene-s-zhaoda-3a (lH) -carboxylic acid, sodium salt in a solution of the compound of Example 49 (310 mg) in methanol (10 mL), and a solution of sodium hydroxide (0.0976N, 6.69 ml). This mixture was stirred at room temperature for 2 hours. The solvent was removed, and the residue was dissolved in water (2 ml) and frozen to obtain the title compound (324 mg) as a white solid. δ (JH, CDCI3): 9.87 (s, 1H, CHO), 5.98 (dd, 1H, H-2, J = 1.5 and 3_6 Hz), 4.69 (s, 1H, Hl,), 3.85 and 4.07 (2d, 2H, 8aCH2, J = 9.6 Hz), 3.47 (s, 3H, 4'-OMe), 3.26 (d, 1H, H-2 ', J = 3.9 Hz), 3.19 (dq, 1H, H-5', J = 5.7 &amp;amp; 9Hz), 3.12 (d, lH, H-3 ', J = 3.9 Hz), 2.97 (dd, 1H, H-4', J = 0.6 and 8.7 Hz), 2.66 (t, 1H, Hl, J = 3.6 Hz); cJ (13C, CDCI3): 209.6 (CHO), 178.6 (C02H), 152.4 (C-3), 130.2 (C-2), 100.1 (C-l '), 78.2 (C -4 '), 77.9 (8aCH2), 73.8 (C-3a), 73.9 (C-5'), 65.6 (C-8a), 59.2 (C-4), 58.2 (4'-OMe), 54.6 (C -2 '), 51.9 (C-3'), 46.4 (Cl) ° Example 5 1, __ -195- _ This paper size applies to China National Standard (CNS) A4 specification (210X 297mm) (please read first (Notes on the back then fill this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央揉準局員工消费合作社印製 ~—--- 五、發明説明（193) [1R-(1 or，3a々，4点，4a/5，7乃，7a«，8a/S )]8a-[(2,3_環硫 _4_ 〇 -甲基-2,3,6-三去氧-卢_D_哌喃甘露糖基氧基）甲基]_4_ 甲醯基-4,4a，5,6,7,7a，8,8a-八氫_7_甲基-3-(1-甲基乙基） -1,4 -亞甲基-5-4丨噠省_3a(iH) -羧酸 將中間體52(0.67毫莫耳），5,5_二甲基_2_硫醇基_2_硫 代-1，3,2-二氧膦烷（3.37毫莫耳）及三乙基胺（4.02毫莫耳) 於播水二曱基甲醯胺（5毫升）内之混合物於1〇〇t加熱48小 時。冷卻後’將混合物倒入水醚内。將有機相蒸發，殘餘 物作閃色層分析純化’用二氣甲烷：甲醇（3 〇 :丨）作洗離劑 ，製得標題化合物（180毫克）。 ^ 〇R, CDC13): 9.77 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=1.2&amp;amp;3.3Hz)，4‘95(d，lH，H-l'，J=l.8Hz)，4.15&amp;amp;3.65 (d,d, 1H, 8a-CH2, J=9.3 Hz), 3.33 (d, 1H, H-4', J=8.7 Hz), 3.18 (m，1H, H-51)，3_14 (m，2H, H-2'及H-3’），2.70 (m，1H， H-l), 2.30 (m, 1H, CH(CH3)2)； ^(13C, CDC13): 204.7 (CHO), 175.6 (C02H), 148.3 (C-3), 130.7 (C-2), 98.5 (C-l')5 79.1 (C-4'), 74.1 (8a-CH2), 73.5 (C-5'), 46.6 (C-l), 35.6 (C-2，)，35.2 (C-3，)，27.5 (£H(CH3)2)。 1 R.S. Edmundson; Tetrahedron, 2J_, 2379 (1965) 〇 實例5 2 [1R-(1 a，3a/3，4y5 ,4a点，7/?，7aa ,8a0 )]8a-[(2,3-脱水-6-去氧-4-0 -丙基-卢-D-哌喃甘露糖基氧基）甲基]-4 -曱醯基 -4,4a,5,6,7,7a,8,8a-八氫-7-甲基-3-(1-甲基乙基）-1,4-亞甲基-s-吲噠省- 3a(lH)-羧酸 -196- 本紙張尺度逍用中國國家標準（CNS ) A4规格（210X297公釐） (請先閲讀背面之注$項再填寫本頁)</span>Printed by the Employee Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs ~ --- V. Description of the Invention (193) [1R- (1 or, 3a々, 4 o'clock, 4a / 5, 7na, 7a «, 8a / S) ] 8a-[(2,3_Episulfo_4_ 〇-methyl-2,3,6-trideoxy-Lu_D_piperanmannosyloxy) methyl] _4_carboxamide-4, 4a, 5,6,7,7a, 8,8a-octahydro_7_methyl-3- (1-methylethyl) -1,4-methylene-5-4 ~ da province_3a ( iH) -carboxylic acid intermediate 52 (0.67 mmol), 5,5_dimethyl_2_thiol_2_thio-1,3,2-dioxane (3.37 mmol) ) And triethylamine (4.02 mmol) in dimethylformamide (5 mL) in water, heated at 100 t for 48 hours. After cooling, the mixture was poured into water ether. The organic phase was evaporated, and the residue was subjected to flash chromatography analysis and purification using methane gas: methanol (30: 丨) as the eluent to obtain the title compound (180 mg). ^ 〇R, CDC13): 9.77 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J = 1.2 &amp;amp; 3.3Hz), 4'95 (d, lH, H-l ', J = l.8Hz), 4.15 &amp;amp; 3.65 (d, d, 1H, 8a-CH2, J = 9.3 Hz), 3.33 (d, 1H, H-4 ', J = 8.7 Hz), 3.18 (m, 1H, H -51), 3_14 (m, 2H, H-2 'and H-3'), 2.70 (m, 1H, Hl), 2.30 (m, 1H, CH (CH3) 2); ^ (13C, CDC13): 204.7 (CHO), 175.6 (C02H), 148.3 (C-3), 130.7 (C-2), 98.5 (C-l ') 5 79.1 (C-4'), 74.1 (8a-CH2), 73.5 (C -5 '), 46.6 (Cl), 35.6 (C-2,), 35.2 (C-3,), 27.5 (£ H (CH3) 2). 1 RS Edmundson; Tetrahedron, 2J_, 2379 (1965). Example 5 2 [1R- (1 a, 3a / 3, 4y5, 4a point, 7 / ?, 7aa, 8a0)] 8a-[(2,3-dehydration -6-deoxy-4-0-propyl-lu-D-piperanmannosyloxy) methyl] -4-methyl-4,4a, 5,6,7,7a, 8,8a -Octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-indida province- 3a (lH) -carboxylic acid-196 National Standard (CNS) A4 specification (210X297mm) (Please read the note $ item on the back and then fill in this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 B7 五、發明説明（194) 於中間體65(400毫克）於醋酸乙酯（100毫升）内之溶液中 在氮氣下加10 %鈀/碳（2〇〇毫克）。此混合物於帕爾裝置内 於20磅/吋2氫壓下在室溫搖動1小時。濾除催化劑，蒸發 去溶劑至乾。所得殘餘物於二氧化矽膠閃柱上作閃色層分 析’用二氣甲烷及二氣甲烷：甲醇（25 : 1)洗離，製得標题 化合物（300毫克），爲白色泡沫。 ά (^, CDC13): 9.76 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=1.5^3.6 Hz), 4.72 (s, 1H, Η-Γ), 4.13^13.65 (2d, 2H, 8a-CH2, J=9 Hz), 3.67 (m, 1H, H-5'), 3.44 (m, 1H, H-4'), 3.25 及3.12 (2d, 2H, H-2', H-3，，J=4.2 Hz)，3.20 (m，2H, OC^CI^CHs)，2.74 (t, 1H, H-l, J=3.9 Hz); d(13C, CDC13): 204.8 (CHO), 175.8 (C〇2H), 130.8 (C-2), 148.2 (C-3), 98.0 (C-l')5 74.9 (C-4'), 74.3 (C-8a-CH2), 72.6 (C-5'), 72.4 (OC^CI^CHs en C-41)，65.6 (C-8a), 59.0 (C-3), 54.2 (C-2')，50.3 (C-3')，18.6 (C-6')。 實例5 3 [1R-(1 «，3a/5，4/5，4a；3，7；5，7aa，8ay5 )]8a-[(2,3-脱水-6· 去氧-4-0 -丙基_0_D_哌喃甘露糖基氧基）甲基]_4·甲醯基 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁〕 -4,4&amp;amp;，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7-甲基-3-(1-甲基乙基）_1，4_ 亞曱基-s-M丨噠省-3a(lH)-叛酸，鈉鹽 於實例52化合物（400毫克）於甲醇（3〇毫升）内之溶液中， 滴加0.0976當量氫氧化鈉水溶液（8_ 15毫升）。將此混合物搜 拌1小時。除去溶劑至乾，將固體殘餘物溶於最少量水（1〇_ 15毫升）内。將此溶液凍晶，製得標題化合物（417毫克）， -197- 本紙張尺度適用中國國家揉準（CNS ) A4規格（210X297公釐） A7 A7 經濟部中央標準局貝工消費合作社印製 B7 五、發明説明（195) 爲白色固體。 ci (lR, CDC13): 9.89 (s, 1H, CHO), 5.97 (dd, 1H, H-2, J=1.5&amp;amp;3.6Hz)，4.70(s，lH，H-l,)，4.09&amp;amp;3.86(2d，2H，8a- CH2, J=9.7 Hz), 3.70 (m, 1H, H-5'), 3.44 (m, 1H, H-4'), 3.24 &amp;amp;3.12(2d，2H，H-2H3，，J=4Hz)，3.20(m，2H, OC迅CH2CH3)，2.65 (t, 1H, H-l，J=3.9 Hz); d(13C, CDCI3)： 209.6 (CHO), 178.38 (C02Na), 152.4 (C-3), 130.1 (C-2), 100.1 (C-l'), 77.9 (OCH2CH2CH3 en C-4'), 76.6 (C- 4 )，73.5 (C-5 )，73.1 (C-8a-^_H2)，66.6 (C-3'), 18.9 (C-6’）。 實例5 4 [1R-(1 a，3a点，4Θ，4a々，7/5，7aa，8a0 )]8a-[(2,3-脱水-4_ 〇 -苄基-6-去氧- /3-D -哌喃甘露糖基氧基）甲基]_4_曱醯基 -4’4&amp;amp;,5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7_甲基-3-(1-甲基乙基）_1,4_ 亞甲基-s -吲噠省-3 a (1 Η)-羧酸 於氫化鈉（22毫克）於無水二甲基甲醯胺（5毫升）内之懸浮 液中滴加中間體63(200毫克）於無水二甲基曱醯胺（7毫升) 内之溶液，將此混合物於室溫攪拌丨小時。反應混合物用i 當量鹽酸中和，加醋酸乙酯（3〇毫升有機層用水及鹽水 洗，於無水硫酸鎂上乾燥，過濾並蒸發至乾。殘餘物於二 氧化硬膠閃柱上作閃色層分析，用二氣甲燒：甲醇（5〇 : 1) 及（35 : 1)作洗離劑’製得標題化合物（15〇毫克），爲白色 泡朱。 ί (1 H，CDC13): 9·86 (s，1H，CHO)，7.3 1 (m，5H，PhCH2〇)， 6.08 (dd，1H，H-2, J=l_2及3.3 Hz)，4.75 (d, 1H, OC^Ph， -198- 本紙張尺度適用中國國家揉準（CNS ) A4規格（210X297公釐） (請先閱讀背面之注意事項再填寫本頁)</span>A7 B7 5. Description of the invention (194) To a solution of intermediate 65 (400 mg) in ethyl acetate (100 ml), add 10% palladium / carbon (200 mg) under nitrogen. This mixture was shaken in a Parr device under hydrogen pressure of 20 psi at room temperature for 1 hour. The catalyst was filtered off and the solvent was evaporated to dryness. The resulting residue was subjected to flash chromatography on a silica gel flash column and washed away with methane and methane: methanol (25: 1) to obtain the title compound (300 mg) as a white foam. ά (^, CDC13): 9.76 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J = 1.5 ^ 3.6 Hz), 4.72 (s, 1H, Η-Γ), 4.13 ^ 13.65 (2d , 2H, 8a-CH2, J = 9 Hz), 3.67 (m, 1H, H-5 '), 3.44 (m, 1H, H-4'), 3.25 and 3.12 (2d, 2H, H-2 ', H-3 ,, J = 4.2 Hz), 3.20 (m, 2H, OC ^ CI ^ CHs), 2.74 (t, 1H, Hl, J = 3.9 Hz); d (13C, CDC13): 204.8 (CHO), 175.8 (C〇2H), 130.8 (C-2), 148.2 (C-3), 98.0 (C-l ') 5 74.9 (C-4'), 74.3 (C-8a-CH2), 72.6 (C- 5 '), 72.4 (OC ^ CI ^ CHs en C-41), 65.6 (C-8a), 59.0 (C-3), 54.2 (C-2'), 50.3 (C-3 '), 18.6 (C -6 '). Example 5 3 [1R- (1 «, 3a / 5, 4/5, 4a; 3, 7; 5, 7aa, 8ay5)] 8a-[(2,3-anhydro-6 · deoxy-4-0- Propyl_0_D_piperanmannosyloxy) methyl] _4 · Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economics (Please read the precautions on the back before filling out this page) -4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) _1,4_methylidene-sM ~ da province-3a (lH) -treason Acid, sodium salt in a solution of the compound of Example 52 (400 mg) in methanol (30 mL) was added dropwise 0.0976 equivalent of aqueous sodium hydroxide solution (8-15 mL). The mixture was stirred for 1 hour. The solvent was removed to dryness , Dissolve the solid residue in the minimum amount of water (10-15 ml). Freeze the crystals of this solution to prepare the title compound (417 mg), -197- This paper size is applicable to China National Standard (CNS) A4 (210X297 mm) A7 A7 Printed B7 by the Beigong Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. The description of invention (195) is a white solid. Ci (lR, CDC13): 9.89 (s, 1H, CHO), 5.97 (dd, 1H, H-2, J = 1.5 &amp;amp; 3.6Hz), 4.70 (s, lH, Hl,), 4.09 &amp;amp; 3.86 (2d , 2H, 8a- CH2, J = 9.7 Hz), 3.70 (m, 1H, H-5 '), 3.44 (m, 1H, H-4'), 3.24 &amp;amp; 3.12 (2d, 2H, H-2H3, , J = 4Hz), 3.20 (m, 2H, OC CH2CH3), 2.65 (t, 1H, Hl, J = 3.9 Hz); d (13C, CDCI3): 209.6 (CHO), 178.38 (C02Na), 152.4 ( C-3), 130.1 (C-2), 100.1 (C-l '), 77.9 (OCH2CH2CH3 en C-4'), 76.6 (C- 4), 73.5 (C-5), 73.1 (C-8a- ^ _H2), 66.6 (C-3 '), 18.9 (C-6'). Example 5 4 [1R- (1 a, 3a point, 4Θ, 4a々, 7/5, 7aa, 8a0)] 8a- [ (2,3-anhydro-4_ 〇-benzyl-6-deoxy- / 3-D-piperanmannosyloxy) methyl] _4_ 曱 膯 基 -4'4 &amp;amp;, 5,6,7 , 7 &amp;amp;, 8,8 &amp;amp; -octahydro-7_methyl-3- (1-methylethyl) _1,4_methylene-s-indap-3a (1 Η) -carboxylic acid in To a suspension of sodium hydride (22 mg) in anhydrous dimethylformamide (5 ml) was added dropwise a solution of intermediate 63 (200 mg) in anhydrous dimethylformamide (7 ml). The mixture was stirred at room temperature for 1 hour. The reaction mixture was neutralized with i-equivalent hydrochloric acid, ethyl acetate (30 mL of organic layer was washed with water and brine, dried over anhydrous magnesium sulfate, filtered and evaporated to dryness. The residue flashed on a silica gel flash column Layer analysis, using two gas methane burning: methanol (50: 1) and (35: 1) as the eluent to prepare the title compound (15 mg), as white foam Zhu. Ί (1 H, CDC13): 9.86 (s, 1H, CHO), 7.31 (m, 5H, PhCH2〇), 6.08 (dd, 1H, H-2, J = l_2 and 3.3 Hz), 4.75 (d, 1H, OC ^ Ph, -198- The size of this paper is applicable to China National Standard (CNS) A4 (210X297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IT A7 B7 經濟部中央樣準局貝工消費合作社印製 五、發明説明（196) J=11.4 Hz), 4.73 (s, 1H, Η-Γ), 4.56 (d, 1H, OCi^Ph, J=11.4</span>IT A7 B7 Printed by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Invention description (196) J = 11.4 Hz), 4.73 (s, 1H, Η-Γ), 4.56 (d, 1H, OCi ^ Ph, J = 11.4</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz)，4.17&amp;amp;3.62(2d，2H，8a-C^，J=9_0Hz),3.32&amp;amp;3.14(2d, 2H，H-3'及H-2' J=3.7 Hz), 3.30 (m, 2H，H-4，，H-5’)，2.71 (t， 1H, H-l); i(13C, CDC13): 204.9 (CHO), 175.8 (COOH), 137.2, 128.14, 128.1 1 (6C-Ph), 148.3 (C-3), 130.8 (C-2), 98.0 (C-l'), 74.4 (C8a-CH2), 74.3 (C-4'), 72.6 (OCH2Ph), 72.5 (C-5'), 65.5 (C-8a), 54.0 (C-2'), 50.3 (C-3'), 18.6 (C-6') o 實例5 5 [1R-(1 a，3a卢，4点，4a/?，7/? ,7aa，8ay5 )]8a-[(2,3-脱水-6- 去氧-D-哌喃甘露糖基氧基）甲基]_4·甲醯基_ 4,4&amp;amp;，5,6,7,7&amp;amp;，8,83-八氫-7-甲基-3-(1-甲基乙基）-1，4. 亞甲基-s -啕噠省-3 a (1 Η)-羧酸 於無水氫化鈉（75毫克）於無水二曱基曱醯胺（5毫升）内之 懸浮液中在氮氣下加中間體66(500毫克）於無水二甲基甲酷 胺（5毫升）内之溶液。將此混合物於氮氣下攪拌3小時。然 後加水使反應停止，並用0.5Μ鹽酸將pH中和至6.5-7。將 此混合物濃縮’殘餘物於水：醋酸乙酯（丨：1，1 〇〇毫升）内 分開。水相用醋酸乙酯（2X20毫升）萃取，合併之有機相用 鹽水處理，於硫酸鎂上乾燥，過濾並眞空濃縮成漿體。再 於二氧化矽膠上作閃柱色層分析，用二氣甲烷：曱醇（4〇 : 1)洗離，製得標題化合物（17 2毫克），爲白色泡沫。 ^ (^, CDC13): 9.76 (s, 1H, CHO), 6.09 (dd, 1H, H-12, J=1.5&amp;amp;3.6Hz)，4.77(s,lH，H-r),3.6^4.21(2d，2H, (請先閲讀背面之注意事項再填寫本頁)</span>Hz), 4.17 &amp;amp; 3.62 (2d, 2H, 8a-C ^, J = 9_0Hz), 3.32 &amp;amp; 3.14 (2d, 2H, H-3 'and H-2' J = 3.7 Hz), 3.30 (m, 2H, H-4 ,, H-5 '), 2.71 (t, 1H, Hl); i (13C, CDC13): 204.9 (CHO), 175.8 (COOH), 137.2, 128.14, 128.1 1 (6C-Ph) , 148.3 (C-3), 130.8 (C-2), 98.0 (C-l '), 74.4 (C8a-CH2), 74.3 (C-4'), 72.6 (OCH2Ph), 72.5 (C-5 ') , 65.5 (C-8a), 54.0 (C-2 '), 50.3 (C-3'), 18.6 (C-6 ') o Example 5 5 [1R- (1 a, 3a Lu, 4 points, 4a / ?, 7 /?, 7aa, 8ay5)] 8a-[(2,3-anhydro-6-deoxy-D-piperanmannosyloxy) methyl] _4 · methanyl_4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,83-octahydro-7-methyl-3- (1-methylethyl) -1,4. Methylene-s-pyda-3a (1 Η) -carboxylic acid in a suspension of anhydrous sodium hydride (75 mg) in anhydrous dimethylformamide (5 mL) was added intermediate 66 (500 mg) in anhydrous dimethylformamide under nitrogen ( 5 ml). The mixture was stirred under nitrogen for 3 hours. Then, water was added to stop the reaction, and the pH was neutralized to 6.5-7 with 0.5M hydrochloric acid. The concentrated 'residue of this mixture was separated in water: ethyl acetate (丨: 1,100 ml). The aqueous phase was extracted with ethyl acetate (2 × 20 ml), the combined organic phases were treated with brine, dried over magnesium sulfate, filtered and concentrated in vacuo to a slurry. Then, flash column chromatography was performed on the silica gel, and washed away with methane: methanol (40: 1) to obtain the title compound (172 mg) as a white foam. ^ (^, CDC13): 9.76 (s, 1H, CHO), 6.09 (dd, 1H, H-12, J = 1.5 &amp;amp; 3.6Hz), 4.77 (s, lH, Hr), 3.6 ^ 4.21 (2d, 2H, (Please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">、1T f丨 199 經濟部中央梯準局貝工消費合作社印製 A7 B7 五、發明説明（197) 8aCH2, J=9 Hz), 3.60 (d, 1H, H-4', J-8.7 Hz), 3.21 (dq, 1H, H-5', J=9^6 Hz), 3.165.3.27 (2d, 2H, H-2'^LH-3', J=3.6 Hz), 2.70 (t, 1H, H-l); ^ (13C, CDC13): 205.5 (CHO), 174.6 (C02H), 148.4 (C-3), 130.8 (C-2), 97.8 (C-l'), 74.1 (8aCH2), 73.9 (C-4'), 73.7 (C-3a), 67.2 (C-5'), 65.5 (C-8a), 59.0 (C-4), 56.5 (C-2’），50.4 (C-31)，46.5 (C-l)。 實例5 6 [1R-(1 «，3a々，4冷，4a/5，7yS ,7aa，8a0 )]8&amp;amp;-[(2,3-脱水-4，6-二去氧-4-氟哌喃塔羅糖基氧基）甲基]-4 -甲醯 基-4,43,5,6,7,7&amp;amp;，8,8己-八氫-7-甲基-3-(1-甲基乙基）-1，4 -亞甲基_S-,5丨噠省_3a(iH)_羧酸 於中間體68(130毫克）於醋酸乙酯（30毫升）内之溶液中在 氮氣下加10%鈀/碳（1〇〇毫克）。此混舍物於帕爾裝置内於 1 〇砖/吋2氫壓下在室溫搖動1小時。濾除催化劑，蒸發去 溶劑至乾。所得殘餘物於二氧化矽膠閃柱上閃色層分析 ，用己烷：醋酸乙酯（4 : 1)及二氣甲烷：甲醇&amp;gt;2^ : 1)洗 離，製得標題化合物（8 2毫克），爲白色泡沫。 ^ Ob., CDC13): 9.79 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=1.2&amp;amp;3.6Hz)，5.13(s，lH，H-l,)，4.75&amp;amp;4.58(2dq，lH,H-5’，J5’F=48.3Hz，J=6.6Hz，J=3.9Hz)，4.18&amp;amp;4.11(2d，lH， H-4'，J=3.9Hz&amp;amp;J4,F=23.1Hz)，4.07&amp;amp;3.61(2d,2H，8aCH2, J=9.3 Hz), 3.77 (m, 2H, H-2'^H-3'), 2.67 (t, 1H, H-l); ^ (13C, CDC13)： 204.6 (CHO), 175.3 (C02H), 148.2 (C-3), 130.7 (C-2), 101.7 (C-1'), 90.2 (d, C-4', JC4,.F-157 Hz), -200- 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公藿） (請先閲讀背面之注項再填寫本頁) -* 7 經濟部中央揉準局員工消费合作社印裝 Α7 Β7 五、發明説明（198) 80.3 (d, C-5', JC5--f=21.4 Hz)574.3 (C-8aCH2), 73.4 (C-3a), 65.4 (C-8a), 58.9 (C-4)，55.9 (C-2')，55.1 (d, C-3'，JC3，_F =6.3 Hz)，16.4 (d，C-6', JC6,_F=21 Hz)。 實例5 7 [1R-(1 π，3a卢，40，4a点，，7aa，8a/? )]8a-[(2,3-脱水-6- 去氧-4-0-(2 -甲氧基乙基）_y?-D-哌喃甘露糖基氧基）曱基] -4 -甲酿基_4,4a，5,6,7,7a, 8,8a-八氫-7 -甲基-3-(1-曱基 乙基）-1，4-亞甲基-s-吲噠省_3a( 1H)-羧酸 於中間體69(140毫克）於醋酸乙酯（50毫升）内之溶液中在 氮氣下加10 %鈀/碳（70毫克）。此混合物於帕爾裝置内於 2 0磅/吋2氫壓下在室溫搖動1小時。濾除催化劑，蒸發去 溶劑至乾。所得殘餘物於二氧化矽膠閃柱上純化，用二氣 曱烷及二氣甲烷：甲醇（4〇 : 洗離，製得標題化合物（74 笔克），爲白色泡沐。 cy Cn, CDC13): 9.78 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=1.2&amp;amp;3.3Hz)，4.74(s，lH，H-r)，4.23&amp;amp;3.60(2d，2H，8a- CH2, J=9 Hz), 3.86-3.50 (m, 4H, OCl·^ C 〇 C H 3 ), 3.38 (s, 3H，C|i3〇CH2CH20),3.3(m3.13(2d,2H，H-2m-3，， J=3.9 Hz), 3.26-3.22 (m，2H, H-4,及H-5’），2.68 (t，1H，H-l， J=3.7 Hz); (13C, CDCI3): 204.8 (CHO), 175.2 (COOH), 148.3 (C-3), 130.8 (C-2), 97.9 (C-l')s 74.2 (C-8aCH2), 72.4 (C-51), 717 及69.9 (0£H2^H20CH3)，54.1 (C-2，），SOCKS’)， 46.5 (QH3OCH2CH2)， 18.5 (C-6') 。 實例5 8 ___-201 -___ 本紙張尺度適用中國國家榡準（CMS ) A4規格（210X297公~ (請先閱讀背面之注意事項再填寫本頁)</span>、 1T f 丨 199 A7 B7 printed by Beigong Consumer Cooperative of Central Bureau of Economics and Development, Ministry of Economic Affairs 5. Description of Invention (197) 8aCH2, J = 9 Hz), 3.60 (d, 1H, H-4 ', J-8.7 Hz) , 3.21 (dq, 1H, H-5 ', J = 9 ^ 6 Hz), 3.165.3.27 (2d, 2H, H-2' ^ LH-3 ', J = 3.6 Hz), 2.70 (t, 1H, Hl); ^ (13C, CDC13): 205.5 (CHO), 174.6 (C02H), 148.4 (C-3), 130.8 (C-2), 97.8 (C-l '), 74.1 (8aCH2), 73.9 (C -4 '), 73.7 (C-3a), 67.2 (C-5'), 65.5 (C-8a), 59.0 (C-4), 56.5 (C-2 '), 50.4 (C-31), 46.5 (Cl). Example 5 6 [1R- (1 «, 3a々, 4 cold, 4a / 5, 7yS, 7aa, 8a0)) 8 &amp;amp;-[(2,3-anhydro-4,6-dideoxy-4-fluoropiper Furanosyloxy) methyl] -4 -carboxamide-4,43,5,6,7,7 &amp;, 8,8hexane-octahydro-7-methyl-3- (1-methyl Ethyl) -1,4-methylene_S-, 5 | dida_3a (iH) _carboxylic acid in a solution of intermediate 68 (130 mg) in ethyl acetate (30 ml) under nitrogen Add 10% palladium on carbon (100 mg). This mixture was shaken at room temperature for 1 hour under a pressure of 10 bricks / inch 2 in a Parr device. The catalyst was filtered off and the solvent was evaporated to dryness. The resulting residue was analyzed by flash chromatography on a silica gel flash column, and washed away with hexane: ethyl acetate (4: 1) and difluoromethane: methanol &amp;gt; 2 ^: 1) to prepare the title compound (8 2 Mg) as a white foam. ^ Ob., CDC13): 9.79 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J = 1.2 &amp;amp; 3.6Hz), 5.13 (s, lH, Hl,), 4.75 &amp;amp; 4.58 ( 2dq, lH, H-5 ', J5'F = 48.3Hz, J = 6.6Hz, J = 3.9Hz), 4.18 &amp;amp; 4.11 (2d, lH, H-4', J = 3.9Hz &amp;amp; J4, F = 23.1Hz), 4.07 &amp;amp; 3.61 (2d, 2H, 8aCH2, J = 9.3 Hz), 3.77 (m, 2H, H-2 '^ H-3'), 2.67 (t, 1H, Hl); ^ (13C , CDC13): 204.6 (CHO), 175.3 (C02H), 148.2 (C-3), 130.7 (C-2), 101.7 (C-1 '), 90.2 (d, C-4', JC4, .F- 157 Hz), -200- This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297 commonweed) (please read the notes on the back and then fill out this page)-* 7 Printed by the Employees Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs Install Α7 Β7 5. Description of the invention (198) 80.3 (d, C-5 ', JC5--f = 21.4 Hz) 574.3 (C-8aCH2), 73.4 (C-3a), 65.4 (C-8a), 58.9 ( C-4), 55.9 (C-2 '), 55.1 (d, C-3', JC3, _F = 6.3 Hz), 16.4 (d, C-6 ', JC6, _F = 21 Hz). Example 5 7 [1R- (1 π, 3a Lu, 40, 4a point, 7aa, 8a /?)] 8a-[(2,3-anhydro-6-deoxy-4-0- (2-methoxy Ethyl) _y? -D-piperanmannosyloxy) methyl] -4 -methylbrenyl_4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl -3- (1-Methylethyl) -1,4-methylene-s-indap_3a (1H) -carboxylic acid in intermediate 69 (140 mg) in ethyl acetate (50 ml) To the solution was added 10% palladium / carbon (70 mg) under nitrogen. This mixture was shaken in a Parr apparatus under hydrogen pressure of 20 psi at room temperature for 1 hour. The catalyst was filtered off and the solvent was evaporated to dryness. The resulting residue was purified on a silica gel flash column, using methane and methane: methanol (40: washed away, the title compound (74 g) was obtained as a white foam. Cy Cn, CDC13) : 9.78 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J = 1.2 &amp;amp; 3.3Hz), 4.74 (s, lH, Hr), 4.23 &amp;amp; 3.60 (2d, 2H, 8a-CH2 , J = 9 Hz), 3.86-3.50 (m, 4H, OCl · ^ C 〇CH 3), 3.38 (s, 3H, C3iCH2CH20), 3.3 (m3.13 (2d, 2H, H-2m -3 ,, J = 3.9 Hz), 3.26-3.22 (m, 2H, H-4, and H-5 '), 2.68 (t, 1H, Hl, J = 3.7 Hz); (13C, CDCI3): 204.8 (CHO), 175.2 (COOH), 148.3 (C-3), 130.8 (C-2), 97.9 (C-l ') s 74.2 (C-8aCH2), 72.4 (C-51), 717 and 69.9 (0 £ H2 ^ H20CH3), 54.1 (C-2,), SOCKS '), 46.5 (QH3OCH2CH2), 18.5 (C-6'). Example 5 8 ___- 201 -___ The paper size is applicable to the Chinese National Standard (CMS) A4 specification (210X297 ~ (Please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央揉準局貝工消費合作社印製 A7 B7 五、發明説明（199) [lR-(l»，3a/?，4y5，4ay5，7/?，7aα，8aβ)]8a-[(2,3-脱水-6- 去氧-4-0-(2-甲氧基丙基）_冷_D_哌喃甘露糖基氧基）甲基] -4 -甲醯基_4,4&amp;amp;，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7_甲基_3-(1-甲基 乙基）-1,4 -亞甲基-s_吲噠省_3a(iH)_羧酸 於中間體70(0.14毫莫耳）於醋酸乙酯（3〇毫升）内之溶液 中在氮氣下加10 %鈀/碳（50毫克）。此混合物於帕爾裝置 内於25磅/吋2氫壓下在室溫搖動3〇分鐘。濾除催化劑， 蒸發去溶劑至乾。所得殘餘物作閃色層分析純化，用二氣 曱虎：甲醇（40 : 1)作洗離劑，製得標題化合物（49毫克) 〇 β (!H，CDC13): 9.76 (s，1H, CHO)，6.09 (dd，1H，H-2， J=1.2^3.3 Hz), 4.73 (s, 1H, H-l'), 4.12^13.65 (2d, 2H, 8a- CH2, J=9.3 Hz)，3.49 (m，1H, H-5’），3.22 (m，3H，H-21 及 CH2-0), 3.13 (m，2H，H-31 及H-4')，2.75 (t，1H，H-l, J=3.9</span>A7 B7 printed by the Beigong Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs 5. Description of the invention (199) [lR- (l », 3a / ?, 4y5, 4ay5, 7 / ?, 7aα, 8aβ)] 8a-[(2 , 3-anhydro-6-deoxy-4-0- (2-methoxypropyl) _cold_D_piperannomannosyloxy) methyl] -4 -methylacetyl_4,4 &amp;amp; , 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7_methyl_3- (1-methylethyl) -1,4-methylene-s_indap province_3a ( iH) _carboxylic acid in a solution of intermediate 70 (0.14 mmol) in ethyl acetate (30 mL) was added 10% palladium on carbon (50 mg) under nitrogen. This mixture was shaken at room temperature for 30 minutes under 25 psi hydrogen pressure in a Parr device. The catalyst was filtered off and the solvent was evaporated to dryness. The obtained residue was analyzed and purified by flash chromatography, using two gas tigers: methanol (40: 1) as the eluent to obtain the title compound (49 mg) 〇β (! H, CDC13): 9.76 (s, 1H, CHO), 6.09 (dd, 1H, H-2, J = 1.2 ^ 3.3 Hz), 4.73 (s, 1H, H-l '), 4.12 ^ 13.65 (2d, 2H, 8a- CH2, J = 9.3 Hz) , 3.49 (m, 1H, H-5 '), 3.22 (m, 3H, H-21 and CH2-0), 3.13 (m, 2H, H-31 and H-4'), 2.75 (t, 1H, Hl, J = 3.9</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 2.33 (m, 1H, CH(CH3)2)； ^(13C, CDC13 ): 204.8 (CHO), 176.0 (C02H), 148.2 (C-3), 130.8 (C-2), 98.0 (C-l')s 77.6 (C-l&amp;quot;), 75.2 (C-4'), 74.3 (8a-CH2), 72.9 (C-3a), 72.6 (C-5'), 65.6 (C-8a), 59.0 (C-4), 54.1 (C-2'), 50.4 (C-3'), 46.4 (C-l), 41.7 (C-4a)，41_3 (C-7a)。 實例5 9 [1R-(1 a，3a/?，4y5，4a/?，7/?，7aa ,8a々）]8a-[(2,3 -脱水-6- 去氧-4-0-(1-甲基乙基）羰基-点-D_哌喃甘露糖基氧基）甲 基]-4 -甲醯基-4,4&amp;amp;，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7-甲基-3-(1-甲 基乙基）-1,4 -亞甲基-s -吲噠省- 3a(lH) -羧酸 -202- (請先閲讀背面之注意事項再填寫本頁) 丁 本紙張尺度逋用中國國家橾準（CNS ) A4規格（210X297公釐） 3^1644 經濟部中央標準局員工消費合作社印装 A7 B7 五、發明説明（2〇q&amp;gt; 於中間體71(140毫克）於醋酸乙酯（20毫升）内之溶液中在 氮氣下加10%鈀/碳（120毫克）。此混合物於帕爾裝置内於 20镑/吋2氫壓下在室溫搖動3〇分鐘。濾除催化劑，蒸發 去溶劑至乾。所得殘餘物於二氧化矽膠上作閃柱色層分析 純化，用己烷：醋酸乙酯（4 : 1)及二氣甲烷：甲醇（20 : 1) 作洗離劑，製得標題化合物（1〇3毫克），爲白色泡沫。 ^ 〇n, CDC13): 9.74 (s, 1H, CHO), 6.09 (dd, 1H, H-2, J=1.5^3.6 Hz), 4.78 (s, 1H, H-l'), 4.66 (d, 1H, H-4', J=9</span>Hz), 2.33 (m, 1H, CH (CH3) 2); ^ (13C, CDC13): 204.8 (CHO), 176.0 (C02H), 148.2 (C-3), 130.8 (C-2), 98.0 (C -l ') s 77.6 (C-l &amp;quot;), 75.2 (C-4'), 74.3 (8a-CH2), 72.9 (C-3a), 72.6 (C-5 '), 65.6 (C-8a), 59.0 (C-4), 54.1 (C-2 '), 50.4 (C-3'), 46.4 (Cl), 41.7 (C-4a), 41_3 (C-7a). Example 5 9 [1R- (1 a, 3a / ?, 4y5, 4a / ?, 7 / ?, 7aa, 8a々)] 8a-[(2,3 -anhydro-6-deoxy-4-0- ( 1-methylethyl) carbonyl-dot-D-piperanmannosyloxy) methyl] -4-carboxyl-4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp;- Octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-indap-3a (lH) -carboxylic acid-202- (please read the notes on the back first Please fill in this page again) Dingben's paper standard uses the Chinese National Standard (CNS) A4 specification (210X297 mm) 3 ^ 1644 Printed by the Ministry of Economic Affairs Central Standards Bureau Employee Consumer Cooperative A7 B7 V. Invention description (2〇q &amp;gt; To a solution of intermediate 71 (140 mg) in ethyl acetate (20 mL) was added 10% palladium / carbon (120 mg) under nitrogen. This mixture was placed in a Parr device under 20 psi hydrogen pressure Shake at room temperature for 30 minutes. Filter off the catalyst and evaporate the solvent to dryness. Purify the resulting residue on silica gel by flash column chromatography, using hexane: ethyl acetate (4: 1) and methane gas : Methanol (20: 1) was used as the eluent to obtain the title compound (103 mg) as a white foam. ^ 〇n, CDC13): 9.74 (s, 1H, CHO), 6.09 (dd, 1H, H-2, J = 1.5 ^ 3.6 Hz), 4.78 (s, 1H, H-l '), 4.66 (d, 1H, H-4', J = 9</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz)，4.1(^3.60(2d,2H，8aCH2，J=9Hz)，3.42(dq,lH，H-5'， J=9及3 Hz)，3.15 (s，2H，H-2,及H-3，），2.78 (m，1H，H-l)， 2.58 (m, 1H, 4'-OCOCHMe2); ci(13C, CDC13): 204.9 (CHO), 176.1, 175.9 (C〇2H及4OCOR)，148,2 (C-3)，130.9 (C-2)， 97.9 (C-l')5 74.5 (C-8aCH2), 72.6 (C-3a), 71.4 (C-4'), 67.8 (C-5’)，66.0 (C-8a), 59.0 (C-4)，18.5及 18.8 (2CH3 of 4，-OCOCHMe-,)。 實例60 [1R-(1 a，3a万，4卢，4a卢，7卢，7aor ,8a/3 )]8a-[(2,3-脱水-6-去氧-4-0-(2,2-二甲基丙醯基）-0-1)-哌喃甘露糖基氧基) 甲基]-4 -甲醯基 _4,4 a, 5,6,7,7a，8,8a-八氫-7 -甲基-3-(1-曱基乙基）-l，4 -亞甲基-s-β噠省- 3a(lH)-羧酸 於中間體72(0.21毫莫耳）於醋酸乙酯（6〇毫升）内之溶液 中在氮氣下加10 %鈀/碳（50毫克）。此混合物於帕爾裝置 内於20磅/吋2氫壓下在室溫搖動3〇分鐘。濾除催化劑， 蒸發去溶劑至乾。殘餘物作閃色層分析純化，用二氣曱烷 _ -203- 本紙張尺度適用中國國家標準（CNS )八4規格（21〇χ297公釐） (請先閲讀背面之注意Ϋ項再填寫本頁) 訂 經济部中央揉準局貝工消費合作社印製 A7 __B7 五、發明説明（2〇1) :甲醇（20 : 1)作洗離劑，製得標題化合物（101毫克）。 S (!Η, CDC13)： 9.75 (s, 1H, CHO), 6.10 (dd, 1H, H-2, J=1.2及3.3 Hz)，4.80 (s, 1H, Η-Γ)，4.64 (d, 1H，H-4'，J=9 Hz)，4.11&amp;amp;3.70(2d，2H，8a-CH2,J=9.3Hz),3.43(m，lH， H-5’），3.13 (m，2H，H-2,及H-3')，2.78 (t，1H，H-l，J = 3.9 Hz), 2.34 (m, 1H, CH(CH3)2); &amp;lt;S(l3C, CDC13): 204.9 (CHO), 177.3&amp;amp;176_5(2xCO2)，148.2(C-3)，130.9(C-2)，98.0(C-Γ)，74.5 (8a-CH2)，72.6 (C-2)，71.3 (C-5，)，67.9 (C-4·)，65.7 (C-8a), 59.0 (C-4), 54.3 (C-2'), 50.1 (C-3'), 46.3 (C-l), 41.8 (C-4a), 41.3 (C-8), 38.8 (C^Bu), 32.0 (C-5), 30.9 (C-7), 18.5 (tBu)。 實例6 1 [1R-(1 a，3a0，4卢，4ay5，7/5 ,7aa，8a；9 )]8a-[(2,3-脱水 Ιο-苄氧羰基-6-去氧-卢-D-哌喃甘露糖基氧基） 甲基]-4-甲 醯基-4,4a，5,6,7,7a，8,8a -八氫-7 -甲基- 3- (1-甲基乙基）-1，4 -亞曱基-s-p引達省- 3a(lH)-幾酸 將中間體73(0 .22毫莫耳）於二氣甲烷（10毫升）内之溶液 於0°C以三氟醋酸（0.1毫升）處理。二小時後，此混合物用 水洗，將有機相蒸乾。殘餘物作閃色層分析純化，用二氣 甲烷：甲醇（40 : 1)作洗離劑，製得標題化合物（6〇毫克） 〇 ^ 〇U, CDC13)： 9.74 (s, 1H, CHO), Ί.31 (m, 5H, Ph), 6.09 (dd，1H, H-2, J=1.5及3.6 Hz)，5.20 (m，2H，C^Ph)，4·75 (s, 1H，Η-Γ)，4.55 (d, 1H，H-4'，J=9 Hz), 4.08及3.70 (2d，2H, _ - 204 - 本&amp;amp;張尺度適用中國國家梂準（CNS ) A4規格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁)</span>Hz), 4.1 (^ 3.60 (2d, 2H, 8aCH2, J = 9Hz), 3.42 (dq, lH, H-5 ', J = 9 and 3 Hz), 3.15 (s, 2H, H-2, and H -3,), 2.78 (m, 1H, Hl), 2.58 (m, 1H, 4'-OCOCHMe2); ci (13C, CDC13): 204.9 (CHO), 176.1, 175.9 (C〇2H and 4OCOR), 148 , 2 (C-3), 130.9 (C-2), 97.9 (C-l ') 5 74.5 (C-8aCH2), 72.6 (C-3a), 71.4 (C-4'), 67.8 (C-5 '), 66.0 (C-8a), 59.0 (C-4), 18.5 and 18.8 (2CH3 of 4, -OCOCHMe-,). Example 60 [1R- (1 a, 3a ten thousand, 4 lu, 4 a lu, 7 Lu, 7aor, 8a / 3)] 8a-[(2,3-anhydro-6-deoxy-4-0- (2,2-dimethylpropionyl) -0-1) -pipermannose Yloxy) methyl] -4 -carboxamide_4,4 a, 5,6,7,7a, 8,8a-octahydro-7 -methyl-3- (1-methylethyl)- l, 4-Methylene-s-βpyridine-3a (lH) -carboxylic acid in a solution of intermediate 72 (0.21 mmol) in ethyl acetate (60 mL) was added 10% under nitrogen Palladium / carbon (50 mg). This mixture was shaken at room temperature for 30 minutes in a Parr device under 20 psi hydrogen pressure. The catalyst was filtered off and the solvent was evaporated to dryness. The residue is analyzed and purified by flash chromatography, using difluoromethane _ -203- The paper size is applicable to the Chinese National Standard (CNS) 84 specifications (21〇 297 mm) (please read the note Ϋ on the back before filling in this Page) A7 __B7 printed by the Beigong Consumer Cooperative of the Ministry of Economic Affairs of the Central Customs Bureau. V. Description of the Invention (2〇1): Methanol (20: 1) as the eluent to obtain the title compound (101 mg). S (! Η, CDC13): 9.75 (s, 1H, CHO), 6.10 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.80 (s, 1H, Η-Γ), 4.64 (d, 1H, H-4 ', J = 9 Hz), 4.11 &amp; 3.70 (2d, 2H, 8a-CH2, J = 9.3Hz), 3.43 (m, lH, H-5'), 3.13 (m, 2H, H-2, and H-3 '), 2.78 (t, 1H, Hl, J = 3.9 Hz), 2.34 (m, 1H, CH (CH3) 2); &amp;lt; S (l3C, CDC13): 204.9 (CHO ), 177.3 &amp;amp; 176_5 (2xCO2), 148.2 (C-3), 130.9 (C-2), 98.0 (C-Γ), 74.5 (8a-CH2), 72.6 (C-2), 71.3 (C-5 ,), 67.9 (C-4 ·), 65.7 (C-8a), 59.0 (C-4), 54.3 (C-2 '), 50.1 (C-3'), 46.3 (Cl), 41.8 (C- 4a), 41.3 (C-8), 38.8 (C ^ Bu), 32.0 (C-5), 30.9 (C-7), 18.5 (tBu). Example 6 1 [1R- (1 a, 3a0, 4 Lu, 4ay5, 7/5, 7aa, 8a; 9)] 8a-[(2,3-anhydrol-benzyloxycarbonyl-6-deoxy-Lu- D-piperanmannosyloxy) methyl] -4-carboxamide-4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3- (1-methyl Ethyl) -1,4-methylidene-sp indica-3a (lH) -chiric acid solution of intermediate 73 (0.22 millimoles) in methane (10 ml) in 0 ° C with trifluoroacetic acid (0.1 ml). After two hours, the mixture was washed with water and the organic phase was evaporated to dryness. The residue was analyzed and purified by flash chromatography, using methane gas: methanol (40: 1) as the eluent, to obtain the title compound (60 mg) 〇 ^ 〇U, CDC13): 9.74 (s, 1H, CHO) , Ί.31 (m, 5H, Ph), 6.09 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 5.20 (m, 2H, C ^ Ph), 4.75 (s, 1H, Η -Γ), 4.55 (d, 1H, H-4 ', J = 9 Hz), 4.08 and 3.70 (2d, 2H, _-204-This &amp;amp; Zhang scale applies to China National Standards (CNS) A4 specification (210X297 Mm) (Please read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標準局負工消費合作社印製 A7 B7 五、發明説明（202) 8a-CH2, J=9 Hz)，3.47 (m，1H，H-5')，3.28及3.16 (d, d, 1H， 1H，H-2,及H-3', J=3.6 Hz), 2.79 (t，1H，H-l, J=3.9 Hz)，2.33 (m, 1H, CH(CH3)2); i(13C, CDC13): 204.8 (CHO), 176.4 (C02H), 154.1 (C03), 148.1 (C-3), 134.6 (Cipso), 130.9 (C- 2), 128.8, 128.7, 128.5, 128.4 (Ph), 97.8 (C-l')5 74.5 (8a-CH2), 72.5 (C-3a), 71.6 (C-51), 71.1 (C-4'), 70.3 (CH2Ph), 65.7 (C-8a), 58.9 (C-4), 53.9 (C-2'), 50.0 (C-3')s 46.2 (C-l), 41.7 (C-4a), 41.3 (C-7a)。 實例62 [1R-(1 a，3ay5，4々，4ay5，7 0 ,7aa，8ay5 )]8a-[(2,3-脱水-6-去氧-4-氧基- 々-D -哌喃甘露糖基氧基）甲基]_4_甲醯基_ 4,4a，5,6,7,7a，8,8a-八氫_7-甲基-3-(l-甲基乙基）-l,4-亞甲基-s -吲噠省-3 a (1 Η)-羧酸 於中間體74(0.26毫莫耳）於醋酸乙酯（30毫升）内之溶液 中在氮氣下加10°/。鈀/碳（50毫克）。此混合物於帕爾裝置 内於25磅/吋2氫壓下在室溫搖動15小時。濾除催化劑， 蒸發去溶劑至乾。殘餘物作閃色層分析純化，用二氣甲烷 :甲醇（20 : 1)作洗離劑，收取適宜部分並蒸發，製得標題 化合物（3 8毫克）。 ^ (^, CDC13): 9.72 (s, 1H, CHO), 6.12 (dd, 1H, H-2, J=1.5&amp;amp;3.6Hz)，4.87(s，lH，H-r)，4.1(^3.76(2d，2H， 8aCH2, J=9 Hz)，3.83 (q，1H，H-5'，J=6.6 Hz)，3.60及3.38 (d， d，1H，1H，3’及2'，J=3.9 Hz), 2.82 (t, 1H，H-l，J:3.6 Hz)， 2.36 (m, 1H, CH(CH3)2)； s (13C, CDC13): 204.9 (CHO), _____-205- 本紙張尺度適用中國國家標準（CNS ) A4規格（21〇x297公董) (請先聞讀背面之注意事項再填寫本頁)</span>A7 B7 printed by the Consumer Labor Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of Invention (202) 8a-CH2, J = 9 Hz), 3.47 (m, 1H, H-5 '), 3.28 and 3.16 (d, d, 1H, 1H, H-2, and H-3 ', J = 3.6 Hz), 2.79 (t, 1H, Hl, J = 3.9 Hz), 2.33 (m, 1H, CH (CH3) 2); i (13C , CDC13): 204.8 (CHO), 176.4 (C02H), 154.1 (C03), 148.1 (C-3), 134.6 (Cipso), 130.9 (C-2), 128.8, 128.7, 128.5, 128.4 (Ph), 97.8 (C-l ') 5 74.5 (8a-CH2), 72.5 (C-3a), 71.6 (C-51), 71.1 (C-4'), 70.3 (CH2Ph), 65.7 (C-8a), 58.9 ( C-4), 53.9 (C-2 '), 50.0 (C-3') s 46.2 (Cl), 41.7 (C-4a), 41.3 (C-7a). Example 62 [1R- (1 a, 3ay5,4々, 4ay5,7 0, 7aa, 8ay5)] 8a-[(2,3-anhydro-6-deoxy-4-oxy-々-D-piran Mannosyloxy) methyl] _4_formyl_4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (l-methylethyl)- l, 4-Methylene-s-indap-3a (1 Η) -carboxylic acid in a solution of intermediate 74 (0.26 mmol) in ethyl acetate (30 mL) was added 10 under nitrogen ° /. Palladium / carbon (50 mg). This mixture was shaken at room temperature for 15 hours at 25 psig hydrogen pressure in a Parr device. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was analyzed and purified by flash chromatography, using methane: methanol (20: 1) as the eluent. The appropriate fraction was collected and evaporated to obtain the title compound (38 mg). ^ (^, CDC13): 9.72 (s, 1H, CHO), 6.12 (dd, 1H, H-2, J = 1.5 &amp;amp; 3.6Hz), 4.87 (s, lH, Hr), 4.1 (^ 3.76 (2d , 2H, 8aCH2, J = 9 Hz), 3.83 (q, 1H, H-5 ', J = 6.6 Hz), 3.60 and 3.38 (d, d, 1H, 1H, 3' and 2 ', J = 3.9 Hz ), 2.82 (t, 1H, Hl, J: 3.6 Hz), 2.36 (m, 1H, CH (CH3) 2); s (13C, CDC13): 204.9 (CHO), _____- 205- This paper size applies to China National Standard (CNS) A4 specification (21〇x297 public director) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標準局貝工消费合作社印製 A7 ____B7 五、發明説明（203) 202.9 (CO-4'), 176.2 (C02H), 148.2 (C-3), 130.9 (C-2), 96.1 (C-Γ), 76.6 (C-5'), 74.7 (8aCH2), 72.1 (C-3a), 65.7 (C-8a), 58.9 (C-4), 54.2及53.5 (C-2,及C-3')，46.1 (C-l), 41.8 (C-4a), 41.3 (C_7a)。 實例6 3 [1R-(1 a，3a0，4/?，4ay?，7/?，7aa，8ay5 )]8a-[(2,3-脱水-4,6-二去氧-4-亞曱基-b-D-哌喃甘露糖基氧基）甲基-4 -曱 醯基-4,4a，5,6,7,7a，8,8a-八氫-7-甲基-3-(l-甲基乙基）-l，4·亞甲基-s·'*5丨噠省-3a(lH)-羧酸 將中間體101(0.17毫莫耳）於二氣甲烷（15毫升）内之溶液 於0°C以三氟醋酸（0.15毫升）處理。二小時後，用水（1〇毫 升）處理。將有機相蒸發，殘餘物溶於乙醇（15毫升）及1當 量鹽酸（1.5毫升）内，於〇°C攪拌2小時。除去溶劑，殘餘物 使用二氣甲烷：曱醇20 : 1作洗離劑純化。蒸發適宜部分 ，製得標題化合物（24毫克）。 (ί CDC13)： 9.75 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=1.2«.3Hz)，5.2(^5.10(s，s，lH，lH，CH2=C)，4.82(d， 1H，H-l，J=2.1 Hz)，4_42 (m，2H，H-51 及H-约，4·19及3.56 (d d, 1H, 1H, 8a-CH2, J=9.6 Hz), 3.65 (m, 1H, H-2'), 2.63 (t, 1H, H-l, J=3.9 Hz), 2.36 (m, 1H, CH(CH3)2); ά CDCI3): 204.7 (CHO), 175.0 (C02H), 148.5 (C-3), 145,6 (C-4-), 130.5 (C-2), 112.1 (CH2=C), 99.5 (C-l'), 74.0 (8a-CH2), 73.0 (C-5’），72.8 (C-3a)，72.2及71.6 (C-2'及C-3，）。 實例6 4 -206- 本紙張尺度逍用中國國家揉準（CNS ) A4規格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁)</span>Printed by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 ____B7 V. Description of Invention (203) 202.9 (CO-4 '), 176.2 (C02H), 148.2 (C-3), 130.9 (C-2), 96.1 (C -Γ), 76.6 (C-5 '), 74.7 (8aCH2), 72.1 (C-3a), 65.7 (C-8a), 58.9 (C-4), 54.2 and 53.5 (C-2, and C-3 '), 46.1 (Cl), 41.8 (C-4a), 41.3 (C_7a). Example 6 3 [1R- (1 a, 3a0, 4 / ?, 4ay ?, 7 / ?, 7aa, 8ay5)] 8a-[(2,3-anhydro-4,6-dideoxy-4-methylene -BD-piperanmannosyloxy) methyl-4-methyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (l- Methylethyl) -l, 4 · methylene-s · '* 5 ~ 3a (lH) -carboxylic acid, intermediate 101 (0.17 mmol) in methane (15 ml) The solution was treated with trifluoroacetic acid (0.15 ml) at 0 ° C. After two hours, treat with water (10 mL). The organic phase was evaporated and the residue was dissolved in ethanol (15 ml) and 1 equivalent of hydrochloric acid (1.5 ml) and stirred at 0 ° C for 2 hours. The solvent was removed, and the residue was purified using dichloromethane: methanol 20: 1 as the eluent. Evaporate the appropriate fraction to obtain the title compound (24 mg). (ί CDC13): 9.75 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J = 1.2 «.3Hz), 5.2 (^ 5.10 (s, s, lH, lH, CH2 = C), 4.82 (d, 1H, Hl, J = 2.1 Hz), 4_42 (m, 2H, H-51 and H-approximate, 4.19 and 3.56 (dd, 1H, 1H, 8a-CH2, J = 9.6 Hz), 3.65 (m, 1H, H-2 '), 2.63 (t, 1H, Hl, J = 3.9 Hz), 2.36 (m, 1H, CH (CH3) 2); ά CDCI3): 204.7 (CHO), 175.0 ( C02H), 148.5 (C-3), 145,6 (C-4-), 130.5 (C-2), 112.1 (CH2 = C), 99.5 (C-l '), 74.0 (8a-CH2), 73.0 (C-5 '), 72.8 (C-3a), 72.2 and 71.6 (C-2' and C-3,). Example 6 4 -206- This paper scale is easy to use China National Standard (CNS) A4 specification ( 210X297mm) (Please read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 B7 ^^1644 五、發明説明（2〇4) [1R-(1 a，3a冷，4冷，4aA，7卢，7aa，8a/? )]8a-(2,3-脱水 ΙΟ-二級丁基叛基-6-去氧-b-D-味喃塔 羅糖基氧基） 曱基 ·4_ 甲醯基-4,4a，5,6,7,7a,8,8a-八氫-7 -甲基-3-(1-甲基乙基） -1,4 -亞甲基- s-4噠省- 3a(lH) -羧酸 將中間體103(0.1毫莫耳）於水（2毫升）内之溶液於〇。〇以三 氟酷酸（3毫升）處理。90分鐘後將此混合物倒入乙醚：水1 :1 (3 0毫升）内。將有機相蒸發，殘餘物作色層分析純化， 用一氣甲烷：甲醇40 : 1作洗離劑，製得標題化合物（32毫 克）。 ^ (!H, CDC13): 9.77 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=1.5&amp;amp;3.6Hz)，4.75(dd,lH，H-4,，J=3.6&amp;amp;4.8Hz),4.68(s, 1H, Η-Γ), 4.17 (d, 1H, 8a-CHa, J=9.3 Hz), 3.66 (m, 2H, 8a- CHb及H-5')，3.57 (t, 1H, H-3'，J=4.2 Hz), 3_17 (d，1H，H-2', J=3.6 Hz), 2.73 (t, 1H, H-l, J=3.9 Hz), 2.33 (m, 1H, cll(CH3)2);(y(13C，CDCl3 ):204.8(CHO)，m.5&amp;amp;175.7(2 XC02), 148.3 (C-3), 130.8 (C-2), 97.9 (C-l'), 74.1 (8a-CH2), 73.0 (C-3a), 71.5 (C-5'), 66.0 (C-4'&amp;gt;, 65.6 (C-8a), 59.0 (C-4), 51_3 (C-2-), 50.7 (C-3，）。 實例6 5 .</span>A7 B7 ^^ 1644 V. Description of the invention (2〇4) [1R- (1 a, 3a cold, 4 cold, 4aA, 7 Lu, 7aa, 8a /?)] 8a- (2,3-dehydrated ΙΟ- 二Grade butyl benzyl-6-deoxy-bD-pyrantalosyloxy) methyl · 4_ carboxyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7 -Methyl-3- (1-methylethyl) -1,4-methylene-s-4pyridine-3a (lH) -carboxylic acid Intermediate 103 (0.1 mmol) in water (2 Ml) in the solution. 〇Treat with trifluoroacid (3 ml). After 90 minutes, the mixture was poured into ether: water 1: 1 (30 ml). The organic phase was evaporated and the residue was chromatographed and purified using one gas methane: methanol 40: 1 as the eluent to obtain the title compound (32 mg). ^ (! H, CDC13): 9.77 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J = 1.5 &amp;amp; 3.6Hz), 4.75 (dd, lH, H-4 ,, J = 3.6 &amp;amp; 4.8Hz), 4.68 (s, 1H, Η-Γ), 4.17 (d, 1H, 8a-CHa, J = 9.3 Hz), 3.66 (m, 2H, 8a-CHb and H-5 '), 3.57 (t, 1H, H-3 ', J = 4.2 Hz), 3_17 (d, 1H, H-2', J = 3.6 Hz), 2.73 (t, 1H, Hl, J = 3.9 Hz), 2.33 (m , 1H, cll (CH3) 2); (y (13C, CDCl3): 204.8 (CHO), m.5 &amp; 175.7 (2 XC02), 148.3 (C-3), 130.8 (C-2), 97.9 (C -l '), 74.1 (8a-CH2), 73.0 (C-3a), 71.5 (C-5'), 66.0 (C-4 '&amp;gt;, 65.6 (C-8a), 59.0 (C-4), 51_3 (C-2-), 50.7 (C-3,) Example 6 5.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[1R-(1 a，3a/?，4/?，4ay5，7卢，7aa，8ay5 )]8a-{[2,3 -賊水- 4_ 〇-(反式-2-丁締基）-6 -去氧-b-D-喊喃甘露糖基氧基）¥奉} -4 -甲醯基-4,4a，5，6,7,7a，8,8a-八氫-7 -甲基- 3-(1-甲基 乙基）-1,4-亞甲基-s-4丨噠省-3a(lH)-羧酸 將中間體47(103毫克）於二氣甲烷（5毫升）内之溶液於〇。〇 -207- 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） (请先聞讀背面之注意事項再填寫本頁) 、11- 經濟部中央標隼局員工消费合作社印製 A7 B7 五、發明説明（205) 以三氟醋酸（100微升）處理。一小時後，此混合物於醋酸乙 酯（50毫升）及飽和硫酸鈉水溶液（50毫升）間分開。有機層 用飽和硫酸鈉水溶液，水及鹽水洗，然後乾燥並蒸發。殘 餘物於二氧化矽膠上作色層分析二次，用己烷：醋酸乙酯 (2 : 1)至（1 : 1)洗離，製得標題化合物（50毫克）。 (ί 〇n, CDC13)： 9.76 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=l.5及3.6 Hz), 5.82-5.68 (m，1H, C|i=CH)，5.62-5.48 (m， 1H, CH=CH), 4.72 (s, 1H, Η-Γ), 4.2-4.1 (m, 2H, O-CHa-C=C及8a-CHa), 4.02-3.92 (m, 1H, OCHb-C=C)，3.63 (d，1H， 8a-CHb，J=9.3 Hz), 3.3-3.15 (m，3H，H-3’，H-4’及tU)，3.12 (d, 1H, H-2', J-3.9 Hz), 2.73 (t, 1H, H-l, J=3.9 Hz), 1.72 (dd, 3H, H3C-C=C, J=1.2及6.6 Hz); d(13C, CDC13): 204.8 (CHO)，175.6 (C02H)，148.2 (C-3), 130.8 (C-2), 131.1 及 126.6 (0-CH2-C=C-CH3), 97.9 (C-l'), 74.2(8a-CH2), 71.2 (0-£H2-C=C-CH3)，73.5&amp;amp;72.5(C-4H5')。 實例6 6 經濟部中央揉準局WC工消费合作社印製 (請先閱讀背面之注意Ϋ項再填寫本頁) [1R-(1 a，3ay9，4y5，4a々，7万，7aa，8a0 )]8a-(2,3-脱水-6-去氧- 4- 0-丙基-b-D -哌喃甘露糖基氧基）曱基-4 -甲醯基_ 4,4&amp;amp;，5,6,7,7壮，8,8&amp;amp;-八氣-7-曱基-3-(1-甲基乙基）_1，4-亞曱基-s-啕噠省-3a(lH)-羧酸 於中間體104 ( 150毫克，0.21毫莫耳）於乙醇（50毫升）， 醋酸乙酯（10毫升）及1N鹽酸（1毫升）内之溶液中，於氮氣 下加10 %鈀/碳（30毫克）。此混合物於帕爾裝置内 (pH2 = 3 5磅/吋2)於室溫搖動3.5小時。濾除催化劑，蒸發 -208- 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） 321644 五、發明説明（2〇6) 去溶劑至乾。殘餘物作色層分析純化，用二氣甲燒：甲醇 : 1作洗離劑，製得標題化合物（6〇毫克）。 ^ On, CDC13): 9.83 (s, 1H, CHO), 6.06 (dd, 1H, H-2, J-1.2^3.6 Hz), 4.75 (s, 1H, H-l'), 4.44A3.42 (dd, 2H, 8a- CH2, J=9.3 Hz)，4.37 (t，1H，H-31，J=2.7 Hz)，4.10 (m，1H, H-4'), 3.74-3.65 (m, 2H, CH20), 3.91 (m, 1H, H-5'), 3.19 (m, 1H, H 2 ), 2.51 (t, 1H, H-l, J=3.6 Hz); δ (13C, CDC13)· (CHO), 174.9 (C02H), 148.6 (C-3), 130.4 (〇-2), 97.9 (C-r)，78.7 (C-4，），73.9(8a-CH2)，73.3 (CH2〇)，69.8 (c_5，）， 69.3 (C-3’），65.3 (C-8a)，59.0 (C-4)，54.6 (C-2')，47.0 (c-l) o 實例67 «，3a万，4万，4a点，7点，7aa，8ay5 )]8^(2,3_脱水-4-疊氮基-4,6 -二去氧_b-D-略喃甘露糖基氧基）甲基_4_甲醯 基 4,4a,5,6,7,7a，8,8a -八.氮-7-甲基-3-(l_甲基乙基）_ 1，4 -亞甲基_s -吲噠省_3a(1H)_羧酸 將中間體106(0.06毫莫耳）於二氣曱烷（5毫升）内之溶液於 〇 c以三氟醋酸（70微升）處理。2小時後，用水及藥水洗。 蒸發去溶劑，殘餘物作色層分析純化，用二氣曱烷：肀婷 3〇 : 1作洗離劑，製得標題化合物（12毫克）。 ^ CDCI3): 9.73 (s, 1H, CHO), 6.09 (d, 1H, H-2, J&amp;quot;3·6</span>[1R- (1 a, 3a / ?, 4 / ?, 4ay5, 7 Lu, 7aa, 8ay5)] 8a-{[2,3 -thiazin-4_ 〇- (trans-2-butenyl)- 6 -deoxy-bD-mannanosyloxy) ¥ Feng} -4 -Methyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3 -(1-Methylethyl) -1,4-methylene-s-4, Provincial-3a (lH) -carboxylic acid, and intermediate 47 (103 mg) in methane (5 mL) Solution in 〇. 〇-207- This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297mm) (please read the notes on the back before filling out this page), 11- A7 printed by the Employee Consumer Cooperative of the Central Standard Falcon Bureau of the Ministry of Economic Affairs B7 5. Description of the invention (205) Treat with trifluoroacetic acid (100 microliters). After one hour, the mixture was separated between ethyl acetate (50 ml) and saturated aqueous sodium sulfate (50 ml). The organic layer was washed with saturated aqueous sodium sulfate, water and brine, then dried and evaporated. The residue was chromatographed twice on silica gel and washed away with hexane: ethyl acetate (2: 1) to (1: 1) to obtain the title compound (50 mg). (ί 〇n, CDC13): 9.76 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 5.82-5.68 (m, 1H, C | i = CH ), 5.62-5.48 (m, 1H, CH = CH), 4.72 (s, 1H, Η-Γ), 4.2-4.1 (m, 2H, O-CHa-C = C and 8a-CHa), 4.02-3.92 (m, 1H, OCHb-C = C), 3.63 (d, 1H, 8a-CHb, J = 9.3 Hz), 3.3-3.15 (m, 3H, H-3 ', H-4' and tU), 3.12 (d, 1H, H-2 ', J-3.9 Hz), 2.73 (t, 1H, Hl, J = 3.9 Hz), 1.72 (dd, 3H, H3C-C = C, J = 1.2 and 6.6 Hz); d (13C, CDC13): 204.8 (CHO), 175.6 (C02H), 148.2 (C-3), 130.8 (C-2), 131.1 and 126.6 (0-CH2-C = C-CH3), 97.9 (C- l '), 74.2 (8a-CH2), 71.2 (0- £ H2-C = C-CH3), 73.5 &amp;amp; 72.5 (C-4H5'). Example 6 6 Printed by the WC Industrial Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs (please read the note Ϋ on the back before filling in this page) [1R- (1 a, 3ay9, 4y5, 4a々, 70,000, 7aa, 8a0) ] 8a- (2,3-anhydro-6-deoxy-4-O-propyl-bD-piperanmannosyloxy) methyl-4-carboxyl_4,4 &amp;amp;, 5,6, 7,7 strong, 8,8 &amp;amp; -octaqi-7-methyl-3- (1-methylethyl) _1,4-methylidene-s-pyridine-3a (lH) -carboxylic acid Intermediate 104 (150 mg, 0.21 mmol) in ethanol (50 ml), ethyl acetate (10 ml) and 1N hydrochloric acid (1 ml) was added 10% palladium / carbon (30 mg) under nitrogen ). This mixture was shaken at room temperature for 3.5 hours in a Parr device (pH 2 = 35 psi). Filter out the catalyst and evaporate -208- This paper scale applies the Chinese National Standard (CNS) A4 specification (210X297mm) 321644 V. Description of the invention (2〇6) Remove the solvent to dryness. The residue was chromatographed and purified using two-gas methane: methanol: 1 as the eluent to obtain the title compound (60 mg). ^ On, CDC13): 9.83 (s, 1H, CHO), 6.06 (dd, 1H, H-2, J-1.2 ^ 3.6 Hz), 4.75 (s, 1H, H-l '), 4.44A3.42 ( dd, 2H, 8a- CH2, J = 9.3 Hz), 4.37 (t, 1H, H-31, J = 2.7 Hz), 4.10 (m, 1H, H-4 '), 3.74-3.65 (m, 2H, CH20), 3.91 (m, 1H, H-5 '), 3.19 (m, 1H, H 2), 2.51 (t, 1H, Hl, J = 3.6 Hz); δ (13C, CDC13) (CHO), 174.9 (C02H), 148.6 (C-3), 130.4 (〇-2), 97.9 (Cr), 78.7 (C-4,), 73.9 (8a-CH2), 73.3 (CH2〇), 69.8 (c_5,) , 69.3 (C-3 '), 65.3 (C-8a), 59.0 (C-4), 54.6 (C-2'), 47.0 (cl) o Example 67 «, 30 million, 40 thousand, 4a points, 7 Point, 7aa, 8ay5)] 8 ^ (2,3_anhydro-4-azido-4,6 -dideoxy_bD-pyranomannosyloxy) methyl_4_carboxamyl 4, 4a, 5,6,7,7a, 8,8a -octa-nitrogen-7-methyl-3- (l_methylethyl) _ 1,4-methylene_s-indap province_3a ( 1H) _carboxylic acid A solution of intermediate 106 (0.06 mmol) in methane (5 ml) was treated with trifluoroacetic acid (70 μl) at 0 c. After 2 hours, wash with water and medicine. The solvent was evaporated, and the residue was purified by chromatographic analysis, using dichloromethane: Tingting 30: 1 as the eluent to obtain the title compound (12 mg). ^ CDCI3): 9.73 (s, 1H, CHO), 6.09 (d, 1H, H-2, J &amp;quot; 3 · 6</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz)，4.73 (s，1H, H-l')，4.12及3.67 (d，d，1H, 1H，8a-CH2， 卜9叫，3.39((1，111，11-4，，卜9 112)，3.33及3.17((1，£1，1»， 1H，H-2'及H-3’，J=3.6 Hz)，3.22 (m, 1H，H-5’)，2.76 (t, l11， -209 私紙張尺度逍用中國國家標準（CNS ) A4規格（210X 297公釐） (請先閲讀背面之注意事項再填寫本頁) 訂 九 ! 經濟部中央揉準局貝工消费合作社印製 A7 B7 五、發明説明（2〇7) H-l, J=3.6 Hz), 2.34 (m, 1H, CH(CH3)2); ^(13C, CDC13): 205.1 (CHO), 175.3 (C02H), 148.4 (C-3), 130.8 (C-2), 97.8 (C-l'), 74.6(8a-CH2), 72.7 (C-5'), 68.0 (C-3a), 65.7 (C-8a), 59.0 (C-4), 58.7 (C-4'), 54.4 (C-2'), 50.1 (C-3'), 46.3 (C-l) o 實例6 8 [1R-(1 a，3a々，4点，4ay5 ,7y5 ,7aa，8a；5 )]8a-[(4-0-烯丙基-2,3 -脱水-6-去氧- b- D-&amp;gt;»底喃甘露糖基）氧基-甲基]-4·甲酿 基- 4,4a，5,6,7,7a，8,8a-八氫-7-曱基-3·(l-甲基乙基）-l，4-亞甲基-s-II5丨噠省-3a(lH)-羧酸 將中間體107(250毫克）於10毫升二氣甲烷及0.2毫升三氟 醋酸混合物内之溶液於〇°C挽拌4小時。將粗製物蒸發至乾 ，殘餘物作閃色層分析純化，用二氣甲烷：曱醇5 0 : 1作 洗離劑，製得140毫克標題化合物，爲白色泡沫。 e Gh，CDC13): 9.77 (s，1H，CHO)，6.08 (dd，1H，H-12， J=1.2及3.3 Hz)，5.90 (m, 1H, CH=CH2)，5.28 (m, 2H, CH=CH2), 4.75 (s, 1H, H-l'), 4.28 (m, 1H, H-5'), 4.21 (d, 經濟部中央標準局貝工消費合作社印裝 (請先閲讀背面之注意事項再填寫本頁) 1H, H-19a, J=9.6 Hz), 4.05 (m, 1H, H-4'), 4.05 (m, 1H, H-4'), 3.60 (d, 1H, H-19b, J=9.6 Hz), 3.27, 3.14 (d, d, 1H, 1H, H-2', H-3，，J=3.9 Hz)，3.25 (m，2H, Cii2-CH=CH2)，2.68 (t, 1H， H-ll, J=4.2 Hz); c^(13C, CDC13): 205.07 (CHO), 174.6 (C〇2H), 148.4 (C-13), 133.7 (CH=CH2), 129.7 (C-12), 118.0 (CH2=CH), 97.8 (C-Γ), 74.17 (C-19), 74.04 (C-4'), 72.5 (C-5'), 71.0 (0-CH2-CH=CH2), 54.1 (C-2'), 50.2 (C-3'), -210- 本紙張尺度逍用中國國家標準（CNS ) A4規格（210X297公釐） 經濟部中央標準局貝工消費合作社印裂 A7 B7 五、發明説明（2〇8) 27.5 (C-14), 22.7 (C-20), 21.2 (C-15), 18.6 (C-6'), 17.4 (C-17)。 實例69 [111-(1£^，3&amp;amp;卢，4々，43卢，7；9,7&amp;amp;«，8&amp;amp;/?)]8&amp;amp;-[(2,3-脱水-6-去氧-4-0-三級丁氧羰基甲基-b-D-哌喃甘露糖基）氧基-曱 基]-4_ 甲醯基-4,4还，5,6,7,7&amp;amp;，8,83-八氫-7-甲基-3-(1-甲 基乙基）-1,4 -亞甲基- s- μ丨噠省_3a(iH) -羧酸 於中間體21(200毫克）於15毫升無水THF内之溶液中於〇 °(：加30毫克氫化鈉。此混合物於〇°C在氮氣下攪拌3〇分鐘 。然後加260微升三級丁基溴醋酸酯，此混合物於在氮氣下 於室溫攪拌3天。粗製物用丨當量氣化銨及醋酸乙酯處理。 有機層用水及鹽水洗’蒸發至乾。殘餘物以標準方法氫化 ，粗製物再作閃色層分析純化，用二氣甲燒：甲醇5〇 : 1 作洗離劑，製得140毫克標題化合物，爲白色泡沫。 δ (]H, CDC13): 9.74 (s, 1H, CHO), 6.08 (dd, 1H, H-12, J=l_5及3_9 Hz), 4_74 (s, 1H, H-l1)，4.21 (dd，1H, H-4，，J=3.6 &amp;amp;6.0Hz),4.16(d，lH，H-19a，J=9Hz),4.12(s，2H，C||2· C02C(CH3)3), 3.63 (d, 1H, H-19b, J=9 Hz), 3.36, 3.14 (d, d, 1H, 1H, H-2', H-3', J=3.9 Hz), 3.30 (m, 1H, H-5'), 2.71 (t, 1H, H-ll, J=3.9 Hz); S (13C, CDC13): 205.7 (CHO), 174.9 (C02C(CH3)3), 168.8 (C02H), 148.4 (C-13), 130.8 (C-12), 97.8 (C-Γ), 82.2 (C(CH3)3), 75.6(C-4'), 72.4 (C-5'), 68.2 (OCH2-CO), 59.0 (C-3), 53.9 (C-2'), 50.3 (C-3'), 27.5 (C- 14)，22.7 (C-20)，21.2 (C-15), 18.6 (C-6')，17.4 (C-17)。 •211 - 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部中央揉準局貝工消費合作社印袋 A7 B7 五、發明説明（2〇9) 實例70 [1R-(1 a，3a点，4 0，4a々，7y9,7aQ^,8a/3)]8a-[(2,3-脱水-6_ 去氧_4-0-乙基-b-D-哌喃甘露糖基）氧基_甲基]_4_甲醯基 -4,4&amp;amp;，5,6,7,7&amp;amp;，8,8已-八氫-7_曱基-3_(1-甲基乙基）-1，4-亞甲基-s-M丨噠省_3a(lH)-幾酸 於中間體21(290毫克）於5毫升無水二甲基甲醯胺内之溶 液中於0C在氮氣下加25毫克氫化鈉。將此混合物於〇。匸攪 拌30分鐘，然後加1毫莫耳乙基碘。於室溫攪拌16小時後 反應即完全。粗製物用1當量氣化銨及醋酸乙酯處理。有機 層用水及鹽水洗，於無水硫酸鎂上蒸發至乾。殘餘物以標 準方法氫化，粗製物再作閃色層分析純化，用二 甲醇50 : 1作洗離劑，製得180毫克標題化合 . 馬白色泡 沫。 ^ (lU, CDC13): 9.73 (s, 1H, CHO), 6.08 (dd, 1H, H-l2 J=3.3 Hz), 4.73 (s, 1H, H-l'), 4.16 (d, 1H, H-19a, J=9 3.78, 3.54 (m，m, 1H，1H，0-Cii2-CH3)，3.63 (s，;H，H l9:， J=9.3 Hz), 3.25, 3.13 (d, d, 1H, 1H, H-2', H-3', j=3 9 3.19 (m，2H，H-4，，H-5，），2.71 (t，1H，H-ll，j=3 3 h HZ)’ (13C，CDC13): 201.8 (CHO)，175.0 (C02H)，148.2 (^’i3^ 130.7 (C-12)，97.9 (C-l’），74.6(C-4，），74.3 (C_19)，72 5 ， 5'), 54.3 (C-2'), 50.3 (C-3'), 27.5 (C-14), 22.7 (0-20^2 (C-15), 18.6 (C-6')，17.4 (C-17)。 ’ · 實例7 1 [1R-(1 « ,3&amp;amp;β ,4β ,4a^ ,1 β ,7a or ,8ay3 ) 1 8 a - Γ r ? 〇 L3 -脱水-6 - 212- 衣紙張尺度適用中國國家揉準（CNS ) A4規格（210X297公釐） (请先閱讀背面之注意1f項再填寫本育)</span>Hz), 4.73 (s, 1H, H-l '), 4.12 and 3.67 (d, d, 1H, 1H, 8a-CH2, Bu 9 called, 3.39 ((1, 111, 11-4, Bu 9 112 ), 3.33 and 3.17 ((1, £ 1, 1 », 1H, H-2 'and H-3', J = 3.6 Hz), 3.22 (m, 1H, H-5 '), 2.76 (t, l11 , -209 The private paper size is free to use the Chinese National Standard (CNS) A4 specification (210X 297mm) (please read the notes on the back before filling this page) Order nine! Printed by the Beigong Consumer Cooperative of the Ministry of Economic Affairs A7 B7 5. Description of the invention (2〇7) Hl, J = 3.6 Hz), 2.34 (m, 1H, CH (CH3) 2); ^ (13C, CDC13): 205.1 (CHO), 175.3 (C02H), 148.4 (C-3), 130.8 (C-2), 97.8 (C-l '), 74.6 (8a-CH2), 72.7 (C-5'), 68.0 (C-3a), 65.7 (C-8a), 59.0 (C-4), 58.7 (C-4 '), 54.4 (C-2'), 50.1 (C-3 '), 46.3 (Cl) o Example 6 8 [1R- (1 a, 3a々, 4 Point, 4ay5, 7y5, 7aa, 8a; 5)] 8a-[(4-0-allyl-2,3-dehydrate-6-deoxy-b-D- &amp;gt; »mannan glycosyl) oxygen -Methyl] -4 · methylamino-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3 · (l-methylethyl) -1,4 -Methylene-s-II5-da-3a (lH) -carboxylic acid, intermediate 107 (250 mg) in 10 ml di The solution in a mixture of methane and 0.2 ml of trifluoroacetic acid was stirred at 0 ° C for 4 hours. The crude material was evaporated to dryness, and the residue was purified by flash chromatography. It was washed away with methane: methanol 50: 1. Preparation, to obtain 140 mg of the title compound as a white foam. E Gh, CDC13): 9.77 (s, 1H, CHO), 6.08 (dd, 1H, H-12, J = 1.2 and 3.3 Hz), 5.90 (m, 1H, CH = CH2), 5.28 (m, 2H, CH = CH2), 4.75 (s, 1H, H-l '), 4.28 (m, 1H, H-5'), 4.21 (d, Ministry of Economic Affairs Central Standard Printed by Bureau Cooper Consumer Cooperative (please read the notes on the back before filling in this page) 1H, H-19a, J = 9.6 Hz), 4.05 (m, 1H, H-4 '), 4.05 (m, 1H, H-4 '), 3.60 (d, 1H, H-19b, J = 9.6 Hz), 3.27, 3.14 (d, d, 1H, 1H, H-2', H-3, J = 3.9 Hz), 3.25 (m, 2H, Cii2-CH = CH2), 2.68 (t, 1H, H-ll, J = 4.2 Hz); c ^ (13C, CDC13): 205.07 (CHO), 174.6 (C〇2H), 148.4 (C-13), 133.7 (CH = CH2), 129.7 (C-12), 118.0 (CH2 = CH), 97.8 (C-Γ), 74.17 (C-19), 74.04 (C-4 '), 72.5 (C-5 '), 71.0 (0-CH2-CH = CH2), 54.1 (C-2'), 50.2 (C-3 '), -210- This paper scale uses the Chinese National Standard (CNS) A4 specifications (210 X297 mm) A7 B7 printed by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of Invention (2〇8) 27.5 (C-14), 22.7 (C-20), 21.2 (C-15), 18.6 (C -6 '), 17.4 (C-17). Example 69 [111- (1 £ ^, 3 &amp;amp; Lu, 4々, 43 Lu, 7; 9,7 &amp;amp; «, 8 &amp;amp; /?)] 8 &amp;amp;-[(2,3-anhydro-6-deoxy- 4-0-tertiary butoxycarbonylmethyl-bD-piperanmannosyl) oxy-methyl] -4_carboxyl-4,4 also, 5,6,7,7 &amp;amp;, 8,83- Octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-μ-soda_3a (iH) -carboxylic acid in intermediate 21 (200 mg) in To a solution in 15 ml of anhydrous THF at 0 ° (: add 30 mg of sodium hydride. This mixture was stirred at 0 ° C under nitrogen for 30 minutes. Then 260 μl of tertiary butyl bromoacetate was added and this mixture was added at Stir at room temperature for 3 days under nitrogen. The crude material is treated with equivalent vaporized ammonium and ethyl acetate. The organic layer is washed with water and brine and evaporated to dryness. The residue is hydrogenated by standard methods and the crude material is purified by flash chromatography , Using two gas methane: methanol 50: 1 as the eluent, to obtain 140 mg of the title compound as a white foam. Δ (] H, CDC13): 9.74 (s, 1H, CHO), 6.08 (dd, 1H , H-12, J = l_5 and 3_9 Hz), 4_74 (s, 1H, H-l1), 4.21 (dd, 1H, H-4 ,, J = 3.6 &amp; 6.0 Hz), 4.16 (d, lH, H-19a, J = 9Hz), 4.12 (s, 2H, C | | 2 · C02C (CH3) 3), 3.63 (d, 1H, H-19b, J = 9 Hz), 3.36, 3.14 (d, d, 1H, 1H, H-2 ', H-3', J = 3.9 Hz), 3.30 (m, 1H, H-5 '), 2.71 (t, 1H, H-ll, J = 3.9 Hz); S (13C, CDC13): 205.7 (CHO), 174.9 (C02C (CH3) 3), 168.8 (C02H), 148.4 (C-13), 130.8 (C-12), 97.8 (C-Γ), 82.2 (C (CH3) 3), 75.6 (C-4 '), 72.4 (C- 5 '), 68.2 (OCH2-CO), 59.0 (C-3), 53.9 (C-2'), 50.3 (C-3 '), 27.5 (C-14), 22.7 (C-20), 21.2 ( C-15), 18.6 (C-6 '), 17.4 (C-17). • 211-This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297mm) (please read the notes on the back before filling in This page) Order the A7 B7 printed bag of the Beigong Consumer Cooperative of the Central Kneading Bureau of the Ministry of Economy V. Description of the invention (2〇9) Example 70 [1R- (1 a, 3a point, 4 0, 4a々, 7y9, 7aQ ^, 8a / 3)] 8a-[(2,3-anhydro-6_deoxy_4-0-ethyl-bD-piperanmannosyl) oxy_methyl] _4_carmidyl-4,4 &amp;amp; , 5,6,7,7 &amp;amp;, 8,8-octahydro-7_methyl-3_ (1-methylethyl) -1,4-methylene-sM Shuda province_3a (lH) -Add a few acids to a solution of intermediate 21 (290 mg) in 5 ml of anhydrous dimethylformamide at 0C under nitrogen and add 2 5 mg sodium hydride. Place this mixture at 0. After stirring for 30 minutes, 1 millimolar ethyl iodide was added. The reaction was complete after stirring at room temperature for 16 hours. The crude product was treated with 1 equivalent of gasified ammonium and ethyl acetate. The organic layer was washed with water and brine, and evaporated to dryness on anhydrous magnesium sulfate. The residue was hydrogenated by standard methods, and the crude product was further purified by flash chromatography. Using dimethanol 50: 1 as the eluent, 180 mg of the title compound was obtained. Horse white foam. ^ (lU, CDC13): 9.73 (s, 1H, CHO), 6.08 (dd, 1H, H-l2 J = 3.3 Hz), 4.73 (s, 1H, H-l '), 4.16 (d, 1H, H -19a, J = 9 3.78, 3.54 (m, m, 1H, 1H, 0-Cii2-CH3), 3.63 (s ,; H, H l9 :, J = 9.3 Hz), 3.25, 3.13 (d, d, 1H, 1H, H-2 ', H-3', j = 3 9 3.19 (m, 2H, H-4 ,, H-5,), 2.71 (t, 1H, H-ll, j = 3 3 h HZ) '(13C, CDC13): 201.8 (CHO), 175.0 (C02H), 148.2 (^' i3 ^ 130.7 (C-12), 97.9 (C-l '), 74.6 (C-4,), 74.3 ( C_19), 72 5, 5 '), 54.3 (C-2'), 50.3 (C-3 '), 27.5 (C-14), 22.7 (0-20 ^ 2 (C-15), 18.6 (C- 6 '), 17.4 (C-17).' Example 7 1 [1R- (1 «, 3 &amp;amp; β, 4β, 4a ^, 1 β, 7a or, 8ay3) 1 8 a-Γ r? 〇L3- Dewatering-6-212- Apparel paper size applies to China National Standard (CNS) A4 specification (210X297mm) (please read note 1f on the back before filling in this education)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央揉準局貝工消費合作社印製 ^21644 at B7 五、發明説明（2， 去氧- 4- 0- (2,3 -二羥基丙基）-b-D -哌喃甘露糖基）氧基_甲 基]]·4 -甲醯基-4，4a,5,6,7,7a,8,8a-八氫-7 -甲基-3-(卜 甲基乙基）-1,4-亞曱基-s-η丨噠省_3a(lH)-羧酸 於中間體108(700毫克）於乙醇（1〇〇毫升）内之溶液中在氮 氣下加10%鈀/碳（350毫克）。此混合物於帕爾裝置内 (pH2 = 25磅/吋2)在室溫搖動i小時。濾除催化劑，蒸發去 溶劑至乾。殘餘物於二氧化矽膠柱上純化，用二氣甲烷及 二氣甲烷：甲醇（25 : 1)作洗離劑，製得425毫克標題化合 物（50 : 50異構物混合物），爲白色粉。 CDC13): 9.75 (s, 1H, CHO), 6.08 (dd, 1H, H-12, J=1.2&amp;amp;3.6Hz)，4.73(s，lH，H-r)，3.98(d，lH，H-19a，J=9.6</span>Printed by Beigong Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs ^ 21644 at B7 5. Description of the invention (2, deoxy-4-0- (2,3-dihydroxypropyl) -bD-pipermannosyl) oxy Yl_methyl]] · 4-methylformyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (p-methylethyl) -1,4-methylene To a solution of methyl-s-η-da provincial_3a (lH) -carboxylic acid in intermediate 108 (700 mg) in ethanol (100 mL) was added 10% palladium / carbon (350 mg) under nitrogen . This mixture was shaken at room temperature for 1 hour in a Parr device (pH 2 = 25 psi). The catalyst was filtered off and the solvent was evaporated to dryness. The residue was purified on a silica gel column, using methane and methane: methanol (25: 1) as the eluent to prepare 425 mg of the title compound (50:50 isomer mixture) as a white powder. CDC13): 9.75 (s, 1H, CHO), 6.08 (dd, 1H, H-12, J = 1.2 &amp;amp; 3.6Hz), 4.73 (s, lH, Hr), 3.98 (d, lH, H-19a, J = 9.6</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 3.81 (d, 1H, H-19b, J=9.6 Hz), 3.81-3.68 (m, 2H,-OCi^-CHOH in C-4'), 3.55-3.31 (m, 3H, -CHOH-CI^OH in C-4'), 3.30-3.11 (m, 4H, H-2', H-3', H-4', H-5'), 2.76 (t, 1H, H-ll, J=3.6 Hz); d(13C, CDC13): 207.70 (CHO), 178.2 (C02H)，150.49 (C-13)，131.44 (C-12)，99.81 (C-l1)，77.07及 76.96 (CH-CH2OH in C-4'), 76.57 (C-19), 73.55 (C-4'), 72.86及72_69 (O-C^-CHOH in C-4，），72.24 (C-5，），55.01 (C-31), 51.89 (C-21), 23.2 (C-20), 21.6 (C-15), 19.4 (C-61), 17.9 (C-17)。 實例72 [1R-(1 a，3a/? ,4々，4a/? ,7y5 ,7aa，8a々）]8a-[(2,3-脱水-6-去氧-4-0-(2,3-二甲氧基丙基）-b-D-哌喃甘露糖基）氧基-甲基]-4 -甲醯基-4,4a,5,6,7,7a，8,8a-八氫-7-甲基-3-(l- -213- 本紙張尺度適用中國國家標準（CNS ) A4規格（210X297公釐） (请先閲讀背面之注意事項再填寫本頁〕</span>Hz), 3.81 (d, 1H, H-19b, J = 9.6 Hz), 3.81-3.68 (m, 2H, -OCi ^ -CHOH in C-4 '), 3.55-3.31 (m, 3H, -CHOH- CI ^ OH in C-4 '), 3.30-3.11 (m, 4H, H-2', H-3 ', H-4', H-5 '), 2.76 (t, 1H, H-ll, J = 3.6 Hz); d (13C, CDC13): 207.70 (CHO), 178.2 (C02H), 150.49 (C-13), 131.44 (C-12), 99.81 (C-l1), 77.07 and 76.96 (CH-CH2OH) in C-4 '), 76.57 (C-19), 73.55 (C-4'), 72.86 and 72_69 (OC ^ -CHOH in C-4,), 72.24 (C-5,), 55.01 (C-31 ), 51.89 (C-21), 23.2 (C-20), 21.6 (C-15), 19.4 (C-61), 17.9 (C-17). Example 72 [1R- (1 a, 3a / ?, 4々, 4a / ?, 7y5, 7aa, 8a々)] 8a-[(2,3-anhydro-6-deoxy-4-0- (2, 3-dimethoxypropyl) -bD-piperanmannosyl) oxy-methyl] -4-carboxyl-4,4a, 5,6,7,7a, 8,8a-octahydro- 7-Methyl-3- (l- -213- This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央揉準局貝工消費合作社印製 A7 __B7_ 五、發明説明（211) 甲基乙基）-1，4-亞甲基-s-吲噠省- 3a(lH)-羧酸 於中間體108 (350毫克）於無水THF(20毫升）内之溶液中 於0°C在氮氣下加氫化鈉（40毫克），將此混合物攪拌30分 鐘。然後加甲基碘（0.5毫升），然後將此混合物於室溫攪拌 2天反應。粗製物用1當量氣化銨及醋酸乙酯處理。有機層 用水及鹽水洗，蒸發至乾。殘餘物以標準方法氫化，不必 如前純化即製得標題化合物（50 : 50異構物混合物），爲白 色泡沫（225毫克）。 (lU, CDC13)： 9.75 (s, 1H, CHO), 6.08 (d, 1H, H-12, J=3.3 Hz), 4.73 (d, 1H, H-l', J=1.5 Hz), 4.18 (d, 1H, H-19b, J=9 Hz)，3.62 (d，1H, H-19b, J=9 Hz)，3.48及3.47 (s, s，3H， 3H，CH2OMe, CHOMe), 3.36-3.20 (m, 4H, H-2', H-3', H-4', H-5'), 2.70 (t, 1H, H-ll, J=3.6 Hz); S〇3C, CDC13 ): 205.2 (CHO), 174.7 (C02H), 148.4 (C-ll), 130.7 (C-12), 97.9 (C- Γ), 79.0 (QHOMe in C，4')，75.6及75.7 (C-4，)，72.4 (C-5')， 71.6&amp;amp;71.5(〇gH2-CHOMeinC_4i),70.1&amp;amp;69.8(-£H2OMe in C-4，)，59.2, 57.9及57.8 (_CHOMe及-CH7OMe in C-4，)， 53.9及50.2 (C-21 &amp;amp;C-3，），22.7(C-20)，21.2(C-15)，18.6(C-6-)，17.4 (C-17)。 實例7 3 [1R-(1 a，3a^，4卢，4a 卢，70，7aa,8ay5 )]8a-[(2,3-脱水-6-去氧-4-0-[(2,3-0-異亞丙基）-2,3-二羥基丙基]-b-D-哌 喃甘露糖基）氧基-甲基]-4 -甲醯基-4,4a，5，6,7,7a,8,8a-八氫-7-曱基-3-(1-甲基乙基）-1,4-亞曱基-s-吲噠省- ___-214-__ 本紙張尺度適用中國國家梂準（CNS ) A4规格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁)</span>A7 __B7_ printed by the Beigong Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs 5. Description of the invention (211) Methyl ethyl) -1,4-methylene-s-indap province- 3a (lH) -carboxylic acid in the middle To a solution of 108 (350 mg) in anhydrous THF (20 ml) was added sodium hydride (40 mg) at 0 ° C under nitrogen, and the mixture was stirred for 30 minutes. Then methyl iodide (0.5 ml) was added, and the mixture was stirred at room temperature for 2 days to react. The crude product was treated with 1 equivalent of gasified ammonium and ethyl acetate. The organic layer was washed with water and brine, and evaporated to dryness. The residue was hydrogenated by standard methods, and the title compound (50:50 isomer mixture) was obtained as a white foam (225 mg) without purification as before. (lU, CDC13): 9.75 (s, 1H, CHO), 6.08 (d, 1H, H-12, J = 3.3 Hz), 4.73 (d, 1H, H-l ', J = 1.5 Hz), 4.18 ( d, 1H, H-19b, J = 9 Hz), 3.62 (d, 1H, H-19b, J = 9 Hz), 3.48 and 3.47 (s, s, 3H, 3H, CH2OMe, CHOMe), 3.36-3.20 (m, 4H, H-2 ', H-3', H-4 ', H-5'), 2.70 (t, 1H, H-ll, J = 3.6 Hz); S〇3C, CDC13): 205.2 (CHO), 174.7 (C02H), 148.4 (C-ll), 130.7 (C-12), 97.9 (C-Γ), 79.0 (QHOMe in C, 4 '), 75.6 and 75.7 (C-4,), 72.4 (C-5 '), 71.6 &amp;amp; 71.5 (〇gH2-CHOMeinC_4i), 70.1 &amp;amp; 69.8 (-£ H2OMe in C-4,), 59.2, 57.9 and 57.8 (_CHOMe and -CH7OMe in C-4,) , 53.9 and 50.2 (C-21 &amp; C-3,), 22.7 (C-20), 21.2 (C-15), 18.6 (C-6-), 17.4 (C-17). Example 7 3 [1R- (1 a, 3a ^, 4 Lu, 4a Lu, 70, 7aa, 8ay5)] 8a-[(2,3-anhydro-6-deoxy-4-0-[(2,3 -0-isopropylidene) -2,3-dihydroxypropyl] -bD-piperanylmannosyl) oxy-methyl] -4-methylacyl-4,4a, 5,6,7, 7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylidene-s-indap-___- 214 -__ This paper size applies to China Standard (CNS) A4 specification (210X297mm) (Please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7</span>A7</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央樣準局貞工消费合作社印装 3a(lH)-羧酸 於中間體109(250毫克）於醋酸乙酯（50毫升）内之溶液中 ，於氮氣下加10%鈀/碳（1〇〇毫克此混合物於帕爾裝置 内（pH2 20時/对2)於室溫搖動i小時。滤除催化劑，蒸發 去溶劑至乾。殘餘物作閃色層分析純化，用正己烷：醋酸 乙酯1 : 1及二氣甲烷：曱醇5〇: 1作洗離劑，製得標題化 合物（5 0 : 5 0異構物混合物）（15〇毫克），爲白色泡沫。 ό (!11, CDC13): 9.75 (s, 1H, CHO), 6.08 (dd, 1H, H-12, J=l.5及3.6 Hz)，4.71 (d，1H，Η-Γ，J=〇.9 Hz)，4.29-4.24 (m， 1H, CHOH in 4'), 4.15-4.01 (m, 3H, H-19a^-OCH2), 3.82- 3.49 (m, 4H，H-19b，OC^-CHOH-C^O), 3.29及3.13 (d，d， 1H，1H，H-2’及H-3’，J=3.9 Hz)，3.27-3.18 (m，2H，H-4iH_ 5')，2.74 (t，1H，H-ll，J=3.6 Hz)，1.41 及 1.35 (d, d，3H, 3H, 異亞丙基之（CH3)2C); (J(13C, CDC13): 204.8 (CHO)，165.7 (CO2H)，148.2(C-ll)，130.8(C-12)，97.9(C-l’），75.7&amp;amp;75.6 (-gHO-CH2OinC-4’），74.4(C-4’），72.8&amp;amp;72.4(C-5')，72.0&amp;amp; 71.6 (0-£H2-0 in C-41)，54.0及53.8 (C-3，），50.3 (C-21)，22.6 (C-20), 21.1 (C-15)，18.6 (C-61)，17.4 (C-17)。 實例74 IMI 362184之特徵 IMI 362184 爲蛛網糞殼菌（ATCC 36386, NRRL 3196)之變 種，此菌株的子囊孢子發生N-甲基-Ν’-硝基-N-亞硝基胍 謗變後即分離出。IMI 362184之特徵基本上與英國專利 1，162,027號就NRRL 3196作的説明相似，只是IMI 362184 -215- 本紙張尺度適用中國國家梂準（〇灿）八4^洛（210乂297公釐） (請先閲讀背面之注意事項再填寫本頁)</span>The Ministry of Economic Affairs Central Bureau of Samples and Services Zhengong Consumer Cooperative printed 3a (lH) -carboxylic acid in a solution of intermediate 109 (250 mg) in ethyl acetate (50 mL) and added 10% palladium / carbon ( 100 mg of this mixture was shaken at room temperature for 1 hour in a Parr device (pH 2 20 hours / pair 2). The catalyst was filtered off and the solvent was evaporated to dryness. The residue was purified by flash chromatography analysis using n-hexane: acetic acid Ethyl acetate 1: 1 and methane gas: methanol 50: 1 as the eluent to prepare the title compound (50:50 isomer mixture) (15 mg) as a white foam. Ό (! 11 , CDC13): 9.75 (s, 1H, CHO), 6.08 (dd, 1H, H-12, J = 1.5 and 3.6 Hz), 4.71 (d, 1H, Η-Γ, J = 0.9 Hz) , 4.29-4.24 (m, 1H, CHOH in 4 '), 4.15-4.01 (m, 3H, H-19a ^ -OCH2), 3.82- 3.49 (m, 4H, H-19b, OC ^ -CHOH-C ^ O), 3.29 and 3.13 (d, d, 1H, 1H, H-2 'and H-3', J = 3.9 Hz), 3.27-3.18 (m, 2H, H-4iH_5 '), 2.74 (t, 1H, H-ll, J = 3.6 Hz), 1.41 and 1.35 (d, d, 3H, 3H, isopropylidene (CH3) 2C); (J (13C, CDC13): 204.8 (CHO), 165.7 ( CO2H), 148.2 (C-ll), 130.8 (C-12), 97.9 (C-l ' , 75.7 &amp;amp; 75.6 (-gHO-CH2OinC-4 '), 74.4 (C-4'), 72.8 &amp;amp; 72.4 (C-5 '), 72.0 &amp;amp; 71.6 (0- £ H2-0 in C-41) , 54.0 and 53.8 (C-3,), 50.3 (C-21), 22.6 (C-20), 21.1 (C-15), 18.6 (C-61), 17.4 (C-17). Example 74 IMI 362184 Characteristic IMI 362184 is a variant of D. arachnidus (ATCC 36386, NRRL 3196), and the ascospores of this strain are isolated after N-methyl-Ν'-nitro-N-nitrosoguanidine. IMI The characteristics of 362184 are basically similar to the description of British Patent No. 1,162,027 on NRRL 3196, except that IMI 362184-215- The paper size is applicable to the Chinese National Standard (〇 Can) 8 4 ^ Luo (210 to 297 mm) ( (Please read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標率局貝工消费合作社印製 A7 B7 五、發明説明（213) 較NRRL 3196在相同條件下產生更多的用以生產索達啉的 4’-脱甲基索達林。 實例7 5 IMI 362947之特徵 IMI 362947爲蛛網糞殼菌（ATCC 36386, NRRL 3 196)之變 種，此菌株的子囊孢子發生N-甲基-N，-硝基-N-亞硝基胍 誘變後即分離出。IMI 362947之特徵基本上與英國專利 1，162,027號就NRRL3196作的説明相似，只是IMI 362947 於瓊脂上不產生子囊孢子。此菌株與NRRL 3196的另一不 同處在於相同條件下較NRRL 3 196產生更多的索達啉。 實例7 6 NCIMB 40675之牿擻 NCIMB 40675爲需氧性 '革蘭氏陽性、不能動的不规則 桿狀’在於28 °C種於加有2 %(重量/容積）酵母萃取物的胰 蛋白酶大豆瓊脂4 8小時時，產生檸檬黃色的、半透明的、 圓形的、完整的、凸起的、直徑〇.5_1毫米的菌落。此微生 物於達37C時生長良好，但於45°C時生長不於此菌株 不見有異染性顆粒，但爲過氧化氫酶陽性、氧化&amp;amp;檢性， 不能以發酵方式代謝葡萄糖。此菌株可利用下述碳源卜&amp;amp; _ D_葡萄糖，D_水果糖，p -羥苯基醋酸，D_甘露糖，甲基\ 丙酮酸酯，乳醯胺，D -海藻糖及蔗糖。此微生物只能利用 少許D-葡糖酸，丙酮酸，及水楊苷作爲主碳源。其菌落及 顯微鏡形態與棒狀桿菌相似^與棒狀桿菌屬之不同處在於 NCIMB 40675的肽聚糖含鳥胺酸而非2,6·二胺基庚二酸或 -216- 本紙張尺度適用中國國家標準（CNS ) A4^格（2I0X297公釐） (請先閲讀背面之注意事項再填寫本頁) 、-β 321644 A7 B7 五、發明説明（214) 一胺基丁酸的内消旋異構物。而且，此微生物含支鏠脂肪· 酸複合混合物也不同於棒狀桿菌所含的，即12 -甲基十四酸 ，14 -甲基十六酸及14 -曱基十五酸。也未測出有α -分支 的-Α -羥基化的脂肪酸。以此等結果爲根據，ncimb 40675最接近下述放線桿菌屬的—種：金黃桿菌， Curtobacterium或纖維單孢菌屬。 澄清NCIMB 40675的分類學上的位置時，以16S rRNA基 因的1100鹼對部分排序與代表放線桿菌及有關菌屬的24種 其他菌種相比較。此分析結果顯示，NCIMB 40675的與金 黃桿菌及Curtobacterium屬間的關係較密，而與纖維單孢菌 屬及棒狀桿菌屬較遠。更精確的此菌株的證實，除了更多 的化學分類學及生理學試驗外，可藉系統發育分析比較多 種金黃桿菌及Curtobacterium各區的rRNA基因完成。 調劑學實例 1 · 傳統口服錠劑 藥物成分 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局貝工消費合作社印製 微結晶纖維素 Crosscarmellose sodium 硬脂酸鎂 將藥物成分與微結晶纖維素. 脂酸鎂摻合，然後打成錠。 100¾'卑 160毫克'、 20毫克 ' 5毫克 \ crosscarmellose sodium^^ -217- 本紙張尺度逋用中國國家揉準（CNS ) A4规格（2丨0X297公釐） 經濟部中央標率局貝工消费合作社印裝 ^1644</span>Printed by the Beigong Consumer Cooperative of the Central Standardization Bureau of the Ministry of Economic Affairs A7 B7 V. Description of Invention (213) Compared with NRRL 3196, it produced more 4’-demethyl sodarin for the production of sodaline under the same conditions. Example 7 5 Features of IMI 362947 IMI 362947 is a variant of D. arachnidus (ATCC 36386, NRRL 3 196), the ascospores of this strain are N-methyl-N, -nitro-N-nitrosoguanidine mutagenized It is separated afterwards. The characteristics of IMI 362947 are basically similar to those described in British Patent No. 1,162,027 for NRRL3196, except that IMI 362947 does not produce ascospores on agar. This strain differs from NRRL 3196 in that it produces more sodaline than NRRL 3 196 under the same conditions. Example 7 6 NCIMB 40675 銿 擞 NCIMB 40675 is aerobic 'Gram-positive, immobile irregular rods' in 28 ° C in 2% (weight / volume) yeast trypsin soybean At 48 hours of agar, lemon yellow, translucent, round, complete, raised, 0.5 mm in diameter colonies were produced. This microorganism grows well up to 37C, but it does not grow better than this strain at 45 ° C. There are no metachromatic particles, but it is catalase-positive, oxidative, and cannot metabolize glucose by fermentation. This strain can use the following carbon sources: _D_glucose, D_fruit sugar, p-hydroxyphenylacetic acid, D_mannose, methyl \ pyruvate, lactamide, D-trehalose and sucrose . This microorganism can only use a little D-gluconate, pyruvate, and salicin as the main carbon source. The colony and microscope morphology are similar to Corynebacterium ^ The difference with Corynebacterium is that the peptidoglycan of NCIMB 40675 contains ornithine instead of 2,6 · diaminopimelic acid or -216- This paper size is applicable Chinese National Standard (CNS) A4 ^ grid (2I0X297mm) (Please read the precautions on the back before filling in this page), -β 321644 A7 B7 V. Description of the invention (214) The racemic difference of monoaminobutyric acid Structure. Moreover, this microbial-containing complex mixture of fat and acid is also different from that contained in coryneform bacteria, namely 12-methyltetradecanoic acid, 14-methylhexadecanoic acid and 14-methylpentadecanoic acid. No alpha-branched-A-hydroxylated fatty acids were also detected. Based on these results, ncimb 40675 is closest to the following species of Actinomyces: Aureobacillus, Curtobacterium, or Cellulomonas. To clarify the taxonomic position of NCIMB 40675, the 1100 base pair portion of the 16S rRNA gene is compared with 24 other species representing Actinobacteria and related genera. The results of this analysis show that NCIMB 40675 is more closely related to the genus Staphylococcus aureus and Curtobacterium, but farther away from the genus Cellulomonas and the genus Corynebacterium. For more accurate confirmation of this strain, in addition to more chemical taxonomy and physiology tests, phylogenetic analysis can be performed to compare the rRNA genes of various regions of Chrysanthemum aureus and Curtobacterium. Example of traditional medicine 1 · Traditional oral lozenge medicinal ingredients (please read the precautions on the back before filling in this page) The Ministry of Economic Affairs Central Standards Bureau Beigong Consumer Cooperatives printed microcrystalline cellulose Crosscarmellose sodium magnesium stearate. Crystalline cellulose. Magnesium fatty acid is blended and then pelletized. 100¾'160mg ', 20mg' 5mg \ crosscarmellose sodium ^^ -217- This paper is based on the Chinese National Standard (CNS) A4 specification (2 丨 0X297mm) Beicong consumption of the Central Standard Rating Bureau of the Ministry of Economic Affairs Cooperative printing ^ 1644</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">五、發明説明（215) 2 · 可嚼的口服錠 藥物成分 100毫克 木糖醇 865毫克 歐薄荷矯味劑 5毫克 天冬醯苯丙胺酸甲酯 10毫克 聚乙缔ρ比略嗣 15毫克 硬脂酸鎂 at 將藥物成分’木糖醇，天冬醯苯丙胺酸甲酯及聚乙烯吡咯 闕掺合到一起，用水製成顆粒，然後乾燥。以此顆粒與歐 薄荷矯味劑及硬脂酸鎂混合，然後打成錠。 口服水溶液   藥物成分 100毫克  羥丙甲基纖維素 150毫克  丙羥基苯甲酸鈉 1毫克  甲羥基苯曱酸鈉 2毫克  禮·橋味劑 10毫克  糖精鈉 5毫克  蔗糖 800毫克  合適緩衝劑 適量  純化水加至 5毫升 將藥物成分及所有賦形劑溶於大部分純化水内，混合。製 成要求容積並混合。可加適宜的緩衝劑以控制pHS最大安 定性範圍内。 (請先閲讀背面之注意事項再填寫本頁)</span>V. Description of the invention (215) 2 · Chewable oral tablet medicinal ingredients 100 mg xylitol 865 mg peppermint flavoring agent 5 mg asparagine methyl ester 10 mg polyethylene bispyridine 15 mg stearic acid Magnesium at blends the pharmaceutical ingredients' xylitol, aspartame and polyvinylpyrrolidine together, granulates with water, and then dries. The granules are mixed with peppermint flavor and magnesium stearate and then beaten into tablets. Oral water solution medicinal ingredients 100 mg hydroxypropyl methylcellulose 150 mg sodium hydroxypropyl benzoate 1 mg sodium hydroxybenzoate 2 mg ritual and bridge flavor 10 mg sodium saccharin 5 mg sucrose 800 mg suitable buffer appropriate amount of purified water is added to Dissolve the pharmaceutical ingredients and all excipients in most purified water in 5 ml and mix. Make the required volume and mix. A suitable buffer can be added to control the pHS maximum stability. (Please read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">321644 A7 B7 五、發明説明（21θ) 非水性口服懸浮液 藥物成分 100毫克  鏗丙甲基纖維素 50毫克  葡萄矯味劑 25毫克  甘露糖醇 800毫克  膠性二氧化矽 10毫克  分餘的椰子油 5毫升 以高剪混合法將藥物成分及甘露糖醇分散於大部分椰子油 内。加剩餘成分並混合。也椰子油加至要求容積並混合。 5_ 膏 藥物成分 200毫克 白軟石蠟 9800毫克 將白软石堪熔化，加藥物成分並混合。繼續混合至凝結成 膏。 (請先閱讀背面之注^^項再填寫本頁) Μ 經濟部中央標準局員工消費合作社印製 6. 注射液 藥物成分 4 0毫克 適宜緩衝劑 適量 適宜抗氧化劑 適量 適宜螯合劑 適量 注射用水加至 0京 將藥物成分溶於大部分注射用水内。可使加適宜的緩衝劑 以控制pH於適宜安定性範圍内。可加適宜的抗氧化劑及螯 -219- 本紙張尺度適用中國國家標準（CNS ) Λ4規格( 210X297公釐了</span>321644 A7 B7 V. Description of the invention (21θ) Non-aqueous oral suspension medicinal ingredients 100 mg propyl methyl cellulose 50 mg grape flavoring agent 25 mg mannitol 800 mg colloidal silica 10 mg surplus coconut oil 5 Milliliters disperse the drug ingredients and mannitol in most coconut oil by high shear mixing method. Add remaining ingredients and mix. Also add coconut oil to the required volume and mix. 5_ ointment medicinal ingredients 200 mg white soft paraffin 9800 mg melted white soft stone, add medicinal ingredients and mix. Continue mixing until it forms a paste. (Please read the note ^^ on the back and then fill out this page) Μ Printed by the Employee Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 6. Injectable medicinal ingredients 40 mg suitable buffer appropriate amount suitable antioxidant appropriate amount suitable chelating agent appropriate amount water for injection plus To 0 Beijing will dissolve the drug ingredients in most of the water for injection. An appropriate buffer can be added to control the pH within the appropriate stability range. Appropriate antioxidants and chelate can be added -219- This paper scale is applicable to China National Standard (CNS) Λ4 specification (210X297mm</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">V 經濟部中央梯準局員工消費合作社印製 321644 A? B7 五、發明説明（217) 合劑以增加注射液的安定性。以注射用水加至要求量。裝 入安瓿或小瓶内，然後高壓滅菌。或者過濾滅菌並在無菌 條件下裝入安叛或小瓶内。 -220- 本紙張尺度適用中國國家標準（CNS ) A4規格（210X 297公釐） (請先閱讀背面之注意事項再填寫本頁)</span>V Printed by the Staff Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economy 321644 A? B7 V. Description of the invention (217) Mixture to increase the stability of the injection. Add to the required amount with water for injection. Fill into ampoules or vials and autoclave. Alternatively, filter sterilize and put it in an antelope or vial under aseptic conditions. -220- This paper scale is applicable to China National Standard (CNS) A4 specification (210X 297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">321644</span>321644</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Sord. NT</span>Sord. NT</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Attondsnsn 新型隱球酵母2867E 團念珠菌2376E 1團念珠菌2375E I假熱帶念珠菌2371Ε 1熱帶念珠菌2808Ε 1白色念珠菌4711 · 白色念珠菌2402E 白色念珠菌2005Ε 白色念珠菌1208E 微生物  &amp;gt;125 3T.OO ' 31.00 0.060 1.000 0,250 j 0.500 ’0,120 0.500   8.00 3LOO 31.00 0.004  0.004 0.008 0,001 0.008 03  0.500 8.00 8.00 0.008 0.120 0.015 0.015 0.008 0.015   31.00 16.00 8.00 1 0.060 16.00 | 0.030 0.060 0.015 0.030   1.00 B.00 β.αο &amp;lt;0.001 0.008 0.001 0.001 0,001 0.001   0.250 0.500 0.500 0.004 1  | 0.008 ' 1 1_ I &amp;lt;0.001 &amp;lt;0.001 &amp;lt;0.001 &amp;lt;0.001 〇  '&amp;lt;0.250 I j 1.000 I 1.000 &amp;lt;0-001 0,150  0Ό0Ί 0.001 0,001 U)  &amp;lt;0.250 1 6.00 4.00 0.060 0.500 0.030 0.060 | 0.001 j 0.060   2_001 4.00 | 4,00 &amp;lt;0.001 0.500 0.001 j 0.001 ' I | 0.001 0.001   &amp;gt;125 16.00 1G.00 I 0.008 0.500 1_ I 0.120 0.120 0.030 0.120 Οτ  1.00 B.00 8.00 0.001 0.030 I 丨―_J | 0.004 0.008 0.001 0.004 Cn ro  2,00 8.00 3.00 &amp;lt;0.01 &amp;lt;ο.οοι| &amp;lt;0.001 ^ΟΌΟΙ 切.001 &amp;lt;0.001 ςη 办  Mol 〇 16.0 Τ6.0 0.015 0.015 0.002 0.008 级001 0.015   g 31.00 1 31.00 I 0.015 0.250 0.030 0.002 0.050 0.060 CD 03  &amp;gt;125 &amp;gt;125 丨 &amp;gt;125 σι cn   CP ω Sord. 被84112259絮4洼奇球_+^絮^鲜^_(85 书 125g/ml畸令j鞒絮</span>Attondsnsn Cryptococcus neoformans 2867E Candida group 2376E 1 Candida group 2375E I Candida pseudotropicalis 2371E 1 Candida tropicalis 2808E 1 Candida albicans 4711 Candida albicans 2402E Candida albicans 2005E Candida albicans 1208E microorganisms&gt; 125 3T. OO '31.00 0.060 1.000 0,250 j 0.500' 0,120 0.500 8.00 3LOO 31.00 0.004 0.004 0.008 0,001 0.008 03 0.500 8.00 8.00 0.008 0.120 0.015 0.015 0.008 0.015 31.00 16.00 8.00 1 0.060 16.00 | 0.030 0.060 0.015 0.030 1.00 B.00 β.αο &amp;lt; 0.001 0.008 0.001 0.001 0,001 0.001 0.250 0.500 0.500 0.004 1 | 0.008 '1 1_ I &amp;lt; 0.001 &amp;lt; 0.001 &amp;lt; 0.001 &amp;lt; 0.001 〇' &amp;lt; 0.250 I j 1.000 I 1.000 &amp;lt; 0-001 0,150 0Ό0Ί 0.001 0,001 U) &amp;lt; 0.250 1 6.00 4.00 0.060 0.500 0.030 0.060 | 0.001 j 0.060 2_001 4.00 | 4,00 &amp;lt; 0.001 0.500 0.001 j 0.001 'I | 0.001 0.001 &amp;gt; 125 16.00 1G.00 I 0.008 0.500 1_ I 0.120 0.120 0.030 0.120 Οτ 1.00 B .00 8.00 0.001 0.030 I 丨 _J | 0.004 0.008 0.001 0.004 Cn ro 2,00 8.00 3.00 &amp;lt; 0.01 &amp;lt; ο.οοι | &amp;lt; 0.001 ^ ΟΌΟΙ .001 &amp;lt; 0.001 ςη Mol 〇16.0 Τ6.0 0.015 0.015 0.002 0.008 level 001 0.015 g 31.00 1 31.00 I 0.015 0.250 0.030 0.002 0.050 0.060 CD 03 &amp;gt; 125 &amp;gt; 125 丨 &amp;gt; 125 σι cn CP ω Sord. 84112259 4 wa odd ball _ + ^ 束 ^ fresh ^ _ (85 book 125g / ml malformation j 鞒 沒</span>
  </p>
</description>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(1)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result">translated from Chinese</div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><claims mxw-id="PCLM107007585" lang="EN" load-source="google" class="style-scope patent-text">
  <claim num="1" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">經濟部中央標準局員工消f合作社印製  3綱驟  號專利申請案 利範圍修正本(86年7月）  A8 B8 C8 D8  申請專利祀圍  1. 一種下式（I)化合物</span>Printed by the Central Bureau of Standards of the Ministry of Economic Affairs, printed by the Cooperative Society of the 3rd Class Patent No. Patent Application Scope of Amendment (July 86) A8 B8 C8 D8 Patent Application Siege 1. A compound of formula (I)</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(I)  其中Z是選自下式的四氫哌喃基  RZ ft</span>(I) wherein Z is a tetrahydropiperanyl group selected from the formula RZ ft</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">w  R .〇&amp;lt; Ί7(b).  及其醫藥上可接受的鹽及溶劑化物（如水合物），其中R1代表氫，画素，羥基，Ci_4烷氧基或醯氧基；R2及R3可各獨立代表氫，Cu烷基或Cb4烷氧基C丨_4  L:\EXTA41\41881.DOC  本紙張尺度適用中國國家標準（CNS ) A4規格（21〇X：297公釐）  (請先閲讀背面之注意事項再填寫本頁)  *1T  S31644 六、申請專利範圍  8 88S ABCD  經濟部中央橾準局員工消費合作社印製  境基，或R2及R3共同與其相聯的碳原子代表C = 〇，c = s 或C3.8環烷基； R代表虱或CH^R7(此處R7是氳，幾基，c]_4燒氧基咬 0C0R8基團，其中^是^一烷基，或苯基或5_或6_元 異芳環（其含有一或多個選自氮、氧或硫之異原子），其 各爲未經取代，或爲一或多個選自鹵素，羥基，Γ 1 - 6現 基，Ci_6烷氧基或c^4烷氧羰基之原子或基團取代）； R5及R6可各獨立代表氫； η代表零或1 ; X及Υ可各獨立代表氧或CR9R10(此處R9及Rl〇可獨立代 表氫’ Cb6烷基’ Cb4烷氧基或Ci-4烷氧基¢^-4烷基， 或R9及R10共同與其相聯的碳原子代表C = 〇，c = S，c3 8環烷基或C^CHR11，此處Rii代表氫或^彳烷基）；或 在X或Y爲乳且η爲零時，-Y_cr2r3或_x_cr2r3可分 別代表-N = CR3 -或- NR12-CR2R3-(此處 CR2 及 R3 是 C = 0，而R12是Ci_4烷基’ COR13醯基，此處R13是c 1 - 6烷基）或在Y是氧且η是零時，X可代表CH基，此基係以 雙鍵聯於喊喃環上； R15代表氫，鹵素，疊氮基，羥基，Cl_6烷氧基（視需要 由1或2個羥基或其縮酮或1或2個烷氧基取代）， C3_6烯氧基，OCOR18基團（此處r18是芳基ci4烷氧 基，烷基或含一或二個雙键之Cb1()烷基）或Ci_6 烷氧羰基C1-4烷氧基，而R!6代表氫或RI5及r16共同與 其相聯的碳原子代表C = 0或C = CH2 ;  L:\EXTA41\41881.DOC  本紙張尺度適用中國國家搮準（CNS ) A4规格（21〇χ297公兼）  (請先聞讀背面之注意事項再填寫本頁)  -、11  申請專利範圍  A8 B8 C8 D8  R]7代表CH2R19，此處r19是氫 w代表氧或硫原子； 又基團（a)之虚線表示有時有另外的鍵存在。 .根據申請專利範圍第1 的基圏  ;而  項之式（I)化合物’其中Z是如  下</span>w R .〇 &amp;lt; Ί7 (b). And its pharmaceutically acceptable salts and solvates (such as hydrates), where R1 represents hydrogen, pixel, hydroxyl, Ci_4 alkoxy or acetyloxy; R2 and R3 may Each independent representative hydrogen, Cu alkyl or Cb4 alkoxy C 丨 _4 L: \ EXTA41 \ 41881.DOC This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (21〇X: 297 mm) (please read first (Notes on the back and then fill out this page) * 1T S31644 VI. Patent application range 8 88S ABCD The Ministry of Economic Affairs Central Consortium Bureau Consumer Cooperative printed the environmental base, or R2 and R3 together with the associated carbon atom representative C = 〇, c = s or C3.8 cycloalkyl; R stands for lice or CH ^ R7 (where R7 is 氲, several groups, c] _4 alkoxy group bite 0C0R8 group, where ^ is ^ -alkyl, or phenyl Or a 5- or 6-membered heteroaromatic ring (which contains one or more heteroatoms selected from nitrogen, oxygen, or sulfur), each of which is unsubstituted, or one or more selected from halogen, hydroxyl, Γ 1 -6 present groups, atom or group substitution of Ci_6 alkoxy or c ^ 4 alkoxycarbonyl); R5 and R6 may independently represent hydrogen; η represents zero or 1; X and Υ may independently represent oxygen or CR9R10 ( Here R9 and Rl〇 can independently represent hydrogen 'Cb6 alkyl' Cb4 alkoxy or Ci-4 alkoxy ^ ^ -4 alkyl, or R9 and R10 together with the carbon atoms associated with it represents C = 〇, c = S , C3 8 cycloalkyl or C ^ CHR11, where Rii represents hydrogen or ^ 彳 alkyl); or when X or Y is milk and η is zero, -Y_cr2r3 or _x_cr2r3 may represent -N = CR3-or -NR12-CR2R3- (where CR2 and R3 are C = 0, and R12 is Ci_4 alkyl 'COR13 acetyl, where R13 is c 1-6 alkyl) or when Y is oxygen and η is zero, X May represent CH group, this group is connected to the ring with a double bond; R15 represents hydrogen, halogen, azido, hydroxy, Cl_6 alkoxy (if necessary from 1 or 2 hydroxyl or ketal or 1 or 2 alkoxy substitutions), C3_6 alkenoxy, OCOR18 group (where r18 is aryl ci4 alkoxy, alkyl or Cb1 () alkyl with one or two double bonds) or Ci_6 alkoxycarbonyl C1-4 alkoxy, and R! 6 represents hydrogen or RI5 and r16 together with the associated carbon atom represents C = 0 or C = CH2; L: \ EXTA41 \ 41881.DOC This paper size is applicable to Chinese national standards ( CNS) A4 specification (21〇297 and public) (Please read the notes on the back first (Fill in this page)-, 11 Patent scope A8 B8 C8 D8 R] 7 represents CH2R19, where r19 is hydrogen w represents oxygen or sulfur atom; and the dotted line of group (a) indicates that sometimes there are additional bonds. .According to the base of the first patent application; and the compound of formula (I) in the item, where Z is as follows</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">或 '〇  R</span>Or '〇 R</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">CH—-CH二 i  〇 FT  {請先W讀背面之注意事項再填寫本頁)  其中x或γ之—是氧，而另—個是氧或CR9Rl0基團。  3·根據申請專利範圍第！或2項之式（1)化合物，其中η  零。  4·根據申請專利範圍第丨或2之式（1)化合物，其中X及Υ都 是氧而R2及R3獨立代表氫或Ci“烷基。  5_根據申請專利範圍第！或2項之式（1)化合物，其中又及丫 之一是氧’而另一個是CR9r1〇基團。  6·根據申請專利範圍第5項之式（1)化合物，其中R9代表氫  或C】_4燒基而Rl〇代表氫或(：119111〇基團代表c〇基，或 C = CHRU。  7.根據申請專利範圍第1或2項之式（1)化合物，其中X是  氧。  8_根據申請專利範圍第i或2項之式化合物，其中R i是  .:\HXT\41\41881.DOC  、1Τ  衄濟部中央榡準局員工消費合作社印製  本紙張JULii财s u家料（CNS ) 210乂^7公复  321644  C8  _______ D8  六、申請專利範圍  氫或羥基而R4是甲基。  9·根據申請專利範圍第！項之式（1)化合物，其中</span>CH—CH 2 i 〇 FT (please read the precautions on the back before filling this page) where x or γ-is oxygen, and the other is oxygen or CR9Rl0 group. 3. According to the scope of the patent application! Or a compound of formula (1) in item 2, wherein η is zero. 4. According to the formula (1) compound of the first or second patent application scope, wherein X and Υ are both oxygen and R2 and R3 independently represent hydrogen or Ci "alkyl. 5_ According to the formula of the patent application scope item 1 or 2 (1) Compounds in which one of them is oxygen and the other is a CR9r10 group. 6. A compound of formula (1) according to item 5 of the patent application scope, in which R9 represents hydrogen or C] _4 burning group and Rl〇 stands for hydrogen or (: 119111〇 group stands for c〇 group, or C = CHRU. 7. The compound of formula (1) according to item 1 or 2 of the patent application scope, where X is oxygen. 8_ According to the patent application scope The compound of formula i or item 2, wherein R i is.: \ HXT \ 41 \ 41881.DOC, 1Τ Printed paper of Juli Choi Susu Household Materials (CNS) 210 ~ ^ 7 Public reply 321644 C8 _______ D8 6. The scope of patent application is hydrogen or hydroxy and R4 is methyl. 9. According to the compound of formula (1) in item 1 of the scope of patent application, where</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">其中W是氧。  10·根據申請專利範圍第2項之式（〗）化合物，其係[丨R_ ( i  ^,3a^ ,4^ ,4a/? ,7^ ,7a^s8a/?)]8a-[[lS, 7R,9R]-2,8-  二氧-9 -曱基-4 -亞曱基-順-雙環[3.4.0]_壬_7_基-氧基-甲基]-4-甲醯基-4,4&amp;amp;，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫-7-甲基-3-(1-甲基乙基）-1，4 -亞甲基-S-吲噠省- 3a-(lH) -羧酸；及 其醫藥上可接受的鹽。  根據申請專利範圍第1項之式（〗）化合物，其係選自[丨R_  (1 «，3a/?，4 ，4ay5，7 /?，7a or，8a々）]8a-[(2,6 -二去氧-  經濟部中央標準局員工消費合作社印製  3,4-0 -異亞丙基卢-D_別卓哌喃糖基氧基）曱基]_4_甲 酿基-4,4a，5，6,7,7a，8,8a -八氫-7-甲基- 3_(1-甲基乙 基）-1,4-亞甲基-s-吲噠省_3a(iH)_羧酸；  [1R-(1 a，3a点，4 点，4a/?，7々，7a a，8a点）]8a-[[l S,4R， 7汉，911]-2,8-二氧-4,9-二曱基-順-雙環[3.4.0]-壬-7-基-氧基-甲基]-4 -曱醯基-4,4a,5，6,7,7a，8,8a-八氫-7-  甲基-3-(1-甲基乙基）4,4-亞甲基-s-p引噠省_3a(lH)-羧 酸；  L:\EXTVUVn881.DOC _ 4 -  本紙張从適用中國國家標準（CNS ) M綱^ (加χ π?公釐）  ^21644  A8 B8 C8 D8  申請專利範圍  6R?Rl(-2a73.a^4/?，4a^，7^，7aflr，8a/5)38a'[[1S54S5 其匕 ，—氧·4,6-二甲基-順-雙環[3.4.0]-壬-8--乳-甲基]-4-甲酿基.4,4a，5,6,7,7a，8,8a_M_7_  酸.-_(1'甲基乙基卜1，4-亞甲基-s“㈣省-3a(lH)-叛  [1R (1 ar,3a/?54/?54a^,7^,7aa，58a/?)]8a_[(253  氧4 〇 -丙基_^_D_哌喃甘露糖基氧基）甲基]_4_ 甲酿基4,4&amp;amp;，5,6,7,7&amp;amp;，8,8&amp;amp;-八氫^_曱基-3_(1.甲基乙 基）]，仁亞甲基十旁連省_3a(iH)邊酸；  a，3a乃，4万，4a々，7々，7&amp;amp;“，8&amp;amp;万）]8&amp;amp;_[(2 3_脱水 6去氧-4_〇_曱基-冷-D -哌喃甘露糖基氧基）曱基]-4-  甲醯基-4,4a，5,6,7,7a，8,8a-八氫-7-曱基-3-(1-甲基乙  基）·1，4-亞甲基_s叫丨噠省_3&amp;amp;(1Η)_羧酸；  及其醫藥上可接受的鹽。  12'種製備根據申請專利範圍第1項之式（I)化合物之方 法，其包括  Ο)使式（II)化合物  (請先閲讀背面之注意事項再填寫本頁)  人  訂  ί  經濟部中央梂準局員工消費合作社印製  XH</span>Where W is oxygen. 10. The compound of formula (〗) according to item 2 of the patent application scope, which is [丨 R_ (i ^, 3a ^, 4 ^, 4a /?, 7 ^, 7a ^ s8a /?)] 8a-[[lS , 7R, 9R] -2,8-dioxo-9-methyl-4-methylidene-cis-bicyclo [3.4.0] _non_7_yl-oxy-methyl] -4-carboxamide -4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-S- Indah-3a- (lH) -carboxylic acid; and its pharmaceutically acceptable salts. According to the formula (〗) compound of the first item of the patent application scope, it is selected from [丨 R_ (1 «, 3a / ?, 4, 4ay5, 7 / ?, 7a or, 8a々)] 8a-[(2, 6 -Dideoxy-printed by 3,4-0 -isopropylidene-D_bezopiperanosyloxy) methyl] _4_methanyl-4, 4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3_ (1-methylethyl) -1,4-methylene-s-indap province_3a (iH) _Carboxylic acid; [1R- (1 a, 3a point, 4 point, 4a / ?, 7々, 7a a, 8a point)] 8a-[[l S, 4R, 7 Han, 911] -2,8- Dioxo-4,9-dimethyl-cis-bicyclo [3.4.0] -non-7-yl-oxy-methyl] -4-methyl-4,4a, 5,6,7,7a , 8,8a-octahydro-7-methyl-3- (1-methylethyl) 4,4-methylene-sp lead-free_3a (lH) -carboxylic acid; L: \ EXTVUVn881.DOC _ 4-This paper is from China National Standard (CNS) M class ^ (plus χ π? Mm) ^ 21644 A8 B8 C8 D8 Patent scope 6R? Rl (-2a73.a ^ 4 / ?, 4a ^, 7 ^, 7aflr, 8a / 5) 38a '[[1S54S5 its dagger, -oxy · 4,6-dimethyl-cis-bicyclo [3.4.0] -non-8--lactyl-methyl] -4-methyl Brewer. 4,4a, 5,6,7,7a, 8,8a_M_7_ acid .-_ (1'Methylethyl 1,4-methylene -s "㈣ 省 -3a (lH)-defect [1R (1 ar, 3a /? 54 /? 54a ^, 7 ^, 7aa, 58a /?)] 8a _ [(253 oxy4 〇-propyl _ ^ _ D _Piperanmannosyloxy) methyl] _4_carbofuran 4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro ^ _methyl-3_ (1.methylethyl )], Renmethylene decapentan province _3a (iH) citric acid; a, 3a is, 40,000, 4a々, 7々, 7 &amp;amp; “, 8 &amp;amp; million)] 8 &amp;amp; _ [(2 3_ Dehydrated 6-deoxy-4_〇_methyl-cold-D-piperanmannosyloxy) methyl] -4-methylacetate-4,4a, 5,6,7,7a, 8,8a- Octahydro-7-methyl-3- (1-methylethyl) · 1,4-methylene_s called 丨 Da province_3 &amp; (1Η) _carboxylic acid; and its pharmaceutically acceptable salts . 12 'methods for preparing the compound of formula (I) according to item 1 of the patent application, which includes Ο) compound of formula (II) (please read the precautions on the back before filling in this page) XH printed by the quasi-bureau employee consumer cooperative</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">YH (II)  L:\EXT\41\41881.DOC  本紙張尺度適用中國國家梂率（CNS ) A*規格（2丨〇 χ 297公簸）  A8 B8 C8 D8  申請專利範圍  (其中R1及R4如上文式（I)中之定義，Rp是羧基保護基， 而X及Y如上文式（I)中之定義，只是X及/或γ不能代表  C R9 R1 〇)反應形成所需的環系統，然後再除去羧基保護  基；  (b)製備Z是（a)基團、γ是氧、η是零、R2&amp;amp;R3是氫、而 X是CH的式（I)化合物時，使式（VII)化合物  (請先閲讀背面之注意事項再填寫本頁)</span>YH (II) L: \ EXT \ 41 \ 41881.DOC This paper scale is applicable to China ’s national frame rate (CNS) A * specifications (2 丨 〇χ 297 hectares) A8 B8 C8 D8 Patent application scope (where R1 and R4 are as above As defined in formula (I), Rp is a carboxyl protecting group, and X and Y are as defined in formula (I) above, except that X and / or γ cannot represent CR 9 R1)) The reaction forms the desired ring system, Then remove the carboxyl protecting group; (b) When preparing the compound of formula (I) where Z is (a) group, γ is oxygen, η is zero, R2 &amp;amp; R3 is hydrogen, and X is CH, use formula (VII) Compound (please read the notes on the back before filling this page)</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(VII)  訂  經濟部中央榡準局員工消費合作社印製  其中R21是CHO基團或其經保護的衍生物，Rp*經保護 的羧基，與二烷基二偶氮甲基膦酸酯反應；  (c)製備Z是（b)基團而W是氧的式（I)化合物時，是環化 式（VIII)化合物  L:\EXT\41\41881.DOC  本紙張用 t 關家；^ ( CNS ) A视(  申請專利範圍</span>(VII) Printed by the Employee Consumer Cooperative of the Central Bureau of Preservation of the Ministry of Economy where R21 is the CHO group or its protected derivative, Rp * protected carboxyl group, and reacts with dialkylbisazomethylphosphonate (c) When the compound of formula (I) where Z is (b) group and W is oxygen, it is the cyclized compound of formula (VIII) L: \ EXT \ 41 \ 41881.DOC This paper uses t Guanjia; ^ ( CNS) A video (Scope of patent application</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">R 15« •R J7a 16a (VIII) (其中 R15a，R16a&amp;amp;Rl7a如上文式（I)tRl5，r16及r17  疋定義’或其經保護的衍生物，Rp是氫或羧基保護基， L是適里的離去基如烷基-或芳基磺醯氧基，而r2 2是氮 或〇 R疋如乙定義之基團），必要時再除去任何存在之保 護基： (d)製備W是硫的式（I)化合物時，是將式（Ιχ)化合物  (請先閲讀背面之注意事項再填寫本頁)  經濟部中央標率局員工消費合作社印製</span>R 15 «• R J7a 16a (VIII) (wherein R15a, R16a &amp;amp; Rl7a are as defined in formula (I) tRl5, r16 and r17 above) or their protected derivatives, Rp is hydrogen or carboxyl protecting group, L is suitable In the leaving group such as alkyl- or arylsulfonyloxy, and r2 2 is nitrogen or 〇R group as defined in B), if necessary, remove any existing protecting groups: (d) Preparation W is For the sulfur compound of formula (I), it is the compound of formula (Ιχ) (please read the precautions on the back before filling out this page). Printed by the Employee Consumer Cooperative of the Central Standardization Bureau</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">,15 R16 ,17 (IX)  r:R15，R16H17如上文式⑴中之定義)用 必要或期望時再作一或多種如下步驟處理： (i)除去任何保護基；  硫供體處  本紙張尺度逍用中國國家榡準（CNS )八4規格（21〇&amp;gt;&amp;lt;297公釐  321644 as  Βδ  C8  __ D8  六、申請專利範圍  (ii) 將一種式（I)化合物或其經保護的衍生物轉化成另— 種式（I)化合物；  (iii) 分離式（I)化合物，呈其醫藥上可接受的鹽形式。  13_ —種治療抗眞菌感染之醫藥組合物，其含有根據申請專  利範圍第1或2項之式（I)化合物，並與—或多種生理β上可 接受的載劑或賦形劑混合。  (請先聞讀背面之注意事項再填寫本頁)  經濟部中央標隼局員工消费合作社印裝  8  一涞 -紙 本  Μ \—/ S Ν C /IV _一準 榡 I家 -國 -囷 I中 用 一逋  一釐 公 7 9 2</span>, 15 R16, 17 (IX) r: R15, R16H17 as defined in the above formula (1), if necessary or desired, do one or more of the following steps: (i) remove any protecting groups; sulfur donor at the paper size Use the Chinese National Standard (CNS) VIII 4 specifications (21〇 &amp;gt; &amp;lt; 297mm 321644 as Βδ C8 __ D8 VI. Scope of patent application (ii) A compound of formula (I) or its protected derivatives Conversion into another compound of formula (I); (iii) Isolation of compound of formula (I) in the form of its pharmaceutically acceptable salt. 13_ — A pharmaceutical composition for the treatment of anti-mycobacterial infections, which contains The compound of formula (I) according to item 1 or 2 and mixed with one or more physiologically acceptable carriers or excipients. (Please read the precautions on the back before filling out this page) Central Standard Falcon, Ministry of Economic Affairs Bureau Staff Consumer Cooperative Printed 8 Yi Lai-Paper Μ \ — / S Ν C / IV _ 一准 榡 I 家-国-囷 I 用 一 逋 個 公 7 7 2</span>
    </claim-text>
  </claim>
</claims>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (4)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CH465771A/en"><a id="link" href="#" class="style-scope state-modifier">CH465771A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1965-12-06</span>
                    <span class="td style-scope patent-result">1968-11-30</span>
                    <span class="td style-scope patent-result">Sandoz Ag</span>
                    <span class="td style-scope patent-result">
  Process for the manufacture of a new antibiotic
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH0615555B2/en"><a id="link" href="#" class="style-scope state-modifier">JPH0615555B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1985-08-14</span>
                    <span class="td style-scope patent-result">1994-03-02</span>
                    <span class="td style-scope patent-result">三共株式会社</span>
                    <span class="td style-scope patent-result">
  Antibiotic Zofimarin
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP3189443B2/en"><a id="link" href="#" class="style-scope state-modifier">JP3189443B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-11-20</span>
                    <span class="td style-scope patent-result">2001-07-16</span>
                    <span class="td style-scope patent-result">萬有製薬株式会社</span>
                    <span class="td style-scope patent-result">
  Antifungal substance BE-31405
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EA002469B1/en"><a id="link" href="#" class="style-scope state-modifier">EA002469B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-09-12</span>
                    <span class="td style-scope patent-result">2002-06-27</span>
                    <span class="td style-scope patent-result">Мерк Энд Ко., Инк.</span>
                    <span class="td style-scope patent-result">Method for treating fungal infections 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (25)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0901493A1/en"><a id="link" href="#" class="style-scope state-modifier">EP0901493A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-05-08</span>
                    <span class="td style-scope patent-result">1999-03-17</span>
                    <span class="td style-scope patent-result">Glaxo Wellcome S.A.</span>
                    <span class="td style-scope patent-result">Process for the preparation of an indacene compound 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6436395B1/en"><a id="link" href="#" class="style-scope state-modifier">US6436395B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-09-18</span>
                    <span class="td style-scope patent-result">2002-08-20</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">Rosellinia subiculata ATCC 74386 and fungus ATCC 74387 for producing sordarin compounds for fungi control 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6040463A/en"><a id="link" href="#" class="style-scope state-modifier">US6040463A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-10-07</span>
                    <span class="td style-scope patent-result">2000-03-21</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">Sordarin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6096511A/en"><a id="link" href="#" class="style-scope state-modifier">US6096511A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-06-10</span>
                    <span class="td style-scope patent-result">2000-08-01</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">Protein elongation factor 2 as a target for antifungal and antiparasitic agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5965612A/en"><a id="link" href="#" class="style-scope state-modifier">US5965612A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-08-22</span>
                    <span class="td style-scope patent-result">1999-10-12</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">4-cyano-4-deformylsordaricin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5972996A/en"><a id="link" href="#" class="style-scope state-modifier">US5972996A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-08-22</span>
                    <span class="td style-scope patent-result">1999-10-26</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">4-cyano-4-deformylsordarin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2300407C/en"><a id="link" href="#" class="style-scope state-modifier">CA2300407C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-08-22</span>
                    <span class="td style-scope patent-result">2010-01-26</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">4-cyano-4-deformylsordarin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6136853A/en"><a id="link" href="#" class="style-scope state-modifier">US6136853A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-10-03</span>
                    <span class="td style-scope patent-result">2000-10-24</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">Sordarin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/FI974385A0/en"><a id="link" href="#" class="style-scope state-modifier">FI974385A0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-12-01</span>
                    <span class="td style-scope patent-result">1997-12-01</span>
                    <span class="td style-scope patent-result">Xyrofin Oy</span>
                    <span class="td style-scope patent-result">
  Preparation of xylitol For the purpose of pharmaceutical treatment and xylitol preparations For the manufacture of xylitol
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7070965B1/en"><a id="link" href="#" class="style-scope state-modifier">US7070965B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-04-14</span>
                    <span class="td style-scope patent-result">2006-07-04</span>
                    <span class="td style-scope patent-result">Zhenhua Yang</span>
                    <span class="td style-scope patent-result">Small molecule anticancer compounds and related production process 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MA26628A1/en"><a id="link" href="#" class="style-scope state-modifier">MA26628A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-05-11</span>
                    <span class="td style-scope patent-result">2004-12-20</span>
                    <span class="td style-scope patent-result">Glaxo Wellcome Sa</span>
                    <span class="td style-scope patent-result">
  MORPHOLINO ETHERS
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000024728A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2000024728A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-10-26</span>
                    <span class="td style-scope patent-result">2000-05-04</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">Microbial transformation product 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2003501488A/en"><a id="link" href="#" class="style-scope state-modifier">JP2003501488A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-06-11</span>
                    <span class="td style-scope patent-result">2003-01-14</span>
                    <span class="td style-scope patent-result">ネオルックス  コーポレイション</span>
                    <span class="td style-scope patent-result">
  High-dose radionuclide complexes for bone marrow suppression
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7094885B2/en"><a id="link" href="#" class="style-scope state-modifier">US7094885B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-07-11</span>
                    <span class="td style-scope patent-result">2006-08-22</span>
                    <span class="td style-scope patent-result">Neorx Corporation</span>
                    <span class="td style-scope patent-result">Skeletal-targeted radiation to treat bone-associated pathologies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6645960B1/en"><a id="link" href="#" class="style-scope state-modifier">US6645960B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-11-11</span>
                    <span class="td style-scope patent-result">2003-11-11</span>
                    <span class="td style-scope patent-result">Glaxo Wellcome S.A.</span>
                    <span class="td style-scope patent-result">Antifungal sordaricin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2001289063A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2001289063A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-15</span>
                    <span class="td style-scope patent-result">2002-03-26</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Company</span>
                    <span class="td style-scope patent-result">Novel thio derivatives of sordarin as antifungal agents 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002249935A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2002249935A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-01-08</span>
                    <span class="td style-scope patent-result">2002-08-19</span>
                    <span class="td style-scope patent-result">Neorx Corporation</span>
                    <span class="td style-scope patent-result">Radioactively labelled conjugates of phosphonates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003007878A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003007878A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-18</span>
                    <span class="td style-scope patent-result">2003-01-30</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">Antifungal agents of sordarin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7045116B2/en"><a id="link" href="#" class="style-scope state-modifier">US7045116B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-12-13</span>
                    <span class="td style-scope patent-result">2006-05-16</span>
                    <span class="td style-scope patent-result">Dow Global Technologies Inc.</span>
                    <span class="td style-scope patent-result">Treatment of osteomyelitis with radiopharmaceuticals 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002351340A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2002351340A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-12-14</span>
                    <span class="td style-scope patent-result">2003-06-30</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">A novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2006513235A/en"><a id="link" href="#" class="style-scope state-modifier">JP2006513235A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-12-31</span>
                    <span class="td style-scope patent-result">2006-04-20</span>
                    <span class="td style-scope patent-result">ネクター  セラピューティクス</span>
                    <span class="td style-scope patent-result">
  Aerosolizable pharmaceutical formulation for fungal infection therapy
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9314524B2/en"><a id="link" href="#" class="style-scope state-modifier">US9314524B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-12-31</span>
                    <span class="td style-scope patent-result">2016-04-19</span>
                    <span class="td style-scope patent-result">Calla Therapeutics Llc</span>
                    <span class="td style-scope patent-result">Topical formulations of Flucytosine 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8419948B2/en"><a id="link" href="#" class="style-scope state-modifier">US8419948B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-11-22</span>
                    <span class="td style-scope patent-result">2013-04-16</span>
                    <span class="td style-scope patent-result">United Laboratories International, Llc</span>
                    <span class="td style-scope patent-result">Wastewater treatment 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2012033427A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2012033427A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-09-08</span>
                    <span class="td style-scope patent-result">2012-03-15</span>
                    <span class="td style-scope patent-result">Dalin Mikhail Viktorovich</span>
                    <span class="td style-scope patent-result">Method for treating mycotic infections and drug for carrying out said method 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/RU2630403C2/en"><a id="link" href="#" class="style-scope state-modifier">RU2630403C2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-02-25</span>
                    <span class="td style-scope patent-result">2017-09-07</span>
                    <span class="td style-scope patent-result">Жанна Владимировна Вараткова</span>
                    <span class="td style-scope patent-result">Abrasive mass for manufacturing tool with high structure numbers 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party, ‡ Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/TW321644B/en"><a id="link" href="#" class="style-scope state-modifier">TW321644B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-12-01</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH06505472A/en"><a id="link" href="#" class="style-scope state-modifier">JPH06505472A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1994-06-23</span>
                    <span class="td style-scope patent-result">
  Bridged cyclic ketal derivatives
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6054478A/en"><a id="link" href="#" class="style-scope state-modifier">US6054478A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-04-25</span>
                    <span class="td style-scope patent-result">Antifungal sordaridin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/IE920056A1/en"><a id="link" href="#" class="style-scope state-modifier">IE920056A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-07-15</span>
                    <span class="td style-scope patent-result">Cyclic ketal derivatives 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1992016530A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1992016530A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-10-01</span>
                    <span class="td style-scope patent-result">Cyclic ketal derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1992012157A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1992012157A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-07-23</span>
                    <span class="td style-scope patent-result">Bridged cyclic ketal derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1296989B1/en"><a id="link" href="#" class="style-scope state-modifier">EP1296989B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-05-23</span>
                    <span class="td style-scope patent-result">Polycyclic xanthones as antibiotics 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2803670A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2803670A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-01-12</span>
                    <span class="td style-scope patent-result">Novel antibacterial compounds, methods of making them, and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3445741A1/en"><a id="link" href="#" class="style-scope state-modifier">EP3445741A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-02-27</span>
                    <span class="td style-scope patent-result">Antimicrobial agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0711784A1/en"><a id="link" href="#" class="style-scope state-modifier">EP0711784A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-05-15</span>
                    <span class="td style-scope patent-result">Antifungal Sordarin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU653446B2/en"><a id="link" href="#" class="style-scope state-modifier">AU653446B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1994-09-29</span>
                    <span class="td style-scope patent-result">Novel alkaloids and processes for their production 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2257422A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2257422A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-12-18</span>
                    <span class="td style-scope patent-result">Dibenzo-oxazepine and -dioxepine derivatives and their use as anti-tumor agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6255339B1/en"><a id="link" href="#" class="style-scope state-modifier">US6255339B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-03</span>
                    <span class="td style-scope patent-result">Tetrahydronaphthofuranone derivatives and process for producing the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20020037730A/en"><a id="link" href="#" class="style-scope state-modifier">KR20020037730A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-05-22</span>
                    <span class="td style-scope patent-result">New iodolocarbazole alkaloids from a marine actinomycete 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20220177484A1/en"><a id="link" href="#" class="style-scope state-modifier">US20220177484A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2022-06-09</span>
                    <span class="td style-scope patent-result">Macrocycles with antioxidant and neuroprotective activities 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH0959275A/en"><a id="link" href="#" class="style-scope state-modifier">JPH0959275A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-03-04</span>
                    <span class="td style-scope patent-result">New substance tryprostatin, its production, cell period inhibitor and antitumor agent 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH07504421A/en"><a id="link" href="#" class="style-scope state-modifier">JPH07504421A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-05-18</span>
                    <span class="td style-scope patent-result">
  Cyclic ketal derivative
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1993007151A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1993007151A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-04-15</span>
                    <span class="td style-scope patent-result">Cyclic ketal derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015145152A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015145152A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-10-01</span>
                    <span class="td style-scope patent-result">Antimicrobial agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2131010A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2131010A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-09-16</span>
                    <span class="td style-scope patent-result">Cyclic ketal derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH06206884A/en"><a id="link" href="#" class="style-scope state-modifier">JPH06206884A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1994-07-26</span>
                    <span class="td style-scope patent-result">Production of new compound thiomarinol b 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH09255680A/en"><a id="link" href="#" class="style-scope state-modifier">JPH09255680A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-09-30</span>
                    <span class="td style-scope patent-result">Spirotryprostatin, its production, cell cycle inhibitor and antitumor agent 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (2)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0712859A1/en"><a id="link" href="#" class="style-scope state-modifier">EP94500173A</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1994-11-08</span>
                    <span class="td style-scope patent-result">Antifungal Sordarin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0711784A1/en"><a id="link" href="#" class="style-scope state-modifier">EP94500175A</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1994-11-08</span>
                    <span class="td style-scope patent-result">Antifungal Sordarin derivatives 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.56922999" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.56922999" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=334204779" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>